Index to Volume 39 Authorindex

[CANCERRESEARCH39, 5187-5216,December1979]

Index to Volume 39

AuthorIndex

A Barlock, Green, Huff, Do, Aitken, and Warren, S.Detectionof BothT Cellandla-LikeAntigens 1973 on Cells from Patients with Acute Myelomono Akiba, N. See Sakiyama, Akiba, and Fujimura, cytic Leukemia and Chronic Myelo9enous Leu Abanobi, S. E., Farber, E., and Sarma, D. 5. R. 502 kemia in Blast Crisis, 4810 Persistence of DNA Damage during Develop Aklyama,S-I., Hidaka, K., Komlyama,S., and Anderson, R. F. See Stehlin, Giovanella, de lpolyi, ment of Uver Angiosarcoma in Rats Fed Dimeth Kuwano, M. Control of Permeation of Bleomy and Anderson, 2255'' ylnitrosamine,1592 cin-A2 by Polyene Antibiotics in Cultured Anderson, T. See Murinson, Anderson, Schwartz, Abdo, S. See Schwab,Kollinger,Haas,Ahuja, Chinese Hamster Cells, 5150 Myers, and Chabner, 2471 : Zwelling, Anderson, Abdo, Anders, and Anders, 519 Albert, R. E. See Pereira, Burns, and Albert, 2556 and Kohn, 365 Ab., T. See Matsuda, Osafune, Nakano, Kotake, Aldenderfer, P. H. See Ruddon, Anderson, Anderason, V. See Oskarsson, Andersson, and Sonoda,Watanabe,Hada,Okochi,Higashino, Meade,Aldenderfer,andNeuwald,3885 TjÃ¤lve,4175 Yamamura, and Abe, 4694 Alexander, L. See Plunkett, Alexander, Chubb, Andreesen, R. See Modolell, Andreesen, Pahlke, Ablin, R. J. See Bhatti, Ablin, Condoulis, and and Loo, 3655 Brugger, and Munder, 4681 Guinan, 3328 Alexander, R. w. See Richman and Alexander, Angler, R. B. See Wallace, Murdock, Angier, and Abraham,S. SeeHillyardandAbraham,4430 459 Durr, 1570 Abrams, H. L See Young, Hollenberg, Kazam, Alexander,S. S., Jr. SeeKollmorgen,Sansing, Aoki, N. See Nakayasu, Shoji, Aoki, Sato, Miwa, Berkowitz, Halnen, Sandor, and Abrams, 1898 Lehman, Fischer, Longley, Alexander, King, and and Sugimura, 4668 Abul-Hajj, V. J. Effect of Catechol Estrogens on McCay, 3458 Aoyagl, V., Ikenaka, T., and Ichlda, F. a-Fetopro RatMammaryTumors,4882 Allegra, J. C., Llppman, M. E., Thompson, E. B., teinas a CarrierProteinin PlasmaandIts Bill Acoft,K.SeeMalley,Burger,Vandenbark,Frikke, Simon, R., Barlock, A., Green, L, Huff, K. K., rubin-binding Ability, 3571 Flnke,Begley,Acott, Black,and Vetto,619' Do, H. M. T., and Aitken, S. C. Distribution, Apffel, C. A. See Pitha, Kociolek, and Apffel, 170 Adams, J. B., Pwnim, 1., Chandra, D. P., Archl Frequency, and Quantitative Analysis of Estro Apuzzo, M. L. J. See Sheikh, Apuzzo, and Weiss, bald,L, andFee,N. S. A Correlationbetween gen, Progesterone, Androgen, and Glucocorti 1733 Estrogen Sulfotransferase Levels and Estrogen coid Receptors in Human Breast Cancer, 1447 Arai, K., Spencer, J. S., Sohn, N., and Wallace, Receptor Status in Human Primary Breast Car Allegra, J. C., Llppman, M. E., Thompson, E. B., H. W. Effect of Hapten plus Antihapten-Tumor clnoma,5124 Simon, R., Barlock, A., Green, L, Huff, K. K., Serum Treatment on Established Rat Fibrosar Adwis, J. D. See Hoffmann, Adams, Brunne Do, H. M. T., Altken, S. C., and warren, R. coma, 6 mann,andHecht,2505 Relationship between the Progesterone, Andro Arai, K., and Wallace, H. W. Effect of Local Im Adams, P. w. see Mathes, Olsen, Hebebrand, gen, and Glucocorticoid Receptor and Re munotherapy of Syngeneic Rat Fibrosarcoma Hoover, Schaller, Adams, and Nichols, 950 sponse Rate to Endocrine Therapy in Metastatic with Hapten and Antihapten-Tumor Serum upon Adamson, D. J. See Bennett, Smithers, Rose, Breast Cancer, 1973 Nonlocally Treated Tumor, 3638 Adamson, and Thomas, 4868 Allen, C. S. See Hurley, Allen, Feola, and Lubawy, Arai, M. See Cohen, Aral, Jacobs, and Friedell, Adamsan, A. H. See Sieber, Correa, Dalgard, and 3134 1207 Adamson, 4545 Allen, J. A. See Coombs, Kissonerghis, Allen, and Archibald, E. L. See Silver, Karim, Archibald, and Adslstsin, E. H. See Berkelhammer, Caines, Dex Vose, 4160 Salinas, 5036 ter. Adelstein, Oxenhandler, and Hook, 4960 Allpass, P. R. See Costa, Nye, Sunderman, All ArchIbald, L. See Adams, Pewnim, Chandra, Ar Asbersold, P. M. Mutation Induction by 5-Fluoro pass, and Gondos, 3591 chibald, and Foo, 5124 deoxyuridlne in Synchronous Chinese Hamster Amaki, I. See Horikoshi, Sasaki, Mizo9uchi, Arendes, J. See MUller, Maidhof, Arendes, Geurt Cells, 808 Miura, Takaku, and Amaki, 1841 sen. Zahn, and Schmidseder, 3768 Agarwal, R. P. Recovery of 2'-Deoxycoformycin Ambrose, w. w. See Hanker, Ambrose, James, Arima, 1. See Niinobe, Tamura, Arima, and Fujii, inhIbited Adenosine Deaminaseof Mouse Eryth Mandelkorn, Yates, Gall, Bossen, Fay, Laszlo, 4212 rocytes and Leukemia Li 210 in Vivo, i 425, and Moore, 1635 Artaza, L. See Seraydarian and Artaza, 2940 Communication Ames, M. M. See Kovach, Ames, Powis, Moertel, Arthur, L 0. See Tagliabue, Herberman, Arthur, Agarwal, S. See Vaage and Agarwal, 1511 Hahn, and Creagan, 4540; Kovach, Ames, Ster and McCoy, 35 Aglietta, M. and Colly, L. Relevance of Recruit nad, and O'Connell, 823: Powis, Ames, and Asch, B. B., Medina, D., and Brinkley, B. R. ment-Synchronization in the Scheduling of 1-/@- Kovach, 3564 Microtubules and Actin-containing Filaments of D-Arablnofuranosylcytosinein a Slow-growing Ames, M. M., Powis, G., Kovach, J. S., and Normal, Preneoplastic, and Neoplastic Mouse Acute Myeloid Leukemia of the Rat, 2727 Eagan, R. T. Disposition and Metabolism of Mammary Epithelial Cells, 893 Ahmsd, A. See Malenka, Rogan, Howe, Nelson, Pentamethylmelamine and Hexamethylmela Ashley, M. P. See Zbar, Canti, Ashley, Rapp, Wrobel, Ahmed, and Humphreys, 4782 minein RabbitsandHumans,5016 Hunter, and Ribi, 1597 Ahmd, F. E., and Setlow, R. B. DNA Repair in Ames, R. S., Jr. See Ng, Ames,Mclntire,and Ashman, L K., Cook, M. 0., and Kotlareki, I. Xeroderma Pigmentosum Cells Treated with Herberman, 4887 Protective Effect of Oral Salmonella enteritidis Combinations of ultraviolet Radiation and N- Anders, A. See Schwab, Kollinger, Hass, Ahuja, 11Rx Infection against Colon Tumor Induction Acetoxy-2-acetylaminofluorene, 471 Abdo, Anders, and Anders, 519 by 1,2-Dimethylhydrazine in Mice, 2768 Ahmsd, N. K., and Welch, A. D. Some Properties Anders, F. See Schwab, Kollinger, Haas, Ahuja, Ashworth, L. K. See Carrano, MayaII,Testa, Ash of Uridine-Cytidine Kinase from a Human Malig Abdo, Anders, and Anders, 519 worth, and Rowley, 2984 nant Lymphoma, 3102 Anderson, A. K. See Paterson, Anderson, Smith, Asp, N-G. See Bauer, Asp, Oste, Dahlqvist, and Ahuja, M. R. See Schwab, Kollinger, Haas, Ahuja, and Smith, 3725 Fredlund, 3752 Abdo, Anders, and Anders, 519 Anderson, C. See Ruddon, Anderson, Meade, AtkInson, E. R. Assessment of Current Hyper Aitlo, M-L. See Yamashita, Aitio, and Dawson, Aldenderfer, and Neuwald, 3885 thermia Technology, 2313â€• 1780 Anderson, 0. J. Delivery of Essential Services to Au, J. L., and Sadee, W. 5-Fluorouracil Concen @ Altken, S. C. See Allegra, Lippman, Thompson, Alcoholics through the â€˜Continuumof Care,â€• trations in Human Plasma following R,S-1-(let Simon, Barlock, Green, Huff, Do, and Altken, 2855â€• rahydro-2-furanyl)-5-fluorouracil (Ftorafur) Ad 1447; Allegra, Lippman, Thompson, Simon, Anderson, J. K., Moore, J. 0., and Metzgar, R. ministration, 4289, Letter to the Editor Auchlncloss, J. H. See Comis, Kuppinger, Gins berg, Crooke, Gilbert, Auchincloss, and Pres aFebruarysymposiumissue,â€˜â€˜InternationalWorkshopon LeukocyteAd tayko, 5076 herence Inhibition.â€• Audy-Jurkovk@,S. See PaveliÃ³,Slijep@evic,Pay aSJunesymposiumIssue,â€˜â€˜Conferenceon HyperthermiainCancerTreat eli& Ivic, Audy-JurkoviÃ¡,Pavelic, and Boranic, ment.â€• 1807 aae Julysymposiumissue,â€˜â€˜AlcoholandCancerWorkshop.â€• Aune, T. See Dybing, von Bahr, Aune, Glaumann,

DECEMBER1979 5187 Author Index to Volume 39

Levitt, and Thorgeirsson, 4206 Barlock, Green, Huff, Do, Aitken, and Warren, Mullen, Brown, and Spomn,1339: Thompson, Austin,F. C. SeeOikawa,Gotohda,Austin,Tak 1973 Becci, Brown, and Moon, 3977 eichi, and Boone, 3519 Barlogle, B. See Bergerat, Barlogie, and Dre Beccl, P. J., Thompson, H. J., Grubbs, C. J., Austin,R.L.SeeParmley,DahI,Austin,Gauthier, winko, 1334: Bergerat, Barlogie, GÃ¶hde,John Brown, C. C., and Moon, R. C. Effect of Delay and Denys, 3834 ston, and Drewinko, 4356; Drewinko, Barlogie, in Administration of 13-cis-Retinoic Acid on the Autrup, H. See Harris, Autrup, Stoner, Trump, and Freireich, 2630: Spitzer, Verma, Barlogie, Inhibition of Urinary Bladder Carcinogenesis in Hillman, Schafer, and Jeffrey, 4401 Beran, and Dicke, 3215 theRat,3141 Autrup, H., Essigmann, J. N., Croy, R.G., Trump, Barlogle, B., Corry, P. M., Yip, E., Llppman, 1., Beck, W. S. See Thomndike,Pelliniemi, and Beck, B. F., Wogan,G. N., and Harris,C. C. Metab Johnston, D. A., KhaIll, K., Tenczynskl, 1. F., 3435 olism of Aflatoxin B, and Identification of the Reilly, E., Lawson, R., Dosik, G., Rigor, B., Beck, W. T., Mueller, T. J., and Tanzer, L R. Major Aflatoxin B,-DNA Adducts Formed in Cul Hankenson, R., and Freireich, E. J Total-Body Altered Surface Membrane Glycoproteins In tured Human Bronchus and Colon, 694 Hyperthermia with and without Chemotherapy Vinca Alkaloid-resistant Human Leukemic Lym Axelrod, J. See Hoffman, Paul, and Axelrod, 4584 for Advanced Human Neoplasms, 1481 phoblasts, 2070 Axeirod, R. S. See Holroyde, Axelrod, Skutches, Barlow, J. J. See Chatterjee, Bhattacharya, and Becker, F. F. Lack of Proportionality between Haff, Paul, and Reichard, 4900 Barlow, 1943 Rate of Cell Division and Induction of Tumors in Aylsworth, C. F., Hodson, C. A., Berg, G., KIed Barna, B. P., and Deodhar, S. D. Immunological Carcinogen-exposed Regenerating Livers, zik, G., and Meites,J. Roleof Adrenalsand Activity of Regional Lymph Nodes in Tumor 5177, Letter to the Editor. See also Hudig, Sell, Estrogen in Regression of Mammary Tumors bearing Mice, 2711 Newell, and Becker, 3715: Liau, Chang, and during Postpartum Lactation in the Rat, 2436 Barney, C. See Tong, Burger, Finke, Barney, Van Becker, 2113: Stout and Becker, 1168 Azarnoff, 0. L. See Reddy, Rao, Azarnoff, and denbark,and Vetto,597 Becker, F. F., and Soil, S. Differences in Serum Sell, 152; Svoboda and Azarnoff, 3419 Barone, R. M. See Belnap, Cleveland, Colmer a-Fetoprotein Concentrations during the Carci Azlzkhan, J. C., Speeg, K. V., Jr., Stromberg, K., auer, Barone, and Pilch, 1174 nogenic Sequences Resulting from Exposure to andGoode,D.Stimulationof HumanChorionic Barra, R., Parsons, J., Koch, M. R., and Lea, M. Diethylnitrosamine or Acetylaminofluorene, Gonadotropin by JAr Line Choriocarcinoma A. SolubleFactorsfromLiverand Hepatomas 1437: a-Fetoprotein Levels and Hepatic Altera after Inhibition of DNA Synthesis, 1952 which Inhibit [3H]Thymidine Incorporation into tions during Chemical Carcino9enesis in Azocar, J., and Essex, N. Incorporation of HLA DNA of Novikoff Hepatoma Cells, 1655 C57BL/6N Mice, 3491 Antigens into the Envelope of RNA Tumor vi Barrett, J. C. See Hollenberg, Barrett, Ts'o, and Bedford, J. S. See Raaphorst, Romano, Mitchell, ruses Grown in Human Cells, 3388 Berhanu, 4166: Tsutsui, Barrett, and Ts'o, 2356 Bedford, and Dewey, 396 Aiuma, I. See Ogura, Namba, Hirao, Yamamura, Barrett, J. C., Crawford, B. D., Mixter, L. 0., Beglelter, A., Lam, H-Y. P., Grover, J., Froese, and Azuma, 4706: Yasumoto, Manabe, Yana Schechtman, 1. M., Ts'o, P. 0. P., and Pollack, E., and Goldenberg, G. J. Evidence for Active gawa, Nagano, Ueda, Hirota, Ohta, Nomoto, R. Correlation of in Vitro Growth Properties and Transport of Melphalan by Two Amino Acid Azuma, and Yamamura, 3262 Tumorigenicity of Syrian Hamster Cell Lines, Carriers in L5178Y Lymphoblasts in Vitro, 353 1504 Begley, D. See MalIey, Burger, Vandenbark, B Barthold, S. W. Autoradlographic Cytokinetics of Frikke, Finke, Begley, Acott, Black, and Vetto, Colonic Mucosal Hyperplasia in Mice, 24 619' Bartholomew, J. C. See Bissell, Bartholomew, BÃ©langer,L. See Liau, Chang, BÃ©langer,and Bachur, N. R. See Egorin, Clawson, Ross, Folkman, Smith, and Stampfer, 4293 Grenier, 162 Schlossberger, and Bachur, 4396 Bartholomew, J. C., Pearlman, A. L., Landoiph, BÃ¶ianger,L., Commer, P., and Chlu, J-F. Isolation Backstrom, J. T. See lsom and Backstrom, 864 J. R., and Straub, K. Modulationof the Cell of Rata,-Fetoprotein Messenger RNAfrom Mom Beeck, A. E. See Parshad, Sanford, Tarone, Cycle of Cultured Mouse Liver Cells by misHepatoma 7777, page 2141 Jones, and Baeck, 929 Benzo(a)pyrene and Its Derivatives, 2538 Ballet, R. E. See Berd, Wilson, Bellet, and Mae Baetcke, K. P. See Morton, King, and Baetcke, Bartle, P. M. See Deen, Hoshino, Williams, No tmangelo,4472 3107 mura, and Bartle, 4336 Belnap, L. P., Cleveland, P. H., Colmerauer, M. Bailey,B.D.SeeHill,Bailey,White,andGoldman, Bartlett, G. L. See Kreider, Bartlett. Boyer, and E. M., Barons, R. M., and PlIch, V. H. Immu 2440 Pumnell,987: Kreider, Bartlett, and Sharkey, nogenidityof Chemically-inducedMurineColon Baird,M.B.,andBlrnbaum,L S.IncreasedPro 273; Purnell, Bartlett, and Kreider, 1; Pumnell, Cancers, 1174 duction of Mutagenic Metabolites of Carcino Bartlett, Kreider, Biro, and Kontra, 4838 Bend, J. B. See Smithand Bend, 2051 gens by Tissues from Senescent Rodents, 4753 Bases, R., Rubinstein, A., Kadlsh, A., Mendez, Bender, R. A. See Jackson and Bender, 4346 Baker, N. See Ookhtens and Baker, 973: 5118 F., Wfttnsr, D., Elequin, F., and Liebeskind, D. Bendlch, A. See Borenfreund, Higgins, Steing Belch, C. M. See Durkin, Ghanta, Balch, Davis. Mutagen-induced Disturbances in the DNA of lass, and Bendlch, 800 and Hiramoto, 402 Human Lymphocytes Detected by Antinucleo Benedict, W. F. See Banerjee and Benedict, 797 Balls, M. E. See Tedde, Balis, Schonberg, and side Antibodies, 3524 Benevenga, N. J. See Steele and Benevenga, Trotta, 3044 Basler, G. See Hasegawa, Shapiro, Posner, and 3935 Balk, S. D., Mitchell, R. S., LeStourgeon, D., and Basler, 2687 BenjamIn, R. S. See Benvenuto, Hall, Farquhar, Hoon, B. S. Thymidine and Hypoxanthine Re Basier, J. See Berezney, Basler, Hughes, and Stewart,Benjamin,andLoo,349;Stewart,Ben quirements for the Proliferation of Normal and Kaplan, 3031 venuto, Leavens, Hall, Benjamin, Plunkett, Rous Sarcoma virus-infected Chicken Fibro Bateman, J. R. See Chlebowski, Irwin, Pugh, Sa McCredie, Burgess, and Loo, 4119 blasts in the Presence of Methotrexate, 1854, doff, Hestorff, Wiener, and Bateman, 4503 Bennett, L L, Jr., Smfthers, D., Rose, L M., Communication Batzlnger, A. P. See Tsuda, Sarma, Rajalakshmi, Adamson, D. J., and Thomas, H. J. Inhibition Ball, J. K., and McCarter, J. A. Biological Char Zubroff, Farber, Batzinger, Cha, and Bueding, of Synthesis of Pyrimidine Nucleotides by 2- acterization of a Leukemogenic virus Isolated 4491 Hydroxy-3-(3,3-Dichloroallyl)-i ,4-Naphtho-Qui from the CFW Mouse, 3080 Bauer, E. A., Uftto, J., Wafters, R. C., and Eisen, none, 4868 Balog, B. See Pegg and Balog, 5003 A. z. Enhanced Collagenase Production by Fl Benson, A. N., Cha, V-N., Buedlng, E., Hales, H. Bamburg, J. R. See Coss, Dewey, and Bamburg, broblasts Derived from Human Basal Cell Car S., and Talalay, P. ElevatIonof Extrahepatic 1911 cinomas, 4594 Glutathione 5-Transferase and Epoxide Hydra Banerjee, A., and Benedict, W. F. Production of Bauer, H. 0., Asp, N-G., Oste, R., Dahlqvist, A., tase Activfties by 2(3)-tert-Butyl-4-hydroxyani Sister Chromatid Exchanges by Various Cancer and Fredlund,P. E. Effectof DietaryFiberon sole, 2971 Chemotherapeutic Agents, 797 the Induction of Colorectal Tumors and Fecal Benvenuto, J. A. See Stewart, Benvenuto, Leav Banerjee, D. See Redman, Yu, Banerjef, and ,8-GlucuronidaseActivity in the Rat, 3752 ens, Hall, Benjamin, Plunkett, McCredie, Bum Morris, 101 Baumann, H., and Chu, F-F. Altered Composition gess, and Loo, 4119 Baptiste, J. See Henderson, Dworsky, Pike, Bap of Membrane Glycoconjugates In Rat Hepatoma Benvenuto, J. A., Hall, S. W., Farquhar, D., Stew tista,Menck,Preston-Martin,and Mack,4507 Tissue Culture Cells after Dexamethasone art, D. J., BenjamIn,R. S., and Lee, 1. L. Barbaric, z. L. See Burgener and Barbaric, 3429 Treatment or in Vivo Growth, 3540 Pharmacokinetics and Disposition of 3-Dea Barbieri, 0. See Zardi, Cecconi, Barbieri, Came Baumann, H., Nudelman, E., Watanabe, K., and zauridine in Humans, 349 molla, Picca, and Santi, 3774 Hakomori, S-i. Neutral Fucolipids and Fucogan Benvenuto, J. A., Llehr, J. G., Wlnkler, T., Far Barbosa, J. A. See Dexter, Barbosa, and Cala gliosides of Rat Hepatoma HTC and H35 Cells, quhar,D., Caprioll,R. M., and Lee, 1. L Human bresi, 1020 Rat Liver, and Hepatocytes, 2637 Urinary Metabolites of 1-(Tetrahydro-2-furanyl)- Bardos, T. J. See Ho, Preisler, and Bardos, 3163 Bear, J. 1. See Howard, Kimball, and Bear, 2568 5-fluorouracil (Ftorafur), 3199 Barker, P. E. See Siciliano, Barker, and Callleau, Beardsley, T. R., and Hays, E. F. Gross Murine Beran, M. A. See Spitzem,verma, Bariogie, Beran, 919 Leukemia virus-induced Alterations in the Thy and Dicke, 3215 Barlock, A. See Allegra, Lippman, Thompson, mus of Preleukemic AKR Mice, 480 Bard, D., WIlson, E. J., Ballet, R. E., and Mae Simon, Barlock, Green, Huff, Do, and Aitken, Becci, P. J. See Moon, Thompson, Becci, Grubbs, trangelo, M. J. Effect of 1-(2-chloroethyl)-3- 1447: Allegra, Lippman, Thompson, Simon, Gander, Newton, Smith, Phillips, Henderson, (4-methylcyclohexyl)-1 -nitrosourea (Methyl

5188 CANCERRESEARCHVOL. 39 Author Index to Volume 39

CCNU) Adjuvant Therapy on Immune Re Nichol, 487; Wikstmandand Bigner, 3235 Nichol, 487 sponsesof Patientswith MalignantMelanoma, Birbeck, M. S. C. See Wilkinson,Birbeck,and Bayer, C. M. See Kreider, Bartlett, Boyer, and 4472 Harrap, 4256 Purnell, 987 Berezn.y, R., Basler, J., Hughes, B. B., and Blrnbaum, L. S. See Baird and Bimnbaum,4753 Boyle, M. D. P. See Lo and Boyle, 3156 Kaplan, S. C. Isolation and Characterization of BIro,1. 0. SeePurnell,Bartlett,Kreider,Biro,and Bracken, W. J. See Slaga, Bracken, Gleason. the NuclearMatrixfromZajdelaAscitesHepa Kontra, 4838 Levin, Yagi, Jerina, and Conney, 67 tomeCells,3031 Bissell,M. J., Bartholomew,J. C., Folkman,J., Bracken, W. M. See Cohen, Bracken, lyer, Berry, Berg, G. See Aylsworth, Hodson, Berg, Kledzik, Smith,H., and Stampfer,M. CultureSystems Selkirk, and Slaga, 4027 and Meites, 2436 for Studying Malignancy, 4293, Meeting Report Bradley,T. R.SeeMartin,Bradley,andHodgson, Bsrger, A. See Goldfeder, Brown, and Berger, Bltner, A. F. See Henle, Bitner, and Dethlefsen, 3244 2966 2486 Bradley,W.P.SeeWeiss,Momantz,Bradley,and Belier, A. E. See Neil, Bergem,McPartland, Grin Bltter-Suermann,D. See Schorlemmer,Opitz, Chretien, 542 dey, and Bloch, 852 Etschenberg, Bittem-Suermann,and Hadding, Brandhorst, J. S. See Peters, Brandhomst,and Berger, M. See Zeller, Berger, and SchmÃ¡hl,1071 1847 Henna, 1353 Brgsrat, J-P., Barlogle, B., and Drewinko, B. Black,H.S.,Henderson,S.V.,Kleinhans,C.M., Brattain, N. G., Green, C., Kimball, P. M., Marks, Effects of cis-Dichlomodiammineplatinum(II)on Phelps, A. W., and Thornby, J. I. Effect of M., and Khaled, M. lsoenzymesof /1-Hexosa Human Colon Carcinoma Cells in Vitro, 1334 Dietary Cholesterol on Ultraviolet-Light Card minidase from Normal Rat Colon and Colonic Berg.rat, J-P., BarlOgie, B., Gohde, W., John nogenesis, 5022 Carcinoma, 4083 sloe, D. A., and Drewlnko, B. In Vitro Cytoki Black, J. See Malley, Burger, Vandenbark, Frikke, Braun,D.P.SeeMokyr,Braun,andDray,785 neticResponseof HumanColonCancerCells Finke, Begley, Acott, Black, and Vetto, 619' Braunschweiger, P. G., and Schlffer, L. M. Effect to cis-Dichlorodlammineplatinum(ll), 4356 Blanco,N. F. SeeGosÃ¡lvez,van Rossum,and of Methylprednisolone on the Cell Kinetic Re Berhanu, P. See Hollenberg, Barrett, Tao, and Blanco, 257 sponse of C3H/HeJ Mammary Tumors to Cy Berhanu,4166 Bligh,J. AspectsofThermoregulatoryPhysiology clophosphamide and Adriamycin, 3812 Berkeihammar, J., Calnes, S. M., Dexter, D. L., Pertinent to Hyperthermic Treatment of Cancer, Breitkreutz, D., de Leon, 1. D., Paglla, L, Gay, Adeistin, E. H., Oxenhandler, R. W., and 2307 â€˜â€˜; Remarks on Physiology and Tissue S., Swarm, R. L, and Stern, R. Histologicaland Heok, R. R., Jr. Adaptation of Sinclair Swine Response in Animals, 2336â€• Biochemical Studies of a Transplantable Rat Melanoma Cells to Long-term Growth in Vitro, Bloch, A. See Neil, Berger, McPartland, Grindey, Chondrosarcoma, 5093 4960 and Bloch, 852 Breland, J. C. See Cory, Breland, and Carter, Berkowitz, D. M. See Young, Hollenberg, Kazam, Blumberg, P. M. See Delclos and Blumbemg, 4905 BerkowItz, Halnen, Sandor, and Abmams,1898 1667; Driedger and Blumberg, 714 Brennhovd,I. See Sanner, Bmennhovd,Christen Berman, J. J., Rice, J. M., Wenk, M. L, and Blumenschein, G. R. See Swenerton, Legha, sen, Jgrgensen, and Kvaley, 654' ROller, P. P. Intestinal Tumors Induced by a Smith, Hortobagyi, Gehan, Yap, Gutterman, and BrÃ©sll,H. See Montesano,BrÃ©sil,and Margison, Single Intraperitoneal Injection of Methyl Blumenschein, 1552 1798 (acetoxymethyl)nitmosaminein Three Strains of Boekelhelde, K. See Vogel, Kemper, Boekel Bresnick, E. See Eastmanand Bresnick, 2400; Rats,1462 heide, Graham, and Jeffs, 1490 4316 Bern, H. A. See Jones and Bern, 2560 Bolognesl, D. P. See Langlois, Holder, Iglehart, Breter, H-J., and Zahn, R. K. Quantitationof In BSI'nacki, R. J. See Klohs, Bemnacki,and Komyt Nelson-Rees, Wells, and Bolognesi, 2604 tracellular Metabolites of [35S]-6-Mercaptopu nyk, 1231 Batten, B. J. See Zaharko, Bolten, Chiuten, and minein L5178Y Cells Grown in Time-Course B.rney, S. See Havas, Barney, Goodis, and Wiemnik,4777 Incubates, 3744 Schlffman, 3783 Bonlver, J. See DeclÃ¨ve,Lieberman, Boniver, and Brlggs, R. C., Campbell, A., Chiu, J-F., Hnllica, Berry, D. L. See Cohen, Bracken, Iyer, Berry, Kaplan, 4322 L S., Lincoln, G., Stein, J., and Stein, G. Selkirk, and Slaga, 4027 Boone, C. W. See Oikawa, Gotohda, Austin, Tak Specificity of DNA-associated Nuclear Antigens Bertino, J. R. Toward Improved Selectivity in Can eichi, and Boone, 3519 in HeLa Cells and Distribution during the Cell cer Chemotherapy: The Richard and Hinda Ro Boone, C. W., Vembu, 0., WhIte, B. J., Takeichi, Cycle, 3683 senthalFoundationAwardLecture,293. See N., and Paranjpe, M. Karyotypic, Antigenic, and Brinkley, B. R. See Asch, Medina, and Brinkley, also Kalghatgl, Moroson, HorvÃ¡th,and Bertino, Kidney-invasive Properties of Cell Lines from 893 3441; KowalandBertino,2285â€• Fibrosarcomas Arising in C3H/10TÂ½Cells Im Broitman, S. A. See Corwin, Varshavsky-Rose, Bertram, J. S. Modulation of Cellular Interactions planted Subcutaneously Attached to Plastic and Broitman, 4350 between C3H/10TÂ½ Cells and Their Trans Plates, 2172 Bronson, D. L. See Williams, Bronson, Myl, Van formed Counterparts by Phosphodiesterase In Boose, R. B. See May, Kohlhepp, Boose, and devoorde, and Elliott, 2447 hibitors, 3502. See also Merriman and Bertram, Reed, 762 Bronzed, D. See Osborne, Monaco, Kahn, Huff, 1661 BoranlÃ©,M. See PaveliÃ´,SIijep@eviÃ¡,PaveliÃ¡,lviÃ³, Bmonzert,and Lippman, 2422 B.rtsch, S. See Marks, Bertsch, and FUrstenber Audy-Jurkovi@ PaveliÃ¡,and Borani@,1807 Brown, A. J., Fickel, T. H., Cleaver, J. E., Lob ger,4183 Bordln, G. M. See Leung, Bordin, Nakamura, man, P. H. N., Wade, M. H., and Waters, R. Bertsch, S., and Marks, F. Effects of Epidermal DeHeer, and Edgington, 2057 Overlapping Pathways for Repair of Damage Chaloneand EpidemmalGrowth Factor on a Borek, E. See Gehrke, Kuo, Waalkes, and Borek, from Ultraviolet Light and Chemical Carcinogens Transplantable EpidemmalCarcinoma (Hewitt) of 1150 in Human Fibmoblasts,2522 the Mouse in Vivo, 239 Borella, L. D. See Holcenbemg,Borella, Camitta, Brown, B. L. See Lowenthal,Parker, Greenblatt, Beschornâ€¢r,V.'. E., Hess, A. D., Nerenberg, 5. and Ring. 3145 Brown, and Samy, 1547 1., and Epstein, R. B. Isolation and Character Borenfreund, E., Higgins, P. J., Steinglass, M., Brown, C. C. See Becci, Thompson, Grubbs, ization of Canine Venereal Tumor-associated and Bendich,A. Carcinogen-inducedAbnor Brown, and Moon, 3141; Moon, Thompson, lnhlbftory and Blocking Factors, 3920 malities in Rat Liver Cells and Their Modification Becci, Grubbs, Gander, Newton, Smith, Phillips, Bex, F., Bruck, C., Mammerickx, M., Portetelle, by Chemical Agents, 800 Henderson, Mullen, Brown, and Spomn,1339; D., Ghy.daol, J., Cleuter, V., Leclercq, M., Bossen, E. H. See Hanker, Ambrose, James, Man Thompson, Becci, Brown, and Moon, 3977 DeIc@, D., and Bumy, A. Humoral Antibody delkorn, Yates, Gall, Bossen, Fey, Laszlo, and Brown, C. E., Warren, S., Chute, R. N., Ryan, K. Response to Bovine Leukemia virus Infection in Moore, 1635 J.,andTodd,R.B.Hormonally-inducedTumors CattleandSheep, 1118 Bottomley, P. A. In Vivo Tumor Discrimination in of the Reproductive System of Parabiosed Male Bhattacharya, M. See Chatterjee, Bhattacharya, a Rat by Proton Nuclear Magnetic Resonance Rats, 3971 andBarlow,1943 Imaging, 468 Brown,D. L. See Brundrett,Colvin,White,Mckee, Bhaftl, R. A., Ablin, R. J., Condoulis, W., and Bourgeade, M. F., Cerutti, I., and Chany, C. Hartman, and Brown, 1328 GuInea, P. D. Arming of Normal Leukocytes Enhancement of Interferon Antitumor Action by Brown, D. M. See Goldfedem,Brown,and Berger, with Sera from Patients with Adenocarcinoma of Sodium Butyrate, 4720 2966 the Prostate, 3328 Bourgeois, S., and Newby, R. F. Correlation be Brown,H. S., Jeffrey, A. M., and Weinstein, I. B. Bhuyan, B. K. Kinetics of Cell Kill by Hyperther tween Glucocorticoid Receptor and Cytolytic Formation of DNA Adducts in 10TÂ½Mouse Em mia,2277â€• Response of Murine Lymphoid Cell Lines, 4750 bryo Fibroblasts Incubated with Benzo(a)pyrene Biaglow,J. E.SeevarnesandBiaglow,2960 Boutwell, R. K. See Mufson, Fischer, Verma, or Dihydrodiol Oxide Derivatives, 1673 Bibor-Hardy, V. See Kessous, Bibor-Hardy, Suh, Gleason, Slaga, and Boutwell, 4791 ; Mufson, Brown,0. E. See Sedwick,Kutler,Frazer,Brown, and Simard, 3225 Simsiman, and Boutwell, 2036; Verma, Lowe, and Laszlo, 3612 Bickel, w. D. See McLaughlin, Hargrave, Bickel, and Boutwell, 1035; Verma, Shapes, Rice, and Bruce, W. R. See Kakizoe, Wang, Eng, Furrer, and RIbI, 1766 Boutwell, 419 Dion, and Bruce, 829 Bigger, C. A. H. See Dipple, Tomaszewski, Moe Bowen, J. M. See Hixson, Bowen, Ohtsuki, Scan Bruck, C. See Bex, Bruck, Mammerickx, Porte chel, Bigger, Nebzydoski, and Egan, 1154 Ion, and Dmochowskl, 199 telle, Ghysdael, Cleuter, Leclercq, Dekegel, and Signer, D. D. See Duch, Bigner, Bowers, and Bowers, S. W. See Duch, Bigner, Bowers, and Bumny,1118

DECEMBER1979 5189 Author Index to Volume 39

Brugger, u. See Modolell, Andreesen, Pahlke, Burleson, G. R. See Caulfield, Burleson, and P01- vum, 3554 Brugger, and Munder, 4681 lard, 2155 Caprioll, R. M. See Benvenuto,Liehr, Winkler, Brundrett,R. B., ColvIn,M., White, E. H., McKee, Burleson, G. R., Caulfield, M. J., and Pollard, M. Farquhar, Caprioli, and Loo, 3199 J., Hartman, P. E., and Brown, D. L. Compari Ozonation of Mutagenic and Carcinogenic Po Carafoli, E. See Eboli, MalmstmÃ¤m,Galeotti, son of Mutagenicity, Antitumor Activity, and lyaromatic Amines and Polyaromatic Hydmocar LÃ³pez-AlamcOn,and Carafoll, 2737 Chemical Properties of Selected Nitrosoureas bons in Water, 2149 Carlstedt.Duke, J. N. B. Tissue Distribution of the and Nitrosoamides, 1328 Burlett, M. See Gerweck, Nygaard, and Burlett, Receptor for 2,3,7,8-Tetrachlomodibenzo-p- Brunk, G. See Gingell, Brunk, Nagel, and Pour, 966 dioxin in the Rat, 3172 4579 Burllngham, W. J. See Simon, Burlingham, Conk Carlstedt-Duke, J. M. B., Elfstrdm, G., Hogb.rg, Brunn, J. C. See Lee, Giovanella,Stehlin, and in,and Fondy,3897 B., and Gustafsson,J-A. Ontogenyof the Rat Bmunn,2928 Burnett, A. K. Thyroid Hormone in 7,12-Dimeth Hepatic 2,3,7,8-Tetrachlorodibenzo-p-dioxin Brunnemann,K. D. See Hoffmann,Adams,Brun ylbenz(a)anthracene-induced Leukemia in Rats. (TCDD) Receptor and Its Endocrine Independ nemann, and Hecht, 2505 4252 ence, 4653 Bruszewski, J. A. See Long, Bruszewski,Chris Burns, C. P., Luttenegger, D. G., Dudley, D. T., Carnemolla,B. See Zardi, Cecconi,Barbieri,Car tensen, and Suk, 2995 Buettner, G. R., and Spector, A. A. Effect of nemolla, Picca, and Santi, 3774 BUcheler, J. See Swenberg, Cooper, BUcheler, Modification of Plasma Membrane Fatty Acid Carrano, A. V., MayaIl, B. H., Testa, J. R., Ash and Kleihues, 465 Composition on Fluidity and Methotrexate worth, L K., and Rowley, J. D. Chromosomal Buchsbaum, D. J., Walker, P. C., and Johnson, Transport in Li 210 Murine Leukemia Cells, DNA Cytophotometry in 20q - Nonspecific Mye E. A. Distributionof RadiolabeledAlloantibodies 1726 bid Disorders, 2984 in Mice Bearing 3-Methylcholanthrene-induced Burns,F. J. See Pereira,Burns,and Albert,2556 Carrel, S., Gross, N., and Mach, J-P. Reactivity Sarcomas, 3363 Burny, A. See Bex, Bruck, Mammerickx,Porte of Anti-Daudi Serum with Acute and Chronic Buedlng, E. See Benson, Cha, Bueding, Heine, telle, Ghysdael, Cleuter, Leclercq, Dekegel, and Leukemias, 5171 and Talalay, 2971 ; Tsuda, Sarma, Rajalakshmi, Bumny,1118 Carrico, C. K., and Glazer, R. I. Effect of 5-Fluo Zubroff, Farber, Batzinger, Cha, and Bueding, Burrows, W. B. See Ramey, Hashim, Burrows, rouracil on the Synthesis and Translation of 4491 Swistel, Munther, and Fitzpatrick, 4796 Polyadenylic Acid-containing RNA from Regen Buenlng,M. K. See Levin,Buening,Wood,Chang, Busch, F. N. See Takami, Busch, Morris, and erating Rat Liver, 3694 Thakker, Jerina, and Conney, 3549 Busch, 2096 Carry, P. J., Prescott, D. M., and Ogllvie, G. K. Buening,M. K., Levin, W., Karle, J. M., Yagi, H., Busch, H. See Marashi, Davis, Busch, Savage, Resistance to Ehrlich Ascites Tumor in a Strain Jerina, 0. M., and Conney, A. H. Tumongenicity and Busch, 59; Merski, Daskal, Crooke, and of Dystrophic Mice, 2139 of Bay Region Epoxides and other Derivatives Busch, 1239; Parker, Rothblum, and Busch, Carter, G. L See Cory, Breland, and Carter, 4905 of Chrysene and Phenanthrene in Newborn 1287; Takami and Busch, 507; Takami, Busch, Carter, J. H., McLafferty, M. A., and Goldman, Mice, 5063 Morris, and Busch, 2096; Wu, Spohn, and P. Effectof 2-Nitrofluorene,1,2-Dimethylhydra Buening,M. K., Levin, W., Wood, A. W., Chang, Busch, 116 zine,and Azoxymethaneon Salmonellatyphi R. L., YagI, H., Karle, J. M., Jerina, D. M., and Busch, H., Daskal, Y., Gyorkey, F., and Smetana, murium Mutants in the Gastrointestinal Tract of Conney, A. H. Tumorigenicityof the Dihydro K. SilverStainingof NucleolarGranulesin Tu Gnotobiotic Rats, 2026 diols of Dibenzo(a,h)anthracene on Mouse Skin momCells, 857 Carter, W. A. Bypassing the â€˜â€˜SpeciesBarrierâ€• and in Newborn Mice, 1310 Busch, H., Gyorkey, F., Busch, R. K., Davis, F. with Carbohydrate-altered Interferon from Leu Buettner, G. R. See Burns, Luttenegger, Dudley, M., Gyorkey, P., and Smetana, K. A Nucleolar kocytes, 3796, Letter to the Editor Buettner, and Spector, 1726; Oberley and Antigen Found in a Broad Range of Human Carter, W. H., Jr., Stablein, D. M., and Wampler, Buettnem,1141 Malignant Tumor Specimens, 3024 G. L. AnImprovedMethodforAnalyzingSurvival Buffkin, D. C. See Pegg, Buffkin, and Webber, Busch, R. K. See Busch, Gyorkey, Busch, Davis, Data from Combination Chemotherapy Experi 1431 Gyorkey, and Smetana, 3024; Marashi, Davis, ments, 3446 Buick, R. N. See Salmonand Buick, 1133 Busch, Savage, and Busch, 59 CascIaro, A. See Chiametti, Casciamo, Minotti, Buick, R. N., Stanlsic, T. H., Fry, S. E., Salmon, Byers, J. F. See Ichinose, Powell, Hoemner, Eboli, and Galeotti, 2195 S. E., Trent, J. M., and Krasovlch, P. Devel Derbes, and Byers, 4270 Caspersson, 1. 0. Quantitative Tumor Cytochem opment of an Agar/Methylcellulose Clonogenic istryâ€”G.H. A. Clowes Memorial Lecture, 2341 Assay for Cells in Transitional Cell Carcinoma Case, C. E., Dahllg, E., Lau, E. V., Lynch, T. P., of the Human Bladder, 5051 C and Paterson, A. R. P. Fluctuationsin Nucleo Bulay, 0., and Mlrvlsh, S. S. Carcinogenesisin side uptake and Binding of the Inhibitor of Nu Rat Esophagus by Intraperitoneal Injection of Cailleau, R. See Siciliano, Barker, and Cailleau, cleoside Transport, Nitrobenzylthioinosine, dum Different Doses of Methyl-n-amylnitrosamine, 919 ing the Replication Cycle of HeLa Cells, 1245 3644 CaIne., S. M. See Berkelhammem,Caines, Dexter, Case, C. E., Tan, T. H., and Selner, M. Antiproli Bulay, 0., Patil, K., Wilson, R., and Shublk, P. Adelstein, Oxenhandlem,and Hook, 4960 ferative Effects of 9-/3-D-Arabinofuranosylade Kidney Tumors Induced in Rats by the Anti Calabresl, P. See Dexter, Barbosa, and Calabresi, nine 5'-Monophosphateand Related Com schistosomal Drug Niridazole, 4996 1020; Stoller, Kaplan, Cummings, and Cala pounds in Combination with Adenosine Deami Bull,A. W., Soullier,B. K., Wilson,P. S., Hayden, bresi, 908 nase Inhibitors against Mouse Leukemia N. T., and Nlgro, N. D. The Promotion of Azox CaIdwell, W. L. Clinical Instrumentation Require Li 210/C2 Cells in Culture, 1563 ymethane-induced Intestinal Cancer by High Fat ments with a Review of the Perth Hyperthermia Casto, B. C. See DiPaoloand Casto, 1008 Diet in Rats, 4956 Experience, 2332â€• Casto, B. C., Meyers, J., and DlPaolo, J. A. Bull, J. M. CombinedModalities,2337' â€˜; Sum Calhoun,B. L. See Minkel,Dolhun,Calhoun,Sam Enhancement of Viral Transformation for Eval mary of the Informal Discussion of Animal yen, and Petering, 2451 ; Saryan, Minkel, Dol uation of the Carcinogenic or Mutagenic Poten Models and Clinical Studies, 2262 â€˜â€˜. See also hun, Calhoun, Wielgus, Schaller, and Petering, tial of Inorganic Metal Salts, 193 O'Donnell, McKoy, Makuch, and Bull, 2547 2457 Catalona, W. J., Ratllif, T. L, and MCCOOI,R. E. Burchenal,J. H. See Chou, Burchenal,Fox, Wa Cameron, E., Paullng, L., and Lelbovltz, B. Concanavalin A-Inducible Suppressor Cells in tanabe, Chu, and Philips, 720 Ascorbic Acid and Cancer: A Review, 663 Regional Lymph Nodes of Cancer Patients, Burgener,F. A., and BarbarIc, Z. L. Treatmentof Camltta, B. M. See Holcenbemg,Borella, Camitta, 4372 VX2 Carcinomas in Rabbits by Percutaneous and Ring, 3145 Catane, R. See Ovejera,Houchens,Catane,Sher Intratumoral Injection of Heated 0.9% NaCI So Campbell, A. See Brlggs, Campbell, Chiu, Hnilica, idan, and Muggia, 3220 lutions, 3429 Lincoln, Stein, and Stein, 3683 Caulfield, M. J. See Bumleson,Caulfield, and Pol Burger, D. R. See Malley, Burger, Vandenbark, Campbell, J. B. See Taylor, Rosney, and Camp lard, 2149 Frikke, Finke, Begley, Acott, Black, and Vetto, bell, 1046 Caulfield, M. J., Burleson, G. R., and Pollard, M. 619 â€˜; Tong, Burger, Finke, Barney, Vanden Campbell, S. See King, Whitehead, Campbell, Ozonation of Mutagenic and Carcinogenic Al bark, and Vetto, 597' and Minardi, 1094 kylating Agents, Pesticides, Aflatoxin B, , and Burger, P. C., Kemper, L A. K., and Vogel, F. S. Canti, G. See Zbar, Canti, Ashley, Rapp, Hunter, Benzidine in Water, 2155 The Cytotoxicity of â€˜y-L-Glutaminyl-4-hydroxy and Ribi, 1597 Cave, W. T., Jr., Dunn, J. T., and MacLeod, R. benzene for Cells that Contain Tyrosinase, a Cantrell, J. L See Ribi, Cantrell, Von Eschen, and M. Effects of Iodine Deficiency and High-Fat Study of Melanocytes in the Hair Follicle of the Schwartzman, 4757 Diet on N-Nitrosomethylurea-induced Mammary Mouse, 1494 Cantrell, J. L, McLaughlIn, C. A., and Rlbl, E. Cancers in Rats, 729 Burgess,M. A. See Stewart,Benvenuto,Leavens, Efficacy of Tumor Cell Extracts in Immunother Cecconl, C. See Zardi, Cecconi, Barbieri, Came Hall, Benjamin, Plunkett, McCredie, Burgess, apy of Murine EL-4 Leukemia, 1159 molla, Picca, and Santi, 3774 and Loo, 4119 Cantrell, J. L., and Wheat, R. W. Antitumor Activ Ceriani, R. L. See Fentiman,Hurst, Cemiani,and Burke, D. See Laskin,Evans,Slocum,Burke,and ity and Lymphoreticular Stimulation Properties Taylor-Papadlmitmiou,4740 Hakala, 383 of Fractions Isolated from Corynebacterium par Cerrone, M. See Evans, Frank, McKlnnon, and

5190 CANCER RESEARCH VOL. 39 Author Index to Volume 39

Cerrone,2016 Chevalier, G. See Rousset, Chevalier, Rousset, Report Cerutti, I. See Bourgeade, Cerutti, and Chany, Dussaulx, and Zweibaum, 531 Cohen, G. M. See MacLeod, Cohen, and Selkirk, 4720 ChIang, T. See Kumar, Chiang, and Deodhar, 3463 Ceruttl, P. A. See Wang and Cerutti, 5165 3515 Cohen, G. M., Bracken, W. M., Iyer, R. P., Berry, Cow's, J. F. See Leong, Cooperband, Deckers, Chiarettl, B., Casclaro, A., Minotti, G., Eboll, M. D. L., Selkirk, J. K., and Slaga, T. J. Anticar Sutherland, Cesare, and Kmementz,2125 L., and Galeotti, 1. QuantitativeEvaluationof cinogenic Effects of 2,3,7,8-Tetracholorodi Cha, V-N. See Benson, Cha. Bueding. Heine, and the Activity of the Malate-Aspartate Shuttle in benzo-p-dioxin on Benzo(a)pyrene and 7,12-Di Talalay, 2971 ; Tsuda, Sarma, Rajalakshmi, Zu Ehriich Ascites Tumor Cells, 2195 methylbenz(a)anthracene Tumor Initiation and broff, Farber, Batzinger,Cha, and Bueding, Chlrigos, M. A. See Stoychkov, Schultz, Chirigos, Its Relationship to DNA Binding, 4027 4491 Pavlidis, and Goldin, 3014 Cohen, G. M., Marchok, A. C., Nettesheim, P., chabn.r, B. A. See Murinson, Anderson, Chirigos,M. A., and Schultz, R. M. AnimalModels Steele, V. E., Nelson, F., Huang, S., and Schwartz,Myers, and Chabner,2471 in Cancer Research which Could be Useful in Selkirk, J. K. Comparative Metabolism of Chamnese, 0. C. See Powell, Garola, Chamness, Studies of the Effect of Alcohol on Cellular Im Benzo(a)pyrene in Organ and Cell Cultures De and McGulre, 1678 munity,2894â€• rived from Rat Tracheas, 1980 Chance, B. See Miko, Drobnica, and Chance, Chlu, J-F. See Belangem,Commer, and Chiu, Cohen, I. K., Moncure, C. W., Wftorsch, R. J., 4242 2141; Briggs,Campbell,Chiu,Hnilica,Lincoln, and Diegelmann, R. F. Collagen Synthesisin Chandra, D. P. See Adams, Pewnim, Chandra, Stein, and Stein, 3683 Capsules Surrounding Dimethylbenzanthra Archibald,andFoe,5124 Chiuten, D. F. See van Echo, Chiuten, Gormley, cene-Induced Rat Breast Tumors and the Effect Chandrassliaran, E. V., and Davidson, E. A. Gly Lichtenfeld, Scoltock, and Wiemnik,3881 ; Za of Pretreatment with fl-Aminopropionitrile, 2923 cosamlnoglycansof Normaland MalignantCul harko, Bolten, Chiuten, and Wiemnik,4777 Cohen, M. H. See Erlichman, Strong, Wiemnik, hired Human Mammary Cells, 870 Chlebowskl, R. T., Irwin, L. E., Pugh, R. P., McAvoy, Cohen, Levine, Hubbard, and Ohab Chang, C. F. See Uau, Chang, and Becker, 2113; Sadoft, L, Hestorff, R., Wiener, J. M., and nem,3992 Uau, Chang,BÃ©langer,and Grenier, 162 Bateman, J. R. Survival of Patients with Meta Cohen, S. M., Aral, M., Jacobs, J. B., and Frie Chang, C-H., and Cheng, Y-c. Demonstration of static Breast Cancer Treated with Either Com dell, G. H. Promoting Effect of Saccharin and Two Components and Association of Adenosine bination or Sequential Chemotherapy: A West DL-Tmyptophanin Urinary Bladder Carcinogen Diphosphate-Cytidine Dlphosphate Reductase em Cancer Study Group Project, 4503 eels, 1207 fromCulturedHumanLymphoblastCells(Molt Cho.Chung, Y. S. See Shafie, Cho-Chung, and Colcher, D. See Drohan, Colcher, and Schlom, 4F), 436; Effects of Nucleoside Triphosphates Gullino, 2501 1696 on Human Ribonucleotide Reductase from Choi, Y. S. See Meriuzzi, Faanes, and Choi, 3647 Collste, L. G., Darzynkiewlcz, Z., Traganos, F., MOLT-4F Cells, 5087; Substrate Specificity of Chou, 1-C., Burchenal, J. H., Fox, J. J., Watan Sharpless, 1. K., Whitmore, W. F., Jr., and Human Rlbonucleotide Reductase from MOLT abe, K. A., Chu, C. K., and Philips, F. S. Me Melamed, N. R. Regional Lymph Node Reactiv 4F Cells,5081 tabolism and Effects of 5-(fl-D-Ribo ity in Explanted Bladder Cancer of Mice as Chang, R. L See Buening, Levin, Wood, Chang, furanosyl)isocytosine in P815 Cells, 720 Measured by Flow Cytometry, 2120 YagI, Kane, Jerina, and Conney, 1310; Levin, Chou, T-H. See Kessel, Ratanatharathomn,and Colly, L. See Agliettaand Colly,2727 Buenlng, Wood, Chang, Thakker, Jerina, and Chou, 3377 Colmerauer, M. E. M. See Belnap, Cleveland, Conney, 3549; Wood, Chang, Levin, Ryan, Chretlen, P. B. See Weiss,Morantz,Bradley,and Colmerauer, Barone, and Pilch, 1174 Thomas, Mah, Karie, Yagi, Jerina, and Conney, Chretien, 542 Colvin, M. See Brundrett,Colvin,White, Mckee, 4069 ChrIstensen, D. A. Thermal Dosimetry and Tem Hartman, and Brown, i 328 Chang, R. L, Wlslocki, P. G., Kapitulnik, J., pematureMeasurements, 2325'' Comls, R. L, Griffin, 1. W., Raso, V., and Gins Weed, A. W., Levin, W., Yagi, H., Mah, H. D., Christensen, I. See Sanner, Brennhovd, Christen berg, S. J. Pharmacokinetics of the Protein Jades, D. M., and Conney, A. H. Carcinogenic sen, Jorgensen, and Kvaley, 654' Antitumor Antibiotic Neocarzinostatin after lty of 2-Hydroxybenzo(a)pyrene and 6-Hydrox Christensen, T., and Moan, J. Photodynamic In Bolus Injection in Humans, 757 ybenzo(a)pyrene in Newborn Mice, 2660 activation of Synchronized Human Cells in Vitro Comic, R. L., Kupplnger, M. S., Ginsberg, S. J., chang, S.K., Harrington, G. W., Rothsteln, M., in thePresenceof Hematopomphyrin,3735 Crooke, S. T., Gilbert, R., Auchlncloss, J. H., Shergalls, W. A., Swern, D., and Vohra, S. K. Christensen, W. L. See Long, Bruszewski, Chris and Prestayko,A. W. The Roleof SingleBreath AcceleratIng Effect of Ascorbic Acid on N-Ni tensen, and Suk, 2995 Carbon Monoxide Diffusing Capacity in Moni trosamine Formation and Nitrosation by Oxy Chu, C. K. See Chou,Burchenal,Fox, Watanabe, toring the Pulmonary Effects of Bleomycin in hyponitrite, 3871 Chu, and Philips, 720 Germ Cell Tumor Patients, 5076 Chany, C. See Bourgeade, Cerutti, and Chany, Chu, F-F. See Baumannand Chu, 3540 Commer, P. See BÃ©langer,Commer, and Chiu, 4720 Chubb, S. See Plunkett, Alexander, Chubb, and 2141 Chapman, C. M. See Lin, Inglis, Rule, Turksoy, Loo, 3655 Comogllo, P. N., Pani, B., Prat, M., Tarone, G., Chapman, Kirley, and Stobach, 4894 Chute, R. N. See Brown, Warren, Chute, Ryan, and Montl-Bragadln,C. Relationshipbetween Chatt@, S. K., Bhattacharya, M., and Barlow, and Todd, 3971 Rous Sarcoma Virus-induced Expression of J. J. Glycosyltransferaseand GlycosidaseAc ChutnÃ¢,J. See HolÃ¡Ã±,ChutnÃ¡,and Ha@ek,593' Membrane Antigen and Phenotypic Transfor tivities in Ovarian Cancer Patients, 1943 Ciminera, J. L. See Mantel and Ciminera, 4308 mation,4745 Chattopadhyay, S. K., Jay, G., Lander, M. R., Clmino, M. C., Rowley,J. D., Klnnealey, A., Var Condoulls, W. See Bhatti, Ablin, Condoulis, and and Levies, A. S. Correlation of the Induction lakojls, D., and Golomb, H. M. BandingStudies Guinan, 3328 ofTranscrIptionoftheAKRMouseGenomeby of Chromosomal Abnormalities in Patients with Conklin, R. See Simon,Burlingham,Conklin,and 5-Iododeoxyuridlne with the Activation of an Acute Lymphocytic Leukemia, 227 Fondy, 3897 Endogenous Murine Leukemia Virus, 1539 Civerchla,L. See Filardi,Codish,Civerchia,How Conloy, F. K. Development of a Metastatic Brain Chavin, W. See Chen, Um, and Chavin, 3485 ard, and McKneally, 3673 Tumor Model in Mice, 1001 Chawla, R. K. See Rudman, Chawla, Nixon, Vog Clark, J. H. See Watson, Medina, and Clark, 4098 Conney, A. H. See Buening,Levin, Karle, Yagi, ler, Keller, and MacDonell, 699 Clawson, R. E. See Egorin, Clawson, Ross, Jerina, and Conney, 5063; Buening, Levin, Chello, P. L, Sirotnak, F. M., and Dorick, D. M. Schlossberger, and Bachur, 4396 Wood, Chang, Yagi, Karle, Jemina,and Conney, Different Effects of vincmistineon Methotrexate Cleaver, J. E. See Brown, Fickel, Cleaver, Loh 1310; Chang, Wislocki, Kapitulnik, Wood, Uptake by Li 210 Cells and Mouse Intestinal man, Wade, and Waters, 2522 Levin, Yagi, Mah, Jerina, and Conney, 2660; Epithella in Vitro and in Vivo, 2106 Cleuter, Y. See Bex, Bruck, Mammerickx, Porte Levin, Buening, Wood, Chang, Thakker, Jerina, Chsn, C-h. B. See McCoy, Chen, Hecht, and telle, Ghysdael, Cleuter, Leclercq, Dekegel, and and Conney, 3549; Slaga, Bracken, Gleason, McCoy, 793 Bumny,1118 Levin, Yagi, Jerina, and Conney, 67; Wood, Chsn, C-h. B., Fung, P. T., and Hecht, S. S. Cleveland, P. H. See Belnap, Cleveland, Colmer Chang, Levin, Ryan, Thomas, Mah, Karle, Yagi, Assay for Microsomal a-Hydroxylation of N'-Ni auer, Barone, and Pilch, 1174 Jerina, and Conney, 4069 trosonorntcotine and Determination of the Deu Cline, J. C. See McMahon,Cline,andThompson, Conrad, H. E. See Roll, Webem,and Conrad, 2550 terium Isotope Effect for a-Hydmoxylation,5057 682 Cook, J. L., Kirkpatrick, C. H., Rabson, A. S., Chei@,V. M., Urn, B. T., and Chavin, W. Serum Codist@,S. D. See Filardi, Codish, Civerchia, How and Lewis, A. M., Jr. Rejectionof Adenovirus Tyrosinase in Malignant Disease, Its Activity, ard, and McKneally, 3673 2-transformed Cell Tumors and Immune Re and the ElectrophoreticPatternsof the Enzyme Coffey, D. S. See lsaacs, Isaacs, and Coffey, sponsiveness in Syrian Hamsters, 4949 as Carded by Immunoglobulins, 3485 2652 Cook, J. L., and Lewis, A. M., Jr. Host Response Cheng, P-J. See Kitamuma,Levine, Cheng, Egeli, Coggin, J. H., Jr. Induction of Transplantation to Adenovirus 2-transformed Hamster Embryo Liu,Good,andDay,2909 Resistance with Soluble Simian Virus 40-in Cell, 1455 Cheng, V-c. See Chang and Cheng, 436; 5081; duced Hamster Tumor-specific Transplantation Cook, J. L., Lewis, A. M., Jr., and Kirkpatrick, C. 5087 Antigen, 2952 H. Age-relatedand Thymus-dependentRejec Chervenick, P. A. See Joyce, Hartmann, and Coggln, J. H., Jr., and zur Hausen, H. Workshop tionofAdenovirus2-transformedCellTumorsin Chervenick, 215 on Papillomaviruses and Cancer, 545, Meeting the Syrian Hamster, 3335

DECEMBER1979 5191 Author Index to Volume 39

Cook, M. G. See Ashman, Cook, and Kotlarski, Dahlqvist, A. See Bauer, Asp, Oste, Dahlqvist, Saint Cyr, 29i 9 2768 and Fredlund, 3752 Dewey, W. C. Recommendations for Future Re Coombe, M. M., Kissonerghis, A-M., Allen, J. A., Dalgard, D. W. See Sieber, Correa, Dalgard, and search in Hyperthermia at the Molecular, Cel and Vose, C. W. Identificationof the Proximate Adamson, 4545 lular, and Animal Levels, 2330' â€˜, See also and Ultimate Forms of the Carcinogen 15,16- Dannaher, C. L. See Liu, Stallard, Koo, and Dan Coss, Dewey, and Bambumg,191 1; Raaphorst, Dihydro- 11-methylcyclopenta[a]phenanthren - naher, 1640 Romano, Mitchell, Bedford, and Dewey, 396 17-one,4160 DarzynklewIcz, Z. See Collste, Darzynkiewicz, Dexter, D. L See Berkelhammer, Caines, Dexter, Cooper, H. K. See Swenberg, Cooper, BUcheler, Traganos, Sharpless, Whitmore, and Melamed, Adelstein, Oxenhandler, and Hook, 4960 and Kleihues, 465 2120; Evenson, Damzynkiewicz,Staiano-Coico, Dexter, D. L, Barbosa, J. A., and Calabresi, P. Cooper,I.A. See Woodcock,Fox,and Cooper, Traganos, and Melamed, 2574 N,N-Dimethylformamide-induced Alteration of 1418 Das, N. R., and Mink, M. M. SequenceHomology Cell Culture Characteristics and Loss of Tumor Cooperband, S. R. See Leong, Cooperband, of Nucleic Acids from Human Breast Cancer igenicity in Cultured Human Colon Carcinoma Deckers, Sutherland, Cesare, and Krementz, Cells and Complementary DNA's from Murine Cells, 1020 2125 Mammary Tumor Virus and Mason Pfizer Mon Diamond, L. See O'Brien, Lewis, and Diamond, Cornetta, K. See Lysik, Comnetta,DiStefano, and key Virus, 5106 4477 Zucker, 30 Daskal, V. See Busch, Daskal, Gyorkey, and Sme Dicke, K. A. See Spitzer, Verma, Barlogie, Beran, Correa, P. See Sieber, Commea,Dalgard, and Ad tana, 857; Merski, Daskal, Crooke, and Busch, and Dicke, 3215 amson, 4545 1239 Dieckman, J. See Valerlote, Medoff, and Dieck Corry, P. M. See Barlogie, Corry, Yip, Lippman, Dave, C. See Feuerstein,Porter,and Dave,4i 30; man, 204i Johnston, Khalil, Tenczynski, Reilly, Lawson, Mikles-Robertson, Feuerstein, Dave, and Por Diegelmann, R. F. See Cohen, Moncure, Wi Dosik, Rigor, Hankenson, and Freimeich,1481 tem, 1919; Porter, Mlkles-Robertson, Kramer, torsch, and Diegelmann, 2923 Corwin, L. M., Varshavsky-Rose, F., and Broit and Dave, 2414; Rustum, Dave, Mayhew, and DiGiovanni, J. See Slaga, Gleason, DiGiovanni, man, S. A. Effect of Dietary Fats on Tumori Papahadjopoulos, 1390 Sukumaran, and Harvey, 1934 genidity of Two Sarcoma Cell Lines, 4350 Davidson,E. A. See Chandrasekaranand David Dion,P. SeeKakizoe,Wang,Eng,Furrer,Dion, Cory, J. G., Breland, J. C., and Carter, G. L. son, 870 and Bruce, 829 Effect of 5-Fluorouracil on RNA Metabolism in Davies, M., and Sabbadini, E. Dose-dependent DiPaolo, J. A. See Casto, Meyers, and DiPaolo, Novikoff Hepatoma Cells, 4905 Adjuvant Effects of Bacillus Calmette-GuÃ«rinon 193; Gart, DiPaolo, and Donovan, 5069 Cory, J. G., and Fleischer, A. E. SpecificInhibi Tumor Immunity in Lewis Rats, 959 DiPaolo, J. A., and Casio, B. C. Quantitative tors Directed at the Individual Components of Davis, D. W. See Durkin, Ghanta, Balch, Davis, Studies of in Vitro Morphological Transforma Ribonucleotide Reductase as an Approach to and Hiramoto, 402 tion of Syrian Hamster Cells by Inorganic Metal Combination Chemotherapy, 4600 Davis, F. M. See Busch, Gyorkey, Busch, Davis, Salts, 1008 Co.., R. A., Dewey, W. C., and Bamburg, J. R. Gyorkey, and Smetana, 3024; Marashi, Davis, Dipple, A. See lype, Tomaszewski, and Dipple, Effects of Hyperthermia (41.5Â°)on Chinese Busch, Savage, and Busch, 59 4925 Hamster Overy Cells Analyzed in Mitosis, 191 1 Dawson, J. R. See Hess, Gall, and Dawson, 2381; Dipple, A., Tomaszewski, J. E., Moechel, R. C., Costa, M., Nyc, J. 5., Sunderman, F. W., Jr., Yamashita, Aitio, and Dawson, i 760 Bigger, C. A. H., Nebzydoski, J. A., and Egan, Allpass, P. R., and Gondos, B. Inductionof Dawson, P. J., Dresler, S. 1., and Fleldsteel, A. M. Comparisonof Metabolism-mediated Binding Sarcomas in Nude Mice by Implantation of Syr H. ErythroidLeukemiaInducedby FriendLym to DNA of 7-Hydroxymethyl-i 2-methylbenz ian HamsterFetal Cells Exposedin Vitro to phatic Leukemia Virus in T-CeIl-depleted Mice, (a)anthracene and 7,12-Dimethylbenz(a)an Nickel Subsulfide, 359i i6i 1 thracene, 1154 Costanza, M. E. See Vaage and Costanza, 4466 Day, N. K. See Kitamura, Levine, Cheng, Egeli. Dirks, J. W. See Wheeler, Dirks, Lunardi, and Coffer, S. M. See Francis, Cotter, Hardy, and Liu, Good, and Day, 2909 Nemiroff, 370 Essex, 3866 Deckers, P. J. See Leong, Cooperband, Deckers, DiStefano, J. F. See Lysik, Comnetta,DiStefano, Coulson, P. See Lozzio, Lopez, Coulson, and Lair, Sutherland, Cesare, and Kmementz,2125 and Zuckem,30 1529 DeclÃ¨ve, A., Lieberman, M., Bonlver, J., and DlStefano, J. F., Lysik, R., and Zucker, S. Pham Cox, R. Differencesin the Removalof N-Methyl Kaplan, H. S. In Vivo Infectivityof the Fibro macological Studies of the Mechanism of Tu N-nitrosourea-methylated Products in DNase I- tropic C-type Viral Isolates from Strain C57BL/ mom-inducedBone Marrow Cytolysis, i 193 sensitiveand -resistantRegionsof Rat Brain KaMice,4322 DiVIto, N. See Sarrif, White, and DiVito, 3903 DNA, 2675 Deen, D. F., Hoshino, T., Williams, M. E., No Dlx, D. E., Lehman, C. P., Jakubowskl, A., Crampton, S. L See McGovren,Neil, Denlinger, mura, K., and Bartle, P. M. Responseof 9L Moyer, J. D., and Handschumacher,R. E. Pym Hall, Crampton, and Swenberg, 4849 Tumor Cells in Vitro to Spirohydantoin Mustard, azofurin Metabolism and Enzyme Inhibition, and Crawford, B. D. See Barrett, Crawford, Mixter, 4336 Resistance Studies with L5i 78Y Cells in Cul Schechtman, Ts'o, and Pollack, 1504 de Harven, E. See Leducand de Harven,2811 ture, 4485 Creagan, E. T. See Kovach, Ames, Powis, Moer DeHeer, D. H. See Leung, Bordin, Nakamura, Dixon, G. H. See Peters, Nishi, Miura, Lorschei tel, Hahn, and Creagan, 4540 DeHeem,and Edgington, 2057 der, Dixon, and Tamaoki, 3702 Creech, H. J. Historical Review of the American DeHoog, J. V. See Welsch, McManus, DeHoog, Dmochowskl, L See Hixson, Bowen, Ohtsuki, Association for Cancer Research, Inc., 1941â€” Goodman, and Tucker, 2046 Scanlon, and Dmochowski, i 99 1978, page 1863 de Ipolyl, P. D. See Stehlin,Giovanella,de lpolyi, Do, H. M. T. See Allegra, Lippman, Thompson, Cress, A. E. See Herman, Cress, and Gerner, and Anderson, 2255â€• Simon, Barlock, Green, Huff, Do, and Aitken, 1937 Dekegel, D. See Bex, Bruck, Mammerickx, Porte 1447; Allegra, Lippman, Thompson, Simon, Croissant, 0. See Orth, Jablonska, Jarzabek telle, Ghysdael, Cleuter, Leclercq, Dekegel, and Barlock, Green, Huff, Do, Aitken, and Warren, Chorzelska, Obalek, Rzesa, Favre, and Crois Bumny,1118 1973 sant, 1074 Delclos, K. B., and Blumberg, P. M. Decrease in Doctor, G. See Vaught, Gurtoo, Parker, LeBoeuf, Crooke, S. T. See Comis, Kuppinger, Ginsberg, Collagen Production in Normal and Rous Sar and Doctor, 3177 Crooke, Gilbert, Auchincloss, and Prestayko, coma Virus-transformed Chick Embryo Fibro Doerjer, G. See Kleihues, Doerjer, Keefer, Rice, 5076; Galvan, Strong, and Crooke, 3948; Mer blasts Induced by Phorbol Myristate Acetate, Roller, and Hodgson, 5136 ski, Daskal, Crooke, and Busch, 1239; Sawyer, 1667 Dolhun, P. J. See Minkel, Dolhun, Calhoun, Sam Prestayko, and Crooke, 1180 de Leon, L D. See Breitkmeutz,do Leon, Paglia, yan, and Petering, 2451 ; Saryan, Minkel, Del Croy, R. G. See Autrup,Essigmann,Croy,Trump, Gay, Swarm, and Stern, 5093 hun, Calhoun, Wielgus, Schaller, and Petering, Wogan, and Harris, 694 Denllnger, R. H. See McGovren, Neil, Denlingem, 2457 Cummings,F. J. See Stollem,Kaplan,Cummings, Hall, Crampton, and Swenberg, 4849 Donoso, J. A., Hasklns, K. M., and Himes, R. H. and Calabmesi,908 Dennert, G. See Lotan and Dennert, 55 Effect of Microtubule-associated Proteins on the Custer, R. P. See Tonelli,Custer,andSorof,1784 Dent, P. B. See Liao, kwong, Thompson, and Interaction of Vincristine with Microtubules and Cuthbertson, T. L. See Li, Li, and Cuthbertson, Dent, 183 Tubulin, 1604 2647 Denys, F. R. See Parmley, DahI, Austin, Gauthier, Donovan, M. K. See Sani and Donovan, 2492 Cysyk, R. L. See Magin, Sikic, and Cysyk,3792 and Denys, 3834 Donovan, P. J. See Gart, DiPaolo, and Donovan, Deodhar, S. D. See Bamnaand Deodham,27i i; 5069 Gautam and Deodhar, 2945; Kumar, Chiang, Dorick, D. M. See Chello, Sirotnak, and Dorick, D and Deodhar, 3515 2106 Derbes, V. J. See Ichinose, Powell, Hoemner, Doroshow, J. H. See Ozols, Locker, Doroshow, DahI, G. V. See Parmley,DahI, Austin,Gauthier, Derbes, and Byers, 4270 Grotzinger, Myers, and Young, 3209 and Denys, 3834 Dethlefsen, L. A. See Henle, Bitner, and Dethlef Dosik, G. See Barlogie, Cormy, Yip, Lippman, DahIIg, E. See Case, Dahlig, Lau, Lynch, and sen. 2486 Johnston, Khalil, Tenczynski, Reilly, Lawson, Paterson, 1245 de Vaux Saint Cyr, C. See Heimerand do Vaux Dosik, Rigor, Hankenson, and Freireich, 1481

5192 CANCERRESEARCHVOL. 39 Author Index to Volume 39

Dougherty, 1. J. See Gomer and Dougherty, 146 gan, 5016 trosourea, 408 Douglas, G. R. See Nestmann, Douglas, Matula, Eaklns, K. E. See Mufson,Kulkamni,Eakins,and Epstein, R. B. See Beschorner, Hess, Nerenberg, Grant, and Kowbel,4412 Weinstein, 3602 and Epstein, 3920 Douglass, H. 0., Jr. See Goldrosen, Russo, How Eastman, A., and Bresnick, E. Metabolismand Erbe, R. W. See Umbreit and Erbe, 2001 elI, Leveson, Moore, Holyoke, and Douglass, DNABindingof 3-Methylcholanthrene,4316; Erickson, B. W. See Shackney, Erickson, and 633' Persistent Binding of 3-Methylcholanthrene to Skramstad, 44i8 Dray, S. See Mokyr, Braun, and Dray, 785; Mokyr, Mouse Lung DNA and Its Correlation with Sus Erlichman, C., Strong, J. M., Wlernlk, P. H., Hengst,Przepiorka,and Dray, 3928 ceptibility to Pulmonary Neoplasia, 2400 McAvoy, L M., Cohen, M. H., Levine, A. S., Dreslor, S. L. See Dawson, Dmesler,and Field Ebina, T. See Yahara, Iwashita, Ebina, Satake, Hubbard, S. M., and Ohabner, B. A. Phase 1 steel, 1611 and Ishida, 4687 Trial of N-(Phosphonacetyl)-L-aspartate, 3992 Drevon, C. See Huberman, Montesano, Drevon, Ebner, K. E. See Prasad and Ebner, 3598 End, I. J., Nesbit, M. E., Hammond, D., Weiner, Kuroki, St. Vincent, Pugh, and Goldfarb, 269; Eboll, M. L. See Chiaretti, Casciaro, Minotti, Eboli, J., and Sather, H. Effective Dose of L-Aspa Kurokiand Drevon,2755 and Galeotti, 2195 raginase for Induction of Remission in Previ Drewinko, B. See Bergerat, Bamlogie,and Dre Eboll,N. L., MalmstrÃ¶m,K., Galeotti,T., Lopez ously Treated Children and Acute Lymphocytic winko, 1334; Bergerat, Barlogle, GÃ¶hde,John Alarcon, L, and Carafoll, E. Calcium Transport Leukemia: A Report from Children's Cancer ston, and Drewinko, 4356; Roper, Drewinko, and Translocation of Adenine Nucleotides in Study Group, 3893 Tsukeda,Mizuno,andNitta,i 428 Mitochondria from Morris Hepatoma 3924A, Essex, M. See Azocar and Essex, 3388; Francis, Drewinko, B., BarIOgIe, B., and Freireich, E. J 2737 Cotter, Hardy, and Essex, 3866; Grant, Pickard, Responseof Exponentially Growing, Stationary Echeverria, 0. M. See VÃ¡zquez-Nin,Echevermia, Ramaika, Madewell, and Essex, 75 Phase, and Synchronized Cultured Human Co and Pedron, 4218 Esslgmann, J. M. See Autrup, Essigmann, Croy, Ion Carcinoma Cells to Treatment with Nitmosou Edglngton, T. S. See Leung, Bordin, Nakamura, Trump, Wogan, and Harris, 694 rca DerIvatives,2630 DeHeer, and Edgington, 2057 Etschenberg, E. See Schorlemmer, Opitz, Ets Driedgsr, P. B., and Blumbeig, P. M. Quantitative Edstrom, S. See Lundholm, Ekman, EdstrÃ¤m, chenberg, Bitter-Suermann, and Hadding, 1847 CorrelatIon between in Vitro and in Vivo Activi Karlberg, Jagenbumg,and ScherstÃ©n,4657 Evans, D. L., Frank, M. K., McKlnnon,K. P., and tiesofPhorbolEsters, 714 Edwards, G. S., Fox, J. G., Poilcastro, P., Goff, Cerrone, M. Immunobiological Characteriza Ddnkwatar, N. R. See Miller, Kadlubar, Miller, U., Wolf, M. H., and Fine, D. H. VolatileNitros tions of Tumor-associated Fetal Antigens, 2016 Pitot, and Drinkwater, 3411 amine Contamination of Laboratory Animal Evans, D. L., Parker, D. V., and Frank, M. K. Drobnica, L See Miko, Drobnica, and Chance, Diets, 1857, Letter to the Editor Biochemical and Physical Characterizations of 4242 Edwards, M. S. See Marton, Edwards,Levin,Lu Tumor-associated Fetal Antigens, 2006 Drohan, W., Coicher, D., and Schlom, J. Use of bich, and Wilson, 993 Evans, R. M. See Laskin,Evans,Slocum,Burke, Molecular Hybridization to Detect Type D Retro Egan,M. See Dipple,Tomaszewski,Moschel,Big and Hakala, 383 virus Markers in Rhesus Placentas and Other gem,Nebzydoski, and Egan, 1154 Evenson, D. P., Darzynkiewlcz, Z., Staiano TIssues, 1696 Egell,R. A. Seekitamura,Levine,Cheng,Egeli, Colco, L, Traganos, F., and Melamed, M. R. Dubin, M. A. See Poirier, Dubin, and Yuspa, 1377 Liu, Good, and Day, 2909 Effects of 9,i 0-Anthracenedione, 1,4-Bis[[2- Dubrow, R., Riddle, V. G. H., and Pardee, A. B. Egorln, M. J., Clawson, R. E., Ross, L. A., [(2-hydroxyethyl)amino]ethyl]amino]-diacetate Different Responses to Drugs and Serum of Schlossberger, N. M., and Bachur, N. R. Cel on Cell Survival and Cell Cycle Progression in CellsTransformedbyVariousMeans,2718 lular Accumulation and Disposition of Aclacino Cultured Mammalian Cells, 2574 Duch, D. S., Blgner, D. D., Bowers, S. W., and mycin A, 4396 Nichol, C. A. Dihydrofolate Reductase in Pri Elsen, A. Z. See Bauer, Uitto, Walters, and Eisen, F mary Brain Tumors, Cell Cultures of Central 4594 Nervous System Origin, and Normal Brain dur Ekman, L. See Lundholm, Ekman, EdstrOm,Karl leg Fetal and Neonatal Growth, 487 berg, Jagenburg, and ScherstOn,4657 Faanes, R. B. See Merluzzi, Faanes, and Choi, Dudley, D. T. See Burns, Luttenegger, Dudley, El Abed, A. See Kemdelhueand El Abed, 4700 3647 Buettner, and Spector, 1726 Elcombe, B. M. See Winkelhake, Elcombe, and Faanes, R. B., Merluzzl, V. J., Williams, N., Tar Dunlap, J. E., Nichols, W. S., Hebebrand, L C., Hodach, 3058 nowskl,G. S., and Ralph,P. Matchingof Chem Mathes, L. E., and Olsen, R. G. Mobility of Elder, P. K. See Getz, Elder, and Moses, 321 otherapy to Mouse Strain and Lymphoid Tumor Lymphocyte Surface Membrane Concanavalin Elequin, F. See Bases, Rubinstein, Kadish, Men Type to Prevent Tumor-induced Suppression of A Receptors of Normal and Feline Leukemia dez, Wittner, Elequin, and Llebeskind, 3524 Specific T- and B-Cell Functions, 4564 Virus-infected Viremic Felines, 956 Elford, H. L, Wampler, G. L., and van't RIet, B. Fache, M-P., Lepault, F., Zelick, R., and Frlndel, Dunn, D. L., Lubst, R. A., and Prough, R. A. The New Ribonucleotide Reductase Inhibitors with E. Influenceof FactorsDerivedfrom EMT6Tu Oxldative Metabolism of Procarbazine, A Them Antineoplastic Activity, 844 momsand from Bone Marrow of Tumor-beaming apeutic 2-Methylbenzylhydrazine, 4555 Elfstrom, G. See Carlstedt-Duke, ElfstrÃ¶m,Hog Mice on Tumor and Bone Marrow Stem Cell Dunn, J. 1. See Cave, Dunn, and MacLeod, 729 berg, and Gustafsson, 4653 Kinetics, 3959 Dunn, P. See Urano, Suit, Dunn, Lansdale,and Elklnd, M. M. See Han and Elkind,123 FahI, W. E. See Shen, FahI, Wrighton,and Jef Sedlacek, 3454 Elliott, A. V. See Williams, Bronson, Myl, Vande coate, 4123 Duquesnoy,R. J., and Pedersen,G. M. Inhibitory voorde, and Elliott, 2447 Fallen, M. See Wang, Steele, Mannick, Fallon, Effect of Growth Hormone on Gross Passage A EllIott, R. S. See Storm, Harrison, Elliott, and and Onikul, 1702 Virus-induced Thymus Leukemia in C3Hf Mice. Morton, 2245â€• Fang, V. S. Cytotoxic Activity of 1-(o-Chloro 41@ Emerson, R. L See Smith, Emerson, and Nixon, phenyl)-i -( p-chlorophenyl)-2,2-dichlomoethane Durkln, W. J., Ghanta, V. K., Belch, C. M., Davis, 2132 (Mitotane) and Its Analogs on Feminizing Adme D. W., and Hlramoto, R. N. A Methodological Endoh, N. See Sekiya, Endoh, Kikuchi, Katoh, nal Neoplastic Cells in Culture, 139 Approach to the Prediction of Anticancer Drug Matsuura, Iwasawa, Takeda, and Takamizawa, Farber, E. See Abanobi, Farber, and Sarma, Effect in Humans, 402 1108 1592; Tsuda, Sarma, Rajalakshmi, Zubroff, Far Durr, F. B. See Wallace, Murdock, Angler, and Endrich, B., Intaglietta, M., Reinhold, H. S., and ber, Batzinger, Cha, and Bueding, 4491 Duff, 1570 Gross, J. F. Hemodynamic Characteristics in Farquhar, D. See Benvenuto, Hall, Farquhar, Dussaulx, E. See Rousset, Chevalier, Roussot, Microcirculatory Blood Channels during Early Stewart, Benjamin, and Loo, 349; Benvenuto, Dussaulx, and Zweibaum, 531 Tumor Growth, i 7 Liehr, Winkler, Farquhar, Caprioli, and Loo, Dworsky, R. See Henderson, Dwomsky,Pike, Bap Eng, V. W. S. See Kakizoe, Wang, Eng, Furrer, 3199 tlsta,Menck,Preston-Martin,andMack,4507 Dion, and Bruce, 829 Farrelly, J. G. See Hecker, Farrelly,Smith, Sea Dybing, B., SÃ¸derlund,E., Haug, L T., and Thor Enouf, J., Lawrence, F., Tempete, C., Robert vedra, and Lyon, 2679 geiresen, S. S. Metabolism and Activation of 2- Gero, M., and Loderer,E. Relationshipbetween Favre, M. See Orth, Jablonska,Jarzabek-Chor AcetylaminofluoreneIn Isolated Rat Hepato Inhibition of Protein Methylase I and Inhibition zelska, Obalek, Rzesa, Favre, and Croissant, cytes, 3268 of Rous Sarcoma Virus-induced Cell Transfor i 074 Dybing, E., von Bahr, C., Aune, T., Glaumann, mation, 4497 Fay, J. W. See Hanker, Ambrose,James, Man H., Levitt, 0. S., and Thorgeirsson, S. S. In Ensminger, W. D. See Garnick, Ensminger, and delkomn,Yates, Gall, Bosson, Fay, Laszlo, and Vitro Metabolism and Activation of Carcinogenic Israel, 4105; Glode, Pitman, Ensminger, Ro Moore, 1635 Aromatic Amlnes by Subcellular Fractions of sowksy, Papathanasopoulos, and Frei, 3707 Feamey, F. See Whitehead, Feamney,and Kim, Human Uver, 4206 Epstein, A. L, and Kaplan, H. S. Feeder Layer 1259 and Nutritional Requirements for the Establish Feldman, D. Virus Particles in the Basal Plate of E mont and Cloning and Human Malignant Lym Rhesus Monkey and Baboon Placenta, 1772 phoma Cell LInes, 1748 Fentiman, I. S., Hurst, J., Cerianl, R. L, and Epstein, J. H. Stimulation of Ultraviolet-induced Taylor-Papadlmltrlou,J. JunctionalIntercellu Eagan, R. T. See Ames, Powis, Kovach, and Ea Carcinogenesis by 1,3-Bis(2-chloroothyl)-i -ni lar Communication Pattern of Cultured Human

DECEMBER1979 5193 Author Index to Volume 39

Breast Cancer Cells, 4740 Fogler, W. E. See Paste, Kirsh, Fogler, and Fidler, Friedman, S. J., and Skehan, P. Morphological Feola, J. M. See Hurley, Allen, Feola, and Lubawy, 88i Differentiation of Human Choriocarcinoma Cells 3134 Foldart, J-M. See Furcht, Masher, Wendel Induced by Methotrexate, 1960 Fernandes, D. J., and Klubes, P. A Biochemical schafer-Crabb, and Foidart, 2077 Frlkke, M. See Malley, Burger, Vandenbark, and Pharmacological Study of Therapeutic Syn Folkman, J. See Bissell, Bartholomew, Folkman, Frikke, Finke, Begley, Acott, Black, and Vetto, ergism with 5-Fluorouracil plus Cyclophospha Smith, and Stampfer, 4293 619' mide in Murine L1210 Leukemia, 1396 Folse,D. S. See Patel,False,andHoloubek,4460 Frindel, E. See Fache, Lepault, Zelick, and Frin Ferrer, J. F. See Jemabek,Gupta, and Ferrer, Fondy,T. P. See Simon,Burlingham,Conklin,and del, 3959 3952 Fondy, 3897 Fresco, E. See Begleiter, Lam, Grover, Froese, Feuerstein,B. See Mikles-Robertson,Feuerstein, Fondy, T. P., Tsiftsoglou, A. S., Jacoby, R. 0., and Goldenberg, 353 Dave, and Porter, 1919 and Sartoreill, A. C. Immunogenicityof Friend Frondoza, C. G., Trivedi, S. M., and Humphrey, Feuerstein, B., Porter, C. W., and Dave, C. A Erythroleukemia Cells Altered in Culture by R. L TemporaryDisappearance(â€œEclipse'â€˜)of Selective Effect of Methylglyoxal-bis(gua Chemical or Physical Agents, 3583 LPC-i Plasmacytoma M Component Synthesis nylhydrazone) on the Synthesis of Mitochondrial Foe, M. S. See Adams, Pewnim, Chandra, Archi following Tumor Cell Transfer, 2497 DNA of Cultured Li 21 0 Leukemia Cells, 4130 bald, and Faa, 5124 Frost, P. See Wiltrout, Frost, Morrison, and kem Flalkoff, H., Goodman, M. F., and Seraydarlan, Fornace, A. J., Jr., and Lfttle, J. B. DNA-Protein bel, 4034 M. W. DifferentialEffect of Adriamycinon DNA Cross-Linking by Chemical Carcinogens in Fry, S. E. See Buick, Stanisic, Fry, Salmon, Trent, Replicative and Repair Synthesis in Cultured Mammalian Cells. 704 and krasovich, 5051 Neonatal Rat Cardiac Cells, 1321 Forni, G. SeeVameslo,Giovarelli,Landolfo,and Frytak, S. See O'Connell, Moertel, Ritts, Frytak, Flbach,E.SeeYamasaki,Weinstein,Fibach,Rif Fomni,4983 and Reitemeier, 3720 kind, and Marks, 1989 Forsgren, B., Gustafsson, J-A., Pousette, A., and Fujil, S. See Niinobe, Tamura, Arima, and Fujil, Fickel, T. H. See Brown,Fickel,Cleaver,Lohman, Hogberg, B. Binding Characteristics of a Major 4212 Wade, and Waters, 2522 Protein in Rat Ventral Prostate Cytosol that In Fujlmura, M., See Pfeiffer, Nagal, Fujimura,and Fldler, I. J. See Poste, Kirsh, Fogler, and Fidler, teracts with Estramustine, a Nitrogen Mustard Tobe, i904 881 Derivative of 17fl-Estradiol, Si 55 Fujlmura,S. See Sakiyama,Akiba,and Fujimura, FIdler, I. J., Gersten, D. N., and Kripke, M. L. Fosseti,M. C.,IIISee Imashuku,Fossett,and 502 Influence of ImmuneStatus on the Metastasis of Green, 3006 Fujlta, M., Takaml, M., Usugane,M., Nampel, S., Three Murine Fibmosarcomasof Different Im Fowler, A. K. See Hellman, Weislow,Twardzik, and Taguchl, 1. Enhancementof Gastric Car munogenicities, 38i 6 and Fowler, 2902 â€˜ cinogenesis in Dogs Given N-Methyl-N'-nitro-N Fleldsteel, A. H. See Dawson, Dresler, and Field Fox, J. G. See Edwards, Fox, Policastro,Gaff, nitrosoguanidine following Vagotomy, 811 steel, 1611 Wolf, and Fine, 1857 Fukuda, M. See Koyama, Nudelman, Fukuda, and Fllardl, M. J., Codlsh, S. D., Civerchia, L., How Fox, J. J. See Chou, Burchenal,Fox, Watanabe, Hakomori, 3677 aid, R. K., and McKneally, M. F. Toxicity of Chu, and Philips, 720 Fukuhara, S., Rowley, J. D., Varlakojls, D., and Intrapleural Bacillus Calmette-Gudrin Treatment Fox, P. A. See Heal, Fox, and Schein,82 Golomb, H. N. Chromosome Abnormalities in in Animals, 3673 Fox, R. N. See Woodcock, Fox, and Cooper, Poorly Differentiated Lymphocytic Lymphoma, Fllipski,J. See Zwelling,Filipski,and Kohn,4989 i 4i 8 3ii9 Fimmel, P. J. See Holt,Fimmel,Finlay-Jones,and Fralley, J. See Jubiz, Frailey, and Smith, 998 Fukushlma, H. See Isohashi, Tsukanaka, Terada, Flower, 564' Francis, D. P., Cotter, S. M., Hardy, W. D., Jr., Nakanishi, Fukushima, and Sakamoto, 5i 32 Finch,L. R. See Harris,Reynolds,and Finch,538 and Essex,M. ComparisonofVirus-positiveand Fung, P. T. See Chen, Fung,and Hecht, 5057 Fine, D. H. See Edwards, Fox, Policastro,Goff, Virus-negative Cases of Feline Leukemia and Funkhouser, W. See Woo, Perini, Sadow, Sulli Wolf, and Fine, 1857 Lymphoma, 3866 van, and Funkhouser, 2429 FInk,D.J. CancerOverview,28i 9â€• Frank, M. K. See Evans, Frank, McKinnon,and Furcht, L T., Mosher, D. F., Wendelschafer Finke, P. See Malley,Burger,Vandenbark,Frikke, Cerrone, 2016; Evans, Parker, and Frank, 2006 Crabb, G., and Foldart, J-M. Reversal by Glu Finke, Begley, Acott, Black, and Vetto, 619 â€¢; Fraumeni,J. F., Jr. EpidemiologicalOpportunities cocorticoid Hormones of the Loss of a Fibmo Tong, Burger, Finke, Barney, Vandenbark, and in Alcohol-related Cancer, 285i â€œ nectin and Procollagen Matrix around Trans Vetto,597' Fraval, H. N. A., and Roberts, J. J. Excision formed Human Cells, 2077 Flnlay-Jones, L. M. See Holt, Fimmel, Finley Repair of cis-Diamminedichloroplatinum(Il)-in Furrer, R. See Kakizoe,Wang, Eng, Furrer,Dion, Jones, and Flower, 564' duced Damage to DNA of Chinese Hamster and Bruce, 829 Fischer, G. See Kollmorgen, Sansing, Lehman. Cells, 1793 FUrstenberger,G. SeeMarks,Bertsch,andFÃ¼r Fischer, Longley, Alexander, King, and McCay, Frazer, T. See Sedwick, Kutler, Frazer, Brown, stenberger, 4i83 3458 and Laszlo, 3612 Furukawa, K. See Tsukada, Gotoh, Mochizuki, Fischer, J. E. See Krause, James, Humphrey, and Fredlund, P. E. See Bauer, Asp, Oste, Dahlqvist, and Furukawa, i 628 Fischer, 3065 and Fredlund, 3752 Fuscoe, J. C., O'Neill, J. P., Peck, R. M., and FIscher, S. M., See Mufson, Fischer, Vemma,Glee Freed, H. See Langenbach, Malick, Tompa, Ku HsIe, A. W. Mutagenicity and Cytotoxicity of 19 son, Slaga, and Boutwell, 4791 szynski, Freed, and Huberman, 3509 Heterocyclic Mustards (ICRCompounds) In Cul FIscher, V. W. See Nadel, Thompson, Fischer, Freedman, H. J. See Gurtoo, Parker, Paigen, tured Mammalian Cells, 4875 and Klein, 2221 Havens, Minowada, and Freedman, 4620 Fisher, B. See Gunduz, Fisher, and Saffer, 3861 Freedman, H. J., Gurtoo, H. L., Mlnowada, J., G Fisher, B., Gebhardt, M. C., Safer, E. A., and Palgen, B., and Vaught, J. B. Aryl Hydrocarbon Fisher,E. R. Effectof Corynebacteriumparvum Hydroxylase (AHH) in a Stable Human B-Lym on Liver Proliferation and Regeneration, 1361 phocyto Cell Line, RPMI-i 788, Cultured in the Galeottl, 1. See Chiametti,Casciamo,Minotti, Eboli, Fisher,B., Wolmark, N., and Safler, E. A. Cellular Absence of Mitogens, 4605 and Galeotti, 2i 95; Eboli, MalmstrOm,Galeotti, Cytotoxicity and Serum Inhibition in Normal Freedman, H. J., Parker, N. B., Marinello, A. J., LOpez-AlarcÃ´n,and Carafoli, 2737 Mice following Transfer of Xenogeneic Tumor Gurtoo, H. L., and Minowada, J. Induction, GalIn, M. See Hill, Hill, Miller, Pfaller,Weiss,and Sensitized Cells, 4772 Inhibition, and Biologic Properties of AryI Hydro Galin, 934 Gallvan, J. Transportand Metabolismof Metho Fisher, E. R. See Fisher, Gebhamdt,Saffem,and carbon Hydmoxylase(AHH) in a Stable Human trexate in Normal and Resistant Cultured Rat Fisher, 1361 B-Lymphocyte Cell Line, RPMI-1788, page 4612 Hepatoma Cells, 735 Fisher, P. B. See Mufson, Fisher, and Weinstein, Freeman, H. J. See Tsao, Freeman, and Kim, Gall, S. A. See Hanker, Ambrose,James, Man 3915 3405 delkomn,Yates, Gall, Bossen, Fey, Laszlo, and Fisher, P. B., Goldstein, N. I., and Weinstein, I. Frel, E., III See Glode, Pitman, Ensminger,Ro Moore, 1635; Hess, Gall, and Dawson, 238i B. PhenotypicPropertiesand TumorPromoter sowsky, Papathanasopoulos, and Frel, 3707; Galvan, L, Strong, J. E., and Crooks, S. T. Use induced Alterations in Rat Embryo Cells Trans Howell, Krishan, and Frel, 1315 of PM-2 DNA Degradation as a Pharmacokinetic formed by Adenovirus, 3051 Freireich, E. J See Bangle, Corry, Yip, Uppman, Assay for Bleomycin, 3948 Fisher,R. I. See Ozols,Grotzingem,Fisher,Myers, Johnston, KhaIiI, Tenczynski, Reilly, La@son, Gams, R. A. See Ostroy, Johnston,and Gems, and Young, 3202 Dosik, Rigor, Hankenson. and Freireich, i,$81; 497i FItzpatrick, H. F. See Ramey, Hashim,Burrows, Drewinko, Barlogle, and Freireich. 2630; Rao, Gander, R. J. See Moon, Thompson, Becci, Swistel, Munther, and Fitzpatrick, 4796 Freireich, Smith, and Loo, 3152 Grubbs, Gander, Newton, Smith, Phillips, Hen Fladmoe, A. V. See Wattenberg, Lam, and Fled Freund, G. PossibleRelationshipsof Alcoholin derson, Mullen, Brown, and Sporn, 1339 moo, i651 Membranes to Cancer, 2899' Garbaczewski, L. See Hill, Wyndem, Gamba Flelscher, A. E. See Cory and Fleischer, 4600 FrIedell, G. H. See Cohen, Arai, Jacobs, and czewski, Games, and Walker, 5101 Flower, R. L. See Holt, Fimmel, Finlay-Jones, and Friedell, 1207 Games, H. See Hill, Wynder, Gambaczewski, Flower, 564' Frledlander, P. See Thomson, Tataryn, O'Connor, Games, and Walker, 5101 Fogh, J. See Sharkey and Fogh, 833 Rauch, Friedlander, Gold, and Shuster, 604' Garnlck, M. B., Ensmlnger,W. D., and Israel, M.

5194 CANCER RESEARCH VOL. 39 Author Index to Volume 39

A ClInIcal-PharmacologIcalEvaluationof He Rats, 4579 stein, 3051 patic ArterIal Infusion of Adriemycin, 4105 Ginsberg, S. J. See Comis, Griffin, Reso, end Gollahon, K. A. See Wood. Tilzer, Gollahon, end GarcIa, A. E. See Powell, Garole, Chemness, and Ginsberg, 757; Comis, Kuppinger, Ginsberg, Undsay, 4588 McGulre, 1678 Crooke, GIlbert, Auchincloss, and Presteyko, Golomb, H. N. See Cimino, Rowley, Kinnealey, Garro, A. J. See Lieber, Seitz, Garro, and Worner, 5076 Veriekojis, end Golomb, 227: Fukuhare, Row 2863â€• Glovanella, B. C. See Lee, Giovenella, Stehlin, ley, Veriakojis. and Golomb, 31 19; Mintz and Gait, J. J., DlPaoIo, J. A., and Donovan, P. J. and Brunn, 2928; Stehlin, Glovanolle, do lpolyi, Golomb, 2366; Testa, Mmix, Rowley, Vardiman, Mathematical Models and the Statistical Analy and Anderson, 2255â€• and Golomb, 36i 9 see of Cell Transformation Experiments, 5069 Glovaneila, B. C., Stehlin, J. S., Shepard, R. C., Gomer, C. J., and Dougherty, T. J. Determination Gaskili, S. P., McGulre, W. L, Osborne, C. K., and Williams, L. J. HyperthormicTreatmentof of [3H]- end [â€˜4C]HematoporphyrinDerivative and Stern, M. P. Breast Cancer Mortality and Human Tumors Hetorotransplanted in Nude Distribution In Malignant end Normal Tissue, Diet in the UnitedStates,3628 Mice, 2236â€• 146 Gautam, S. C., and Diodhar, S. D. Presence of Glovarelll, M. See Varesio, Giovemelli,Landolfo, Gomez, G. A. See Leong, Sokal, Gomez, and Suppressor Cells In Spleens of Mice Bearing a and Forni, 4983 Horoszewicz, 2704 Weakly Immunogenic Syngeneic Tumor, 2945 GItlow, S. E. The Diseaseof Alcoholism, 2836' â€˜ Gondos, B. See Costa, Nye, Sundermen, Allpass, Gauthisr, P. A. See Parmley, DehI, Austin, Geu Glaumann, H. See Dybing, von Behr, Aune, GIau and Gondos, 3591 tliler, and Denys, 3834 mann, Levitt, end Thorgeirsson, 4206 Good, R. A. See Kitamure, Levine, Cheng, Egeli, Gay, S. See Breltkreutz, de Leon, Peglia, Gay, Glazer, R. I. See Cerrico and Glazer, 3694 Liu, Good, end Day, 2909 Swarm, and Stern, 5093 Gleason, G. L. See Mufson, Fischer, Verme, Glee Goode, D. See Azizkhen, Speog, Stromberg, and Gebhardt, M. C. See Fisher, Gebhemdt,Safer, son, SIege, and Boutwell, 4791 ; SIege, Goode, i952 and Fisher, 1361 Bracken, Gleason, Levin, Yegi, Jerine, end Con Goodis, A. See Haves, Barney, Goodis, end Gehan, B. A. See Swenerton, Leghe, Smith, Hor ney, 67; SIege, Gleason, DiGiovenni, Suku Schiffmen, 3783 tobagyl, Gehan, Yap, Gutterman, and Blumen meran, end Harvey, 1934 Goodman, G. T. See Welsch, McMenus, DeHoog, schelfi, 1552 Glober, G. A. See Mower, Ray, Shoff, Stemmer Goodman, end Tucker, 2046 Gshrkâ€¢,C. W., Kuo, K. C., Waalkes, T. P., and mann, Nomure, Globom,Kemlyama, Shimada, Goodman, M. F. See Fielkoff, Goodman, end Sem Borsk, E. Patterns of Urinary Excretion of Mod end Yemekawe, 328 eyderian, 132i ffied Nucleosides, I 150 Glode, L M., Pltman, S. W., Ensminger, W. D., Gormley, P. E. See Van Echo, Chiuten, Gormley, GilboIn, H. V. See Okano, Miller, Robinson, and Rosowsky, A., Papathanasopoulos, N., and Uchtenfeld, Scoltock, end Wiemnik,3881 Gelboin, 3184 Frel, E., III A Phase 1 Study of High Doses of GosÃ¡lvez,M., van Rossum, G. D. V., and Blanco, Garner, E. W. See Herman, Cress, and Garner, Aminopterin with Leucovorin Rescue in Patients M. F. Inhibition of Sodium-Potassium-activated I 937 with Advanced Metastatic Tumors, 3707 Adonosine 5'-Triphosphetese and Ion Transport Garner, E. W., Holmes, P. W., and McCullough, Glover, E. See Poland and Glovem,3341 by Adriamycin, 257 J. A. Influence of Growth State on Several Thor Goeritler, K., Loehrke, H., Schweizer, J., and Gosslee, D. G. See Holland, Gosslee, and Wil mel Responses of EMT6/Az Tumor Cells in Hesse, B. Systemic Two-Stage Cercinogenesis hams, i7i8 Vitro, 981 in the Epithellumof the Fomestomechof Mice Gotoh, M. See Tsukade, Gotoh, Mochizuki,and Gsrstsn, D. M. See Fidler, Gersten, and Kmipke, Using 7,12-Dimothylbonz(a)anthrecene as Initi Fumukawa,1628 3816 atomand the Phorbol Ester 12-O-Tetradeceno Gotohda, E. See Olkawa, Gotohda,Austin,Tek Gerweck, L E. See Suit end Gerweck, 2290â€• ylphorbol-i 3-acetate as Promoter, 1293 oichi, and Boone, 3519 Gerweek, L E., Nygaard, T. G., and Burleti, M. Golf, U. See Edwards, Fox, Policastro, Goff, Wolf, Goulian, M. See Kiessling and Goulian, 2062; Van Response of Cells to Hyperthermia under Acute end Fine, 1857 Bevemenand Goulian, 2532 and Chronic Hypoxic Conditions, 966 GOhde,W. See Bergorat, Bamlogie,GOhdo,John Graham, D. G. See Vogel, Kemper,Boekelheido, Getz, M. J. See Moses, Wells, Swartzendruber, ston, and Drewinko, 4356 Graham, end Jeffs, i 490 and Getz, 4516 Gold, P. See Thomson, Tataryn, O'Connor, Grant, C. E. See Nestmann, Douglas, Matula, G.tz, M. J., Elder, P. K., and Moses, H. L Com Reuch, Friedlendor, Gold, end Shuster, 604' Grant, and Kowbel, 4412 plexity and Abundance of Murine Leukemia Vi Goldenberg, G. J. See Bogleitem,Lam, Grover, Grant, C. K., Pickard, D. K., Ramaika, C., Ma rue-related Nuclear end Messenger RNA Se Froose, end Goldenberg, 353 dewell, B. R., and Essex, M. Complementend quences In Mouse Embryo Cell Lines Which Are Goldfarb, S. See Hubemman,Montesano, Drevon, Tumor Antibody Levels in Cats, and Changes Differentially Sensitive to Carcinogen-induced Kuroki, St. Vincent, Pugh, and Goldferb, 269 Associated with Natural Feline Leukemia Virus VirusACtivatIOn,321 Goidieder, A., Brown, D. M., and Berger, A. Infection and Malignant Disease, 75 Geurtssn, W. See MUller, Meidhof, Arendes, Enhancement of Radioresponse of a Mouse Grass, E. H. See Philpott, Grass, and Parker, Geurtsen, Zahn, and Schmldseder, 3768 Mammary Carcinoma to Combined Treatments 2084 Gewirtz, D. A., White, J. C., Randolph, J. K., and with Hyporthermie end Radiosonsitizer Misoni Green, A. A. See Imashuku, Fossott,and Green, Goldman, I. D. Formation of MethotmexatePol dazolo, 2966 3006 yglutamates In Rat Hepetocytes, 29i 4 Goidflne, I. D. See Pezzino, Vignemi,Siperstein, Green, C. See Brattain, Green, Kimball, Marks, Ghanta, V. K. See Durkin, Ghenta, Belch, Davis, and Goldfine, 1443 and Khalod, 4083 and Hlramoto, 402 Goidln, A. See Stoychkov, Schultz, Chirigos, Pay Green, L. See Allegra, Lippmen, Thompson, Si Ghysdael, J. See Bex, Bruck, Memmerlckx, lidis, and Goldin, 3014 mon. Bemlock, Green, Huff, Do, and Aitken, Portetelle, Ghysdael, Cleutem,Leclercq, Deke Goldman, I. D. See Gowirtz, White, Randolph, and 1447; Allogra, Lippmen, Thompson, Simon, gel,andBumy, 1118 Goldman, 29i 4; HIll, Bailey, White, and Gold Barlock, Green, Huff, Do, Aitken, and Warren, Giacomeni, D. Tumorigenicity end Intrecistemnal man, 2440 1973 A ParticlesExpressionof HybridsbetweenMu Goldman, P. See Carter, McLafferty, and Gold Green, M. See Wold, Mackey, Rigden, and Green, mineMyelomaandLymphocytes,4481 man, 2026 3479 Glbblns, J. R. See Reid and Gibbins, 4724 Goidrosen, M. H. Demonstration and Evaluation Greenblatt, D. J. See Lowenthal, Parker, Green Glesbrscht, K. See Skinnider end Giesbrecht, of the Leukocyte Adherence Inhibition Assay, blatt, Brown, and Samy, 1547 3332 624 â€¢; Summery end Future Prospects of Lou Grenier, A. See Liau, Cheng, BÃ©langer,and Gren Gilbert, R. See Comis, Kuppinger, Ginsberg, kocyte Adherence Inhibition, 660 , See also br, 162 Crooke, Gilbert, Auchlncloss, end Presteyko, Howell, Russo, and Goldrosen, 612 â€¢; Leveson, Griesemer, R. A. See Topping, Griesemer, and 5076 Howell, Peolini, Tan, Holyoke, end Goldrosen, Nottesheim, 4823; 4829 GIIbsrt, S. L See P101km,Wldes, Gilbert, Wolf, 582 GrIffIn, T. W. See Comis, Griffin, Raso, and Gins Hagen, and Prout,3856 Goidrosen, M. H., Howell, J. H., and Holyoke, E. berg, 757 Gillette, E. L. Large Animal Studies of Hyperthem D. Demonstrationof theMicrotestVersionofthe Grimes, W. J. See Litin and Grimes, 2595 misand IrradIation,2242' Leukocyte Adherence Inhibition Assay, 630' Grindey, G. B. See kinahan, Otten, end Grindey, Gillette, R. W., Szekerczes, J., Wunderllch, D. Goldrosen, M. H., Russo, A. J., Howell, J. H., 3531 ; Neil, Berger, McPartlend, Grindey, end A., and Gillotte, S. Changes in Macmomoleculer Leveson, S. H., and Holyoke, E. D. Cellular and Bloch, 852; Steinberg, Otten, and Grindey, Synthesis by Thy-Positive Lymphomas in Re Humorel Factors Involved in the Mechanism of 4330 sponse to Mltogen, 751 the Micro-Leukocyte Adherence Inhibition Re Grodzlckl, R. L. See Rao, Grodzicki, and Mitchell, Gillette, S. See Gillette, Szekerczes, Wunderlich, action, 587 174 and GIllette, 751 Goldrosen, M. H., Russo, A. J., Howell, J. H., Gross, J. F. See Endrich, Integlietta, Reinhold, Gingell, R. See Pour, Wallcave, Gingell, Negel, Leveson, S. H., Moore, M. C., Holyoke, E. D., andGross, 17 Lawson, Salmasi, end Tines, 3828 and Douglass, H. 0., Jr. Evaluationof Micro Gross, N. See Carrel, Gross, and Mach, 517i Gingell, R., Brunk, G., Nagel, D., and Pour, P. Leukocyte Adherence Inhibition as en Immuno Grosser, N. See Thomson and Grosser, 576' Metabolism of Three Radlolabeled Pancreatic diagnostic Test for Pancreatic Cancer, 633' Grotzlnger, K. R. See Ozols, Gmotzinger,Fisher, Carcinogenic Nitrosamines In Hamsters end Goldstein, N. I. See Fisher, Goldstein, end Wein Myers, end Young, 3202: Ozols, Locker, Doro

DECEMBER1979 5195 Author Index to Volume 39

show, Grotzingor, Myers, and Young, 3209 Hyperthermia, 2264' â€˜;Summary of the Infor nosylcytosine, 538, Communication Grover, J. See Begleiter, Lam, Grover, Froese, mel Discussion of Adjuvant Techniques for Hy Harris, C. C. See Autrup, Essigmann, Cray, and Goldenberg, 353 perthermia, 2299 â€˜â€˜. See also Kepp end Hahn, Trump, Wogan, and Harris, 694 Grubbs, C. J. See Bocci, Thompson, Grubbs, 4630; Mermor, Hilemio,and Hahn, 2i66 Harris, C. C., Autrup, H., Stoner, G. D., Trump, Brown, and Moon, 3141; Moon, Thompson, Hahn, R. G. See Kovach,Ames, Powis,Moertel, B. F., HIlIman,E., Schafer, P. W., and Jeffrey, Becci, Grubbs, Gander, Newton, Smith, Phillips, Hahn, and Creagan, 4540 A. M. Metabolismof Benzo(a)pymene,N-Nitro Henderson, Mullen, Brown, and Spomn,1339 Hainau, B. LuminalPlasmaMembraneOrganize sodimethylamine and N-Nitmosopymrolldineand Guarino, A. M., Rozencweig,M., Kline, I., Penta, tion in Rat Urinary Bladder Urotholium after Identification of the Major Carcinogen-DNA Ad J. S., Venditti, J. M., Lloyd, H. H., Holzworth, Direct Exposure in Vivoto N-Methyl-N-nitrosou ducts Formed in Cultured Human Esophagus, D. A., and Muggia, F. M. Adequaciesand In roe, 3757 4401 adequacies in Assessing Murino Toxicity Data Hainen, R. See Young, Hollonberg,Kazam, Bor Harris, L F., Hamparian,V. V., Young,E. A., and with Antinooplastic Agents, 2204 kowitz, Heinen, Sandor, and Abrems, 1898 Hughes, J. H. LymphocyteTransformationfor Guinan, P. D. See Bhatti, Ablin, Condoulis,and Hakala, M. T. See Laskin,Evens,Slocum,Burke, the Detection of Herpesvirus-induced Tumor-es Guinan, 3328 and Hakala, 383 sociated Antigens, 3996 Gullino, P. M. See Shafie, Cho-Chung,and GuI Hakomori, S-i. See Beumann,Nudelman,Watan Harrison, W. H. See Storm, Harrison, Elliott, and lino, 2501 abe, and Hekomomi,2637; Koyame, Nudolman, Morton,2245â€• Gunduz,N., Fisher, B., and Sailer, E. A. Effectof Fukude, end Hekomori, 3677 Hartman, P. E. See Brundrett, Colvin, White, Surgical Removalon the Growth and Kinetics of Hall, J. D., and Tokuno, S-I. EnhancedTransfor Mckee, Hartman, and Brown, 1328 Residual Tumor, 3861 matian of Xerodemma Pigmentosum Variant Hartman, S. P. See Shah, Hertman, end Wein Gupta, P. See Jerabok,Gupta, and Ferrer, 3952 Cells by Ultraviolet Light-irradiated Simian Virus house, 3942 Gupta, R. K., Silver, H. K. B., Reisfeld,R. A., and 40, page 4064 Hartmann, 0. See Joyce, Hartmann, and Chor Morton, D. L. Isolation and Immunochemical Hall, S. W. See Bonvenuto,Hall, Farquhar,Stew venick, 215 Characterization of Antibodies from the Sore of art, Benjamin, and Loo, 349; Stewart, Benven Harvey, R. G. See Slaga, Gleason, DiGiovanni, Cancer Patients which Are Reactive against Hu uto, Leavens, Hell, Benjamin, Plunkett, Mc Sukumaman,and Harvey, 1934 man Melanoma Cell Membranes by Affinity Credie, Burgess, and Loo, 4 119 Hasegawa, H., Shapiro, W. R., and Posner, J. B. Chromatography, 1683 Hall, T. L. See McGovren,Neil, Denlingem,Hall, Chemotherapyof Experimental Metastetic Brain Gurtoo, H. L. See Freedman, Gurtoo, Minowada, Crampton, and Swenborg, 4849 Tumors in Female Wistar Rats, 2691 Paigen, and Vaught, 4605; Freedman, Parker, Halliday, W. J. Historical Background and As Hasegawa, H., Shapiro, W. R., Posner, J. B., and Marinollo, Gurtoo, and Minowada, 4612; pocts of the Mechanism of Loukocyte Adher Basler, G. Effect of 1-(4-Amino-2-mothyl-5-pyr Vaught, Gurtoo, Parker, LeBoeuf, and Doctor, ence Inhibition, 558 â€˜. See also Maluish and imidinyl)mothyl-3-(2-chloroethyl)-3-nitrosouroa 3177 Halliday, 625' Hydrochloride on Experimental Brain Tumors, Gurtoo, H. L., Parker, N. B., Palgen, B., Havens, Hammond, D. See Ertel, Nesbit,Hammond,Wei 2687 M. B., Mlnowada, J., and Freedman, H. J. nor, and Sather, 3893 HaSek, M. See HolÃ¡Ã±,ChutnÃ¡,and HaSek, 593 â€¢; Induction, Inhibition and Some Enzymologic Hamparlan,V. V. See Harris,Hamperien,Young, HolÃ¡Ã±,@Ibl,and HeOok,65i' Properties of Aryl Hydrocarbon Hydmoxylase end Hughes, 3996 Hashim, G. A. See Ramey, Heshim, Burrows, (AHH) in Fresh Mitogen-activeted Human Lym Han, A., and Elklnd, M. M. Transformationof Swistel, Munther, and Fitzpatrick, 4796 phocytes, 4620 Mouse C3H/i 0TÂ½Cells by Single and Frec Hashimoto, K. See Tekeheshi,Kinoshita,Hashi Gusella, J. F. See Tsiftsoglou, Gusella, Volloch, tionated Dosesof X-Raysand Fission-Spectrum moto, end Yasuhire, 1814 and Housman, 3849 Neutrons, 123 Haskins, K. M. See Donoso, Haskins, and Himes, Gustafsson, J-A. See Carlstedt-Duke, Elfstrom, Handler, E. S. See Steinbergand Handler, 1575 1604 HOgbemg,and Gustafsson, 4653; Fomsgren, Handschumacher, R. E. See Dix, Lehman, Jaku Haug, L. T. See Dybing, Soderlund,Haug, and Gustafsson, Pousette, and Hogberg, 5155 bowski, Moyer, end Hendschumachom,4485; Thorgeirsson, 3268 Gutterman, J. U. See Morris, Horsh, Hsi, Gutter Moyer end Handschumacher, 3089; Schwartz Haut, M. J. See Scialla,Spockart,Haut, and Kim man, Marshall, and Mavligit, 219; Swenorton, and Hendschumacher, 3095 ball, 2031 Legha, Smith, Hortobagyl, Gohan, Yap, Gutter Hankenson, R. See Barlogie, Corry, Yip, Lippman, Havas, H. F., Barney, S., Goodis, A., and Schlff man, and Blumenschein, 1552 Johnston, khalil, Tenczynski, Reilly, Lawson, man, G. Effect of Splenectomyon the Immune Gyorkey, F. See Busch, Daskal, Gyorkey, and Dosik, Rigor, Hankenson, end Freimeich,1481 Response of BALB/c Mice Bearing an Immu Smetana, 857; Busch, Gyorkey, Busch, Davis, Hanker, J. S., Ambrose, W. W., James, C. J., noglobulin M Plasmacytome (TEPC-i 83), 3783 Gyorkey, and Smetana, 3024 Mandelkorn, J., Yates, P. E., Gall, S. A., Boa Havens, M. B. See Gurtoo, Parker, Peigen, He Gyorkey, P. See Busch,Gyorkey, Busch,Davis. sen, E. H., Fay, J. W., Laszlo, J., and Moore, vens, Minowada, and Freedman, 4620 Gyorkey, end Smetana, 3024 J. 0. FacilitatedLightMicroscopicCytochemi Hayata, I. See Kitamura,Okamoto,Hayate, Uch cal Diagnosis of Acute Myelogenous Leukemia, ida, Yamaguchi, and Matsumoto, 4713 1635 Hayden,M. T. See Bull,Soullier,Wilson,Hayden, H Hanna, M. G., Jr. See Peters, Brendhomst,end and Nigro, 4956 Henna, 1353 Hays, E. F. See Beardsleyand Hays, 480 Haas, J. See Schwab, Kollinger, Haas, Ahuja, Hara, E. See Kawajiri,Yonokawa,Hare, and Ta Heal, J. N., Fox, P. A., and Schein, P. 5. Effect Abdo, Anders, and Andems,519 gashima,1089 of Carbamoylation on the Repair of Nitrosourea Hackett, A. J. See Smith, Springer, and Hackett, Hard, G. C. Effect of Age at Treatmenton Inci induced DNAAlkylatian Damagein Li 210 Cells, 332 dence and Type of Renal Neoplasm Induced in 82 Hada, T. See Matsuda,Osafune,Nakano,Kotake, the Rat by a Single Dose of Dimethylnitrosa Hebebrand, L C. See Dunlap, Nichols, Hobo Sonoda, Watanabe, Hada, Okochi, Higashino, mine,4965 brand, Mathes, and Olson, 956; Mathos, Olsen, Yamamura, and Abe, 4694; Okochi, Seiko, Hi Harder, H. C. See Pore and Harder, 1279; Pera, Hebebrend, Hoover, Scheller, Adams, and Ni gashino, Hada, Watanabe, Yamamura, Ito, Mat Zook, and Harder, 1269 chols, 950 suda, Osafune, Kotake, end Sonoda, 1829 Hardy, W. D., Jr. See Francis,Cotter,Hardy,and Hebebrand, L. C., Olsen, R. G., Mathes, L. E., Haddlng, U. See Schomlommem,Opitz, Etschon Essex, 3866 and NIchols, W. S. Inhibitionof Human Lym berg, Bitter-Suermann, and Hadding, 1847 Hargrave, S. L. See McLaughlin, Hargmave, phocyte Mitogon and Antigen Response by a Haddox, M. K., and Russell, D. H. Cell Cycle Bickel, and Ribi, 1766 15,000-Dalton Protein from Feline Leukemia specific Locus of Vitamin A Inhibition of Growth, Harguindey, S., Henderson, E. S., and Naeher, Virus, 443 2476 C. Effectsof SystemicAcidificationof Mice with Hecht, 5. S. See Chen, Fung, and Hecht, 5057; Haddox, M. K., Scott, K. F. F., and Russell,D. H. Sarcoma 180, page 4364 Hoffmenn, Adams, Brunnomann, and Hecht, Retinal Inhibition af Ornithine Decarboxylase Hank, S. I., and Sutton, C. H. Putrescineas a 2505; McCoy, Chen, Hecht, and McCoy, 793 Induction and G Progression in Chinese Ham Biochemical Marker of Malignant Brain Tumors, Hecker, E. See kinzel, Kreibich, Hecker, and ster Ovary Cells, 4930 5010 SUss,2743 Half, A. C. See Holroyde, Axelmod,Skutches, Haff, Harlos, J. P. See Weiss and Herbs, 2481 Hecker, L. I., FancIly, J. G., SmIth, J. H., Sea Paul, and Reichard, 4900 Harrap, K. R. See Wilkinson, Birbeck, and Herrap, vedra, J. E., and Lyon, P. A. Metabolism of the Hagemeijer, A., Hoehn, W., and Smit, E. M. E. 4256 Liver Carcinogen N-Nitrosopymrolidino by Rat Cytogenetic Analysis of Human Renal Carci Harrington, G. W. See Chang, Harrington,Roth Liver Microsomes, 2679 noma Cell Lines of Common Origin (NC 65), stein, Shergalis, Sworn, and Vohra, 3871 Heckman, C. A. See Hubermen, Hockman, end 4662 Harrington, J. T. See Lavergne,Lamm,Redwin, Lengenbach, 26i 8; Scott, Heckman, Nettesh Hagen, I. K. See Plotkin, Widos, Gilbert, Wolf, and Harrington, 1985 eim, and Snyder, 207 Hagen, and Prout, 3856 Harris, A. W., Reynolds, E. C., and Finch, L R. Heckman, C. A., and Olson, A. C. Morphological Hahn, E. W. See Kimand Hahn, 2258' Effect of Thymidine on the Sensitivity of Cul Markers of Oncogenic Transformation In Ros Hahn, G. M. Potentialfar Therapy of Drugsand lured Mouse Tumor Cells to 1-/3-D-Arabinofura piratory Tract Epithelial Cells, 2390

5196 CANCERRESEARCHVOL. 39 Author Index to Volume 39

Heidelberger, C. See Peterson, Peterson, and Two Lines of L5178Y Lymphoblasts, One with tivity between Bacillus Calmette-Guerin and Heidelberger, 131 Impaired Transport of Methotrexate, 2440 Rous Virus-induced Sarcoma Detected in Rats Heimer, R., and de Vaux Saint Cyr, C. Circulating Hill, D. L., Shih, T-W., and Struck, R. F. Macro- by Tube Leukocyte Adherence Inhibition Assay. Immune Complexes in Sera of Hamsters Bearing molecular Binding and Metabolism of the Car 593' Simian Virus 40-induced Tumors, 2919 cinogen 4-Chloro-2-methylaniline, 2528 HolÃ¡n,V., Sibl. O.. and Hasek, M. Monitoring of Heine, H. S. See Benson. Cha, Bueding. Heine, Hill, G. J., II See Hill. Hill. Miller. Pfaller. Weiss, Antitumor Immunity in Patients with Larynx Can and Talalay, 2971 and Galin. 934 cer by Tube Leukocyte Adherence Inhibition Heine, U. I. See Rapp. Keski-Oja, and Heine, Hill, H. Z., Hill, G. J., II, Miller, C. L., Pfaller, M., Assay, 651 â€¢ 4111 Weiss, K., and Galin, M. Effects of 5-<3,3-Di- Holcenberg, J. S., Borella, L. D., Camitta, B. M., Heise, E. R., Kucera, L. S., Raben, M., and methyl-1 -triazeno)imidazole-4-carboxamide, 1- and Ring, B. J. Human Pharmacology and Tox Homesley. H. Serological Response Patterns to (2-ChloroethyD-3-(4-methylcyclohexyl)-1-nitro- icology of Succinylated Acinetobacter Gluta- Herpesvirus Type 2 Early and Late Antigens in sourea. and L-Phenylalanine Mustard on B16. minase-Asparaginase. 3145 Cervical Carcinoma Patients, 4022 Cloudman, S91. and Harding-Passey Mouse Holder, W. D., Jr. See Langlois. Holder. Iglehart, Hellman. A., Weislow, O. S., Twardzik, D. R., Melanomas. 934 Nelson-Rees, Wells, and Bolognesi, 2604 and Fowler, A. K. Type C Retrovirus Activation Hill, J. M. See Khan, Hogan, and Hill, 3476 Holland, J. F. See Takahashi. Ohnuma. and Hol and Possible Functions in the Normal and Tu Hill, P.. Wynder, E. L., Garbaczewski, L., Games, land. 1264 mor-bearing Host, 2902' â€¢â€¢ H., and Walker, A. R. P. Diet and Urinary Ste Holland, J. M., Gosslee, D. G., and Williams, Hellstrom, l. See HellstrÃ¶mand HellstrÃ¶m,649' roids in Black and White North American Men N. J. Epidermal Carcinogenicity of Bis(2.3-ep- Hellstrom, K. E., and HellstrÃ¶m, l. The Need to and Black South African Men, 5101 oxycyclopentyDether, 2,2-Bis(p-glycidyloxy- Establish whether the Leukocyte Adherence In Hill, R. P. See Pallavicini. Lalande, Miller, and Hill, phenyDpropane, and m-Phenylenediamine in hibition Test is a Reliable Assay of Tumor Im 1891 Male and Female C3H and C57BL/6 Mice. munity in Humans, 649' Hilliard, S. See Roberts, Peck, Milliard, and 1718 Henderson, B. E.. Dworsky, R., Pike, M. C., Bap- Wingo, 4048 Hollenberg, M. D., Barrett, J. C., Ts'o, P. 0. P., tista, J., Menck, H., Preston-Martin, S., and HulmÃ¡n. E. See Harris, Autrup, Stoner. Trump. and Berhanu, P. Selective Reduction in Recep Mack, T. Risk Factors for Nodular Sclerosis and Hillman, Schafer, and Jeffrey, 4401 tors for Epidermal Growth Factor-Urogastrone Other Types of Hodgkin's Disease, 4507 Hillyard, L. A., and Abraham, S. Effect of Dietary in Chemically-transformed Turmorigenic Syrian Henderson, E. S. See Harguindey, Henderson, Polyunsaturated Fatty Acids on Growth of Mam Hamster Embryo Fibroblasts. 4166 and Naeher, 4364 mary Adenocarcinomas in Mice and Rats. 4430 Hollenberg, N. K. See Young, Hollenberg. Kazam, Henderson, S. V. See Black, Henderson, Klein- Himes, R. H. See Donoso, Haskins, and Himes, Berkowitz, Hainen, Sandor, and Abrams, 1898 hans, Phelps, and Thornby. 5022 1604 Holmes, P. W. See Gerner. Holmes, and Mc- Henderson, W. R. See Moon, Thompson, Becci, Hiramoto, R. N. See Durkin. Ghanta. Balch, Davis, Cullough, 981 Grubbs, Gander. Newton, Smith, Phillips. Hen and Hiramoto. 402 Holoubek, V. See Patel, Folse. and Holoubek, derson, Mullen, Brown, and Sporn, 1339 Hirao, F. See Ogura. Namba, Hirao, Yamamura, 4460 Hengst, J. C. D. See Mokyr, Hengst, Przepiorka, and Azuma, 4706 Holroyde, C. P., Axelrod, R. S., Skutches, C. L., and Dray, 3928 Hirohashi, S., Shimosato, Y., Kameya, T., Koide, Haff, A. C., Paul, P., and Reichard, G. A. Lac- Henle, K. J., Bitner, A. F. and Dethlefsen, L. A. T., Mukojima, T., Taguchi, Y., and Kageyama, tate Metabolism in Patients with Metastatic Co- Induction of Thermotolerance by Multiple Heat K. Production of a-Fetoprotein and Normal Se lorectal Cancer, 4900 Fractions in Chinese Hamster Ovary Cells, 2486 rum Proteins by Xenotransplanted Human Hep- Holt, P. G., Fimmel, P. J., Finlay-Jones, L. M., Henle, K. J., and Leeper, D. B. Effects of Hyper- atomas in Relation to their Growth and Mor and Flower, R. L. Evaluation of the Microplate thermia (45Â°) on Macromolecular Synthesis in phology, 1819 Leukocyte Adherence Inhibition Test and Its Chinese Hamster Ovary Cells, 2665 Hirota, N. See Yasumoto, Manabe, Yanagawa, Reproducibility, Sensitivity, and Relationship to Henle, W. See Klein, Penn, and Henle, 1137 Nagano, Ueda. Hirota, Ohta, Nomoto. Azuma, Other Tests of Cellular Immunity. 564 â€¢ Henson, P. See Selksy, Henson. Weichselbaum, and Yamamura. 3262 Holtzman, S. See Shellabarger, Holtzman, and and Little, 3392 Hissin, P. J., and Hilf, R. Effects of Estrogen to Stone, 3345; Stone, Holtzman, and Shellabar Herberman, R. B. See Ng, Ames, Mclntire, and Alter Amino Acid Transport in R3230AC Mam ger, 773 Herberman, 4887; Tagliabue, Herberman, Ar mary Carcinomas and Its Relationship to Insulin Holtzman, S., Stone, J. P., and Shellabarger, C. thur, and McCoy, 35 Action, 3381 J. Influence of Diethylstilbestrol Treatment on Herman, T. S., Cress, A. E., and Gerner, E. W. Hites, R. A. See Kaden, Hites, and Thilly, 4152 Prolactin Cells of Female ACI and Sprague- Collateral Sensitivity to Methotrexate in Cells Hixon, B. See Meyer and Hixon, 4042 Dawley Rats, 779 Resistant to Adriamycin, 1937 Hixson, D. C., Bowen, J. M., Ohtsuki, Y., Scan- Holyoke, E. D. See Goldrosen. Howell. and Hoi- Hersh, E. M. See Morris, Hersh, Hsi, Gutterman, Ion, M., and Dmochowski, L. Strain-related yoke. 630'; Goldrosen. Russo, Howell. LevÃ©- Marshall, and Mavligit. 219 Variation in the Interaction of Ferritin-conju- son, and Holyoke, 587'; Goldrosen, Russo. Hess, A. D. See Beschorner, Hess, Nerenberg, gated Plant Lectins with Mouse Mammary Tu Howell. Leveson. Moore. Holyoke. and Doug and Epstein, 3920 mor Viruses. 199 lass, 633'; Leveson. Howell. Paolini, Tan, Hol Hess, A. D., Gall, S. A., and Dawson, J. R. Inhi Hnilica, L. S. See Briggs, Campbell. ChiÃ¹,Hnilica, yoke. and Goldrosen. 582* bition of in Vitro Lymphocyte Function by Cystic Lincoln, Stein, and Stein, 3683 Holzworth, D. A. See Guarino, Rozencweig. Kline, and Ascitic Fluids from Ovarian Cancer Patients, Ho, Y-k.. Preisler, H. D., and Bardos, T. J. Effects Penta, Venditti, Lloyd, Holzworth, and Muggia. 2381 of Partially Thiolated Polycytidylic Acid on the 2204 Hesse, B. See Goerttler, Loehrke, Schweizer, and Clonogenicity of Murine Leukemic Stem Cells. Homesley, H. See Heise, Kucera, Raben, and Hesse, 1293 3163 Homesley. 4022 Hestorff, R. See Chlebowski, Irwin, Pugh, Sadoff, Hodacri. A. See Winkelhake, Elcombe, and Hod- Honma, Y., Kasukabe, T., and Hozumi, M. Inhi Hestorff, Wiener, and Bateman, 4503 ach, 3058 bition of Differentiation of Cultured Mouse Mye- Hewitt, H. B. See Rapp and Hewitt, 4285 Hodgson, G. S. See Martin, Bradley, and Hodg loid Leukemia Cells by Nonsteroidal Antiinflam- Hidaka, K. See Akiyama. Hidaka. Komiyama, and son, 3244 matory Agents and Counteraction of the Inhibi Kuwano, 5150 Hodgson, R. M. See Kleihues, Doerjer. Keefer. tion by Prostaglandin E, 2190 Higashino, K. See Matsuda, Osafune, Nakano, Rice, Roller, and Hodgson, 5136 Honma, Y., Kasukabe, T., Okabe, J., and Hoz Kotake, Sonoda, Watanabe, Hada, Okochi, Hi Hodson, C. A. See Aylsworth, Hodson, Berg, umi, M. Prolongation of Survival Time of Mice gashino. Yamamura, and Abe, 4694; Okochi, Kledzik, and Meites, 2436 Inoculated with Myeloid Leukemia Cells by In- Seike, Higashino, Hada, Watanabe, Yamamura, Hoehn, W. See Hagemeijer. Hoehn. and Smit. ducers of Normal Differentiation. 3167 Ito. Matsuda, Osafune, Kotake, and Sonoda, 4662 Hook, R. R., Jr. See Berkelhammer, Caines. Dex 1829 Hoerner, H. E. See Ichinose. Powell, Hoerner, ter, Adelstein, Oxenhandler, and Hook. 4960 Higgins, N. P., and Strauss, B. S. Differences in Derbes, and Byers, 4270 Hoon, B. S. See Balk, Mitchell, LeStourgeon, and the Ability of Human Lymphoblastoid Lines to Hoffman, A. R., Paul, S. M., and Axelrod, J. Hoon. 1854 Exclude Bromodeoxyuridine and in their Sensi Catecholestrogen Synthesis and Metabolism by Hoover, E. A. See Mathes, Olsen, Hebebrand, tivity to Methyl Methanesulfonate and to Incor Human Breast Tumors in Vitro, 4584 Hoover, Schaller, Adams, and Nichols, 950; porated [3H]Thymidine, 312 Hoffmann, D., Adams, J. D., Brunnemann, K. D., Rojko, Hoover, Mathes, Krakowka. and Olsen, Higgins, P. J. See Borenfreund, Higgins, Stein- and Hecht, S. S. Assessment of Tobacco-spe 3789 glass, and Bendich, 800 cific A/-Nitrosamines in Tobacco Products. 2505 Horikoshi. A., Sasaki, R., Mizoguchi, H., Miura, Hilerio, F. J. See Marmor, Hilerio, and Hahn, 2166 Hogan, S. See Khan, Hogan, and Hill. 3476 Y., Takaku, F., and Amaki, I. Alterations in the Hilf, R. See Hissin and Hilf, 3381 Hogberg. B. See Carlstedt-Duke, ElfstrÃ¶m. Hog- Response to Erythropoietin and RNA-depend- Hill, B. T., Bailey, B. D., White, J. C., and Gold berg, and Gustafsson. 4653; Forsgren, Gustafs- ent DNA Polymerase Activity in Mouse Spleen man, I. D. Characteristics of Transport of 4- son. Pousette, and Hogberg, 5155 Cells Infected with Friend Leukemia Virus, 1841 Amino Antifolates and Folate Compounds by HolÃ¡n,V., Chutna. J., and Hasek, M. Cross-Reac Horn, T. M., and Kano-Sueoka, T. Effects of

DECEMBER 1979 5197 Author Index to Volume 39

Hormones an Growth and a-Lactalbumin Activ Huber, S. A. See Yang, Hubor, and Lucas, 4802 trosamine-induced Urinary Bladder Cancer in ity in the Transplantable Rat Mammary Tumor Huberman, E. See Langenbach, Malick, Tampa, Rats by Administration of Disulfimamin the Diet, MCCLX. 5028 Kuszynski, Freed, end Huberman, 3509 3040 Horoszewlcz, J. S. See Leong, Sokal, Gamez, Huberman, E., Heckman, C., and Langenbach, IrwIn, L E. See Chlebowski, Irwin, Pugh, Sadoff, and Horoszowicz, 2704 R. Stimulationof DifferentiatedFunctionsin Hu Hostorff, Wiener, and Bateman, 4503 Hortobagyi, G. N. See Swenerton, Legha, Smith, man Melanoma Cells by Tumor-promoting lsaacs, J. T., lsaacs, W. B., and Coffey, D. S. Hortobagyl, Gehan, Yap, Guttemman,and Blu Agents and Dimethyl Sulfoxide, 2618 Modelsfor Developmentof NonreceptomMoth menschein, 1552 Huberman, E., Montesano, R., Drevon, C., Ku ods for Distinguishing Androgen-sensitive and HorvÃ¡th,C. See Kalghatgi, Momoson,HorvÃ¡th,and roki, T., St. Vincent, L., Pugh,T. D., and Gold -Insensitive Prostatic Tumors. 2652 Bertino, 3441 farb, S. y-Glutamyl Transpeptidase end Malig Isaacs, W. B. See lsaacs, lsaecs, end Coffey. Hoshino,K. See Tsuchida,Hoshino,Sata, Ito,and nant Transformation of Cultured Liver Cells, 2652 Sato, 4200 269, Communication lee, H. See Sakakibara, Kaweuchi, Takayenagi, Hoshino, T. See Deen, Hoshino, Williams, No Huberman, E., and Slaga, T. J. Mutegenicity and and Ise, 1347 mura, and Bartle, 4336 Tumor-initiating Activity of Fluorinated Derive Ishlda, N. See Yahara, Iwashite, Ebine, Satake, Hoshlya, T. See Yasuzumi, Hyo, Hashiya, and lives of 7,i 2-Dimethylbenz(a)anthracene,41i and Ishide, 4687 Yasuzumi, 4645 Hudig, D., Sell, S., Newell, L, and Becker, F. F. Ishihara, K. See Nagai, Kataoka, kobayeshi, Hostetler, K. Y., Zenner, B. D., and Morris, H. P. Rat a-Macrofetopmotein(Acute-Phase a2-Mac Ishihama,Tobioka, Nakashima, Naruse, Saito, Phospholipid Content of Mitochondrial and Mi moglobulin)during Hepatocarcinogenesis, 37i 5 end Sakume, 1835 crosomal Membranes from Morris Hepatomas Huff, K. K. See Allegma,Lippman, Thompson, Si Isobe, M. See Yano end Isobe, 5147 of Varying Growth Rates, 2978 mon. Bariock, Green, Huff, Do, and Aitken, Isohashl, F., Tsukanaka, K., Terada, M., Nak Houchens, D. P. See Ovejema,Houchons, Catane, 1447; Allegme, Lippman, Thompson, Simon, anlshl, Y., Fukushima, H., and Sakamoto, V. Sheridan, and Muggia, 3220 Berlock, Green, Huff, Do, Aitken, and Warren, Alteration in Binding of Dexamethasone to Glu Houghton, J. A., Houghton, P. J., and Wooten, 1973; Osborne, Monaco, Kahn, Huff, Bronzert, cocortlcoid Receptors in RegenematlngRat Liver R. S. Mechanismof InductionofGastrointestinal and Lippman, 2422 after Partial Hopatectomy, 5132 Toxicity in the Mouse by 5-Fluomouracil,5-FIuo Hughes, B. B. See Berezney, Baslem,Hughes, and Isom, H. C., and Backstrom, J. T. Aberrant Reg rouridine, end 5-Fluoro-2'-deoxyuridine, 2406 Kaplan, 303i ulation of OmnlthineDecarboxylase by Serum, Houghton, P. J. See Houghton, Houghton, and Hughes, J. H. See Harris, Hemparian, Young, and Putmoscine,end Spermidmnein Cytomegalovlrus Woolen, 2406 Hughes, 3996 transformed Human CoIls, 864 Housman,D. E. See Tsiftsoglou,Gusella,Volloch, HultIn, T. See NygÃ¢mdand Hultin, 3349 Israel, M. See Gemnick,Ensminger, end Israel, and Housman, 3849 Humphrey, C. See Krause. James, Humphrey, 4105 Howard, R. A., Kimball, A. P., and Bear, J. L. and Fischer, 3065 Ito, F. See Okochi, Seiko, Higashino, Heda, We Mechanism of Action of Tetme-@-camboxyIatodi Humphrey,R. L. See Frondoza,Trivedi,andHum tanabe, Yamamura, Ito, Matsuda, Osafune, Ko rhodium(Il) in Li 210 Tumor Suspension Culture, phrey, 2497 take, and Sonoda, 1829 2568 Humphreys, R. E. See Malenka, Rogan, Howe, Ito, N. See Tsuchlda, Hoshino, Sato, Ito, and Sato, Howard, R. K. See Filerdi, Codish, Civerchia, Nelson, Wmobel,Ahmed, end Humphreys, 4782 4200 Howard, end McKneally, 3673 Hunter, J. T. See Zbam, Canti, Ashley, Rapp, IvId, J. See PavellO, Slijep@eviO,Pevelic1,lviO, Howe, R. C. See Malenka, Rogen,Howe, Nelson, Hunter, and Ribl, 1597 Audy-JumkoviO,PavellO,end BoraniO, i 807 Wrobel, Ahmed, end Humphmeys,4782 Hurley, L. H., Allen, C. S., Feola, J. M., and Iwasawa, H. See Seklye, Endoh, Kikuchi, Katoh, Howell, J. H. Current Status of Loukocyte Adhom Lubawy, W. C. In Vitro end in Viva Stability of Matsuume,Iwasawe,Takeda, and Takamizawa, once Inhibition, 556' . See also Goldmosen, Anthmamycln-DNAConjugate and Its Potential 1108 Howell, and Holyoke, 630' ; Goldmosen,Russo, Application as an Anthramycin Prodrug, 3i 34 Iwashita, S. See Yahama,Iweshita, Ebine, Sateke, Howell, Leveson, and Holyoke, 587 â€¢; Goldmo Hum, I. See Rudolph,Woodward,and Hum, 3689 and Ishide, 4687 sen, Russo, Howell, Levoson, Moore, Holyoke, Hurst, J. See Fentimen, Hurst, Ceriani, end Tay lyer, R. P. See Cohen, Bracken, lyem,Berry, Sel and Douglass, 633' ; Levoson, Howell, Paolini, Iom-Papadimitriou,4740 kirk, end Siege, 4027 Ten, Holyoke, end Goldmosen,582' Huybrechts, M., Symann, M., and Trouet, A. lype, P. T., Tomaszewski, J. E., and Dipple, A. Howell, J. H., Russo,A. J., and Goldrosen,M. H. Effects of Deunomubicinand Doxomubicin,Free Biochemical Basis for Cytotoxicity of 7,12-Di Characterization of MumineTumor-associated and Associated with DNA,on Homopoletic Stem methylbenz(a)anthmaceneIn Rat Liver Epitheliel Antigens by the Micro-Leukocyto Adherence Cells, 3738 Cells, 4925 Inhibition Assay, 612' Hyatt, C. See Thorpe, Loeb, Hyatt, and Rosen Howell, S. B., Jenkins, R. S., and Strelfel, J. berg, 277 J Activity of Thymidmneas a Chemotherapeutic Hyo, Y. See Yasuzumi,Hyo, Hoshiye,and Yesu Agent against HumanTumor Xenogmaftsin Nude zumi, 4645 Mice, 3875 Jablonska, S. See Orth, Jeblonske, Jerzabek Howell, S. B., Krlshan, A., and Frel, E., Ill Cyto Chomzelska,Obalek, Rzosa, Favme,and Crois kinetic Comparison of Thymidino end Leucovo sent, 1074 mmRescueofMarrowinHumansafterExposure Jackson, D. V., Jr., and Bender, R. A. Cytotoxic to High-Dose Mothotrexato, 1315 Ichida, F. See Aoyagi,Ikenake,and Ichida,357i Thresholds of Vincristino in a Murine end a Howett, M. K., Pegg, A. E., and Rapp, F. En Ichinose, H., Powell, L, Hoerner, H. E., Derbes, Human Leukemia Cell Line in Vitro, 4346 hancement of Biochemical Transformation of V. J., and Byers,J. F. The PotentialHistogenic Jacobs, J. B. See Cohen, Amei,Jacobs, and Frie Mammalian Cells by Herpes Simplex Virus fol Relationship of the Peripheral Nerve to Syno doll, 1207 lowing NitrosomethylumeaTreatment, i 041 vioma, 4270 Jacoby, R. 0. See Fondy, Tsiftsoglou, Jacoby, Hozumi, M. See Honma, Kasukebe, end Hozumi, Iglehart, J. D. See Langlois. Holder, Iglehert, Nel and Sertomolli,3583 2190; Honma, kasukabe, Okebe, end Hozumi, son-Roes, Wells, end Bolognesi, 2604 Jagenburg, 0. See Lundhoim, Ekmen, EdstrOm, 3167; Sugiyama, Hozumi, end Okabe, 1056; lida, H. See Tsumuo,lide, Tsukegoshi, and Saku Keriberg, Jagenburg, end ScherstOn,4657 Yamamoto, Tomida, and Hozumi, 4170 mel,1063 Jakobs, E. S. See Paterson, Jakobs, Lauzon, atid Hozumi, M., Umezawa, T., Takenaga, K., Ohno, ikawa, V. See Sato, Kojime, Nishizawe, and Weinstein, 2216 T., Shiklta, M., and Yamane, I. Characterization Ikewe, ili3 Jakobsson, S. W. See Prough, Patrizi, Okita, of Factors Stimulating Differentiation of Mouse Ikenaka, T. See Aoyagi, Ikenaka, and Ichida, Masters,and Jakobsson,i i 99 Myeloid Leukemia Cells from a Yoshida Sam 357i Jakubowskl, A. See Dix, Lehman, Jekubowski, coma Cell Line Cultured in â€œSerum-free'â€˜Mo Imashuku, S., Fossett, M. C., III, and Green, A. Moyer, end Handschumacher,4485 dium,5127 A. Characterizationof AdenosineCyclic 3':5'- Jalanko, H., and Ruoslahtl, E. Differential Expres Hsl, B. P. See Morris, Hersh, Hsi, Guttermen, Monophosphete-binding Proteins in Human don of a-Fetopmoteinand â€˜y-Glutamyltranspepti Marshall, and Mavllgit, 219 Neumoblastome,3006 dase in Chemical end Spontaneous Hepatocar Hsle, A. W. See Fuscoe,O'Neill, Peck, and Hsie, lnaba, M., Kobayashl, H., Sakural, Y., and John cinogenesls, 3495 4875 son, R. K. ActiveEfflux of Daunorubicinand Jamasbi, R. J., and Nettesheim, P. Increase in Huang, K. C., Wenczak, B. A., and Llu, V. K. Adriemycin in Sensitive end Resistant Sublines Immunogenicity with Concomitant Loss of Tu Renal Tubular Transport of Methotmexate in of P388 Leukemia, 2200 morigenicity of Respiratory Tract Carcinomas Rhesus Monkey and Dog, 4843 Inglis, N. R. See Lin, Inglis, Rule, Tumksoy,Chap during in Vitro Culture, 2466 Huang, S. See Cohen, Marchok, Nettesheim, man, Kirby, and Stolbach, 4894 James, C. J. See Hanker, Ambrose, James, Man Steele, Nelson, Hueng, and Selkirk, 1980 Intagiletta, M. See Endrich, Intagliette, Reinhold, delkorn, Yates, Gall, Bossen, Fey, Laszlo, end Hubbard, S. M. See Erlichman, Strong, Wiemnik, and Gross, 17 Moore, 1635 McAvoy, Cohen, Levine, Hubbard, end Oheb IrvIng, C. C., TIce, A. J., and Murphy, W. M. James, J. H. See Krause,James,Humphrey,and nor, 3992 Inhibition of N-n-Butyl-N-(4-hydmoxybutyl)fli Fischer, 3065

5198 CANCERRESEARCHVOL. 39 Author Index to Volume 39

Jarman, M., Mllstsd, R. A. V., Smyth, J. F., Kinas, ama, 1819 mura, 3353 A.W.,Pankiewlcz,K.,andStec,W.J.Corn Kahn, C. R. See Osborne, Monaco, Kahn, Huff, Kawajiri, K., Yonekawa, H., Hara, E., and Tags parative Metabolism of 2-[Bis(2-chloro Bmonzert.and Lippman, 2422 shira, V. Activation of 2-Acetylaminofluoreno in ethyl)amlno]tetrahydmo-2H-1,3,2-oxaza-phos Kainer,R. A. See Luoker,Stewart,Kainem,Schen the Nuclei of Ret Liver, 1089 phorine-2-oxide (Cyclophosphamide) and Its grund. Reprnan,end Shefflem,3277 Kawauchi, H. See Sakekibama,Kawauchi, Tak Enantlomers in Humans, 2762 Kakizoe, T., Kawachi, T., and Sugimura, T. Ag ayanagi, and Ise, 1347 Jarzabek-Chorzelska, M. See Orth, Jablonske, glutination of Bladder Cells by Concanavalin A Kazam, E. See Young, Hollonbeng, Kazam, Ben Jarzabek-Chorzelske, Obelek, Rzesa, Favro, during the Early Phaseof Treatment of Rats with kowitz, Hainen, Sandom,and Abmems,1898 and Croissant, 1074 N-Butyl-N-(4-hydroxybutyl)nitrosamine, 3353 Keefer, L. K. See Kleihues, Doenjer,Koefor, Rico, Jay, 0. See Chattopedhyay,Jay, Lander, end Kakizoe, 1., Wang, T-T., Eng, V. W. S., Furrer, Roller, and Hodgson, 5136 Levine, 1@39 R., Dion,P., and Bruce,W. R. VolatileN-Nitros Kelleon, J. See Waterhouse, Joanpretre, and KoiI Janpretrs, N. See Waterhouse, Joanpmotmo,and emines in the Urine of Normal Donors and of son, 1968 Kellson, 1968 Bladder Cancer Patients, 829 Keller, J. W. See Rudmen, Chewla, Nixon, Vogler, Jetcoate, C. R. See Shen, Fehi, Wrighton, end Kalberer, J. T., Jr., and Newell, G. R., Jr. Funding Keller, end MacDonell, 699 Jefcoate, 4123 Impact of the National Cancer Act and Beyond, Keller, M. A Historical Overview of Alcohol and Jeffrey, A. M. See Brown, Jeffrey, and Weinstein, 4274 Alcoholism, 2822 â€˜ 1673; HarrIs, Aufrup, Stoner, Trump, Hilimen, Kalghatgl, K. K., Moroson, B. A., HorvÃ¡th, C., Kemp, R. G. See Lengle, Kmishnamej,and Kemp, Schafer, and Jeffrey, 4401 and Bertino, J. R. Enhancementof Antitumor 817 Jeffs, P. W. See Vogel, Kempom,Boekoihelde, Activity of 2,4-Diamino-5-(3',4'-dichlomophen Kemper, L. A. K. See Burger, Kemper, and Vogel. Graham, and Jeffs, 1490 yI)-6-mothylpyrimidmneand Baker's Antifol (Tn 1494; Vogel, Kempem,Boekelheide, Graham. Jenkins, R. S. See Howell, Jenkins, and Streifel, azinate) with Carboxypeptidase G, , 3441 and Jeffs, i490 3875 Kameya, T. See Hirohashi,Shimosato,Kameya, Kennel, S. J. Characterization of a Tumor Cell Jerabsk, L, Gupta, P., and Ferrer, J. F. An Koide, Mukojima, Taguchi, end Kageyeme, Surface Protein with HetemologousAntisera to a InfectIvity Assay for the Bovine Leukemia virus i 819 Spontaneous BALB/c Lung Carcinoma, 2934 Using the Immunoperoxidase Technique, 3952 Kamlnskas, E. Inhibition of Sugar Uptake by Kerbel, R. S. See Wiltrout, Frost, Morrison, and Jermna,0. M. See Buening, Levin, Kemle,Yagi, Mothotrexato in Cultured EhmlichAscitos Card Kerbel, 4034 Jerlna, and Conney, 5063; Buenlng, Levin, noma Cells, 90 Kerdelhue,B., and El Abed, A. Inhibitionof Preo Wood, Chang. Yagi, Karle, Jerina, and Conney, Kamiyama, S. See Mower, Ray, Shoff, Stemmer vulatory GonadotmopinSecretion end Stimula 1310; Q@ang, Wislocki, Kapitulnik, Wood, mann, Nomura, Glober, Kamlyama, Shimade, tion of ProlactinSecretionby 7,12-Dimethyl Levin, Yagi, Mah, Jerina, end Conney, 2660; end Yemekawe, 328 bonz(a)anthracene in Spregue-Dawley Rats, Levin,Buenlng,Wood, Chang,Thakkem,Jomina, Kano-Sueoka, T. See Horn and Kano-Sueoka, 4700 and Conney, 3549; SIege, Bracken, Gleason, 5028 Kerler, R. See Rabes, Kemler,Wilhelm, Rode, end Levin, Yagl, Jermna,end Conney, 67; Wood, Kanter, P. M., and Schwartz, H. S. Effectsof N- Riess, 4228 Chang, Levin, Ryan, Thomas, Mah, Kane, Yagi, Tnifluoroacetyladmiemycin-i4-velerate and Re Keski-Oja, J. See Repp, Koski-Oja, end Home, Jerlna, and Conney, 4069 lated Agents on DNA Strand Damage and Thy 4i 11 Jofte, L Z. See Schoental,Joffe, and Yagon, midino Incorporation in CCRF-CEM CoIls, 448; Kessel, D., Ratanatharathorn, V., and Chou, T 2179 Quantitative Models for Growth Inhibition of Hu H. ElectrofocusingPatternsof Fucosyltransfom Johnson, E. A. See Buchsbaum, Walker, and man Leukemia Coils by AntitumomAnthrecyclino ases in Plasma of Patients with Neoplastic Dis Johnson,3363 Derivatives, 3661 ease, 3377 Johnsen, R. Summary of the Informal Discussion Kapltuinlk, J. See Chang, Wislocki, Kepitulnik, Kessous, A., Bibor.Hardy, V., Suh, M., and Si ofThermal Dosimetry,2328â€• Wood, Levin, Yegi, Mah, Jenina, and Conney, mard, R. Analysis of Chromosomes,Nucleic Johnson, R. K. See Inabe, Kobayashi, Sakumai, 2660 Acids, and Polypeptidos in Hamster Cells Trens and Johnson, 2200; Magin and Johnson, 4534 Kaplan, H. G. See Stollor, Kaplan, Cummings, end formed by Herpes Simplex Virus Typo 2, 3225 Johnston, 0. A. See Barloglo, Comry,Yip, Lipp Calabresi, 908 Khaled, M. See Brattain, Green, Kimball, Marks, man,Johnston,KhalIl,Tenczynski,Reilly,Law Kaplan, H. S. Summaryof the InformalDiscussion and Khaled, 4083 son, Dosik, Rigor, Hankenson, and Frelmoich, of Future Clinical and Basic Research Needs, Khalil, K. See Barlogie, Corny, Yip, Lippmen, 1481; Bergerat, Barlogie, GOhde, Johnston, 2338' â€˜. See also DedlOve,Lieberman, Bonivom, Johnston, Khalil, Tenczynski, Reilly, Lawson, and Drewmnko,4356 end Kaplan, 4322; Epstein and Kaplan, i 748 Dosik, Rigor, Henkenson, and Fmoiroich,1481 Johnston, R. B. See Ostroy, Johnston, end Gems, Kaplan, S. C. See Bemozney,Basler, Hughes, and Khan,A., Hogan,S.,and Hill, J. M.Immunosup 4971 Kaplan,303i prossivo Effects of Sulfeto-trans-(â€”)-1,2-die Jones, G. M. See Parshad, Sanford, Tamone, Kapp, D. S., and Hahn, G. M. Thermosensitizetion minocydlohexeneplatinum(ll), 3476 Jones, and Baeck, 929 by Sulfhydryl Compounds of Exponentially Khwaja, T. A., Kigwana, L. J., and Mien, A. M. Jones, L. A., and Bern, H. A. Cervicoveginal end Growing Chinese Hamster Cells, 4630 Antileukomic Activity of 1-@8-o-Amabinofumanosyi Mammary Gland Abnormalities in BALB/cCrgl Karim, K. A. See Silver, Kanim, Archibald, end 2-amino-i ,4(2H)-4-iminopymimidlno,a Now Do Mice Treated Neonatally with Progesterone and Salinas, 5036 pot Form of 1-$-D-Amablnofumenosylcytosine, Estrogen, Alone or In Combination, 2560 Karlberg, I. See Lundholm, Ekman, Edstrdm, Karl 3129 Jones, L. A., and Pacillas-Verjan, R. Transplant berg, Jagenbumg,and ScherstOn,4657 Kido, H., Tomihara, V., Watanabe, I., Ohsawa, ability and Sex Steroid Hormone Responsive Kane, J. M. See Buoning, Lovin, Kamle,Yagi, N., and Katunuma, N. Amplification of Growth ness of Cervlcovaglnal Tumors Derived from Jemina, end Connoy, 5063; Buening, Levin, Inhibition by Glucocorticoid on L5i 78Y end Female BALB/cCrgl Mice Neonatally Treated Wood, Chang, Yegi, Kane, Jerina, end Connoy, Li 210 Lymphoblests in Viva, 3258 with Ovarian Steroids, 2591 1310; Wood, Chang, Levin, Ryan, Thomas, Kidwell, W. R. See Wicha, Liotta, and Kidwoll, JÃ¸rgsnssn, 0. See Sanner, Brennhovd, Christen Mah, Kane, Yagi, Jerina,and Connoy,4069 426 son, Jergensen, and Kvaley, 654' Kasukabe, T. See Honma, Kesukebe, end Hoz Klessllng, A. A., and Goullan, M. Detection of Joyce, R. A., Hartmann, 0., and Chervenick, P. umi, 2i 90; Honme, Kesukabe, Okabo, and Hoz Reverse Transcniptaso Activity in Human Cells, A. SplenicGranulopoiesisIn Mice followingAd umi, 3167 2062 mlnlstmatlonof Cyclophosphamido, 215 Kataoka, M. See Negei, Kataoka, kobayeshi, Kigwana, L. J. See Khweja, Kigwena,and Mien, Jubla, W., Frailey, J., and Smith, J. B. Inhibitory Ishihara, Tobioka, Nekashima, Namuse,Saito, 3129 Effect of Prostaglandin F@aon the Growth of a and Sekuma, 1835 Kikuchi, V. See Sokiye, Endoh, Kikuchi, Katoh, Hormone-dependentRet MammaryTumor,998 Kataoka, T., Oh-hashi, F., and Sakural, V. Im Matsuure, Iwasawa, Tekede, and Takamizawa, munothorapeutic Response of Concenavalin A- 1108 K bound Li 210 Vaccine Enhanced by a Stmepto KIm,J. H., and Hahn, E. W. ClinicalandBiological coccel Immunopotontiator, OK-432, 2807 Studios of Localized Hyperthommia,2258 Katoh, T. See Sekiye,Endoh,Kikuchi,Katoh, Kim, V. S. See Tsao, Freemen, end Kim, 3405; Kaden, D. A., Hites, R. A., and ThllIy, W. G. Matsuuma,Iwesawa,Takeda, and Takamizawa, Whitehead, Feamney,and Kim, 1259 Mutagenlcity of Soot and Associated Polycyclic 1i 08 Kimball, A. P. See Howard, Kimball,and Boar, Aromatic Hydrocarbons to Salmonella typhimu Katunuma, N. See Kido, Tamihara, Wetanabe, 2568 rium, 4152 Ohsawa, and Katunuma, 3258; Tsuda, Katun Kimball, D. B. See Scialla, Speckart, Haul, and Kadish, A. See Bases, Rubinstoin, Kadish, Men uma, Morris, and Webor, 305 Kimball, 2031 dez, Wittner, Elequin, and Liebeskind, 3524 Katyal, S. L. See Shinozuka, Sells. Ketyal, Sell, Kimball, P. M. See Brettein, Green, Kimball, Kadlubar, F, F. See MIller, Kadlubam,Miller, Pitot, end Lombardi, 2515 Marks, and Khaled,4083 and Drinkwater, 3411 Katzenellenbogen, B. S. See Tsai, Rutledge, and Kinahan, J. J., Often, M., and Grmndey,G. B. Kagsyama, K. See Himoheshi, Shimosato, Ke Katzonellenbogen, 5043 Evaluation of Ribonuclooside and Dooxyribo meya, Koide, Mukojima, Taguchi, and Kagey Kawachi,T. See Kakizoe,Kawachi,and Sugi nucleoside Triphosphete Pools in Cultured Lou

DECEMBER1979 5199 Author Index to Volume 39

kemia Cells during Exposure to Methatrexate or Establishment of a Cell Culture Line from a Calmette-GuÃ©rinImmunotherapy of Postsungi Methatrexate Plus Thymidine, 3531 Transplantable Rat Stomach Cancer Induced by cal Metastases of 13762A Rat Mammary Ad Kinas, R. W. See Jarman,Milsted,Smyth,Kinas, N-Methyl-N'-nitro-N-nitrasoguanidine, 5141 onocarcinoma, 987 Pankiewicz, and Stec, 2762 Koch, M. R. See Bamna,Parsons, Koch, and Lea, Krelder, J. W., Bartlett, G. L, and Sharkey, F. E. King, C. M. See Morton,King,andBaetcke,3107 i 655 Primary Neoplestic Transformation in Viva of KIng, C. M., Traub, N. R., Lortz, Z. M., and Kociolek, K. See Pitha, Kaciolek, and Apffel, 170 Xenogeneic Skin Grafts on Nude Mice, 273, Thissen, M. R. MetabolicActivationof Arylhy Kohl, F.-V. See RUdiger,Marxon,Kohl,Meldenis, Communication draxamic Acids by N-O-Acyltransferase of Rat and Wichert, 1083 Kreiser, D. M. See San, Shimada, Maslansky, Mammary Gland, 3369 Kohlhepp,S. J. See May, Kohlhepp,Boose,and Kneisen,Laspia, Rice, and Williams, 4441 King, M. M. See Kallmorgen, Sansing, Lehman, Reed, 762 Krementz, E. T. See Leang, Coopomband,Dock Fischer, Langley, Alexander, King, and McCay, Kohn, K. W. See Zwelling,Anderson,and Kohn, ens, Sutherland, Cosano, and Kmementz,2125 3458 365; Zwelling, Filipski, and Kahn, 4989 Kripke, M. L. See Fidlem,Gensten,and Kripke, King, R. J. B., Whltehead, M. I., Campbell, S., Kohnoe, K. See Takumitsu, Tokumitsu, Kohnoe, 38i 6 and Minardi,J. Effectof EstrogenandProgestmn and Takeuchi, 4733 Krishan, A. See Howell, Knishan,and Frei, 1315 Treatments an Endometniafrom Postmenopau Koide, T. See Hinohashi, Shimosato, Kameya, Krishnaraj,R. See Longle,Knishnarej,and Kemp, sal Women, 1094 Koido, Mukojima, Taguchi, and Kageyama, 817 Kinnealey, A. See Cimino, Rowley, Kinnealey, 1819 Kroeger'Koepke, M. B., and Michejda, C. J. Ev Vaniakojis, and Golomb, 227 Kojima, K. See Sato, Kajima, Nishizawa, and idonco for Several Demothylase Enzymes in the Kinoshita, K. See Takahashi, Kinoshita,Hashi Ikawa, 1113 Oxidation of Dimethylnitmosaminoand Phenyl mob, and Yasuhira, 1814 Kollinger, G. See Schwab, Kallinger, Hess, Ahuja, mothylnitrasamino by Rat LivenFractions, 1587 Klnzel, V., Krelblch,G., Hacker, E., and SUss,R. Abdo, Andems,and Andens,519 Krueger, W. C. See Li, Kuontzel, Munch, Pschi Stimulation of Choline Incorporation in Cell Cul Koilmorgen,G. M., Sensing, W. A., Lehman, A. goda, and Krueger, 4816 tunesby PhonbolDerivatives and Its Correlation A., Fischer, G., Longley, R. E., Alexander, S. Krupa, T. A. See Mastro, Knupa,and Smith, 4078 with their Irritant and Tumor-promoting Activity, S., Jr., King, M. M., and McCay, P. B. Inhibition Kucera, L S. See Heise, Kucena, Raben, and 2743 of Lymphocyte Function in Rats Fed High-Fat Homesloy, 4022 Kirk-Bell,S. See Lehmann,Kirk-Bell,and Mayne, Diets, 3458 Kuenizel, S. L See Li, Kuentzel, Murch, Pschi 4237 KomeijI, D. V. See Matsumoto, Takata, and Ko goda, and Krueger, 48i6 Kirkpatrick, C. H. See Cook,Kirkpatrick,Rabson, meiji, 3070 Kula, N. See Newbonno,Weigert,and Kula, 3986 and Lewis, 4949; Cook, Lewis, and Kirkpatrick, Komlyama, S. See Akiyama,Hidake, Komiyama, Kulkami, P. See Mufson, Kulkamni,Eakins, and 3335 and Kuwano, 5150 Weinstein, 3602 Kirley, S. D. See Lin,Inglis,Rule,Turksoy,Chap Kontra,J. See Punnell,Bartlett,Kneidor,Bino,and Kumar, M. S., Chlang, T., and Deodhar, S. D. man, Kirby, and Stalbach, 4894 Kontra, 4838 Enhancing Effect of Thyroxine on Tumor Growth Klrsh,R. See PasteandKimsh,2582; Paste,Kinsh, Koo, V. See Liu, Stallard, Koo, and Dannaher, and Metastases in Syngeneic Mouse Tumor Foglen,and Fidler, 881 1640 Systems, 3515 Kissonerghls, A-M. See Coombs, Kissonenghis, Korytnyk, W. See Klohs, Bornacki. and Konytnyk, Kuo, K. C. See Gehnke,Kuo,Waalkes,andBomek, Allen, and Vase, 4160 1231 1150 Kitagawa, T., Pltot, H. C., Miller, E. C., and Kosaka, K. See Okabe, Suzuki, Ohsawa, Kosaka, Kuppinger, M. S. See Comis, Kuppinger,Gins Miller, J. A. Promotionby DietaryPhenobanbital and Temasima,4189 berg, Crooke, Gilbert, Auchincloss, and Pros of Hepatocarcinogenesis by 2-Methyl-N,N-di Kotake, T. See Matsuda, Osafune, Nakano, Ko tayko, 5076 methyl-4-aminoazobenzene in the Rat, 112 take, Sonoda, Watanabe, Hada, Okochi, Hi Kuroki, T. See Huberman, Montesano, Dnevon, Kitamura, H., Levine, P., Cheng, P-J., Egeli, R. gashino, Yemamuna,and Abe, 4694; Okochi, Kunoki, St. Vincent, Pugh, and Goldfamb,269 A., Liu, V-P., Good, R. A., and Day, N. K. Seiko, Higashino, Hada, Watanabe, Yamamuna, Kurokl, T., and Drevon, C. Inhibitionof Chemical Fonssman-like Antibody Levels in Sore of Pa Ito, Matsuda, Osafune, Katake, and Sonoda, Transformation in C3H/ 10TÂ½Cells by Protoaso tionts with Lunq Cancer, 2909 1829 Inhibitors, 2755 Kitamura, V., Okamoto, S., Hayata, I., Uchida, Kotlarski, I. See Ashman, Cook, and Kotlarski, Kuszynski, C. See Langenbach, Malick, Tampa, N., Yamaguchl, K., and Matsumoto, K. Dovel 2768 Kuszynski, Freed, and Hubonman.3509 apment of Androgen-indepondent Spindle-Cell Kovach, J. S. See Amos, Powis, Kovach, and Kutler, M. See Sedwick, Kutlem,Frazor, Brown, Tumors from Androgen-dependont Medullany Eagan, 50i 6; Powis, Ames, and Kovach, 3564 and Leszlo, 3612 Carcinoma SC115 in Andnogen-depleted Nude Kovach,J. S., Ames, N. M., Powis, G., Moertel, Kuwano, M. See Akiyama, Hidaka, Komlyama, Mice, 4713 C. G., Hahn, R. G., and Creagan, E. T. Toxicity and Kuwano, Si 50 Klanjscek, G. See Plesnicam,Klanjscek, Modic, and Phanmacokinetics of a PymmolizidinoAlka Kvaloy, S. See Sannon,Bnennhovd,Christensen, and Rustia, 4575 bid, Indicino N-Oxide, in Humans, 4540 Jorgensen, and Kvaloy, 654' Kledzik, G. See Aylswarth, Hodson, Berg, Kied Kovach,J. S., Ames, M. M., Stemad, M. L, and Kwong, P. C. See Lisa, Kwong,Thompson,and zik, and Meitos, 2436 O'Connell, M. J. Phase 1 Trial and Assay of Dent, 183 Klelhues, P. See Swenberg, Cooper, BUcheler, Rubidazone (NSC 16401 1) in Patients with Ad and Kleihues, 465 vanced Solid Tumors, 823 L Kleihues, P., Doerjer, G., Keefer, L. K., Rice, J. Kowal, C. D., and Bertino,J. R. PossibleBenefits M., Roller, P. P., and Hodgson, R. M. Conrela of Hyperthemmiato Chemotherapy, 2285 â€˜ tion of DNA Methylation by Methyl (acetoxy Kowal, R. See Parsons,Todd, and Kowel,4341 Laccetti, P. See Moldolosi and Laccotti, 2796 mothyl)nitnosammnewith Organ-specific Carci Kowbel, D. J. See Nestmann, Douglas, Matula, Ladisch, S., Reaman, G. H., and Popiack, D. G. nogenicityin Rats,5136 Grant, and Kowbol, 4412 Bacillus Calmette-Gudrin Enhancement of Col Klein, D. L. See Nadel, Thompson,Fischer,and Koyama, K., Nudelman, E., Fukuda, M., and any-stimulating Activity and Myeloid Colony For Klein, 2221 Hakomori, S-I. Correlation of Glycosyletion in a matlon following Administration of Cyclophos KleIn, G., Penn, I., and Henle, W. Request far Membrane Protein with a Molecular Weight of phemide, 2544 Specimens from Organ Transplant and Immu 150,000 with Tumonigonic Property of Rat Fl Lair, S. V. See Lozzio,Lopez, Coulson,and Lain, nodoficiency Patients Who Developed Lympho bmosarcamaVariants, 3677 1529 mas, 1137, Letter to the Editor Krakowka, S. See Rojko, Hoover, Mathes, Kra Lalande, M. E. See Pellavicini,Lalando, Miller, Kleinhans, C. M. See Black, Henderson,Klein kowka, and Olson, 3789 and Hill, i891 hans, Phelps, and Thonnby, 5022 Kramer, D. See Porter, Mikles-Robertson,Kma Lam, H-V. P. See Begleiten, Lam, Grover, Froese, Kline, I. See Guamino,Rozencweig,Kline, Penta, men,and Dave, 2414 and Goldenborg, 353 Venditti, Lloyd, Holzworth, and Muggia, 2204 Krasovlch, P. See Buick, Stanisic,Fry, Salmon, Lam, L. K. T. See Wattenbeng,Lam, end Fladmoe, Klohs, W. D., Bemnacki,R. J., and Korytnyk, W. Trent, end Knasovich,505i 1651 Effects of Nucleotides and Nuclootide: Analogs Krause, R., James, J. H., Humphrey, C., and Lambert, B., Ringborg, U., and Skoog, L. Age an Human Serum Sialyltrensfenase, 1231 Fischer,J. E. Plasmaand BrainAminoAcidsin related Decrease of Ultraviolet Light-induced Klubes, P. See Fernendosend Klubos,1396 Walker 256 Carclnosarcoma-boaning Rats, DNARepair Synthesis in HumanPeripheral Lou Kobayashl, H. See Inaba, Kobayeshi, Sakunai, 3065 kocytes,2792 and Jahnson, 2200 Kreibich, G. See Kinzel, Kreibich, Hecken, and Lamm, D. L See Lavengne,Lamm,Redwin,and Kobayashi, H. See Takeichi, Suzuki, and Kobay SUss,2743 Hannington,i 985 ashi, 3749 Kreider, J. W. See Punneli,Bartlett,and Kreider, Lander, M. R. See Chettopadhyay,Jay, Lender, Kobayashi, S. See Nagai, Kataoka, Kabayeshi, 1; Punnell, Bartlett, Kreider, Biro, and Kontra, and Levine, 1539 Ishihara, Tobiaka, Nakashima, Nanuse, Saito, 4838 Landolfo, S. See Vanesio, Giovanelli, Landolfo, and Sakuma, 1835 Krelder, J. W., Bartlett, G. L, Bayer, C. M., and and Fomni,4983 Koborl, 0., Martin, F., MartIn, M., and Turc, C. Purnell, D. M. Conditionsfar EffectiveBacillus Landolph,J. R. See Bartholomew,Peanlman,Len

5200 CANCER RESEARCH VOL. 39 Author Index to Volume 39

dolph, and Straub, 2538 loins, 3281 , Meeting Report L. M., and Krueger, W. C. ComparativeBiolog Landry, J., and Marceau, N. Cell Growth Rocov Leibovitz, B. See Cameron, Pauling, and Loibov ical and Biochemical Effects of Nogalamycmn ely after Treatments at Various Supmaoptimal itz,663 and Its Analogs on Li 210 Leukemia, 48i 6 Temperatures,1218 Lengle, E. E., Krishnaraj, R., and Kemp, R. G. Li, S. A. See Li, Li, and Cuthbontson, 2647 Langenbach, B. See Hubenman, Heckman, and Inhibition of the Lectin-inducod Mitogenic Re Liao, S-K., Kwong, P. C., Thompson, J. C., and Langenbach, 2618 sponse of Thymocytes by Glycalipids, 817 Dent, P. B. Spectrumof MelanomaAntigenson Langenbach, R., Malick, L, Tompa, A., Kuszyn Leong, S. P. L., Cooperband, S. R., Deckers, P. Cultured Human Malignant Melanoma Cells as ski, C., Freed, H., and Huberman, E. Mainte J., Sutherland, C. M., Cesare, J. F., and Kre Detected by Monkey Antibodies, 183 nance of Adult Rat Hepatocytes on C3H/ 10TÂ½ mentz, E. T. Antibody-induced Movement of Liau, M. C., Chang, C. F., and Becker, F. F. Cells, 3509 Common Melanoma Membrane Antigens an the Alteration of 5-Adenosylmethionine Synthe Langlels, A. J., Holder, W. D., Jr., Iglehart, J. 0., Surface of Unfixed Human Melanoma Cells, tases during Chemical Hepatocamcino9enesis Nelson-Bass, W. A., Wells, S. A., Jr., and Bol 2125 and in Resulting Carcinomas, 21 13 ogneel, D. P. Morphological and Biochemical Leong, S. S., Sokal, J. E., Gomez, G. A., and Liau, M. C., Chang, C. F., BÃ©langer,L., and Properties of a New Human Breast Cancer Cell Horoszewlcz, J. S. Circulating Colony-farming Grenier, A. Correlationof IsozymePatternsof Line, 2604 Cells in Different Stages of Chranic Myelacytic S-Adenosylmothionine Synthotase with Fetal Lansdale,T. See Unano,Suit,Dunn,Lansdale, Leukemia,2704 Stages and Pathological States of the Liver, i 62 end Sedlacek,3454 Leopold, W. R., Miller, E. C., and Miller, J. A. Lichtenfeld, J. L See Van Echo, Chiuten, Gorm Larkin, J. M. A Clinical Investigation of Total-Body Cancmnogenicityfo Antitumor cis-Platinum(lI) Co by, Lichtenfeld, Scoltock, and Wiemnik,388i Hyperthermia as Cancer Therapy, 2252 ordination Complexes in the Mouse and Rat, Lieber, C. S., Seitz, H. K., Garro, A. J., and Laskin, J. D., Evans, R. M., Slocum, H. K., Burke, 913 Werner, T. M. Alcohol-related Diseases end 0., and Hakala, M. T. Basis for Natural Variation Lepault, F. See Fache, Lepault, Zelick, and Frin Carcinogenosis, 2863''' in Sensitivity to 5-Fluoroumacil in Mouse and del, 3959 Lieberman, M. See DoclÃ¨ve,Lioberman, Banivem, Human Cells in Culture, 383 Lesko, S. A. See Lorentzen, Leska, McDonald, and Kaplan, 4322 Laspla, M. F. See San, Laspia, Solefer, Maslan and Ts'o, 3194 Liebeskind, D. See Bases, Rubinstoin, Kadish, sky, Rice, and Williams, 1026; San, Shimada, Lester,0. ModesofAlcoholAdministrationAppro Mendez, Wittner, Elequin, and Liebeskind, Maslansky, Krelser, Laspia, Rico, and Williams, pniate for the Study of the Role of Alcohol in 3524 4441 Cancinogenesis,2891 Liehr, J. G. See Benvenuto, Liohr, Winkler, Far Laszlo, J. See Hanker, Ambrose, James, Mandel LeStourgeon, 0. See Balk, Mitchell, LeStourgean, quhar, Caprioli, and Lao, 3199 korn, Yates, Gall, Bossen, Fey, Laszlo, and end Hoon, 1854 Lijlnsky, W. Current Status of Experimental Moore, 1635; Sedwick, Kutler, Frazor, Brown, Leung, J. P., Bordin, G. M., Nakamura, R. M., Chemical Carcinogonesis and Its Applications and Laszlo, 3612 DeHeer, D. H., and Edgington,T. S. Frequency to HumanCancerRisk, 2887 â€˜â€˜. See also Latt, S. A. See Shuler end Latt, 2510 of Association of Mammary Tumor Glycoprotein Quanies, Sega, Schenley, end Lijinsky, 4525; Lau, E. V. See Case, Dahlig, Lau, Lynch, and Antigen and Other Markers with Human Breast Roznik-SchUllerand Lijinsky, 72 Paterson, 1245 Tumors, 2057 Lim, B. T. See Chen, Lim, and Chevin, 3485 Lauxon, G. J. See Paterson, Jakobs, Lauzon, and Leveson, S. H. See Goldrosen, Russo, Howell, Lin, C-W., inglis, N. R., Rule, A. H., Turksoy, R. Weinstein, 2216 Leveson, and Halyake, 587 â€¢; Goldnasen, N., Chapman, C. M., Kirley, S. D., and Stol Lavergne, J. A., Lamm, 0. L., Radwln, H. M., and Russo, Howell, Leveson, Moore, Halyoke, and bach, L. L. Histaminase and Other Tumor Harrlngton, J. T. Leukocyto Migration Inhibition Douglass, 633' Markers in Malignant Effusion Fluids, 4894 in Vitro in Bladder Carcinoma, 1985 Leveson, S. H., Howell, J. H., Paollni, N. S., Tan, Lin, V. C., Talley, 0. J., and VIllee, C. A. In Lawrence, F. See Enouf, Lawrence, Tompete, M. H., Holyoke, E. 0., and Goldrosen, M. H. creased Progesterone Receptor Concentrations Robert-Gero, and Lederer, 4497 Correlations between the Leukocyte Adherence in Bladder Lesions of Estrogen-treated Syrian Lawson, R. See Banlogie, Corny, Yip, Uppman, Inhibition Microassay and in VivaTests of Trans Hamsters, 2614 Johnston, KhaIiI, Tenczynski, Reilly, Lawson, plantation Resistance, 582 Lincoln, G. See Briggs, Campbell, Chiu, Hnilica, Dosik,Rigor,Hankenson,endFmoimeich,1481 Levin, V. A. See Marion, Edwards,Levin,Lubich, Lincoln, Stein, and Stein, 3683 Lawson, T. See Pour, Weilcave, Gingoll, Nagel, and Wilson, 993 Lindsay, J. M. See Wood, Tilzer, Gollehon, and Lawson, Saimasi, and Tines, 3828 Levin,W. See Buening,Levin,Kanle,Yagi,Jerina, Lindsay, 4588 Lea, M. A. See Bamra,Parsons, Koch, and Lea, end Conney, 5063; Buening, Levin, Wood, Liotta, L. A. See Wicha, Liotta, and Kidwoll, 426 1655; Perrella and Lea, 1382 Cheng, Yagi, Kane, Jerina, and Conney, 1310; Lippman, L See Banlogie,Carry, Yip, Lippman, Leavens, M. See Stewart, Bonvenuto, Loavens, Chang, Wislocki, Kapitulnik, Wood, Levin, Yagi, Johnston, KhallI, Tenczynski, Reilly, Lawson, Hall, BenjamIn, Plunkett, McCredlo, Burgess, Mah, Jemina, and Conney, 2660; Slaga, Dosik, Rigor, Hankenson, and Froinoich, 1481 and Leo, 4119 Bracken, Gleason, Levin, Yagi, Jenina,and Can Lippman,M. E. See Allegra,Lippman,Thompson, LeBoeuf, R. See Vaught, Gumbo, Parker, Le ney, 67; Wood, Chang, Levin, Ryan, Thomas, Simon, Barlock, Green, Huff, Do, end Aitken, Boeuf, and Doctor, 3177 Mah, Kane, Yagi, Jenina,and Conney, 4069 i 447; Allegna, Lippman, Thompson, Simon, Leciercq, M. See Sex, Bruck, Mammonickx,Porte Levin, W., Buoning,M. K., Wood, A. W., Chang, Banlock, Green. Huff, Do, Aitken, and Warren. telle, Ghysdael, Cleuten,Leclercq, Dekegel, and R. L., Thakker, 0. R., Jermna,0. M., and Con 1973; Osborne, Monaco, Kahn, Huff, Bronzert, Bumy, 1118 ney, A. H. TumonigonicActivityof 3-Methyl and Lippman, 2422; Strabl and Lippman, 3319 Ladirer, B. See Enouf, Lawrence, Tompete, Rob cholenthrene Metebolitos an Mouse Skin and in Lltin, B. S., and Grimes, W. J. Two-Dimensional o,1-Gero,and Lederem,4497 Newborn Mice, 3549 Electrophoresis of Membrane Proteins from Leduc, E. H., and dsHarven, E. Obituary Wilhelm Levine, A. S. See Chattopadhyay,Jay, Lander, Normal and Transformed Cells, 2595 Bernhard,1920-1978, page 2811 and Levine, 1539; Erlichman, Strong, Wiemnik, Little, J. B. Quantitative Studies of Radiation Lee, S. H., and Sartersili, A. C. Biochemical Ac McAvoy, Cohen, Levine, Hubbard, and Oheb Transformation with the A31-i 1 Mouse BALB/ lion of the Antineoplestic Agent 2-Fommylpymi non,3992 3T3 Cell Line, 1474. See also Fomnaceand dIne N-oxide Benzenesulfonylhydrazono, 2625 Levine, A. S., Slvulich, N., Wiernlk, P. H., and Little, 704; Selsky, Henson, Weichsolbaum, end Lee, S-S., Glovanslia, B. C., Stehlin, J. S., Jr., Levy, H. B. Initial Clinical Trials in Cancer Pa Little, 3392 and Brunn,J. C. Regressionof HumanTumors tiontsof Polymiboinosinic-PalyribocytidylicAcid Llu, V. K. See Huang, Wenczak, and Liu, 4843 EstablishedIn Nude Mice after ContinuousIn Stabilized with PoIy-t.-Iysine, in Carboxymeth Llu, V. K., Stallard, S., Koo, V., and Danriaher, fusion of Thymidmne,2928 ylcollulose [Poly(ICLC)], a Highly Effective Inter C. L. Serum InhibitorActivityof Granulocyte Leeper, D. B. See Henle and Looper, 2665 fomonInducer, 1645 Macrophage Colony Formation in Patients with Legato,, M. S. See Rlnkus and Legator, 3289 Levine, P. See Kitamura, Levine, Cheng, Egeli, Cancer, 1640 Legha, S. S. See Swenerton, Legha, Smith, Han Liu, Good, and Day, 2909 Liu, V-P. See Kitamura, Levine, Cheng, Egeli, Liu, tobagyl,Gehan, Yap, Gutterman,and Blumen Levftt, 0. S. See Dybing, von Bahr, Aune, Glau Good, and Day, 2909 schemn,1552 mann, Levitt, and Thomgeirsson,4206 Lloyd, H. H. See Guarina, Razencweig, Kline, Lehman, A. A. See Kollmorgen, Sansing, Lehman, Levy, H. B. See Levine. Sivulich, Wiemnik,and Penis, Venditti, Lloyd, Holzworth, and Muggia, Fischer, Longley, Alexander, King, and McCay, Levy, 1645 2204 3458 Lewis, A. M., Jr. See Cook, Kirkpatrick,Rabson, Lo, T. N., and Boyle, M. D. P. Relationshipbe Lehman, C. P. See Dix, Lehman, Jakubowski, and Lewis, 4949; Cook and Lewis, 1455; Cook, tween the Intracellular Cyclic Adenosine 3':S'- Moyer, and Handschumechon,4485 Lewis, and Kirkpatrick, 3335 Monophosphate Level of Tumor Cells and their Lelimann, A. R., Kirk-Bell, S., and Mayne, L Lewis, M. A. See O'Brien, Lewis, and Diamond, Sensitivity to Killing by Antibody and Comple Abnormal Kinetics of DNA Synthesis in Ultravi 4477 ment, 3156 olet Light-irradiated Cells from Patients with Li, J. J., LI, S. A., and Cuthbertson, T. L. Nuclear Locker, G. V. See Ozals, Locker, Donoshow,Gmat Cockayne'sSyndrome,4237 Retention of All Steroid Hormone Receptor zinger, Myers, and Young, 3209 Lehmann, F-G. Sixth Meeting of the International Classes in the Hamster Renal Carcinoma, 2647 Loeb, W. See Thorpe, Loob, Hyatt, and Rosen Research Group for CercinoembryonicPro LI, L. H., Kuenizel, S. L., Murch, L L., Pschlgoda, bong,277

DECEMBER1979 5201 Author Index to Volume 39

Loehrke, H. See Goerttler, Loehrke, Schweizen, Lunardi,I. See Wheeler,Dinks,Lunandi,andNem otenLeukocyte Adherence Inhibition Technique, and Hesse, 1293 raft, 370 625' Lohman, P. H. M. See Brown, Fickel, Cleaver, Lundholm, K., Ekman, L., EdstrOm, S., Karlberg, Mammerlckx, M. See Box, Bruck, Mammonickx, Lohman, Wade, and Waters, 2522 I., Jagenburg, 0., and ScherstÃ©n,T. Protein Portetolle, Ghysdael, Cleuter, Leclercq, Deke Lohrmann, H-P. See Schreml and Lohrmann, Synthesis in Liver Tissue under the Influence of gel, and Bunny, 1118 4195 a Methylcholanthnene-induced Sarcoma in Manabe, H. See Yasumoto, Menabe, Yanagawa, Lohrmann, H-P., and Schreml, W. Sensitivityof Mice, 4657 Nagano, Uoda, Himota,Ohte, Nomoto, Azuma, Human Granulopoiesis in Vitro to Adniamycin Luttenegger, D. G. See Burns, Luttoneggen,Dud and Yamamuna,3262 before and after Exposure in Vivo, 527 ley, Buottnen,and Spector, 1726 Mandelkorn, J. See Hanker, Ambrose, James, Lombardi, B. See Shinozuka,Sells, Katyal, Sell, Lynch, T. P. See Case, Dehlig, Lau, Lynch, and Mandolkomn,Yates, Gall, Bossen, Fey, Leszlo, and Lombardi, 2515 Paterson, 1245; Paterson, Panan, Yang, end and Moore, 1635 Long, C. W., Bruszewski,J. A., Christensen,W. Lynch, 3607 Mannlck, J. A. See Wang, Steele, Mannick, Fal L., and Suk, W. A. Effectsof PrateaseInhibitors Lyon, P. A. See Heckon, Fennelly,Smith, Saa ion, and Onikul, 1702 on ChemicalInductionof TypeC Virus,2995 vedne,and Lyon, 2679 Manson, L A. See Tax and Manson, i 739 Longley,R. E. See Kollmongon,Sensing.Lehman, Lysik, R. M. See DiStefano, Lysik, and Zucker, Mantel, N., and Ciminera, J. L. Use of Logrank Fischer, Langley, Alexander, King, and McCay, 1193 Scones in the Analysis of Litter-matched Date 3458 Lysik, R. M., Cornetta, K., DiStefano, J. F., and on Time to Tumor Appearance, 4308 Loo, T. L. See Benvonuto, Hall, Fanquhar,Stewart, Zucker, S. Bone Marrow CytolysisInducedby MÃ£ntylÃ , M. J. Regional Blood Flow in Human Benjamin, and Lao, 349; Benvenuta, Liehr, Hepatome, Tenatocancinoma,and Transformed Tumors, 2304 â€˜ Winkler, Farquhan, Capnioli, and Lao, 3199; Fibroblasts, 30 Marashi, F., Davis, F. M., Busch, R. K., Savage, Plunkett, Alexander, Chubb, and Loo, 3655; H. E., and Busch, H. Purificationand Partial Rao, Freiroich, Smith, and Lao, 3152; Stewart, M Characterization of Nucloolar Antigen-i of the Benvenuto, Loavens, Hall, Benjamin, Plunkett, Novikoff Hopatoma, 59 McCnedie, Burgess, and Loo, 4119 Marceau, N. See Landry end Marceeu, i 218 Lopez, 0. M. See Lozzia, Lopez, Coulson, and Marchok, A. C. See Cohen, Marchok, Nettesheim, Lair,1529 MacDonell, R. C. See Rudman, Chawla, Nixon, Steele, Nelson, Huang, end Selkirk, 1980; Lopez, M. See Thamson, Tataryn, Lopez, Vogler, Keller, and MacDonell, 699 Steele, Merchok, end Notteshoim, 3805 Schwartz, and MacFarlane, 638' MacFarlane, J. K. See Thomson,Tataryn,Lopez, Margison, G. P. See Montesano, BrÃ©sil,and Mar Lopez-AlarcOn, L. See Eboli, Malmstnom,Gal Schwartz, end MacFanlano,638' gison, 1798; Stumpf, Margison, Montesano, eotti,LOpez-AlarcOn,andCamafoli,2737 Mach, J-P. See Cannel,Gross,and Mach, 5171 and Pegg, 50 LOpez-Revllla,R. See Mendaza-Figuenos,Lopez Mack, T. See Henderson, Dwomsky,Pike, Bap Marmnello,A. J. See Freedman, Parker, Maminello, Revilla, and ViIla-TmeviÃ±o,3254 tista, Menck, Preston-Martin, and Mack, 4507 Gumtoo,and Minowada, 46i2 Lorentzen, R. J., Lesko, S. A., McDonald, K., Macjey, J. K. See Wold, Mackey, Rigden, and Marini, M. See Mushinski end Mamini,I 253 and Ts'o, P. 0. P. Toxicity of Metabolic Green, 3479 Marks, F. See Bertschand Marks, 239 Benzo(a)pyrenodiones to Cultured Cells and the MacLeod, M. C., Cohen, G. M., and Selkirk, J. K. Marks, F., Bertsch, S., and Furstenberger, G. Dependence upon Molecular Oxygen, 3i 94 Metabolism and Macromalocular Binding of the Onnithino Decerboxylese Activity, Cell Prolifer Lorscheider, F. L. See Peters, Nishi, Miuna, Lam Carcinogen Benzo(a)pyrono and its Relatively ation,endTumorPromotioninMouseEpidermis scheidon, Dixon, and Tamsoki, 3702 Inert Isomer Bonzo(e)pyrone by Hamster Em in Viva, 4183 Lortz, Z. M. See king, Traub, Lontz,and Thissen, bryo CoIls, 3463 Marks, M. See Brattain, Green, Kimball,Marks, 3369 MacLeod, R. M. See Cave, Dunn, end MacLood, and Khaled, 4083 Lotan, R. DifferentSusceptibilitiesof HumanMel 729 Marks, P. A. See Yamasaki, Weinstein, Fibach, anamaandBreastCarcinomaCellLinesto Re MacManus,J. P. Occurrenceof a Low-Molecular Rifkind, and Marks, 1989 tinoicAcid-inducedGrowthInhibition,1014 Weight Calcium-binding Protein in Neoplastic Marmor, J. B. Interactionsof Hyperthenmiaand Lotan, R., and Dennert, G. Stimulatory Effects of Liver, 3000 Chemotherapy in Animals, 2269â€• Vitamin A Analogs on Induction of Cell-mediated Madewell, B. R. See Grant, Pickard, Ramaika, Marmor, J. B., Hilerlo, F. J., and Hahn, G. M. Cytotoxicity in Viva, 55 Madewell,and Essex,75 Tumor Eradication and Cell Survival after Lo Lotan, R., and Nicolson, G. L. Heterogeneityin Magin, R. L, and Johnson, R. K. Effects of Local calized Hyperthermie Induced by Ultrasound, Growth Inhibition by fl-trans-Retinoic Acid of Tumor Hyporthemmiaon the Growth of Solid 2i 66 Metastatic Bi 6 Melanoma Clones and in Viva Mouse Tumors, 4534 Marsh, J. C. Comparison of the Sensitivities of Selected Coil Variant Lines, 4767 Magln, R. L, Sikic, B. I., and Cysyk, R. L. En Human,Canine, and MuminoHometopoiotic Pro Lowe, N. J. See Venma,Lowe,andBoutwoll,1035 hancemont of Bleomycin Activity against Lewis cursor Cells to Adniamycmnand N-Tnlfluoraace Lowenthal, I. S., Parker, L N., Greenblatt, 0. J., Lung Tumors in Mice by Local Hyperthenmia, tyladriamycmn-14-valemate,360 Brown, B. L., and Samy, T. S. A. Pharmacoki 3792, Communication Marshall, M. N. See Morris, Hensh,Hsi, Gutter noticAnalysisofNeocanzinostatininNormaland Mah, H. 0. See Cheng, Wislocki, Kapitulnik, man, Marshall, end Mavllgit, 219 Tumor-bearing Rodents, 1547 Wood, Lovin, Yagi, Mah, Jenina, and Conney, Martin, F. See Kobori, Martin, Martin, and Turc, Lozzlo, B. B., Lopez, D. M., Coulson, P., and 2660; Wood, Chang, Lovin, Ryan, Thomas, 5141 Lair, S. V. High Incidenceof MammaryTumors Mah, Kanlo,Yagi, Jenina,and Conney, 4069 MartIn, M. See Koboni,Martin, Martin, and Turc, in Mice with Inherited Asplenia Carriers for the Maidhof, A. See MUllen,Maidhof, Anendes,Gount 5141 Nude Gone, i 529 sen. Zehn, end Schmidsedom,3768 Martin, R. F., Bradley,T. R., and Hodgson,G. S. Lu, C. C., and Meistrich, M. L. CytotoxicEffects Mak, T. W. See Wan and Mek, 398i Cytotoxicity of an â€˜25l-labeled DNA-binding of Chemothonapeutic Drugs on Mouse Testis Makley, J. T. See Powell, Sloss, and Mekloy, Compound that Induces Double-Stranded DNA Cells, 3575 658' Breaks, 3244 Lu, L-J. W., and Randerath, K. Effectsof 5-Aza Makuch, R. W. See O'Donnell,McKoy, Makuch, Marten, L J., Edwards, M. S., Levmn,V. A., Lu cytidine on Transfer RNA Methyltransfenases, end Bull, 2547 bich, W. P., and Wilson, C. B. Predictive Value 940 Malenka, 0. J., Rogan, K. M., Howe, R. C., Nd of CemobmospinalFluid Polyamines in Medullo Lubawy, W. C. See Hunley, Alien, Feola, end son, B. S., Wrobel, C. J., Ahmed, A., and blastoma, 993 Lubawy,3134 Humphreys,R. E. VariableExpressionfo Mom Marxen, J. See RUdiger,Merxen, Kohl,Moldenis, Lubet, R. A. See Dunn, Lubet, and Prough, 4555 bneno Proteins among Munine Lymphoblastoid and Wichert, 1083 Lublch, W. P. See Marton, Edwards, Levin, Lu Tumors as Seen with Sodium Dodecyl Sulfate Masaki, S. See Yoshida, Yamade, Masaki, end bich, and Wilson, 993 Polyacrylemide Gradient Gel Electrophorosis of Saneyoshi, 3955 Lucas, Z. J. See Yang, Huber, and Lucas, 4802 [35S)Mothionine-IabeledCell Membranes, 4782 Maslansky, C. J. See San, Laspia, Solefer, Mac Lueker, 0. C., Stewart, I. B., Kalner,R. A., Schen Malick, L. See Langonbach,Melick, Tampa, Ku lensky, Rico, and Williams, 1026; San, Shi grund, C-L., Repman, M. A., and Sheffler, B. szynski, Freed, and Huberman, 3509 made, Masiansky, Kmoiser,Laspia, Rice, and A. Correspondencero: Beth AllysonSheffler, Malley, A., Burger, 0. R., Vandenbark, A. A., WillIams, 4441 Many Ann Repman, and Cara-Lynne Schen Frlkke, M., Finke, P., Begley, D., Acoti, K., Masters, B. S. S. See Prough. Petmizi,Okita, Mac grund. Development of a Neonatal and Mote Black, J., and Vetto, R. M. Association of Mel tens,and Jekobsson, 1199 static Mumine Neuroblestoma Model. Cancer enoma Tumor Antigen Activity with $rMicmo Mastrangeio, M. J. See Bond,Wilson, Bellot. and Res., 39: 711â€”713,1979, page 3277, Letterto globulin, 6i9' Mastmengelo,4472 the Editor Malmstroni, K. See Eboli, MalmstnOm,Galeotti. Mastro, A. M., Krupa, T. A., and Smith, P. Inter Luk, K. H., and PhillIps,T. L. ThermalDosimetry LOpoz-AlancOn,and Cemafoli,2737 action of the Tumor Promoter 12-0-Totradeca and Clinical Requirements, 2300 Maluish, A. E. Experienceswith LeukocyteAd noylphorbol-1 3-acetate with Cells in Mixed Lukash, W. M. The Family Physician and Confron hemoncoInhibition in Human Cancer, 644 Lymphocyte Culture, 4078 tation in Alcoholism, 2834 â€˜â€˜ Malulsh, A. E., and Halliday, W. J. Hemocytom Mathes, L E. See Dunlap, Nichols,Hebebmend,

5202 CANCER RESEARCH VOL. 39 Author Index to Volume 39

Mathes, and Olsen, 956; Hebebmend,Olsen, McCullough, 98i Metzgar, R. S. See Anderson, Moore, and Metz Mathes, and Nichols, 443; Rojko, Hoover, McDonald, K. See Lorentzen, Lesko, McDonald. gar, 4810 Mathes, Krakowka, and Olsen, 3789 and Ts'o, 3194 Meyer, J. S., and Hixon, B. AdvancedStage and Mathes, L E., Olsen, R. G., Hebebrand, L C., McGovren, J. P., Neil, G. L, Denllnger, R. H., Early Relapse of Breast Carcinomas Associated Hoover, E. A., Schaller, J. P., Adams, P. W., Hall, T. L, Crampton, S. L, and Swenberg, J. with High ThymidmneLabeling Indices, 4042 and Nichols, W. S. Immunosuppressive Prop A. Chronic CardiotoxicityStudies in Rabbits Meyers, J. See Casto, Meyers, and DiPsolo, 193 cribs of a Virion Polypeptide, a 15,000-Dalton with 7-Con-O-Mothylnogsrol, a New Anthnecy Meyskens, F. L., Jr., and Salmon, S. E. inhibition Protein, from Feline Leukemia Virus, 950 dine AntitumonAgent, 4849 of Human Melanoma Colony Formation by Re Matsuda, M. See Okochi, Seiko, Higeshino, Hada, McGuire, W. L. See Gaskill, McGuire, Osborne. tinoids, 4055 Watanabe, Yamamure,Ito, Metsude, Osafuno, and Stern, 3628; Powell, Gamola,Chamness, Mian, A. M. See Khwaja, Kigwana, and Mian, Kotake, and Sonoda, 1829 and McGuine, 1678 3129 Matsuda, M., Osafun., M., Nakano, E., Kotake, Mclntire, R. K. See Ng, Amos, Mclntire, and Hen Mlchejda, C. J. See knoegen-Koepko end Mi T., Sonoda,T., Watanabe,S., Hada,T., Oko berman, 4887 chojda, 1587 chi, T., Hlgashlno,K., Yamamura,V., and Abe, McKee, J. See Brundrett,Calvin,White, Mckee, Michelacci, V. M. See MourÃ£o,Michelacdi, and 1. Characterization of an Established Cell Line Hartman, and Brown, 1328 Toledo, 2802 from Human Renal Carcinoma, 4694 McKinnon, K. P. See Evans, Frank, McKinnon, Mihailovich, N. See Vesselinovitch, Rao, end Mi Matsukage, A. See Ono, Oheshi, Yamamoto,Mat and Cemmone,20i 6 hailovich, 4378 sukage,Takahashl,Saneyoshl,endUeda,4673 McKneally, M. F. See Filandi, Codish, Civerchia, MIkIes-Robertson, F. See Porter, Mikles-Robent Matsumoto, H. See Matsushima, Matsumoto, Shi Howard, and McKneally, 3673; Mayer and son, Kramer, and Dave, 2414 ral, Sawamura,and Sugimuna,3780 McKneally, 3276 Mikles-Robertson, F., Feuersteln, B., Dave, C., Matsumoto, H., Takata, R. H., and Komeiji, 0. V. McKoy, W. S. See O'Donnell, Mckay, Makuch, and Porter, C. W. The Generality of Methyl Synthesisof the GlucumonicAcid Conjugateof and Bull, 2547 glyaxal Bis(guanylhydrazone)-inducod Mit Methylazoxymethanol, 3070 MCLafIertY, M. A. See Carter, McLsfferty, and chandnial Damage and the Dependence of this Matsumoto, K. See Kitamura, Okemoto, Hayata, Goldman, 2026 Effect on Cell Proliferation, 1919 Uchida, Yamaguchi, and Metsumoto, 4713 McLaughlin,C. A. See Cantrell,McLaughlin,and Miko, M., Drobnlca,L., and Chance, B. Inhibition Matsushima, 1., Matsumoto, H., Shlral, A., Se Ribi,1159 of Energy Metabolism in Ehnlich Ascites Cells wamura, M., and Sugimura, T. Mutagenicity of McLaughlin, C. A., Hargrave, S. L., Bickel, W. Treated with Dactylaninin Vitro, 4242 theNaturally-occurrIngCarcinogenCycesmnand 0., and Ribi, E. SynergisticActivityof Compo Milder,J. W. SymposiumonHyporthenmiainCan SyntheticMethylazoxymethanolConjugatesin nents of Mycobectenia and Mutant Salmonella conTreatment, 2235 , Foreword Salmonella typhimurium, 3780 in Causing Regression of Line-i 0 Tumors in MIller, C. L. See Hill, Hill, Miller, Pfaller, Weiss, Matsuura, A. See Sekiya, Endoh, Kikuchi, Katoh, Guinea Pigs, i 766 and Galin, 934 Matsuura, Iwasawa, Takeda, end Takemizawa, McMahon, R. E., Cline, J. C., and Thompson, C. Miller,E. C. See Kitagawa,Pitat,Miller,andMiller, 1108 z. Assayof 855 TestChemicalsinTenTester 112; Leopold, Miller, and Miller, 913 Mattison, 0. R., and Thorgelrsson, S. S. Ovarian Strains Using a Now Modification of the Amos Miller, E. C., Kadlubar, F. F., Miller, J. A., Pitot, ArylHydrocarbonHydnoxylaseActivityand Pni Test for Bacterial Mutagens, 682 H. C., and Drinkwater, N. R. The N-Hydroxy mordial Oocyte Toxicity of Polycyclic Aromatic McManus,M. J. See Welsch,McMenus,DeHoog, Metabolites of N-Mothyl-4-aminoazobenzene Hydrocarbons In Mice, 3471 Goodman, and Tucker, 2046 and Related Dyes as Proximate Carcinogens in Matula, T. I. See Nestmenn, Douglas, Matula, McPartland, R. P. See Neil, Berger, McPartland, the Rat and Mouse, 341 1 Grant, and Kowbel, 4412 Gnindey,and Bloch, 852 MIller, H. N. See Okano, Miller, Robinson,and Matier, A. M. See Murphy, Melvin, and Mauer, Meade, K. S. See Ruddon, Anderson, Moade, Gelbain,3184 1534 Aldendomfem,and Nouwald, 3885 Miller,J. A. See Kitagaws,Pilot,Miller,andMiller, Mayer, C., and Mckneally, M. Preparation of Au Medina, D. See Asch, Medina, and Brinkley, 893; 112; Leopold, Miller, and Miller, 913: Miller, tologous Tumor Cell Vaccine from Human Lung Watson, Medina, and Clark, 4098 Kadlubar, Miller, Pilot, and Dninkwater, 341 1 Cancer, 3276, Letter to the Editor Medoff, G. See Valemiote,Medoff, and Dieckmsn, Miller, R. G. See Pallavicini,Lalsnde,Miller, and MavilgIt, G. M. See Morris, Hensh,Hsi, Guttomman, 2041 Hill, i89i Marshall, and Mavllgit, 219 Meistrich,M. L. See Lu and Meistnich,3575 Mllsted, R. A. V. See Jarman, Milsted, Smyth, May, H. Eâ€¢,KOhIhPP, S. J., Boose, R. B., and Meltes, J. See Aylsworth,Hodsan,Borg,Kledzik, Kinas, Pankiewicz, and Stec, 2762 Reid, D. J. Synthesis and Identification of Prod and Moites, 2436 Minardl, J. See King, Whitehoad,Campbell,and ucts Derived from the Metabolism oftho Cancin Melamed, M. R. See Collste, Danzynkiewicz,Tra Minandi,i094 ostatic 1-(2-Chlomoethyl)-3-(trans-4-mothylcy ganos, Shamploss, Whitmone, and Melamed, Mink, M. M. See Des and Mink, 5106 clohexyl)-1-nhtrosourea by Rat Liven Micro 2i 20; Evenson, Danzynkiewicz, Staiano-Coico, Minkel, D. T. See Saryan, Minkol, Dolhun,Cal comes, 762 Traganos, and Melamed, 2574 houn, Wielgus, Schallen,and Petening,2457 Mayail, B. H. See Canrano, Mayell, Tests, Ash Melchionne, S. See Van Duumen,Tsong, Segal, Minkel, D. T., Doihun, P. J., Calhoun, B. L., worth, and Rowley, 2984 Smith, Molchionne, and Seidman, 2644 Saryan, L. A., and Petering, 0. H. Zinc Dofi Mayhew, E. See Rustum, Dave, Mayhow, and Maidens, H. See RUdiger,Manxen,Kohl, Meldenis, cioncy and Growth of Ehnlich Ascites Tumor, Papahadjopoulos, 1390 and Wichort, i 083 2451 Mayne, L See Lehmann, Kink-Bell, and Mayne, Meldolesi, M-F., and Laccetti, P. Phosphofructo Minotti, G. See Chianetti,Casciaro, Minotti, Eboli, 4237 kinase Regulation in Some Transplantable Thy and Galeotti, 2195 McAvoy, L. M. See Enlichman, Strong, Wiomnik, raid Tumors, 2796 Minowada,J. See Freedman,Gurtoo,Minowada, McAvoy, Cohen, Levine, Hubbard, and Oheb Melvin, S. L. See Murphy, Melvin, and Msuer, Paigen, and Veught, 4605; Freedman, Parker, ner, 3992 1534 Maninollo, Gurtoo, end Minowads, 461 2; Gur McCavtsr, J. A. See Ball end McCamter,3080 Menck, H. See Henderson, Dworsky, Pike, Bap too, Parker, Paigen, Havens, Minowada, and McCay, P. B. See Kolimongen,Sensing, Lehman, tista, Menck, Preston-Martin, and Mack, 4507 Freedman, 4620 Fischer, Longley, Alexander, King, and McCay, Mendez, F. See Bases,Rubinstein,Kadish,Men Mlntz, U. See Tests, Mintz, Rowley, Vardiman, 3458 doz, Wittner, EIequin, and Liebeskind, 3524 and Golomb, 3619 McCool, R. E. See Catalona,Ratliff,and McCooI, Mendoza-Figu.roa, T., LÃ³pez-Revllla, R., and Mlntz, U., and Golomb, H. M. Splenectomy as 4372 Villa-TreviÃ±o, S. Dose-dependent DNA Rup Initial Therapy in Twenty-six Patients with Lou McCoy, E. C. See McCoy, Chon, Hecht, end tunes Induced by the Procarcinagen Dimethyl komic Reticuloendatheliosis (Hairy Cell Leuke McCoy, 793 nitmosaminoon Primary Rat Liver Cultures, 3254 mis),2366 McCoy, G. D., Chen, C-h. B., Hecht, S. S., and Merluzzl, V. J. See Fasnes, Monluzzi, Williams, Mlrvish, S. S. See Bulsy and Mirvish, 3644 McCoy, E. C. Enhanced Metabolism and Muta Tannowski,and Ralph, 4564 Mishkin, S., Morris, H. P., Yalovsky, M. A., and genesis of Nltrosopymrolidinein Liver Fractions Merluzzi, V. J., Faanes, R. B., and Chol, V. S. Murthy, P. V. N. Increased Survival of Rats Isolated from Chronic Ethanol-consuming Ham Restoration of Cyclophosphamide-induced BeaningMorris Hepatoma 7800 after Induction stems,793 Suppression of Thymus-denived Cytotoxic Cell of Hypothyroidism, 2371 McCoy, G. D., and Wynder, E. L Etiological and Generation by Normal Thymocytes, 3647 Mitchell, J. B. See Raspharst,Romano,Mitchell, PreventIve Implications in Alcohol Carcinogen Merriman, R. L., and Bertram, J. S. Reversible Bedford, and Dewey, 396 eels,2844â€• Inhibition by Retinoids of 3-Methylcholanthrene Mitchell, M. S. See Rso, Gnodzicki, and Mitchell, McCoy, J. Lâ€¢See Taglisbuo, Horberman, Arthur, induced Nooplastic Transformation in C3H/ 174 and McCoy, 35 10TÂ½Clone 8 Cells, 166i Mitchell, R. S. See Balk, Mitchell, LeStourgeon, MCCr.dIe, K. B. See Stewart, Benvenuto, Leav Merskl, J. A., Daskal, V., Crook., S. T., and and Hoon, 1854 ens,Hall,Benjamin,Plunkett,McCmedio,Bum Busch, H. Acute Ultrastructunal Effects of the Miura, K. See Peters, Nishi, Miurs, Lonscheider, gaas, and Lao. 4119 Antitumon Antibiotic Cenminomycmnon Nucleoli Dixon, and Tamsaki, 3702 McCullough, J. A. See Gemnen,Holmes, end of Ret Tissues, 1239 Mlura, V. See Homikashi,Sasaki, Mizoguchi,

DECEMBER1979 5203 Author Index to Volume 39

Miurs,Takaku, and Amaki, 1841 Moran, R. E., and Straus, M. J. Cytokinotic Anal Muggla, F. M. See Guamino,Rozoncweig, Kline, Miwa, M. See Nakayasu,Shaji, Aoki,Sato, Miws, ysis of Li 210 Leukemia after Continuous Infu Penis, Vonditti, Lloyd, Holzworth, and Muggla, and Sugimurs, 4668 sian of Hydnoxyuroain Viva, 1616 2204; Ovejers, Houchens, Catane, Sheridan, Mixter, L. 0. See Barrett, Crawford, Mixter, Morantz, R. A. See Weiss, Morantz, Bradley, and and Muggis, 3220; Weiss and Muggia, 3799 Schechtman, Ts'a, and Pollack, 1504 Chretien, 542 Mukojima,T. See Hirohashi,Shlmosato,Kameys, Miyagl, T., and Tsuiki, S. Characterizationof Rat Morgan, R. T. See Quinn, Moore, Morgan, and Koide, Mukojima, Taguchi, and Kagoyama, Hepatoms Glucasamine 6-Phosphate Synthase Woods, 4914; Woods, Morgan, Quinn, Moore, 1819 and Its Relation to Liver and Fetal Forms, 2779; Somple, and Stedman, 4449 Mullen, L T. See Moon, Thompson, Becci, Glucasamine 6-Phosphate Synthase of Regen Moroson, B. A. See Kalghatgi, Momoson,HorvÃ¡th, Grubbs, Gander, Newton, Smith, Phillips, Hen orating Rat Liver, 2783 and Bertino, 3441 demson,Mullen, Brown, and Sporn, i 339 Mlyakawa, M. See Sumiand Miyakawa,2733 Morris,D. L., Hersh,E. M., Hsi, B. P., Gutterman, MUller,W. E. G., Maidhof,A., Arendes,J., Geurt Miyamoto, K. See Tonasakiand Miyamoto,250 J. U., Marshall, M. M., and Mavligit, G. M. sen, W., Zahn, R. K., and Schmidseder, R. Miyamoto, T. See Naksjims,Miyamoto,Tanabo, Recall Antigen Delayed-type Hypersensitivity Additive Effects of Bleomycmnand Neocanzinos Watanabe, and Terasima, 3763 Skin Testing in Melanoma and Acute Leukemia latin an Degradation of DNA, Inhibition of DNA Mizoguchi, H. See Honikoshi, Sssaki, Mizoguchi, Patients and their Associates, 219 Polymeraso /3,and Cell Growth, 3768 Miuna,Takaku, and Amaki, 1841 Morris, D. R. See Seyfniedand Morris,486i MUller,W. E. G., and Zahn, R. K. Metabolismof Mlzuno, S. See Roper, Drewinko,Tsukeda, Mi Morris, H. P. See Hostetlem,Zennen,and Morris, 1-fl-o-Anabinofuranosylumscilin Mouse L5178Y zuna, and Nitta, 1428 2978; Mishkin, Morris, Yalovsky, and Murthy, Cells, 1102 Moan, J. See Christensenand Moan, 3735 2371 ; Prsjda, Morris, and Weben, 3909; Red Munder, P. G. See Modolell,Andreesen,Pahlke, Mochizuki, Y. See Tsukada, Gotoh, Mochizuki, man, Yu, Bsnenjeo, and Morris, 101: Reynolds Brugger, and Mundon,468i and Fumukawa,1628 and Morris, 2988; Shatton, Morris, and Woin Munther, A. See Ramey,Hashim,Burrows,Swis Modic, S. See Plesnican,Klsnjscek,Madic, and house, 492; Tsksmi, Busch, Morris, and Busch, tel, Munther, end Fitzpatrick, 4796 Rustia, 4575 2096; Tsuds, Katunuma, Morris, and Weben, Murch, L. L. See Li, Kuentzel,Mumch,Pschigoda, Modoleil, M., Andreesen, R., Pahlke, W., Brug 305 and Krueger, 4816 ger, U., and Munder,P. G. Disturbanceof Phos Morrison, M. K. See Wiltrout, Frost, Morrison, and Murdock, K. C. See Wallace, Mundock, Angior, phalipid Metabolism during the Selective Do kerbel, 4034 and Dunn,1570 strudtian of Tumor Cells Induced by Alkyl-Ly Morton, 0. L. See Gupta, Silver, Reisfeld, and Murinson, D. S., Anderson, T., Schwartz, H. S., sophaspholipids, 4681 Morton, i 683; Storm, Harrison, Elliott, and Mar Myers, C. E., and Chabner, B. A. Competitive Moe, R. E. See Namkung, Moo, and Potna,1124 ton, 2245'' Binding Radioassay for 5-Fluorodeoxyumidine Moertel, C. G. See Kovach, Ames, Powis, Moertel, Morton, K. C., King, C. M., and Baetcke, K. P. 5'-Monophosphate in Tissues, 2471 Hahn, and Cresgan, 4540; O'Connell, Moortel, Metabolism of Bonzidine to N-Hydnoxy-N,N'-di Murphy, G. P. Introductionto the LoukocytoAd Ritts, Frytak, and Roitemeier, 3720 scetylbenzidine and Subsequent Nucleic Acid horence Inhibition Workshop, 555' Mokyr, M. B., Braun,0. P., and Dray, S. Augmen Binding and Mutagenicity, 3107 Murphy, S. B., Melvin, S. L., and Mauer, A. M. tationof AntitumarCytotoxicityin MOPC-315 Moschel, R. C. See Dipple, Tomaszewski, Mos Correlation of Tumor Cell Kinetic Studios with Tumor Bearer Spleen Cells by Depletion of chel, Bigger, Nebzydoski, and Egan, 1154 Surface Marker Results in Childhood Non Glass-adherent Cells Prior to in Vitro Activation, Moses, H. L. See Getz, Elder, and Moses, 321 Hodgkin's Lymphoma, 1534 785 Moses, H. L., Wells, 0. J., Swartzendruber, 0. Murphy, W. M. See Irving, Tico, and Murphy, Mokyr, M. B., Hengst, J. C. 0., Przepiorka, 0., E., and Getz, M. J. Comparisonof RNA Metab 3040 and Dray, S. Augmentationof AntitumomCyto olism in G, Arrested and Stimulated Non-trsns Munch, H. See Powell, Sloss, Smith, and Munrell, toxicity of MOPC-3i 5 Tumor Bearer Spleen formed and Chemically-transformed Mouse Em 570' Cells by Depletion of Dinitrophenol-adhenent brya Cells in Culture, 4516 Murthy, P. V. N. See Mishkin, Morris, Yalovsky, Cells prior to in Vitro Immunization, 3928 Mosesson,M. W. See Smith,Riggs,and Moses and Murthy, 2371 Mompanler, L. F. See Mompenler, Vesely, Mom son, 4i38 Mushlnskl, J. F., and Marini, M. Tumor-sssoci parlor, and Rivard, 3822 Mosher, 0. F. See Funcht, Masher, Wendel ated Phenylalanyl Transfer RNA Found In a Momparler, R. L., Vesely, J., Momparler, L. F., schafer-Cmsbb,and Foidart, 2077 Wide Spectrum of Ret and Mouse Tumors but and Rivard, G. E. SynergisticActionof 5-Aza MourÃ¡o,P. A. S., Michelacci, V. M., and Toledo, Absent in Normal Adult, Fetal, end Regenerating 2'-deaxycytidine and 3-Doazauridine on Li 210 0. M. S. Glycosammnoglycsnsand Proteogly Tissues, 1253 Leukemic Cells and EMT6 Tumor Cells, 3822 cans of Normal and Tumonal Cartllsges of Hu Myers, C. E. See Muninson,Anderson, Schwartz, Monaco,M. E. See Osborne,Monaco,Kahn,Huff, mans and Rats, 2802 Myers, and Chabner,2471 ; Ozols, Gmotzinger, Bnonzent,and Lippman, 2422 Mower, H. F., Ray, R. M., Shoff, R., Stemmer Fisher, Myers, and Young, 3202; Ozols, Locker, Moncure, C. W. See Cohen, Moncume,Witonsch, mann, G. N., Nomura, A., Glober, G. A., Ks Doroshow, Gnotzinger,Myers, and Young, 3209 and Diegelmsnn, 2923 miyama, S., Shimada, A., and Vamakawa, H. Myl, A.D. See Williams, Bronson, Myl, Vande Montesano, R. See Hubenman,Montesano, Dre Focal Bile Acids in Two Japanese Populations voorde, and Elliott, 2447 von, Kunoki, St. Vincent, Pugh, and Goldfsrb, with Different Colon Cancer Risks, 328 269; Stumpf, Msrgison, Montesano, and Pegg, Moyer, J. 0. See Dix, Lehman, Jakubowski, N 50 Mayer, and Hsndschumachem,4485 Montesano, R., BrÃ©sli,H., and Margison, G. P. Moyer, J. 0., and Handschumacher,R. E. Selec Increased Excision of 06-Methylguanine from tive Inhibition of Pynimidine Synthesis and De Nadel, E. M., Thompson, S. C., Fischer, V. W., Rat Liven DNA after Chronic Administration of pletion of Nucleotido Pools by N-(Phosphons and Klein, 0. L. Correspondenceno:D. L. Klein, Dimothylnitmosamine,1798 cetyl)-L-aspantste, 3089 K. Pork, J. E. Dshlborg,W. Brown, end J. W. Montgomery, R. See VandrÃ©,Shepherd, and Mueller, T. J. See Beck, Mueller, and Tanzen, Pearson. Isolation end Characterization of a Montgomery, 4091 2070 Spontaneous Lymphocytic Leukemia (L-76) in Monti-Bragadin,C. See Comaglia,Pani,Pmat,Tsr Mufson, R. A., Fischer, S. M., Verma, A. K., the Strain 2 Guinea Pig. Cancer Res., 38: one, and Monti-Bragadmn,4745 Gleason, G. L., Slaga, T. J., and Boutwell, R. 3i54â€”3i60, 1978, page 2221, Letter to the Moon, R. C. See Becci, Thompson, Grubbs, K. Effects of i 2-O-Tetnadecsnoylphorbol-i3- Editor Brown, and Moan, 3141; Thompson, Becci, acetate and Mozenein an Epidonmal Omnithine Naeher, C. See Henguindoy,Henderson,andNae Brown, and Moan, 3977 Decanboxylase Activity, isoprotonenol-stimu her, 4364 Moon, R. C., Thompson, H. J., Becci, P. J., lated Levels of Cyclic Adenosino 3':S'-Mono Nagai, R., Kataoka, M., Kobayashi,S., Ishihara, Grubbs, C. J., Gander, R. J., Newton, 0. L, phosphate, and Induction of Mouse Skin Tu K., Tobloka, N., Nakashima, K., Naruse, M., Smith, J. M., Phillips,S. L., Henderson,W. R., momsin Viva, 4791 5db, K., and Sakuma, S. Estrogenand Pro Mullen, L. T., Brown, C. C., and Sporn, M. B. Mufson, R. A., Fisher, P. B., and Welnsteln, I. B. gostomonoReceptors in Human Breast Cancer N-(4-Hydnoxyphonyl)metmnemide,A Now Reti Effect of PhonbolEster Tumor Promoters on the with Concomitant Assay of Plasma 17$-Edna noid far Prevention of Breast Cancer in the Ret, Expression of Melanogenosis in B-i 6 Melanoma diol, Progesterone, and Prolactin Levels, 1835 1339 Cells, 3915 Nagal, T. See Pfoiffer,Nsgai,Fujimure,andTobe, Moore, G. E. See Quinn, Moore, Morgan, and Mufson, R. A., Kulkarni, P., Eaklns, K. E., and 1904 Woods, 4914; Woods, Morgan, Quinn, Moore, Welnstein, I. B. Effectsof PhorbolEsterTumor Nagano, N. See Yssumoto,Manabe, Yanagews, Semple, and Stedman, 4449 Promoters in Platelet Aggregation and Platelet Negano, Ueda, Hirota, Ohta, Nomota, Azuma, Moore, J. 0. See Anderson,Moore,and Metzgsr, Production of CycbooxygenaseProducts, 3602 end Ysmamune,3262 4810; Hanker, Ambrose, James, Mandelkomn, Mufson, R. A., Simsiman, R. C., and Boutwell, R. Nagel, 0. See Gingell, Brunk, Nagel, end Pour, Yates, Gall, Bossen, Fey, Laszlo, and Moore, K. IncreasedCyclicAdonosino3':5'-Monophos 4579; Pour, Wsllcsvo, Gingoll, Negel, Lawson, 1635 phate PhosphodiestonasoActivity in the Epidor Salmasi, and Tines, 3828 Moore, M. C. See Goldrosen, Russo, Howell, misof PhanbolEster-treatedMouseSkinandin Nakajima, V., Miyamoto,T., Tanab., M., Watan Leveson, Moore, Holyoke, and Douglass, 633' Papillamas, 2036 abe, I., and Terasima, T. Enhancementof Mam

5204 CANCERRESEARCHVOL. 39 Author Index to Volume 39

mallen Cell Killing by 5-Fluorounacil in Combi Nichol, C. A. See Duch, Bignon,Bowers, and tivation with AntitumonEffect on Rat Syngeneic nation with X-Rays, 3763 Nichol, 487 Fibrasarcama by Nacardis rubra Cell-Wall Skel Nakamura, R. M. See Loung, Bordin, Nakamuns, Nichols,A. V. See Shu and Nichols,1224 elan, 4706 DeHeer, and Edglngton,2057 Nichols, W. S. See Dunlap, Nichols, Hebebrand, Ohabner, B. A. See Enlichmsn,Strong, Wionnik, Nakamura, 1. See Tatsumi,Teshims,Shinakawa, Mathos, and Olson, 956; Hebebrand, Olsen, McAvoy, Cohen, Levine, Hubbard, and Ohab Nakamura,and Uchino,1623 Mathes, end Nichols, 443; Mathes, Olsen, ner, 3992 Nakanishi, V. See Isohashi, Tsuksnaka, Tenada, Hebebmand,Hoover, Schaller, Adams, and Ni Ohanlan, S. H. See Schlsgerand Ohanian, 1369 Nakanishi, Fukushima, end Sakamoto, 5132 chals, 950 Ohashi, A. See Ona, Ohashi, Yamamato, Matsu Nakano, E. See Matsuda, Osafune, Nakeno, Ko Nicolson,G. L. See Lotanand Nicolson,4767 kage, Takahashi, Ssneyashi, and Ueds, 4673 take, Sonoda, Watanabo, Hade, Okochi, Hi Nielsen, 0. 5., and Overgaard, J. Effect of Extra Oh-hashi, F. See Kstaoka, Oh-hashi, and Sakursi, gashino, Yamamume,and Abe, 4694 cellular pH on Thenmotobonanceand Recovery 2807 Nakashima, K. See Nagel, Katsoka, Kabayashi, of HyperthenmicDamage in Vitro, 2772 Ohno, T. See Hozumi, Umezawa, Takenags, Ishihara, Tobloka, Nekashima, Nenuse,Saito, Nigro, N. 0. See Bull, Soullion,Wilson, Hayden, Ohno, Shikita, and Yamane, 5127 and Sakuma, 1835 and Nigmo,4956 Ohnuma, T. See Tskshashi, Ohnums, and Hal Nakayasu,M., Shoji,M., Aoki, N., Sato, S., Miwa, Niinobe, M., Tamura, V., Arima, T., and Fujil, S. land,1264 M., and Suglmura, T. Enhancing Effect of Phor Immunological Properties of and Neuraminidsse Ohsawa, N. See Kida, Tomihara, Watanabe, bol Esters on Induction of Differentiation of Action an Aminopeptidases and Arylamidasos Ohsawa, and Katunuma, 3258; Oksbe, Suzuki, Mouse Myeioid LeukemiaCells by HumanUn in Human Normal and Cancer Tissues, 4212 Ohsawa, Kosaka, and Terasima, 4189 nary Protein and Upopolysacchsnide, 4668 Nlshi, S. See Peters, Nishi, Miurs, Lorscheiden, Ohta, M. See Yasumota,Manabe,Ysnagaws,Na Namba, N. See Ogura,Nambs,Hirao,Yamsmuna, Dixon, and Tamsoki, 3702 gano, Ueds, Hirota, Ohta, Nomoto, Azums, and and Azuma,4706 Nlshimura, T. See Suzuki, Nishimuna,and Tan Yamamura, 3262 Namkung, P. C., Moe, R. E., and Petra, P. H. aks, 2787 Ohtsuki,V. See Hixson,Bowen,Ohtsuki,Scanlan, Stability of Estrogen Receptors in Frozen Hu Nishlzawa, K. See Sata, Kojima,Nishizaws,and and Dmochowski, 199 man Breast TumorTissue, 1124, Communica Ikaws, 1113 Olkawa, T., Gotohda, E., Austin,F. C., Takelchi, tion Nitta, K. See Roper, Drewinka, Tsukeda, Mizuna, N., and Boone, C. W. Temperature-dependent Nampei, S. See Fujita, Takemi, Usugane, Nampoi, and Nitta, 1428 Alteration in Immunogenicity of Tumom-associ end Taguchl,811 Nixon,0. W. See Rudman,Chawla,Nixon,Vogler, sled Transplantation Antigen Monitored via Par Naruse, M. See Nagai, Kateoka, Kobayashi, Ishi Keller, and MacDonoll, 699 sformsldehyde Fixation, 3519 hera, Tobloka, Nakeshima, Naruse, Saito, and Nixon, L. K. See Smith, Emerson, and Nixon, Okabe, J. See Honma, Kasukabe, Oksbe, and Sakuma, 1835 2132 Hazumi, 3167; Sugiysms, Hazumi, and Okabe, Nebzydoskl, J. A. See Dipple, Tomsszewski, Nomoto, K. See Yssumota,Msnsbe, Yanagaws, 1056 Moschel, Bigger, Nebzydoski, and Egan, 1154 Nagsno, Ueda, Hirota, Ohta, Namata, Azums, Okabe, T., Suzuki, A., Ohsawa, N., Kosaka, K., Nell, G. L. See McGovnon,Neil, Denlingon,Hall, and Yamamurs, 3262 and Terasima, T. ImmuneEliminationof Host Crampton,and Swenbeng,4849 Nomura, A. See Mower, Ray, Shaft, Stemmer Fibroblasts for the Cultivation of Human Tumors Nell, G. L, Berger, A. E., McPartland, R. P., mann, Nomurs, Gbober, Ksmiysma, Shimads, Transplanted into Nude Mice, 4189 Grmndey,G. B., and Bloch, A. Biochemical and and Yamakaws, 328 Okamoto, S. See Kilamurs, Okamoto, Hsyata, Pharmacological Effects of the Fermentation Nomura, K. See Deen, Hashino, Williams, No Uchids, Yamaguchi, and Mstsumata, 4713 derived Antitumor Agent, (aS,55)-a-Amino-3- muna,and Bsrtle, 4336 Okano, P., Miller, H. N., Robinson, R. C., and chloro-4,5-dihydmo-5-isoxezoloscetic Acid (AT Nomura,T. PotentMutagonicityof Unethan(Ethyl Gelboin, H. V. Comparison of Benzo(a)pyrene 125), 852 Canbamate) Gas in Drosophila melanogaster, and (â€”)-trans-7,8-Dihydnaxy-7,8-dihydno Nelsen, F. See Cohen, Menchok, Nettoshoim, 4224 benzo(a)pyneno Metabolism in Human Blood Steele, Nelson,Huang,end Selkirk, 1980 Nudelman, E. See Baumsnn,Nudelman,Wstsn Monocytes and Lymphocytes, 3184 Nelson, B. S. See Malenka, Rogan, Howe, Nelson, abe, and Hakamari, 2637; Koyama, Nudelman, Okita, R. T. See Prough,Pstnizi,Okita, Masters, Wrobei, Ahmed, and Humphnoys,4782 Fukuds, and Hakomoni,3677 and Jakobsson, 1199 Nelson-Bees, W. A. See Langlois, Holder, 1gb Nyc, J. S. See Costs, Nye, Sundemman,Alipsss, Okochi, T. See Matsuda, Osafune, Nakana, Ko hart, Nelson-Roes, Wells, and Bolognesi, 2604 and Gondos, 3591 take, Sonada, Watanabe, Hada, Okochi, Hi Nemiroff, M. J. See Wheeler, Dinks,Lunandi,and Nygaard, T. G. See Gerweck, Nygaard,and Bum gsshina, Ysmamura, and Abe, 4694 Nemlroff, 370 Iett, 966 Okochi, T., Seike, H., Higashino, K., Hada, T., Nerenberg, S. T. See Beschonnor, Hess, Nemen NygÃ¡rd,0., and Hultin, T. Early Effects of Di Watanabe, S., Vamamura, V., Ito, F., Matsuda, berg, and Epstein,3920 methylnitrosamine on Protein Chain Initiation M., Osafune, M., Kotake, T., and Sonoda, T. Nesbit, M. E. See Ertel, Nosbit, Hammond, Wei and PostmicnosomalPolysdenylic Acid-contain Alteration of Hexosaminidase Isazymes in Hu nor, and Sathem,3893 ing RNA Content in Mouse Liven,3349 man Renal Carcinoma, 1829 Nestmann, E. R., Douglas, G. R., Matula, T. I., OIah, E., and Weber, G. Giemsa-bandingkary Grant, C. E., and Kowbel, D. J. Mutagonic atypo of Rat Hepatomas of Different Growth Activity of Rhodamine Dyes and their Impurities 0 Rates, 1708 as DetectedbyMutationInductioninSalmonella Olive, P. L. Correlation between Metabolic Reduc and DNA Damage in Chinese Hamster Ovary Obalek, S. See Orth, Jsbbansks, Jsrzsbek-Chor lion Rates and Electron Affinity of Nitrohetemo Cells,4412 zelsks, Obabok, Rzess, Fsvre, and Croissant, cycles, 4512 Netteshelm, P. See Cohen, Msnchok, Nettesheim, 1074 Olsen, R. G. See Dunlap, Nichols, Hebebrand, Steele, Nelson, Huang, end Selkirk, 1980; Ja Oberley, L. W., and Buettner, G. R. Role of Su Mathes, and Olsen, 956; Hebebrand, Olsen, masbi and Netteshoim, 2466; Scott, Heckmsn, peroxide Dismutase in Cancer: A Review, 1141 Mathes, snd Nichols, 443; Mathes, Olsen, He Nettesheim,andSnyder,207; Steele, Msrchok, O'Brien, T. G., Lewis, M. A., and Diamond, L. bebrand, Hoover, Schalier, Adams, and Nichols, and Netteshelm, 3805; Tenzaghi and Nettesh Ornithine Decarboxylase Activity and DNA Syn 950; Rojka, Haavem,Mathes, Krskawka, and elm, 4003; Topping, Gniesomen,and Nettesh thesis after Treatment of Cells in Culture with Olson, 3789 elm,4823; 4829 12-O-Tetradecanaylphanbol-i 3-acetate, 4477 Olson, A. C. See Heckman and Olson, 2390 Neuwald, P. D. See Ruddon,Anderson,Meade, O'Connell,M. J. See Kovsch,Ames,Stemnsd,and Olson,J. W., and Russell,D. H. PralangedInduc Aldendemfer,and Neuwald, 3885 O'Connell, 823 lion of Hepatic OmnithineDecarboxylaso and its Newberne, P. M., Welgert, J., and Kula, N. Ef O'Connell, M. J., Moertel, C. G., Rifts, R. E., Jr., Relation to Cyclic Adenosine 3':5'-Monophos feds of Dietary Fat on Hepatic Mixed-Function Frytak, S., and Reitemeier, R. J. A Comparative phate-dependent Protein Kinase Activation after Oxidases and HepatocellulamCsminomsInduced Clinical and Immunological Assessment of a Single Administration of Diethylnitrosamine, by Aflatoxin B, In Rats, 3986 Methanol Extraction Residue of Bacillus Cal 3074 Newby, R. F. See Bourgeois and Newby, 4750 mette-GuÃ©rinversus Placebo in Patients with Olson, M. E. and Sheehan, D. M. Failureof Ro Newell, G. R., Jr. See Kalbemonand Newell, 4274 Advanced Cancer, 3720 tenane to Interfere with 17$-Estradiol Action in Newell, L. See Hudig, Sell, Newell, and Becker, O'Connor, R. See Thomson,Tstaryn, O'Connor, the Rat Uterus, 4438 3715 Rauch, Fniedlander, Gold, and Shuster, 604' O'Neill, J. P. See Fuscoo,O'Neill,Peck, and Hsie, Newton, D. L. See Moon, Thompson, Becci, O'Donnell, J. F., McKoy, W. S., Makuch, R. W., 4875 Grubbs,Gander, Newton,Smith,Phillips,Hen and Bull, J. M. Increased in Vitro Toxicity to Ong, T-m. See Whongand Ong, 1525 derson, Mullen, Brown, end Spomn,1339 Mouse Bone Marrow with 1,3-Bis(2-chlaro Onikul, S. R. See Wang, Steele, Mannick, Fabian, Ng, A-K., Ames, R. S., Jr., Mcintire, R. K., and ethyl)-1-nitnosounes and Hypenthenmis, 2547 and Onikul, 1702 Herberman, R. B. In Vitro Studies of Cell-me Ogilvie, G. K. See Carry, Prescott, and Ogilvio, Ono, K., Ohashi, A., Vamamoto, A., Matsukage, dialed Immunity to Moloney Munine Leukemia 2139 A., Takahashi, T., Saneyoshi, M., and Ueda, Virus and Moboney Leukemia-associated Sun Ogura, T., Namba, N., Hirao, F., Vamamura, V., T. InhibitoryEffectsof 9-$-D-Amabinafuranasyl face Antigens,4887 and Azuma, I. Associationof MacnaphageAc gusnine 5'-Triphosphate and 9-$-D-Anabinafu

DECEMBER1979 5205 Author Index to Volume 39

ranasyladenine 5'-Triphosphste on DNA Palym Brugger, and Munder, 4681 4996 erases from Munine Cells and Onconnavirus, Palgen, B. See Freedman, Gurtoo, Minoweds, Patrizi, V. W. See Prough,1'stnizi,Okits, Masters, 4673 Psigen, and Vsught, 4605; Gurtoa, Parker, Psi and Jskabsson, 1199 Ookhtens, M., and Baker, N. Evalualianof im gen, Havens, Minawada, and Freedman, 4620 Patterson, D. See Waldnenand Patterson, 4975 paired Triglyceride Fatty Acid Transport and Palan, P. R., and Romney, S. L. CellularBinding Pattillo, R. A., Story, M. T., and Ruckert, A. C. F. Oxidation fan the Detection of Cancer in Mice, Proteins for Vitamin A in the Normal Human Expression of Cell-mediated Immunity end 51 18; Fatty Acid Oxidation to H2O by Ehrlich Uterine Cervix and in Dysplasiss, 3114 Blocking Factor Using a Now Line of Ovarian Asciles Carcinoma in Mice, 973 Pallavicini, M. G., Lalande, M. E., Miller, R. G., Cancer Cells in Vitro, 1185 Opitz, W. See Schanlemmon,Optiz, Elschenborg, and Hill, R. P. Cell Cycle Distributionof Chron Paul, P. See Holmoyde,Axelmod,Skutchos,Haff, Bitton-Suenmsnn,and Hadding, 1847 ically Hypoxic Cells and Determination of the Paul, and Roichand,4900 0mm,W. See Varani,0mm,and Ward, 2376 CbonogenicPotential of Cells Accumulated in G2 Paul, S. M. See Hoffman,Paul,andAxelmod,4584 Orth, G., Jablonska, S., Jarzabek-Chorzelska, + M Phases after Irradiation of a Solid Tumor in Pauling, L See Cameron,Pauling,end Leibovitz, M., Obalek, S., Rzesa,G., Favre,M., and Crois Viva, 1891 663 cant, 0. Characteristics of the Lesions and Risk Pani, B. See Camoglia, Pani, Prat, Tarane, and Pavelic, J. See PaveliO,SIijep@eviO,Pavolic,IviO, of Malignant Conversion Associated with the Manti-Brsgadin, 4745 Audy-Junkovic, Pavelic, and BomsniO,1807 Type of Human Papillamavirus Involved in Epi Pankiewicz, K. See Janman, Milsted, Smylh, PaveIl@,K., Slijeptevi6, M., PaveliÃ³,J., lyle, J., dermodysplasis Vernucifanmis,1074 Kinas, Psnkiewicz, and Stec, 2762 Audy-JurkoviO,S., PaveilÃ©,Z. P., and Boranid, Osafune,M. See Matsuds,Osafune,Nakana, Ko Paolini, N. S. See Leveson, Howell, Paolini, Tan, M. Growthand Treatmentof EhrlichTumor in take, Sonods, Watanabe, Hada, Okochi, Hi Holyoke, and Goldrosen, 582' Mice with Alloxan-induced Diabetes, 1807 gashina, Yamamura, and Abe. 4694; Okochi, Papahadjopoulos, D. See Rustum, Dave, May Pavelid, Z. P. See PeveliO,SIijop@eviO,Psvelic, Seike, Higashmna,Hads, Watanabe, Yamamura, how, and Papahadjopaulos, 1390 lviO,Audy-JumkoviL,PaveliO,and BoranlO,1807 Ito, Malsuda, Osafune, Kotske, and Sonods. Papathanasopoulos, N. See Glodo, Pitman, En Pavlldis,N. A. See Stoychkov,Schultz,Chinigos, 1829 sminger, Rosowsky, Pspathsnssopoubos, and Psvlidis, and Goldin, 3014 Osborne, C. K. See Gaskill, McGuire, Osborne, Frei,3707 Pearlman,A. L. See Bartholomew,Peanlman,Len and Stern, 3628 Paran, J. H. See Paterson, Panan, Yang, and dolph, and Strsub, 2538 Osborne, C. K., Monaco, M. E., Kahn, C. R., Huff, Lynch, 3607 Peck, C. See Roberts, Peck, Hilliand,and Wingo, K., Bronzert, D., and Llppman, M. E. Direct Paranjpe, M. See Boone, Vembu, White, Takeichi, 4048 Inhibition of Growth and Antagonism of Insulin and Parsnjpe, 2172 Peck, R. M. See Fuscoo, O'Neill, Peck, end Hsie, Action by Glucacarticoids in HumanBreast Can Pardee, A. B. See Dubrow,Riddle, and Psrdee, 4875 cer Cells in Culture, 2422 2718 Pedersen, G. M. See Duquesnoy and Pedensen, Osborne, M. R.Correspondence no:Iden A. Smith, Parker, C. W. See Philpatl, Grass, and Parker, 415 Gregory D. Benger,Paul G. Seybald, and M. P. 2084 Pedron, J. See VÃ¡zquez-Nmn,Echevemnia,end Serve. Relationships between Carcinogenicity Parker, D. L, Rothblum, L. I., and Busch, H. A Pedmon,4218 and Theoretical Reactivity Indices in Polycyclic 3.6-Megadslton, Highly Repetitive Eca A, Frag Pegg, A. E. See Howott, Pegg, and Rapp, i 04i; Aromatic Hydrocarbons. Cancer Research, 38: mont in the Genome of Novikoff Hepstoms, Stumpf, Mamgison,Montesano, and Pogg, 50 2968â€”2977,1978, page 4761. Letter to the 1287 Pegg, A. E., and Balog, B. Formation and Sub Editor Parker, D. V. See Evans,Parker,and Frank,2006 sequent Excision of 06-Ethylguanino from DNA Oskarsson, A., Andersson, V., and Tjalve, H. Parker, L. M. See Lowenthsl, Parker, Greenblatt, of Ret Livenfollowing Administration of Diothyl Fate of Nickel Subsulfide during Carcinagenesis Brawn, and Samy, 1547 nilmosamino,5003 Studied by Autarsdiogrsphy and X-Ray Powder Parker, N. B. See Freedman, Parker, Marinelba, Pegg, A. E., Buffkin, D. C., and Webber, M. M. . Diffraction, 4175 Gurtoo, and Minowada, 4612; Gurtoo, Parker, Correspondence no: Donald C. Buffkin, Milo M. Oste, R. See Bauer, Asp, Cole, Dahlqvist,and Psigen, Havens, Minowada, and Freedman, Webber, Warren D. Davidson, Linda F. Bassist, Fredlund, 3752 4605; Vsught, Gumbo, Parker, LeBoeuf, and and Ramesh C. Verms. Omnithineas a Possible Ostroy, F., Johnston, R. B., and Gams, R. A. Doctor, 3177 Marker of Cancer, Cancer Res. 38: 3225â€” Effect of Hypoxia on 67Ga Incorporation into Parker, S. See Presentand Parker, 345 3229, 1978, page 143i ,LettertotheEditor Human Granubocyles,4971 Parmley, R. T., DahI, G. V., Austin, R. L., Gau Pellinleml, T-T. See Thorndike, Polliniemi, and O'Toole, C., and Unsgaard,B. ClinicalStatusand thier, P. A., and Denys,F. R. Ultrastructureand Beck, 3435 Rate af Recovery of Blood Lymphocyte Levels Cytakinetics of Leukemic MyoboblastsContain Penn, I. See Klein,Penn,and Henle, 1137 after Radiotherapy far Bladder Cancer, 840 ing Giant Granules, 3834 Penta, J. S. See Guenino,Rozoncweig, Kline, Often, M. See Kinahan, Often, and Gnindey,3531; Parshad, R., Sanford, K. K., Tarone, R. E., Jones, Penis, Venditli, Lloyd, Holzworth, and Muggia, Steinberg, Otten, and Gnindey,4330 G. M., and Baeck, A. E. IncreasedSusceptibility 2204 Ovejera, A. A., Houchens, D. P., Catane, R., of Mouse Cells to Fluorescent Light-induced Pera, M. F., Jr., and Harder, H. C. Effects of Sheridan, M. A., and Muggia, F. M. Efficacyaf Chromosome Damage after Long-Term Culture Mannitol or Furosemide Diunosison cis-Dichlo 6-Diszo-5-oxo-L-narbeucine and N-jN-'y-Gluls and Malignant Transformation, 929 rodiammineplalinum(Il) Antitumon Activity and myl-6-diazo-5-oxa-nanleucinyl}-6-diazo-5-oxo Parsons,J. See Barra, Parsons,Koch, and Lea, Toxicity to Host-renewing Cell Populations in narleucine against Experimental Tumors in Con 1655 Rats, 1279 ventional and Nude Mice, 3220 Parsons, R. G., Todd, H. D., and Kowal, R. Iso Pera, M. F., Jr., Zook, B. C., and Harder, H. C. Overgaard,J. See Nielsenand Ovorgasrd,2772 Islion and Identification of a Human Serum Fi Effects of Mannitol or Furosemide Diumesison Overgaard,J., and Suit, H. D. Time-Temperature broneclin-like Protein Elevated during Malig the Nephrotoxicity and Physiological Disposition Relationship in Hyperthermic Treatment of Ma nant Disease, 4341 of cis-Dichbarodiamminoplstinum(II) in Rats, lignantand Normal Tissue in Viva, 3248 Paid, N. T., Folse, D. S., and Holoubek, V. 1269 Oxenhandler, R. W. See Berkelhammer,Cainos, Release of Repetitive Nuclear RNA into the Cy Pereira, M. A., Bums, F. J., and Albert, R. E. Dexter, Adebstein, Oxenhandler, and Hook, taplasm in Liven of Rats Fed 3'-Methyl-4-Di Dose Response for Benzo(a)pynoneAdducts in 4960 methylaminaazobenzene,4460 Mouse Epidermal DNA, 2556 Ozols, R. F., Grotzinger, K. R., Fisher, R. I., Paterson, A. R. P. See Case, Dshlig, Lau, Lynch, Perini, F. See Woo, Penini,Sadow, Sullivan, and Myers, C. E., and Voung, R. C. kinetic Char and Paterson, 1245 Funkhouser, 2429 actenizatian and Response to Chemotherapy in Paterson, A. R. P., Jakobs, E. S., Lauzon, G. J., Perreila, F. W., and Lea, M. A. Spermine-induced a Transplantable MunineOvarian Cancer, 3202 and Weinstein,W. M. DrugSequence-depend Variations in the Adenosine 5'-Diphosphsto RI Ozols, R. F., Locker, G. V., Doroshow, J. H., ent Toxicity and Small Bowel Mucosal Injury in bosybstionPatterns of Nuclear Proteins from Rat Grotzinger, K. R., Myers, C. E., and Young, R. Mice Treated with Low Dosesof 3-Deazauridino Liver end Hepatoma, 1382 C. Phanmacakinetics of Adriamycin and Tissue and 1-$-o-Arsbinafursnasylcylosine, 2216, Petering, D. H. See Minkel, Dolhun, Calhoun, Penelnalian in Murine Ovarian Cancer, 3209 Communication Sanyan, and Potening, 2451 : Ssnysn, Minkol, Paterson, A. R. P., Paran, J. H., Yang, Se., and Dolhun, Calhoun, Wiolgus, Schelbem,and Peter Lynch, T. P. Protectionof Mice againstLethal ing, 2457 p Dosages of Nebulanine by Nitrobenzylthioino Peters, E. H., Nishi, S., Miura, K., Lorschelder, sine,anInhibitorof NucleosideTransport,3607 F. L., Dixon, G. H., and Tamaoki, T. In Vitro Paterson, M. C., Anderson, A. K., Smith, B. P., Synthesis of Murine Pne-a-feloprotein, 3702 Paclllas-Verjan, R. See Jones and Pacillas-Ver and Smith, P. J. EnhancedRadiosensitivityof Peters, L. C., Brandhorst, J. S., and Hanna, M. jan,2591 Cultured Fibroblasts from Ataxis Telangiectasis G., Jr. Preparationof ImmunothonspeuticAutol Paglia, L. M. See Breitkreutz,de Leon, Paglia, Hetorozygotes Manifested by Defective Colony ogaus Tumor Cell Vaccines from Solid Tumors, Gay, Swarm, and Stern, 5093; Saboman,Paglia, farming Ability and Reduced DNA Repair Rep 1353 and Verbruggen, 4387 licatian after Hypoxic â€˜y-lnrsdiation,3725 Peterson, A. R., Peterson, H., and Heldelberger, Pahike, W. See Modalell, Andreesen, Pahlke, Path, K. See Buisy, Pstil, Wilson, and Shubik, C. Oncagenosis,Mutagenesis,DNA Damage,

5206 CANCER RESEARCH VOL. 39 Author Index to Volume 39

and Cytotoxlcilyin Cultured MammalianCells Poiitzer, P., Regglo, P. H., and Pollizer, I. R. Preston-Martin, S. See Henderson, Dworsky, Treated with Alkylallng Agents, 131 Interdisciplinary Cancer Research Workshop, Pike, Baptists, Menck, Preston-Martin, and Peterson, H. See Peterson, Peterson, and Hal 4291 , Meeting Report Mack, 4507 delberger, 131 Pollack, R. See Barrett, Crawford, Mixtor, Prough,R. A. See Dunn,Lubet,andPrough,4555 Pstra, P. H. See Namkung, Moo, and Pelma,1124 Schechtman, Ts'o, and Pollack, 1504 Prough, R. A., Patrizi, V. W., Okita, R. T., Mae Pewnim, T. See Adams, Pewnim, Chandra, Ar Pollard, M. See Burleson, Caulfield, and Pollard, ters, B. S. S., and Jakobsson, S. W. Chsnsc chibald, and Foo, 5124 2149; Caulfield, Bunbeson,and Pollard, 2155 tenisticsof Benzo(a)pynenoMetabolismby Kid Pezzine, V,, Vigneri, R., Sipersteln, M. D., and Poplack, D. G. See Ladlsch, Rosman, and ney, Liven,and Lung Microsomal Fractions from Gcidfins, I. D. Insulin and Glucagon Receptors Poplack, 2544 Rodents and Humans, 1i 99 In Morris Hepatomas of Varying Growth Rates, Porter, C. W. See Feuerstein,Porter, and Dave, Prout, G. R., Jr. See P101km,Wides, Gilbert, Wolf, 1443 4i 30; Mikbos-Rabortson,Feuenslein,Dave, and Hagen, and Prout, 3856 NaIler, M. See Hill, Hill, Miller, Pfellen,Weiss, end Porter,1919 Pruitt, B. See Rose and Pnuitt,3968 GalIn, 934 Porter, C. W., MlkIes-Robertson, F., Kramer, D., Przepiorka, D. See Mokyr, Hengst, Pnzepionks, Pfelffer, C. J., Nagal, T., Fujimura, M., and Tobe, and Dave, C. Correlationof Ultrastructunsiand and Dray, 3928 T. SpontaneousRegressiveEpitheliomesin the Functional Damage to Mitochondnia of Asciles Pschigoda, L. M. See Li, Kuentzol, Munch, Pschi Japanese Newt, Cynops pyrrhagaster, 1904 Li 210 CoIlsTreated in Vivawith Methylglyoxal gods, and Krueger, 4816 PhsIps, A. W. See Black, Henderson, Klelnhans, bis(guanylhydrszone) or Ethidium Bromide, Pugh, R. P. See Chlebowski, Irwin, Pugh, Sadoff, Phelps, and Thornby, 5022 24i 4 Heslorff, Wiener, and Balemsn, 4503 Philips, F. S. See Chou, Bunchenal, Fox, Wetan Portetelle, D. See Box, Bruck, Msmmerickx, Pugh, T. D. See Hubermen,Montesana,Drovon, abe, Chu, and Philips, 720 Portotelbe,Ghysdael, Cleuter, Lecbercq, Doke Kuraki, St. Vincent, Pugh, and Goldfsrb, 269 Phillips, S. L See Moon, Thompson, Bocci, gel, end Bunny, 1118 Purnell, D. M. See Kreider, Bartlett, Bayer, and Grubbs, Gander, Newton, Smith, Phillips, Hen Posner, J. B. See Hasegawa, Shapiro, and Pas Purnell, 987 derson, Mullen, Brown, end Spomn,1339 non, 2691 ; Hasegawa, Shapiro, Posner, and Purnell,D. M., Bartlett, G. L., and Krelder, J. W. PhiNips, 1. L. See Luk end Phillips, 2300' Bsslem,2687 Effects of Dose and Schedule of Immune Slim PhIlpott, G. W., Grass, E. H., and Parker, C. W. Paste, G., and Kirsh, R. Rapid Decay of Tumari ulant on Efficacy of Combination Corynebacte Affinity Cytotoxicity with en Alcohol Dohydro cidsl Activity and Loss of Responsiveness to rium parvum-CycbophosphamidoTreatment for genase-Anhibody Conjugate and Allyl Alcohol, Lymphakines in Inflammatory Macnophagos, a MunineMammary Adenocancinoma, 1 2084 2582 Pumnell,D. M., Bartlett, G. L., Kreider, J. W., Picca, M. See Zardi, Cecconi, Banbieni,Came Poste, G., Kirsh, R., Fogler, W. E., and Fidler, I. Biro, T. G., and Kontra, J. ComparativeAntitu molla, Picca, and Sanli, 3774 J. ActivationofTumonicidslPropertiesinMouse mar Effects of Corynebacterium parvum, Bar Pickard, D. K. See Grant, Pickard, Ramaika, Macrophagos by Lymphokines Encapsulated in detella pertussis, Bacillus Calmette-Gudrin and Madeweib,and Essex, 75 Liposomes, 881 LevamisobeAlone or in Combination with Cyclo Pickart, L., and Thaler, M. M. Suppression of Pour, P. See Gingell, Brunk, Nagel, and Pour, phosphamido in a MunineMammary Adenocam Tumor-associated Hyperfibmmnogonemiaand 4579 cinoma (CaD2)System, 4838 Free Fatty Acidemlawith p-Phenoxybenzalbu Pour, P., Walicave, L, Gingell, R., Nagel, D., tyrate (Ciofibrate), 3845 Lawson, T., Salmasi, S., and Tines, S. Carci Pike, M. C. See Henderson, Dwomsky,Pike, Bep nogenic Effect of N-Nilnoso(2-hydnoxypnopyl)- 0 tlsta, Menck, Preston-Martin, and Mack, 4507 (2-oxopnopyl)amine, a Postulated Proximate Plich, V. H. See Belnep, Cleveland, Colmemauon, Pancreatic Carcinogen in Syrian Hamsters, Quarles, J. M., Sega, M. W., Schenley, C. K., Barone, and PlIch, 1174 3828 and Lijlnsky, W. Transformationof Hamster Pinaky, S. D., Tew, K. 0., Smulson, M. E., and Pousette, A. See Forsgren, Gustafsson, Pousette, Fetal Cells by Nitnasated Pesticides in a Trans Woolisy, P. V., Ill Modification of Li 210 Cell and Hogbong,5155 placental Assay, 4525 Nuclear Proteins by 1-Methyl-i -nitrosoumoaand Powell, A., Sboss,A. M., and Makley, J. T. Im Quinn, L. A. See Woods,Morgan,Quinn,Moore, 1-Methyl-3-nhtro-i-nltrosoguanidine,923 munological Basis of Close-Contact Sensitiza Sempbe,and Stodman, 4449 Pitha, J., Kocieisk, K., and Apffel, C. A. Opposite lion to Osteosarcoms, 658' Quinn, L. A., Moore, G. E., Morgan, R. T., and Effects of Dextrans Substituted with Sulthydryls Powell, A., Sloss, A. M., Smith, R. N., and Mur Woods, L. K. Cell Lines from Human Colon or Mercuryon TumorGrowth,170 mdl,H. AnligenicSpecificityand CellularMoch Carcinoma with Unusual Cell Products, Double Pitman, S. W. See Glodo, Pitmen, Ensminger, anisms in Loukocyte Adherence Inhibition Anal Minutes, and Homogeneously Staining Regions, Rosoweky, Papathanesopoubos,and Fmei,3707 ysis of Immunity to Simple Proteins and Haplen 4914 Pitot, H. C. See Kitagawa,Pilot,Miller,and Miller, Protein Conjugates, 570' 112; MIller, Kadiuban, Miller, Pilot, and Drink Powell, B., Garola, R. E., Chamness, G. C., and R water,3411 McGuire, W. L. Measurementof Progesterone Plager, J. E. See Tomita and Plegon,4407 Receptor in Human Breast Cancer Biopsies, Plssnicar, S., Klanjsc.k, G., Medic, S., and Rue 1678 Raaphorst, G. P., Romano, S. L, Mitchell, J. B., tia, M. Growth Characteristics of Pulmonary Me Powell,L. See Ichinose,Powell,Hoennem,Denbes, Bedford, J. S., and Dewey, W. C. Intrinsic tastasesfromHumanSarcomas,4575 end Byems,4270 Differences in Heat and/or X-Ray Sensitivity of Plotkln, G. M., Wides, R. J., Gilbert, S. L., Wolf, Powis, G. See Ames,Pawis,Kovach,and Esgan, Seven Mammalian CobbLines Cultured and 0.,Hag.n,I.K.,andProut,G.R.,Jr.Galactosyl 50i 6; Kovach, Amos, Pawis, Moortol, Hahn, Treated under Identical Conditions, 396 Transferase Activity in Human Transitional Cell end Cnesgan,4540 Raben, M. See Heise, kucers, Raben, and Carcinoma Lines and in Benign and Nooplestic Powis, G., Ames, M. M., and Kovach, J. S. Met Homesbey,4022 Human Bladder Epithelium, 3856 abolic Conversion of Indicine N-Oxide to mdi Rabes, H. M., Kerler, R., Wilhelm, R., Rode, G., Plunkstt, W. See Stewart, Benvenuto,Leavens, cinein RabbitsandHumans,3564 and Riess, H. Aikylationof DNA end RNA by Hail, Benjamin, Plunkett, McCmedie,Burgess, Prajda, N., Morris, H. P., and Weber, G. Glu [â€˜4C]Dlmethylnitrosaminein Hydroxyurea-syn and Loo,4119 tamine-Phosphonibosylpynophosphate Amido chronized Regenerating Rat Liver, 4228 Piunkett, W., Alexander, L, Chubb, S., and Loo, tmensferase (Amidophosphoribo@yItnsnsfenase, Rabes, H. M., and Szymkowlak, R. Cell Kinetics T. L. BiochemicalBasisoftheIncreasedActivity EC 2,4,2.1 4) Activity in Normal, Differentialing, of Hepalocytos during the Preneoplastic Period of 9-$-o-Arabinofuranosyledenmnein the Pros end Neoplastic Kidney, 3909 of Diethylnitrasamine-inducedLivenCarcino ence of Inhibitors of Adonosine Deeminaso, Prasad, R. V., and Ebner, K. E. Isolation and genesis, 1298 3655 Charectemizalionof a-Lsclalbumin from a Rat Rabson, A. S. See Cook, Kirkpatrick, Rabson, Pollier, L. A. See Theiss, Shlmkin, and Poiniem, Mammary Tumor, 3598 and Lewis, 4949 391 Prat, M. See Comoglia,Pani, Pral, Tarane, and Radwin,H. M. See Lsvergne,Lsmm,Radwin,and Poirier, M. C., Dubin, M. A., and Yuspa, S. H. Monti-Bragadin, 4745 Hamnington,1985 Formationand Removalof SpecificAcetylami Preisler, H. D. See Ho, Preisler, and Bsmdos, Ragin, R. C. See Urenand Ragin, 1927 nofluorene-DNA Adducts in Mouse and Human 3163; Rustum and Preisler, 42 Rajalakshml,S. See Tsuds,Sarma, Rsjsiakshmi, Cells Measured by Radloimmunoassey, 1377 Present, C. A., and Parker, S. Imidoesler Inhibi Zubroff, Farber, Batzingen, Cha, and Bueding, Poland, A., and Giover, E. An Estimate of the lionof LymphocyteDNASynthesis,345 4491 Maximum in Vivo Covalent Binding of 2,3,7,8- Prescott, D. M. See Carry, Prescott, and Ogilvie, Ralph, P. See Fasnos, Menluzzi,Williams, Tar Tetrachborodibenzo-p-dioxin to Rat Liver Pro 2139 nowski, and Ralph, 4564; Tsnnowski, Ralph, tein. Rlbosomal RNA, and DNA, 3341 Pressman, D. See Soon and Pressman, 4423 and Stock, 3964 Policastro, P. See Edwards, Fox, Policastro, Gaff, Prestayko, A. W. See Comis, Kuppinger, Gins Ramalka, C. See Grant, Pickard, Ramaiks, Wolf, and Fine, 1857 berg, Crooke, Gilbert, Auchincloss, and Pros Madewell, and Essex, 75 Polltzer, I. R. See Politzem,Reggio, and Politzer, tayko, 5076; Sawyer, Prostayko, and Crooke, Ramey, W. G., Hashim, G. A., Burrows, W. B., 4291 1180 Swistel, A. J., Munther, A., and Fitzpatrick, H.

DECEMBER1979 5207 Author Index to Volume 39

F. Detectionof BreastTumorAntigen-Sensitive Mice with EL4 Tumors, 4856 Rojko, J. L, Hoover, E. A., Mathes, L E., Kra Circulating T-Lymphocytos by Antigen-Stimu Repman, M. A. See Lueker, Stewart, kainer, kowka, S., and Olsen, R. G. Influenceof Adne batedActive Rosette Farmstion, 4796 Schengrund, Repmsn, and Sheffber, 3277; nabCarticastoroids an the Susceptibility of Cats Randerath, K. See Lu and Randerath,940 Sheffben,Repman, and Schengnund, 711 to Feline Leukemia Virus Infection, 3789, Cam Randolph, J. K. See Gewirtz, While, Randolph, Reynolds,E. C. See Harris,Reynolds,and Finch, municatian and Goldman, 2914 538 Roil,D. E., Weber, M. J., and Conrad, H. E. Effect Rao, G. V. R. See Tompkins,Raa, and Tompkins, Reynolds, R. D., and Morris, H. P. Effects of of GrowthConditionson the Contentof the 2160 Dietary Vitamin B6an the in Vitro Inactivation of Major Groups of Carbohydrates in Chick Em Rao, K. V. N. See Vessobinovitch,Rao, and Mihai RatTyrosino Aminotnansfenasoin Host Livenand bmyoFibnobbssls,2550 bovich,4378 Morris Hepatomas, 2988 Roller, P. P. See Berman, Rice, Wenk, and Roller, Rao, M. S. See Reddy, Rsa, Azamnoft,and Sell, Reznik-SchUIIer, H., and Lijinsky, W. In Viva Au 1462; Kbeihues,Doorjom,Keofen, Rice, Roller, 152; Scarpebliand Raa, 452 toradiognaphyand Nitrosoheplamethyleneimine and Hodgson, 5136 Rao, P. N., Freireich,E. J, Smith, M. L., and Loo, Carcinogonesis in Hamsters, 72 Romano, S. L. See Raaphorst, Romano, Mitchell, T. L. Cell Cycle Phase-specificCytotoxicityof Ribi, E. E. See Cantrell, McLaughlin, and Ribi, Bedford, and Dewey, 396 the Antiluman Agent Maylansine, 3152 1159; McLaughlin, Hangnave,Bickel, and Ribi, Romney,S. L. See Pabanand Romney,31 14 Rao, V. S., Grodzicki, R. L., and Mitchell, M. S. i 766; Zbsn, Canti, Ashley, Rapp, Hunter, and Room, R. Measurementsof DrinkingPatterns in Specific in Viva Inhibition of Macrophage Re Ribi, i 597 the General Population and Possible Applica ceptors far CytaphibicAntibody by Soluble Im Ribi, E. E., Cantrell, J. L., Von Eschen, K. B., and lions in Studies of the Role of Alcohol in Cancer, mune Complexes, 174 Schwartzman, S. M. Enhancementof Endotoxic 2830 â€¢â€˜ Rapp, F. See Howell, Pegg, and Rspp, 1041 Shock by N-Acetyb-muramyl-L-abanyl-(L-soryl) Roper,P. R., Drewinko,B., Tsukeda, H., Mizuno, Rapp, H. J. See Yarkani and Rspp, 535; 1518; D-isogbutsmine(MuramybDipeptide), 4757 S., and Nitta, K. CellSurvivalfollowingTreat Zbar, Canti, Ashley, Rapp, Hunter, and Ribi, Rice, H. M. See Verms, Shapas, Rice, and mont with Antitumor Drugs, Correspondence no: 1597 Boutwell, 419 Hahka Tsukeda, Satashi Mizuno, and Kszuo Rapp, H. J., and Hewitt, H. B. Appropriatenessof Rice, J. M. See Berman,Rice, Wenk, and Roller, Nitta. Susceptibilities of Normal and Malignant Animal Models for the Immunology of Human 1462; Kleihues, Doonjen,Keefer, Rice, Robber, Human Lung Coils in Culture to the Cytocidsi Cancer. Correspondence re: H. B. Hewitt, The and Hodgson, 5136; San, Laspia, Soiefem,Mas Action of Antilumor Agents. Cancer Res, 38: Choice of AnimalTumors for Experimental Stud lsnsky, Rice, and Williams, 1026; San, Shi 2529-2532, 1978, page 1428, Letter to the los of Cancer Therapy. Adv, Cancer Res., 27: mads, Masbsnsky, Kreiser, Laspla, Rice, and Editor 149â€”200,1978, page 4285, Letter to the Editor Williams, 4441 Rose, D. P., and Pruitt, B. Modification of the Rapp,U. R., Keski-Oja,J., and Hems, U. I. Estab Rlchman, A. V., and Alexander, R. W. Immunity Effect of a Gonadoliborin Analog on 7,12-Di lishment and Characterization of the Epithelial to Cell Surface Antigens and Immune Complex methylbonz(a)anthnsceno-induced Rat Mam Mouse Embryo Cell Line MMC-E, 4111 Glomerulonephnitisin Hamsters BeamingHuman manyTumors by Hormone Replacement, 3968 Raso, V. See Camis,Griffin,Raso,and Ginsberg, EpithebiabTumors, 459 Rose, L. M. See Bennett,Smithens,Rose, Adam 757 Riddle,V. G. H. See Dubrow,Riddle,and Pardee, san, and Thomas, 4868 Ratanatharathorn, V. See kossel, Ratanathars 2718 Rosenberg, S. A. See Thorpe, Loob, Hyatt, and thorn, and Chou, 3377 Rieber, M., and Rieber, M. S. Heterogeneity in Rosenberg, 277 Ratbiff,T. L. See Catabona,Ratbiff,and McCaab, Cell-associated Transformation-sensitive Pro Rosenthal, R. L. See Stevens,Stevens,and Ro 4372 loins AntigenicsibyRelated to Fibronectin, 1803 sonthal, 4939 Rauch, J. See Thomson, Tataryn, O'Connor, Rieber, M. S. See Rieber and Rieber, 1803 Rosney, C. M. See Taylor, Rosnoy, and Campbell, Rauch, Fniedbsnder,Gold, and Shuster, 604 Riess, H. See Rabes, Kenben,Wilhelm, Rode, and 1046 Ray,R. M. See Mower,Ray,Shaft,Stommonmann, Riess, 4228 Rosowsky, A. See Glade, Pitman, Ensmingen,Ro Nomura, Gbobor,Kamiysma, Shimada, and Ys Rifkind, R. A. See Ysmasaki, Weinstein, Fibach, sowsky, Papathanasopoulos, and Frei, 3707 makaws, 328 Rifkind, and Marks, 1989 Ross, L. A. See Egonin,Clawson, Ross, Schloss Reaman, G. H. See Ladisch, Reaman, and Rigden, P. See Wold, Mackey, Rigden, and berger, and Bachur, 4396 Paplack, 2544 Green, 3479 Rothblum,L. I. See Parker,Rothblum,andBusch, Reddy, B. S., and Watanabe, K. Effect of Chobes Riggs, J. L. See Smith, Riggs, and Mosesson, 1287 tonal Metsbobitesand Promoting Effect of Lith 4138 Rothstein, M. See Chsng, Hsnnington,Rothstein, ochabicAcid in Colon Carcinogenesis in Germ Rigor,B. See Banlogie,Carry,Yip,Lippman,John Shongsbis,Sworn, and Vohna,3871 freeandConventionalF344Rats,1521 stan, Khsbil,Tenczynski, Reilly, Lawson, Dosik, Rousset, J-P. See Roussot, Chevalier, Roussot, Reddy, J. K., Rao, M. S., Azamnoff, D. L., and Rigor, Hankenson, and Freimeich,1481 Dussaulx, and Zweibsum, 53i Sell, S. Mitogenic and Carcinogenic Effects of Rljksen, G. See van Veebon,Venbiest,ZUIch,van Rousset, M., Chevalier, G., Rousset, J-P., Due a Hypolipidemic Peraxisome Prabifenstar, [4- keteb, van der Vbist,Vlug, Rijksen, and Steal, saulx, E., and Zweibaum, A. Presence and Cobb Chbora-6-(2,3-xybidino)-2-pyrimidinybthiajacotic 4263 Growth-related Variations of Glycogon in Hu Acid (Wy-i 4,643), in Rat and Mouse Liver, 152 Rindber,M. J. See Reid,Stiles,Saion,and Rindler, man CobomectabAdonocancinoms Coil Lines in Redman, C. M., Vu, S., Banerjee, D., and Morris, 1467 Culture, 531 H. P. In Vitro Synthesis and Secretion of Abbu Ring, B. J. See Holcenberg, Borells, Camitla, and Rowley, J. D. See Carrsno, Msyalb,Tests, Ash mm by Morris Hepatamas 5123C and 7800, Ring,3145 worth, and Rowley, 2984; CimIno, Rowley, Kin page 101 Ringborg, U. See Lambert, Ringborg, and Skoog, nesbey,Variakojis, and Golomb, 227; Fukuhana, Reed, D. J. See May, Kohlhepp, Boose, and Reed, 2792 Rawbey,Vsniakajis, and Golomb, 31 19; Tests, 762 Rinkus,S. J., and Legator, M. S. ChemicalChar Mintz, Rowley, Vardiman, and Gobomb, 3619 Reggio, P. H. See Pabitzer,Reggia, and Palitzer, actenizationof465KnownorSuspectedCsrcin Rozencweig,M. See Guanina,Rozencweig,Kline, 4291 ogens and their Correlation with Mutagonic Ac Penta, Venditti, Lloyd, Holzworth, and Muggie, Reich, E. See Wilsonand Reich, 1579 livity in the Salmonella typhimurium System, 2204 Reichard,G. A. See Habrayde,Axelnod,Skutches, 3289 Rubinstein, A. See Bases, Rubinstoin,Kadish, Haft, Paul, and Reichard, 4900 Rifts, R. E., Jr. See O'Connell, Moerteb, Ritts, Mondoz, Wittner, Eboquin, and Lieboskind, Reid, G. H., and Gibbins, J. R. Fate of Cultured Frytak, and Reitemeior, 3720 3524 Cells after Injection into the Circulation of Syn Rivard,G. E. See Mompanbom,Veseby,Mompamler, Ruckert, A. C. F. See Pattibla,Story, and Ruckert, genoic Animals, 4724 and Rivand,3822 1185 Reid, L. M., Stiles, C. D., Salem,M. H., Jr., and Robbins,G. F. RehabilitationandContinuingCare Ruddon, R. W., Anderson, C., Meade, K. S., Rindler, M. J. Growthof NantumonigenicCells of Cancer Patients, 2853 â€˜ Aldenderfer, P. H., and Neuwald, P. D. Content in Milbipare Diffusion Chambers Implanted in Robert-Gero, M. See Enouf, Lawrence, Tempete, of Gonadotropins in Cultured Human Malignant Mice and Implications for in Viva Growth Rogu Robert-Gena,and Lederer, 4497 Cells and Effects of Sodium ButynatoTreatment balian, 1467 Roberts,D., Peck, C., Hilliard,S., and Wingo, W. on GonadotnopinSecretion by HeLa Cells, 3885 Reilly,E. See Banbagie,Corny,Yip,Lippmsn,John Methotrexate-induced Changes in the Levels of RUdiger,H. W., Marxen, J., Kohl, F.-V., Melderis, stan, Khsbib,Tenczynski, Reilly, Lawson, Dasik, 1-$-D-ArsbinofunsnosylcylosineTriphosphalo in H., and Wichert, P. v. Metabolismand Fonma Rigor, Hankenson, and Freireich, 1481 Li 210 Cells, 4048 lion of DNA Adducts of Bonzo(a)pyreno in Hu Reinhold,H. S. See Endrich,Intsgbietts,Reinhold, Roberts,J. J. See Fravaband Roberts,1793 man DipboidFibmoblasls,1083 and Grass, 17 Robinson, R. C. See Okana, Miller, Robinson, and Rudman,D., Chawla, R. K., Nixon,D. W., Vogler, Reisfeld, R. A. See Gupta, Silver, Roisfeld,and Gebboin,3184 W. R., Keller, J. W., and MacDonell, R. C. Morton, 1683 Rode, G. See Rabes, Kerber,Wilhelm, Rode, and Protoinunis with Disseminated Neoplestic Dis Reitemeier, R. J. See O'Connell, Moenteb,AllIs, Rioss, 4228 ease, 699 Frytak, and Reilemeler, 3720 Rogan, K. M. See Mabenka,Rogan, Howe, Nelson, Rudolph, R., Woodward, M., and Hum, I. Ultra Relter, H. Effect of Thymidine on the Survival af Wrobel, Ahmed, and Humphneys,4782 structure of Doxorubicin (Adrismycin)-induced

5208 CANCER RESEARCH VOL. 39 Author Index to Volume 39

Skin Ulcers in Rats, 3689 Salmon, S. E. See Buick, Slanisic, Fry, Salman, Sala, 4200 Rube,A. H. See Un, Inglis, Rube,Tunksoy, Chap Trent, and krssovich, 505i ; Moyskons and Savage,H. E. See Msrashi,Davis,Busch,Savage, man, Kirby, and Stolbach, 4894 Salmon, 4055 and Busch, 59 Ruoslahtl, E. See Jalanko and Ruaslahti, 3495 Salmon, S. E., and Buick, R. N. Preparationof Sawamura, M. See Mstsushima, Matsumota, Shi Russell, D. H. See Heddox and Russell, 2476; Permanent Slides of Intact Soft-Agan Colony rai, Sawamura, and Sugimura, 3780 Haddox, Scott. and Russell, 4930; Olson and Cultures of Hemstopoietic and Tumor Stem Sawyer, T. H., Prestayko, A. W., and Crooks, S. Russell, 3074 Cells, 1133, Communication T. Purificationand Mechanismof Actionof Ma Russo, A. J. See Goldnosen,Russo, Howell, Love Salomon, D. S., Paglia, L. M., and Verbruggen, cromomycin, 1180 son, and Holyoke, 587 â€˜; Goldrosen, Russo, L. Hormone-dependentGrowthaf a Rat Chon Scanbon,M. See Hixson, Bowen, Ohtsuki, Scan Howell, Leveson, Moore, Holyoke, and Doug drosancomain Viva, 4387 Ion, and Dmochowski, i 99 lass, 833' ; Howell, Russo, and Gobdrosen, Samy,T. S. A. See Lowonthal,Parker,Gneonblatt, Scarpelli, D. G., and Rao, M. S. Transplantable 612' Brawn, and Samy, 1547 Ductsl Adenocancinoma of the Syrian Hamster Rustia, M. See Plesnicam,Klanjscek, Madic, and San, R. H. C., Laspia, M. F., Solefer, A. I., Mac Pancreas, 452 Rustia, 4575 lansky, C. J., Rice, J. M., and Williams, G. M. Schafer, P. W. See Harris, Autnup,Stoner, Trump, Rustle, M., and Shubik, P. Effects of Transpla A Survey of Growth in Soft Agar and Cell Sum Hibbman,Schafer, and Jeffrey, 4401 cenlal Exposure to Diethybstibbostraban Card face Properties as Markers far Transformation Schaller, J. P. See Mathos, Olsen, Hebebrand, nogenic Susceptibility during Postnatal Life in in Adult Rat Liven Epitheliab-bike CoIl Cultures, Hoover, Schalber,Adsms, and Nichols, 950 Hamster Progeny, 4636 1026 Schaller, M. See Saryan, Minkel, Doihun, Cal Rustum, V. M., Dave, C., Mayhew, E., and Pa San, R. H. C., Shimada, T., Maslansky, C. J., houn, Wielgus, Schalber,and Potoring, 2457 pahadjopouios, D. Role of Liposame Type and Kreiser, D. M., Laspia, M. F., Rice, J. M., and Schamhart, D. H. J., van de Poll, K. W., and van Route of Administration in the Anlitumor Activity Williams,G. M. GrowthCharacteristicsand En Wijk, R. ComparativeStudies of Glucose Me of Uposome-entrapped 1-$-o-Arsbinofurano zyme Activities in a Survey of Transformation Isbobismin HTC, RLC, MH,C, and Reuber H35 sylcytosine against Mouse Li 210 Leukemia, Markers in Adult Rat Liven Epithebiab-likoCell Rat Hepatoms Cells, 1051 1390 Cultures, 4441 Schechtman, L. M. See Barrett, Crawford, Mixtom, Rustum, V. M., and Prelsier, H. D. Correlation Sandor, T. See Young, Hollenbeng, Kazam, Ben Schechtman, Ts'o, and Pobback,1504 between Leukemic Cell Retention of i -$-o-Ars kowitz, Hainen, Sandor, and Abrams, 1898 Schein, P. S. See Heal, Fox, and Schein, 82; binofuranosylcytosine 5'-Tniphosphate and Re Saneyoshl,M. See Ona, Ohashi,Yamamola,Mat Sudhakar, Tow, Schein, Woolbey,and Smubson, sponse to Therapy, 42 sukage, Takahashi, Sanoyashi, and Ueda, 1411 Rutledge, S. See Tsai, Rutledge, and Kstzenobben 4673; Yoshida, Yamads, Masaki, and Sane Schengrund, C-L. See Luoker, Stewart, Kainer, bogen, 5043 yashi,3955 Schengrund, Repman, and Sheffbon, 3277; Ryan, D. E. See Wood, Chang, Levin, Ryan, Sanford, K. K. See Panshad,Sanford, Tanone, Sheffber,Repmsn, and Schengrund, 711 Thomas,Mah, Kane, Yegi, Jomina,and Conney, Jones, end Beeck, 929 Schenley, C. K. See Quarbes, Sega, Schenbey, 4069 Sani, B. P., and Donovan, M. K. Localization of and Lijinsky, 4525 Ryan, K. J. See Brown, Warren, Chute, Ryan, and Relinoic Acid-binding Protein in Nuclei and the ScherstÃ©n,T. See Lundholm, Ekman, Edslrbm, Todd, 3971 Nuclear Uptake of Retinaic Acid, 2492 Karbbeng,Jagenbung,and SchenstÃ©n,4657 Rzesa, G. See Orth, Jabbonska,Janzsbek-Chor Sanner, T., Brennhovd, I., Christensen, I., Jor Schlfter, L. M. See Brsunschweiger and Schiffer, zeiska, Obalek, Rzesa, Fsvne, and Croissant, gensen, 0., and Kvaley, S. Cellular Antilumon 3812 1074 Immune Response in Women with Risk Factors Schiffman, G. See Haves, Bornoy, Goodis, and fanBreastCancer,654â€¢ Schiffmsn,3783 S Sensing, W. A. See Kalbmongen,Sensing, Leh Schlager, S. I., and Ohanlan, S. H. Physical and man, Fischer, Langley, Alexander, King, and Chemical Composition of SubceibuisrFractions McCay, 3458 from Tumor Cells Treated with Metabolic Inhib Saav.dra, J. E. See Heckon,Farrelly, Smith, Sea Santi, D. V. See Wsshtien and Santi, 3397 tonsor Hormones,1369 vedra,and Lyon,2679 Santi, L. See Zandi, Cecconi, Barbieni,Came Schiom, J. See Drohan, Cobcher,and Schlom, Sabbadini, E. See Davies and Sabbadini, 959 malls, Picca, and Santi, 3774 1696 Sade, W. See Au end Sadee, 4289 Sapareto, S. A. See Schrekand Sapaneta,2220 Schiossberger, N. M. See Egorin, Clawson, Ross, Sadoff, L. See Chlebowski, Irwin, Pugh, Sadoft, Sarma, D. S. R. See Abanobi,Farber,and Sanma, Schbossberger,and Bachur, 4396 Hestorif, Wiener, and Bateman, 4503 i 592; Tsuda, Sanma,Rajabakshmi,Zubroff, Fan Schmahl, D. See Zebler, Bongor, and SchmÃ¡hb, Sadew, J. See Woo, Ponini,Sadow, Sullivan, and ben,Batzingen,Chs, and Buoding, 4491 1071 Funkhouser, 2429 Sarrif, A. M., White, W. E., Jr., and DiVito, N. Schmidseder, R. See Muller, Maidhof, Arendes, Saffer, E. A. See Fisher, Gebhardl, Safter, and Establishment of Pholoaffinity Label Derivatives Geurtsen, Zshn, and Schmidseder, 3768 Fisher, 1361 ; Fisher, Wolmerk, and Saffer, of Fluorene as Probes in Studies of Chemical Schmidt, T. J., and Thompson, E. B. Glucocor 4772; Gunduz,Fisher,and Saftor,3861 Cancinagenesis in Mammalian Cell Culture, ticoid Receptors and Glulsmine Synthetase in Baler, M. H., Jr. See Reid, Stiles, Ssien, and 3903 Leukemic SÃ©zaryCells, 376 Rindler, 1467 Sartorelli, A. C. See Fondy,Tsiftsogiau,Jacoby, Schoental, R., Jofte, A. Z., and Vagen, B. Car Salto, H., and Watanabe, T. Effect of a Bscteni and Sartonelli, 3583; Lee and Sartorelli, 2625; diovascular Lesions and Various Tumors Found acm Produced by Mycobacterium smegmatis Tsiftsogbauand Sartorelli, 4058 in Rats Given T-2 Toxin, s Tnichotheceno Me on Growth of Cultured Tumor and Normal Cells, Saryan, L. A. See Minkob,Doihun, Calhoun, San labobiteof Fusarium, 2179 5114 yen, and Petening,2451 Schonberg, R. See Tedde, Balls, Schanborg, and Saito, K. See Nagai, katsoka, Kabsyashi, Ishi Saryan, L A., Minkel, D. T., Dolhun, P. J., Cal Trolls, 3044 hara, Tobioka, Nakashlma,Namuse,Saito, and houn, B. L., Wielgus, S., Schaller, M., and Schorlemmer, H-U., Opltz, W., Etschenberg, E., Sakuma, 1835 Petering, D. H. Effects of Zinc Deficiencyon Bitter-Suermann, D., and Hadding, U. Killing of Sakakibara, F., Kawauchi, H., Takayanagi, G., Cellular Processes and Morphology in Ehnbich Tumor Coils in Vitro by Macraphages from Mice and lee, H. Egg Lectin of Ranajaponica and Its Ascites Tumor Cells, 2457 Treated with Synthetic Dohydrodipeptides, Receptor Glycoprotoin of EhnbichTumor Cells, Sasaki, R. See Honikoshi, Sasaki, Mizoguchi, 1847 1347 Miurs, Takaku, and Amaki, 1841 Schrek, R. Utility and Efficiency of Viable Cell SakamOtO,V. See Isoheshi, Tsukensks, Torada, Sasaki, T., and Vamamoto, M. Potentisting Effect Counts. Correspondence ro: Pamela R. Roper Nakanlshi, Fukushima, and Sakamoto, 5132 of $-Aminopmopionitribeon the DNA Synthesis and Benjamin Drewinko. CobbSurvival following Saklyama, S., Akiba, N., and Fujimura, S. Char induced by Isoproterenob,2751 Treatment with Antitumar Drugs. Cancer Res., actedzation of Messenger RNA for Fructose Satake, M. See Yahars, Iwashits,Ebina, Salake, 39: 1428â€”1429,1979, page 4288, Letter to 1,6-BisphosphaleAldoisse A Isozyme of Rat and Ishids, 4687 the Editor Asciles Hepatoma AH 7974 CoIls, 502 Sather, H. See Ertel, Nosbit,Hammond,Weiner, Schrek, R., and Sapareto, S. A. Critical Temper Sakuma, S. See Negai, Kataoks, Kobsyashi, Is and Sathen,3893 sturo of Mammalian Cells. Correspondence me: hihara, Tobloka, Nakashima, Namuse,Saito, and Sato, C., Kojima, K., Nishizawa, K., and Ikawa, S. A. Sspsreta, L. E. Hopwood, W. C. Dewey, Sakuma, 1835 V. Early Decrease in Hyaburonidase-sensitive M. R. Raju, and J. W. Gray. Effects of Hypor Sakurai, V. See Ineba, Kobayeshi, Sakursi, and Cell Surface Charge during the Differentiation thermia on Survival and Progression of Chinese Johnson, 2200; Kateoks, Oh-hsshi, and Saku of Friend Erylhrobeukemic Cells by Dimethyl Hamster Ovary Cells. Cancer Res., 38: 393â€” ral, 2807; Tsuruo, lids, Tsukagoshi, and Ssku Sulfoxide, 1113 400, 1978, page 2220, LettertotheEditor mel,1063 Sato, K. See Tsuchids, Hoshino,Sata, Ito, and Schremb,W. See Lohrmsnn and Schneml,527 Salinas,F. A. SeeSilver,Kanim,Archibald,and Salo, 4200 Schreml, W., and Lohrmann, H-P. Effect of High Salinas, 5036 Sato, S. See Nakayasu, Shoji, Aoki, Sato, Miwa, Dose Methotmexatewith CitrovomumFactor on Salmasi, S. See Pour, Wailcave, Gingell, Nagol, and Sugimuna,4668 Human Gmsnubopoiesis,4195 Lawson, Sabmasi,and Tines, 3828 Sato, T. SeeTsuchida,Hoshino,Sato,Ito, and Schultz, R. M. See Chinigos and Schultz,

DECEMBER1979 5209 Author Index to Volume 39

2894 â€˜â€˜â€˜; Stoychkov, Schultz, Chinigos, Pavli Seraydarian, M. W., and Artaza, L. Modification Shinozuka, H., Sells, M. A., Katyal, S. L., Sell, dis, and Goldin, 3014 by Adenosine of the Effect of Adriamycin on S., and Lombardi,B. Effectsof a Chobine-de Schwab, M., kollinger, G., Haas, J., Ahuja, M. MyocardiabCells in Culture, 2940 void Diet on the Emergence of â€˜y-Glutsmyllmans R., Abdo, S., Anders, A., and Anders, F. Ge Sery, T. W. Photodynamic Killing of Retinobbas peptidase-positive Foci in the Liver of Cancino netic Basis of Susceptibility for Neunobbastoma tama Cells with Hematoporphyninand Light, 96 gen-trested Rats, 2515 following Treatment with N-Methyb-N-nitrasau Sallow, R. B. See AhmedandSellow,471 ;Wood Shiral, A. See Matsushims, Matsumolo, Shimsi, roe and X-Rays in Xiphophorus, 5i 9 head, Setlow, and Scully, 2698 Sawamuns,and Sugimurs, 3780 Schwartz, A. G. Inhibition of Spontaneous Breast Seyfried, C. E., and Morris, D. R. Relationship Shirakawa, S. See Tatsumi,Tsshima,Shirakswa, Cancer Formation in Female C3H (A@/a) Mice between Inhibition of Polysmine Biosynthesis Nsksmuns, and Uchino, 1623 by Long-term Treatment with Dehydroepian and DNA Replication in Activated Lymphocytes, Shiu, R. P. C. Prolactin Receptors in Human drosterone, 1129, Communication 4861 Breast Cancer Cells in Long-term Tissue Cub Schwartz, H. S. See Kanter and Schwartz, 448; Shackney, S. E., Erickson, B. W., and Skram lure,4381 3661 ; Murinsan, Anderson, Schwartz, Myers, stad, K. S. The T-Lymphocyteas a Dipboid Shoff, R. See Mower, Ray, Shoft, Stemmonmsnn, and Chabner, 247i Reference Standard for Flow Cylomotry, 4418 Nomuns,Gbobon.Ksmiysma, Shimeds, and Ya Schwartz, P. M., and Handschumacher, R. E. Shatie, S. M., Cho-Chung, V. S., and Gulllno, P. makawa, 328 Selective Antagonism of 5-FluorounacilCytotax M. CyclicAdenasine3':S'-Monophosphateand Shoji, M. See Nakayssu, Shoji, Aaki, Solo, Miws, icily by 4-Hydroxypyrazabopynimidine(Ablapuri Protein kinsse Activity in Insulin-dependent and and Sugimurs, 4668 nol) in Vitro, 3095 -independent Mammary Tumors, 250i Shu, H. P., and Nichols, A. V. Benzo(a)pyreno Schwartz, R. See Thomson, Tataryn, Lopez, Shah, H., Hartman,S. P., and Weinhouse,S. Uptake by Human Plasma Lipopratoins in Vitro, Schwartz, and MacFarbane,638' Formation of CanbanybChloride in Carbon Tel 1224 Schwartzman, S. M. See Ribi, Cantrebi, Von rschboride Metabolism by Rat Liver in Vitro, Shublk,P. SeeBulay,Paul,Wilson,andShubik, Eschen, and Schwsrtzman, 4757 3942 4996; Rustle and Shubik, 4636 Schweizer, J. See Goerttber,Loehrke, Schweizer, Shapas, B. G. See Verms, Shapas, Rice, and Shuler, C. F., and Latt, S. A. Sister Chromalid and Hesse, 1293 Boutwell, 419 Exchange Induction Resulting from Systemic, Scialla, S. J., Speckart, S. F., Haut, M. J., and Shapiro,W. R. See Hasogawa,Shapiro,and Pos Topical, and Systemic-Topical Presentations of Kimball, D. B. Alterationsin Platelet Surface nor, 2691 ; Hasegaws, Shapiro, Posner, and Carcinogens, 2510 Sialyltransferase Activity and Platelet Aggrega Bssber,2687 Shuster, J. See Thomson, Tstenyn, O'Connor, tion in a Groupof CancerPatientswitha High Sharkey, F. E. See Kreider,Bartlett,andSharkey, Rauch, Fniedbsnder,Gold, and Shuston, 604' Incidence of Thrombosis, 203i 273 @Ibl,0. SeeHolÃ¡Ã±,@Ibb,andHatak,651' Scoltock, M. See Van Echo, Chiuten, Gonmbey, Sharkey, F. E., and Fogh, J. Incidenceand Path Slclllano, M. J., Barker, P. E., and Cailleau, R. Lichtenfebd,Scoltock, and Wiennik,3881 ologicab Features of Spontaneous Tumors in Mutually Exclusive Genetic Signatures of Hu Scott, C. C., Heckman, C. A., Nettesheim, P., Athymic Nude Mice, 833 man Breast Tumor Cell Lines with a Common and Snyder, F. Metabolism of Ether-linked Sharpless,T. K. See Coibste,Danzynkiewicz,Tra Chramosomal Marker, 919 Glycerobipids in Cultures of Normal and Neo ganos, Shsmpbess,Whilmano, and Molamed, Sidransky, H., and Verney, E. Effect of Nutritional plastic Rat Respiratory Tract Epithebium, 207 2120 Alterations on Protein Synthesis in Transplant Scott, K. F. F. See Haddox, Scott, and Russell, Shatton, J. B., Morris, H. P., and Weinhouse, S. abbeHopstomas and Host Livers of Rats, 1995 4930 Cresline Kinase Activity and Isazymo Composi Sieber, S. M., Correa, P., Dalgard, 0. W., and Scully, P. M. See Woodhead, Setlow, and Scully, tion in Normal Tissues and Neoplasms of Rats Adamson, R. H. Induction of Osleogenic Sam 2698 and Mice, 492 comes and Tumors of the Hepatobilisry System Sedlacek, R. S. See Urana, Suit, Dunn, Lsnsdabe, Sheehan, D. M. See Olsonand Sheehan,4438 in Non-human Primates with Aflatoxin B, , 4545 and Sedlacek, 3454 Sheffler, B. A. See Lueken, Stewart, kainer, Sikic, B. I. See Magin, Sikic, and Cysyk, 3792 Sedwick, W. D., Kutber,M., Frazer, T., Brown, 0. Schengrund, Repman, and Sheffler, 3277 Silver, H. K. B. See Gupta, Silver, Reisfeld,and E., and Laszlo,J. NewDose-TimeRelationships Sheffler, B. A., Repman,M. A., and Schengrund, Morton, 1683 of Fobate Antagonists to Sustain Inhibition of CL. Developmentof a NeonatalandMetastatic Silver, H. K. B., Karim, K. A., Archibald, E. L., Human Lymphobbasts and Leukemic Cells in MunineNeunabbastamaModel, 711 and Salinas, F. A. Serum Sialic Acid end Sia Vitro, 3612 Sheikh, K. M. A., Apuzzo, M. L J., and Weiss, byltransferaseas Monitors of Tumor Burden in Sega, M. W. See Quanbes,Sega, Schenboy,and M. H. Specific Cellular ImmuneResponsesin Malignant Melanoma Patients, 5036 Lijinsky, 4525 Patients with Malignant Gliamas, 1733 Slmard, R. See Kessous,Bibom-Hardy,Suh, and Segal, A. See Van Duuren, Tseng. Segal. Smith, Shellabarger, C. J. See Hobtzman,Stone, and Simard, 3225 Melchionne, and Seidman, 2644 Shoblabanger779; Stone, Holtzman, and Shel Simon, P., Burlingham,W. J., Conklin, R., and Seidman,I. See VanDuuren,Tseng,Segal,Smith, Isbargen, 773 Fondy, T. P. N-Bromoscetyl-$-o-glucosamino Mebchionne,and Seidmsn, 2644 Shellabarger,C. J., Holtzman, S., and Stone, J. Tetra-O-acetste and N-Bromoacetyl-f3-o-galac Seike, H. See Okochi, Seiko, Higashino,Hada, P. Apparent Rat Strain-related Sensitivityto tosamine Tetra-O-ecotsto as Chemotherspeutic Watanabo, Ysmamums,Ito, Matsuda, Osafune, PhonbobPromotion of Mammary Carcinogene Agents with immunopotentieting Effects in Ehm Kotako, and Sonoda, 1829 515,3345 bichAscites Tumor-bearing Mice, 3897 Seitz, H. K. See Lieber, Seitz, Gamma,and Warner, Shen, A. L., Fahi, W. E., Wrighton, S. A., and Simon, R. See Albegra,Lippmsn, Thompson, Si 2863''' Jefcoate, C. R. Inhibition of Benzo(a)pynene man, Banbock,Green, Huff, Do, end Aitkon, Seklya, S., Endoh, N., Kikuchi, V., Katoh, T., and Benza(a)pynene 7,8-Dihydnodiol Metabo 1447; Allogna, Lippman, Thompson, Simon, Matsuura, A., iwasawa, H., Takeda, B., and bismby Benzo(a)pyneneQuinones, 4123 Banbock,Green, Huff, Do, Ailkon, and Warren, Takamizawa, H. In Vivaand in VitroStudiesof Shepard, R. C. See Giovsnebla,Stehbin,Shepsrd, 1973 Experimental Ovarian Adonocarcinoma in Rats, and Williams, 2236'' Simone,J. V. ChildhoodLeukemiaas a Modelfor 1108 Shepherd, V. L. See VandrÃ©,Shepherd, and Cancer Research: The Richard and Hinds Ro Selkirk, J. K. See Cohen, Bracken, iyer, Berry, Montgomery, 4091 senthal Foundation Award Lecture, 430i Selkirk, and Sbsga,4027; Cohen, Marchok, Net Shergalis, W. A. See Chang, Hannington,Roth Simsiman, R. C. See Mufson, Simsiman, and tesheim, Steele, Nelson, Huang, and Selkirk, stein,Shergalis,Sworn,andVohns,387i Bautwell, 2036 1980; MacLeod, Cohen, and Selkirk, 3463 Sheridan, M. A. See Ovejens,Houchens,Catane, Siperstein, M. D. See Pezzino,Vignomi,Sipemstoin, Sell, S. See Becker and Sell, 1437; 3491 ; Hudig, Sheridan, and Muggia, 3220 and Gobdflne,i443 Sell, Newell, and Becker, 3715; Reddy, Rso, Shlh, T-W. See Hill, Shih, end Struck, 2528 Sirotnak, F. M. See Chelbo,Sirotnak, end Danick, Azamnoft,and Sell, 152: Shinozuka, Sells, Ka Shikita, M. See Hozumi, Umezaws, Tskensgs, 2106 lyab,Sell, and Lambardi, 2515 Ohno, Shikila, and Ysmane, 5127 Sirover, M. A. Inductionof the DNA Repair En Sells, M. A. See Shinozuks, Sells, Katyab,Sell, Shimada, A. See Mower, Ray, Shaft, Stemmer zyme Unacil-DNAGlycosylese in Stimulated Hu and Lombardi, 2515 mann, Nomurs, Gboben,ksmiyams, Shimads, man Lymphocytes, 2090 Selner, M. See Cass,Tan, and Semen,1563 and Yamakswa, 328 Slvulich, M. See Levine, Sivubich, Wiomnik,and Selsky, C. A., Henson, P., Weichselbaum, R. R., Shimada, T. See San, Shimads, Maslansky, Levy, 1645 and Little, J. B. DefectiveReactivationof Ultra Kneiser,Laspis, Rico, and Williams, 4441 Skehan, P. See Friedmanand Skehan, 1960 violet Light-irradiated Henpesvirusby a Bloom's Shimkin, M. B. Committeean Growth, 1945- Skinnider, L F., and Giesbrecht, K. Inhibitionof Syndrome Fibroblast Strain, 3392 1956: Another Noble Experiment, 262; Epon Phorbol MynistatoAcetate and Phytohomagglu Sample,T. U. See Woods,Morgan,Quinn,Moore, ymic Cancer Institutes in the United States, 1mmStimulationofHumanLymphocytesbyRet Sempbe,and Stedman, 4449 221 1. See also Theiss, Shimkin, and Poinier, inol, 3332 Seen, B. K., and Pressman, D. Retinal-Binding 391 Skoog, L. See Lambort, Ringbong, and Skoog, Protein in the Urine of Cancer Patients, 4423 Shimosato, V. See Hinohashi, Shimosalo, Ks 2792 Seraydarian, M. W. See Fialkaft, Goodman,and meya, Koide, Mukajims, Taguchi, and Kagey Skramstad, K. S. See Shacknoy, Erickson,and Soraydarian, 1321 ama, 1819 Skmsmstad,4418

5210 CANCER RESEARCH VOL. 39 Author Index to Volume 39

Skutchâ€¢s,C. L See Holnoydo,Axelnod,Skutches, take, Sonoda, Watanabe, Hads, Okochi, Hi O'Connell, 823 Haff,Paul,andReichard,4900 gashino, Ysmamurs, and Abe, 4694; Okochi, Stevens, J., and Stevens, V-W. Physicochomical Stage, 1. J. See Cohen, Bracken, lyon, Berry, Seiko, Higashino, Hada, Walanabe, Yamamura, Differences betwee.@ Glucocorticoid-binding Selkirk, and Slaga, 4027; Huberman end Siege, Ito, Matsuds, Osafune, kotske, and Sonoda, Components from the Corticoid-sensilive and 411; Mufson,Fischer,Vemma,Gleason,Slags, 1829 -resistantStrainsof MouseLymphomaP1798, and Boutwell, 479i Sorof, S. See Tonobli,Custer, and Sorof, 1784 page 4011 Slaga, T. J., Bracken, W. J., Gleason, G., Levin, Soullier, B. K. See Bull, Soullier, Wilson, Hayden, Stevens,J., Stever,e,V-W., and Rosenthal,R. L W., VagJ,H., Jedna, D. M., and Conney, A. H. and Nigno,4956 Chsnsctenizatic, of Cylosolic and Nuclear Glu Marked Differences in the Skin Tumor-initiating Speckart, S. F. See Scialls, Specksrt, Haul, and cocorticoid-binding Components in Human Lou Activities of the Optical Enentiomensoflhe Diss Kimball, 2031 kemic Lymphocytes, 4939 tereomeric Benzo(a)pymone 7,8-DioI-9,i 0- Spector, A. A. See Burns, Lutteneggon, Dudley. Stevens, V-W. See Stevensand Stevens,401 1; Epoxides, 67 Buettner, and Spector, 1726 Stevens, Stevens, and Rosenthal, 4939 Siege, T. J., Gleason, G. L., DiGiovannl, J., Suk Speeg, K. V., Jr. See Azizkhan, Spoeg, Strom Stewart, D. J. See Bonvonuto,Hall, Farquhar, umaren, K. B., and Harvey, R. G. Potent Tumor berg, and Goode, 1952 Stewart, Benjamin, and Lao, 349 inItiatIng Activity of the 3,4-Dihydrodiol of 7,12- Spencer, J. S. See Arai, Spencer, Sohn, and Stewart, D. J., Benvenuto, J. A., Leavens, M., Dlmethyibenz(a)anlhraceno in Mouse Skin, Wallace, 6 Hall, S. W., â€˜enjamin,R. S., Plunkett, W., 1934 Spitzer, G., Verma, 0. S., Barbogle, B., Beran, M. McCredie, K. B., Burgess, M. A., and Loo, T. SilJip6iviÃ©,N. See Pavelic, Slijop@evic,Pevelic, A., and Dicke, K. A. PossibleMechanismsof L. Penetrationof 3-Deazauridineinto Human iviO,Audy-Jurkovic, Payable,and BoraniO,i 807 Action of Lithium on Augmentation of in Vitro Brain, IntracerebrabTumor, and Cerebmospinab Sbocum,H. K. See Laskin, Evens, Slocum, Burke, Spontaneous MyoboidColony Formation, 3215 Fluid, 4119 and Hakala, 383 Spohn, W. H. See Wu, Spohn, and Busch, 116 Stewart, I. B. See Lueker,Stewart,ksiner, Schon 51055,A. M. SeePowelb,Sloss, and Makley, 658'; Sports, M. B. See Moon, Thompson, Becci, grund, Repman, and Shoffbon,3277 Powell, Sides, Smith, and Murrell, 570' Grubbs, Gander, Newton, Smith, Phillips, Hen Such, H. F., Wei, L., and Whiting, R. F. Enhance Smetana, K. See Busch, Deskal, Gyonkey, and denson,Mullen, Brown, and Spomn,1339 mont of the Chromosome-damaging Action of Smetana,857; Busch,Gyonkey,Busch,Davis, Springer,E. L. See Smith,Springer,and Hackett, Asconbateby Transition Metals, 4145 Gyorkey,andSmetana,3024 332 Stiles, C. D. See Reid, Stiles, Ssier, and Rindlen, Smit, E. N. E. See Hagemeijer, Hoehn, and Smil, Staal,G. E. J. SeevanVeeben,Venbiest,ZUIch, 1467 4662 van Kelel, vandor Vlisl, VIug, Rijksen, and Sisal, Stock, C. C. See Tamnowski,Ralph, and Stock, Smith, A. C. See Van Duuren, Tseng, Segsl, 4263 3964 Smith, Meichlonne, and Seidman, 2644 Stablein, D. M. See Carter, Stabbein,and Wamp Stolbach, L. L. See Lin, Inglis, Rule, Turksoy, Smith, B. P. See Paterson, Anderson, Smith, and len,3446 Chapman, Kirby, and Slobbach,4894 Smith, 3725 Stalano-Coico, L. See Evenson, Darzynkiewicz, Stoiler, R. G., Kaplan, H. G., Cummings, F. J., Smith, B. R., and Bend, J. R. Metabolism and Slsiano-Coico, Traganos, and Mebamed,2574 and Calabresi, P. A Clinicaland Phanmacobog Excretion of Benzo(a)pymene4,5-Oxide by the Stallard,S.SeeLiu,Slsllsrd,Koo,andDsnnsher, ical Study of High-Dose Melhotrexate with Mm Isolated Perfused Rat Liver, 2051 1640 imal LeucovoninRescue, 908 Smith, H. See Bissell, Bartholomew, Folkmsn, Stampfer, M. See Bissell,Bartholomew,Folkman, Stone, J. P. See Holtzmsn,Stone,and Shellabar Smith,andStampfer,4293 Smith, and Stsmpfon,4293 gem,779; Shebbsbsmger,Holtzman, and Stone, Smith, H. S., Riggs, J. L., and Mosesson, M. W. Stanisic, T. H. See Buick, Stanisic,Fry, Salmon, 3345 Production of Flbronectin by Human Epilhobiab Trent, and Kmssovich,5051 Stone, J. P., Holtzman, S., and Sheblabarger,C. CellsInCulture,4138 Stec, W. J. See Janman, Mibsted,Smyth, Kinas, J. NeoplasticResponsesandCorrelatedPlasma Smith, H. S., Springer, E. L, and Hackett, A. J. Pankiewicz, and Stec, 2762 Prolactin Levels in Diothylstilbestmol-tneatedACI Nuclear Ulfrastructure of Epithebiel Cell Lines Stedman, K. E. See Woods, Morgan, Quinn, and Sprague-Dawley Rats, 773 Derivedfrom HumanCarcinomas and Nonmalig Moore, Semple, and Stedman, 4449 Stoner, G. D. See Harris,Autrup,Stoner,Trump, nant TIssues, 332 Steele, G., Jr. See Wang,Steele,Msnnick,FabIan, Hiblman,Schafer, and Jeffrey, 4401 Smith, J. B. See Jublz, Freiboy,and Smith, 998 and Onikub,1702 Storm, F. K., Harrison, W. H., Elliott, R. S., and Smith, J. H. See Heckem,Fammelly,Smith, Sas Steele, R. D., and Benevenga, N. J. Identification Morton, D. L. NormalTissue and Solid Tumor vedra, and Lyon, 2679 of a Transaminative Pathway for Ethionine Cs Effects of Hyporthermis in Animal Models and Smith, J. M. See Moon, Thompson, Becci, tabolism, 3935 Clinical Trials, 2245 Grubbs,Gander,Newton,Smith,Phillips,Hen Steele, V. E. See Cohen, Msrchak, Netlesheim, Story, M. T. See Pattibbo,Story, and Ruckert, 1185 dorson, Mullen, Brown, and Sporn, 1339 Steele, Nelson, Huang, and Selkirk, 1980 Stout, D. L., and Becker, F. F. Metabolismof 2- Smith, L. D., Emerson, R. L, and Nixon, L. K. Steele, V. E., Marchok, A. C., and Nettesheim, Aminofluorene end 2-Acotybaminofluoreno to Effect of Hepatocercinogonson the Adonine P. OncogenicTransformationin EpithelialCell Mutagens by Rat Hepatocyte Nuclei, 1168 Purine Nucleolide Cycle during the Initiation Lines Derived from Tracheal Explants Exposed Stoychkov,J. N., Schultz, R. M., Chirigos,M. A., Phase of Carcinogenesis, 2132 in Vitro to N-Methyl-N'-nitro-N-nitrosogusni Pavlldis, N. A., and Goldin, A. Effects of Adris Smith, M. L. See Rao, Froimoich,Smith, and Loo, dine, 3805 mydin and Cyclophosphamide Tmestmonton In 3152 Stehlin,J. S., Jr. SeeGiovanells,Stehbin,Shop duclion of Mscrophage Cylotoxic Function in Smith, P. See Mastro, Knupa,and Smith, 4078 ard, and Williams, 2236' â€¢; Lee, Giovsnells, Mice, 3014 Smith, P. J. See Paterson, Anderson, Smith, and Stehlin, and Bnunn,2928 Straub, K. See Bartholomew, Pearlman, Lan Smith, 3725 Stehlin,J. S.,Jr., Glovanella,B. C.,de lpolyi,P. doiph, and Stmsub,2538 Smith, R. N. See Powell, Sloss, Smith, and Mur D., and Anderson,R. F. Resultsof Eleven Straus, M. J. See Moran and Straus, 1616 roll, 570' Years' Experience with Hosted Perfusion for Strauss, B. S. See Higginsand Strauss,312 Smith, T. See Swenerton, Leghs, Smith, Horto Melanoma of the Extremities, 2255'' Streifel, J. See Howell, Jenkins, and Slroifel, bagyl, Gehan, Yap, Gullenman, and Blumen Stein, G. See Bniggs,Campbell, Chiu, Hnibics, 3875 schein, 15@2 Lincoln, Stein, and Stein, 3683 Strobi, J. S., and Lippman, M. E. ProlongedRe Smithers, D. See Bennett, Smithers, Rose, Ad Stein, J. See Briggs, Campbell, Chiu, Hnilica, tentionof Estmadiolby HumanBreastCancer emson,andThomas,4868 Lincoln, Stein, and Stein, 3683 Cells in Tissue Culture, 3319 Smulson, M. B. See Plnsky, Tow, Smulson, end Stelnberg, H. N., and Handler, E. S. Leukemic Stromberg, K. See Azizkhsn,Speeg, Stromberg, Woolbey,923; Sudhakan,Tow, Schein. Woolley, Host Influence on Normal Enythrocytic and andGoode, 1952 end Smulson, 141 1; Sudheker, Tow, and Smul Gnsnulocytic Colony Formation in in Viva Strong, J. E. See Gabvan,Strong, and Crooke, son, 1405 Plasma Clot Diffusion Chamber Cultures, 1575 3948 Smyth, J. F. See Jamman,Mibsted,Smyth, kinas, Steinberg, J. A., Often, M., and Grindey, G. B. Strong, J. M. See Erbichman,Strong, Wiornik, Panklewlcz, and Slec, 2762 Isolation of a DNA Polymenase a-Associated McAvay, Cohen, Levine, Hubbard, and Ohab Snyder, F. See Scott, Heckman, Nettesheim, and Regulatory Protein from Calf Thymus, 4330 nor, 3992 Snyder,207 Steinglass, M. See Bonenfreund, Higgins, Stein Struck, R. F. See Hill, Shih,and Struck, 2528 Soderlund, E. See Dybing, Sodonlund,Haug, and glass, and Bendich, 800 Stumpf, R., Margison,G. P., Montesano,R., and Thorgiersson, 3268 Stemmermann,G. N. See Mower,Ray, Shaft, Pegg, A. E. Formation and Loss of Abkybated Satin, M. See Aral, Spencer, Sohn, and Wallace, Slemmermann, Namurs, Gbober, Kamiyams, Purines from DNAof Hamster Liver after Admin 6 Shimsds, and Ysmsksws, 328 islration of Dimothylnitrosamine, 50 Soiefer, A. I. See San, Laspia, Soiefer, Maslan Stern,M. P.SeeGaskibi,McGuine,Osborne,and St. Vincent,L. SeeHubermsn,Montesano,Dm0- sky. Rice, and Williams, 1026 Stern, 3628 von, kuroki, St. Vincent, Pugh, and Goldfanb, Solid, J. E. See Leong, Sokal. Gomez, and Ho Stern, R. See Broitkreutz, do Loon, Paglis, Gay, 269 roszewicz, 2704 Swarm, and Stern, 5093 Sudhakar, S., Tew, K. D., Schein, P. S., Woolley, Sonoda, T. See Matsuda, Osefuno, Nakano, Ko Sternad, M. L. See Kavach, Ames, Stemnad,and P. V., and Smuison,M. E. Nitnosoureainter

DECEMBER1979 521 1 Author Index to Volume 39

action with Chromatin and Effect on and McCoy, J. L. CellularImmunityto Tumor Tatsumi, K., Tashima, M., Shirakawa, S., Naka Poby(AdenosineDiphosphste Ribaso) Polymer associated Antigens of Transplantable Mam mura, T., and Uchino,H. Enhancementby Caf ase Activity, 1411 mary Tumors of C3H/HeN Mice, 35 feineof NoocsnzinastatinCytatoxicityin Munine Sudhakar, S., Tew, K. D., and Smulson, M. E. Taguchi,T. See Fujits,Takami,Usugano,Nampei, Leukemia Li 210 Cells, 1623 Effect of 1-Methyl-i -nitrosourea on Poby and Taguchi,81 1 Tax, A., and Manson, L. A. ImmunologicalAnal (Adenosine Diphosphate-Ribose) Polymerase Taguchi, Y. See Himohashi,Shimasato, Kameys, ysis of A Strain Mice Bearing the A-i 0 Mammary Activity at the Nucloasomai Level, 1405 Koide, Mukojims, Taguchi, and Kegeysms, Adonocarcinoms, 1739 Sugimura, T. See kakizoe, Kawachi, and Sugi 1819 Taylor, A. M. R., Rosney, C. M., and Campbell, mura, 3353; Matsushima, Matsumoto, Shinsi, Takahashi, G., Kinoshita,K., Hashimoto,K., and J. B. UnusualSensitivityof AlexisTelengiecta Sawamura, and Sugimurs, 3780; Nakayssu, Yasuhira, K. Identificationof Benzo(a)pynene sis Cells to Bbeamycin,1046 Shaji, Aoki, Sato, Miwa, and Sugimura, 4668 Metabobites by Gas Chromatograph-Mass Taylor-Papadimitniou,J. See Fenlimsn, Hurst, Sugino, V. See Tsuksmota and Sugino, 1305 Spectrometer, 1814 Ceniani,and Taybor-Pspsdimilniau,4740 Suglyama, K., Hozumi, M., and Okabe, J. Induc Takahashi,I., Ohnuma,T., and Holland,J. F. A Tedde, A., Balls, M. E., Schonberg, R., and lion of Differentiation of Rauscher Virus-induced Comparison of the Biological Effects of Dichbo Trotta, P. P. Effects of 2'-Deoxycoformycin In Mouse Myeloid Leukemia Cells with a Factor(s) mamethatrexale and Melhotrexsle on Human fusionon MouseAdenosineDesminase,3044 in Ascitic Fluid and Inhibitors of Nucleic Acid Leukemic Cells in Culture, 1264 Tempete, C. See Enauf, Lawrence, Tempote, and Protein Syntheses, 1056 Takahashi, T. See Ona, Ohashi,Ysmamoto,Mat Rabert-Gero, and Ledener,4497 Suh, M. See Kessaus,Bibor-Hardy,Suh, and Si sukage, Tskahsshi, Saneyoshi, and Ueda, 4673 Tenczynski, T. F. See Barlogie,Corny,Yip, Lipp mand,3225 Takaku, F. See Horikoshi, Sasaki, Mizoguchi, man,Johnston,khsbil,Tenczynski,Reilly,Law Suit, H. D. See Ovengasrdand Suit, 3248; Unano, Miura, Takaku, and Amaki, 1841 son, Dosik, Rigor, Hankenson, and Freinoich, Suit, Dunn, Lansdsbe,and Sedlacek, 3454 Takaml, H., and Busch, H. Two-Dimensional Gel 1481 Suit, H. D., and Gerweck, L. E. Potential far Ebectraphoretic Comparison of Proteins of Nu Terada, M. See Isohashi, Tsuksnaka, Tonads, Hyporthermia and Radiation Therapy, 2290'' clean Fractions of Normal Liver and Novikoff Nsksnishi, Fukushims, and Sakamolo, 5132 Suk, W. A. See Long, Bruszewski,Christensen, Hepatoma, 507 Terasaki, T., and Mlyamoto, K. Correlation of the and Suk, 2995 Takami, H., Busch, F. N., Morris, H. P., and Ebeclrapharotic Mobility and Oxygen Uptake of Sukumaran, K. B. See Slaga, Gleason, Di Busch, H. Comparison of Salt-extractable Nu EhniichAscites Tumor Cells, 250 Giovanni, Sukumanan,and Harvey, 1934 clear Proteins of Regenerating Liver, Fetal Liven, Terasima, T. See Naksjims, Miyamoto,Tansbe, Sullivan, C. See Woo, Penini, Sadow, Sullivan, and Morris Hopatomas9618A and 3924A, page Watanabo, and Temasima,3763; Okabe, Suzuki, and Funkhousor, 2429 2096 Ohsswa, Kasaks, and Terasims, 4189 Sumi, V., and Miyakawa, M. Gastrointestinal Car Takami, M. See Fujils,Tskami,Usugane,Nampoi, Terzaghl, M., and Nettesheim, P. DynamiÃ sof dinogenesis in Germ-free Rats Given N-Methyl and Taguchi, 81 1 Nooplastic Development in Carcinogen-ox N'-nilno-N-nitrosogusnidine in Drinking Water, Takamizawa, H. See Sekiys,Endoh,Kikuchi,Ks posed Tracheal Mucosa, 4003 2733 toh, Matsuurs, Iwasaws, Takeds, and Takami Testa, J. R. See Csnnsno,Maysbb,Tests, Ash Sunderman, F. W., Jr. See Costs, Nyo, Sunder zaws, 1108 worth, and Rowley, 2984 man, Abipass,and Gondos, 3591 Takata, R. H. See Mstsumolo,Takata, and Ko Testa, J. R., Mlntz, U., Rowley, J. D., Vardiman, Bess, R. See Kinzeb,Kneibich,Hecker, and SÃ¼ss, meiji, 3070 J. W., and Golomb,H. M. Evolutionof Kanyo 2743 Takayanagi, G. See Sakakibams,Kswauchi,Tak typos in Acute Nonlymphocytic Leukemia, 3619 Sutherland,C. M. See Leong,Cooperbsnd,Deck ayanagi, and Ise, 1347 Tew, K. D. See Pinsky,Tow, Smulson,and Wool ens, Sutherland, Cesane, and Krementz, 2125 Takeda, B. See Sekiys, Endoh, Kikuchi, Kstoh, by, 923; Sudhakan,Tow, Schoin, Woolbey,and Sutton, C. H. See Hank and Sutton, 5010 Mstsuura, Iwasaws, Takeda, and Takamizawa, Smubson,141 1; Sudhaker, Tow, and Smulson, Suzuki, A. See Oksbe, Suzuki,Ohssws,Kosaks, 1108 1405 and Terasima, 4189 Takeichi, N. See Boone, Vembu, White, Tskeichi, Thakker, D. R. See Levin,Buening,Wood,Cheng, Suzuki, H., Nishimura, T., and Tanaka, N. DNA and Psnanjpo, 2172; Oikswa, Gotohds, Austin, Thakken,Jenins, and Conney, 3549 Strand Scission in Viva and in Vitro by Auno Tskeichi, and Boone, 3519 Thaber,M. M. See Pickartand Thaben,3845 momycin, 2787 Takeichi, N., Suzuki, K., and Kobayashi, H. A Thelss, J. C., Shimkin, M. B., and Poirier, L A. Suzuki, K. See Takeichi,Suzuki,and Kobsyashi, Thymus Cell Marker in MunineLeukemia Virus Induction of Pulmonary Adenomas in Strain A 3749 induced Lymphamas of Rats, 3749 Mice by Substituted Organohabides,391 Svoboda, D. J., and Azarnoff, D. L. Tumors in Takenaga, K. See Hozumi,Umezswa,Takenaga, Thilly, W. G. See ksden, Hitos,and Thilly,4152 Male Rats Fed Ethyl Chborophenoxyisobutyrste, Ohno, Shikits, and Ysmane, 5127 Thlssen, M. R. See King, Treub, Lortz, and This a HypobipidemicDrug, 3419 Takeuchi, T. See Tokumilsu,Tokumilsu,Kohnoo, son, 3369 Swarm, R. L. See Breitkreutz,de Loon, Paglis, and Tskouchi, 4733 Thomas, H. J. See Bennett,Smithens,Rose, Ad Gay, Swarm, and Stern, 5093 Talalay, P. See Benson, Chs, Bueding, Home, smson, and Thomas, 4868 Swantzendruber, D. E. See Moses, Wells, Swartz and Tabalay,2971 Thomas, P. E. See Wood, Cheng, Lovin, Ryan, endruber, and Getz, 4516 Talley, D. J. See Lin,Talley, and Villee,2614 Thomas, Mah, Kanbe,Yagi, Jemina,and Conney, Swenberg, J. A. See McGovnen, Neil, Donbingen, Tamaoki, T. See Peters, Nishi, Miura, Lonschei 4069 Hall, Cmsmptan,and Swenberg, 4849 der, Dixon, and Tamsoki, 3702 Thompson, C. Z. See McMshon, Clino, end Swenberg, J. A., Cooper, H. K., BUcheler, J., Tamura, V. See Niinabe,Tamurs,Amims,andFujii, Thompson, 682 and Kbeihues, P. 1,2-Dimethybhydmazine-in 4212 Thompson, E. B. See Albegra,Lippmsn, Thomp duced Methybationof DNA Bases in Various Rat Tan, M. H. See Leveson, Howell, Psolini, Tan, son, Simon, Bsnlack, Green, Huff, Do, and Alt Organs and the Effect of Pretreatment with Di Hobyoke,and Goldrosen, 582' ken, 1447; Ailegrs, Lippman, Thompson, Si sulfiram, 465 Tan, T. H. See Case,Tan, and Selnor, 1563 man, Barbock,Green, Huff, Do, Ailken, end War Swenerton, K. D., Legha, S. S., Smith, T., Hor Tanabe, M. See Nakajims, Miyamoto, Tanabe, men,1973; Schmidt and Thompson, 376 tobagyi, G. N., Gehan, E. A., Yap, H-V., Gut Watanabe, and Tenasima,3763 Thompson, H. J. See Becci, Thompson, Grubbs, terman, J. U., and Blumenscheln,G. R. Prog Tanaka, N. See Suzuki, Nishimurs,and Tanaka, Brawn, and Moon, 3i4i ; Moon, Thompson, noslic Factors in Motastatic Breast Cancer 2787 Becci, Gmubbs,Gander, Newton, Smith, Phillips, Treated with Combination Chemotherapy, 1552 Tanzer, L. R. See Beck, Mueller, and Tsnzer, Henderson, Mullen, Brown, and Spomn,i 339 Swern, D. See Chang, Hsnmington,Rolhstein, 2070 Thompson, H. J., Becci, P. J., Brown, C. C., and Shergabis,Sworn, and Vohrs, 3871 Tarnowski, G. S. See Fasnes,Monluzzi,Williams, Moon, R. C. Effect of the Duration of Rotinyl Swistel,A. J. See Ramoy,Hashim,Burrows,Swis Tsnnowski, and Ralph, 4564 Acetate Feeding on Inhibition of i -Methyl-i -ni tel, Munther, and Fitzpatrick, 4796 Tarnowski, G. S., Ralph, P., and Stock, C. C. trosoumos-inducedMammary Carcinogenesis in Symann, M. See Huybnechts, Symsnn, and Sensitivity to Chemothorapeulic and Immuno the Rat, 3977 Trauot, 3738 modulating Agents of Two Mouse Lymphomas Thompson, J. C. See Lisa, kwong, Thompson, Szekerczes, J. See Gillette,Szekerczes,Wunder and of a MacnophageTumor, 3964 and Dent, 183 lich, and Gillette, 751 Tarone, G. See Comoglio,Pani,Prat,Tenono,and Thompson, S. C. See Nadel, Thompson, Fischer, Szymkowiak, R. See Rabes and Szymkowisk, Monti-Bragadmn,4745 end Klein, 2221 1298 Tarone, R. E. See Parshad, Sanford, Tanone, Thomson, D. M. P. Demonstration of Tube Lou Jones, and Beeck, 929 kocyte Adherence Inhibition Assay with Coded Tashima, M. See Tslsumi, Tashims, Shimskswa, Samples of Blood, 627' T Nakamura, and Uchino, i 623 Thomson, D. M. P., and Grosser, N. Immunolog Tataryn, D. N. See Thomson, Tataryn, Lopez, cabMechanisms of Tube Leukocyte Adherence Tagashlra, V. See Kawajiri,Yonokaws,Hams,and Schwartz, and MacFarlane, 638' ; Thomson, Inhibition, 576' Tagashina, 1089 Tataryn, O'Connor, Rsuch, Fniedlanden,Gold, Thomson, D. M. P., Tataryn, D. N., Lopez, M., Tagliabue, A., Herberman, R. B., Arthur, L. 0., and Shuster, 604' Schwartz, R., and MacFarlane, J. K. Human

5212 CANCER RESEARCH VOL. 39 Author Index to Volume 39

Tumor-specific Immunity Assayed by a Compul Townsend, L. B. See Wolning and Townsend, and Chromosomab Aberrations Induced by a enlzed Tube Leukocyto Adherence Inhibition, 3018 Direct DNAPerturbation of Synchronized Syrian 638' Traganos, F. See Coblste,Darzynkiewicz, Trags Hamster Embryo Cells, 2356 Thomson, D. M. P., Tataryn, D. N., O'Connor, R., nos, Shanpiess,Whitmore, and Mebamed,2120; Tucker, H. A. See Websch,McManus, DeHoog, Rauch, J., Frledlander, P., Gold, P., and Shus Evonson, Darzynkiewicz, Staisno-Coico, Tna Goodman, and Tucker, 2046 ter, J. Evidencefor the Expressionof Human ganos, and Mebsmed,2574 Turc, C. See Koboni,Martin, Martin, and Turd, Tumor-specific Antigens Associated with $2-Mi Traub, N. R. See king, Traub, Lortz, and Thissen, 5141 croglobulln In Human Cancer and in Some Co 3369 Turksoy, R. N. See Lin, Inglis, Rule, Turksoy, Ion Adenomasand Benign Breast Lesions, 604' Trent, J. M. See Buick, Stanisic, Fry, Salmon, Chapman, Kirby, and Stolbach, 4894 Thorgeirsson, S. S. See Dybing, Sodenlund, Trent, and Knasovich, 5051 Tuyns, A. J. Epidemiologyof Alcoholand Cancer, Haug, and Thorgeirsson,3268; Dybing, von Trivedi, S. M. See Frondaza, Trivodi, and Hum 2840' Bohr, Aune, Gbaumenn,Levitt, and Thorgomns phrey, 2497 Twardzlk, D. R. See Heibman,Weisbow,Twamdzik, son, 4206; Mattison end Thongeirsson, 3471 Trotta, P. P. See Tedde, Balis, Schanbeng, and and Fowler,2902''' Thereby, J. I. See Black, Henderson, Kbeinhans, Trolls,3044 Phelps,and Thomnby,5022 Trouet, A. See Huybnechls, Symsnn, and Trouet, U Thorndike, J., Pelliniemi, T-T., and Beck, W. S. 3738 Serine HydroxymothybtmansferaseActivity and Trump, B. F. See Autrup, Essigmann, Cray. Uchida, N. See Kitamura, Okamoto, Hsysts, Uch Serine Incorporation in Leukocytes, 3435 Trump, Wogan, and Harris, 694; Harris, Autmup, ida, Yamaguchi, and Malsumoto, 47i3 Thorpe, W., Loeb, W., Hyatt, C., and Rosenberg, Stoner, Trump, Hiblman,Schafer, and Jeffrey, Uchino, H. See Tatsumi, Tashims, Shirakawa, S. A. AlkalinePhosphataseMeasurementsof 4401 Nsksmurs, and Uchina, 1623 Paired Normal and Osteosancoma Tissue Cul Tsal, T-L S., Rutledge, S., and Kaizenellenbo Ueda, H. See Yssumoto, Manabe, Ysnagaws, Na lureUnesObtainedfromtheSamePatient,277, gen, B. S. AntiostnogenModulation of the gano, Uods, Hirots, Ohts, Namolo, Azums, and Communication Growth and Biochemistry of Ovarian-Autono Ysmsmura, 3262 Tics, A. J. See Irving, Tice, end Murphy, 3040 mous and Ovarian-Dependent Mammary Tu Ueda, T. See Ono, Ohashi, Ysmamoto, Matsu Tilzer, S. A. See Wood, Tilzon, Goilahon, and momsin Rats, 5043 kage, Takahashi, Ssneyoshi, and Ueds, 4673 Lindsay.4588 Tsao, D., Freeman, H. J., and Kim, V. S. fl-Hex Uitto, J. See Bsuem,Uitlo, Walters, and Eisen, Tines, S. See Pour, Wellcave, Gingeli, Nageb, osaminidase lsoenzymes in Tissues, Cultured 4594 Lawson, Sabmasi,and Tines, 3828 Cells, and Media from Human Fetal Intestine Umbreit,J. N., and Erbe, R. W. TransferofTumor TjÃ¤lve,H. See Oskamsson,Andenssan,and TjÃ¤lve, and Colonic Adenocancinoms, 3405 Cells between Cell Aggregates as a Model far 4175 Tseng, S-S. See Van Duunon, Tsong, Segab, Adhesive Changes in Metastasis, 2001 Tobe, T. See Pfelffen,Nagai, Fujimurs, and Tobe, Smith, Mebchionne,and Seidman, 2644 Umezawa, T. See Hozumi,Umezawa,Takensga, 1904 Tsiftsoglou, A. S. See Fandy, Tsiftsogbau. Ja Ohno, Shikila, and Ysmane, 5127 Tobloka, N. See Nagsi, Ketsoks, Kobsyashi, Is coby, and Sartorelbi,3583 Unsgaard, B. See O'Toole and Unsgssnd, 840 hihara, Tobloka, Nekeshima, Nsnuse,Seita, and Tsiftsoglou, A. S., Gusella, J. F., Volloch, V., and Urano, M., Suit, H. D., Dunn, P., Lansdale, T., Sakuma, 1835 Housman, D. E. Inhibitionby Dexamethasone and Sedlacek, R. S. Enhancementof the Them Todd, H. D. See Parsons, Todd, and Kowab,4341 of Commitment to ErythmoidDifferentiation in mel Response of Animal Tumors by Corynebac Todd, R. B. See Brown, Warren, Chute, Ryan, and MunineEnythroboukemisCells, 3849 terium parvum, 3454 Todd, 3971 Tsittsoglou, A. S., and Sartorelli, A. C. Dimethyb Uren, J. R., and Ragin, R. C. improvementin the TOkUmItSU, K. See Tokumitsu, Tokumitsu, Sulfoxide-inducod Differentiation of Friend Therspeulic, Immunological, snd Clearance Kohnoe, and Takeuchi, 4733 ErylhmoleukemiaCells in the Absence of Cyto Properties of Escherichia coli and Erwinia car TOIWmItsU,S-i., Tokumftsu, K., Kohnoe, K., and kinesis, 4058 otovora L-Aspsrsginsses by Attachment of Paby Takeuchi, T. Characterization of Liver-typo Al Ts'o, P. 0. P. See Barrett, Crawford, Mixter, DL-absnylPeptides, 1927 kalinePhosphatasefromHumanGastricCarci Schechtman, Ts'o, and Poliack, 1504; Halben Usugane, M. See Fujits,Takami, Usugsne,Nam noma Cells (KMK-2) in Vitro, 4733 berg, Barrett, Ts'o, and Berhanu, 4166; Loren pei, and Taguchi, 81 i Tokuno, S-i. See Hall and Tokuno, 4064 tzen, Losko, McDonald, and Ts'a, 3194; Tsut Toledo, 0. M. S. See MourÃ£o,Michelacci, and sui, Barrett, and Ts'a, 2356 Toledo,2802 Tsuchida, S., Hoshino,K., Sato, T., Ito, N., and V Tomaszewskl, J. E. See Dippbe, Tomsszowski, Sato,K. Purificationof â€˜y-Gbutsmybtnsnsferasos Moscheb,Bigger, Nobzydoski, and Egan, 1154; from Rat Hepstomas and Hyperplaslic Hepatic Vaage, J., and Agarwal, S. EndogenousTumor lype, Tomaszewski,and Dipple,4925 Nodules, and Comparison with the Enzymefrom Growth Factor Indicated by Increased Omnithine Tomida, M. See Yamamoto, Tomida, and Hozumi, Rat Kidney, 4200 Decsnbaxybase Activity in Malignant Cells 4170 Tsuda, H., Sarma, D. S. R., Rajalakshmi, S., Treated with Host Serum onAsciles Fluid, 151 1 Tomihara, V. See Kido, Tomihams, Walanabe, Zubroff, J., Farber, E., Batzinger, R. P., Cha, Vaage, J., and Costanza, M. E. The Effects of Ohsawa,and Katunuma,3258 V-N., and Bueding, E. Induction of Hepstic Neo Combination Drug Therapy on the Subcula Tomita, K., and Plager, J. E. In Viva Cell Cycle plastic Lesions in Mice with a Single Dose of neous and Pulmonary Growth of a Slow and a Synchronization of the Munine S-i 80 Tumor Hycanthono Methanesulfanste after Partial Fast Growing C3H/He Mammary Carcinoma, following Alternating Periods of Hydnoxyures Hopsloclomy, 4491 4466 Blockade and Release, 4407 Tsuda, M., Katunuma, N., Morris, H. P., and Valerlote, F., Medoff, G., and Dleckman, J. Po Tampa, A. See Langenbach, Malick, Tomps, Ku Weber, G. Purification, Properties, and Immu tentiation of Anticancer Agent Cylotoxicity szynskl, Freed, end Hubemman,3509 natitnation of Hepstoms Glutsmine Phosphori against Sensitive and Resistant AKR Leukemia Tompkins, M. B., Rao, G. V. R., and Tompkins, bosylpyrophasphate Amidotransferase (Amido by Ampholericin B, 2041 W. A. F. Increased Tumomigenicityand Resist phosphonibosybtransferase,EC 2.4.2. 14), 305 Van Beveren, C., and Goulian, M. Detectionof anco to Antibody Lysis of Human Colon Tumor Tsuikl, S. See Miysgi and Tsuiki, 2779; 2783 Sequences in Human Leukemic Cell DNA Ho CellsXenograftedinCongenitallyAthymicMice, Tsukada, H., Gotoh, M., Mochizuki, V., and Fu mobogouswith Maloney Mouse Leukemia Viral 2160 rukawa, K. Changes in Peroxisomes in Proneo RNA, 2532 Tompkins, W. A. F. See Tompkins, Rao, and plastic Liver and Hopatoma of Mice Induced by Vandenbark, A. A. See Malley, Burger,Vanden Tompkins, 2160 a-Benzone Hexachionide, 1628 bark, Fnikke, Finke, Begbey,Acatl, Black, and Tonelll, 0. J., Custer, R. P., and Sorof, S. Trans Tsukagoshi,S. See Tsuruo,lids,Tsuksgoshi,and Volta, 619; Tang, Burger, Finke, Barney, Van formation of Cultured Mouse Mammary Glands Sakumsi,1063 denbank, and Vetlo, 597' by AromaticAminesand Amidesand Their Do Tsukamoto,K.,andSugino,V.TumorAngiogen van de Poll, K. W. See Schsmhart,van de Pall, rivatives, 1784 osis Activity in Cbansl Cells Transformed by and van Wijk, 1051 Tong, A. W., Burger, D. R., Finks, P., Barney, C., Bovine AdenovinusType 3, page 1305 van der Vlist, M. J. M. See van Veelen, Venbiest, Vandenbark, A. A., and Vetto, R. M. Assess Tsukanaka, K. See Isohashi,Tsukansks,Terada, ZÃ¼lch,van Ketel, van dor Vlist, VIug, Rijksen, ment of the Mechanism of the Leukocyte Ad Nsksnishi, Fukushims, and Sakamoto, 5132 and SIsal, 4263 herence Inhibition Test, 597' Tsukeda, H. See Roper, Dnewinka,Tuskeds, Mi Vandevoorde, J. P. See Williams, Bransan, Myl, Topping, D. C., Griesemer, R. A., and Nettesh zuno, end Nuts, 1428 Vandevoonde,and Elliott, 2447 elm, P. Developmentand Fate of Focal Epithebisb Tsuruo,T., ilda, H., Tsukagoshi,S., and Sakural, VandrÃ©,D. D., Shepherd,V. L., and Montgomery, LesionsinTrachealMucosafollowingExposure Y. Comparisonof CytotoxicEffectandCellular R. Effectsof Macnomomycinon the Ultrastruc to 7, 12-Dlmethylbonz(a)anthrsceno, 4829; Uptake of 1-fl-o-Arsbinafunsnosylcytasine and tuneand Biological Properties of Cultured Mam Quantitative Assessment of Generalized Epithe Its N4-AcybDerivatives,Using Cultured KB Cells, mabianCells, 4091 hal Changes in Tracheal Mucosa following Ex i 063 Van Duuren,B. L., Tseng, S-S., Segal, A., Smith, posure to 7, 12-Dimothybbonz(a)enthraceno, Tsutsui, T., Barrett, J. C., and Ts'o, P. 0. P. A. C., Melchionne,S.,andSeidman,I. Effects 4823 Morphological Transformation, DNA Damage, of StructuralChangeson theTumor-promoting

DECEMBER1979 5213 Author Index to Volume 39

Activity of Phorbol Mynistate Acetate on Mouse 619 â€˜; Tong, Burger, Finke, Barney, Vanden ubeInduction in Vitro, 744 Skin,2644 bark, and Volta, 597' Warren, R. See Abbogra,Lippmsn,Thompson,Si Van Echo, D. A., Chiuten, D. F., Gormley, P. E., Vigneri, R. See Pezzino, Vignemi,Sipenstein, and man, Barbock,Green, Huff, Do, Ailkon, and Wan Lichtenfeld, J. L., Scobtock,M., and Wiernik, Galdfine, 1443 ron, 1973 P. H. PhaseI Clinical and Pharmacological VilIa-TreviÃ±o,S. See Mendoza-Figuenos, Lopez Warren, S. See Brown, Warren, Chute, Ryan and Study of 4'-(9-Acnidinylsmina)mothanosulfon Revilla, and Villa-TreviÃ±o,3254 Todd, 3971 m-anisidide Using an Intermittent Biweekly Vllbee,C. A. See Lin, Tsbley,end Vilbee,2614 Washtien, W. L., and Santi, D. V. Assayof Intra Schedule, 3881 Viug, A. M. C. See van Veelen, Verbiest,ZUIch, cellular Free and Mecromolecuism-bound Me van Ketel, B. A. See van Veelen,Verbiest,ZUIch, van Keteb,vandenVlist, VIug, Rijksen, and Steel, tebolitos of 5-Fluorodeoxyunidino end 5-Fluo van ketel, van denVbist,VIug, Rijksen, and Stsal, 4263 rourecib,3397 4263 Vogel, F. S. See Burger, Kemper, and Vogel. Watanabe, I. See Kida, Tomihsra, Walsnabo, van Rossum,G. D. V. See GosÃ¡bvez,vanRossum, 1494 Ohsawa, and Kalunums, 3258 and Blanco, 257 Vogel, F. S., Kemper, L. A. K., Boekelheide, K., Watanabe, I. See Nekajims, Miyamoto,Tenabe, van't Rid, B. See Elford,Wampber,andvent Riot, Graham, D. G., and Jeffs, P. W. Intracellular Watenabo, end Tonasima,3763 844 Activation of â€˜y-i-Glutsminyl-4-hydroxybenzene Watanabe, K. See Baumsnn,Nudelmsn,Watan van Veelen, C. W. M., Verbiest, H., ZUIch, K. J., by Tynosinase, a Mechanism for Selective Cy abe, end Hakomoni,2637 van Ketel, B. A., van der Vllst, M. J. M., VIug, lotaxicity against Melanocancinoma, 1490 Watanabe, K. See Roddyand Watenabe, 1521 A. M. C., Rijksen,G., and Staal,G. E. J. L-a Vogler, W. R. See Rudman, Chawla, Nixon, Vog Watanabe, K. A. See Chou, Burchenab,Fox, We Alanine Inhibition of PymuvatoKinase from Tu Ion,Keller, end MacDanell, 699 tanabe, Chu, and Philips, 720 momsof the Human Central Nervous System, Vohra, S. K. See Chang, Hsrrington,Rathstein, Watanabe, S. See Mstsuda, Osafune, Nakano, 4263 Shergalis, Sworn, and Vohma,3871 kotako, Sonoda, Wetenabe, Heda, Okochi, Hi van Wijk, R. See Schamhsrt,vando Poll,and van Volboch,V. See Tsiftsogbou,Guselba,Vobloch,and gashino, Ysmamuns, and Abe, 4694; Okochi, Wijk, 1051 Housmsn, 3849 Seiko, Higashino, Hads, Watanabe, Yemamurs, Varani, J., 0mm,W., and Ward, P. A. Hydrolytic von Bohr, C. See Dybing,von Bshr, Aune, GIsu Ito, Matsuds, Osafune, Kolake, end Sonods, Enzyme Activities, Migratory Activity, and in mann, Levitt, and Thorgoirsson, 4206 1829 Viva Growth and Metastatic Potential of Recent VonEschen,K. B. See Ribi,Cantrell,VonEschen, Watanabe, T. See Ssitoand Watenabe,5114 Tumor Isolates, 2376 and Schwsmtzman,4757 Waterhouse, C., Jeanpretre, N., and Kellson, J. Vardiman, J. W. See Tests, Mintz, Rowley,Var Vose, C. W. See Coombs, Kissonerghis, Allen, Glucaneogonosis from Alanine in Patients with diman, and Gobomb,3619 and Vase, 4160 Progressive Malignant Disease, 1968 Varesio, L., Giovareill, M., Landolfo, S., and Waters, R. See Brown, Fickol, Cleaver, Lohman, Forni,G. Suppressionof ProliferativeResponse w Wade, and Waters, 2522 and Lymphokine Production during the Progres Watson, C. S., Medina, D., and Clark, J. H. sianof a SpontaneousTumor,4983 Waalkes, T. P. See Gehrke, kuo, Wealkes, and Characterization and Estrogen Stimulation of Variakojis, D. See Cimina, Rowley, Kinnealey, Borek, 1150 Cytoplesmic Progesterone Receptor in the Vsniskojis, and Gobomb,227; Fukuhars, Row Wade, M. H. See Brown,Fickeb,Cleaver,Lahmsn, Ovarian-dependent MXT-3590 Mammary Tu ley, Vaniakojis,and Golomb. 3119 Wade, and Waters, 2522 mar Line, 4098 Varnes, M. E., and Biagbow,J. E. Interactionsof Wakisaka, S. In Vitro Correlation of Drug Cancen Wattenberg, L. W., Lam, L. K. T., and Fladmoe, the Carcinogen 4-Nitroquinobine 1-oxide with tratians and Rsdiosonsilizstion in Combination A.V.InhibitionofChemicalCarcinogen-induced the Nan-Protein Thiols of Mammalian Cells, Therapy with 5-Bmomo-2'-deoxyunidine,Metho Nooplesia by Coumaninsand a-Angelicalaclone, 2960 trexste, and Radiation, 244 1651 Varshavsky-Rose, F. See Corwin, Varshavsky Waldren, C. A., and Patterson, D. Effectsof Cat Webber, M. M. See Pegg, Buffkin,and Wobbem, Rose, and Broitman, 4350 feine on Purine Metabolismand Ultraviolet 143i Vaught, J. B. See Freedman,Gurtoo,Minowads, Light-induced Lethality in Cultured Mammalian Weber, G. See Olah and Wobor, 1708; Pnajds, Paigen, and Vaught, 4605 Cells, 4975 Morris, and Weber, 3909; Tsuds, Ketunuma, Vaught, J. B., Gurtoo, H. L., Parker, N. B., La Walker, A. R. P. See Hill,Wyndor,Ganbsczewski, Morris, and Webor, 305 Boeuf, R., and Doctor, G. Effects of Smoking Games, and Walker, 5101 Weber, M. J. See Roll, Weber, and Conrad, 2550 on Benzo(a)pyrene Metabolism by Human PIe Walker, P. C. See Buchsbsum,Walker,andJohn Wei, L. See Stich, Wei, and Whiting, 4145 confabMicrosomos, 3177 son, 3363 Weichseibaum, R. R. See Selsky, Henson, Wel VÃ¡zquez-Nln,G. H., Echeverria, 0. M., and Ped Wallace, H. W. See Arsi, Spencer, Sohn, and chsebbaum,and Little, 3392 ron, J. Ultrastruclunaband Autoradiographic Wallace, 6; Amaiand Wallace, 3638 Weigert, J. See Newbenne, Weigert, and Kula, Study of the Effects of Bbeomycinon the Inter Wallace, R. E., Murdock, K. C., Angler, R. B., 3986 phase Nucleus of Cultured Normal Cells, 4218 and Durr, F. E. Activity of a Novel Anthracene Weiner, J. See Ertob,Nesbil, Hammond, Weiner, Vembu, D. See Boone, Vombu,White, Tskeichi, diane, 1,4-Dihydroxy-5,8-bis({{2-((2-hydroxy and Sather, 3893 and Paranjpo, 2172 ethyl)eminojethyl} amino) ) -9, 10-anthracene Wesnhouse, S. A Report of the US-Japan Confer Venditti, J. M. See Guamino,Rozoncweig, Kline, diono Dihydrochlonide, against Experimental enco on Gene Denopression end Host-Tumor Penis, Venditti, Lloyd, Holzworth, and Muggis, Tumors in Mice, 1570 Relationships in Cercinogenosis, 3279. Meeting 2204 Walicave, L. See Pour, Wallcave, Gingell, Nagel, Report. See also Shah, Hertmsn, end Wein Verbiest, H. See van Veoben,Verbiest, ZUIch, van Lawson, Saimasi, and Tines, 3828 house, 3942; Shattan. Morris, and Weinhouse, Koteb,van don Vbist,VIug, Rijksen, and Steal, Walter, N. T. Continuing Care of the Cancer Pa 492 4263 lient as a Social Engineering Problem, 2859''' Weinstein, I. B. See Brown, Jeffrey, and Woin Verbruggen, L. See Sslomon, Paglis, and Ver Walters, R. C. See Bsuor, Uitto, Walters, and stein, 1673; Fisher, Goldstein, and Weinstein, bruggen, 4387 Elsen, 4594 3051 ; Mufson, Fisher, and Weinstein, 3915; Verma, A. K. See Mufson,Fischer,Venma,Glee Wampler, G. L. See Carter, Sleblein,and Wemp Mufson, Kubkenni,Eskins, and Weinstein, 3602; son, Slsga, end Boutwell, 4791 Ion,3446; Elfond,Wamplen,and vent Riot, 844 Ysmasaki, Weinstein, Fibach, Rifkind, and Verma, A. K., Lowe, N. J., and Boutwell, R. K. Wan, C-W., and Mak, T. W. Effect of Tetnahy Marks, 1989 Induction of Mouse EpidommabOmnithinoDecar drauridine on the Action of 1-fl-o-Anabinofuns Weinstein, W. M. See Paterson,Jakobs,Lauzon, boxylase Activity and DNA Synthesis by Ultra nosylcytosmneIn Synchronized Cultures of Nor and Weinstein, 2216 violet Light, 1035 mel Rat kidney Cells, 3981 Weinstein, V. See Yorushebmiand Weinstein, Verma, A. K., Shapas, B. G., Rice, H. M., and Wang, B. S., Steele, G., Jr., Mannick, J. A., 1126 Boutwell, R. K. Correlation of the Inhibition by Fallon,M., and Onikul, S. R. In VivaEffectsand Weisbow,0. 5. See Hellman, Woisbow,Twardzik, Retinoids of Tumor Promoter-induced Mouse Parallel in Vitro Cytotoxicity of Splenocytos Her and Fowlem,2902 â€˜â€˜â€˜ Epidermal OmnithineDecarbaxybaseActivity and vested from Treated or Control C57BL/6J Mice Weiss, J. F., Morantz, R. A., Bradley, W. P., and of SkinTumorPromotion,419 after Adjuvant Immunotherapy of Pulmonary Chretlen, P. B. Serum Acute-Phase Proteins Verma, D. S. See Spitzer,Venma,Banlogie,Boran, Metsstsses Using Xenogonoic RNA Specific to and Immunoglobubinsin Patients with Gliomes, and Dicke, 3215 Bi 6 Murino Melanoma, 1702 542, Communication Verney, E. See Sidrsnskyand Vornoy,1995 Wang, T-c. V., and Cerutti, P. A. Formationend Weiss, K. See Hill, Hill, Miller, Pfslbor,Weiss, and Vesely, J. See Mompsnler,Veseby,Mamparbor, Removal of Aflatoxin B-induced DNA Lesions Galin, 934 and Rivard, 3822 in Epitholioid Human Lung Cells, 5165 Weiss, L., and Harlos, J. P. Differences in the Vesselinovltch,S. D., Rao, K. V. N., and Mihal Wang, T-T. See Kakizoe, Wang. Eng, Funrer, Peripheries of Walker Cancer Cells Growing in bovich,N. Trsnspbsconlsland LactslianalCam Dion, and Bruce, 829 DiffomonlSilos in the Rat, 2481 cinogenesis by Safrole, 4378 Ward, P. A. See Vsnani,Omr,end Wend,2376 Weiss, M. H. See Sheikh, Apuzzo, and Weiss, Vetto, R. M. See Malbey, Burger, Vsndonbark, Wamer, M. R. Effects of PeminslalTestosterone 1733 Frikke, Finke, Bogbey,Adolf, Black, end Volta, on Mouse Mammary Duct Morphology and Lob Weiss, R. B., and Muggla, F. M. WorkingConfer

5214 CANCER RESEARCH VOL. 39 Author Index to Volume 39

once on MesotheliomaTreatmentTrials, 3799, Williams,N. J. See Holland,Gossbee,and Wil Woodward, M. See Rudolph, Woodward, and Meeting Report hams, 1718 Hum, 3689 Welch, A. D. See Ahmed and Welch, 3102 Williams, R. 0., Bronson, 0. L., Myl, A. D., Van Woolley, P. V., Ill See Pmnsky,Tew, Smubson,and Wells, D. J. See Moses, Wells, Swertzendnuben, devoorde, J. P., and Elliott, A. V. Carcinoem Woolbey,923; Sudhsksr, Tow, Schein, Woolbey, end Getz, 4516 bmyonic Antigen-like Substance Derived from end Smubson,1411 Wells,S. A., Jr. See Langbais,Holder,Igbohart, Human Prostate, 2447 Wooten, R. S. See Houghton, Houghton, end Nelson-Rees, Wells, and Bobognosi,2604 Wilson, C. B. See Marton, Edwards, Levin, Lu Woolen, 2406 Welsch, C. W., McManus, M. J., DeHoog, J. V., bich, end Wilson, 993 Worner, T. M. See Liober,Seitz, Genro,end War Goodman, G. 1., and Tucker, H. A. Hormone Wilson, E. J. See Bend, Wilson, Belbel,and Mas nor, 2863'â€• Induced Growth and Lactogenesis of Grafts of Imangobo,4472 Wotring, L. L., and Townsend, L. B. Studyof the Bovine Mammary Gland Maintained in the Wison, E. L., and Reich, E. Modulation of PIes Cytatoxicity and Metabolism of 4-Amino-3-car Athymlc â€œNudeâ€•Mouse, 2046 minogen Activator Synthesis in Chick Embryo boxsmido-i -(fl-o-ribofurenasyl)pyrezobo[3,4-d] Wenczak, B. A. See Huang, Wonczak, end Liu, Fibnobbaslsby Cyclic Nucbeotidesand Phorabol pyrimidinoUsingInhibitorsof AdonasinoKinase 4843 Mynislete Acetate, 1579 end Adonosine Deeminaso, 3018 Wendeischafer-Crabb, G. See Furcht, Masher, Wilson, P. S. See Bull, Soullier, Wilson, Hayden, Wrighton, S. A. See Shen, Fahi, Wrighton,and Wendelschafer-Crebb, and Foidert, 2077 end Nigra, 4956 Jefcoste, 4123 Week,M.L.SeeBerman,Rico,Wenk,andRoller, Wilson, R. See Bulsy, Palil, Wilson, end Shubik, Wrobel,C. J. See Mebenks,Rogen,Howe,Nelson, 1462 4996 Wrabel, Ahmed, and Humphreys, 4782 Wheat, B. W. See Cantroll and Wheel, 3554 Wiltrout, R. H., Frost, P., Morrison, M. K., and Wu, B. C., Spohn, W. H., and Busch, H. Two Wheeler, A. H., Dirks, J. W., Lunardi, I., and Kerbel,R.S. Immune-mediatedArrestandRe Dimensional Gel Eboclraphoresis of Cylosol Nemiroff, M. J. Effect of Hyperbaric Oxygen on vensal of Established Visceral Molasteses in Phosphaprateins of Novikoff Hepalama and Re the Cytotoxicity of Admismycin and Nitrogen Athymic Mice, 4034 gonensting Liver, 116 Mustard in Cultured Burkilt's Lymphoms Cells, Wingo, W. See Roberts. Peck Hilliard, and Wingo, Wunderlich,D. A. See Gillette,Szekenczes,Wun 370 4048 donlich, and Gillette, 751 White, B. J. See Boone, Vembu, White, Takoichi, Winkelhake,J. L., Elcombe,B. M.,andHodach, Wynder, E. L. See Hill, Wynder, Gsrbsczewski, and Paranjpe, 2172 A. ImmunologicalBlockto Synthetica-Meleno Games, and Walker, 5101; McCoy and Wyndor, Whit., E. H. See Brundrett, Colvin, White, Mckee. cyte-slimubsling Hormone: Meisnocyle Inlerac 2844''' Hartman. and Brown, 1328 lion by Antibodies Isolated from Cobb-Column White,J. C.SeeGewirtz,While,Randolph,and immunoadsorbents, 3058 Goldman,2914; Hill, Bailey,While,andGold Winkler, T. See Benvenuto,Liehr, Winkler, Far V man, 2440 quher, Caprioli, and Loo, 3199 White, W. E., Jr. See Sarnif, While, and DiVilo, Wlslocki, P. G. See Cheng, Wislocki, Kepilulnik, Yagen, B. See Schoenteb,Joffe,and Ysgen,2179 3903 Wood, Levin, Ysgi, Meh, Jenins, and Connoy, Vagi, H. See Buening,Levin,Kambe,Yagi, Jenins, Whltehsad, J. S., Feamey, F. J., and Kim, V. S. 2660 and Conney, 5063; Buening, Levin, Wood, Glycosyllransferase and Glycosidsse Activities Witorech, R. J. See Cohen, Mancure, Witorsch, Chang, Ysgi, Kanbe,Jenina,and Connoy, 1310; in Cultured Human Fetal and Colonic Adonocam and Diegebmsnn,2923 Cheng, Wisbacki,Kepilulnik, Wood, Levin, Ysgi, cinoma Cell Lines, 1259 Wittner, D. See Bases, Rubinslein,Kadish,Men Msh, Jenins, and Connoy, 2660; SIege, Whltehsad, M. I. See King, Whilehead, Campbell, dez, Wittner, Elequin, and Liebeskind, 3524 Bracken, Gleason, Levin, Yagi, Jenins,and Can and Minardi, 1094 Wogan, G. N. See Autrup, Essigmann, Cray, ney, 67; Wood, Chang, Levin, Ryan, Thomas, Whiting, R. F. See Stich, Wei, and Whiling, 4145 Trump, Wogan, and Harris, 694 Msh, Karbo,Yagi, Jerine,and Conney,4069 Whitmors, W. F., Jr. See Collste, Darzynkiewicz, Weld, W. S. M., Mackey, J. K., Rlgden, P., and Vahara, I., Iwashita, S., Ebina, T., Satake, M., Traganos, Sharploss, Whilmone,and Melsmed, Green, M. Analysis of Human Cancer DNA's for and Ishida, N. Inhibitionof Ligend-Indopendent 2120 DNA Sequences of Human Adenovirus Sero Cap Formation of Mouse Lymphocytes and Raji Whong, W-Z., and Ong, T-m. Mediated Mutsgen typos 3, 7, ii, 14, 16, and 21 in Group B, 3479 Cells by Neocsnzinostelin, 4687 esis of Dlmethylnitrosamlno in Neurospora Wolf,G.SeePbolkin,Wides,Gilbert,Wolf,Hagen, Vabovsky,M. A. See Mishkin, Morris, Yelovsky, crassa by Various Metabolic Activation Sys end Proul, 3856 and Murthy, 2371 lems, I 525 Wolf, M. H. See Edwards, Fox, Policsslno,Gaff, Vamada, M. See Yoshids,Ysmads, Masaki, and Wioha, M. S., Uotta, L. A., and Kidweli, W. R. Wolf, and Fine, 1857 Saneyoshi, 3955 Effects of Free Fatty Acids on the Growth of Wolmark, N. See Fisher, Wolmerk, end Sefter, Vamaguchi, K. See Kitemura,Okamoto,Heyste, Normal and Neoplaslic Rat Mammary Epithelisb 4772 Uchids, Yamaguchi, and Matsumolo, 4713 Cells,426 Woo, K. B., Perini, F., Sadow, J., Sullivan, C., Vamakawa, H. See Mower, Ray, Shaft, Stemmer WIChert, P. V. See RUdiger, Msrxen, Kohl, Meld and Funkhouser, W. PabysmineContent end mann, Namura, Gboben,Ksmiysms, Shimade, ens, and Wicherl, 1083 Release during the Proliferalian of Burkilt's and Yemaksws, 328 Wides, R. J. See Plolkin, Widos, Gilbert, Wolf, Lymphoma Cells in Vitro, 2429 Yamamoto,A. See Ono,Ohashi,Yememoto,Mat Hagen, and Prout, 3856 Wood, A. W. See Buening, Lovin, Wood, Chang, sukage, Takeheshi, Seneyoshi, and Uoda, 4673 Wisigus, S. See Saryan, Minkol, Dolhun, Calhoun, Yagi, Karlo, Jenina,end Conney, 1310; Cheng, Yamamoto, M. See Sasaki and Ysmamoto, 2751 Wielgus. Schaller, and Petening,2457 Wisbocki, Kapilulnik, Wood, Levin, Yagi, Mah, Yamamoto,V., Tomida, M., and Hozumi,M. Slim Wiener, J. M. See Chbebowski,Irwin, Pugh, Se Jerins, and Conney, 2660; Levin, Buening, ubelianof Differentiation of Mouse MyeboidLou doff, Hestorff,Wiener,and Batemsn,4503 Wood, Cheng, Thskker, Jerina, and Conney, kemic Cells and Induction of interferon in the Wiernik, P. H. See Eriichmen, Strong, Wiennik, 3549 Cells by Double-Stranded Polymibonucleolides, McAvoy, Cohen, Levine, Hubbard, and Oheb Wood, A. W., Chang, R. L., Levin, W., Ryan, D. 4170 ner. 3992; LevIne,Sivulich,Wiemnik,end Levy, E., Thomas,P. E., Mah, H. D., Kane, J. M., Vamamura, V. See Malsuds, Osafune, Nakano, 1645; VanEcho,Chiulen,Gonmloy,Lichtenfeld, Vagi, H., Jerina, D. M., and Conney, A. H. Kolako, Sonads, Walenabe, Heds, Okochi, Hi Scollock, and Wiemnik,3881 : Zahanko,Bollen, Mutagenidity and Tumonigenicily of Phenan geshino, Yemamure, end Abe, 4694; Ogura, Chiuten,and Wlemnik,4777 throne and Chrysene Epoxides and Dial Epox Namba, Hinso, Yamamurs, and Azuma, 4706; Wlkstrand, C. J., and Bigner, D. D. Surface An ides,4069 Okochi, Seiko, Higashina, Heds, Wstansbo, Ye tigens of Human Gliome Cells Shared with Nor Wood, G. W., Tibzer, S. A., Gollahon, K. A., and mamure, Ito, Malsuds, Osafune, Kolake, end mal Adultand Fetal Brain,3235 Lindsay, J. M. Association between Immuno Sonoda, 1829; Yesumola, Menebe, Yanagawe, Wilhelm, R. See Rebes, Konler, Wilhelm, Rode, globulin end Macrophages in Primary Methyl Nsgsna, Ueds, Hirota, Ohta, Nomoto, Azume, and Riess, 4228 cholanthrene-induced Sarcomas, 4588 end Yememurs, 3262 Wilkinson, R., Birbeck, M. S. C., and Harrap, K. Woodcock, D. M., Fox, R. M., and Cooper, I. A. Vamane, I. See Hozumi, Umezawe, Takenege, R. Enhancementof the Nuclear Reactivityof Evidence for a Now Mechanism of Cytataxicily Ohno, Shikite, and Ysmane, 5127 Alkylaling Agents by Prednisolono, 4256 of 1-$-D-Arabmnafurenosylcytosino,1418 Vamasaki, H., Weinstein, I. B., Flbach, E., Rif Williams, G. M. See San, Laspis, Soiofor, Meslan Woodhead, A. D., Sallow, R. B., and Scully, P. kind, R. A., and Marks, P. A. TumorPromoter sky, Rice, and Williams,1026; San, Shimada, M. Migration of IntreporitoneebbyInjected Thy induced Adhesion of the DS19 Clone of Murine Maslansky, Kreiser, Laspis, Rice, and Williams, raid Cells in the Amazon Molly, Poecilia for ErythrobeukemisCells, 1989 4441 moss, 2698 Vamashita, K., Aitlo, M-L.., and Dawson, J. R. Williams, L. J. See Giovanolia, Stehlin, Shepard, Woods, L. K. See Quinn, Moore, Morgan, and Characterization of the Carcinoembryonic Anti andWilliams,2236â€• Woods, 4914 gen Activity Associated with Cyst Fluids of Mu Williams, M. E. See Doen, Hoshino, Williams, Woods, L. K., Morgan, R.T., Quinn, L. A., Moore, dinaus Ovarian Cystsdenocarcinome, 1760 Nomura, and Bartbe,4336 G. E., Semple,T. U., and Sledman, K. E. Vanagawa, E. See Yssumato, Msnabe, Yana WillIams, N. See Feanes,Menluzzi,Williams,Tsr Comparison of Four New Cell Lines from Pa gewa. Nagano, Ueda, Hirota. OhIa, Nomolo, nowski,and Ralph,4564 tients with Adenocarcinoma of the Ovary, 4449 Azuma, end Ysmemura, 3262

DECEMBER1979 5215 Author Index to Volume 39

Yang, J. A., Huber, S. A., and Lucas, Z. J. Inhi Resistance to Tumor Growth of Athymic Nude Hunter, J. T., and Ribi, E. Eradicationby Im bition of DNA Synthesis in Cultured Lympho Mice Pretreated by Combined Local Hyperther munizalion with MycabactoniebVaccines end Tu cyles end Tumor Cells by Extracts of Betel Nut, mis and X-lmradiation,1126, Communication mar Cells of Microscopic Moleslsses Remaining Tobacco, and Miang Leaf. Plant Substances Yip, E. See Benbogie,Carry, Yip, Lippman, John sfterSurgeny,1597 Associated with Cancer of the Ororespiratory stan,Khelib,Tenczynski,Reilly,Lawson,Dosik, Zelick, R. See Fache,Lopeull,Zelick,endFnindol, Epithelium, 4802 Rigor, Henkenson, and Freireich, 1481 3959 Yang, S-a.See Paterson,Peren,Yang,andLynch, Vonekawa,H. See Kewsjiri,Yonekaws,Hare,and Zebler,W. J., Berger, M., and SchmÃ¤hl,D. Syn 3607 Tagashira, 1089 ergislic Action of Vincnisline end Adniamydinin Vano, K., and Isobe,M. MutagenicilyofN-Methyl Voshida,S., Yamada, M., Masaki, S., and Sane the Treatment of Experimental Rat Leukemia N'-anyl-N-nitrosauress and N-Melhyb-N'-aryl-N' yoshi, M. Utilizationof 2'-Deoxy-6-thioguano L5222, page 107i methyb-N-nitrosoureesin Relation to their Alkyl sine 5'-Triphosphale in DNA Synthesis in Vitro Zenner, B. D. See Hoslelbor,Zennor,and Morris, sling Activity, 5147 by DNA Pobymerasea from Calf Thymus, 3955 2978 Yap, H-V. See Swenerton,Legha, Smith, Horlo Young, E. A. See Harris,Hempenian,Young,and Zielke, H. R. isolationofThymidine-resislantCells bagyi, Gehan, Yap, Gutterman, and Bbumen Hughes, 3996 from a Thymidine-sensilive Acute Lymphoblas schein,1552 Young, R. C. See Ozols, Gralzinger, Fisher, tic Leukemia CobbLine, 3373 Yarkoni, E., and Rapp, H. J. Influence of Oil Myers, end Young, 3202; Ozols, Locker, Doro Zighelboim, J. Deficiency of Anlibody-dopendont Concentration on the Efficacy of Tumor Regnes show, Grotzinger, Myers, end Young, 3209 Cellular Cyloloxicily and Milogon-induced Cel sianby EmulsifiedComponentsof Mycobecte Young, S. W., Hollenberg, N. K., Kazam, E., bularCylotoxicity EffectamCell Function in Pa mis,535, Communication;Tumor Regression Berkowitz, D. M., Hainen, R., Sandor, T., and lients with Acute MyebogenausLeukemia in Re after IntrabesionabInjection of Mycobectenial Abrams, H. L. RestingHost end Tumor Penfu mission,3357 Components Emulsified in 2,6,10,15,19.23- sian as Determinantsof TumorVascularRe Zook, B. C. See Pens,Zook, end Harder, 1269 Hexamethyl-2,6,i 0, 14,18,22-tetracosahex spanses to Norepinephrino, 1898 Zubroff, J. See Tsuds, Serma, Rsjsbskshmi, Zu eone(Squsbene),2,6, 10,15,19,23-Hexemethyl Vu, S. See Redmsn, Yu, Banenjee, and Morris, broft, Farber, Bslzingon, Che, and Bueding, letrecasano (Squaleno), Peanut Oil, or Mineral ioi 4491 Oil,1518 Yuspa,S. H. See Poinien,Dubin,and Yuspe,1377 Zucker, S. See DiSlefano, Lysik, and Zucken, Vasuhira, K. See Takahashi, Kinoshila, Hashi 1193; Lysik, Connetts, DiStefano, and Zucker, mob, end Yssuhima,1814 30 Yasumoto, K., Manabe, H., Vanagawa, E., Na z ZUIch,K. J. See vanVeeben,Venbiest,ZUIch,van gano, N., Ueda, H., Hirota, N., Ohla, M., Nom Kelel, van don Vbist,VIug, Rijksen, and Steal, 010, K., Azuma, I., and Vamamura, V. Nonspe 4263 cific Adjuvant immunotherapy of Lung Cancer Zaharko, D. S., Bolten, B. J., Chiuten, D., and zur Hausen, H. See Cogginand zur Heusen,545 with Cell Well Skeleton of Mycobacterium bovis Wiemnik,P. H. PhanmacakinelicStudiesduring Zweibaum, A. See Raussot, Chevalier, Rousset, Bacillus Calmette-Gudrin, 3262 PhaseITrials of High-DoseThymidine Infusions, Dussaubx,and Zweibaum, 531 Yasuzumi, F. See Yasuzumi,Hyo, Hoshiya,end 4777 Zweliing, L. A., Anderson,T., and Kohn, K. W. Yesuzumi, 4645 Zahn, R. K. See Breter end Zahn, 3744; MUller, DNA-Protein and DNA Inlerstrand Cross-linking Yasuzumi, G., Hyo, V., Hoshiya, T., and Yasu Maidhaf, Arendes, Geurtsen, Zehn, and by cis- end trans-Pbatinum(ll)Diemminedichbon zumi, F. Effects of Bleomycin on HumanTongue Schmidseder, 3768; MUller and Zshn, 1102 ide in Li 210 Mouse Leukemia Cells and Role Carcinoma Cells Revealed by Electron Micros Zardi, L., Cecconi, C., Barbieri, 0., Carnemolla, tionto Cytotaxicily,365 copy,4645 B., Picca,M., and Santi, L. Concentrationof Zwelling, L. A., Filipski, J., and Kahn, K. W. Yates, P. E. See Hanker, Ambrose,James,Man Fibronectin in Plasma of Tumor-bearing Mice Effect of Thioumoson Survival and DNA Cross delkomn,Yates, Gall, Bossen, Fay, Laszbo,and and Synthesis by Ehrlich Asciles Tumor Cells, Link Formation in Cells Treated with Pbslinum(ll) Moore, 1635 3774 Complexes, L-Phenylalanine Mustend, end Verushalmi,A., and Weinstein, V. Stimulationof Zbar, B., Canti, G., Ashley, M. P., Rapp, H. J., Bis(2-Chboroolhyl)melhylamine,4989

5216 CANCER RESEARCH VOL. 39 Subject Index

Acetanilde, N-(acetyloxy)[email protected] Acetamide, N-fluoren-2-yl- (cont'd) Antibodyspecificity Mutsgenic metabolite C-8adducts,1377 Liver,rat,1168 C-8adducts Oxygenases Epidermal cells, mouse, 1377 DNA binding 1089 Fibroblests, human, 1377 Nuclei, liver, rat, 1089 Deoxyguanosine Phenol, p@nitro Antibody specificity, 1377 Nucleic acids, binding 3268 DNA adducts Acetamide, ]%@methyl-)%@nitroso Radioimmunossssy, mouse, human, 1377 DNA repair Ames test Fibroblasts, in vitro, human, 2522 Mutagenic activity, 1328 Xeroderma pigmentosum, 471 Acetamide, N-nitroso-]%Lpropyl@ Fibroblasts Ames test DNA-protein cross-links, 704 Mutagenic activity, 1328 Xeroderma pigmentosum, 471 Acetic acid, aminooxy Mammary neoplasms, experimental Carcinoma, Ehrlich tumor Tissue culture, mouse, 1784 Malate-aspartate shuttle, 2195 Ultraviolet rays DNA repair, 471 Acetic acid, methylnitrosaminomethyl ester DNA methylation Carcinogenic metabolites, rat, 5136 Acetamide, N(2-chloroethyl)-N@nitroso. Esterases Ames test Carcinogenic metabolites, rat, 5136 Mutagenic activity, 1328 Mechanism of action, in viv4 5136 Intestinal neoplasms Acetamide,iV-fluoren-2-yl Histological study, rat, 3 strains, 1462 Alphafetoprotein Neurilemmoma Carcinogenesis, mouse, 3491 Peritoneal neoplasms, 1462 Splenic neoplasms Precancerousconditions, 3491 Angiosarcoms, 1462 Serum levels, 1437 Testicular neoplasms Barbituric acid, 5-ethyl-5-phenyl Mesothelioma, 1462 Mutagenic metabolite, 1168 5,6-Benzoflavone Nucleic acids, binding 3268 Acetic acid, trichioro Cell transformation, neoplastic Liver neoplasms Photosensitiveanalogs, 3903 AMP deaminase@2132 Ultraviolet radiation, 3903 Cholanthrene, 3-methyl Acetimidic acid, methyl DNA binding 1089 DNA synthesis Mutagenic metabolite, 1168 Lymphocyte transformation, 345 Nuclei, liver, rat, 1089 Acetohydroxamic acid, N.4-biphenyl Choline N,O-Acyltransferase Alpha fetoprotein, 2515 Lactating mammary gland, rat, 3369 )â€˜-Glutamyltranspeptidase, 2515 DNA adducts Acetohydroxamic acid, Nfluoren-2-yl Radioimmunosssay, mouse, human, 1377 N,O-Acyltransferase Enzymeactivation Lactating mammary gland, rat, 3369 Liver, rat, 1168 Mammary neoplasms,experimental Hepatoma(s) Tissue culture, mouse, 1784 Alphafetoprotein,3491 Microsomes, liver Choline, 2515 Ames test, 3268 Histological study, rat, 1437 ]V-Acetoxy-2.acetylaminofluorene Methionine adenosyltransfersse, 2113 see Acetamide, N-(acetyloxy)-N.9H@fluaren@2@yl@ RNA, transfer,methyltransferases,2113 Liver neoplasms Acetyl coenzyme A Adenylosuccinate lyase, 2132 Benzidine Mammary neoplasms, experimental Carcinogenic metabolite, 3107 Tissue culture, mouse, 1784 Benzidine, N-hydroxy-N,N-cliacetyl Metabolism Amestest, 3107 Liver microsome, human, in vitr4 4206 f%@Acetyl./3.D-hexos@nini@a@e Microsomes, liver Colonic neoplasms Ames test, 3268 Normal/neoplsstic colon, rat, 4083

DECEMBER 1979 5217 Subject Index to Volume39

1%@Aeetyl-$-D-hexosaminidase (cont'd) Acriflavine see Acridinium, 3,6-diamino-lO-methyl-, chloride Isozymes Actia Normal/neoplastic colon, rat, 4083 Microfilaments 2-Acetylaminofluorene Adenocarcinoma(s), 893 see Acetamide, N-fluoren-2-yl Normal/preneoplastic/neoplastic mammary tissue, mouse, 893 Acetylgalactosaminyltransferase Colonic neoplasms Actinomycin D Adenocarcinoma(s), 1259 Amphotericin B Epithelial cells, human, 1259 Drug resistance, mouse, 2041 HeLa cells N.Acetylmuramyl-L-alanyl(L-seryl)-D-isoglutamine Gonadatropins, chonionic, 3885 Skin neoplasms Hyperthermia, systemic Endotaxins, bacterial, 4756 Review, 2264 Toxicity, guinea pig, 4756 Lymphoma(s) 3-Acetylpyridine Immunosuppression, 4564 Sec Ketone, methyl 3-pyridyl 12-O-Tetradecanoylphorbol-l3-acetate Temperature sensitivemutants, 1579 Acetyltransferases Uracil-DNAglycosylase Hepatoma Polyribonucleotide synthetases, 2090 4-[Chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid, 152 Acyl hydroxamicacids LeukemiaLl2lO Acid-base equilibrium Ribonucleotide reductase, 844 Sarcoma, Cracker I 80 Diet, 4364 N,GAcyltransferase Laboratory diet, 4364 Acetohydraxamic acid, N-4.biphenyl Neopiasm regression, spontaneous, 4364 Lactating mammary gland, rat, 3369 Cis-acid Acetahydroxamic acid, N-fluoren-2-yl Lactating mammary gland, rat, 3369 Colanic neoplasms Aryihydroxamic acids Cytotoxicity, human, in vitr4 2630 Lactating mammary gland, rat, 3369 Acinetobacter glutaminsificans 9H-Adenlne, 9-$-D-arabinofuranosyl Asparsginsse-glutaminsse 9H-Adenine, 9-/3-D-arabinofuranosyl-, 5'-triphosphate Antitumor activity, succinylated enzyme, 3145 Bone marrow/intestinal mucosa, mouse, 3655 Toxicity, child patient, 3145 Leukemia, lymphocytic, 3655 AclacinomycinA Adenine, erythro-9-(2-hydroxy-3-nonyl)- Leukemia(s) Antiproliferative activity, 1563 Cellular distribution, 4396 Adenosine deaminase Cytoplasm, 4396 Bonemarrow/intestinal mucosa,mouse, 3655 Thymidine/uridine incorporation, 4396 Coformycin, 2'-deoxy Antiproliferative activity, 1563 ACNU DNA synthesis Brain neoplasms Bone marrow/intestinal mucosa, mouse, 3655 Antineoplastic agents, 2687 Leukemia Ll2lO Cyclophosphamide, 2687 DNA synthesis,I563 Metastatic brain tumor model, rat, 2687 Leukemia, lymphocylic Primary brain tumar model, rat, 2687 Adenosine deaminase, 3655 Carcinoma, Walker 256 DNA synthesis,3655 Metastatic brain tumor model, rat, 2691 9II@Adenine, 9-$-D-arabinofuranosyl-, 5'-monophosphate Acridine, 3,6-diamino Adenine, crythro-9-(2-hydroxy-3-nonyl)- Ozone Antiproliferative activity, I 563 Ames test, 2149 Coformycin, 2'-deoxy Acridine, 6,9-diamino-2.ethoxy-5-iodo Antipraliferstive activity, 1563 Iodine rsdioisotopes Leukemia Ll210 DNA, binding 3244 Adenine, erythro-9-(2-hydroxy-3-nonyl)-, 1563 L cells Coformycin, 2'-deoxy-, 1563 Cytotoxicity, 3244 DNA synthesis,1563 Acridinium, 3,6-diamino-lO-methyl-,chloride Adenine,9-f3-D-arabinofuranosyl-,5'-triphosphate Ozone DNA polymerases Ames test, 2149 Enzyme inhibition, 4673 Adenine, erythro-9-(2-hydroxy-3-nonyl)- Neoplasms DNA synthesis Pharmacokinetics, 3881 Bone marrow/intestinal mucosa, mouse, 3655 Phase 1 clinical trial, 3881 Leukemia, lymphocytic, 3655

5218 CANCER RESEARCH VOL.39 Subject Index to Volume39

Adenine, erythro-9-(2-hydroxy-3-nonyl)- (cont'd) Adenocarcinoma(s) (cont'd) 9H-Adenine,9-$-D-srsbinofuranosyl Thrombosis Antiproliferative activity, 1563 Platelet aggregation, 2031 9H-Adenine,9-/3-D-arsbinofuranosyl-,5'-monophosphate Transplantation, heterologous Antiproliferative activity, 1563 Hyperthermia, 2236 Leukemia L1210 Transplantation, homologous 9H-Adenine,9-/3.D-arabinofuranosyl-,5'- I.v. injection, neoplastic cells, 4724 monophosphate, 1563 Metastases, 4724 Adeninenucleotidetranslocase Adenoma(s) Hepatoma(s) Pituitary neoplasms Adenine nucleotides, 2737 Diethylstilbestrol, 773, 779 Adenosine Adenine nucleotides Adriamycin Hepatoma(s) Cardiotoxicity, rat, 2941 Adenine nucleotide translocase, 2737 Adenosine 5'-monophosphate, 2737 Adenosine cyclic 2':3'-monophosphate Cell transformation, neoplastic Adenocarcinoma(s) Growth inhibition, mixed normal and malignant fi Amidophosphonbosyltransferase broblasts, 3502 Purine synthesis,kidney, mouse, 3909 Antigens, nucleolar Adenosinecyclic 3':5'-monophosphate Immunofluorescence, 3024 Diabetes mellitus Bloodplatelets Mammary tumor regression, mouse, 2501 Factor VIII, 2031 Diethylamine, N-nitroso Sialyltransferase, 2031 Protein kinase, 3074 Breast neoplasms Hepatoma(s) Chemotherapy, 4503 Antibody-dependent cell cytotoxicity, 3156 Cell transformation, neoplastic Antineoplastic agents, 3156 Amidoohosahoribosvltransferase. 3909 Mammary neoplasms, experimental Colonic neoplasms Streptozotocin,2501 1259 Neuroblastoms(s) Galactosyltransferases, 1259 Carrier proteins, 3007 Glycosidases, 1259 Pancreatic neoplasms Platinum(II), diamminedichloro-, cis-, 4356 Secretin, 452 Siayltransferase, 1259 Phosphofructokinase Transplantation, heterologous, 833 Normal/neoplastic tissue, rat, 2796 Estrogen Skin neoplasms Bladder, hamster, 2614 Mezerein, 4791 Follicle-stimulating hormone 12-O-Tetradecanoylphorbate-l3-acetate, 4791 Parabiosed rats, 3971 12-O-Tetradecanoylphorbol-13-acetate Formamide, N,N-dimethyl Plasminogen activators, 1579 Tumorigenicity, vs growth characteristics, 1020 Hyperthermia Adenosine deaminase Radio-frequency heating, 2236 9H-Adenine, 9-$-D-arabinofuranosyl Kidneyneoplasms Bone marrow/intestinal mucosa, mouse, 3655 Karyotyping 4662 Coformycin, 2'-deoxy Luteinizing hormone Erythrocytes, mouse, 1425 Parabiosed rats, 3971 Tissue distribution, mouse, 3044 Mammary neoplasms, experimental Colonic neoplasms Diethylstilbestrol, 773 Coformycin, 2-deoxy-, 3044 Linaleic acid, 4430 Leukemia L1210 Metastases Coformycin, 2'-deoxy-, 1425 Cytokinetic parameters, in vivo, mouse, 3861 Leukemia, lymphocytic Ovarian neoplasms 9H-Adenine, 9-/3-D-arsbinofuranosyl-, 3655 Animal model, rat, 1108 Adenosinediphosphate Benz(a)anthracene, 7,12-dimethyl-, 1108 Thrombosis Cholanthrene, 3-methyl-, 1108 Platelet sggregation, 2031 Prostatic neoplasms Androgen, 2652 Adenosine diphosphate reductase Receptors, hormone Leukemia, lymphoblastic Bladder, hamster, 2614 Isolation and characterization, 436 Stomach neoplasms Adenosinekinase Guanidine, N-methyl-N-nitro-N-nitroso-, 811 Pyrazofurin Suppressor cells Phosphorylstion, 4485 Immune response,mouse, 4983 Adenosine 5'-monophosphate Surgery Hepatoma(s) Cytokinetic parameters, in vivo, mouse, 3861 Adenine nucleotides, 2737

DECEMBER 1979 5219 Subject Index to Volume39

Adenosine-3'-phosphate.5'-phosphosulfate Adriamycin (cont'd) Breast neoplasms Breast neopiasms Estrogen sulfotransferase, 5124 Dose-responsestudy, 1552 Hematopoiesis, 527 Adenosinetriphosphatase Burkitt's lymphoma Adriamycin Hyperbaric oxygen, 370 Heart microsomes, rabbit, 257 Cell survival Hepatoma(s) Chinese hamster ovary cells, 1937 Precancerous conditions, 1298 Dye exclusion tests, 1428 7-Con- O-methylnogarol Cardiotoxicity, rabbit, 4849 S.Adenosyl-L-methionine decarboxylase Creatine kinase l2-O-Tetradecanoylphorbol-l3-acetate Cardiotoxicity, rat, 2941 Retinoic acid, 419 DNA repair Ultraviolet rays Cardiac cells, rat, 1321 Nude mouse, 1035 DNA synthesis S-Adenosylmethionine synthetase Administration route, 3202 Hepatoma(s) Cardiac cells, rat, 1321 Isozymes, 162 Mechanism of action, in vitr4 448 Isozymes Drug resistance Normal/pathological liver, human, 162 P388 leukemia cells, 2200 Normal/regenerating, fetal/adult liver, rat, 162 Emux mechanism Adenylcyclase P388 leukemia cells, 2200 Glucose Pancreatic neoplasms Efflux mechanism, 2200 Neoplasm transplantation, 452 Heart Adenylosuccinate lyase Nucleolar ultrastructure, rat, 1239 Liver neoplasms Hematopoietic stem cells Acetamide, N-fluoren-2-yl-, 2132 Human/dog/mouse, in vivo, 360 Aniline, N,N-dimethyl-4-(tolylazo)-, 2132 Hyperthermia, localized Benzenamine, N,N-dimethyl-4-((3- Cytotoxicity in vitro/in vivo, 2269 methylphenyl)azo)-, 2132 Hyperthermia, systemic Butyric acid, 2-amino-4-(ethylthio)-, 2132 Review, 2264 Leukemia L5222 Adrenal cortex hormones Proteus mirabilis Vincristine, 1071 Liver neoplasms Glucocorticoid amplifying factor, 3258 Administration via the hepatic artery, 4105 Virus, bovine adeno 3 Macrophage cytotoxic activity Angiogenesis factor, 1305 Immune response,mouse, 3014 Adrenal cortex neoplasms Mammary neoplasms, experimental Ethane, 2-(o-chlorophenyl)-2-(.,p-chlorophenyl)-l,I- Carcinoma(s), 4466 dichloro Maytansine Cytotoxicity, in vitro, 139 Cytotoxicity, 3152 Ultrastructural study, I 39 Myocardial contraction Cardiotoxicity, rat, 2941 Adrenalectomy Ovarian neoplasms Chondrosarcoms Administration route, 3209 Growth, 4387 Tissue distribution, 3209 Dexamethasone Phenol, 2,4-dinitro Receptors, hormone, 5132 DNA synthesis Efflux mechanism, 2200 Potassium transport Normal/regenerating liver, rat, 5132 Kidney, rabbit, 257 Mammary neoplasms, experimental Skeletal muscle Benz(a)anthracene, 7,12-dimethyl-, 2436 Nucleolar ultrastructure, rat, 1239 Prolactin, 2436 Tetrahydrofolate dehydrogenase Tumor regression, lactating rat, 2436 Drug sensitivity, 1937 Adriamycin Ultraviolet rays Adenosine DNA repair, 1321 Cardiotoxicity, rat, 2941 Vincristine Adenosine monophosphate Synergistic activity, rat, 1071 Energy metabolism, 2941 In vitro vs in vivo activity, mouse/human, 402 Adenosine 5'-triphosphatase Adriamycin, N-trifluoroacetyl Heart microsomes, rabbit, 257 DNA synthesis Adenosine triphosphate Mechanism of action, in vitr4 448 Energy metabolism, 2941 Amphotericin B Adriamycin, ]â€˜i#rifluoroacetyl-, valeric acid Drug resistance, mouse, 2041 DNA synthesis

5220 CANCER RESEARCH VOL.39 Subject Index to Volume39

Adrismycin, ]%4rifluoroacetyl-, valeric acid (cont'd) Alcohol (cont'd) Mechanism of action, in vitr4 448 Mechanisms of carcinogenesis, review, 2887, 2899 Hematopoietic stem cells Routes of administration Human/dog/mouse, in vivo, 360 Mechanisms of carcinogenesis, review, 2891 Tobacco Aflatexin B, Bronchus Mechanisms of carcinogenesis, review, 2844 DNA binding 694 Alcoholdehydrogenase Carcinogenic metabolites Haptens DNA binding 694 Enzyme-antibody complex, 2084 Colon DNA binding 694 Alcoholism DNA adducts Drug dependence Pharmacological and sociological comparison, 2836 Epithelial cells, lung, human, 5165 Isolation and characterization, 5165 Neoplssms Role of the physician, 2834, 2853 Gastrointestinal neoplasms Carcinogenic activity, monkey, 4545 Social adjustment, 2853 Hepatoma(s) Diet, 3986 Aldolase A Liver neoplasms see Fructose 1,5-biphosphate aldolase Histological study, monkey, 4545 Oxidases Aldosterone Liver microsomes,ret, 3986 Carcinoma(s) Ozone Receptors, hormone, 2647 Amestest, 2155 Sarcoma, osteogenic Alkaline phosphatase Carcinogenic activity, monkey, 4545 Histaminase Aglag Malignant effusion fluid, human, 4894 DNA repair Sarcoma, osteogenic Ultraviolet rays, 2792 Tumor tissue vs normal skin, human, 277 Stomach neoplasms DL-Alanine-Ncarboxyanhydride Carcinoma(s), 4732 Asparaginase Enzyme properties, 1927 Alloantibodies Therapeutic activity/immunologic properties, 1927 Neoplasm transplantation Erwinia carotovora Tissue distribution, mouse, in vivo, 3363 Asparaginase, 1927 Sarcoma(s) Polymer modification, 1927 Cholanthrene, 3-methyl-, 3363 Escherichiaco/i RBC-binding, in vitro, 3363 Asparaginase, 1927 Allopurinol Polymermodification,1927 see H-Pyrazolo(3,4-d)pyrimidin-4-ol Albumin Alpha fetoprotein Hepatoma(s) Acetamide, N-fluoren-2-yl Synthesis, normal vs tumor, liver, rat, 101 Carcinogenesis, mouse, 3491 Alcohol Precancerous conditions, 3491 Alcoholism Serum levels, 1437 History, 2822 Bilirubin Cell membrane Carrier proteins, 3571 Mechanismsof carcinogenesis,review, 2899 Chlordane Diet Carcinogenesis, mouse@3491 Mechanisms of carcinogenesis, review, 2863 Precancerousconditions, 3491 Disease 4-[Chloro-6-(2,3.xylidino)-2-pyrimidinylthiol acetic acid History, 2822 Acatalasemic mouse, 152 Enzymes DNA synthesis,152 Mechanisms of carcinogenesis, review, 2863 Choline Gastrointestinal neoplasms Acetamide, N-fluoren-2-yl-, 2515 Mechanisms of carcinogenesis, review, 2863 Diethylamine, N-nitroso-, 2515 Headandneckneoplasms Diethylamine, N-nitroso Epidemiological studies, review, 2844 Serum levels, 1437 Tobacco, 2844 a-Glutamyltranspeptidase Immunosuppression Carcinogenesis, mouse, 3495 Animal model, mouse, 2894 Hepatoma(s) Neoplasms Acetamide, N-fluoren-2-yl-, 3491 Alcoholism, 2822 o-Aminoazotoluene, 3495 Epidemiology, 2840, 2851 Chlordane, 3491 Etiology, overview, 2840 Polyribosomes, Morris tumor, 2141 Etiology, review, 2819 RNA, messenger,2141

DECEMBER 1979 5221 Subject Index to Volume39

Alphafetoprotein(cont'd) Amestest(cont'd) Serum levels, hepatocarcinogenesis, rat, 3715 Mutagenic activity, 1328 Transplantation, heterologous, 1819 Preproteins Amidophosphoribosyltransferase Synthesis, 3702 Adenocarcinoma(s) RNA, messenger Purine synthesis, kidney, mouse, 3909 Synthesis, 3702 Cell transformation, neoplastic Synthesis Adenocarcinoma(s), 3909 Wheat germ cell-free system, 3702 Hepatoma(s) Purine-biosynthetic pathway, 305 Alphamacrofetoprotein Isolation and characterization Hepatoma(s) Normal/neoplastic liver, rat, 305 Serum levels, hepatocarcinogenesis, rat, 3715 Amino acids a-Amanitin Carcinoma, Walker 256 Cell transformation, neoplastic Anorexia, 3065 DNA synthesis, 4516 Plasma/brain concentrations, 3065 American Cancer Society Glucosamine 6-phosphate synthetase Research grants Regenerating liver, rat, 2783 Historical review, 1945-1956, 262 Malnutrition Plasma/brain concentrations, 3065 Amestest Mammary neoplasms, experimental Acetamide, N-(2-chloroethyl)-N-nitroso Estradiol,3381 Mutagenic activity, 1328 Insulin, 3381 Acetamide, N-fluoren-2-yl Sarcoma(s) Microsomes, liver, 3268 Liver, mouse, 4657 Acetamide, N-methyl-N-nitroso Proteins, 4657 Mutagenic activity, 1328 RNA, nibosomal,4657 Acetamide, N-nitroso-N-propyl (aS,5S)-a-Amino-3-chloro.4,5..djhydro,5.isoxazolencetic acid Mutagenic activity, 1328 Acetohydroxamic acid, N-fluoren-2-yl see 5-Isoxazoleacetic acid, (aS,5S)-a-amino-3-chloro-4,5- dihydro Microsomes, liver, 3268 I ,3-Benzenediamine, 4-methoxy Microsomes, liver, 3268 Nitrobenzylthioinosine Benzidine, N-hydroxy-N,N-diacetyl Antitoxicity, lymphoblastoid cells, human, 3607 Acetyl coenzyme A, 3107 Antitoxicity, mouse, in viv4 3607 Benzo(a)pyrene 4-Amino-7(ft-D-ribofuranosyl)pyrrolo(2,3@d)pyrimidine Microsomes, liver, 4752 Nitrobenzylthioinosine Chrysene Antitoxicity, lymphoblastoid cells, human, 3607 Epoxide and dihydro derivatives, 4069 Antitoxicity, mouse, in vivo, 3607 Epoxide hydrase@4069 Fluoren-2-amine Aminoazo dyes Microsomes, liver, 3268, 4752 N-Hydroxy metabolites Fluorene, 2-nitro Carcinogenic activity, weanling rat, 3411 Host-mediated assay, 2026 @-Aminoazotoluene Lactobacillus p/antaruni, 2026 â€˜eealso o.Toluidine, 4-(o-tolyazo)- Hydrazine, 1,2-dimethyl Hepatoma(s) Host-mediated assay, 2026 Alphafetoprotein,3495 Lactobacillus plantaruni, 2026 Methane, szoxy p-h-Am1nooicyciot,.,..,1)heptane@2@ca1-boxylicacid Host-mediated assay, 2026 see Carboxylic acid, $-2-aminobicyclo(2,2,l)heptane Lactobacillus p/antaruni, 2026 S.(2-Aminoethyl)isothiouronium dihydrobromide Methanol, (methyl-ONN-azoxy) see Pseudourea, (2-aminoethyl)-2-thio, dihydrobromide Mutagenic derivative, 3070 Phenanthrene 2-Aminofluorene Epoxide and dihydro derivatives, 4069 see Fluoren-2-amine Epoxide hydrase@4069 Aminooxyacetate Platinum(II), bis(cyclopentamine)dichloro-, cis-, 913 see Acetic acid, aminooxy Platinum(II), diamminedichloro-, cis-, 913 Rhodamine B f3-Aminopropionitrile Rhodamine 6C, 4412 seealso Propionitrile, 3-amino Urea, 1,3-bis(2-chloroethyl)-l-nitroso Isoproterenol Mutagenic activity, I 328 DNA synthesis,2751 Urea, l-(chloroethyl)-l-nitroso Aminopterin Mutagenic activity, 1328 Citrovorum factor Urea, methyl nitroso Phase I clinical study, 3707 Mutagenic activity, 1328 Leukemia(s) Urea, N-nitroso-N-propyl Membrane transport, lymphoblasts, 2440

5222 CANCER RESEARCH VOL.39 Subject Index to Volume39

AMP deamlnase Moxie Liver neoplasms Hyperthermis Acetic acid, trichloro-, 2132 Lethality, Chinese hamster cells, in vitro, 966 Benzenamine, N,N.dimethyl-4-((3- Sarcoma(s) methylphenyl)azo)-, 2132 Cellcyclekinetics, 1891 Amphetamines 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis Hodgkin's disease (((2-[(2-hydroxyethyl)aminoJethyl)amino))-, dihydrochloride Riskfactors,4507 Antitumor activity, mouse Amphotericin B Administration route, 1570 Actinomycin D Drug resistance,mouse,2041 9,10-Anthracenedione, 1,4-bis((2-([2.hydroxy Adriamycin ethyl)aminoj ethyl)amino)-diacetate Drug resistance, mouse, 2041 Cell cycle Bleomycin Cytotoxicity, in vitro, 2574 Synergistic activity, hamster cells, in vitr4 5150 Hyperthermia, localized Review, 2264 Anthracycline antibiotics Leukemia, lymphocytic Antineoplastic agents Virus, AKR murine leukemia, 2041 Kinetic/statistical models, 3661 Vincristine Mechanism of action, 3661 Drug resistance, mouse, 2041 Cytosine, l-$-D-arabinofuranosyl Clinical trial, 42 Androgen Leukemia, myeloblastic, 42 Breast neoplasms Leukemia(s) Receptors, hormone, 1447 Kinetic/statistical models, 3661 Diet Mechanism of action, 3661 Urinary excretion, black vs white male, 5101 Nogalamycin Prostatic neoplasms Analog activity, 4816 Adenocarcinoma(s), 2652 Cell growth inhibition, 4816 Enzymeassays,rat tissue,2652 Mechanism of action, in vitr4 4816 Histological study, rat tissue, 2652 Anthramycin Sa-Androstan-3-one,17j3-hydroxy DNA adduct Carcinoma(s) Antitumor activity, 3134 Receptors,hormone,4713 Pharmacokinetics, mouse, 3134 Anemia,aplastic DNA repair Benz(a)enthracene, 7,12-dimethyl Nucleic acid conjugate, 3134 Thyroidectomy, 4252 DNA synthesis Nucleic acid conjugate, 3134 a-Angelicalactone Lymphoma(s) see2(3H)-Furanone,5-methyl DNA adduct, 3134 Angiogenesisfactor Hepatoma(s) Anthranilic acid, 4-chloro-JV@furfuryl-5-sulfamoyl Kidney tubules Virus, bovine adeno 3, 1305 Lungneoplasms Metabolism, rat, 1269 Virus,bovineadeno3, 1305 Leukemia(s) Plstinum(II), diamminedichloro-, cis@ 1279 Sarcoma(s) Platinum (II), diamminedichloro-, cis Virus, bovine adeno 3, 1305 Blood urea nitrogen, 1269 Virus, bovine adeno 3 DNA synthesis, 1279 Adrenal cortex hormones, 1305 Glomerular filtration rate, 1269 Cell transformation, viral, 1305 Hippuric acid, p-amino-, 1269 Chorioallantoic membrane@ 1305 DNA, viral, 1305 Toxicity, rat, 1279 Anglosarcoma Anti-antibodies Liver neoplasms Melanoma Dimethylamine, N-nitroso-, 1592 Melanocyte-stimulating hormones, 3058 Aniline, N,JV-dlmethyl-4-(tolylazo)- Antibodies, neoplasm Liver neoplasms Mammaryneoplasms,experimental Adenylosuccinate lyase, 2132 Immunogenicity, A-ID ascitic tumor, 1739 Virus, feline leukemia Aniline, p-(3-methylphenylazo)- Immune response, cat, 75 N-Hydroxy metabolites Carcinogenic activity, weanling rat, 3411 Antibodies, viral Lymphosarcoma(s) Anorexia Virus, bovine leukemia, I 118 Carcinoma, Walker 256 Virus, bovine leukemia Amino acids, 3065 Milk/serum levels, cow/sheep, I 118

DECEMBER 1979 5223 Subject Index to Volume39

Antibody-dependent cell cytotoxicity Antigens, neoplasm (cont'd) Colonic neoplasms Leukocyte adherence inhibition Transplantation, heterologous, 2160 Diagnosis, 638 Hepatoma(s) Isolation and characterization, 604, 612 Adenosine cyclic 3':S'-monophosphate, 3156 Mechanism of action, 576 Antibody formation Review, 649 Antineoplastic agents Transplantation immunology, 582 B-Lymphocytes, 4564 Mammaryneoplasms,experimental Immune response, mouse@35 Antibodyspecificity Melanoma(s) Acetamide, N-(acetyloxy)-N-9H-fluoren-2-yl Bacillus Ca/mette-Gueri'n, 2125 C-8 adducts, 1377 Characterization, 1683 Deoxyguanosine, 1377 Cultured cells, tumor/fetal, human, 183 Glioma(s) Fetal globulins, 1683 Antigenic determinants, 3235 Isolation and characterization, 612 Mammary neoplasms, experimental 132-Microglobulin, 619 Immunogenicity, A-b sscitic tumor, 1739 Monkey antisera, 183 Antiestrogens /32-Microglobulin Mammary neoplasms, experimental Isolation and characterization, 604 Castration,rat,5043 Precancerous conditions Prolactin, 5043 Leukocyte adherence inhibition, 604 Receptors, hormone, 5043 Prostatic neoplasms Immune response,hamster, 459 Immune response, human, 3328 Antigenic determinants Leukocyte adherence inhibition assay, 3328 Brain neoplasms Retinoblastoms Glioma, 3235 Cultured cells, tumor/fetal, human, 183 Breast neoplasms Monkey antisera, 183 Glycoproteins, 2057 Sarcoma(s) Glioma Characterization, 1683 Antibody specificity, 3235 Transplantation immunology Antigens, neoplasm, 1733 Immune response, hamster, 459 Lung neoplasms Virus, Maloney murine leukemia Cell membrane, 2935 Immune spleen cells, infected mouse, 4887 Virus, Rous sarcoma Antigens, chromatin Transformation, viral, 4744 HeLa cells Cell cycle distribution, 3683 Antigens, nucleolar Cell type specificity, 3683 Hepatoma(s) Isolation and characterization, rat, 59 Neoplasm indicator, human Antigens, neoplasm Immunofluorescence, 3024 Bladder neoplasms Antigens, T-lymphocyte associated Immunity, cellular, 1985 Histocompatibility antigens Breast neoplasms Immunoprecipitation, 4810 T-Lymphocytes, 4796 Leukemia, myeloblastic Carcinoma(s) Histocompatibility antigens, 4810 Characterization, 1683 Leukemia, myelocytic Colonic neoplasms Histocompatibility antigens, 4810 Isolation and characterization, 612 Lymphoma(s), 751 Cystadenocarcinoma Serum blocking factor, 1185 Antigens, viral Glioma Histocompatibility antigens Antigenic determinants, 1733 Antigen-antibody reactions, 3388 Head and neck neoplssms Infectivity, human cell, 3388 Leukocyte adherence inhibition, 597 Immunity, cellular Hepatoma(s) Lymphocyte transformation, 3996 Isolation and characterization, rat, 59 Mammary neoplasms, experimental Immune response, mouse Immune response, mouse, 35 Culture conditions, tumor cells, 3519 Immunity, cellular, 35 Immunogenicity Virus, herpes simplex 2 Culture conditions, tumor cells, 3519 Cervix neoplasms, 4022 Immunotherapy Immune response,hamster, 3996 Culture conditions, tumor cells, 3519 Virus, Moloney murine leukemia Soluble extracts, EL-4 tumor cells, 1159 Immune spleen cells, infected mouse, 4887 Leukemia, lymphocytic Virus, murine mammary tumor Immunotherapy, 1159 Immunologic deficiency syndromes, 1529

5224 CANCER RESEARCH VOL.39 Subject Index to Volume39

Antilymphocyte serum Antineoplastic agents (cont'd) Erythroleukemia Adenosine cyclic 3':S'-monophosphate, 3156 T-Lymphocytes, 1611 Hexamelamine Antimony Pharmacokinetics, rabbit/human, 5016 Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)- Virus, adeno 7 Antitumor activity, mouse, 934 Co-carcinogenic effect, metal salts, 193 Indicine, N-oxide Antimycin A Clinical trial, 4540 Cell transformation, chemical Gastrointestinal neoplasms, 4540 Growth, 2718 Metabolism, human/rabbit, 3564 Intracellular membrane Antineoplastic agents 4'-(9-Acridinylamino)methanesulfon-m-anisidide Chemical/enzyme characteristics, guinea pig cells 1369 Neoplasms, 3881 Acyl hydroxamic acids 5-Isoxazoleacetic acid, (aS,55)-a-amino-3-chloro-4,5- dihydro Leukemia Ll210, 844 9,10-Anthracenedione, l,4-bis((2-([2- Antitumor activity, mouse, 852 hydroxyethyljamino)-ethyl)amino-diacetate Cytotoxicity, mouse leukemia cells, 852 Cellcycle, 2574 Leukemia, myeloblastic 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-([2- Clinical trial, 42 hydroxyethyl] amino)ethyl)amino-, dihydrochioride B-Lymphocytes Antitumor activity, mouse, 1570 Antibody formation, 4564 9,lO-Anthracenedione, l,4-dihydroxy-bis((2-([2- T-Lymphocytes hydroxyethyl]amino)ethyl)amino-, dihydrochioride Immunity, cellular, 4564 Cytotoxicity, in vitr4 2574 Lymphoma(s) Anthracycline antibiotics Hematopoietic stem cells, 4564 Leukemia(s), 4396 Trial of 5 agents, mouse, in viv4 3964 Anthracycline derivatives Mammary neoplasms, experimental 7-Con-O-methylnogarol, 4849 Cell cycle kinetics, spontaneoustumors, mouse Kinetic/statistical models, 3661 3812 Mechanism of action, 3661 Dose schedules, 3812 Maytansine Anthramycin Cytotoxicity, 3152 DNA adduct, 3134 Methotrexste Aryl hydroxamic acids Binding/activity, 1264 Leukemia L12l0, 844 Methotrexate, 3',S'-dichloro 5-Aza-2'-deoxycytidine Binding/activity, 1264 3-Deazauridine, 3822 Neocarzinostatin 5-Azacytidine Pharmacokinetics, human, 757 Liver, mouse, in vivo/in vitro, 940 Nogalamycin Bleomycin Analog activity, 4816 Toxicity, 5076 Cell growth inhibition, 4816 Brain neoplasms Pentamethylmelamine ACNU, 2687 Phase I clinical trial, 5016 N-Bromoacetyl-13-D-glucosamine tetra- 0-acetate L-Phenylalanine mustard Carcinoma, Ehrlich tumor, 3897 Antitumor activity, mouse, 934 Leukemia Ll210@ 3897 N-(Phosphonacetyl)-L-aspartate Carcinoma, Walker 256 Phase I clinical trial, 3992 Cytochemical study, 4256 Plasma membrane Ultrastructural study, 4256 Chemical/enzyme characteristics, guinea pig cells Combination chemotherapy 1369 Statistical analysis, mouse survival, 3446 Platinum(II), sulfato- trans-(-)-1,2-diaminocyclohexane Cytosine, l-/3-D-arabinofuranosyl-, 5'-triphosphste Immune response, mouse, 3476 Leukemia myeloblssts, in vitr4 42 Immunosuppression, 3476 Dactylarin Pyrimidine, 2,4-diamino-5-(3,4-dichlorophenyl)-6-methyl Carcinoma, Ehrlich tumor, 4242 Carboxypeptidase G, 3441 3-Deazauridine Retinoids Pharmacokinetics, 349 Melanoma(s), 4055 Dichloroallyl lawsone Rubidazone Mechanism of action, 4868 Phase I clinical trial, 823 Dihydrofolate reductase Sarcoma(s) Review, 293 Cytochemical study, 4256 Ethane, 2-(o-chlorophenyl)-2-(p.chlorophenyl)-I,1- Ultrastructural study, 4256 dichloro Spermatogenesis Analogs, 139 Cytotoxicity, testis cells, mouse, 3575 Hematopoietic stem cells Thymidine Immune response,mouse, 4564 PhaseI clinical trial, 4777 Hepatoma(s) Thymoma, 4856

DECEMBER 1979 5225 Subject Index to Volume39

Antineoplastic agents (cont'd) Aryl hydrocarbon hydroxyleses Toxicology Benz(a)anthracene Dose-response relationship, mouse, 2204 B-Lymphocytes, 4605, 4612 Triazinste Lymphocytes, mitogen-stimulated, 4620 Carboxypeptidase G, 3441 Benzo(a)pyrene Urea, 1-(2-chlorcethyl)-3-(4-methylcyclohexyl)-1-nitroso B-Lymphocytes, 4612 Antitumor activity, mouse, 934 Placental metabolism, 3177 Urea, hydroxy Smoking I 199 Related compounds, 844 Cholanthrene, 3-methyl Vincristine B-Lymphocytes, 4612 Adriamycin, 1071 Lymphocytes, mitogen-stimulated, 4620 Ovarian enzyme activity, mouse, 3471 Antipain Dibenz(a,h)anthracene Virus, Kirsten murine sarcoma B-Lymphocytes, 4605, 4612 Virus activation, 2995 Dibenzo-p-dioxin Apudoma B-Lymphocytes, 4612 Colonic neoplasms Dibenzo-p.dioxin, 2,3,7,8-tetrachloro Casereport, 4914 Lymphocytes, mitogen-stimulated, 4620 B-Lymphocytes are-A Mitogens, 4605 see 9H-Adenine, 9-/3-D-arabinofuranosyl Polycyclic aromatic hydrocarbons are-A derivatives Primordial oocyte toxicity, mouse, 3471 Leukemia Ll2lO Pyrrolidine, l-nitroso DNA synthesis,1563 Ethyl alcohol, 793 Aryl hydrocarbon moaooxygenase are-AMP see 9H-Adenine, 9-/3-D-arabinofuranosyl-, 5'- Benzo(a)pyrene 7,8-Diol, diol-epoxide, and tetrol derivatives, 2538 monophosphate era-C Aryl hydroxamic acids N, 0-Acyltransferase see Cytosine, l-/3-D-arabinofuranosyl Lactating mammary gland, rat, 3369 ara-CTP Leukemia L12l0 see Cytosine, l-/3-D-arabinofuranosyl-, 5'-triphosphate Ribonucleotide reductase, 844 are-U Arylamidase see Uracil, l-j3-D-arabinofuranosyl Liver neoplasms Immunological typing, 4212 Lung neoplasms Sec Cytosine, 1-@3-D-arabinofuranosy1-,5'-triphosphate Immunological typing, 4212 Stomachneoplasms 1-/3-D-Arebinofurenosyluracil Immunological typing, 4212 see Uracil, 1-13-D-arabinofuranosyl Ascitic fluid Carcinoma(s) 9-$-D-Arebinofurenosyladenine Ornithine decarboxylase, 1511 see 9H-Adenine, 9-13-D-arabinofuranosyl Fibrosarcoma(s) Ornithine decarboxylase, 1511 Leukemia Ll210 1-/3-D-Arebinofurenosylcytosine Ornithine decarboxylase, 1511 Sec Cytosine, l-/3-D-arabinofuranosyl Ovarian neoplasms Characterization, lymphocyte inhibitory factor Arginase 2381 Hepatoma(s) Immunosuppression, 2381 DNA synthesis, 1655 Lymphocyte transformation, 2381 Arginine Lymphocytotoxicity, 2381 Hepatoma(s) Ascorbic acid Thymidine incorporation, 1655 Chromosome aberrations Chinese hamster ovary cells, 4145 Arsenic Virus, adeno 7 Metals Co-carcinogenic effect, metal salts, 193 Chromosome aberrations, 4145 Neoplasms Arsenic acid, disodium salt Review, 663 Fibroblasts DNA-proteincross-links,704 Aspara@ DL-Aianine-N-carboxyanhydride Arsenite Enzyme properties, 1927 Carcinoma, Ehrlich tumor Therapeutic activity/immunologic properties, 1927 Glycolysis, 2195 Erwinia carotovora

5226 CANCER RESEARCH VOL.39 Subject Index to Volume39

Asparaginase(cont'd) 5-Azacytidine DL-Alanine-N-carboxyanhydride, 1927 RNA transfercytosine-5-methyltransferase Escherichia co/i Liver, mouse, in vivo/in vitr4 940 DL-Alanine-N-carboxyenhydride, 1927 5-Azauridine Leukemia, lymphoblestic Cell transformation, chemical Remission induction, child, 3893 Growth, 2718 Leukemia(s) Escherichia co/4 1927 6-Azauridine Polymermodification,1927 Leukemia L5178Y Plasma clearance Drug resistance,mutants, 4485 Polymer modification, 1927 Orotidine-5'-phosphate decarboxylase Drug resistance, mutants, 4485 Asparaglnase-glutamlnase Acinetobacter g/uraminsiuicans Azobenzene, 4-amino-J%@hydroxy Antitumor activity, succinylatedenzyme, 3145 Hepatoma(s) Toxicity, child patient, 3145 Carcinogenic activity, weanling rat, 3411 Carcinoma, epidermoid Azobenzene, N.ethyl-4-amino-N-hydroxy Antitumor activity, succinylated enzyme, 3145 Hepatoma(s) Leukemia,lymphoblastic Carcinogenic activity, weanling rat, 3411 Antitumor activity, succinylated enzyme, 3145 Azocine, octehydro-1-nitroso Leukemia, myeloblastic Lung neoplasms Antitumor activity, succinylated enzyme, 3145 Autoradiographic study, hamster, 72 Aspartic acid, J%@(phosphonoacetyl) Clara cells, 72 Leukemia Ll2lO Azoxymethane Cytosine nucleotides, 3089 see Methane, azoxy Nucleotides,3089 Uracil nucleotides, 3089 Bacillus Cahnette-Guerin Lungneoplasms Adriamycin Cytosine nucleotides, 3089 Immune response, mouse, 3014 Nucleotides, 3089 Bone marrow Uracil nucleotides, 3089 Colony-forming units, mouse, 2544 Orotic acid Corynebacterium parvum Metabolism,mouse,3089 Regenerating liver, rat, 1361 Pyrimidine synthesis Cyclophosphamide Antitumor activity, 3089 Antitumor activity, mouse, 4838 Metabolism,mouse,3089 Bone marrow, 2544 Colony-stimulating activity, serum, mouse, 2544 Immune response, mouse, 3014 s@ Sialic acid DNA synthesis Regenerating liver, rat, 1361 Ataxiatelangiectasie Endotoxins Anoxie Cellwall immunotherapy,1597 Fibrosarcoma(s) Fibroblasts, heterozygotes, 3725 Mineral oil emulsification, 535 Bleomycin Hepatoma(s) Chromosome aberrations, 1046 Cell wall immunotherapy, 1597, 1766 DNA repair, 1046 Metastases, 1597 Dose-response, lymphocytes, in vitro, 1046 Mineral oil emulsification, 535 DNA repair Neoplasm regression, guinea pig 1766 Fibroblasts, heterozygotes, 3725 Tumor cell vaccine, 1353 Gamma rays Immune status Fibroblests, heterozygotes, 3725 Placebo control, clinical study, 3720 Immunotherapy Bacterial cell-wall skeleton, 3262 Auromomycin Leukemia L12l0 DNA, viral Immunotherapy, 2807 DNA synthesisinhibition,in vitr4 2787 Leukocyte adherence inhibition Ethanol, 2-mercapto Immunity, cellular, 564, 593 DNA synthesisinhibition,in vitr4 2787 Lung neoplasms Lymphoblastoma Bacterial cell-wall skeleton, 3262 DNA synthesisinhibition,in vitro, 2787 Clinical trial, 3262 Intrapleural administration, hamster, 3673 5â€•Aza'2'-deoxycytidine Mammary neoplasms, experimental 3-Deazauridine Antitumor activity, mouse, 4838 Leukemia L1210, 3822 Metastases, 987 Mammary neoplasms, experimental, 3822 Melanoma(s) Synergistic cytotoxicity, 3822 Antigens, neoplasm, 2125

DECEMBER 1979 5227 Subject Index to Volume39

Bacillus Calmette-Guerin (cont'd) Benz(e)anthracene, 3,4-dihydro-3,4-dihydroxy-7,12-dimethyl Immune serums, 2125 Benz(e)anthracene,5,6-dihydro-5,6-dihydroxy-7,l2- Methanol-extraction residue dimethyl Placebo control, clinical study, 3720 Carcinogenic activity, mouse, 1934 Mineral oil Carcinogenic metabolite(s), 1934 Vaccines, emulsified, 1518 Papilloma(s) Peanut oil Carcinogenic activity, mouse, 1934 Vaccines, emulsified, 1518 Benz(a)anthrecene, 5,6-dihydro-5,6-epoxy Squalane Fibroblasts Antitumor activity, mouse, 1518 DNA-protein cross-links, 704 Vaccines, emulsified, 1518 Squalene Benz(e)anthrecene, 7,12-dimethyl Antitumor activity, mouse, 1518 Acriflevine Vaccines, emulsified, 1518 Carcinogenic activity, mouse, 2149 Surgery Anemia, aplastic Adjuvant therapy, rat, 987 Thyroidectomy, 4252 Trehalose-6,6'-dimycolate Aryl hydrocarbon hydroxylases Cell wall immunotherapy, 1597 Lymphocytes, mitogen-stimulated, 4620 Vaccine, tumor-cell Carcinogenic metabolites Antitumor activity, rat, in vivo 959 DNA binding 1154 Immune response, rat, 959 Cell transformation, neoplastic Transplacental host-mediated assay, 4525 Bacteriocins Chromosome aberrations Cell membrane Mucosal cells, Chinese hamster, 2510 Adsorption, 5114 Dibenzo-p-dioxin, 2,3,7,8-tetrachloro Cell transformation, viral Carcinogenesis inhibition, skin, mouse@4027 Cell adhesion, 5114 DNA adducts,4027 Lymphatic metastasis Diethyistilbestrol Cell adhesion, 5114 Synergistic activity, 4636 Mycobacterium smegmatis Transplacental carcinogenicity, hamster, 4636 Cell membrane, 5114 Epithelium Teratoid tumor Carcinogenesis, rat, 4829 Cell adhesion, 5114 Carcinogenesis, trachea, rat, 4823 Virus, SV4O Toxicity, trachea, rat, 4823 Cell transformation, viral, 5114 Tracheal transplants, rat, 4829 Bacteroides vulgatus Fibroblasts Fluorene, 2-nitro DNA-protein cross-links, 704 Fluoren-2-amine, 2026 Fluorinated derivatives Metabolism, 2026 Mutagenic activity, hamster V79 cells, 411 Gonadotropins Baker's antifol Estrus, 4700 see Triazinate Hepatoma(s) Barbituric acid, 5-ethyl-5-phenyl Cytotoxicity, normal vs neoplastic cells, 4925 Acetamide, N-fluoren-2-yl DNA binding 4925 Mutagenic metabolite, 1168 Leukemia(s) Dimethylamine, N-nitroso Thyroidectomy, 4252 Demethylase, 1587 Liver microsomes, mouse Fluoren-2-amine DNA binding I 154 Mutagenic metabolite, 1168 Mammary neoplasms, experimental Hepatoma(s) Adrenalectomy, 2436 m-Toluidine, N,N-dimethyl-4-(phenylazo)-, 112 Collagen, 2923 Estradiol benzoate, 2436 BCNU Streptozotocin, 2501 see Urea, 1,3-bis(2-chloroethyl)-l-nitroso Ouabain resistance Mutagenic activity, hamster V79 cells, 411 Hence Jones protein Ovarian neoplasms Fanconi syndrome Adenocarcinoma(s), 1108 Retinol, 4423 Ozone Benz(a)anthracene Ames test, 2149 Aryl hydrocarbon hydroxylases Papilloma(s) B-Lymphocytes, 4605, 4612 Retinoic acid, 419 Lymphocytes, mitogen-stimulated, 4620 13-cis-Retinoic acid, 419 Benzo(a)pyrene, 7,8-dihydro-7,8-dihydroxy Phorbol Lymphocytes, 3184 Strain sensitivity, mouse, 3345 Monocytes, 3184 Pituitary hormones Fibroblasts Serum levels, rat, 4700 DNA-protein cross-links, 704 Prolactin

5228 CANCER RESEARCH VOL.39 Subject Index to Volume39

Benz(a)anthracene,7,12-dimethyl-(cont'd) Benzldine (cont'd) Estrus, 4700 Carcinogenic metabolite, 3107 Retinoic acid Cholanthrene, 3-methyl Ornithine decarboxylase, 419 Carcinogenic metabolite, 3107 Skin neoplasms Microsomes, liver Papilloma(s), 411, 419 Carcinogenic metabolite, 3107 12-0-Tetradecanoylphorbol-l3-acetate, 419 Ozone Structure-activity relationship Ames test, 2155 Carcinogenic metabolite(s), 1934 Water pollutants, chemical, 2155 12-0-Tetradecenoylphorbol-13-acetate Benzidine,N@hydroxy-N,N-diacetyl Co-carcinogenic effect, mouse, 1293 Ornithine decerboxylase, 419 Acetyl coenzyme A Amestest, 3107 Stomach neoplasms, 1293 Thyroidectomy RNA, transfer Binding 3107 Carcinogenesis, rat, 4252 Virus, adeno 5 Benzo(a)pyren-3-ol Cell transformation, viral, 3051 Trachea Beaz(a)anthracene,7,12-dimethyl-2-fluoro Metabolism, organ/cell cultures, 1980 Skin neoplasms Benzo(a)pyren-9-ol Benz(a)anthracene, 7,l2-dimethyl-5-fluoro-, 411 Trachea Carcinogenicity, mouse, 411 Metabolism, organ/cell cultures, 1980 Benz(a)anthracene, 7,12-dimethyl-li-fluoro Benzo(a)pyrene Ouabainresistance Aging Mutagenicactivity,hamsterV79cells, 411 Microsomes, liver, 4752 Skin neoplasms Mutagenic metabolite, 4752 Papilloma(s),411 Aryl hydrocarbon hydroxylases Beaz(a)anthracene-7-methanol, 12-methyl B-Lymphocytes, 4612 Carcinogenic metabolites Placentalmetabolism,3177 DNA binding 1154 Barbituric acid, 5-ethyl-5-phenyl Liver microsomes, mouse Metabolism, liver/lung microsomes, 1199 DNA binding I 154 Benzo(a)pyrene, 4,5-oxide Propane, l,l,1-trichloro-2,3-epoxy Metabolism, liver/lung microsomes, 1199 DNA binding I 154 Benzo(a)pyrene quinones Liver microsomes,rat, 4123 Bea@mnIae, N,Ndimethyl-4-((3-methylphenyl)azo)- Binding, nucleolar RNA and DNA Liver neoplasms Embryo cells, hamster, 3463 Adenylosuccinate lyase, 2132 Bronchus AMP deaminase@2132 DNA binding 694 RNA Carcinogenic metabolites Cytoplasm, liver, rat, 4460 Chromatographic separation, 1814 Beanenamine, N-methyl-]%@nltroso Embryo cells, hamster, 3463 Demethylase Speciesdifference, 1199 Liver, rat, 1587 Cell transformation,neoplastic Oxidation Statistical model, â€˜one-hit'curve, 5069 Steady state kinetics and isotope effect, 1587 Cholanthrene, 3-methyl Metabolism,liver/lung microsomes, 1199 Bananas,4-sllyl-1,2-(methylenedioxy)- Chylomicrons Hepatoma(s) Lipoproteins, 1224 Perinatal carcinogenicity, 4378 Colon Kidney neoplasms DNA binding 694 Perinatal carcinogenicity, 4378 Corn oil Benzene,4-hydroxy-, â€˜y-L-glutaminyl Metabolism, liver/lung microsomes, 1199 Melanocytes Cyclohexenoxide Cytotoxicity, 1494 DNA adducts,diploidfibroblasts,human, 1083 Melanoma(s) Dibenzo-p-dioxin, 2,3,7,8-tetrachloro Antitumor activity, nude mouse, 1490 Carcinogenesis inhibition, skin, mouse, 4027 Benzoic acid, p-(dipropylsulfamoyl)-, 1490 DNA adducts, 4027 Tyrosinase 7,8-Diol, diol-epoxide, and tetrol derivatives Cytotoxicity, 1494 Cell cycle, liver epithelial cells, mouse, 2538 Quinone metabo1ite@1490 DNA 1,3-Beazenedismine,4-methoxy DNA adducts,epidermis,mouse,2556 Microsomes, liver DNA adducts,diploidfibroblasts,human Ames test, 3268 Aging, 1083 Dose-response relationship Beazidine DNA adducts,epidermis,mouse,2556 Acetylcoenzyme A Epoxidehydratase

DECEMBER 1979 5229 Subject Index to Volume39

Benzo(a)pyrene (cont'd) Benzo(a)pyrene, 7,8-dlhydro-9,1O-epoxy-7,8,9,1O-tetrahydro Placental metabolism, 3177 DNA adducts Esophagus Metabolism, fibroblasts, mouse embryo, 1673 DNA adducts,4401 Fibroblasts Fibroblasts DNA adducts, 1673 DNA adducts,1673 Skin neoplasms Hydroxyl metabolites Carcinogenic activity, mouse, 67 Chromatographic separation, 1814 Dekeratinization, 67 Lipoproteins Benzo(a)pyrene,7,8-dihydro-7,8,9-trihydroxy Cellmembrane,1224 Carcinogenic metabolites Metabolism, plasma, human, 1224 Chromatographic separation, 1814 Lungneoplasms Carcinogenic activity, neonatal mouse, 2660 Benzo(a)pyrene, 7,8-dihydrodiol DNA adducts,diploidfibroblasts,human, 1083 Benzo(a)pyrene quinones Lymphocytes Liver microsomes, rat, 4123 High-pressure liquid chromatography assay, 3184 Metabolites B-Lymphocytes Liver microsomes, ret, 4123 Metabolism, 4605 Uridine diphosphoglucuronic acid, 4123 Melanoma(s) Benzo(a)pyrene-1,6-dione DNA adducts,diploid fibroblasts,human, 1083 DNA synthesis Metabolites Thymidine incorporation, 3194 Liver microsomes, rat, 4123 Uridine diphosphoglucuronic acid, 4123 Benzo(a)pyrene-3,6-dione Microsomes, liver Oxygen Ames test, 4752 Cytotoxicity, 3194 Monocytes RNA synthesis Uridine incorporation, 3194 Metabolism, 3184 7,8-Napthoflavone Benzo(a)pyrene-6,12-dlone DNA adducts,diploidfibroblasts,human, 1083 Oxygen Ozone Cytotoxicity, 3194 Ames test, 2149 Benzo(a)pyrene, 2-hydroxy Propane, 1,l,1-trichloro-2,3-epoxy DNA adducts,diploidfibroblasts,human, 1083 Lung neoplasms Carcinogenic activity, neonatal mouse, 2660 Salmonella typhimurium Salmonellatyphimurium Metabolites, liver microsomes, 2660 Metabolites,liver microsomes, 2660 Mutagenic activity, Chinese hamster V79 cells Mutagenic activity, Chinese hamster V79 cells 2660 2660 Skin neoplasms Carcinogenic metabolite, 67 Benzo(a)pyrene, 6-hydroxy Dose-response study, mouse, 1718 Lung neoplasms Smoking Carcinogenic activity, neonatal mouse, 2660 Aryl hydrocarbon hydroxylases, I 199 Salmonella typhimurium Carcinogenic metabolites, 3177 Metabolites, liver microsomes, 2660 Placental metabolism, 3177 Mutagenic activity, Chinese hamster V79 cells 12-0-Tetradecanoylphorbol-13-acetate 2660 Metabolism, trachea, rat, 1980 Benzo(a)pyrene, 4,5-oxide Trachea Epoxidehydrase Metabolism, organ/cell cultures, 1980 Conjugatedmetabolites,liver, rat, 2051 Virus, adeno 5 Glutathione transferases Cell transformation, viral, 3051 Conjugated metabolites, liver, rat, 2051 Benzo(a)pyrene, 4,5-dihydro-4,5-dihydroxy Metabolismand excretion,rat, 2051 Metabolism and excretion, rat, 2051 Benzo(a)pyrene quinones Benzo(a)pyrene, 7,8-dihydro-7,8-dihydroxy Benzo(a)pyrene Benz(a)anthracene Liver microsomes, rat, 4123 Lymphocytes, 3184 Benzo(a)pyrene, 7,8-dihydrodiol Monocytes, 3184 Liver microsomes, rat, 4123 Lymphocytes Benzo(e)pyrene High-pressure liquid chromatography assay, 3184 Binding, nucleolar RNA and DNA Monocytes Embryo cells, hamster, 3463 Metabolism, 3184 Carcinogenic metabolites Trachea Embryo cells, hamster, 3463 Metabolism, organ/cell cultures, 1980 5,6-Benzoflavone Benzo(a)pyrene, 9,1O-dihydro-9,10-dihydroxy Acetamide, N-fluoren-2-yl Trachea Nucleic acids, binding 3268 Metabolism, trachea, rat, 1980 Aryl hydrocarbon hydroxylases

5230 CANCER RESEARCH VOL.39 Subject Index to Volume39

5,6-Benzoflavone (coat'd) Bladder neoplasms (cont'd) Lymphocytes,mitogen-stimulated,4620 Concanavalin A, 3353 Ozone l3-cis-Retinoic acid Ames test, 2149 Dose-response study, rat, 3141 7,8-Benzoflavone Bleomycin Aryl hydrocarbon hydroxylases Amphotericin B, 5150 Lymphocytes, mitogen-stimulated, 4620 Ataxia telangiectasia Beuzoic acid, chloroacetylmethyl ester Chromosome aberrations, 1046 Erythroleukemia DNA repair, 1046 Cercinogenicity, cells, 3583 Dose-response,lymphocytes,in vitro, 1046 Cytotoxicity, cells, 3583 Cell survival Dihydroxyacetoneanalogs, 3583 Dye exclusiontests, 1428 Immunogenicity, cells, 3583 Disgerminoma Pulmonary function tests, 5076 Benzole acid, p4dlpropylsulfamoyl)- DNA, circular Melanoma(s) Pharmacokinetic assay, serum, cancer patients Benzene, 4-hydroxy-, â€˜y-L-glutaminyl-, 1490 3948 Betel nut Epithelium DNA synthesis Ultrastructural study, rat, 4218 L/neoplestic cells, rat, mouse, 4802 Filipin, 5150 Lymphocytes, human, 4802 Hepatocytes Ultrastructural study, rat, 4218 BHA Hyperthermia s@ Phenol, 2-tert-butyl-4-methoxy Synergistic antitumor activity, mouse, 3792 Bilirubin Hyperthermia, localized Alpha fetoprotein Cytotoxicity in vitro/in vivo, 2269 Carrier proteins, 3571 Review, 2264 Lung neoplasms Binding proteins Hyperthermia, 3792 s@ Carrier proteins Neocarzinostatin Bladder neoplasms Synergistic activity, tumor cells, 3768 Antigens, neoplasm Nystatin, 5150 Immunity, cellular, 1985 Pentamycin,5150 1-Butanamine, N-butyl-N-nitroso Pimaricin, 5150 Urinary excretion, human, 829 Platinum(II), diamminedichloro-, cis 1-Butanol, 4-(butylnitrosamino)- Toxicity, 5076 Disulfide, bis(diethylthiocarbamoyl)-, 3040 Synergistic activity, hamster cells, in vitr4 5150 Histological study, rat, 3040 Testicular neoplasms l3-cis-Retinoic acid, 3141 Pulmonary function tests, 5076 Carcinoma, transitional cell Tongue neoplasms Clonogenic cell assay, 5051 Carcinoma(s), 4645 Immunity,cellular, 1985 Necrosis, 4645 Karyotyping 5051 Vinblastine Ultrastructural study, 5051 Toxicity, 5076 Dimethylamine, N-nitroso Urinary excretion, human, 829 Blood platelets Disulfide, bis(diethylthiocarbamoyl) Liver neoplasms Carcinogenesis inhibition, 3040 Metastases, 2031 Estrogen Blood proteins Receptors, hormone, 2614 Hepetoma(s) Formamide,N-[4-(5-nitro-2-furyl)-2-thiazolyl]- Transplantation, heterologous, 1819 Sodiumsaccharin, 1207 Tryptophan, 1207 Blood urea nitrogen Ultrastructural study, rat, 1207 Platinum (II), diamminedichloro-, cis Galactosyl transferase Anthranilic acid, 4-chloro-N-furfuryl-5-sulfamoyl Assay, human, 3856 1269 Leukocytes Mannitol, 1269 Cellmigrationinhibition, 1985 Bloom's syndrome Lymphnodes DNA repair Lymphocyte stimulation, 2120 Nucleicacids Virus, herpes simplex 1, 3392 Ultraviolet rays Lymph nodes, 2120 Papilloma(s) Virus, herpes simplex I, 3392 Formamide, N-[4-(5-nitro-2-furyl)-2-thiazolyl]- Body temperature 1207 Thermotolerance Precancerousconditions X-rays, 396

DECEMBER 1979 5231 Subject Index to Volume39

Body weight Breast neoplasms(cont'd) Hepatoma(s) Dose-response study, 1552 Short-term survival, rat, 2371 Hematopoiesis, 527 Androgen Bone marrow Receptors,hormone, 1447 Bacillus Calmette- Guerin Blood cell count Colony-forming units, mouse, 2544 Prognosis, 1552 Cyclophosphamide, 2544 Carcinoma, ductal Carcinoma, Walker 256 Glycoproteins, 2057 Cytolysis, 1193 Metastases, 2057 Dibutyryl cyclic AMP, I 193 Carcinoma(s) Hematopoietic stem cells Catechol-0-methyltransferase, 4584 Diffusable stimulatory factor, 3959 Glycoproteins, 2057 Hyperthermis Receptors, hormone, 1835 Urea, N,JV'-bis(2-chloroethyl)-N-nitroso-, 2547 Steroid hydroxylases, 4584 Leukemia, myelocytic Thymidine labeling index, 4042 Colony formation, 1575 Carcinoma, scirrhous Mammary neoplasms, experimental Receptors, hormone, 1835 Tumor growth kinetics, EMT, cells, mouse, 3959 Cells, cultured Peptide hydrolases Morphological/biochemical properties, 2604 Tumor-induced cytotoxicity, 1193 Chemotherapy Transformed fibroblasts, rat Metastases, 4503 Cytotoxicity of tumor cells, 30 Sequential vs combination, 4503 Virus, C-type RNA tumor Cortisol Virus replication, 4322 Receptors,hormone, 1973 Brain neoplasms Cyclophosphamide ACNU Dose-response study, 1552 Cyclophosphamide, 2687 Dexamethasone Metastatic brain tumor model, rat, 2687 Insulin, 2422 Primary brain tumor model, rat, 2687 Nucleoside uptake, in vitro, 2422 Antineoplastic agents Thymidine kinase@2422 ACNU, 2687 Diet 3-Deazauridine Mortality, United States, 3628 Penetration blood-brain barrier, human, 4119 Diethylstilbestrol Dihydrofolate reductase Receptors, hormone, 1973 Methotrexate titration assay, 487 Drug therapy, combination Normal/neoplastic brain tissue, embryo/neonatal Prognosis, 1552 rat, 487 Estradiol Glioma Binding assay, tissue culture, human, 3319 Antigenic determinants, 3235 Plasma levels, 1835 Immunoglobulins Receptors, hormone, 1835 Serum levels, human, 542 Serum albumin, 3319 Medulloblastoms Tamoxifen, 3319 Cerebrospinal fluid, human, 993 Estrogen Polyamines, 993 Receptors, hormone, 1447 Metastases Estrogen sulfotransferase Animal model, mouse, 1001 Adenosine3':S'-phosphosulfate,5124 Radiation, ionizing 1001 Receptors, hormone, 5124 Proteins Glucocorticoids Serum levels, human, 542 Receptors, hormone, 1447 Putrescine Glycoproteins Biochemical marker, neoplasms, human, 5010 Antigenic determinants, 2057 Pyruvate kinase Glycosaminoglycans Cell differentiation, neoplastic, 4263 Isolation and characterization, 870 Sarcoma(s) Immunologic deficiency syndromes Animal model, mouse, 1001 Animal model, asplenic mouse, 1529 Spermidine Insulin Biochemical marker, neoplasms, human, 5010 Binding, cultured cells, 2422 Spirohydantoin mustard Intercellular junctions Cell cycle kinetics, 4336 Uridine nucleotide transfer study, 4739 DNA synthesis,4336 Karyotyping T-2 toxin Cells, cultured, 2604 Histological study, rat, 2179 Leukocyte adherence inhibition Breast neoplasms Identification of high-risk patients, 654 Adenocarcinoma(s) T-Lymphocytes Chemotherapy, 4503 Antigen-stimulated rosette forming assay, 4796 Adriamycin Antigens, neoplasm, 4796

5232 CANCER RESEARCH VOL.39 Subject Index to Volume39

Breast neoplasms(cont'd) Burkitt's lymphoma(cont'd) Histocompatibility antigens, 4796 Liquid suspension culture Metastases Agar clonal culture, 1749 Prognosis, 1552 Methanesulfonic acid, methyl ester Receptors,hormone, 1447 Lymphoblastoid cell lines, human, 312 Thymidinelabelingindex, 4042 Peptides Tyrosinase, 3485 Macrophagecytotoxicity, 1847 Neoplasm transplantation Putrescine Cells, cultured, 2604 Cell cycle kinetics, 2429 Progesterone Spermidine Plasma levels, 1835 Cell cycle kinetics, 2429 Receptors, hormone, 1447, 1678, 1835 Spermine Prolactin Cell cycle kinetics, 2429 Plasma levels, 1835 Thymidine Receptors, hormone, 4381 DNA, 312 Radiotherapy Uridine, 5-bromo-2'-deoxy Prognosis, 1552 DNA, 312 Receptore, hormone Estrogen, 1124 Frozen tissue, 1124 1-Butanol, 4-thutylnltrosemino)- Metastases,1973 Bladder neoplasms Sucrose gradient assay, 1678 Disulfide, bis(diethylthiocarbamoyl).., 30413 Tissueculture,4381 Histological study, rat, 3040 Tumor size and location, 1447 13-cis-Retinoic acid, 3141 Retinoic acid Urinary excretion, human, 829 Growth inhibition, human cell, in vitr4 1014 Diethylamine, N-nitroso RNA@viral Urinary excretion,human, 829 DNA-RNA hybridization,5106 Precancerousconditions Sialyltransferase Epithelial cells, bladder mucosa, rat, 3353 Isolation and characterization, human serum, 1231 Ultrastructural study, 3353 Steroid hydroxylases Precancerous conditions, 4584 Tamoxifen 2(3)-tert-Butyl-4-hydroxyanisole see Phenol, 2-tert-butyl-4-methoxy Receptors, hormone, 1973 Thymidinelabelingindex J%Z@Butyl@N.((4-hydroxybutyl)nifroumine)- Patient prognosis, 4042 s@ 1-Butanol, 4-(butylnitrosamino)- Uracil, 5-fluoro Butyric acid, 2-amino-4-(ethylthio)- Dose-response study, 1552 Virus,Mason-Pfizermonkey Liver neoplasms Adenylosuccinate lyase, 2132 RNA, viral, 5106 Virus, murine mammarytumor Butyric acid, 2-amino-4-mercapto RNA, viral, 5106 Protein arginine methyltransferase &Adenosyl analogs, 4497 A@Brooacetyl-$-D-geIactosam1netetra-O-acetate Virus, Rous sarcoma Carcinoma, Ehrlich tumor Cell transformation, viral, 4497 Immune stimulation, mouse, 3897 Mechanism of action, in vitro vs in vivo@ 3897 Butyric acid, 4-[pbis(2-chloroethyl)aminophenyl]- Leukemia L1210 Prednisolone Immune stimulation, mouse, 3897 Carcinoma,Walker 256, 4256 Mechanismof action,in vitro vsin vivo, 3897 Sarcoma(s), 4256 N@Bromoacetyl-js-u-glucosamlne tetra-0-acetate Butyric acid, sodium salt Antineoplasticagents HeLa cells Carcinoma,Ehrlich tumor, 3897 Gonadotropins, chorionic, 3885 Leukemia L1210, 3897 Hepatoma(s) Carcinoma,Ehrlichtumor Cell transformation, neoplastic, 800 Immune stimulation, mouse, 3897 Interferon Mechanism of action, in vitro vs in viva 3897 Antitumor activity, 4720 Leukemia L1210 Leukemia Ll2lO Immune stimulation, mouse, 3897 Interferon, 4720 Mechanism of action, in vitro vs in vivo@ 3897 Sarcoma(s) Interferon, 4720 Bromodeoxyurldine s@ Uridine, 5-bromo-2'-deoxy Cadmium Burldttâ€•slymphoma Virus, adeno 7 Co-carcinogenic effect, metal salts, 193 Hyperbaric oxygen Adriamycin, 370 Caffeine Nitrogen mustard, 370 Carbamicacid, ethyl ester

DECEMBER 1979 5233 Subject Index to Volume39

Caffeine (cont'd) Carboxypeptidese G, (cont'd) Mutagenic activity, Drosophila melanogaste, 4224 Triazinate, 3441 Cell transformation, chemical Pyrimidine, 2,4-diamino-5-(3,4-dichlorophenyl)4.methyl Growth, 2718 Synergistic activity, rat, in vitro/in viv4 3441 Cell transformation, neoplastic Triazinate Growth inhibition, mixed normal and malignant fi Synergistic activity, rat, in vitro/in viv4 3441 broblasts, 3502 Leukemia Ll2lO Carcinoembryonic antigen Neocarzinostatin, 1623 Colonic neoplasms Neocarzinostatin Nude mouse, 2160 Cytotoxicity, 1623 Transplantation, heterologous, 2160 Purines Cystadenoma, mucinous Synthesis,4975 Isolation and characterization, cyst fluid, 1760 Ultraviolet rays Receptors,concanavalinA, 1760 DNA repair, 4975 Histaminase Lethality, CHO-KI cells, 4975 Malignant effusion fluid, human, 4894 Purines, 4975 Ovarian neoplasms Cystadenoma, mucinous, 1760 Calcium Prostate neoplasms Cell transformation, neoplastic Isolation and characterization, 2447 Epithelium, 4441 Hepatoma(s) Carcinogenesis Carrier proteins, 3000 Alcohol Phosphodiesterase, 3000 Review, 2887 Cancer patient Carcinogens, chemical Hospices Ascorbic acid Administration, 2859 Review, 663 Role of the physician, 2859 Escherichia coil Candidaalbicans Tryptophan auxotrophs, 682 Viral proteins Mutagenicity vs carcinogenicity Lymphocyte transformation, 443 Review, 3289 Sa/monlla typhimurium Cerbemic ecid, ethyl ester Histidine suxotrophs, 682 Caffeine Structure-activity relationship Mutagenic activity, Drosophila melanogaste, 4224 Letter to the editor, 4760 Gamma radiation Mutagenic activity, Drosophila melanogaste, 4224 Carcinoma, basal cell Collagenese Carbemic acid, lithium salt Fibroblasts, 4594 Bone marrow Gynecologic neoplasms Myeloid colony formation, human, in vitr4 3215 Estradiol,2591 Cell adhesion Myeloid colony formation, human, in vitr4 3215 Cercinoma, ductal Breastneoplasms Carbamic acid, ]V@methy1-]%@nitroso-,ethyl ester Glycoproteins, 2057 Cell transformation, neoplastic Metastases, 2057 Transplacental host-mediated assay, 4525 Pancreatic neoplasms Colonic neoplasms Dipropylamine, 2,2'-dioxo-N-nitroso-, 452 Transplantation immunology, I 174 Carcinoma, Ehrlich tumor Carbohydrates Acetic acid, aminooxy Cell transformation, viral Malate-aspartateshuttle, 2195 Fibroblasts, chick embryo@ 2550 Antineoplastic agents Growth condition variation N-Bromoacetyl-$-D-glucosamine tetra- 0-acetate Fibroblasts, chick embryo@ 2550 3897 Temperature Dactylarin, 4242 Fibroblasts, chick embryo, 2550 Arsenite Virus, Rous sarcoma Glycolysis, 2195 Fibroblasts, chick embryo, 2550 Cell movement Carbon tetrechioride Oxygenuptake, 250 Metabolism, liver, rat, in vitr4 3942 Diabetes mellitus Carboxylic acid, f3-2-eminobicyclo(2,2,1)heptene Neoplasm transplantation, 1807 Leukemia(s) Fatty acids Melphalan, 353 Oxidation, in viv4 973 Carboxypeptidase G Fibronectin Carcinoma, Walker 256 Plasma/ascitic fluid, mouse, in vivo, 3774 Pyrimidine, 2,4-diamino-5-(3,4-dichlorophenyl)-6- Growth methyl-, 3441 Diabetic mouse, 1807

5234 CANCER RESEARCH VOL.39 Subject Index to Volume39

Carcinoma,Ehrlich tumor (cont'd) Carcinoma,medullary Guanosine, 5'-deoxy- see Carcinoma(s) Ribonucleotide reductase, 4600 Inosine Carcinoma, oat cell Ribonucleotide reductase@4600 Thymidine Insulin Xenografts, nude mice, 3875 Antitumor activity, 1807 Carcinoma, renal cell Lactate dehydrogenase see Adenocarcinoma(s) Glycolysis, 2195 Lectins Carcinoma(s) Rana japonica, 1347 5a-Androstan-3-one, 17$-hydroxy Receptor, glycoprotein, 1347 Receptors, hormone, 4713 Membrane proteins Antigens, neoplasm Agglutination, 1347 Characterization, 1683 NAD Ascitic fluid Oxidation-reduction, 2195 Ornithine decarboxylase@1511 Neoplesmtransplantation Biochemicalandbiologicalproperties Mouse, dystrophic strain, 2139 Cultured cells@4732 Oxamate Breast neoplasms Malate-espartateshuttle, 2195 Catechol-0-methyltransferase,4584 Palmitate Glycoproteins,2057 Oxidation, in viv4 973 Receptors, hormone, 1835 Palmitic acid Steroid hydroxylases, 4584 Metabolism, 5118 Thymidine labeling index, 4042 Pyridoxal phosphate Chromosome abnormalities Ribonucleotide reductase, 4600 Neoplasm transplantation, 4713 Quinoline, 4-nitro-, 1-oxide Diethylstilbestrol Nonproteinthiols, 2961 Kidney,hamster,2647 Thiosemicarbazones Hyperthermia Ribonucleotide reductase, 4600 Intratumoral injection with fine needle, rabbit Triglycerides 3429 Metabolism,5118 Radio-frequencyheating,2236 Zinc Immune serums DNA, 2457 Ornithinedecarboxylase,1511 Glycolysis, 2457 Kidney neoplasms Oxidative phosphorylation, 2457 New cell line, 4694 RNA, 2457 Receptors, hormone, 2647 Ultrestructural study, 2457 Mammary neoplasms,experimental Adriamycin, 4466 Carcinoma,epidermold Cyclophosphamide,4466 Antigens, nucleolar Methotrexate, 4466 Immunofluorescence, 3024 Uracil, 5-fluoro-, 4466 Asparaginase-glutaminase Neoplasmtransplantation Antitumor activity, succinylated enzyme, 3145 Nude mouse, 4713 Gynecologicneoplasms Norepinephrine Estradiol, 2591 Angiography, hepatic, 1898 Immunogenicity Rabbit V2 tumor, 1898 Chemically-induced respiratory tract tumors, rat Ornithine decarboxylase 2466 Neoplastic cell assay, 1511 Morphological markers Receptors, hormone Trachea,rat, 2390 Celldifferentiation,4713 Neoplesmtransplantation Kidney, hamster, 2647 Chemically-induced respiratory tract tumors, rat Sodium chloride 2466 Intratumoral injection with fine needle, rabbit Neoplasms, multiple primary 3429 Epidermodysplasia verruciformis, 1074 Stomach neoplasms Skin neoplasms Alkaline phosphatase, 4732 Ultravioletrays, 408 Prednisolone,4732 12-0-Tetradecanoylphorbol-13-acetate Tongue neoplasms Tumor-promoting activity, skin, mouse, 2644 Bleomycin, 4645 Transplantation, homologous Transplantation, heterologous I.v. injection, neoplasticcells, 4724 Hyperthermia, 2236 Metastases,4724 Carcinoma, scirrhous Carcinoma,lobular Breastneoplasms see Carcinoma(s) Receptors, hormone, 1835

DECEMBER1979 5235 Subject Index to Volume39

Carcinoma, spindle cell Carrier proteins (cont'd) see Carcinoma(s) Cervix neoplasms trans-Retinoic acid, 3114 Carcinoma, squamous cell Retinol, 3114 s@ Carcinoma, epidermoid Fanconi syndrome Carcinoma, transitional cell Retinol, 4423 Bladder neoplasms Hepatoma(s) Clonogenic cell assay, 5051 Calcium, 3000 Immunity, cellular, 1985 Isolation and characterization, 3000 Karyotyping 5051 Isolation and characterization Ultrastructural study, 5051 Normal/regenerating/neoplestic liver, fetal/adult Galactosyl transferase rat, 3000 Assay, human, 3856 LeUkemia, plasmacytic Ultrastructural study, human bladder, 3856 Retinol, 4423 Neuroblastoma(s) Carcinoma,ACNUWalker 256 Adenosinecyclic3':5'-monophosphate,3007 Isolation and characterization, human, 3007 Cyclophosphamide, 2687 Ovarian neoplasms Metas@aticbrain tumor model, rat, 2691 DNA, 4341 Amino acids Plasma/brainconcentrations, 3065 PleuralDNA,neoplasms4341 Anorexia Amino acids, 3065 Catechol-O-methylfransferase Bone marrow Breast neoplasms Cytolysis, 1193 Carcinoma(s), 4584 CCNU c@NU Metastatic brain tumor model, rat, 2691 Carcinoma, Walker 256 CyclophosphamideMetastaticbrain tumor model, rat, 2691 Metastatic brain tumor model, rat, 2691 Dexamethasone Cell adhesion Metastaticbrain tumor model, rat, 2691 Cell transformation,viral Dibutyryl cyclic AMP Bacteriocins, 5114 Bone marrow, 1193 Lymphatic metastasis Electrophoretic mobility Bacteriocins, 5114 Metastases, 2481 Metastases Metastases In vitro model system, fibroblasts, hamster, 2001 Electrophoretic mobility, 2481 Teratoid tumor Site-associated modification, 2481 Bacteriocins, 5114 Methyl-CCNU @ Metastatic brain tumor model, rat, 2691 aggre8atlon Melanoma(s) Neocarzinostatin In vitro model system, fibroblasts, hamster, 2001 Pharmacokinetics, mouse, rat, 1547 Neuraminidase Cell cycle Electrophoretic mobility, 2481 9,10-Anthracenedione, l,4-bis((2-([2- Norepinephrine hydroxyethyl]emino)-ethyl)amino-diacetate Angiography, hepetic, 1898 Cytotoxicity, in vitr4 2574 Prednisolone Urea, hydroxy Butyricacid,4..[p-bis(2-chloroethyl)aminophenyl]- Synchronizedhamsterembryocells, 2356 4256 Cyclophosphamide, 4256 Cell differentiation L-Sarcolysin, 4256 Brain neoplasms Procarbazine Pyruvete kinase, 4263 Metastatic brain tumor model, rat, 2691 Carcinoma(s) Pyrimidine, 2,4-diamino-5-(3,4-dichlorophenyl)-6-methyl- Receptors, hormone, 4713 Carboxypeptidase0,, 3441 Choriocarcinoma Triazinate Methotrexate, 1960 CarboxypeptidaseG,, 3441 Ultrastructural study, BeWocells, 1960 Uracil, 5-fluoro- Dexamethasone Orotidine-5'phosphate decarboxylase, 3095 Indomethacin, 2190 Dimethyl sulfoxide Carminomycin Melanoma(s), 2618 Heart Epitheium Nucleolar ultrastructure, rat, 1239 hillipore diffusion chamber implants, 1467 Skeletal muscle Erythroleukemia Nucleolar ultrastructure, rat, 1239 Cytokinesis, 4058 Carrier proteins Dexamethasone@ 3849 Alpha fetoprotein Dimethyl sulfoxide, 1113 Bilirubin, 3571 12-0-Tetradecanoylphorbol-13-acetate, 1989

5236 CANCER RESEARCH VOL.39 Subject Index to Volume39

Cell differentiation (cont'd) Cell survival Fibroblasts Radiation, ionizing Milhipore diffusion chamber implants, 1467 Hoechst33432,1891 Leukemia,myelocytic Viable cell count Ascitic fluid factor, 1056 Dyeexclusionmethod,4288 Dexamethasone@2190 Letter to the editor, 4288 D-Factor, 4170 Cell transformation Immunity, cellular, 3167 Colony-stimulating factor Indomethacin, 2190 Isolation and characterization, 5127 Isolation and characterization, 1056 Leukemia,myelocytic Lipopolyssccharides, 4668 Sarcoma,Yoshida, 5127 Phorbol esters, 4668 Spleen cells, MOPC-315-bearing mouse ProstaglandinsE, 2190 Cytotoxicity, in vitr4 785 RNA, 4170 Xeroderma pigmentosum 12-0-Tetradecanoylphorbol-13-acetate, 4668 Virus, SV4O, 4064 Virus, Rauscher, 1056 Melanoma(s) Cell transformation,chemical Cholanthrene,3-methyl Phorbolesters,3915 Proteaseinhibitors, 2755 12-0-Tetradecanoylphorbol-13-acetate, 3915 Growth Peptides Cell transformation, viral, 2718 Mammae@2046 Virus, herpes simplex 2 Phorbol-12,13-diacetate Urea, N-methyl-N-nitroso-, 1041 Melanoma(s),2618 Phorbol dibutyrate Cell transformation,neoplastic Melanoma(s),2618 Acetamide,N-fluoren-2-yl Phorbol-12-myristate-13-acetate Photosensitive analogs, 3903 Melanoma(s), 2618 Ultraviolet radiation, 3903 Adenocarcinoma(s) Amidophosphoribosyltransferase, 3909 Cell divisioa Adenosine cyclic 2':3'-monophosphate L cells Growth inhibition, mixed normal and malignant fi Pyruvaldehyde bis(amidinohydrazone), 1919 broblasts, 3502 a-Amanitin Call membrane DNA synthesis,4516 Alcohol Benz(a)anthracene, 7,12-dimethyl Mechanismsof carcinogenesis,review, 2899 Transplacental host-mediated assay, 4525 Bacteriocins Benzo(a)pyrene Adsorption, 5114 Statistical model, â€˜one-hit'curve, 5069 Mycobacterium smegmatis, 5114 Caffeine Cell transformation,neoplastic Growth inhibition, mixed normal and malignant fi Lipids,4350 broblasts, 3502 Normal/neoplastic liver, rat, 1026 Carbamic acid, N-methyl-N-nitroso-, ethyl ester Glycoproteins Transplacental host-mediated assay, 4525 Cell lines, hamster Cell transformation, neoplastic, 2595 Colony formation, 1505 Neuraminidase, 2595 Tumorgenicity vs growth characteristics, 1505 Hyperthermia Cell membrane Microfilament complex, 1911 Lipids,4350 Mitosis, 1911 Cell surface properties Lung neoplasms Normal/neoplastic liver, rat, 1026 Antigenic determinants, 2935 Cholanthrene, 3-methyl Proteins, 2935 Retinoids, 1661 RNA, 4516 Cell transformation, neoplastic, 2595 RNA polymerases,4516 Neureminidase, 2595 Dibutyryl cyclic AMP Cell membranepermeability Growth inhibition, mixed normal and malignant fi Leukemia L1210 broblasts, 3502 Dietary fats, 1726 Dimethylamine, N-nitroso Methotrexate, 1726 Transplacentalhost-mediatedassay, 4525 Epithelium Cell movement Calcium, 4441 Carcinoma,Ehrich tumor Glucose, 2-deoxy-, 4441 Oxygen uptake, 250 Glutamyl transpeptidase, 4441 Glucose Liver, rat, 4441 Tumor vs normal thymus cells, 250 Trachea, rat, 2390 Oxygen uptake Fibrinolysis Tumor vs normal thymus cells, 250 Cell lines, hamster, 1505

DECEMBER 1979 5237 Subject Index to Volume39

Cell transformation, neoplastic (cont'd) Cell transformation, viral (cont'd) Fluorescent light Cortisol Chromosome abnormalities, 929 Fibronectin, 2077 Glycoproteins Procollagen, 2077 Cell membrane, 2595 Dexamethasone Growth, soft agar Fibronectin, 2077 Normal/neoplastic liver, rat, 1026 Procollagen, 2077 Guanidine, N-methyl-N-nitro-N-nitroso Fibronectin Tracheal mucosa, rat, in vitr4 4091 Immunoprecipitation, 1803 Hepatoma(s) Ornithine decarboxylase Butyrate, sodium, 800 Embryo cells, human, 864 Cell surface properties, 1026 Phenotype Dimethyl sulfoxide, 800 Embryo cells, rat, 3051 Growth, soft agar, 1026 Polyamines Mallory bodies, 800 Embryo cells, human, 864 Ultrastructural study, 800 12-O-Tetradecanoylphorbol-l3-acetste Kidney neoplasms Collagen, 1667 Plate-induced tumor cell lines, mouse, 2172 Embryo cells, rat, 3051 Mammary neoplasms,experimental Phospholipids, 2743 Tissue culture, mouse, 1784 Plasminogen activators, 1579 Metal salts Virus, adeno 2 Syrian hamster cells, 1008 Ultraviolet rays, 1455 Morphological markers Virus, adeno 5 Trachea, rat, 2390 Benz(a)anthracene, 7,12-dimethyl-, 3051 Mycoplasma hyorhinis Benzo(a)pyrene, 3051 Cell surface properties, 1026 Temperature sensitivemutants, 3051 Nickel subsulfide Virus, adeno 7 Fetal cells, hamster, 3591 Co-carcinogenic effect, metal salts, 193 Pesticides Virus, B77 Nitroso compounds, 4525 Fibronectin, 1803 Phosphodiesterase inhibitors Virus, bovine adeno 3 Growth inhibition, mixed normal and malignant fi Angiogenesisfactor, 1305 broblasts,3502 Virus, herpes simplex 2 Proteins Chromosomes, 3225 Cell membrane, 2595 Polypeptides, 3225 Radiation, ionizing Virus, Rous sarcoma Dose fractionation, 123 Butyric acid, 2-amino-4-mercapto, 4497 Dose-response study, 1474 Collagen, 1667 Dose-response study, embryo cells, mouse, 123 Hypoxanthine, 1855 Hamster cells, 5069 Methotrexate, 1855 Mouse 3T3 cells, 1474 Protein arginine methyltransferase, 4497 Neutrons, 123 Thymidine, 1855 Statistical model, â€˜one-hit'curve, 5069 Virus, SV4O Receptors, hormone Bacteriocins, 5114 Fibroblasts, Syrian hamster embryo, 4166 Fibronectin, 2077 Superoxide dismutase Procollagen, 2077 Manganese depletion, review, 1141 Theophylline Cells, colony-forming Growth inhibition, mixed normal and malignant fi Leukemia, myelocytic broblasts, 3502 Myeloblasts, 2704 Ultraviolet rays Myelocytes, 2704 Dose-response study, 1474 Cervix neoplasms Mouse 3T3 cells, 1474 trans-Retinoic acid Uridine, 5-fluoro Carrier proteins, 3114 DNA synthesis, 4516 Retinol Virus, murine leukemia RNA, viral, 321 Carrier proteins, 3114 Xanthine, 3-isobutyl-l-methyl Precancerous conditions, 3114 Virus, herpes simplex 2 Growth inhibition, mixed normal and malignant fi broblasts, 3502 Serum antibody levels, patients, 4022 Chalones Cell transformation, viral Bacteriocins Skin neoplasms Cell adhesion, 5114 Antitumor activity, mouse, in vivo@ 239 Carbohydrates Purification, epidermal G, chalone, 239 Fibroblasts, chick embryo, 2550 Chemotherapy Cell transformation, chemical Breast neoplasms Growth, 2718 Adenocarcinoma(s), 4503

5238 CANCER RESEARCH VOL.39 Subject Index to Volume39 chemotherapy(cont'd) ChoLanthrene,9,10-dihydro-9,10-dihydroxy-3-methyl Metastases,4503 Microsomes,liver Sequential vs combination, 4503 DNA, binding 4316 Hyperthermia Cholanthrene, 11,2-dihydro-11,12-dihydroxy-3-methyl Review, 2285 Microsomes, liver Synergistic effects, 2285 DNA, binding 4316 Hyperthermie, systemic Waterblanketset, 2252 Cholanthrene,3-methyl Leukemia, lymphoblastic Acetamide, N-fluoren-2-y1- Review, 4301 DNA binding 1089 Mammary neoplasms, experimental Mutagenic metabolite, 1168 Metastases, 4466 Nuclei, liver, rat, 1089 Aryl hydrocarbon hydroxylases Chlorsmbucil B-Lymphocytes, 4612 s@ Butyric acid, 4..[p.bis(2-chloroethyl)aminophenyl]- Lymphocytes, mitogen-stimulated, 4620 @hlordane Benzidine Alphafetoprotein Carcinogenicmetabolite,3107 Carcinogenesis, mouse, 3491 Carcinogenic metabolites Precancerous conditions, 3491 Newborn mouse, 3549 Hepatoma(s) Skin, mouse, 3549 Alpha fetoprotein, 3491 Cell transformation, chemical Protease inhibitors, 2755 4.cldoro4-butanol DNA synthesis s@ 2-Propanol, 1,1,1-trichloro-2-methyl- Call transformation, neoplsstic, 4516 Fibrosarcoma(s) [email protected] benzoate ser Benzoic acid, chioroacetylmethyl ester Fetal globulins, 2006 Hyperthermia, 3248 4-Chloro-2-methylenlline Fluoren-2-amine s@ o-Toluidine, 4-chloro- Mutagenic metabolite, 1168 4-[Cbloro-6-(2,3-xylidino)-2-pyrlmidinylthio]aceticacid Lung Binding,neoplasmsliver DNA, mouse,2400 Alpha fetoproteins Acatalasemic mouse, 152 Binding, lung DNA, mouse, 2400 Microsomes, liver DNA synthesis c@arcinogenicmetabolites,4316 Alphafetoproteins,152 DNA, binding 4316 Hepatoma Ornithine, -DL Acetyltransferases, 152 Metabolism, 1431 Carcinogenic activity, mouse, rat, 152 Ovarian neoplasms Peroxisome proliferation Adenocarcinoma(s), I 108 Acatalasemic mouse, 152 Ozone 1,3-BIs(2'.chloroethyl)-l-mtrosouree Ames test@2149 ser Urea, 1,3-bis(2-chloroethyl)-l-nitroso- Retinoids Celltransformation,neoplastic,1661 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosouree RNA ser Urea, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-I- Call transformation, neoplastic, 4516 nitroso- RNA polymerases 1,3.Bis(2-chloroethyl)-N@nltrosourea Cell transformation, neoplastic, 4516 s@ Urea, l,3-bis(2-chlorcethyl)- I -nitroso- Sarcoma(s) IgO, 4588 cidoroleukemia s@ Leukemia, myelocytic Cholera toxin 12-O-Tetradecanoylphorbol-l3-acetate p-@h1oromercurlphenylsulfonic acid Plasminogen activators, 1579 seeMercury,chloro-(p.phenylsulfonate) Cholestane-3$,5a,6$-triol 1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane Colonic neoplasms ser Ethane, 2-(o-chlorophenyl)-2-(p.chlorophenyl)-l,l- Guanidine, N-methyl-N-nitro-N-nitroso-, 1521 dichloro Cholesterol cidoroquine Colonic neoplasms Cell transformation, chemical Guanidine, N-methyl-N-nitro-N-nitroso-, 1521 Growth, 2718 Sarcoma(s) 5$..cholan-24-oic acid, 3a-hydroxy-, monosodium salt Growth, 4350 Colonic neoplasms Cholesterol-5a,6a-epoxide Guanidine, N-methyl-N-nitro-N-nitroso-, 1521 Colonic neoplasms @oIanthren-2-ol,3-methyl Guanidine, N-methyl-N-nitro-N-nitroso-, 1521 Carcinogenicmetabolites Cholic acids DNA, binding 4316 Colonicneoplasms

DECEMBER 1979 5239 Subject Index to Volume39

Cholic acids (cont'd) Chromosome aberrations (cont'd) Diet, 328 Fluorescent light Cell transformation, neoplastic, 929 Choline Cells, mouse, in vitro, 929 Acetamide, N-fluoren-2-yl Hepatoma(s) Alpha fetoproteins, 2515 Giemsa-banding karyotype, Morris tumor, 1708 â€˜y-Glutamyltranspcptidase, 2515 Growth rates, 1708 Diethylamine, N-nitroso Alpha fetoproteins, 2515 Leukemia, lymphoblastic Karyotyping 227 â€˜y-Glutamyltranspeptidase, 2515 Leukemia, nonlymphocytic Hepatoma(s) Blood/bone marrow cells, human, 3619 Acetamide, N-fluoren-2-yl-, 2515 Lymphosarcoma Diethylamine, N-nitroso-, 2515 B-Lymphocytes, 3119 Phorbol esters Null cells, 3119 Phospholipids, 2743 Myeloproliferativedisorders l2-O-Tetradecanoylphorbol-l3-acetate Casereports, 2984 Phospholipids, 2743 Chromosome 20, human, 2984 Chondrocytes DNA cytophotometry,2984 Chondrosarcoma Ovarian neoplasms Normal/neoplastic, young vsadult mammals, 2802 Cystadenocarcinoma, 4449 Isoenzyme phenotype, 4449 Chondrosarcoma Pancytopenia Adrenalectomy Chromosome 20, human, 2984 Growth, 4387 Psoralen, 8-methoxy Chondrocytes Mucosalcells,Chinesehamster, 2510 Normal/neoplastic, young vs adult mammals, 2802 Thrombocytopenia Collagen Chromosome 20, human, 2984 Animal model, Swarm rat, 5093 Ultraviolet rays Ultrestructural study, 5093 Mucosal cells, Chinese hamster, 2510 Cortisone Synchronized hamster embryo cells, 2356 Receptors, hormone, 4387 Uridine, 5-bromo-2'-deoxy Hypophysectomy Growth, 4387 Synchronized hamster embryo cells, 2356 RNA, messenger Chromosomes Animal model, Swarm rat, 5093 Kidney neoplasms G-bandmg 4694 Choriocarcinoma Nuclear membrane Cell differentiation Hyperthermia, 1911 Ultrastructural study, BeWo cells, 1960 Plasmacytoma Cytosine, 1-$-D-arabinofuranosyl Hybrid cells, 4481 Gonadotropins, chorionic, 1952 Virus, herpes simplex 2 Gonadotropins, choriomc DNA synthesis,1952 Cell transformation, viral, 3225 Methotrexete Chrysene Cell differentiation, 1960 Ames test Gonadotropins, chorionic, 1952 Epoxide and dihydro derivatives, 4069 Urea, hydroxy Bay region epoxides Gonadotropins,chorionic, 1952 Carcinogenicity, mouse, 5063 Uridine, 2'-deoxy-5-fluoro Carcinogenetic activity, skin, mouse Gonadotropins, chorionic, 1952 Epoxide and dihydro derivatives, 4069 Chromium Epoxidehydrase Ames test, 4069 Virus, adeno 7 Co-carcinogenic effect, metal salts, 193 Citrate Phosphofructokinase Chromosome aberrations Normal/neoplastic tissue, rat, 2796 Ascorbic acid Thyroid neoplasms Chinese hamster ovary cells, 4145 Phosphofructokinase, 2796 Metals, 4145 Benz(a)anthracene, 7,12-dimethyl Citrovorum factor Mucosal cells, Chinese hamster, 2510 Aminopterin Carcinoma(s) Neoplasms, 3707 Neoplasm transplantation, 4713 Phase 1 clinical study, 3707 Cyclophosphamide Leukemia,lymphoblastic Mucosal cells, Chinese hamster, 2510 Methotrexate, 3',S'-dichloro-, 1264 Cystadenocarcinoma Methotrexate Cell line, 4449 Cell growth inhibition, 1264 Fibrosarcoma(s) Chemotherapy, mouse, 3202 Plate-induced tumor cell lines, mouse, 2172 Marrow recovery kinetics, human, 1315

5240 CANCER RESEARCH VOL.39 Subject Index to Volume3@9 cftrovorum factor (cont'd) Colonic neoplasms Plasma clearance vs toxicity, 908 N-Acetyl-$-D-hexosaminidase Methotrexate, 3',5'-dichloro Normal/neoplastic colon, rat, 4083 Cell growth inhibition, 1264 Acetylgalactosaminyltransferase Epithelial cells, human, 1259 clofibrate Cia-acid seealso p-Phenoxybenzalbutyrate Cytotoxicity, human, in vitr4 2630 Peroxisomes Adenocarcinoma(s) Carcinogenic activity, rat, 3419 Acetylgalactosaminyltransferase, 1259 Codc*yne'ssyndrome Galactosyltransferases, 1259 Ultravioletrays Glycosidases, 1259 DNA repair, 4237 Platinum(II), diamminedichloro-,cia-, 4356 DNA synthesis,4237 Siayltransferase, 1259 Transplantation, heterologous, 833 Coformycin, 2'.deoxy 9,lO-Anthracenedione, 1,4-dihydroxy-5,8-bis(((2-([2- 9H-Adenine, 9-$-D-arabinofuranosyl hydroxyethyl]amino)ethyl)amino-, dihydrochloride Antiproliferative activity, 1563 Antitumor activity, mouse, 1570 9H@Adenine, 9-j3-D-arabinofuranosyl-, 5'-monophosphate Antigens, neoplasm Antiproliferative activity, 1563 Isolation and characterization, 612 Adenosine deaminase Lymphocyteadherenceinhibition, 627 Enzyme inhibition and recovery, 1425 APUD properties Erythrocytes, mouse, 1425 Cell lines, human, 4914 Thymus gland, 3044 Carbamic acid, methylnitroso-, ethyl ester Tissue distribution, mouse, 3044 Transplantation immunology, 1174 Colonic neoplasms Carcinoembryonic antigen Adenosine deaminase, 3044 Nude mouse, 2160 Nucleoside phosphorylase, 3044 DNA synthesis Chromosome aberrations Cell lines, human, 4914 Bone marrow/intestinal mucosa, mouse, 3655 Coformycin, 2-deoxy Leukemia, lymphocytic, 3655 Adenosine deaminase, 3044 Leukemia Ll2lO Nucleoside phosphorylase, 3044 9H-Adenine, 9-13-D-arabinofuranosyl-, 5'- Creatinine monophosphate, 1563 Nucleosides, 1150 Adenosine deaminase, 1425 Diet Nucleoside phosphorylase Cholic acids, 328 Tissue distribution, mouse, 3044 Deoxycholic acids, 328 Colddciae Epidemiology, Hawaii-Japan, 328 12-O.Tetradecanoylphorbol-l3-acetate Dietary fiber Cell adhesion, 1989 $-Glucuronidase, 3752 Phospholipids, 2743 Formamide, N,N-dimethyl Cailds, ulcerative Tumorgenicity, vs growth characteristics, 1020 Galactosyltransferases Antigens, nucleolar Epithelial cells, human, 1259 Immunofluorescence, 3024 Glycogen CoBegea Metabolism, human tumor cells, 531 Chondrosarcoma Guanidine, N-methyl-N-nitro-N-nitroso Animal model, Swarmrat, 5093 5/3-Cholan-24-oic acid, 3a-hydroxy-, monosodium Ultrastructural study, 5093 salt, 1521 DNA synthesis Cholestane-3$,5a,6$-triol, 1521 Kidney/ bladder/ liver/ pancreas, rat, 2751 Cholesterol, 1521 Parotid/submandibular glands, mouse, 2751 Cholesterol-5a,6a-epoxide, 1521 Mammary neoplasms,experimental ConventionaVgerm-free rat, 1521 Benz(a)anthracene, 7,12-dimethyl-, 2923 $-Hexosaminidase Propionitrile, 3-amino-, 2923 Isoenzymes,3405 12-O-Tetradecanoylphorbol-13-acetate Histocompatibility antigens Cell transformation, viral, 1667 Transplantation immunology, 1174 Virus, Rous sarcoma Hydrazine, l,2-dimethyl Cell transformation, viral, 1667 Salmonella typhimurium, 2768 12-O-Tetradecanoylphorbol-l3-acetate, 1667 Transplantation immunology, 1174 Immunologic techniques Carcinoma,basalcell Animal model, rat, 1174 Lactate Fibroblasts, 4594 Serum levels, human, 4900 Coloaicdiseases Leukocyte adherence inhibition Hyperplasia Diagnosis, 625 Cell cyclic kinetics, mouse, 24 Nucleosides DNA synthesis,24 Urinaryexcretion,1150

DECEMBER 1979 5241 Subject Index to Volume39

Colonic neoplasms (cont'd) Cortisone Platinum(II), diamminedichloro-, cia- Chondrosarcoma Cell cycle kinetics, 4356 Receptors, hormone, 4387 RNA, transfer Virus,Grossmurineleukemia Nucleosides, 1150 T-Lymphocytes, 480 Pseudouridine, 1150 Corynebacterluin parvum Rubidazone Antitumor activity Phase I clinical trial, 823 Isolation of active component, 3554 Salmonella typhimurium Cyclophosphamide Immune response, mouse, 2768 Synergistic treatment, mouse, I Thymidine DNA synthesis Xenografts, nude mice, 3875 Regenerating liver, rat, 1361 Transplantation, heterologous Fibrosarcoma(s) Antibody-dependent cell cytotoxicity, 2160 Hyperthermis, 3454 Carcinoembryonic antigen, 2160 Hyperthermia Nude mouse, 2160 Synergistic activity, 3454 Spontaneous tumor incidence, nude mouse, 833 Immunogenicity Urea, N,N-bis(2-chloroethyl)-N-nitroso- Isolation of active component, 3554 Cytotoxicity, human, in vitr4 2630 Leukemia Ll210 Colony-stimulating factor Immunotherapy, 2807 Cell transformation Mammaryneoplasms,experimental Isolation and characterization, 5127 Cyclophosphamide, I Sarcoma, Yoshida Metastases, 987 Serum-free cell culture, 5127 Surgery Adjuvant therapy, rat, 987 Combination chemotherapy see Drug therapy, combination Counsarins Mammary neoplasms, experimental 7-Con-O-methylnogarol Antineoplastic activity, mouse, 1651 Adriamycin Cardiotoxicity, rabbit, 4849 Creatinekinase Adriamycin Concanavalin A Cardiotoxicity, rat, 2941 Bladder neoplesms Isozymes Precancerous conditions, 3353 Normal/neoplastic tissues, 492 Epithelial cells, bladder mucosa, rat Normaiineopismic tissues Ultrastructural study, 3353 Embyro/neonatal/adult rat/mouse, 492 Gangliosides Creatine phosphokinase T-Lymphocytes, 817 Creatine kinase Leukemia Ll2lO Vaccines, 2807 3',5'-Cyclic AMP phosphodiesterese T-Lymphocytes Papilloma(s) Suppressor cells, 4372 12-O.Tetradecanoylphorbol-I3-acetate, 2036 Urologic neoplasms Phorbol esters Lymph nodes, 4372 Epidermis, mouse, 2036 T-Lymphocytes, 4372 12-O-Tetradecanoylphorbol-l3-acetate Virus, Gross murine leukemia' Epidermis, mouse, 2036

Virus,T-Lymphocytes,murine mammary480tumor Cyclohexane,Hepatoma(s)1,2,3,4,5,6-hexachloro Oligosaccharides, 199 @cinogenesis,mouse, 1628 Corticosteroids Peroxisomes,1628 Leukemia L1210 Cyclohexenoxide Growth inhibition, 3258 &nzo@a)pyrene Macrophages DNA adducts, diploid fibroblasts, human, 1083 Leukemia, Moloney murine, 2894 Virus, feline leukemia Cycloheximide Resistance to infection, cat, 3789 Fibroblasts DNA-protein cross-links, 704 Corticotropin Glucose Proteus mirabilis @cinom@Ehrlich tumor, 90 Glucocorticoid amplifying factor, 3258 HeLa cells Cortisol Gonadotropins,chorionic, 3885 Breastneoplasms Ultraviolet rays Receptors, hormone, 1973 Ornithine decarboxylase, 1035 Cell transformation, viral Uracil-DNA glycosylase Fibronectin, 2077 Polyribonucleotide synthetases, 2090 Procollagen, 2077 Virus, Kirsten murine sarcoma

5242 CANCER RESEARCH VOL.39 Subject Index to Volume39

Cyelohexlmlde (cont'd) Cystadenoma, mucinous (cont'd) Proteaseinhibitors, 2995 Receptors, concanavalin A, 1760 Ovarian neoplasms Cyclophosphamide Carcinoembryonic antigen, 1760 Antitumor activity, mouse Immunity, cellular, 1185 Bordetella pertussis, 4838 BacillusCalmette-Guerin Cysteamine Antitumor activity, mouse, 4838 see Ethanethiol, 2-amino Bone marrow, 2544 Cysteine Colony-stimulating activity, serum, mouse, 2544 Hyperthermia Brain neoplasms ACNU, 2687 Cytotoxicity, 4630 Breast neoplasms Cysticfluid Dose-responsestudy, 1552 Ovarian neoplasms Carcinoma, Walker 256 Lymphocyte transformation, 2381 Metastatic brain tumor model, rat, 2691 Lymphocytotoxicity, 2381 Chromosome aberrations Cytidine, deoxy Mucosal cells, Chinese hamster, 2510 Cytosine, 1-$-D-arabinofuranosyl Corynebacterium parvum Gonadotropins, chorionic, 1952 Synergistic treatment, mouse, I Uracil, 5-fluoro DNA synthesis Inosine, 4905 Bone marrow/intestine, mouse, 1396 Enantiomers and racemate Cytidine diphosphate reductase Metabolism, human, 2762 Leukemia, lymphoblastic Hematopoiesis Isolation and characterization, 436 Spleen, mouse, 215 Cytochalasin B Immunity, cellular 12-O-Tetradecanoylphorbol-l3-acetate T-Lymphocyteprecursors,spleen,mouse,3647 Cell adhesion, 1989 Leukemia Ll210 Cytochrome P450 Statistical analysis, mouse survival, 3446 Liver microsome, human, in vitro Uracil, 5-fluoro-, 1396 Electrophoretic characterization, 4206 Leukocytes Pyrrolidine, 1-nitroso Hematopoiesis, 215 Ethyl alcohol, 793 Levamisole Cytokinesis Antitumor activity, mouse, 4838 Erythroleukemia T-Lymphocytes Celldifferentiation,4058 Immunosuppression, 3647 Phenotype expression, 4058 Macrophage cytotoxic activity Cytosine, 1-$-D-arabinofuranosyl Immuneresponse,mouse,3014 Anthracycline antibiotics Mammary neoplasms, experimental Clinical trial, 42 Carcinoma(s), 4466 Leukemia, myeloblastic, 42 Corynebacterium parvum, 1 Choriocarcinoma Prednisolone Gonadotropins, chorionic, 1952 Carcinoma, Walker 256, 4256 Chromosome aberrations Sarcoma(s), 4256 Lymphocytes, 1814 Uracil, 5-fluoro Cytidine, deoxy Alkylating metabolites, 1396 Gonadotropins, chorionic, 1952 Cynops pyrrhogaster Cytosine, l-$-D-arabinofuranosyl-, 5'-triphosphate Skin neoplasms Leukemia myeloblasts, in vitr4 42 Neoplasm regression, spontaneous, 1904 Deaminase-resistant derivative Antitumor activity, 3129 Cystadenocarcinoma 3-Deazauridine Antigens, neoplasm Sequence-dependent toxicity, 2216 Serum blocking factor, 1185 DNA synthesis Ascitic fluid Cell cycle kinetics, 1814 Serum blocking factor, 1185 Lymphocytes, 1814 Chromosome abnormalities Glycoproteins Cell line, 4449 Drug resistance, 2070 Immunity, cellular HeLa cells Lymphocytotoxicity, 1185 Gonadotropins, chorionic, 3885 Ovarian neoplasms Immunity, cellular Chromosome abnormalities, 4449 Leukemia, myeloblastic, 3357 Estrone, 4449 Intestinal mucosa Immunity, cellular, 1185 Toxicity, mouse, 2216 Cystadenoma,mucinous Isocytosine, 5-(/3-D-ribofuranosyl)- Carcinoembryonicantigen Drug sensitivity,in vitro/in viv4 720 Isolation and characterization, cyst fluid, 1760 Leukemia Ll2lO

DECEMBER 1979 5243 Subject Index to Volume39

Cytosine, 1-$-D-arabinofuranosyl- (cont'd) Daunomycin (cont'd) Cytosine, 1-b-D-arabinofuranosyl-5'-triphosphate Leukemia, myeloblastic, 3357 4048 Leukemia(s) Deoxycytidine kinase, 4048 Cell nucleus, 4396 Methotrexate, 4048 Cellular distribution, 4396 Leukemia, myeloblastic Thymidine/uridine incorporation, 4396 Cell cycle synchronization, 2727 Phenol,2,4-dinitro Colony-forming units-spleenassay, 2727 Efflux mechanism, 2200 Dosescheduling,rat, 2727 Daunorubicin Leukemia P815 DNA Isocytosine, 5-($-D-ribofuranosyl)-@ 720 Colony-forming units-spleen, mouse, 3738 Liposomes Colony-forming units-stem cells, mouse, 3738 Antitumor activity, 1390 Dose-response,in viv4 3738 Drug encapsulation, 1390 Hematopoietic stem cells, 3738 Lymphoma(s) DNA synthesis Immunosuppression, 4564 Mechanismof action, in vitr4 448 Maytansine Rubidazone Cytotoxicity, 3152 Analyticmethod,plasma,823 Methotrexate Dosage schedule, mouse, 4048 3-Deazauridine Serum levels, mouse, 4048 Antineoplastic agents N'-Acyl derivatives Pharmacokinetics, 349 KB cells,cytoxicityvsuptake,1063 5-Aza-2'-deoxycytidine Tetrahydrouridine Leukemia Ll2lO, 3822 Kidney cells, rat, 3981 Mammary neoplasms,experimental, 3822 Thymidine Synergistic cytotoxicity, 3822 Lymphoma(s), 538 Brain neoplasms Mastocytoma, 538 Penetrationblood-brainbarrier, human, 4119 Myeloma(s), 538 Cytosine, I-$-D-arabinofuranosyl Synergistic activity, mouse, in vitr4 538 Sequence-dependenttoxicity, 2216 Uracil, l-$-D-arabinofuranosyl Intestinal mucosa Mechanism of action, in vitr4 1102 Toxicity,mouse,2216 Uridine, 5-bromo-2'-deoxy 5-Isoxazoleacetic acid, (aS,5S)-a-amino-3-chloro-4,5- DNA repair, 1814 dihydro Antitumor activity, mouse, 852 Cytosine, 1-$-D-arabinofuranosyl-,5'-triphosphate LeukemiaLl2lo, 852 Antineoplastic agents Leukemia myeloblasts, in vitr4 42 Dehydroepiandrosterone Cytosine, l-/3-D-arabinofuranosyl Mammary neoplasms,experimental Leukemia myeloblasts, in vitr4 42 Antitumor activity, mouse, 1129 Leukemia L1210 Glucosephosphate dehydrogenase, I 129 Cytosine, 1-$-D-arabinofuranosyl-, 4048 Demethylase Cytosinenucleotides Benzenamine,N-methyl-N-nitroso Leukemia L1210 Liver, rat, 1587 Aspartic acid, N-(phosphonoacetyl)-, 3089 Dimethylamine, N-nitroso Lung neoplasms Barbituric acid, 5-ethyl-5-phenyl-, 1587 Aspartic acid, N-(phosphonoacetyl)-, 3089 Liver, rat, 1587 Cytotoxicity, Immunologic 2'-Deoxy-6-thioguanoslne 5'-trlphosphate Sarcoma(s) 6-Thioguanosine Neoplasmtransplantation, 2711 DNA synthesis,3955 Cytoxan Deoxycholic acids Colonic neoplasms ser Cyclophosphamide Diet, 328 D@ Deoxycytidine kinase Antineoplastic agents Carcinoma,Eh.rlichtumor, 4242 LeUkemiaL1210 Cytosine, l-$-D-arabinofuranosyl-, 4048 Oxidative phosphorylation Carcinoma, Ehrlich tumor, 4242 Deoxyguanosine Acetamide, N-(acetyloxy)-N-9H-fluoren-2-yl Daunomycin Antibody specificity, 1377 Drug resistance P388leukemiacells, 2200 Deoxyribonuclease Efflux mechanism Guanine, 0-methyl-, 2675 P388leukemiacells, 2200 Brain cell nuclei, rat, 2675 Glucose Retinoic acid Efflux mechanism, 2200 Lungneoplasms,2492 Immunity,cellular Urea, N-methyl-N-nitroso

5244 CANCER RESEARCH VOL.39 Subject Index to Volume39

Deoxyribonuclease(cont'd) Dibenz(a,h)anthracene(cont'd) Brain cell nuclei, rat, 2675 Carcinogenicactivity, mouse, 1310 Dezamethisone Skin neoplasms Breastneoplasnis 12-O-Tetradecanoylphorbol-13-acetate, 1310 Insulin, 2422 Dibenz(a,h)anthracene, 1,2-dihydro-1,2-dihydroxy Nucleoside uptake, in vitr4 2422 Skin neoplasms Thymidine kinase@2422 12-O-Tetradecanoylphorbol-l3-acetate, 1310 Carcinoma(s) Receptors,hormone, 2647 Dibenz(a,h)anthracene,3,4-dihydro-3,4-dihydroxy Carcinoma,Walker 256 Skin neoplasms Metastaticbraintumormodel,rat, 2691 12-O-Tetradecanoylphorbol-I3-acetate, 1310 Cell transformation, viral Dibenz(a,h)anthracene,5,6-dihydro-5,6-dihydroxy Fibronectin, 2077 Skin neoplasms Procollagen, 2077 l2-O-Tetradecanoylphorbol-13-acetate, 1310 DNA synthesis Normal/regenerating liver, rat, 5132 Dlbenz(a,h)anthracene,3,4-dihydmxy-1,2,3,4-tetrahydro Erythroleukemia Dibenz(a,h)anthracene Carcinogenic metabolite, 1310 Cell differentiation, 3849 Liver neoplasms Dimethyl sulfoxide, 3849 Glycolipids Carcinogenic metabolite, 1310 Tumorcells,rat@3540 Lung neoplasms Glycoproteins Carcinogenic activity, mouse, 1310 Tumorcells,rat, 3540 Carcinogenic metabolite, 1310 Indomethacin Dibenzo-p.dioxin Cell differentiation, 2190 Aryl hydrocarbon hydroxylases Phagocytosis, leukemia cells, mouse, 2190 B-Lymphocytes, 4612 Leukemia,myelocytic Cell differentiation, 2190 Dibenzo-p-dloxin, 2,3,7,8-tetrachloro Immunity, cellular, 3167 Aryl hydrocarbon hydroxylases Receptors, hormone Lymphocytes,mitogen-stimulated,4620 Adrenalectomy,5132 Benz(a)anthracene,7,12-dimethyl Genes, structural, 4749 Carcinogenesis inhibition, skin, mouse, 4027 Normal/regenerating liver, rat, 5132 DNA adducts,4027 Thymoma(s) Benzo(a)pyrene Receptors, hormone, 4749 Carcinogenesis inhibition, skin, mouse, 4027 Transplantationimmunology DNA adducts,4027 Nudemouse,3167 Binding sites Liver, rat, 4653 Dextrano Dibenzofuran, tetrachloro Mammary neoplasms, experimental Receptors, 3172 Mercury or sulThydryl substituted, 170 DNA Mercury or sulfhydryl substituted Liver macromolecules,rat, 3341 Antitumor activity, 170 Endocrine dependence Diabetesmeilitus Binding sites, 4653 Adenosinecyclic3':5'-monophosphate Liver macromolecules, rat Mammary tumor regression,mouse, 2501 Carcinogenicity, 3341 Proteins Carcinoma, Ehrlich tumor Neoplasmtransplantation, 1807 Liver macromolecules, rat, 3341 Receptors Histone kinase Mammarytumorregression,mouse,2501 Tissuedistribution, rat, 3172 RNA Diamide Liver macromolecules, rat, 3341 ser Formamide, l,l'-azbis(N,N-dimethyl) Dibutyryl cyclic AMP 2,4-Dlamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine Carcinoma, Walker 256 sce Pyrimidine, 2,4-diamino-5-(3,4-dichlorophenyl)-6- Bone marrow, 1193 methyl Cell transformation, neoplastic 2,4-Diamlnoanisole Growth inhibition, mixed normal and malignant 6- ace 1,3-Benzenediamine,4-methoxy broblasts, 3502 Metabolism Dichloroallyl lawsone Liver microsome,human,in vitr4 4206 seealso 2-Hydroxy-3-(3,3-dichloroallyl)-l,4-naphthoquinone Dlbenz(a,h)snthracene Uridine Aryl hydrocarbon hydroxylases Dihydroorotate dehydrogenase, 4868 B-Lymphocytes, 4605, 4612 Diet Dibenz(a,h)anthracene, 3,4-dihydroxy-l,2,3,4-tetrahydro Aflatoxin B1 Carcinogenic metabolite, 1310 Hepatoma(s), 3986 Lung neoplasms Alcohol

DECEMBER 1979 5245 Subject Index to Volume39

Diet (cont'd) Diethylamine, J%@nitroso-(cont'd) Mechanisms of carcinogenesis, review, 2863 Ornithine decarboxylase Androgen Liver, rat, 3074 Urinary excretion, black vs white male, 5101 Protein kinase Colonic neoplasms Liver, rat, 3074 Cholic acids, 328 Diethylnitrosamine Deoxycholic acids, 328 see Diethylamine, N-nitroso-;Ethanamine, N-ethyl-N- Epidemiology, Hawaii-Japan, 328 nitroso Estrogen Urinary excretion, black vs white male, 5101 Diethyistilbestrol Hepatoma(s) Benz(a)anthracene, 7,l2-dimethyl Polyribosomes, 1995 Synergistic activity, 4636 Sarcoma, Crocker 180 Transplacental carcinogenicity, hamster, 4636 Acid-base equilibrium, 4364 Breast neoplasms Receptors, hormone, 1973 Dietary fats Carcinoma(s) Leukemia Ll210 Kidney, hamster, 2647 Cellmembranepermeability,1726 Mammary neoplasms,experimental Lipoprotein Adenocarcinoma(s), 773 Serum levels, rat, 3458 Prolactin, 773 Lymphocyte blastogenesis Strain differences, rat, 773 Immune response, rat, 3458 Pituitary neoplasms Mammary neoplasms,experimental Adenoma(s), 773, 779 Prostaglandins, 4430 Prolactin, 773, 779 Tumor incidence, rat, 3458 Strain differences, rat, 773, 779 Methane, azoxy Prolactin Gastrointestinal neoplasms, 4956 Plasmalevels, 773, 779 Rat, 4956 Sarcoma(s) Immune response, mouse, 4350 DNA synthesis Ornithine decarboxylase, 4861 Dietary fiber Polyamines Colonic neoplasms Ornithine decarboxylase, 4861 /3-Glucuronidase, 3752 /3-Glucuronidase Digestivesystemneoplasms Tumor incidence, rat, 3752 T-2 toxin Histological study, rat, 2179 Diethylamine, 2,2'-dichloro Ozone 15,16-Dihydro-11-methylcyclopenta(a)phenanthv Ames test, 2155 Carcinogenic metabolite Binding, in vivo and in vitr4 4160 Diethylamine, 2,2'-dichloro-1V@methyl DNA Bone marrow Carcinogenic metabolite, 4160 Tumor-induced cytotoxicity, 1193 Dihydrofolate reductase Diethylamine, J%@nifroso seealso Tetrahydrofolate dehydrogenase Adenosine cyclic 3':S'-monophosphate Antineoplastic agents Protein kinase, 3074 Review, 293 Adenosine triphosphatase Brain neoplasms Precancerous conditions, 1298 Methotrexate titration assay, 487 Alpha fetoproteins Normal/neoplastic brain tissue, embryo/neonatal Serum levels, 1437 rat, 487 1-Butanamine, N-butyl-N-nitroso Methotrexate Urinary excretion, human, 829 Folateantagonists,293 Choline Alpha fetoproteins, 2515 Dihydroorotate dehydrogenase y-Glutamyltranspeptidase, 2515 Dichloroallyl lawsone DNA alkylation Uridine, 4868 Mechanism of action, liver, rat, 5003 5a-Dihydrotestosterone DNA synthesis Carcinoma(s) Precancerous conditions, 1298 Receptors, hormone, 2647 O@-Ethylguanine Mechanism of action, liver, rat, 5003 Dimethylsulfoxide Hepatoma(s) Erythroleukemia Cell cycle kinetics, 1298 Cell differentiation, I 113 Choline, 2515 Dexamethasone, 3849 Histological study, rat, 1437 Electrophoretic mobility, I I I 3 Precancerous conditions, 1298 Plasmamembrane, 1113 O'-Methylguanine Hepatoma(s) Mechanism of action, liver, rat, 5003 Cell transformation, neoplastic, 800

5246 CANCER RESEARCH VOL.39 Subject Index to Volume39

Dlmethyl sulfoxide (cont'd) 1,2-Dimethylhydrazine Melanoma(s) see Hydrazine, 1,2-dimethyl Cell differentiation, 2618 Dimethylnitrosamine see Dimethylamine, N-nitroso 5-(3,3-dimethyl-l-triazeno)- Dlmethyladipimete Leukocyte adherence inhibition DNA synthesis Immune response,mouse, 570 Lymphocyte transformation, 345 Dipropylemine, 2,3'@dloxo-J%Z@nitroso Metabolism,hamsterand rat, 4579 Pancreatic neoplasms Dlmethylamine, N-nitroso Carcinoma, ducts!, 452 Barbituric acid, 5-ethyl-5-phenyl Neoplasm transplantation, 452 Demethylase, 1587 Dipropylamine, 2-hydroxy-JV@nitroso-2'-oxo Bladder neoplasms Urinaryexcretion,human, 829 Metabolism, hamster and rat, 4579 Cell cycle synchronization Dirhodium(II), tetra-ns-carboxylato Regenerating liver, rat, 4228 Leukemia L12l0 Cell transformation, neoplastic Cytotoxicity, rhodium(II) carboxylates, 2568 Transplacental host-mediated assay, 4525 Disgerminoma Demethylase Bleomycin Liver, rat, 1587 Pulmonary function tests, 5076 DNA Liver, hamster, 50 Disulfide, bis(diethylthiocarbamoyl) Liver, rat, 3254 Bladder neoplasms Molecular weight and sedimentationvelocity, 3254 1-Butanol, 4-(butylnitrosamino)-, 3040 DNA alkylation Carcinogenesis inhibition, 3040 Liver, rat, 1798 Hydrazine, 1,2-dimethyl DNA synthesis DNA methylation,465 Guanine, 7-methyl-, 465 RNA synthesis,4228 Purine, 2-amino-6-methoxy-,465 Tissue levels, rat, 1798 Purine, 2-amino-6-methoxy Esophagus Colon, rat, 465 DNA adducts,4401 Guanine, 7-methyl Disulfiram DNA alkylation, 1798 see Disulfide, bis(diethylthiocarbamoyl) Guanine,7-methyl-,0 DNA Liver, hamster, 50 Benzo(a)pyrene Hepatoma(s) 7,8-Diol, diol-epoxide, and tetrol derivatives, 2538 Cell cycle synchronization, 5177 DNA adducts, epidermis, mouse, 2556 Kidney neoplasms Carcinoma, Ehrlich tumor Agefactors,4965 Zinc, 2457 Animal model, mouse, 4965 Daunorubicin Dietary carbohydrates, 4965 Hematopoietic stem cells, 3738 Laboratory animal food Dimethylamine, N-nitroso Letter to theeditor, 1857 Liver, hamster, 50 Liver neoplasms Liver, rat, 3254 Angiosarcome, 1592 Molecular weight and sedimentation velocity, 3254 Diet, rat, 1592 Doxorubicin Mutagenic metabolite Hematopoietic stem cells, 3738 Activation systems, in vivo, in vitro, 1525 2-Formylpyridine N-oxide benzenesulfonylhydrezone Neurospora crassa Sarcoma, Crocker 180, 2625 Adeninemutation, 1525 Guanidine, N-methyl-N-nitro-N-nitroso Mutagenic metabolite, 1525 Liver, rat, 3254 Molecular weight and sedimentation velocity, 3254 Oxidation Hepatoma(s) Steady state kinetics and isotope effect, 1587 Nucleic acid hybridization, 1287 Protein synthesis Nucleolus, Novikoff tumor, 1287 Mouseliver 5-30system, 3349 Hyperthermia Purine, 2-amine-6-methoxy Growth rate, Chinese hamster ovary cells, 2665 DNA alkylation, 1798 Leukemia L12l0 Purine, 2-amino-6-methoxy Platinum(II), diamminedichloro-, trans-, 365 Liver, hamster, 50 T-Lymphocytes RNA, messenger Diploid cells, 4418 Mouseliver5-30system,3349 Ovarian neoplasms Smoking Carrier proteins, 4341 Urinary excretion, human, 829 Pleural neoplasms

DECEMBER 1979 5247 Subject Index to Volume39

DNA (cont'd) DNA repair(cont'd) Carrier proteins, 4341 Fibroblasts, in vitro, human, 2522 Rhodamine B Streptozotocin Alkaline sucrosesedimentation, 4412 DNA alkylationdamage,82 Rhodamine 6C Ultraviolet rays Alkaline sucrose sedimentation, 4412 Acetamide, N-(acetyloxy)-N-fluoren-2-yl-, 471 RNA Adriamycin, 1321 Growth rate, Chinese hamster ovary cells, 2665 Aging, 2792 Thymidine Cardiac cells, rat, 1321 Lymphoblastoid cell lines, human, 312 Fibroblasts, in vitro, human, 2522 o-Toluidine, 4-chloro Leukocytes, 2792 Microsomes,liver, rat, 2528 Xeroderma pigmentosum, 471 Ultraviolet rays Urea, 3-13-D-glucopyranosyl-l-methyl-l-nitroso Synchronized hamster embryo cells, 2356 DNA alkylationdamage,82 Uridine, 5-bromo-2'-deoxy Urea, N-methyl-N-nitroso Lymphoblastoid cell lines, human, 312 Brain cell nuclei, rat, 2675 Synchronized hamster embryo cells, 2356 Virus, herpes simplex 2 DNA, neoplasm Guanine, 7-methyl-, 1041 DNA, viral Purine, 2-amino-6-methoxy-, 1041 Hybridization studies, human/hamster, 3479 Urea, N-methyl-N-nitroso-, 1041 Leukemia, myeloblastic Xeroderma pigmentosum RNA, viral, 2532 Virus, SV4O, 4064 Leukemia(s) DNA repairenzymes RNA, viral, 2532 see Polyribonucleotide synthetases RNA, viral Hybridization studies,normaVleukemic cells, hu DNA synthesis man, 2532 9H-Ademne, 9-$-D-arabinofuranosyl Virus, adeno group B Bonemarrow/intestinal mucosa,mouse, 3655 Hybridization studies, human/hamster, 3479 Adriamycin Cardiac cells, rat, 1321 DNA polymerases Mechanism of action, in vitr4 448 Adenine, 9-j3-D-arabinofurenosyl-, 5'-triphosphate Adriamycin, N-trifluoroacetyl Enzymeinhibition, 4673 Mechanism of action, in vitr4 448 Guanine, 9-j3-D-arabinofuranosyl-, 5'-triphosphate Adriamycin, N-trifluoroacetyl-, valeric acid Enzymeinhibition, 4673 Mechanism of action, in vitr4 448 Nucleosides Amidophosphoribosyltransferase DNA synthesis,4330 Adenocarcinoma(s), 3909 Regulatory protein BacillusCalmette-Guerin Thymus gland, calf, 4330 Regenerating liver, rat, 1361 Virus, Rauscher murine leukemia Benzo(a)pyrene-1,6-dione Guanine, 9-/3-D-arabinofuranosyl-, 5'-triphosphate Thymidine incorporation, 3194 4673 Brain neoplasms Spirohydantoin mustard, 4336 DNA repair Cell transformation, neoplastic Acetamide, N-(acetyloxy)-N-9H-fiuoren-2-yl a-Amanitin, 4516 Fibroblasts, in vitro, human, 2522 Uridine, 5-fluoro-, 4516 Xeroderma pigmentosum, 471 4-[Chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid Adriamycin Alpha fetoproteins, 152 Cardiac cells, rat, 1321 Choriocarcinoma Ataxia telangiectasia Gonadotropins, chorionic, 1952 Fibroblasts, heterozygotes, 3725 Cockayne's syndrome Blcom's syndrome Ultraviolet rays, 4237 Virus, herpessimplex 1, 3392 Collagen Caffeine Kidney/ bladder/ liver/ pancreas,rat, 2751 Ultraviolet rays, 4975 Parotid/submandibular glands, mouse, 2751 Cockayne's syndrome Corynebacterium parvum Ultravioletrays, 4237 Regenerating liver, rat, 1361 Cytosine, I-/3-D-ara@inofuranosyl Cytosine, 1-f3-D-arabinofuranosyl Uridine, 5-bromo-2'-deoxy-, 1814 Cell cycle kinetics, 1814 Guanine, 7-methyl Daunorubicin Urea, N-methyl-N-nitroso-, 1041 Mechanismof action, in vitrc@448 Platinum (II), diamminedichioro-, cia a-Difluoromethylornithine Cell cycle kinetics, 1793 Ornithine decarboxylase, 4861 Hamster V79 cells, 1793 Dimethylamine, N-nitroso Purine, 2-amino-6-methoxy Tissue levels, rat, 1798 Urea, N-methyl-N-nitroso-, 1041 DNA polymerases Quinoline, 4-nitro-, 1-oxide Nucleosides, 4330

5248 CANCER RESEARCH VOL.39 Subject Index to Volume39

DNA synthesis(cont'd) Doxorubicin Hepatoma(s) DNA Arginase, 1655 Colony-forming units-spleen, mouse, 3738 Macromomycin, 1180 Colony-forming units-stem cells, mouse, 3738 Thymidine incorporation, 1655 Dose-response, in viv4 3738 Isoproterenol Hematopoietic stem cells, 3738 $-Aminopropionitrile, 2751 Drug dependence Leukemia L1210 Alcoholism 9H-Adenine,9-/3-D-arabinofuranosyl,1563 Pharmacological and sociological comparison, 2836 9H-Adenine, 9-/3-D-arabinofuranosyl-, 5'- monophosphate, 1563 Drug therapy, combination era-A derivatives, 1563 Breast neoplasms Methylglyoxal bis(guanylhydrazone), 4130 Prognosis, 1552 Leukemia,lymphocytic EC 1.15.1.1 9H-Adenine,9-/3-D-arabinofuranosyl-,3655 see Superoxide dismutase Lymphocytes EC 2.1.1.6 Imidoesters, 345 ser Catechol- O-methyltransferese Methylglyoxal bis(guanylhydrazone) Analogs, 4861 EC 2.1.1.23 Mechanism of action, 4130 ser Protein arginine methyltransferase Plant substances EC 2.4.2.14 L cells,4802 ser A Lymphocytes, 4802 Mammary neoplasms,experimental, 4802 EC 2.4.99.1 Platinum(II), diamminedichloro-, cia seeSialyltransferase Anthranilic acid, 4-chloro-N-furfuryl-5-sulfamoyl BC 2.5.1.18 1279 see Glutathione &transferase Cell cycle kinetics, 4356 Mannitol, 1279 EC2.5.16 Polyamines see Methionine adenosyltransferase Lymphocytes, 4861 EC2.7.1.48 Propionitrile, 3-amino sec Uridine-cytosine kinase Kidney/ bladder/ liver/ pancreas, rat, 2751 EC3.5.4.6 Parotid/submandibular glands, mouse, 2751 see AMP deaminase 12-O-Tetradecanoylphorbol-l3-acetate Cells, cultured, 4477 EC 4.1.2.13 Fibroblasts, 4477 see Fructose 1,5-biphosphate aldolase 6-Thioguanosine EC 4.3.2.2 2'-Deoxy-6-thioguanosine5'-triphosphate, 3955 see Adenylosuccinate lyase Mechanism of carcinogenic activity, 3955 . Virus, AKR murine leukemia EC 6.3.4.4 RNA, viral, 1539 ser Adenylosuccinate synthetase DNA, viral Ehrlich ascites tumor Auromomycin seealso Carcinoma,Ehrlichtumor DNA synthesisinhibition,in vitr4 2787 Zinc DNA, neoplasm Tumor growth, in vivo, mouse, 2451 Hybridization studies, human/hamster, 3479 Uptake, cultured cells, 2451 Virus, adenogroup B Endotoxins, bacterial Hybridization studies, human/hamster, 3479 Skin neoplasms Virus, bovine adeno3 N-Acetylmuramyl-L-alanyl(L-seryl)-D-isoglutamine Angiogenesisfactor, 1305 4756 Virus, herpes simplex 2 Trehalosemycolate,4756 Nucleic acid hybridization, 3225 Enzymes Virus, Mason-Pfizer monkey Alcohol Placenta, 1696 Mechanisms of carcinogenesis, review, 2863 Dope oxidase Ependymoma Melanoma(s) ACNU Sinclair swine cells, 4960 Cyclophosphamide, 2687 Dosimetry, thermal Epidermodysplasia verruciformis Hyperthermia Carcinoma, epidermoid High-resistanceleads, 2325 Neoplasms, multiple primary, 1074 Optical-fiberprobes,2325 Virus, papilloma, 1074 Radio-frequency heating 2325 Virus, papilloma Tomography, ultrasound, 2325 DNA-RNA hybridization,1074

DECEMBER 1979 5249 Subject Index to Volume39

Epihalohydrins Erythrocytes Erythroleukemia Leukemia, myelocytic Carcinogenicity, cells, 3583 Colony formation, 1575 Cytotoxicity, cells, 3583 Erythroleukemia Immunogenicity, cells, 3583 Antineoplastic agents Epipodophyllotoxin, 4'-demethyl-,9-(4,6-O-ethylidene Carcinogenicity, cells, 3583 13-D-glucopyranoside), 1481 Cytotoxicity, cells, 3583 Neoplasms Immunogenicity, cells, 3583 Hyperthermia, 1481 Benzoic acid, chloroacetylmethyl ester Carcinogenicity, cells, 3583 Epithelialfocus-formingunit Cytotoxicity, cells, 3583 Benz(a)anthracene, 7,12-dimethyl Dihydroxyacetone analogs, 3583 Carcinogenesis, rat, in viv4 4003 Immunogenicity, cells, 3583 Tracheal neoplasms Cell differentiation In vitro assay, 4003 Dexamethasone, 3849 Carcinogenesis, rat, in viv4 4003 Cytokinesis Epithelium Cell differentiation, 4058 Benz(a)anthracene, 7,12-dimethyl Phenotype expression, 4058 Carcinogenesis, rat, 4829 Dexamethasone Carcinogenesis, trachea, rat, 4823 Dimethyl sulfoxide, 3849 Toxicity, trachea, rat, 4823 Dimethyl sulfoxide Tracheal transplants, rat, 4829 Cell differentiation, 1113 Bleomycin Cytochalasin B, 4058 Ultrastructural study, rat, 4218 Electrophoretic mobility, 1113 Cell transformation,neoplastic Hyaluronidase, 1113 Calcium, 4441 Plasmamembrane,1113 Glucose, 2-deoxy-, 4441 Epihalohydrins Glutamyl transpeptidase, 4441 Carcinogenicity, cells, 3583 Liver, rat, 4441 Cytotoxicity, cells, 3583 Trachea, rat, 2390 Immunogenicity, cells, 3583 Fibronectin T-Lymphocytes Dc novo synthesis, human cell lines, 4138 Antilymphocyte serum, 1611 Glutamyl transpeptidase 12-O-Tetradecanoylphorbol-l3-acetate Hepatoma(s), 269 Cell adhesion, 1989 Normal/neoplastic, liver, rat, 269 Cell differentiation, 1989 Growth conditions Virus, Friend murine leukemia Millipore diffusion chamber implants, 1467 Thymectomy, 1611 Tumor vs nontumor cells, mouse, 1467 Erythropoiesis Guanidine, N-methyl-JV'-nitro-N-nitroso Virus, Friend spleen focus-forming Tracheal mucosa, rat, in vitr4 4091 Heme, 1841 Nuclear ultrastructural study, human Reversetranscriptase, 1841 Normal/neoplastic cell lines, 332 Erythropoietin Epoxide hydrase Virus, Friend spleen focus-forming Benzo(a)pyrene Heme, 1841 Placental metabolism, 3177 Reversetranscriptase, 1841 Benzo(a)pyrene, 4,5-oxide Eschenchia coil Conjugated metabolites, liver, rat, 2051 DL-Alanine-N-carboxyanhydride Chrysene Polymermodification,1927 Ames test, 4069 Asparaginase Glutathione S-transferase DL-Alanine-N-carboxyanhydride, 1927 Tissue microsomes, rat, 2971 Immunization, 1927 Phenanthrene Carcinogens, chemical Ames test, 4069 Tryptophan auxotrophs, 682 Bis(2,3-Epoxycyclopentyl)ether Leukemia(s) Skin neoplasms Asparaginase, 1927 Dose-response study, mouse, 1718 Esophagealneoplasms Erwinia carotovora Pentylamine, N-methyl-N-nitroso DL-Alanine-N-carboxyanhydride Dose-response study, rat, 3644 Polymer modification, 1927 Esophagus Asparaginase Benzo(a)pyrene DL-Alanine-N-carboxyanhydride, 1927 DNA adducts, 4401 Immunization, 1927 Dimethylamine, N-nitroso Erythro-9-(2-hydroxy-3-nonyl)adenine DNA adducts,4401 see Adenine, erythro-9-(2-hydroxy-3-nonyl)- Pyrrolidine, l-nitroso

5250 CANCER RESEARCH VOL.39 Subject Index to Volume39

Esophagus(cont'd) Estrogen(cont'd) DNA adducts,4401 Receptors, hormone, 2614 Receptors, hormone Acetic acid, methylnitrosoaminomethylester Endometrium, post-menopausal, 1094 Carcinogenic metabolites, rat, 5136 Ovarian-dependent MXT-3590 mouse tumor, 4098 Mechanism of action, in vivo, 5136 Estrogensulfotransferase Fibrosarcoma(s) Breast neoplasms Humanserum-adaptedcells,mouse,2376 Adenosine 3':S'-phosphosulfate, 5124 Estradiol Receptors, hormone, 5124 Breast neoplasms Estrone Binding assay, tissue culture, human, 3319 Ovarian neoplasms Plasma levels, 1835 Cystadenocarcinoma, 4449 Receptors, hormone, 1835 Carcinoma(s) Estrone, 2-hydroxy Receptors, hormone, 2647 Mammary neoplasms, experimental Estremustine Antitumor activity, 4882 Binding, prostate gland, rat, 5155 Estrus Mechanism of action, in vitro and in viva 5155 Benz(a)anthracene, 7,12-dimethyl Gynecologic neoplasms Gonadotropins, 4700 Neonatal mouse, 2591 Prolactin, 4700 Ovariectomy, 2591 Progesterone,2591 Ethane, 2-(o-chlorophenyl)-2-(pchlorophenyl)-1,1-djchloro.. Lactalbumin Adrenal cortex neoplasms Nudemouse,2046 Cytotoxicity, in vitr4 139 Mammary neoplasms, experimental Ultrastructural study, 139 Aminoacids, 3381 Analogs Antitumor activity, 4882 Cytotoxicity, in vitro, 139 Castration, rat, 5043 Ethenethiol, 2-amino Neonatal mouse, 2560 Hyperthermia Ovariectomy Cytotoxicity, 4630 Vagina, cervix, mouse, 2560 Pituitary neoplasms Ethanol, 2-bromo Prostaglandin F20, 998 Lung neoplasms Rotenone Carcinogenicity, mouse, 391 Receptors,hormone,4438 Ethanol,2-hydrazino Estradiol benzoate Ozone Mammary neoplasms, experimental Amestest, 2155 Benz(a)anthracene, 7,12-dimethyl-, 2436 Water pollutants, chemical, 2155 Prolactin, 2436 Ethanol, 2-mercepto Tumorregression,lactatingrat, 2436 Auromomycin Estradiol, 2-hydroxy DNA synthesisinhibition, in vitro, 2787 Mammary neoplasms,experimental Macromomycin Antitumor activity, 4882 DNA degradation, I 180 Estramustine Ethidium bromide Estradiol Leukemia Ll210 Binding, prostate gland, rat, 5155 Mitochondrial damage, in vivo, 2414 Mechanism of action, in vitro and in viv4 5155 Ultrastructural study, 2414 Estriol Ethyl alcohol Mammary neoplasms, experimental Pyrrolidine, 1-nitroso Antitumor activity, 4882 Aryl hydrocarbon hydroxylases, 793 Cytochrome P-450, 793 Estrogen Glucosephosphatase, 793 Bladder neoplasms Metabolism, liver, hamster, 793 Receptors, hormone, 2614 Mutagenic activity, 793 Breast neoplasms NADPH cytochromeC reductase,793 Receptors, hormone, 1124, 1447 Diet Ethyl cerbamate Urinary excretion, black vs white male, 5101 see Carbamic acid, ethyl ester Mammary neoplasms, experimental Ethyl chlorophenoxyisobutyrate Animal model, rat, 5028 see Clofibrate Receptors, hormone, 4098 Precancerous conditions Ethyl methanesulfonete Endometrium, post-menopausal, 1094 see Methanesulfonic acid, ethyl ester Progesterone Ethylamine, 2-chloro-N,N.dimethyl Endometrium,post-menopausal,1094 Lung neoplasms

DECEMBER 1979 5251 Subject Index to Volume39

Ethylamine, 2-chloro-N,Ndimethyl- (cont'd) Fibronectin Carcinogenicity, mouse, 391 Carcinoma, Ehrlich tumor Plasma/ascitic fluid, mouse, in vivo, 3774 O'-Ethylguarnne Carcinoma(s) Diethylamine, N-nitroso Dc novosynthesis,humancelllines, 4138 Mechanism of action, liver, rat, 5003 Cell transformation, viral D-Factor Cortisol, 2077 Leukemia, myelocytic Dexamethasone, 2077 Cell differentiation, 4170 Immunoprecipitation, 1803 Interferon, 4170 Epithelium Dc novosynthesis,humancelllines, 4138 Fanconi syndrome Metastases Bence Jones protein Dc novo synthesis, human cell lines, 4138 Retinol, 4423 Ovarian neoplasms Retinol Effusion fluids, 4341 Carrier proteins, 4423 Pleural neoplasms Fatty acids Effusion fluids, 4341 Carcinoma, Ehrlich tumor Virus, B77 Oxidation, in viv4 973 Cell transformation,viral, 1803 Epithelium Temperaturesensitivemutants, 1803 Normal/neoplastic mammary tissue, rat, 426 Virus, SV4O Hormones Cell transformation,viral, 2077 Normal/neoplastic mammary tissue, rat, 426 Fibrosarconia(s) Leukemia L12l0 Ascitic fluid Methotrexate, 1726 Ornithine decarboxylase, 1511 Mammary neoplasms, experimental Bacillus Calmette- Guerin Normal/neoplastic mammary tissue, rat, 426 Mineral oil emulsification, 535 p-Phenoxvbenzalbutvrate Cholanthrene, 3-methyl Rat,in viv4 3845 Sarcoma(s) Fetal globulins, 2006 Hyperthermia, 3248 Growth, 4350 Chromosome aberrations Ferricytochrome c Plate-induced tumor cell lines, mouse, 2172 sec Cytochrome c Corynebacterium par Vum Ferritin Hyperthermia, 3454 Esterases Virus, murine mammary tumor Human serum-adaptedcells,mouse, 2376 Oligosaccharides, 199 Fetal globulins Plant agglutinins, 199 Chemical/physical properties, 2006 Fetalantigens /3-Glucuronidase see Fetal globulins Human serum-adapted cells, mouse, 2376 Fetalglobulins Glycoproteins Cellmembrane Carcinogenicity, cell lines, rat, 3677 Glycosidase Immunologic capping, 2006 Human serum-adapted cells, mouse, 2376 Fibrosarcoma(s) Histocompatibility antigens Chemical/physical properties, 2006 Plate-induced tumor cell lines, mouse, 2172 Cholanthrene, 3-methyl-, 2006 Hyperthermia Hepatoma(s) Time-temperature relationship, 3248 Cell nucleus, Morris tumor, 2096 Melanoma(s) Hyperthermia, localized Antitumor activity, mouse, 2258 Antigens, neoplasm, 1683 Immune serums Sarcoma, osteogenic Ornithine decarboxylase, 1511 Chemical/physical properties, 2006 L-Phenylalanine mustard, 6, 3638 Virus, Moloney murine sarcoma, 2006 Immunogenicity Fetalproteins Chemically-induced respiratory tract tumors, rat see Fetal globulins 2466 Immunotherapy a-Fetoprotein Tumor regression,rat, 3638 see Alpha fetoprotein Metastases Fibroblasts Normal and immunosuppressedmouse, 3816 Cell differentiation Migratory activity Millipore diffusion chamber implants, 1467 Humanserum-adaptedcells,mouse,2376 Fibrinogen Mineral oil emulsification Cell differentiation, 1467 Administration method, mouse/guinea pig 535 Growth conditions Neoplasm transplantation Millipore diffusion chamber implants, 1467 Chemically-induced respiratory tract tumors, rat Tumor vs nontumor cells, mouse, 1467 2466

5252 CANCER RESEARCH VOL.39 Subject Index to Volume39

Fibrosareoma(s)(cont'd) 5-Fluoro-2'-deoxyuridine Nocardia rubra see Uridine, 2'-deoxy-5-fluoro Cell-wall skeleton, 4706 Macrophages, 4706 5-Fluoro-2'-deoxyurldlnemonophosphate Ornithine decarboxylase sec Uridine, 2'-deoxy-S-fluoro-, monophosphate Neoplastic cell assay, 1511 Peptides 5-Fluorouradil Macrophage cytotoxicity, 1847 sec Uracil, 5-fluoro Plastics 5-Fluorouridine Foreign body reaction, 2172 sec Uridine, 5-fluoro Suppressor cells Immunogenetics,2945 Fluorouridine kinase Spleen, mouse, 2945 Uracil, 5-fluoro Transplantation,homologous Cytotoxicity vs enzyme activity, human/mouse, in Human serum-adaptedcells, mouse, 2376 vitr4 383 Virus, SV4O Folate antagonists IgG, 2919 Carboxypeptidase G1 Immune complex, 2919 Review, 293 Radioimmune assay; sera, hamster, 2919 Leucovorin FNlpin Review, 293 Bleomycin Methotrexate Synergistic activity, hamster cells, in vitr4 5150 Dihydrofolate reductase, 293 Toxicity, lymphoblasts/leukemiacells, human Huoren-2-amlne 3612 Aging Triazinate Microsomes, liver, 4752 Review, 293 Mutagenic metabolite, 4752 Barbituric acid, 5-ethyl-5-phenyl Folicacid Hepatoma(s) Mutagenicmetabolite,1168 Cholanthrene,3-methyl Metabolism, Reuber H35 cells, 735 Leukemia(s) Mutagenic metabolite, 1168 Membranetransport, lymphoblasts, 2440 Enzymeactivation Liver, rat, 1168 Fluorene,2-nitro Folicacid,5-methyltetrahydro Bacteroidesvulgatus,2026 Hepatoma(s) Mammary neoplasms,experimental Metabolism,ReuberH35cells, 735 Tissue culture, mouse, 1784 Leukemia(s) Metabolism Membranetransport,lymphoblasts,2440 Liver microsome, human, in vitr4 4206 Microsomes,liver Folicacid,tetrahydro-,5-formyl Ames test, 3268, 4752 Methotrexate Mutagenic metabolite Membranetransport, lymphoblasts, 2440 Liver,rat,1168

Thucma Foreign body reaction Mammary neoplasms,experimental Fibrosarcoma(s) Tissue culture, mouse, 1784 Plastics, 2172 Fluorene,2-nitrO Ames test Formamide,1,1'-azobis(N,Ndimethyl)- Host-mediatedassay,2026 Quinoline, 4-nitro-, 1-oxide Bacteroides vulgatus Metabolism, 2961 Metabolism, 2026 Fluoren-2-amine Formamide, N,Ndimethyl Bacteroides vulgatu@ 2026 Adenocarcinoma(s) Lactobacilusplantarum Tumorgenicity, vs growth characteristics, 1020 Ames test, 2026 Formamide,N-[4-(5-nitro-2-furyl)-2-thiazolyl]- Mammary neoplasms,experimental Bladderneoplasms Tissueculture,mouse, 1784 Papilloma(s), 1207 Thoreeoentlight Sodiumsaccharin, 1207 ChrOinatids Tryptophan, 1207 Cells, mouse, in vitr4 929 Ultrastructural study, rat, 1207 Chromosomeabnormalities 2-Formylpyridine J%@OxIdebenzenesulfonylhydrazone Cell transformation, neoplastic@ 929 Sarcoma,Crocker 180 Cells, mouse,in vitr4 929 DNA, 2625

DECEMBER 1979 5253 Subject Index to Volume39

Gamma radiation

5;? Folic acid, tetrahydro-, 5-formyl see Radiation, ionizing Forrsman antigen Gangliosides Lung neoplasms Lymphocyte transformation Isoantibodies, 2909 T-Lymphocytes, 817 T-Lymphocytes Fructose 1,5-biphosphete aldolese Hepatoma(s) Concanavalin A, 817 RNA, messenger,502 Gastrointestinal neoplasms RNA, messenger Aflatoxin B Isolation and characterization, 502 Carcinogenic activity, monkey, 4545 Ftorefur Alcohol see Uracil, 5-fluoro-l-(tetrahydro-2-furanyl)- Mechanisms of carcinogenesis, review, 2863 Guanidine, N-methyl-N-nitro-N-nitroso Fucogengliosides Germ-freerat, 2733 Fucolipids Microflora, 2733 Liver, rat, 2637 Indicine, N-oxide Hepatoma(s) Pharmacokinetics, 4540 Fucolipids, 2637 Toxicity, 4540 Fucolipids Methane,azoxy Fucogangliosides Dietary fats, 4956 Liver, rat, 2637 Rubidazone Hepatoma(s) Phase I clinical trial, 823 Fucogangliosides, 2637 Giemsa-banding karyotype, Moms tumor Fucosyltransferases Hepatoma(s) Agranulocytosis Chromosome abnormalities, 1708 Isoenzymes, plasma, human, 3377 Glioma Infectious diseases ACNU Isoenzymes, plasma, human, 3377 Cyclophosphamide, 2687 Leukemia, myeloblastic Antigenic determinants Isoenzymes, plasma, human, 3377 Antibody specificity, 3235 FUra Cell membrane, 3235 Uracil, 5-fluoro Antigens, neoplasm Cytotoxicity vs enzyme activity, human/mouse, in Antigenic determinants, 1733 vitr4 383 Brain neoplasms Antigenic determinants, 3235 2-Furaldehyde, 5-nitro-, semicarbazone Immunity, cellular Metabolic reduction Leukocyte adherence inhibition test, 1733 Polarographic analysis, 4512 Immunoglobulins 2(311)-Furanone, 5-methyl Serum levels, human, 542 Mammary neoplasms,experimental Proteins Antineoplastic activity, mouse, 1651 Serum levels, human, 542 Furosemide Glomerular filtration rate Platinum (II), diamminedichloro-, cia Platinum (II), diamminedichloro-, cia Glomerular filtration rate, 1269 Anthranilic acid, 4-chloro-N-furfuryl-5-sulfamoyl Galectosyltransferases 1269 Bladder neoplasms Furosemide, 1269 Assay, human, 3856 Mannitol, 1269 Epithelium, 3856 Glucagon Carcinoma, transitional cell Glucosamine 6-phosphate synthetase Assay,human, 3856 Regenerating liver, rat, 2783 Ultrastructural study, human bladder, 3856 Hepatoma(s) Colonic neoplasms Receptors, hormone, 1443 Adenocarcinoma(s), 1259 Epithelial cells, human, 1259 Glucocorticoids Epithelium Breast neoplasms Ultrastructural study, human bladder, 3856 Receptors, hormone, 1447 Leukemia, lymphocytic Ovarian neoplasms Lymphocytes, 4939 Serum levels, human, 1943 Leukemia(s) Receptors, hormone, 376 Gallium citrate Lymphoma(s) Granulocytes Binding, corticoid-sensitive tumor cells, mouse Hypoxia, 4971 4011 Uptake, cell lysosomes, 4971 Receptors, hormone, 4011

5254 CANCER RESEARCH VOL.39 Subject Index to Volume 39

3j3.DGtucopyranosyl-1.methyl-1-nitrosourea Glutamyl transpeptidase seeUrea, 3-$-D-glucopyranosyl-1-methyl-1-nitroso Cell transformation, neoplastic Epithelium, 4441 Glucosamine 6-phosphate synthetase Epithelium Amino acids Normal/neoplastic, liver, rat, 269 Regenerating liver, rat, 2783 Hepatoma(s) Glucagon Epithelium, 269 Regenerating liver, rat, 2783 Kidney neoplasms Heparin New cell line, 4694 Regenerating liver, rat, 2783 Normal/neoplastic cell lines, embryo, hamster Hepatoma(s) SV4O transformed fibroblasts, 269 Isolation and characterization, 2779 Isolation and characterization y-Glutamyltransferase Regenerating liver, rat, 2783 Hepatoma(s) Normal liver, fetal/adult, rat Isolation and characterization, 4200 Isolation and characterization, 2779 Normal kidney/normal liver, rat, 4200 Triiodothyronine y-Glutamyltranspeptidase Regenerating liver, rat, 2783 Alpha fetoprotein Carcinogenesis, mouse, 3495 Glucose Adriamycin Choline Acetamide, N-fluoren-2-yI-, 2515 Emux mechanism, 2200 Diethylamine, N-nitroso-, 2515 Cell movement Hepatoma(s) Tumor vs normal thymus cells, 250 o-Toluidine, 4-(o-tolyazo)-, 3495 Daunomycin Efflux mechanism, 2200 Glutathione transferases Hepatoma(s) Benzo(a)pyrene, 4,5-oxide Enzyme activity, 1051 Conjugated metabolites, liver, rat, 2051 Metabolism, rat cell lines, 1051 Epoxide hydratase Tissue microsomes, rat, 2971 Glucose, 2deoxy Phenol, 2-tert-butyl-4-methoxy Cell transformation, neoplastic Tissue microsomes, rat, 2971 Epithelium, 4441 Neocarzinostatin Glycerolipids Metabolism, 4687 Epithelium Phorbol esters Metabolism, rat, 207 Metabolism, in vitro vs in vivo, 714 Phospholipids 12-O-Tetradecanoylphorbol-l3-acetate Metabolism, rat, 207 Metabolism, in vitro vs in vivo, 714 Tracheal neoplasms Phospholipids, 207 Glucosephosphatase Pyrrolidine, 1-nitroso 2,2-Bis(pGlycidyloxyphenyl)propane Ethyl alcohol, 793 see Propane, 2,2-bis(,p-glycidyloxyphenyl)- Glucosephosphate dehydrogenase Glycogen Colonic neoplasms Kidney neoplasms Metabolism, human tumor cells, 531 New cell line, 4694 Mammary neoplasms, experimental Metabolism, human tumor cells Cell cycle synchronization, 531 Dehydroepiandrosterone, 1129 Glycolipids $-Glucuronidase Dexamethasone Colonic neoplasms Tumor cells, rat, 3540 Dietary fiber, 3752 Dietary fiber Glycolysis Tumor incidence, rat, 3752 Carcinoma, Ehrlich tumor Fibrosarcoma(s) Arsenite, 2195 Human serum-adapted cells, mouse, 2376 Lactate dehydrogenase, 2195 Methanol, (methyl-ONN-azoxy) Zinc, 2457 Mutagenic derivative, 3070 Glycoprotein EDCI Glutamlnase@asparaginase Neoplasms seeAsparaginase-glutaminase Urological disease, 699 Glutsmlne-phosphoribosylpyrophosphate amidotransferase Glycoproteins Breast neoplasms Amidophosphoribosyltransferase Antigenic determinants, 2057 Ghitamlne synthetase Carcinoma, ductal, 2057 Leukemia(s) Carcinoma(s), 2057 Prognostic indicator, 376 Cell membrane Sezary syndrome, 376 Carcinogenicity, cell lines, rat, 3677

DECEMBER 1979 5255 Subject Index to Volume39

Glycoproteins (cont'd) Granulocytes (cont'd) Ultrastructural study, rat, 3677 Colony-inhibitingactivity, human, 1640 Cell transformation, neoplastic Leukemia, myelocytic Cell membrane, 2595 Colony formation, 1575 Cytosine, l-13-D-arabinofuranosyl Neoplasms Drug resistance, 2070 Serum inhibitor, 1640 Dexamethasone Growth factors Tumor cells, rat, 3540 Skin neoplasms Fibrosarcoma(s) Antitumor activity, mouse, in vivo, 239 Carcinogenicity, cell lines, rat, 3677 Leukemia(s) Growth hormone Vinblastine, 2070 see Somatotropin Neuraminidase Gusnidine, N@ethyl-N-nifro-A6nltroso Cell membrane, 2595 DNA repair Vinbiastine DNA, alkylation, 131 Drug resistance, 2070 Mutagenic activity Glycosaminoglycans V79 cells, hamster, 131 Isolation and characterization Thioguanine resistance Normal/neoplastic breast tissue, human, 870 Mutagenic activity, 131

Glycosidases Guanidine, N@methyl-N-nltro-Nmitroso Colonic neoplasms Cell transformation,neoplastic Adenocarcinoma(s), 1259 Tracheal mucosa, rat, in vitro, 4091 Fibrosarcoma(s) Colomc neoplasms Human serum-adapted cells, mouse, 2376 5j3-Cholan-24-oic acid, 3a-hydroxy-, monosodium salt, 1521 Ovarian neoplasms Cholestane-3f3,5a,6$-triol, 1521 Serum levels, human, 1943 Cholesterol, 1521 Cholesterol-5a,6a-epoxide, 1521 Gonadotropins, chorionic Conventional/germ-free rat, 1521 Benz(a)anthracene, 7,12-dimethyl DNA Estrus, 4700 Liver, rat, 3254 Choriocarcinoma Lymphocytes, 3524 Cytosine, l-$-D-arabinofuranosyl-, 1952 Molecular weight and sedimentationvelocity, 3254 DNA synthesis, 1952 DNA repair Methotrexate, 1952 DNA, alkylation, 131 Urea, hydroxy-, 1952 Epitheium Uridine, 2'-deoxy-5-fluoro-, 1952 Tracheal mucosa, rat, in vitro, 4091 Cytosine, l-$-D-arabinofuranosyl Fibroblasts Cytidine, deoxy-, 1952 DNA-protein cross-links, 704 HeLa cells Gastric secretion Actinomycin D, 3885 Vagotomy, 811 l43-Arabinofuranosylcytosine, 3885 Gastrointestinal neoplasms Butyric acid, sodium salt, 3885 Germ-free rat, 2733 Cycloheximide, 3885 Microflora, 2733 Histaminase HeLa cells Malignant effusion fluid, human, 4894 Immunoreactivity, in vitro, 3524 Methotrexate Histones Thymidine, 1952 Binding, tumor cells, 923 Neoplasms Lymphocytes Secretion, 82 human cell lines, 3885 Immunoreactivity,in vitro, 3524 Uridine, 2'-deoxy-S-fluoro Mutagenic activity Thymidine, 1952 V79 cells, hamster, 131 Nucleoproteins Graft vs host reaction Binding, tumor cells, 923 Platinum(II), sulfato-trans-(-)-l,2-diaminocyclohexane Ozone Immune response, mouse, 3476 Ames test, 2155 Thymectomy Protease inhibitors Newborn/weanling hamster, 4949 Mutagenic activity, hamster, 2755 Virus, Gross murine leukemia Stomach neoplasms T-Lymphocytes, 480 Adenocarcinoma(s), 811 Granulocytes New cell line, rat, 5141 Gallium citrate Vagotomy, 811 Hypoxia, 4971 Thioguanine resistance Uptake, cell lysosomes, 4971 Mutagenic activity, 131 Immune serums Ultrastructural study, 5141

5256 CANCERRESEARCHVOL.39 Subject Index to Volume39

Guanidine, 1,1'-(methylethanediylenedlnltrilo)- Heart neoplasms Leukemia Ll210 T-2 toxin Mitochondrial damage, in vivo, 2414 Histological study, rat, 2179 Ultrastructuralstudy, 2414 Heat Heat-conditioning Guanidine, 1,1â€• HU monohy Survival, Chinese hamsterovary cells, 2486 drste Heat regulation physiology Cell transformation, chemical Toxic effects of high temperatures, 2336 Growth, 2718 HeLa cells Actinomycin D Guanine, 9-/3-D-arablnofuranosyl.,5'-trlphosphate Gonadotropins, chorionic, 3885 DNA polymerases Antigens, chromatin Enzyme inhibition, 4673 Cell cycle distribution, 3683 Virus, Rauscher murine leukemia Cell type specificity, 3683 DNA polymerases, 4673 1-/3-Arabinofuranosylcytosine Guaalae, 7-methyl Gonadotropins, chorionic, 3885 Butyric acid, sodium salt Dimethylamine, N-mtroso Gonadotropins, chorionic, 3885 DNA alkylation, 1798 Hydrazine, 1,2-dimethyl Cycloheximide Gonadotropins, chorionic, 3885 Disulfide, bis(diethylthiocarbamoyl)-, 465 Hyperthermia Urea, N-methyl-N-nitroso DNA repair, 1041 Growth recovery kinetics, 1218 Immune serums Virus, herpes simplex 2 Nonhistone protein:DNA complexes, 3683 DNA repair, 1041 Nucleolar argyrophilicgranules, 857 Gusnine, Omethyl Phorbol esters Deoxyribonuclense, 2675 Phospholipids, 2743 Brain cell nuclei, rat, 2675 Radiation, non-ionizing Diethylamine, N-nitroso Growth recovery kinetics, 1218 Mechanism of action, liver, rat, 5003 l2-O.Tetradecanoylphorbol-13-acetate Guanine, 7-methyl-, (? Phospholipids, 2743 Uracil, 5-fluoro Dimethylamine, N-nitroso Liver, hamster, 50 H-Pyrazolo(3,4-d)pyrimidin.4-ol, 3095 Guanosine, 5'-deoxy Hemangioma Carcinoma, Ehrlich tumor Cytosine, 1-)3-D-arabinofuranosyl Ribonucleotide reductase, 4600 DNA synthesis, 1814 Gynecologic neoplasms Hematopolesis Estradiol Breast neoplasms Neonatal mouse, 2591 Adriamycin, 527 Ovariectomy, 2591 Hematopoletic stem cells Progesterone Adriamycin Estradiol, 2591 Human/dog/mouse, in vivo, 360 Neonatal mouse, 2591 Toxicity, in vitro, 527 Ovariectomy, 2591 Adriamycin, N-trifluoroacetyl-, valeric acid Human/dog/mouse, in vivo, 360 seeDiethylstilbestrol Antineoplastic agents Immune response, mouse, 4564 H@ Daunorubicin Alcohol dehydrogenase DNA, 3738 Enzyme-antibody complex, 2084 Doxorubicin Enzyme-antibody complex DNA, 3738 Cytotoxicity, HEp2 cells, 2084 Histology Head and neck neoplasms Permanent slide, technique, 1133 Alcohol Lymphoma(s) Antineoplastic agents, 4564 Epidemiological studies, review, 2844 Tobacco, 2844 Poly C Hyperthermia, localized Cell cycle kinetics, 3163 Radio-frequency heating 2332 Colony formation, 3163 Radiotherapy, 2332 Partially thiolated derivatives, 3163 Leukocyte adherence inhibition Soft-agar colony cultures Antigens, neoplasm, 597 Permanent slide, technique, 1133 Hypersensitivity, delayed, 597 Hematoporphyrin Pentylamine, N-methyl-N-nitroso Mammary neoplasms, experimental Dose-response study, rat, 3644 Photosensitization, 146

DECEMBER1979 5257 Subject Index to Volume39

Hematoporphyrin (cont'd) Hepatoma(s) (cont'd) Photochemotherapy AmidophosphorthosyltransfÃ¨rase Cell cycle synchronization, 3735 Isolation and characterization, 305 Dose-response studies, human, 3735 o-Aminoazotoluene Photosensitization Alpha fetoprotein, 3495 Cytotoxicity, in vitro, 96 Antigens, nucleolar Retinoblastoma Isolation and characterization, rat, 59 Photosensitization, 96 Antineoplastic agents Synthesis, derivative Adenosine cyclic 3':S'-monophosphate, 3156 Tissue distribution, derivative, 146 Arginase DNA synthesis, 1655 Heme Arginine Virus, Friend spleen focus-forming Thymidine incorporation, 1655 Erythropoiesis, 1841 Azobenzene, 4-amino-N-hydroxy Erythropoietin, 1841 Carcinogenic activity, weanling rat, 3411 Hemocyanin Azobenzene, N-ethyl-4-amino-N-hydroxy Leukocyte adherence inhibition Carcinogenic activity, weanling rat, 3411 Immune response, human, 570 Bacillus Calmette- Guerin Immunity, cellular, 570 Cell wall immunotherapy, 1597, 1766 Metastases, 1597 Heparin Mineral oil emulsification, 535 Glucosamine 6-phosphate synthetase Neoplasm regression, line 10 tumor, guinea pig Regenerating liver, rat, 2783 1766 Hepatoblastoma(s) Tumor cell vaccine, 1353 see Hepatoma(s) Benz(a)anthracene, 7,12-dimethyl Cytotoxicity, normal vs neoplastic cells, 4925 Hepatocellular carcinoma DNA binding 4925 see Hepatoma(s) Benzene, 4-allyl-l,2-(methylenedioxy)- Hepatocytes Perinatal carcinogenicity, 4378 Acetamide, N-fluoren-2-yl Biological transport Culture mouse embryo cells, 3509 Calcium ion, 2737 Bleomycin Body weight Ultrastructural study, rat, 4218 Short-term survival, rat, 2371 Tyrosine aminotransferase Bone marrow Culture mouse embryo cells, 3509 Cytotoxicity of tumor cells, 30 Calcium Hepatoma(s) Carrier proteins, 3000 Acetamide, N-fluoren-2-yl Phosphodiesterase, 3000 Alpha fetoprotein, 3491 Carrier proteins Histological study, rat, 1437 Isolation and characterization, 3000 Methionine adenosyltransferase, 2113 Cell nucleus RNA, transfer, methyltransferases, 2113 Isolation and characterization, Zajdela tumor, 3031 Acetamine, N-fluroen-2-yl Cell transformation, neoplastic Alpha fetoprotein, 3715 Butyrate, sodium, 800 Adenine nucleotides Cell surface properties, 1026 Adenine nucleotide translocase, 2737 Dimethyl sulfoxide, 800 Adenosine 5'-monophosphate, 2737 Growth, soft agar, 1026 Adenosine cyclic 3':S'-monophosphate IgCl, 800 Antibody-dependent cell cytotoxicity, 3156 Mallory bodies, 800 Adenosine triphosphatase Receptors, concanavalin A, 800 Precancerous conditions, 1298 Ultrastructural study, 800 S.Adenosylmethionine synthetase Chlordane Isozymes, 162 Alpha fetoprotein, 3491 Aflatoxin B 4@[Chloro@6@(2,3.xylidino)-2.pyrimidinylthio] acetic acid Diet, 3986 Acetyltransferases, 152 Albumin Carcinogenic activity, mouse, rat, 152 Synthesis, normal vs tumor liver, rat, 101 Choline Alcohol Acetamide, N-fluoren-2-yl-, 2515 Epidemiology, 2863 Diethylamine, N-nitroso-, 2515 Mechanisms of carcinogenesis, review, 2863 Chromosome abnormalities Alpha fetoprotein Giemsa-banding karyotype, Morris tumor, 1708 Serum levels, hepatocarcinogenesis, rat, 3715 Cyclohexane, l,2,3,4,5,6-hexachloro Alpha fetoproteins Peroxisomes, 1628 Polyribosomes, Morris tumor, 2141 Dexamethasone RNA, messenger, 2141 Cell membrane, 3540 Alpha macrofetoprotein Diet Serum levels, hepatocarcinogenesis, rat, 3715 Mechanisms of carcinogenesis, review, 2863

5258 CANCERRESEARCHVOL.39 Subject Index to Volume39

Hepatoma(s) (cont'd) Hepatoma(s) (cont'd) Polyribosomes, 1995 Nucleic acids Diethylamine, N-nitroso Cell nucleus, 3031 Cell cycle kinetics, 1298 Nucleolar argyrophilic granules Histological study, rat, 1437 Normal/regenerating/neoplastic liver, rat, 857 Precancerousconditions, 1298 Nucleoproteins Dimethylamine, N-nitroso Cell nucleus, Morris tumor, 2096 Cell cycle synchronization, 5177 Normal/neoplastic liver, rat, 507 DNA synthesis, 5177 Ornithine, -DL Hepatectomy, 5177 Metabolism, 1431 DNA Peptides Nucleic acid hybridization, 1287 Protease inhibitors, 3031 Nucleolus, Novikoff tumor, 1287 Phospholipids DNA synthesis Cell nucleus, 3031 Thymidine incorporation, 1655 Microsomes, mitochondria, 2978 Enzymatic vs mechanical disaggregation Phosphoproteins Tumor cell vaccine, 1353 NormaVregenerating/neoplastic liver, rat, I 16 Ethanamine, N.ethyl-N-nitroso Plasma membrane Alpha fetoprotein, 3715 Chemical/enzyme characteristics, guinea pig cells Fetal globulins 1369 Cell nucleus, Morris tumor, 2096 Pyridoxine Folic acid Tyrosine aminotransferase, 2988 Metabolism, Reuber H35 cells, 735 Sodium chloride Folic acid, 5-methyltetrahydro Protein synthesis, rat, 1995 Metabolism, Reuber H35 cells, 735 Threonine Fructose 1,5-biphosphate aldolase Protein synthesis, rat, 1995 RNA, messenger, 502 Thymidine incorporation Fucolipids Inhibitory factors, Novikoff tumor, 1655 Fucogangliosides, 2637 Thyroxine Glucagon Short-termsurvival, rat, 2371 Receptors, hormone, 1443 m-Toluidine, N,N-dimethyl-4-(phenylazo)- Glucosamine 6-phosphate synthetase Barbituric acid, 5-ethyl-5-phenyl-, 112 Isolation and characterization, 2779 Histological study, rat, I 12 Glucose o.Toluidine, 4-(o-tolyazo). Enzyme activity, 1051 a-Glutamyltranspeptidase, 3495 Metabolism, rat cell lines, 1051 Transplantation, heterologous Glutamyl transpeptidase Alpha fetoproteins, 1819 Epithelium, 269 Blood proteins, 1819 y-Glutamyltransferases Nude mouse, 1819 Isolation and characterization, 4200 Tryptophan Normal kidney/normal liver, rat, 4200 Protein synthesis, rat, 1995 Growth rates Tyrosine aminotransferase Chromosome abnormalities, 1708 Adrenalectomy, 2988 Hycanthone methanesulfonate Uracil, 5-fluoro Histological study, mouse, 4491 Metabolism, drug-resistantcell line, 4905 Hypothyroidism Uracil, 6-propyl-2-thio Body weight, 2371 Short-term survival, rat, 2371 Short-termsurvival, rat, 2371 Virus, bovine adeno 3 Insulin Angiogenesis factor, 1305 Growth rate, Morris tumor, 1443 Receptors, hormone, 1443 Hexamelamine Intracellularmembrane Pentamethylmelamine ChemicaVenzyme characteristics,guinea pig cells Pharmacokinetics, rabbit/human, 5016 1369 Macromomycin Hexosaminidases DNA synthesis, 1180 Epithelium Nucleic acids, 1180 Fetal/adult, normal/neoplastic, human, 3405 Metastases Isoenzymes Tumor cell vaccine, 1353 Epithelium, 3405 Methionine adenosyltransferase Normal/neoplastic, kidney/placenta, human, 1829 Isoenzymes, 2113 Methotrexate Metabolism, Reuber H35 cells, 735 Hippuric acid, p-amino Tetrahydrofolate dehydrogenase, 735 Platinum (II), diamminedichioro-,cis. Thymidylate synthetase, 735 Anthranilic acid, 4-chloro.N-furfuryl-5-sulfamoyl Nuclear magnetic resonance 1269 Imaging technique, rat, 468 Mannitol, 1269

DECEMBER1979 5259 Subject Index to Volume39

Hodgkin's disease (cont'd) Alkaline phosphatase Epidemiology Malignant effusion fluid, human, 4894 Los Angeles County, 4507 Carcinoembryonic antigen Malignant effusion fluid, human, 4894 Hoechst 33432 /3-Human chorionic gonadotropin Flow cytometric analysis Malignant effusion fluid, human, 4894 Experimental tumor, mouse, 1891 Radiation, ionizing Cell survival, 1891 Histidinol Homocystelne Virus, Kirsten murine sarcoma see Cell transformation, viral Protease inhibitors, 2995 Hormones Ascorbic acid Histocompatibiity antigens Review, 663 see also Antigens, neoplasm Intracellular membrane Antigens, T-lymphocyte associated Chemical/enzyme characteristics, guinea pig cells Immunoprecipitation, 4810 1369 Breast neoplasms Plasma membrane T-Lymphocytes, 4796 Chemical/enzyme characteristics, guinea pig cells Colonic neoplasms 1369 Transplantation immunology, 1174 Fibrosarcoma(s) Hospices Plate-induced tumor cell lines, mouse, 2172 Cancer patient Immune serums Administration, 2859 Antitumor activity, rat, 6 Role of the physician, 2859 Leukemia, lymphocytic Hybrid cells Leukemia, myeloblastic, 4810 Lymphocytes Leukemia, myeloblastic A-type particles, 4481 Antigens, T-lymphocyte associated, 4810 Leukemia, myelocytic Plasmacytoma A-type particles, 4481 Antigens, T-lymphocyte associated, 4810 B-Lymphocytes Chromosomes, 4481 Leukemia, myeloblastic, 4810 Hycanthone methanesulfonate T-Lymphocytes Hepatoma(s) Leukemia, myeloblastic, 4810 Histological study, mouse, 4491 Sarcoma(s) Sarcoma(s) Transplantation immunology, 2952 Histological study, mouse, 4491 Virus, SV4O, 2952 Virus, feline leukemia Hydantoin, 1-((5-nltrofurfurylidene)amino)- Infectivity, human cell, 3388 Metabolic reduction Virus, SV4O Polarographic analysis, 4512 Transplantation immunology, 2952 Hydrazine, 1,2-dimethyl Ames test Histology Host-mediated assay, 2026 Hematopoietic stem cells Colonic neoplasms Permanent slide, technique, 1133 Salmonella typhimurium, 2768 Nucleolar argyrophilic granules Transplantation immunology, 1174 Silver staining technique, 857 Disulflde, bis(diethylthiocarbamoyl) DNA methylation, 465 Guanine, 7-methyl-, 465 Histone kinase Purine, 2-amino-6-methoxy-, 465 Diabetes mellitus Lactobacillus plantarum Mammary tumor regression, mouse, 2501 Ames test, 2026 Mammary neoplasms, experimental Ozone Streptozotocin, 2501 Ames test, 2155 Water pollutants, chemical, 2155 Histones Purine, 2-amino-6-methoxy Leukemia L12l0 Colon, rat, 465 Urea, N-methyl-N-nitroso-, 923 Hydrogen-ion concentration Historical Review of the American Association Hyperthermia for Cancer Research, Inc., 1941-1978, 1863 Lethality, Chinese hamster cells, in vitro, 966 Hodgkin's disease Lung cells, mouse, 2772 Amphetamines Thermotolerance Risk factors, 4507 Lung cells, mouse, 2772

5260 CANCERRESEARCHVOL.39 Subject Index to Volume39

@Hydrony-N4-acety1am1nobiphenyl Hyperthermla (cont'd) seeAcetohydroxamicacid,N-4-biphenyl- High-resistanceleads,2325 Optical-fiber probes, 2325 N@Hydrozy-2-aeetylam1nofluorene Radio-frequency heating 2325 seeAcetohydroxamicacid,N-fluoren-2-yl- Tomography,ultrasound,2325 N@Hydrnay-4-amlnoazobenzene Fibrosarcoma(s) seeAzobenzene,4-amino-N-hydroxy- Cholanthrene,3-methyl-, 3248 Corynebacterium parvum, 3454 NHydrozy-N..euiy.-'.-aminoazobenzene Time-temperature relationship, 3248 @ Azobenzene, N-ethyl-4-amino-N.hydroxy- HeLa cells 7-Hydrozyaethyl-12-methylbenz(a)anthracene Growth recovery kinetics, 1218 seeBenz(a)anthracene-7-methanol,12-methyl- Hydrogen-ionconcentration Lethality, Chinese hamster cells, in vitro, 966 iv-vs.Hydrozyphenyl)retinamide Lung cells, mouse, 2772 seeRetinamide,N-(4-hydroxyphenyl)- HY@,OXia Hydroxyproline Lethality, Chinese hamster cells, in vitro, 966 seeProline, 4-hydroxy. Lung neoplasms Bleomycin, 3792 Hyperbaric oxygen Transplantation immunology, 1126 Adriamycin Mammary neoplasms, experimental Cytotoxicity, in vitro, 370 Radiation, ionizing 2966 Burkitt's lymphoma Ultrasonics, 2166 Adriamycin, 370 Melanoma(s) Nitrogen mustard, 370 Radio-frequency heating 2236 Nitrogen mustard Mitosis Cytotoxicity, in vitro, 370 Chinese hamster ovary cells, 1911 Hyperfibrinogenemia Neoplasms p.Phenoxybenzalbutyrate Antitumor activity, solid tumors, mouse, 4534 Rat, in vivo, 3845 Epipodophyllotoxin, 4'-demethyl-,9-(4,6-O. ethylidene-, 1481 Hypei'seiisitivity, delayed Melphalan, 1481 Immunogenetics Toxicity, whole-body heating 1481 Immune response, human, 219 Nuclear membrane Leukemia(s) Chromosomes, 1911 Immune response, human, 219 Proteins Leukocyte adherence inhibition Growth rate, Chinese hamster ovary cells, 2665 Head and neck neoplasms, 597 Radio-frequency heating Melanoma(s) Antitumor activity, nude mouse, 2236 Immune response, human, 219 Radiotherapy Urea, [email protected])-3-(4-methylcyclohexyl)- Hyperthermic sensitivity, mammalian cells, 2290 nitroso-, 4472 Review, 2290 Hyperthermia Spontaneous tumors, dog 2242 seealso Thermotolerance RNA Adenocarcinoma(s) Growth rate, Chinese hamster ovary cells, 2665 Radio-frequency heating 2236 SulfliydrylCytotoxicity,compounds4630 Carcinoma(s) Intratumoral injection with fine needle, rabbit TechnologyReview, 2313 3429 Radio-frequencyheating 2236 ThermotoleranceLetter to the editor, 2220 Cell cycle kinetics Review, 2277 Normal/malignant cells, 2220 Urea, N,N-bis(2-chloroethyl)-N-nitroso Cell division Bone marrow, 2547 Cell membraneGrowth recovery kinetics, 1218 Cytotoxicity, in vitro, mouse, 2547 Microfilament complex, 1911 Hyperthermla, localized Mitosis, 1911 Adriamycin Chemotherapy Cytotoxicity in vitro/in vivo, 2269 Review, 2285 Amphotericin B Synergistic effects, 2285 Review, 2264 Corynebacterium parvuin Bleomycin Synergistic activity, 3454 Cytotoxicity in vitro/in vivo, 2269 DNA Review, 2264 Growth rate, Chinese hamster ovary cells, 2665 Chemotherapy Dose-response assay Review, 2269 Spontaneous tumors, dog 2242 Fibrosarcoma(s) Dosimetry, thermal Antitumor activity, mouse, 2258 Clinical trials, 2300 Head and neck neoplasms

DECEMBER1979 5261 Subject Index to Volume39

Hyperthermia, localized (cont'd) IgG (cont'd) Radio-frequency heating 2332 Plasmacytoma Radiotherapy, 2332 Neoplasm transplantation, 2497 Melanoma(s) Sarcoma(s) Regional perfusion, 2255 Cholanthrene, 3-methyl-, 4588 Melphalan Immunoglobulins, Fc, 4588 Regional perfusion, 2255 1gM Nitrosoureas Melanoma(s) Review, 2264 Characterization, 1683 Platinum(II), diamminedichloro-, cis Cytotoxicity in vitro/in vivo, 2269 Immune response, human, 1683 Plasmacytoma Review, 2264 Immune response, mouse, 3783 Pseudourea, (2-aminoethyl)-2.thio, dihydrobromide Cytotoxicity in vitro/in vivo, 2269 Imidazole4-carboxamide, 5-(3,3-dlmethyl-1-triazeno)- Radio-frequency heating Melanoma(s) Clinical trials, 2245 Antitumor activity, mouse, 934 Toxicity tests, dog/sheep/pig 2245 1H-Imidazole-1-ethanol, a-(methoxymethyl)-2-nitro Radiotherapy Metastases, 2258 Mammary neoplasms, experimental Radiation, ionizing 2966 Skin neoplasms, 2258 Urea, l,3-bis(2-chloroethyl)-l-nitroso Imidazole-1-ethanol, 2-methyl-5-nitro Cytotoxicity in vitro/in vivo, 2269 Metabolic reduction Polarographic analysis, 4512 Hyperthermia, systemic Actinomycin D Imidoesters Review, 2264 Lymphocytes Adriamycin DNA synthesis, 345 Review, 2264 Immune complex Chemotherapy Fibrosarcoma(s) Water blanket set, 2252 Virus, SV4O, 2919 l,3-Bis(2-Chloroethyl)-l-nitrosourea Leukemia Ll2lO Cytotoxicity in vitro/in vivo, 2269 Immunosuppression, 174 Heat regulation physiology Review, 2307 Immune serums Immunotherapy Carcinoma(s) Water blanket set, 2252 Ornithine decarboxylase, 1511 Nitrosoureas Fibrosarcoma(s) Review, 2264 Ornithine decarboxylase, 1511 Platinum(II), diamminedichloro-,cis L-Phenylalanine mustard, 6, 3638 Review, 2264 Granulocytes Radiotherapy Colony-inhibiting activity, human, 1640 Water blanket set, 2252 Histocompatibility antigens Review Antitumor activity, rat, 6 Methods of raising body temperature, 2307 Leukemia Ll2lO Ornithine decarboxylase, 1511 Hypophysectomy Leukemia, lymphoblastic Chondrosarcoma Lymphoblastoid B-cell line, Daudi, 5171 Growth, 4387 Leukemia, lymphocytic Hypothyroidism Lymphoblastoid B-cell line, Daudi, 5171 Hepatoma(s) Leukemia, myeloblastic Short-term survival, rat, 2371 Lymphoblastoid B-cell line, Daudi, 5171 Leukemia, myelocytic Hypoxanthine Lymphoblastoid B-cell line, Daudi, 5171 Fibroblasts B-Lymphocytes Cell transformation, viral, 1855 Cytotoxicity, human lymphoblastoid cell lines Virus, Rous sarcoma 5171 Cell transformation, viral, 1855 T-Lymphocytes Hypoxia Cytotoxicity, human lymphoblastoid cell lines see also Anoxia 5171 Gallium citrate Macrophages Granulocytes, 4971 Colony-inhibiting activity, human, 1640 Melanoma IgG Antigenic specificity, 183 Fibrosarcoma(s) Melanoma(s) Virus, SV4O, 2919 Bacillus Calmette-Guerin, 2125 Melanoma(s) L-Phenylalanine mustard Characterization, 1683 Antitumor activity, rat, 6 Immune response, human, 1683 Tumor regression, rat, 3638

5262 CANCER RESEARCH VOL.39 Subject Index to Volume39

Immunity Immunization Ascorbic acid Cytoxicity, spleen/lymph node cells Review, 663 Xenogenic tumor-sensitized cells, 4772 Mammary neoplasms, experimental Immunity, cellular Cytoxicity, spleen/lymph node cells, 4772 Antigens, neoplasm Virus, Moloney murine leukemia, 4887 Immunogenetics Antigens, viral Hypersensitivity, delayed Virus, Moloney murine leukemia, 4887 Immune response, human, 219 Antineoplastic agents Venereal tumor T-Lymphocytes, 4564 Blocking factor, serum, dog, 3920 Bacillus Calmette. Guerin Immunogenicity Vaccine, tumor-cell, 959 Antigens, neoplasm Bladder neoplasms Culture conditions, tumor cells, 3519 Antigens, neoplasm, 1985 Carcinoma, epidermoid Carcinoma, transitional cell, 1985 Chemically-induced respiratory tract tumors, rat Cyclophosphamide 2466 T-Lymphocyte precursors, spleen, mouse, 3647 Fibrosarcoma(s) Cystadenocarcinoma Chemically-induced respiratory tract tumors, rat Lymphocytotoxicity, 1185 2466 Cytotoxicity, spleen/lymph node cells Xenogenic tumor-sensitized cells, 4772 Immunoglobulins, Fc Glioma Leukocyte adherence inhibition Leukocyte adherence inhibition test, 1733 Mechanism of action, 576 Leukemia, myeloblastic Mammary neoplasms, experimental Cytosine, 1-$-D-arabinofuranosyl-, 3357 Immunogenicity, A-10 ascitic tumor, 1739 Daunomycin, 3357 Sarcoma(s) Purine-6(lJi)-thione, 2-amino-, 3357 IgG, 4588 Leukemia, myelocytic Macrophages, 4588 Cell differentiation, 3167 Immunologic deficiency syndromes Dexamethasone, 3167 Breast neoplasms Lipopolysaccharides, 3167 Animal model, asplenic mouse, 1529 Leukocyte adherence inhibition Mammary neoplasms, experimental Bacillus Ca/mette-Guerin, 564, 593 Animal model, asplenic mouse, 1529 Comparative study, mouse, 564 Receptors, hormone, 1529 Hemocyanin, 570 Virus, murine mammary tumor, I529 Review, 556 Virus, murine mammary tumor Virus, Rous sarcoma, 593 Antigens, viral, 1529 Liposomes Immunology Macrophage-activating factor, 881 Neoplasms Lymphocyte transformation Appropriate animal models, 4285 Antigens, viral, 3996 Mammary neoplasms, experimental Immunopotentiators Antigens, viral, 35 Leukemia Ll210 Embryo extract, mouse, 35 Vaccines, 2807 Tumor-associated antigen, 35 Immunosuppression Melanoma(s) Alcohol RNA, 1702 Animal model, mouse, 2894 Neoplasm transplantation Antineoplastic agents Neonatal thymectomized hamster, 3335 Platinum(II), sulfato-trans-(-)-l,2- Ovarian neoplasms diaminocyclohexane, 3476 Cystadenocarcinoma, 1185 Cyclophosphamide Cystadenoma, mucinous, 1185 T-Lymphocytes, 3647 Serum blocking factor, I 185 Fibrosarcoma(s) Plasmacytoma Metastases, 3816 Cytotoxicity, spleen cells, mouse, in vitro, 3928 Leukemia Ll2lO Sarcoma(s) Immune complex, 174 Cholanthrene, 3-methyl-, 3363 Leukemia, Moloney murine Spleen cells, MOPC-315-bearing mouse Urea, l,3-bis(2.chloroethyl)-l-nitroso-, 2894 Cytotoxicity, in vitro, 785 Lymphoma(s) Fractionation of active cells, 785 Actinomycin D, 4564 Suppressor cells Cytosine, 1/3-D-arabinofuranosyl-, 4564 Macrophages, 4983 Mitomycin C, 4564 Thymectomy Polyinosinic:polycytidylic acid, 4564 Newborn/weanling hamster, 4949 Macrophages Virus, adeno type 2 Receptors, antibody, 174 Neonatal thymectomized hamster, 3335 Ovarian neoplasms

DECEMBER 1979 5263 Subject Index to Volume39

Immunosuppression (cont'd) Insulin Ascitic fluid, 2381 Breast neoplasms Virus, feline leukemia Binding, cultured cells, 2422 Viral proteins, 950 Dexamethasone, 2422 Viral vaccines, 950 Carcinoma, Ehrlich tumor Antitumor activity, 1807 Hepatoma(s) Immunotherapy Growth rate, Morris tumor, 1443 Antigens, neoplasm Receptors, hormone, 1443 Culture conditions, tumor cells, 3519 Mammary neoplasms, experimental Soluble extracts, EL-4 tumor cells, 1159 Amino acids, 3381 Bacillus Calmette- Guerin Receptors, hormone Bacterial cell-wall skeleton, 3262 Fibroblasts, Syrian hamster embryo, 4166 Vaccine, tumor-cell, 959 Intercellular junctions N-Bromoacetyl-/3-D-galactosamine tetra-O-acetate Breast neoplasms Mechanism of action, in vitro vs in vivo, 3897 Uridine nucleotide transfer study, 4739 Corynebacterium parvum Regenerating liver, rat, 1361 Interferon Fibrosarcoma(s) Butyric acid, sodium salt Tumor regression, rat, 3638 Antitumor activity, 4720 Hyperthermia Interspecies activity Synergistic activity, 3454 Letter to the editor, 3796 Hyperthermia, systemic Leukemia L12l0 Water blanket set, 2252 Butyric acid, sodium salt, 4720 Leukemia Ll2lO Leukemia, myelocytic Vaccines, 2807 D-Factor, 4170 RNA, 4170 Leukemia, lymphocytic Antigens, neoplasm, 1159 Leukemia(s) Polyriboinosinic:polyribocytidylic acid, 1645 Mitomycin C, 1159 Polyriboinosinic:polyribocytidylic acid Neoplasm regression, 1159 Serum levels, 1645 Lung neoplasms Sarcoma(s) RNA, 1702 Butyric acid, sodium salt, 4720 Lymphoma(s) Trial of 10 agents, mouse, in vivo, 3964 Interstitial cell tumor Melanoma(s) Follicle-stimulating hormone RNA, 1702 Parabiosed rats, 3971 RNA Luteinizing hormone Cytotoxicity, mouse, in vivo vs in vitro, 1702 Parabiosed rats, 3971 Intracellular membrane Indicine Noxide Antineoplastic agents Antineoplastic agents Chemical/enzyme characteristics, guinea pig cells Metabolism, human/rabbit, 3564 1369 Gastrointestinal neoplasms Hepatoma(s) Pharmacokinetics, 4540 Chemical/enzyme characteristics, guinea pig cells Toxicity, 4540 1369 Leukopenia Hormones Thrombocytopenia, 4540 Chemical/enzyme characteristics, guinea pig cells 1369 Indomethacin Dexamethasone Iodine radloisotopes Cell differentiation, 2190 Acridine, 6,9-cliamino-2-ethoxy-5-iodo Phagocytosis, leukemia cells, mouse, 2190 DNA, binding 3244 Leukemia, myelocytic L cells Cell differentiation, 2190 Cytotoxicity, 3244 Inosine lodorivanol Carcinoma, Ehrlich tumor seeAcridine, 6,9-diamino-2-ethoxy-5-iodo Ribonucleotide reductase, 4600 Isoantibodles Uracil, 5-fluoro Lung neoplasms Cytidine, deoxy-, 4905 Age factors, 2909 Metabolism, drug-resistant cell line, 4905 Blood groups, 2909 Thymidylate synthetase, 4905 Forrsman antigen, 2909 Inosine, 5'-deoxy 3-Isobutyl-1-methylxanthine see Guanosine, 5'-deoxy seeXanthine,3-isobutyl-1-methyl Inox Isobutyric acid, 2-amino secInosine Leukemia(s)

5264 CANCER RESEARCH VOL.39 Subject Index to Volume39

Isobutyrle acid, 2-amino- (cont'd) Kidney neoplasms (cont'd) Melphalan, 353 Hexosaminidases Isobutyric acid, 2-(methylamino)- KaryotypingIsoenzymes, 1829 Leukemia(s) Clone cells, 4662 Melphalan, 353 Metastases, 4662 Isocytosine, 543-D-ribofuranosyl)- Niridazole Cytosine, 1-13-D-arabinofuranosyl- Carcinogenicity, rat, 4996 Drug sensitivity, in vitro/in vivo, 720 1. cells Leukemia P815 Cytosine, l-13-D-arabinofuranosyl-, 720 Acridine,Cytotoxicity,6,9-diamino-2-ethoxy-5-iodo3244 Drug sensitivity, in vitro/in vivo, 720 Iodine radioisotopes Mechanism of action, 720 Cytotoxicity, 3244 Isosizymes Plant substances Creatine kinase DNA synthesis, 4802 Nornial/neoplastic tissues, 492 Pyruvaldehyde bis(amidinohydrazone) Hexosaminidases Cell division, 1919 Normal/neoplastic, kidney/placenta, human, 1829 l2-@Tetrad@oylpho@l-l3-acetate Kidney neoplasms Phospholipids, 2743 Hexosaminidases, 1829 Lactalbumin Isoproterenol Mammary neoplasms, experimental /3-Aminopropionitrile Animal model, rat, 5028 DNA synthesis, 2751 Isolation and characterization, rat, 3598 5-Iaozszoleacetic acid, (aS,5S)-a-amlno-3-chloro-4,5-dihydro- PeptidesNude mouse, 2046 3-Deazauridine Antitumor activity, mouse, 852 Transplantation,Nude mouse,heterologous2046 LeukemiaLl210,852 Deoxyribonucleosides Lactate Cytotoxicity, mouse leukemia cells, 852 Colonic neoplasms Testosterone Metastases, 4900 Antitumor activity, mouse, 852 serum levels, human, 4900 Earyotyping Lactate dehydrogenase Kidney neoplasms Carcinoma, Ehrlich tumor Adenocarcinoma(s), 4662 Glycolysis, 2195 Clone cells, 4662 Sarcoma, mast cell Metastases, 4662 Peptides, 1847 Leukemia, lymphoblastic Tyrosine, acetyldehydro-3-(2.furyl)alanyl Chromosome aberrations, 227 Macrophage cytotoxicity, 1847 Prognostic significance, 227 Tyrosine, acetyldehydro-3-(2-thienyl)alanyl@ KB cells Macrophage cytotoxicity, 1847 Nucleolar argyrophilic granules, 857 Lactobadilus plantarum Keto.e, methyl 3-pyridyl Fluorene, 2-mtro Cell transformation, chemical Ames tests 2026 Hydrazine, l,2.dimethyl Growth, 2718 Ames test, 2026 Kidney neoplasms Methane, azoxy Adenocarcinoma(s) Ames test, 2026 Karyotyping 4662 @ Benzene, 4-allyl-l,2-(methylennhoxy)- n@@me Perinatal carcinogenicity, 4378 LeukocytePatientadherencefollow-up,inhibition651 Carcinoma(s) New cell line, 4694 Receptors, hormone, 2647 Cell transformation, neoplastic Carcinoma, Ehrlich tumor Plate-induced tumor cell lines, mouse, 2172 Rana Japonic@ 1347 Chromosomes Receptor, glycoprotein, 1347 G-banding 4694 Rana Japonica Dimethylamine, N-nitroso- Isolation and characterization, 1347 Age factors, 4965 Animal model, mouse, 4965 LETS glycoprotein Dietary carbohydrates, 4965 see also Fibronectin Glucosephosphate dehydrogenase Phorbol esters New cell line, 4694 Fibroblasts, chick embryo, 714 Glutamyl transpeptidase l2-O-Tetradecanoylphorbol-l3.acetate New cell line, 4694 Fibroblasts, chick embryo, 714

DECEMBER1979 5265 Subject Index to Volume39

Leucovorin Leukemia L1210 (cont'd) seeCitrovorum factor ara-A derivatives, 1563 Methylglyoxal bis(guanylhydrazone), 4130 Leukemia, acute myelogenous Ethidium bromide see Leukemia, myeloblastic Mitochondrial damage, in vivo, 2414 Leukemia, acute myelomonocytic Ultrastructural study, 2414 see Leukemia, myeloblastic Growth inhibition Glucocorticoid amplifying factor, 3258 Leukemia, feline Guanidine, N-methyl-N-nitro-N-nitroso Virus, feline leukemia Histones, 923 Clinical and pathological characteristics, 3866 Nucleoproteins, 923 Epidemiology, 3866 Guanidine, l,1'-(methylethanediylenedinitnlo)- Leukemia, Friend Mitochondrial damage, in vivo, 2414 9,lO-Anthracenedione, l,4-bis((2-([2- Ultrastructural study, 2414 hydroxyethyl@amino)ethyI)amino-diaCetate IgO Cytotoxicity, in vitro, 2574 Immunosuppression, 174 1gM Leukemia, hairy cell Immunosuppression, 174 Splenectomy Immune complex 5.Year survival rate, 2366 Immunosuppression, 174 Leukemia L1210 Immune serums 4-amino-3-carboxamido-1-($-D-ribofuranosyl)- Ornithine decarboxylase, 1511 Antitumor activity, in vivo, in vitro, 3018 Immunoglobulins, Fc 9H-Adenine, 9-/3-D-arabinofuranosyl Immunosuppression, 174 DNA synthesis, 1563 5-Isoxazoleacetic acid, (aS,5S)-a-amino-3-chloro.4,5- 9H-Adenine, 9-I3-D-arabinofuranosyl-, 5'-monophosphate dihydro Adenine, erythro.9-(2-hydroxy-3-nonyl)-, 1563 3-Deazauridine, 852 Coformycin, 2'-deoxy-, 1563 Methotrexate DNA synthesis, 1563 Cell membrane permeability, 1726 9,10-Anthracenedione, l,4-dihydroxy-5,8-bis(((2-([2- Cytosine, l-,6-D-arabinofuranosyl-, 4048 hydroxyethyl]amino)ethyl)amino-, dihydrochloride Fatty acids, 1726 Antitumor activity, mouse, 1570 Intestinal absorption, 2106 Antineoplastic agents Tetrahydrofolate dehydrogenase, 2106 N-Bromoacetyl-/3-D-glucosamine tetra- O.acetate Mitomycin C 3897 Statistical analysis, mouse survival, 3446 Ascitic fluid Neocarzinostatin Ornithine decarboxylase, 1511 Caffeine, 1623 Aspartic acid, N-(phosphonoacetyl) Cytotoxicity, 1623 Cytosine nucleotides, 3089 DNA synthesis, 1623 Nucleotides, 3089 Pharmacokinetics, mouse, rat, 1547 Uracil nucleotides, 3089 Nitrogen mustard 5-Aza-2'-deoxycytidine Statistical analysis, mouse survival, 3446 3-Deazauridine, 3822 Nogalamycin Butyric acid, sodium salt Analog activity, 4816 Interferon, 4720 Mechanism of action, in vitro, 4816 Coformycin, 2'-deoxy Ornithine decarboxylase Adenosine deaminase, 1425 Neoplastic cell assay, 1511 Concanavalin A L-Phenylalanine mustard Vaccines,2807 Urea, thio-, 4989 Corticosterone Platinum(II), diamminedichloro-, cis Growth inhibition, 3258 Urea, thio-, 4989 Cyclophosphamide Platinum(II), diamminedichloro-, trans. DNA synthesis, 1396 DNA, 365 Statistical analysis, mouse survival, 3446 Mechanism of action in vitro, 365 Cytosine, l-f@-D-arabinofuranosyl Urea, thio-, 4989 Cytosine, l-b-D-arabinofuranosyl-5'-triphosphate Pyrazolo(3,4-d)pyrimidine, 4-amino- l-Q3-D- 4048 ribofuranosyl) Deoxycytidine kinase, 4048 Antitumor activity, in vivo, in vitro, 3018 Liposomes, 1390 Pyrimidine, l-f3-D-arabinofuranosyl-2-amino-1.4(2Th-4- Dichloroallyl lawsone imino Dihydroorotate dehydrogenase, 4868 Antitumor activity, 3129 Uridine, 4868 Ribonucleotide reductase Dietary fats Acyl hydroxamic acids, 844 Cell membrane permeability, 1726 Aryl hydroxamic acids, 844 Dirhodium(II), tetra-m.carboxylato Streptozotocin Cytotoxicity, rhodium(II) carboxylates, 2568 Cytotoxicity, mouse, in vivo, 82 DNA synthesis Mechanism of action, 82

5266 CANCERRESEARCHVOL.39 Subject Index to Volume39

Leukemia L1210 (cont'd) Leukemia, lymphoblastic (cont'd) Triamcinolone acetonide Prognostic significance, 227 Growth inhibition, 3258 Liquid suspension culture Uracil, 5-fluoro Agar clonal culture, 1749 Cyclophosphamide, 1396 B-Lymphocytes DNA synthesis, 1396 Cell differentiation, 1534 Urea, 1,3-bis(2-chloroethyl)-1-nitroso T-Lymphocytes Antitumor activity, 1328 Cell differentiation, 1534 Urea, I-(chloroethyl)-l-nitroso 6-Mercaptopurine Antitumor activity, 1328 Remission induction, child, 3893 Urea, 3-/3-D-glucopyranosyl-1-methyl-l-nitroso Methotrexate Cytotoxicity, mouse, in vivo, 82 Cell growth inhibition, 1264 Mechanism of action, 82 Thymidine-resistant cell line, human, 3373 Urea, hydroxy Methotrexate, 3',S'-dichloro Cytokinetics, 1616 Citrovorum factor, 1264 Dose-response study, 1616 Ribonucleotide reductase Related compounds, 844 Isolation and characterization, 436 Urea, methyl nitroso Thymidine Antitumor activity, 1328 Methotrexate, 3373 Urea, N-methyl-N-nitroso Thymidine kinase Histones, 923 Thymidine-resistant cell line, human, 3373 Nucleoproteins, 923 Thymidine phosphorylase Vaccines Immunotherapy, 2807 Thymidine-resistant cell line, human, 3373 Vincristine Ultrastructure, guinea pig tumor Synergistic activity, 2106 Letter to the editor, 2221 Vincristine sulfate Vincristine sulfate Cytotoxic thresholds, 4346 Cytotoxic thresholds, 4346 Virus-like particles Leukemia L5222 Ultrastructure, guinea pig tumor, 2221 Vincristine Adriamycin, 1071 Leukemia, lymphocytic 9H-Adenine, 9-/3.D-arabinofuranosyl Leukemia L5178Y Adenosine deaminase, 3655 6-Azauridine Drug resistance, mutants, 4485 DNA synthesis, 3655 Pyrazofurin Amphotericin B Drug resistance, mutants, 4485 Drug resistance, mouse, 2041 Orotidine-5'-phosphate decarboxylase, Antigens, neoplasm Immunotherapy, 1159 Leukemia, lymphoblastic Glucocorticoids Adenosine diphosphate reductase Lymphocytes, 4939 Isolation and characterization, 436 Histocompatibility antigens Adriamycin Leukemia, myeloblastic, 4810 Mechanism of action, in vitro, 448 Immune serums Adriamycin, N-trifluoroacetyl Lymphoblastoid B-cell line, Daudi, 5171 Mechanism of action, in vitro, 448 Adriamycin, N-trifluoroacetyl-, valeric acid Immunotherapy Neoplasm regression, 1159 Mechanism of action, in vitro, 448 Lymphocytes Asparaginase-glutaminase Antitumor activity, succinylated enzyme, 3145 Glucocorticoid-binding components, 4939 L-Asparaginase Mitomycin C Remission induction, child, 3893 Immunotherapy, 1159 Cell differentiation Phorbol Null cells, 1534 Strain sensitivity, mouse, 3345 Chemotherapy Virus, AKR murine leukemia Review, 4301 Amphotericin B, 2041 Child Virus, Friend murine leukemia Review, 4301 Cell-free spleen extract, 1611 Tumor cell kinetics, 1534 Leukemia, Moloney murine Chromosome aberrations Macrophages Karyotyping 227 Cytidine diphosphate reductase Corticosteroids, 2894 Isolation and characterization, 436 Prostaglandins, 2894 Daunorubicin Stress, 2894 Mechanism of action, in vitro, 448 Stress Immune serums Immune response, mouse, 2894 Lymphoblastoid B-cell line, Daudi, 5171 Urea, l,3-bis(2-chloroethyl)-1-nitroso Karyotyping Immunosuppression, 2894

DECEMBER1979 5267 Subject Index to Volume39

Leukemia, myeloblastic Leukemia, myelocytlc (cont'd) Antibody-dependent cytotoxicity Immunity, cellular, 3167 Immune response, human, 3357 Erythrocytes Antineoplastic agents Colony formation, 1575 Clinical trial, 42 Grnnulocytes Asparaginase-glutaminase Colony formation, 1575 Antitumor activity, succinylated enzyme, 3145 Histocompatibility antigens Cellular inclusions Antigens, T-lymphocyte associated, 4810 Auer rods and Phi bodies, 1635 Immune serums Cytochemical diagnosis, 1635 Lymphoblastoid B-cell line, Daudi, 5171 Cytosine, l-$-D-arabinofuranosyl Indomethacin Anthracycline antibiotics, 42 Cell differentiation, 2190 Cell cycle synchronization, 2727 Interferon Colony-forming units-spleen assay, 2727 D-Factor, 4170 Dose scheduling, rat, 2727 RNA, 4170 DNA, neoplasm Lipopolysaccharides RNA, viral,2532 Immunity, cellular, 3167 Fc receptor cells Transplantation immunology, 3167 Immune response, human, 3357 Phorbol esters Fucosyltransferases Cell differentation, 4668 Isoenzymes, plasma, human, 3377 Prostaglandins E Histocompatibility antigens Cell differentiation, 2190 Antigens, T-lymphocyte associated, 4810 Muramidase, 2190 Immune serums Sarcoma, Yoshida Lymphoblastoid B-cell line, Daudi, 5171 Cell transformation, 5127 Immunity, cellular Serum-free cell culture, 5127 Cytosine, l-f3-D-arabinofuranosyl-, 3357 l2-O-Tetrndecanoylphorbol-l3-acetate Daunomycin, 3357 Cell differentation, 4668 Purine-6(lJi)-thione, 2-amino-, 3357 Phagocytosis, 4668 Leukemia, lymphocytic Virus, C-type RNA tumor Histocompatibitity antigens, 4810 Reverse transcriptase, 2063 B-Lymphocytes Virus, Friend murine leukemia Histocompatibility antigens, 4810 Cell-free spleen extract, 1611 T-Lymphocytes Virus, Rauscher Histocompatibility antigens, 4810 Cell differentiation, 1056 Immune response, human, 3357 Leukemia, myeloid Mitogen-induced cytotoxicity seeLeukemia,myelocytic Immune response, human, 3357 Myeloblasts Leukemia, myelomonocytic Cytokinetic study, 3834 seeLeukemia,myelocytic Ultrastructural study, abnormal granules, 3834 Leukemia, nonlymphocytic Peroxidases Chromosome abnormalities Cellular inclusions, 1635 Blood/bone marrow cells, human, 3619 Virus, C-type RNA tumor Karyotyping Reverse transcriptase, 2063 Blood/bone marrow cells, human, 3619 LeUkemia, myelocytlc Bone marrow Leukemia P388 Mitomycin C Colony formation, 1575 Statistical analysis, mouse survival, 3446 Cell differentation Lipopolysaccharides, 4668 Nitrogen mustard Statistical analysis, mouse survival, 3446 Cell differentiation Ascitic fluid factor, 1056 Leukemia P815 Isocytosine, 5-(f3.D-ribofuranosyl)- DNA synthesis inhibitors, 1056 Cytosine, 1-/3-D-arabinofuranosyl-, 720 D-Factor, 4170 Mechanism of action, 720 Immunity, cellular, 3167 Isolation and characterization, 1056 LeUkemia, plasmacytic RNA, 4170 Retinol RNA synthesis inhibitors, 1056 Carrier proteins, 4423 Cells, colony-forming Leukemia(s) Comparison of circulating levels, remission vs blas Aclacinomycin A tic stage, 2704 Cellular distribution, 4396 Myeloblasts, 2704 Cytoplasm, 4396 Myelocytes, 2704 Thymidine/uridine incorporation, 4396 Colony formation Aminopterin Plasma clot diffusion chamber, 1575 Membrane transport, lymphoblasts, 2440 Dexamethasone 9,10-Anthracenedione, l,4-dihydroxy-5,8-bis(((2-([2- Cell differentiation, 2190 hydroxyethyljamino)ethyl)amino-, dihydrochloride

5268 CANCER RESEARCH VOL.39 Subject Index to Volume39

Leukemia(s) (cont'd) Leukocyte adherence inhibition (cont'd) Antitumor activity, mouse, 1570 Isolation and characterization, 604, 612 Antigens, nucleolar Mechanism of action, 576 Inimunofluorescence, 3024 Review, 649 Asparaginase Bacillus Calmette-Guerin Polymer modification, 1927 Immunity, cellular, 593 Benz(a)anthracene, 7,12-dimethyl- Brmst neoplasms Thyroidectomy, 4252 Identification of high-risk patients, 654 Daunomycin Colonic neoplasms Cell nucleus, 4396 Immune response, mouse, 582 Cellular distribution, 4396 Cytotoxicity, peritoneal cells Thymidine/uridine incorporation, 4396 Cytotoxicity, lymph node cells, 593 DNA, neoplasm Diagnosis RNA, viral, 2532 Computerized assay, 638 Escherichia coli Correlation with tumor stage, 644 Asparaginase, 1927 Dinitrophenyl-bovine-'y-globulin Folic acid Immune response, mouse, 570 Membrane transport, lymphoblasts, 2440 Head and neck neoplasms Folic acid, tetrahydro-, methyl Membrane transport, lymphoblasts, 2440 Antigens, neoplasm, 597 Glucocorticoids Hemocyanin Sezary syndrome, 376 Immune response, human, 570 Glutamine synthetase Hemocytometer assay technique Prognostic indicator, 376 Diagnosis, 625 Sezary syndrome, 376 Hemocytometer technique assay, 570 Hypersensitivity, delayed History, 558 Immune response, human, 219 Hypersensitivity, delayed Meiphalan Head and neck neoplasms, 597 Carboxylic acid, ,6-2-aminobicyclo(2,2,l)heptane Immunity, cellular 353 Bacillus Calmette-Guerin, 564 Isobutyric acid, 2-amino-, 353 Comparative study, mouse, 564 Isobutyric acid, 2-(methylamino)-, 353 Hemocyanin, 570 Mechanism of action, in vitro, 353 Review, 556 Methotrexate Immunoglobulins, Fc Membrane transport, lymphoblasts, 2440 Mechanism of action, 576 Platinum(II), diamminedichioro-, cis Laryngeal neoplasms Anthranilic acid, 4-chloro-N-furfuryl-5-sulfamoyl- Patient follow-up, 651 1279 B-Lymphocytes Mannitol, 1279 Mechanism of action, 587 Poly C T-Lymphocytes Partially thiolated derivatives, 3163 Mechanism of action, 587 Polyriboinosinic:polyribocytidylic acid Mechanism, review, 558 Clinical study, 1645 Melanoma(s) Interferon, 1645 Immune response, mouse, 582 Pyruvaldehyde bis(amidinohydrazone) Microtest assay technique, 630 Mitochondrial swelling 1919 Monocytes Receptors, hormone Mechanism of action, 576, 587 Glucocorticoids, 376 Neoplasms Saiine hydroxymethyltransferase Review, 556 Leukocytes, 3435 Pancreatic neoplasms Thyroxine Diagnosis, 633 Transplantation,Antitumor activity,homologous4252 Precancerous conditions. Spontaneous tumor incidence, nude mouse, 833 Antigens, neoplasm, 604 Uracil, 5-fluoro- Identification of high-risk patients, 654 H-Pyrawlo(3,4-d)pyrimidin4-ol, 3095 Reviews 660 Vinblastine Sarcoma, osteogenic Drug resistance, 2070 Diagnosis, 658 Glycoproteins, 2070 Transplantation immunology Virus, Gross murine leukemia Antigens, neoplasm, 582 T-Lymphocytes, 415 Vifll5, Rous sarcoma Somatotropin, 415 Immunity, cellular, 593 Leukocytes Laukocyte adherence Inhibition Bladder neoplasms Antigens, neoplasm Cell migration inhibition, 1985 Diagnosis, 627, 638 Urologic diseases Immune serums, 597 Cell migration inhibition, 1985

DECEMBER1979 5269 Subject Index to Volume39

Leupeptin Liver neoplasms (cont'd) Virus, Kirsten murine sarcoma Immunological typing 4212 Virus activation, 2995 Norepinephrine Levamisole Angiography, hepatic, 1898 Cyclophosphamide Lung neoplasms Antitumor activity, mouse, 4838 Adenoma(s) Mammary neoplasms, experimental Benzo(a)pyrene, 2660 Antitumor activity, mouse, 4838 Benzo(a)pyrene, 2-hydroxy-, 2660 Benzo(a)pyrene, 6-hydroxy-, 2660 Leydig cell tumor Luteinizing hormone Arylamidase Parabiosed rats, 3971 Immunological typing 4212 Aspartic acid, N-(phosphonoacetyl) Linoleic acid Cytosine nucleotides, 3089 Mammary neoplasms, experimental Nucleotides, 3089 Adenocarcinoma(s), 4430 Uracil nucleotides, 3089 Growth, 4430 Azocine, octahydro-l-nitroso Autoradiographic study, hamster, 72 Lipids Claracells,72 Cell transformation, neoplastic Bacillus Calmette- Guerin Cell membrane, 4350 Bacterial cell-wall skeleton, 3262 Lipopolysaccharides Clinical trial, 3262 Leukemia, myelocytic Intrapleural administration, hamster, 3673 Cell differentation, 4668 Benzo(a)pyrene Immunity, cellular, 3167 Carcinogenic activity, neonatal mouse, 2660 Transplantation immunology, 3167 DNA adducts, diploid fibroblasts, human, 1083 Transplantation immunology Benzo(a)pyrene, 2-hydroxy Nude mouse, 3167 Carcinogenic activity, neonatal mouse, 2660 Benzo(a)pyrene, 6-hydroxy Lipoproteins Carcinogenic activity, neonatal mouse, 2660 Benzo(a)pyrene Bleomycin Metabolism, plasma, human, 1224 Hyperthermia, 3792 Lithium carbonate Cellmembrane see Carbamic acid, lithium salt Antigenic determinants, 2935 Immunoprecipitation, 2935 Liver microsomes, mouse Isolation and characterization, mouse, 2935 Benz(a)anthracene, 7,l2-dimethyl Cholanthrene, 3-methyl DNA binding I 154 Binding, liver DNA, mouse, 2400 Benz(a)anthracene-7-methanol, 12-methyl Binding, lung DNA, mouse, 2400 DNA binding 1154 Dibenz(a,h)anthracene Liver neoplasms Carcinogenic activity, mouse, 1310 Acetamide, N-fluoren-2-yl Dibenz(a,h)anthracene, 3,4-dihydroxy-1,2,3,4-tetrahydro Adenylosuccinate lyase, 2132 Carcinogenic activity, mouse, 1310 Acetic acid, trichloro Carcinogenic metabolite, 1310 AMP deaminase, 2132 Forrsman antigen Adriamycin Isoantibodies, 2909 Administration via the hepatic artery, 4105 Hyperthermia Aflatoxin B Transplantation immunology, 1126 Histological study, monkey, 4545 Isoantibodies Angiosarcoma Age factors, 2909 Dimethylamine, N-nitroso-, 1592 Blood groups, 2909 Aniline, N,N-dimethyl.4-(tolylazo)- T-Lymphocytes Adenylosuccinate lyase, 2132 Transplantation immunology, 1126 Arylamidase Metastases Immunological typing 4212 Radiation, ionizing 1001 Benzenamine, N,N-dimethyl.4-((3-methylphcnyl)azo)- Neuraminidase Adenylosuccinate lyase, 2132 Immunological typing 4212 AMPdeaminase, 2132 Organohalides Blood platelets Carcinogenicity, mouse, 391 Metastases, 2031 Proteins Butyric acid, 2-amino-4-(ethylthio)- Cell membrane, 2935 Adenylosuccinate lyase, 2132 Radiation, ionizing Dibenz(a,h)anthracene, 3,4-dihydroxy-l,2,3,4-tetrahydro Transplantation immunology, 1126 Carcinogenic metabolite, 1310 Retinoic acid Dimethylamine, N-nitroso Deoxyribonuclease, 2492 Diet, rat, 1592 Pronase, 2492 DNA, 1592 Proteins, 2492 Neuraminidase Ribonuclense, 2492

5270 CANCER RESEARCH VOL.39 Subject Index to Volume39

Lung neoplasms (cont'd) Lymphocytes (cont'd) RNA Immunological capping, 4687 Immunotherapy, 1702 Plant substances Sarcoma(s) DNA synthesis, 4802 Animal model, mouse, 1001 Polyamines Thymidine DNA synthesis, 4861 Xenografts, nude mice, 3875 Sarcoma(s) Transplantation immunology Immune response, mouse, 2711 Nude mouse, 1126 Spleen, lymph nodes, mouse Vaccines Cytotoxicity blocking factor, 2711 Autologous tumor cell preparations, human, 3276 l2-O-Tetradecanoylphorbol-l3-acetate Letter to the editor, 3276 Mixed lymphocyte culture blastogenesis, 4078 Virus, bovine adeno 3 Virus, feline leukemia Angiogenesis factor, 1305 Receptors, concanavalin A, 956 Luteinizing hormone B-Lymphocytes Neoplasms Antineoplastic agents Secretion, 82 human cell lines, 3885 Antibody formation, 4564 Lymph nodes Benz(a)anthracene Bladder neoplasms Aryl hydrocarbon hydroxylases, 4605, 4612 Lymphocyte stimulation, 2120 Benzo(a)pyrene Nucleic acids, 2120 Aryl hydrocarbon hydroxylases, 4612 Urologic neoplasms Metabolism, 4605 Concanavalin A, 4372 Cholanthrene, 3-methyl Suppressor cells, 4372 Aryl hydrocarbon hydroxylases, 4612 Dibenz(a,h)anthracene Lymphatic metastasis Aryl hydrocarbon hydroxylases, 4605, 4612 Bacteriocins Dibenzo-p-dioxin Cell adhesion, 5114 Aryl hydrocarbon hydroxylases, 4612 Lymphoblastoma Histocompatibility antigens Auromomycin Leukemia, myeloblastic, 4810 DNA synthesis inhibition, in vitro, 2787 Immune serums Cytotoxicity, human lymphoblastoid cell lines Lymphocyte depletion 5171 Virus, Friend murine leukemia Lymphoma(s) T-Lymphocytes, 1611 Antineoplastic agents, 3964 Lymphocyte transformation Immunotherapy, 3964 Gangliosides Lymphosarcoma T-Lymphocytes, 817 Chromosome aberrations, 3119 Immunity, cellular Macrophages Antigens, viral, 3996 Immune response, mouse, 4983 Ovarian neoplasms Mitogens Ascitic fluid, 2381 Aryl hydrocarbon hydroxylases, 4605 Cystic fluid, 2381 T-Lymphocytes Platinum(II), sulfato-trans.(-)-l,2-diaminocyclohexane Antineoplastic agents Immune response, mouse, 3476 Immunity, cellular, 4564 Polyribonucleotide synthetases Breast neoplasms Uracil-DNA glycosylase, 2090 Antigen-stimulated rosette forming assay, 4796 Viral proteins Antigens, neoplasm, 4796 Candida albican.s 443 Histocompatibility antigens, 4796 Streptodornase and streptokinase, 443 Concanavalin A Virus, feline leukemia Suppressor cells, 4372 Viral proteins, 443 Cyclophosphamide Lymphocytes Immunosuppression, 3647 9,10-Anthracenedione, 1,4-bis((2-([2. Diploid cells hydroxyethyl)amino)ethyl)amino-diacetate Flow cytometry, 4418 Cytotoxicity, in vitro, 2574 DNA Benzo(a)pyrene Diploid cells, 4418 High-pressure liquid chromatography assay, 3184 Erythroleukemia Benzo(a)pyrene, 7,8-dihydro-7,8-dihydroxy Antilymphocyte serum, 1611 Benz(a)anthracene, 3184 Gangliosides High-pressure liquid chromatography assay, 3184 Concanavalin A, 817 Hybrid cells Lymphocyte transformation, 817 A-type particles, 4481 Histocompatibility antigens Imidoesters Leukemia, myeloblastic, 4810 DNA synthesis, 345 Immune serums Neocarzinostatin Cytotoxicity, human lymphoblastoid cell lines

DECEMBER 1979 5271 Subject Index to Volume39

T-Lymphocytes (cont'd) Lymphoma(s) (cont'd) Cytotoxicity, human lymphoblastoid cell lines Glucocorticoids 5171 Binding, corticoid-sensitive tumor cells, mouse, 4011 Leukemia(s) Immunosuppression Virus, Gross murine leukemia, 415 Actinomycin D, 4564 Lung neoplasms Cytosine, l$-D-arabinofuranosyl., 4564 Transplantation immunology, 1126 Mitomycin C, 4564 Lymphoma(s) Polyinosinic:polycytidylic acid, 4564 Antineoplastic agents, 3964 Immunotherapy Immunotherapy, 3964 Trial of 10 agents, mouse, in vivo, 3964 Mitogens, 751 Lymphocytes Macrophages Receptors, concanavalin A, 956 Immune response, mouse, 4983 B-Lymphocytes Transplantation immunology Cell differentiation, 1534 Newborn/weanling hamster, 4949 Virus, murine leukemia, 3749 Urologic neoplasms T-Lymphocytes Concanavalin A, 4372 Cell differentiation, 1534 Mitomycin C, 4372 Mitogens, 751 Virus, Friend murine leukemia Mitogens Lymphocyte depletion, 1611 DNA synthesis, 751 Virus, Gross murine leukemia Protein synthesis, 751 Concanavalin A, 480 RNA synthesis, 751 Cortisone, 480 Neocarzinostatin Graft vs host reaction, 480 Bleomycin, 3768 Immune response, AKR mice, 480 Phytohemagglutinin Somatotropin, 415 Dose-response study, 751 Protein synthesis Lymphoepithelioma RNA synthesis,751 seeCarcinoma,epidermoid Proteins Cell membranes, mouse, 4782 Lymphokines Isolation and characterization, 4782 Macrophages Sodium dodecyl sulfate-polyacrylamide gradient gel Melanoma(s), 2582 electrophoresis, 4782 Syngeneic/allogeneic embryo cells, mouse, 2582 Purine-6-thiol Lymphoma, feline Metabolism, in vitro, 3744 Virus, feline leukemia Receptors, hormone Clinical and pathological characteristics, 3866 Glucocorticoids, 4011 Epidemiology, 3866 Serine hydroxymethyltransferase Leukocytes, 3435 Lymphoma, histiocytic Uracil, l-$-D-arabinofuranosyl see Sarcoma, reticulum cell Mechanism of action, in vitro, 1102 Lymphoma, lymphocytic Uridine seeLymphosarcoma Phosphorylation inhibitors, 3102 Uridine.cytosine kinase Lymphoma(s) Isolation and characterization, human, 3102 Adriamycin Virus, C-type RNA tumor Cell survival, 1428 Murine fibrotropic isolate, 4322 Anthramycin Virus, murine leukemia DNA adduct, 3134 Rosette formation, rat tumors, 3749 Antigens, nucleolar Thymus gland, rat, 3749 Immunofluorescence, 3024 Lymphosarcoma(s) Antigens, T-lymphocyte associated, 751 Chromosome aberrations Antineoplastic agents Chromosomes, human, 3119 Hematopoietic stem cells, 4564 Nuilcells, 3119 Trial of 5 agents, mouse, in vivo, 3964 Immunoglobulins, surface Bacterial lipopolysaccharide B-Lymphocytes, 3119 Dose-response study, 751 Nuilcells,3119 Bleomycin B-Lymphocytes Cell survival, 1428 Chromosome aberrations, 3119 Cell differentiation Transplantation, homologous Null cells, 1534 Spontaneous tumor incidence, nude mouse, 833 Child Virus, bovine leukemia Tumor cell kinetics, 1534 Antibodies, viral, I 118 Concanavalin A Dose-response study, 751 phosphatldylchollnes DNA synthesis Sarcoma(s) RNA synthesis, 751 Phospholipid metabolism, 4681

5272 CANCER RESEARCH VOL.39 Subject Index to Volume39

Lysozyme Maleimide, N-ethyl- (cont'd) s@ Muramidase Metabolism, 2961 Quinoline, 4-nitro-, 1-oxide Macromomycin Nitro radicals, 2961 Amino acids Malnutrition Isolation and characterization, 1180 Amino acids DNA degradation Plasma/brain concentrations, 3065 Antitumor activity, 1180 Mammae Ethanol, 2-mercapto Peptides DNA degradation, I 180 Hepatoma(s) Cell differentiation, 2046 Transplantation, heterologous DNA synthesis, I 180 Nucleic acids, 1180 Nude mouse, 2046 Mammary neoplasms, experimental Acetamide, N-(acetyloxy)-N@fluoren@2@yl. Macromycin Tissue culture, mouse, 1784 Breast neoplasms Acetamide, N-fluoren-2-yl Ultrastructural study, human, 4091 Tissue culture, mouse, 1784 Carcinoma, epidermoid Acetohydroxamic acid, N-fluoren-2-yl DNA synthesis, 4091 Tissue culture, mouse, 1784 Protein synthesis, 4091 Adenocarcinoma(s) RNA synthesis, 4091 Diethylstilbestrol, 773 Milk, human Linoleic acid, 4430 DNA synthesis,4091 Adrenalectomy Protein synthesis, 4091 Prolactin,2436 RNA synthesis, 4091 Tumor regression, lactating rat, 2436 Macrophage inhibitory factor Amino acids Suppressor cells Estradiol, 3381 Immune response, mouse, 4983 Insulin, 3381 Transport studies, rat, in vivo and in vitro, 3381 Antibodies, neoplasm Corticosteroids Immunogenicity, A-b ascitic tumor, 1739 Leukemia, Moloney murine, 2894 Antibody specificity Embryo cells, mouse Immunogenicity, A-b ascitic tumor, 1739 Cytoxicity,in vitro,881 Antiestrogens Fibrosarcoma(s) Castration, rat, 5043 Nocardia rubra, 4706 Prolactin, 5043 Immune serums Receptors, hormone, 5043 Colony-inhibiting activity, human, 1640 Antigens, viral Immunosuppression Immune response, mouse, 35 Receptors, antibody, 174 Immunity, cellular, 35 B-Lymphocytes Antineoplastic agents Immune response, mouse, 4983 Cell cycle kinetics, spontaneous tumors, mouse T-Lymphocytes 3812 Immune response, mouse, 4983 Doseschedules,3812 Lymphokines 5-Aza-2'-deoxycytidine Melanoma(s), 2582 3-Deazauridine, 3822 Syngeneic/allogeneic embryo cells, mouse, 2582 Bacillus Calmette- Guerin Lymphoma(s) Antitumor activity, mouse, 4838 Antineoplastic agents, 3964 Benz(a)anthracene, 7,12-dimethyl Immunotherapy, 3964 Adrenalectomy, 2436 Melanoma(s) Collagen, 2923 Cytoxicity, in vitro, 881 Estradiol benzoate, 2436 Macrophage-activating factor, 881 Streptozotocin, 2501 Neoplasms Bone marrow Serum inhibitor, 1640 Tumor growth kinetics, EMT, cells, mouse, 3959 Nocardia rubra Bordetella pertussis Antitumor activity, 4706 Antitumor activity, mouse, 4838 Pr@dins Carcinoma(s) Leukemia, Moloney murine, 2894 Adriamycin, 4466 Sarcoma(s) Cyclophosphantide, 4466 Immunoglobulins, Fc, 4588 Methotrexate, 4466 Stress Uracil, 5-fluoro-, 4466 Leukemia, Moloney murine, 2894 Cell transformation, neoplastic Tissue culture, mouse, 1784 Milsimide, N-ethyl Chemotherapy Quinoline, 4-hydroxyamino-, 1-oxide Metastases, 4466

DECEMBER 1979 5273 Subject Index to Volume39

Mammary neoplasms, experimental (cont'd) Mammary neoplasms, experimental (cont'd) Corynebacterium parvum Tissue culture, mouse, 1784 Cyclophosphamide, I 1-Naphthylamine Coumarins Tissue culture, mouse, 1784 Antineoplastic activity, mouse, 1651 2-Naphthylamine Cytotoxicity, spleen/lymph node cells Tissue culture, mouse, 1784 Immunization, 4772 Phorbol Dehydroepiandrosterone Strain sensitivity, mouse, 3345 Antitumor activity, mouse, 1129 Plant substances Glucosephosphate dehydrogenase, I 129 DNA synthesis, 4802 Dextrans Pregnancy Mercury or sulihydryl substituted, 170 Animal model, rat, 5028 Dietary fats Progesterone Prostaglandins, 4430 Neonatal mouse, 2560 Tumor incidence, rat, 3458 Prolactin Diethylstilbestrol Animal model, rat, 5028 Prolactin, 773 1,2-Propanediol, 3-j.@1,2,3,4-tetrahydro-6-methoxy Strain differences, rat, 773 Castration, rat, 5043 Embryo extract, mouse Propionitrile, 3-amino Immune response, mouse, 35 Antitumor activity, 2923 Estradiol Collagen, 2923 Castration, rat, 5043 Prostaglandin F2a Neonatal mouse, 2560 Antitumor activity, rat, in vivo, 998 Estradiol benzoate Progesterone, 998 Prolactin, 2436 Radiation, ionizing Tumor regression, lactating rat, 2436 Hyperthermia, 2966 Estrogen 1H-Imidazole-1-ethanol, a-(methoxymethyl)-2-nitro Animal model, rat, 5028 2966 Fatty acids Receptors, hormone Normal/neoplastic mammary tissue, rat, 426 Estrogen, 4098 Fluoren-2-amine Progesterone, 4098 Tissue culture, mouse, 1784 Prolactin, 5028 Fluorene Retinamide, N.(4-hydroxyphenyl)- Tissue culture, mouse, 1784 Pharmacokinetics, rat, 1339 Fluorene, 2-nitro- Retinyl acetate Tissue culture, mouse, 1784 Carcinogenesis inhibition, rat, in vivo, 3977 2(3 H)-Furanone, 5-methyl- Streptozotocin Antineoplastic activity, mouse, 1651 Adenosine cyclic 3':S'-monophosphate, 2501 Hematopoietic stem cells Histone kinase, 2501 Diffusable stimulatory factor, 3959 Surgery Hematoporphyrin Cytokinetic parameters, in vivo, mouse, 3861 Photosensitization, 146 Thermotolerance Tissue distribution, derivative, 146 Cultures, exponentially growing vs plateau phase Hyperthermia 981 Cell survival, 2166 Tumor-associated antigen Ultrasonics, 2166 Immune response, mouse, 35 Hypophysectomy Immunity, cellular, 35 Animal model, rat, 5028 Urea, N-methyl-N-nitroso Immunity, cellular Retinamide, N-(4-hydroxyphenyl)-, 1339 Embryo extract, mouse, 35 Retinol acetate, 1339 Immunoglobulins, Fc Virus, murine mammary tumor Immunogenicity, A-10 ascitic tumor, 1739 Immunologic deficiency syndromes, 1529 @ Immunologic deficiency syndromes M I @ Animal model, asplenic mouse, 1529 0 Kidney tubules Receptors, hormone, 1529 a-Lactalbumin . Metabolism, rat, 1269 Animal. model rat, 5028 Leukemia(s ...... Platinum(II), diamminedichloro-, cia-, 1279 Isolation and charactenzation rat, 3598 . â€¢ . . . Platinum III) diamminedichloro-, cis. Levamisole . . . Blood urea nitrogen, 1269 . Antitumor activity, mouse, 4838 DNA synthesis, 1279 Lmoleic acid Growth, 4430 Glomerular. . .filtration rate, 1269 Hippuric acid, p-amino-, 1269 Metastases . . . Toxicity, rat, 1279 Bacillus Calmette- Guerin, 987 Corynebacterium parvum, 987 Maytansine Cytokinetic parameters, in vivo, mouse, 3861 Adriamycin Naphthalene Cytotoxicity, 3152

5274 CANCER RESEARCH VOL.39 Subject Index to Volume39

Maytansine (cont'd) Melanoma(s) (cont'd) Cytosine, l-$-D-arabinofuranosyl. Antigens, neoplasm, 1683 Cytotoxicity, 3152 Hypersensitivity, delayed HeLa cells Immune response, human, 219 Cell cycle kinetics, 3152 Hyperthermia Cytotoxicity, 3152 Radio-frequency heating 2236 Mitosis Hyperthermia, localized Cell cycle kinetics, 3152 Regional perfusion, 2255 IgG Mechlorethamlne Characterization, 1683 see Nitrogen mustard Immune response, human, 1683 1gM Characterization, 1683 Medulloblastoma Immune response, human, 1683 Polyamines Imidazole-4-carboxamide, 5-(3,3-dimethyl-l-triazeno). Cerebrospinal fluid, human, 993 Antitumor activity, mouse, 934 Patient surveillance, 993 Leukocyte adherence inhibition Diagnosis, 625 Meeting report Macrophages A Report of the US-Japan Conference on Gene Cytoxicity, in vitro, 881 Derepression and Host Relationships in Carcinogenesis, Lymphokines, 2582 3279 Macrophage-activating factor, 881 Culture Systems for Studying Malignancy, 4293 Melanocyte-stimulating hormones Interdisciplinary Cancer Research Workshop, 4291 Receptors, hormone, 3058 Sixth Meeting of the International Research Group for Metastases Carcinoembryonic Proteins, 3281 Growth characteristics, 4575 Working Conference on Mesothelioma Treatment Trials In vitro model system, fibroblasts, hamster, 2001 3799 Tyrosinase, 3485 Workshop on Papillomaviruses and Cancer, 545 Neoplasm transplantation Tumor cell-doubling time, 934 Melanocyte-stlmulating hormones L-Phenylalanine mustard Melanoma Antitumor activity, mouse, 934 Anti-antibodies, 3058 Phorbol-l2,l3-diacetate Receptors, hormone, 3058 Cell differentiation, 2618 Phorbol dibutyrate Melanocytes Cell differentiation, 2618 Benzene, 4-hydroxy-, y-L-glutaminyl Phorbol esters Cytotoxicity, 1494 Cell differentiation, neoplastic, 3915 Phorbol-12-myristate-13-acetate Melanoma(s) Cell differentiation, 2618 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis(((2-([2- Retinoic acid hydroxyethyl] Growth inhibition, human cell, in vitro, 1014 Antitumor activity, mouse, 1570 Growth inhibition, in vitro, 4767 Anti-antibodies Retinoids Melanocyte-stimulating hormones, 3058 Cell colony formation, in vitro, 4055 Antigens, neoplasm RNA Characterization, 1683 Immunity, cellular, 1702 Cultured cells, tumor/fetal, human, 183 Immunotherapy, 1702 Isolation and characterization, 612 Metastases, 1702 Lymphocyte adherence inhibition, 627 Sialic acid /32-Microglobulin, 619 Patient surveillance, 5036 Monkey antisera, 183 Plasma levels, 5036 Bacillus Calmette-Guerin Sialyl transferase Antigens, neoplasm, 2125 Patient surveillance, 5036 Immune serums, 2125 Plasma levels, 5036 Benzene, 4-hydroxy-, â€˜y-L-glutaminyl Sinclair swine cells Antitumor activity, nude mouse, 1490 Ultrastructural study, 4960 Benzoic acid, p-(dipropylsulfamoyl)-, 1490 l2-O.Tetradecanoylphorbol@l3acetate Benzo(a)pyrene Cell differentiation, neoplastic, 3915 DNA adducts, diploid fibroblasts, human, 1083 Thymidine Cell aggregation Xenografts, nude mice, 3875 In vitro model system, fibroblasts, hamster, 2001 Transplantation, heterologous Dimethyl sulfoxide Hyperthermia, 2236 Cell differentiation, 2618 Urea, l-(2-chloroethyl)@3.(4-methylcyclohexyl)-nitr@.. Dopa oxidase Antigen-antibody reactions, 4472 Sinclair swine cells, 4960 Antitumor activity, mouse, 934 Fetal globulins Hypersensitivity, delayed, 4472

DECEMBER1979 5275 Subject Index to Volume39

Melanoma(s) (cont'd) Metastases (cont'd) Vinblastine Fibrosarcoma(s) Immunologic capping 2125 Normal and immunosuppressed mouse, 3816 Hepatoma(s) Melphalan Bacillus Calmette-Guerin, 1597 Hyperthermia, localized Regional perfusion, 2255 Tumor cell vaccine, 1353 Hyperthermia, localized Leukemia(s) Radiotherapy, 2258 Carboxylic acid, /3-2-aminobicyclo(2,2,l)heptane 353 Kidney neoplasms Karyotyping 4662 Isobutyric acid, 2-amino-, 353 Liver neoplasms Isobutyric acid, 2-(methylamino)-, 353 Mechanism of action, in vitro, 353 Blood platelets, 2031 Lung Neoplasms Hyperthermia, 1481 Melanoma(s), 4575 Sarcoma(s), 4575 Prednisolone Lung neoplasms Carcinoma, Walker 256, 4256 Radiation, ionizing 1001 Sarcoma(s), 4256 Mammary neoplasms, experimental Menopause Bacillus Calmette-Guerin, 987 Breast neoplasms Chemotherapy, 4466 Receptors, hormone, 1447 Corynebacterium parvum, 987 Melanoma 2-Mercaptoethanol Tyrosmase, 3485 seeEthanol, 2-mercapto Melanoma(s) 6-Mercaptopurine Growth characteristics, 4575 .seealso Purine-6-thiol In vitro model system, fibroblasts, hamster, 2001 Leukemia, lymphoblastic RNA, 1702 Remission induction, child, 3893 Neoplasm(s) Nuclear ultrastructural study, human, 332 Mercury, chloro-(p-phenylsulfonate) Tyrosinase, 3485 Methotrexate Neuroblastoma Membrane transport, lymphoblasts, 2440 Age factors, 711 Fusarium metabolite Animal model, mouse, 711, 3277 see T-2 toxin Letter to the editor, 3277 Plasmacytoma Metal salts Cytotoxicity, spleen cells, mouse, in vitro, 3928 Cell transformation, neoplastic Sarcoma(s) Syrian hamster cells, 1008 Animal model, nude mouse, 4034 Lethality, in vitro Growth characteristics, 4575 Transplacental carcinogenesis, hamster, 1008 Immune response, 4034 Syrian hamster cells Stomach neoplasms Lethality, in vitro, 1008 Vagotomy, 811 Metals Thyroid gland Ascorbic acid Cell migration, 2698 Chromosome aberrations, 4145 Poeciia formosa, 2698 Tyrosinase Metastases Serum levels, human, 3485 Adenocarcinoma(s) Transplantation, homologous, 4724 Bacillus Calmette-Guerin Methane, azoxy Tumor cell vaccine, 1353 Ames test Brain neoplasms Host-mediated assay, 2026 Animal model, mouse, 1001 Dietary fats Radiation, ionizing 1001 Gastrointestinal neoplasms, 4956 Breast neoplasms Rat, 4956 Carcinoma, ductal, 2057 Lactobadilus plantarum Chemotherapy, 4503 Ames test, 2026 Prognosis,1552 Receptors, hormone, 1973 Methanesulfonlc acid, ethyl ester Tyrosinase, 3485 DNA repair Carcinoma, epidermoid DNA, alkylation, 131 Transplantation, homologous, 4724 Mutagenic activity Carcinoma, Walker 256 V79 cells, hamster, 131 Electrophoretic mobility, 2481 Oxygen Site-associated modification, 2481 Cytotoxicity, 3194 Cell adhesion Thioguanine resistance In vitro model system, fibroblasts, hamster, 2001 Mutagenic activity, 131

5276 CANCERRESEARCHVOL.39 Subject Index to Volume39

Methanesulfonic acid, methyl ester Methotrexate (cont'd) Burkitt's lymphoma Fatty acids, 1726 Lymphoblastoid cell lines, human, 312 Intestinal absorption, 2106 DNA Tetrahydrofolate dehydrogenase, 2106 Lymphocytes, 3524 Leukemia, lymphoblastic DNA repair Cell growth inhibition, 1264 DNA, alkylation, 131 Thymidine, 3373 HeLa cells Leukemia(s) Immunoreactivity, in vitro, 3524 Membrane transport, lymphoblasts, 2440 Lymphocytes Mammary neoplasms, experimental Immunoreactivity, in vitro, 3524 Carcinoma(s), 4466 Mutagenic activity Mercury, chloro-(p.phenylsulfonate) V79 cells, hamster, 131 Membrane transport, lymphoblasts, 2440 Thioguanine resistance Pharmacokinetics, Rhesus monkey, dog Mutagenic activity, 131 Urinary excretion, Rhesus monkey, dog 4843 Methanol, (methyl-ONN-azoxy) Polyglutamate derivatives Glucuronic acid conjugate Hepatocytes, rat, 2914 Synthesis, 3070 Probenecid Glucuronidase Urinary excretion, Rhesus monkey, dog 4843 Mutagenic derivative, 3070 Pyrimidine, 2,4-diamino-5-(3',4'.dichlorophenyl)-6- methyl Methionine adenosyltransferase Toxicity, lymphoblasts/leukemia cells, human Hepatoma(s) 3612 Acetamide, N-fluoren-2-yl-, 2113 Radiosensitizatjon Methotrexate Fibroblasts, mouse, in vitro, 244 Cell survival Ribonucleosides Chinese hamster ovary cells, 1937 Leukemia(s), 3531 Choriocarcinoma Serum albumin @ Cell differentiation, 1960 Binding/activity, 1264 Gonadotropins, chorionic, 1952 Sodium azide Citrovorum factor Membrane transport, lymphoblasts, 2440 Cell growth inhibition, 1264 Tetrahydrofolate dehydrogenase Chemotherapy, mouse, 3202 Adriamycin resistance, 1937 Marrow recovery kinetics, human, 1315 Thymidine Cytosine, l-13-D-arabinofuranosyl Gonadotropins, chorionic, 1952 Dosage schedule, mouse, 4048 Marrow recovery kinetics, human, 1315 Serum levels, mouse, 4048 Trophoblast Deoxyribonucleosides Cell differentiation, 1960 Leukemia(s), 3531 Uracil, 1-f3-D-arabinofuranosyl DNA synthesis Serum levels, mouse, 4048 Administration route, 3202 Vincristine Fibroblasts Synergistic activity, 2106 Cell transformation, viral, 1855 Virus, Rous sarcoma Folate antagonists Cell transformation, viral, 1855 Dihydrofolat@reductase, 293 X-rays Folicacid Fibroblasts, mouse, in vitro, 244 Urinary excretion, Rhesus monkey, dog 4843 Methotrexate, 3',5'-dichloro Folic acid antagonists Citrovorum factor Toxicity, lymphoblasts/leukemia cells, human 3612 Cell growth inhibition, 1264 Folic acid, tetrahydro-, 5-formyl Leukemia, lymphoblastic Citrovorum factor, 1264 Membrane transport, lymphoblasts, 2440 Glucose Serum albumin Carcinoma, Ehrlich tumor, 90 Binding/activity, 1264 Glucose, 2-deoxy Methyl acetimidate Phosphorylation, 90 see Acetimidic acid, methyl Glucose, 3-0-methyl Hypoxanthine, 90 Methyl(acetoxymethyl)nitrosamine Hepatoma(s) seeAcetic acid, methylnitrosaminomethylester Metabolism, Reuber H35 cells, 735 NMethyl-4-aminobenzene Tetrahydrofolate dehydrogenase, 735 see Aniline, p-(3-methylphenylazo)- Thymidylate synthetase, 735 Leucovorin Methyl-n.amylnitrosamine Plasma clearance vs toxicity, 908 s@ Pentylamine,N-methyl-N-nitroso Leukemia Ll210 Methyl-CCNU Cell membrane permeability, 1726 Carcinoma, Walker 256 Cytosine, l-13-D-arabinofuranosyl-, 4048 Metastatic brain tumor model, rat, 2691

DECEMBER1979 5277 Subject Index to Volume39

3-0-Methyl-D-glucose Microfilaments see Glucose, 3-0-methyl Actin Methyl methanesulfonate Normal/preneoplastic/neoplastic mammary tissue, see Methanesulfonic acid, methyl ester mouse, 893 Microtubules N-Methyl-N-nitro-N-nitrosoguanidine Normal/preneoplastic/neoplastic mammary tissue, see Guanidine, N-methyl-N-nitro-N-nitroso mouse,893

1-Methyl-1-nitrosourea Microfluorometry see Urea, N-methyl-N-nitroso Neoplasms N-Methyl-N-nitrosourethan Review, 2341 see Carbamic acid, methylnitroso-, ethyl ester /31-Microglobulin Methylazoxymethanol Antigens, neoplasm see Methanol, (methyl-ONN-azoxy) Isolation and characterization, 604 Melanoma(s) 3-Methylcholanthrene Antigens, neoplasm, 619 see Cholanthrene, 3-methyl Microinterferometry Methylglyoxal-bis(guanylhydrazone) Neoplasms see Guanidine, 1,I'-(methylethanediylenedinitr Pyru- Review, 2341 valdehyde bis(amidinohydrazone) DNA synthesis Microtubules Analogs, 4861 Microfilaments Mechanism of action, 4130 Adenocarcinoma(s), 893 Leukemia Ll210 Normal/preneoplastic/neoplastic mammary tissue, DNA synthesis, 4130 mouse, 893 Polyamines Vincristine Analogs, 4861 Spiral formation, brain tissue, bovine, 1604 Methylglyoxal bis(guanylhydrazone) dihydrochloride monohy Migration Inhibitory factor drate Virus, Moloney murine leukemia see Guanidine, l,1'-(methyleth HC1 Immune response, mouse, 4887 monohydrate Immune spleen cells, infected mouse, 4887 0-Methylgunnine Mineral oil see Guanine, 0-methyl Bacillus Calmette- Guerin Vaccines, emulsified, 1518 @Methylgnanine Trehalose-6,6'-dimycolate see Purine, 2-amine-6-methoxy Vaccines, emulsified, 1518 Methylprednisolone Misonidazole Adriamycin see I H-Imidazole-l-ethanol, a-(methoxymethyl)-2-nitro Cell cycle kinetics, spontaneous tumors, mouse 3812 Mithramycin Mammary neoplasms, experimental, 3812 Flow cytometric analysis Cyclophosphamide Experimental tumor, mouse, 1891 Cell cycle kinetics, spontaneous tumors, mouse 3812 Mitogens Mammary neoplasms, experimental, 3812 B-Lymphocytes Virus, feline leukemia Aryl hydrocarbon hydroxylases, 4605 Leukemogenesis, cat, 3789 Lymphoma(s) Resistance to infection, cat, 3789 T-Lymphocytes, 751 Methyltetrahydrofolate Mitomycin C see Folic acid, tetrahydro-, methyl Leukemia L12l0 Statistical analysis, mouse survival, 3446 Metronidazole Leukemia, lymphocytic see Imidazole-1-ethanol, 2-methyl-5-nitro Immunotherapy, 1159 Mezerein Leukemia P388 Skin neoplasms Statistical analysis, mouse survival, 3446 Adenosine 3':5'-monophosphate, 4791 Lymphoma(s) Ornithine decarboxylase, 4791 Immunosuppression, 4564 12- 0-Tetradecanoyl-phorbate-13-acetate Urologic neoplasms Carcinogenesis, skin, mouse, 4791 T-Lymphocytes, 4372 Suppressor cells, 4372 Miangleaf DNA synthesis Mitosis L/neoplastic cells, rat, mouse, 4802 Cell membrane Lymphocytes, human, 4802 Hyperthermia, 1911

5278 CANCER RESEARCH VOL.39 Subject Index to Volume39

Monocytes /3-Naphthoflavone Benzo(a)pyrene see 5,6-Benzoflavone Metabolism, 3184 1-Naphthylamine Benzo(a)pyrene, 7,8.dihydro-7,8-dihydroxy Mammary neoplasms, experimental Benz(a)anthracene, 3184 Tissue culture, mouse, 1784 Metabolism, 3184 Leukocyte adherence inhibition 2-Naphthylamine Mechanism of action, 576, 587 Mammary neoplasms, experimental Tissue culture, mouse, 1784 MOPC-315 tumor see Plasmacytoma 7,8-Napthoflavone Benzo(a)pyrene Morpheme, N-nltroso DNA adducts, diploid fibroblasts, human, 1083 Smoking Urinary excretion, human, 829 National Cancer Institute History Muramidase Grant programs, review, 4274 Leukemia, myelocytic Nebularine Prostaglandins E, 2190 see 9-$-D-Ribofuranosylpurine Muramyl dipeptide Neocarzinostatin see N-Acetylmuramyl-L.alanyl(L-seryl)-D-isoglutamine Bisamino derivative Mustards, heterocydic Metabolism and excretion, mouse, rat, I547 Mutagenicity; Chinese hamster ovary cells Pharmacokinetics, mouse, rat, 1547 Carcinogenicity, Chinese hamster ovary cells, 4875 Bleomycin DNA, 3768 Mycobacteriumsinegmatis DNA polymerase 13, 3768 Bacteriocins Synergistic activity, tumor cells, 3768 Cellmembrane,5114 Caffeine Mycoplasma hyorhinis Cytotoxicity, 1623 Cell transformation, neoplastic DNA synthesis, 1623 Cell surface properties, 1026 Carcinoma, Walker 256 Pharmacokinetics, mouse, rat, 1547 Myeloblasts Cell membrane Leukemia, myeloblastic Microfilaments, 4687 Cytokinetic study, 3834 Glucose, 2-deoxy Ultrastructural study, abnormal granules, 3834 Metabolism, 4687 Leukemia, myelocytic Immunological capping Cells, colony-forming, 2704 Raji cells, 4687 Leukemia Ll210 Myelocytes Caffeine, 1623 Leukemia, myelocytic Cytotoxicity, 1623 Cells, colony-forming, 2704 Pharmacokinetics, mouse, rat, 1547 Myeloma Lymphocytes Antigens, nucleolar Immunological capping, 4687 Immunofluorescence, 3024 Pharmacokinetics, human Bolus injection, 757 Myeloprollferative disorders Chromosome aberrations Neoplasm transplantation Case reports, 2984 Alloantibodies Chromosome 20, human, 2984 Tissue distribution, mouse, in vivo, 3363 DNA cytophotometry, 2984 Carcinoma, Ehrlich tumor Diabetes mellitus, 1807 Myocardial contraction Mouse, dystrophic strain, 2139 Adriamycin Carcinoma, epidermoid Cardiotoxicity, rat, 2941 Chemically-induced respiratory tract tumors, rat N'-Nltrosonornicotine 2466 ser Nicotine, 1'.clemethyl-I'-nitroso Carcinoma(s) Chromosome abnormalities, 4713 NAD Nude mouse, 4713 Carcinoma, Ehrlich tumor Cell lines, hamster Oxidation-reduction, 2195 Tumorgenicity vs growth characteristics, 1505 NADPH cytochrome C reductase Fibrosarcoma(s) Pyrrolidine, 1-nitroso Chemically-induced respiratory tract tumors, rat Ethylalcohol,793 2466 Immunity, cellular Naphthalene Neonatal thymectomized hamster, 3335 Mammary neoplasms, experimental Melanoma(s) Tissue culture, mouse, 1784 Tumor cell-doubling time, 934

DECEMBER 1979 5279 Subject Index to Volume39

Neoplasm transplantation (cont'd) Neoplasms (cont'd) Neoplasms, heterologous Diagnostic marker, 3485 Elimination of mouse fibroblasts from human tu Ultramicrospectrophotometry mors,4189 Review, 2341 Pancreatic neoplasms Urological disease Adenylcyclase,452 Glycoprotein EDCI, 699 Dipropylamine, 2,2'-dioxo-N-nitroso-, 452 Virus, adeno group B Plasmacytoma DNA viral sequences, 3479 Arginine pulse-labeling technique, in vivo, mouse 2497 Neoplasms, heterologous IgO, 2497 Neoplasm transplantation Sarcoma(s) Elimination of mouse fibroblasts from human tu Cytotoxicity, immunologic, 2711 mors,4189 Immune response, mouse, 2711 Neoplasms, multiple primary Venereal tumor Carcinoma, epidermoid Blocking factor, serum, dog, 3920 Epidermodysplasia verruciformis, 1074 Neoplasms NeUraminIdase Alcohol Aminopeptidase Alcoholism, 2822 Liver neoplasms, 4212 Epidemiology, 2840, 2851 Lung neoplasms, 4212 Etiology ,eview, 2819 Etiology, overview, 2840 Stomach neoplasms, 4212 Mechanisms of carcinogenesis, review, 2887, 2899 Arylamidase Alcoholism Liver neoplasms, 4212 Role of the physician, 2834, 2853 Lung neoplasms, 4212 Appropriate animal models Stomach neoplasms, 4212 Letter to the editor, 4285 Carcinoma, Walker 256 Ascorbic acid Electrophoretic mobility, 2481 Review, 663 Glycoproteins Cytological techniques Cell membrane, 2595 Review, 2341 Liver neoplasms Granulocytes Immunological typing 4212 Serum inhibitor, 1640 Lung neoplasms Hyperthermia Immunological typing, 4212 Antitumor activity, solid tumors, mouse, 4534 Proteins Epipodophyllotoxin, 4'-demethyl-,9-(4,6-0. Cell membrane, 2595 ethylidene-, 1481 Stomach neoplasms Melphalan, 1481 Immunological typing 4212 Toxicity, whole-body heating 1481 Neuroblastoma(s) Immunity, cellular Adenosine cyclic 3':S'-monophosphate Leukocyte adherence inhibition, 604 Immunology Carrier proteins, 3007 Carrier proteins Appropriate animal models, 4285 Latency period Isolation and characterization, human, 3007 Metastases Litter-matched data scoring, 4308 Mantel-Haenzel analyses, 4308 Age factors, 711 Leukocyte adherence inhibition Animal model, mouse, 711, 3277 Correlation with tumor stage, 644 Letter to the letter, 3277 Review, 556 Radiation, ionizing Macrophages Genotypes, Xiphophoru@ 519 Serum inhibitor, 1640 Transplantation, homologous Metastases Metastases, 711 Nuclear ultrastructural study, human, 332 Transplantation immunology Tyrosinase, 3485 Administration route, 3277 Microfluorometry Urea N-methyl-N-nitroso Review, 2341 Radiation, ionizing 519 Microinterferometry Neurospora ciussa Review, 2341 Dimethylamine, N-nitroso Proteins Adenine mutation, 1525 Radioimmunoassay, 699 Mutagenic metabolite, 1525 Urinary excretion, 699 Quantitative cytochemistry Nickel submilfide Review, 2341 Cell transformation, neoplastic Thymidine Fetal cells, hamster, 3591 Pharmacokinetics, 4777 Sarcoma(s) Phase I clinical trial, 4777 Carcinogenic activity, mouse, in vivo, 4175 Tyrosinase X-ray powder diffraction studies, 4175

5280 CANCER RESEARCH VOL.39 Subject Index to Volume39

Nicotinamide NNitroso(2-hydroxypropylX2-oxopropyl)amii@e (cont'd) T-2toxin Carcinogenicity, hamster, in vivo, 3828 Carcinogenic activity, 2179 Nitrosoheptamethylenelnilne Nicotinamide adenine dinucleotide see Azocine, octahydro-1-nitroso Spermine Nucleoproteins, 1382 Nitrosomethylurethane s@ Carbamicacid, N-methyl-N-nitroso-, ethyl ester NicOtine, 1'-demethyl-l'-nitroso a-Hydroxylation N-Nltrosopyrrolidlne Liquid chromatography assay, 5057 see Pyrrolidine, l-nitroso Microsomes, liver, rat, 5057 Nitrosoureas Niridazole Hyperthermia, localized Kidney neoplasms Review, 2264 Carcinogenicity, rat, 4996 Hyperthermia, systemic NitrO compounds Review, 2264 Radiation-sensitizing agents Nocardia rubra Electron affinity, 4512 Fibrosarcoma(s) Metabolic reduction, 4512 Cell-wall skeleton, 4706 4-(n-Nitrobenzyl)pyridine Macrophages, 4706 Urea, N-methyl-N-aryl-N-methyl-nitroso Macrophages Salmonella typhimurium, 5147 Antitumor activity, 4706 Urea, N-methyl-jV-aryl-N-nitroso Nogalamycin Salmonella typhimurium@ 5147 LeukemiaLl2lO Nltrobenzylthiolnoslne Analog activity, 4816 see also 9H-Purine, 6-(4-nitrobenzyl)thio-9-/3-D-ribo Mechanism of action, in vitro, 4816 furanosyl 4-Amino-5-cyano-7(J3-D-ribofuranosyl)pyrrolo(2,3-d)pyri Norepinephrine midine Carcinoma(s) Antitoxicity activity, lymphoblastoid cells, human Angiography, hepatic, 1898 3607 Rabbit V2 tumor, 1898 Antitoxicity activity, mouse, in vivo, 3607 Carcinoma, Walker 256 4-Amino-7(,B-D-ribofuranosyl)pyrrolo(2,3-d)pyrimidine Angiography, hepatic, 1898 Antitoxicity activity, lymphoblastoid cells, human Liver neoplasms 3607 Angiography, hepatic, 1898 Antitoxicity activity, mouse, in vivo, 3607 9-$-D-Ribofuranosylpurine Nuclear magnetic resonance Antitoxicity activity, mouse, in vivo, 3607 Hepatoma(s) Imaging technique, rat, 468 N-Nltrobis(2-oxopropyl)amine ser Dipropylamine, 2,2'.dioxo-N-nitroso Nuclear membrane Nitroflirantoin Hyperthermia see Hydantoin, l-((5-nitrofurfurylidene)amino)- Chromosomes, 1911 Nitrofurazone Nucleic acids see 2-Furaldehyde, 5-nitro-, semicarbazone Bladder neoplasms Nitrogen mustard Lymph nodes, 2120 see Diethylamine, 2,2'-dichloro-N-methyl Hepatoma(s) Burkitt's lymphoma Macromomycin, 1180 Hyperbaric oxygen, 370 Leukemia L12l0 Nucleoproteins Statistical analysis, mouse survival, 3446 Hepatoma(s) Leukemia P388 Cell nucleus, Morris tumor, 2096 Statistical analysis, mouse survival, 3446 Normal/neoplastic liver, rat, 507 Steroid derivatives Leukemia Ll210 Binding, prostate gland, rat, 5155 Urea, N-methyl-N-nitroso-, 923 Mechanism of action, in vitro and in vivo, 5155 Spermine 4-Nitroqulnoline 1-oxide Nicotinamide adenine dinucleotide, 1382 seeQuinoline,4-nitro-,1-oxide Nucleoside diphosphates Nitrosamines Ribonucleotide reductase Laboratory animal food Nucleoside triphosphates, 5081 Letter to the editor, 1857 Nucleoside phosphorylase Tobacco Coformycin, 2-deoxy Analysis, side-stream/ mainstream smoke, 2505 Tissue distribution, mouse, 3044 N-Nltroso(2-hydroxypropylX2-oxopropyl)amine Colonic neoplasms Adenocarcinoma(s) Coformycin, 2-deoxy-, 3044

DECEMBER 1979 5281 Subject Index to Volume39

Nucleosides Ornithine decarboxylase (cont'd) DNA polymerases Chinese hamster ovary cells, 4930 DNA synthesis, 4330 Retinol 9H-Purine, 6-(4-nitrobenzyl)thio-9-/3-D-ribofuranosyl Cell cycle studies, Chinese hamster ovary cells Membrane binding 1245 2476 Chinese hamster ovary cells, 4930 Skin neoplasms Nucleotide diphosphates Mezerein, 4791 Ribonucleotide reductase 12-0.Tetradecanoyl-phorbate-13-acetate, 4791 Nucleotide triphosphates, 5087 l2-0-Tetradecanoylphorbol-13-acetate Cells, cultured, 4477 Fibroblasts, 4477 Nucleotide triphosphates Retinoic acid, 419 Ribonucleotide reductase Ultraviolet rays Molt-4F cells, human, 5087 Cycloheximide, 1035 Nucleotide diphosphates, 5087 Nude mouse, 1035 l,3,5-Triazin-2(IH)-one, 4-amino-1$-D. Nucleotides ribofuranosyl-, 1035 Leukemia Ll210 Aspartic acid, N-(phosphonoacetyl)-, 3089 Ornithine, -DL Lung neoplasms Cholanthrene, 3-methyl Aspartic acid, N-(phosphonoacetyl)-, 3089 Metabolism, 1431 Ribonucleotide reductase Hepatoma(s) Molt-4F cells, human, 5081 Metabolism, 1431 Nucleoside diphosphates, 5081 Orotic acid Aspartic acid, N-(phosphonoacetyl) Nutrition Metabolism, mouse, 3089 Alcohol Pyrazofurin Gastrointestinal neoplasms, 2863 Metabolism, mouse, 3089 Nystatin Orotidine-5'-phosphate decarboxylase Bleomycin Leukemia L5178Y Synergistic activity, hamster cells, in vitro, 5150 Pyrazofurin, 4485 OK-432 Uracil, 5-fluoro Leukemia L1210 H-Pyrazolo(3,4-d)pyrimidin-4-ol, 3095 Immunotherapy, 2807 Orotidylate decarboxylase Oligosaccharides see Orotidine-5'-phosphate decarboxylase Virus, murine mammary tumor Osteosarcoma Cell membrane, 199 see Sarcoma, osteogenic Concanavalin A, 199 Ferritin, 199 Ouabain Cell transformation, chemical Organohalides Growth, 2718 Lung neoplasms Adenoma(s), 391 Ovarian neoplasms Adenocarcinoma(s) Ornithine decarboxylase Animal model, rat, 1108 Benz(a)anthracene, 7, 12-dimethyl Benz(a)anthracene, 7,12-dimethyl-, 1108 Retinoic acid, 419 Cholanthrene, 3-methyl-, I 108 l2-0-Tetradecanoylphorbol-13-acetate, 419 Adriamycin Carcinoma(s) Administration route, 3209 Ascitic fluid, 1511 DNA synthesis, 3202 Immune serums, 1511 Tissue distribution, 3209 Cell transformation, viral Ascitic fluid Embryo cells, human, 864 Characterization, lymphocyte inhibitory factor Diethylmine, N-nitroso 2381 Liver, rat, 3074 Immunosuppression, 2381 DNA synthesis Lymphocyte transformation, 2381 a-Difluoromethylornithine, 4861 Lymphocytotoxicity, 2381 Fibrosarcoma(s) Chromosome abnormalities Ascitic fluid, 1511 Isoenzyme phenotype, 4449 Immune serums, 1511 Cystadenocarcinoma Leukemia L1210 Chromosome abnormalities, 4449 Ascitic fluid, 1511 Estrone, 4449 Immune serums, 1511 Immunity, cellular, 1185 Polyamines Cystadenoma, mucinous a-Difluoromethylornithine, 4861 Carcinoembryonic antigen, 1760 Retinoids Immunity, cellular, 1185

5282 CANCER RESEARCH VOL.39 Subject Index to Volume39

Ovarian neoplasms (cont'd) Palmitic acid Cystic fluid Carcinoma, Ehrlich tumor Lymphocyte transformation, 2381 Metabolism, 5118 Lymphocytotoxicity, 2381 DNA Pancreatic neoplasms Carrier proteins, 4341 Antigens, neoplasm Fibronectin Lymphocyte adherence inhibition, 627 Carcinoma, ductal Effusion fluids, 4341 Galactosyltransferases Dipropylamine, 2,2'-dioxo-N-nitroso-, 452 Serum levels, human, 1943 Dipropylamine, 2,2'-dioxo-N-nitroso Neoplasm transplantation, 452 Glycoside hydrolases Serum levels, human, 1943 Leukocyte adherence inhibition Diagnosis, 633 Immunity, cellular Serum blocking factor, 1185 Neoplasm transplantation Adenyl cyclase, 452 Methotrexate Secretin DNA synthesis, 3202 Sialyltransferase Adenosine cyclic 3':S'-monophosphate, 452 Serum levels, human, 1943 Pancytopenia Teratoid tumor Chromosome aberrations Chemotherapy, mouse, 3202, 3209 Chromosome 20, human, 2984 Ovariectomy Papilloma(s) Estradiol Benz(a)anthracene, 3,4-dihydro-3,4-dihydroxy-7,12- Vagina, cervix, mouse, 2560 dimethyl Gynecologic neoplasms Carcinogenic activity, mouse, 1934 Estradiol, 2591 Skin neoplasms, 1934 Progesterone, 2591 Benz(a)anthracene, 7,12-dimethyl Progesterone Retinoic acid, 419 Vagina, cervix, mouse, 2560 13-cis-Retinoic acid, 419 Bladder neoplasms Oxamate Formamide, N-[4-(5-nitro-2-furyl)-2-thiazolyl]- Carcinoma, Ehrlich tumor 1207 Malate-aspartate shuttle, 2195 Skin neoplasms 1,2-Oxathiolane 2,2-dioxide Benz(a)anthracene, 7,12-dimethyl-, 411, 419 Ozone Benz(a)anthracene, 7,12-dimethyl-Il-fluoro-, 411 Ames test,2155 Ultrastructural study, Japanese newt, 1904 12-0-Tetradecanoylphorbol- 13-acetate 2-Oxetanone 3',S'-Cyclic AMP phosphodiesterase, 2036 Ozone Tumor-promoting activity, skin, mouse, 2644 Ames test,2155 Transplantation immunology Oxidation-reduction Nude mouse, 273 Carcinoma, Ehrlich tumor Virus, Shope papilloma NAD, 2195 Transplantation, homologous, 273 Oxidative phosphorylation Peanutoil Carcinoma, Ehrlich tumor Bacillus Calmette- Guerin Zinc, 2457 Vaccines, emulsified, 1518 Trehalose-6,6'-dimycolate Oxygen Vaccines, emulsified, 1518 Benzo(a)pyrene-3,6-dione Cytotoxicity, 3194 Pentamethylmelamine Benzo(a)pyrene-6,12-dione Antineoplastic agents Cytotoxicity, 3194 Phase I clinical trial, 5016 Methanesulfonic acid, ethyl ester Hexamelamine Cytotoxicity, 3194 Pharmacokinetics, rabbit/human, 5016 Oxygenases Pentamycin Acetamide, N-fluoren-2-yl Bleomycin DNA binding 1089 Synergistic activity, hamster cells, in vitro, 5150 Nuclei, liver, rat, 1089 Pentylamine, N@methyl-N-nitroso Ozone Carcinoma, epidermoid Water pollutants, chemical Dose-response study, rat, 3644 Carcinogenic/mutagenic activity, 2149 Esophageal neoplasms Mutagenic activity, 2155 Dose-response study, rat, 3644 Head and neck neoplasms Pahnitate Dose-response study, rat, 3644 Carcinoma, Ehrlich tumor Papilloma(s) Oxidation, in vivo, 973 Dose-response study, rat, 3644

DECEMBER1979 5283 Subject Index to Volume39

Peptic ulcer L-Phenylalaninemustard Antigens, nucleolar Fibrosarcoma(s) Immunofluorescence, 3024 Immune serums, 6, 3638 Peptide hydrolases Immune serums Bone marrow Antitumor activity, rat, 6 Tumor-induced cytotoxicity, 1193 Tumor regression, rat, 3638 Melanoma(s) Peptides Antitumor activity, mouse, 934 Burkitt's lymphoma Urea, thio Macrophage cytotoxicity, 1847 DNA interstrand crosslinks, 4989 Fibrosarcoma(s) Leukemia L1210, 4989 Macrophage cytotoxicity, 1847 Lactalbumin Phenylalanyl transfer RNA Nude mouse, 2046 Column chromatography Mammae Normal/neoplastic/regenerating tissue, mouse/rat Cell differentiation, 2046 1253 Sarcoma, mast cell Wye base alteration Lactate dehydrogenase, 1847 Normal/neoplastic/regenerating tissue, mouse/rat Macrophage cytotoxicity, 1847 1253 Peroxisomes Clofibrate n,-Phenylenediamine Carcinogenic activity, rat, 3419 Skin neoplasms Hepatoma(s) Dose-response study, mouse, 1718 Cyclohexane, 1,2,3,4,5,6-hexachloro-, 1628 Phenylmethylnitrosamine Pesticides see Benzenamine, N-methyl-N-nitroso Nitroso compounds Phorbol Cell transformation, neoplastic, 4525 Leukemia, lymphocytic Phagocytosis Strain sensitivity, mouse, 3345 Leukemia, myelocytic Mammary neoplasms, experimental l2-0.Tetradecanoylphorbol-l3-acetate, 4668 Strain sensitivity, mouse, 3345 Phenanthrene Phorbol-12,13-diacetate Ames test Melanoma(s) Epoxide and dihydro derivatives, 4069 Cell differentiation, 2618 Bay region epoxides Phorbol dibutyrate Carcinogenicity, mouse, 5063 Melanoma(s) Carcinogenetic activity, skin, mouse Cell differentiation, 2618 Epoxide and dihydro derivatives, 4069 Epoxide hydrase Phorbol esters Ames test, 4069 Choline Phospholipids, 2743 Phenobarbital 3',S'-Cyclic AMP phosphodiesterase seeBarbituric acid, 5-ethyl-5-phenyl Epidermis, mouse, 2036 Phenol, 2-tert-butyl-4-methoxy Derivatives/stereoisomers Glutathione S@transferase Irritant effects, skin, mouse, 2644 Tissue microsomes, rat, 2971 Tumor-promoting activity, skin, mouse, 2644 Nonprotein sulfliydryl Erythroleukemia Gastrointestinal mucosa, rat, 2971 Celladhesion,1989 Urinary bladder, rat, 2971 Glucose, 2-deoxy Metabolism, in vitro vs in vivo, 714 Phenol, 2,4â€”dinitro LETS protein Adriamycin Fibroblasts, chick embryo, 714 Efflux mechanism, 2200 Leukemia, myelocytic Daunomycin Cell differentation, 4668 Efflux mechanism, 2200 Melanoma(s) Phenol, p-nitro Cell differentiation, neoplastic, 3915 Phospholipids Acetamide, N-fluoren-2-yl HeLa cells, 2743 Nucleic acids, binding 3268 Platelet aggregation p.Phenoxybenzalbutyrate Correlation with tumor promotion, 3602 Fatty acids Prostaglandin synthetase, 3602 Hepatoma(s), 3845 Phorbol-12-myristate-13-acetate Rat, in vivo, 3845 see 12-0-Tetradecanoylphorbol-l3-acetate Hyperfibrinogenemia Hepatoma(s), 3845 Phosphodiesterase Rat, in vivo, 3845 Hepatoma(s)

5284 CANCERRESEARCHVOL.39 Subject Index to Volume39

Phospbodlesterase (cont'd) Pituitary neoplasms (cont'd) Calcium, 3000 Estradiol, 998 Prolactin, 998 Phosphofructokinase Thyroid neoplasms Placenta Citrate, 2796 Virus, Mason-Pfizer monkey DNA, viral, 1696 Phospholipids Epitheium Plant agglutlnins Metabolism, rat, 207 Virus, murine mammary tumor Glycerolipids Ferritin, 199 Metabolism, rat, 207 Plant substances Hepatoma(s) DNA synthesis Microsomes, mitochondria, 2978 L cells, 4802 Microsomes, mitochondria Lymphocytes, 4802 Normal/regenerating liver, adult/fetal rat, 2978 Mammary neoplasms, experimental, 4802 Phorbol esters Choline, 2743 Plasma membrane HeLa cells, 2743 Antineoplastic agents @ 12-0.Tetradecanoylphorbol-13-acetate Chemical/enzyme characteristics, guinea pig cells Cell transformation, viral, 2743 1369 Choline, 2743 Erythroleukemia Colcbicine, 2743 Dimethyl sulfoxide, 1113 HeLa cells, 2743 Hepatoma(s) L cells, 2743 Chemical/enzyme characteristics, guinea pig cells Tosylphenylalaninechloromethyl ketone 1369 l2-0.Tetradecanoylphorbol-l3-acetate, 2743 Hormones Tracheal neoplasms Chemical/enzyme characteristics, guinea pig cells Glycerolipids, 207 1369 Urea, N-methyl-N-nitroso JWPhos@acetyD-L-aspartate Ultrastructural study, urinary bladder, rat, 3757 Antineoplastic agents Phase I clinical trial, 3992 Plasmacytoma Cell transformation Phosphoproteins Immunity, cellular, 785 Hepatoma(s) 2,4-Dinitrophenyl Normal/regenerating/neoplastic liver, rat, 116 Immune response, mouse, 3783 Photochemotherapy Hybrid cells Hematoporphyrin A-type particles, 4481 Cell cycle synchronization, 3735 Chromosomes, 4481 Dose-response studies, human, 3735 1gM Immune response, mouse, 3783 PhotosensItIzatIon Neoplasm transplantation Hematoporphyrin Arginine pulse-labeling technique, in vivo, mouse Cytotoxicity, in vitro, 96 2497 Mammary neoplasms, experimental IgG, 2497 Hematoporphyrin, 146 Pneumococcal polysaccharides Retinoblastoma Immune response, mouse, 3783 Hematoporphyrin, 96 Splenectomy Picolinlc acid Immune response, mouse, 3783 Cell transformation, chemical Plasminogen activators Growth, 2718 l2-0-Tetradecanoylphorbol-l3-acetate Adenosine cyclic 3':5'-monophosphate, 1579 Bleomycin Cell transformation,viral, 1579 Synergistic activity, hamster cells, in vitro, 5150 Cholera toxin, 1579 Fibroblasts, chick embryo, 1579 PItuitary hormones Benz(a)anthracene, 7,12.dimethyl Virus, Rous sarcoma, 1579 Serum levels, rat, 4700 Virus, Rous sarcoma Temperature sensitive mutants, 1579 Pituitary neoplasms Plastics Adenoma(s) Fibrosarcoma(s) Diethylstilbestrol, 773, 779 Diethylstilbestrol Foreign body reaction, 2172 Prolactin, 773, 779 Platelet aggregation Strain differences, rat, 773, 779 Adenocarcinoma(s) Hyperplasia Thrombosis, 2031 Diethylstilbestrol, 779 Thrombosis Prostaglandin F2a Adenosine diphosphate, 2031

DECEMBER1979 5285 Subject Index to Volume39

Platelet aggregation (cont'd) Platinum(II), dipyrrolidinedichloro-, cia Ristocetin, 2031 Adenoma(s), 913 Sialic acid, 2031 Carcinogenic/mutagenic activity, mouse/rat, 913 Platinum Platinum(II), sulfato-trans-(-)-1,2-diaminocyclohexane Virus, adeno 7 Antineoplastic agents Co-carcinogenic effect, metal salts, 193 Immunosuppression, 3476 c/s-Platinum Graft vs host reaction see Platinum(II), diamminedichloro-, cis Immune response, mouse, 3476 Lymphocyte transformation Platinum(II), bis(cyclopentamine)dichloro-, c/s. Immune response, mouse, 3476 Carcinogenic/mutagenic activity, mouse/rat, 913 Sarcoma(s), 913 Pleural neoplasms DNA Platinum(II), diamminedichloro-, c/a- Carrier proteins, 4341 Adenoma(s), 913 Fibronectin Anthranilic acid, 4-chloro-N-furfuryl-5-sulfamoyl Effusion fluids, 4341 Blood urea nitrogen, 1269 DNA synthesis, 1279 Poecilia Formosa Glomerular filtration rate, 1269 Thyroid gland Hippuric acid, p-amino-, 1269 Metastases, 2698 Toxicity, rat, 1279 Bleomycin Toxicity, 5076 Poly(adenosine diphosphate-ribose) polymerase Bone marrow Spermine DNA synthesis, 1279 Normal/neoplastic/regenerating liver, rat, 1382 Carcinogenic/mutagenic activity, mouse/rat, 913 Urea, methyl nitroso Colonic neoplasms HeLa cells, 1405 Adenocarcinoma(s), 4356 Cell cycle kinetics, 4356 Croton oil Poly C Skin neoplasms, 913 Hematopoietic stem cells DNA repair Cell cycle kinetics, 3163 Cell cycle kinetics, 1793 Colony formation, 3163 Hamster V79 cells, 1793 Partially thiolated derivatives, 3163 DNA synthesis Leukemia(s) Cell cycle kinetics, 4356 Partially thiolated derivatives, 3163 Furosemide Glomerular filtration rate, 1269 Hyperthermia, localized Polyamines Cytotoxicity in vitro/in vivo, 2269 Brain neoplasms Review, 2264 Biochemical marker, neoplasms, human, 5010 Hyperthermia, systemic Cell transformation, viral Review, 2264 Embryo cells, human, 864 Intestinal mucosa a-Difluoromethylornithine DNA synthesis, 1279 Ornithine decarboxylase, 4861 Leukemia(s) DNA synthesis Anthranilic acid, 4-chloro-N-furfuryl-5-sulfamoyl Lymphocytes, 4861 1279 Medulloblastoma Mannitol, 1279 Cerebrospinal fluid, human, 993 Mannitol Patient surveillance, 993 Blood urea nitrogen, 1269 Methylglyoxal bis(guanylhydrazone) DNA synthesis, 1279 Analogs, 4861 Glomerular filtration rate, 1269 Polycyclic aromatic hydrocarbons Hippuric acid, p.amino-, 1269 Aryl hydrocarbon hydroxylase Toxicity, rat, 1279 Primordial oocyte toxicity, mouse, 3471 Sarcoma(s), 913 Carbonium ion Urea, thio Carcinogenic activity, 4760 DNA interstrand crosslinks, 4989 Salmonella typhimurium Leukemia L1210, 4989 Mutation assay, complex mixtures, 4152 In vitro vs in vivo activity, mouse/human, 402 Structure-activity relationship Platinum(II), diamminedichloro-, trans. Letter to the editor, 4760 Leukemia L1210 Polycytidylic acid DNA, 365 seePoly C Mechanism of action in vitro, 365 Urea, thio Polypeptides DNA interstrand crosslinks, 4989 Virus, herpes simplex 2 Leukemia L12l0, 4989 Cell transformation, viral, 3225

5286 CANCERRESEARCHVOL.39 Subject Index to Volume39

rlbolnosinic:polyrlbocytidylic acid Probenecid Interferon see Benzoic acid, p-(dipropylsulfamoyl) Serum levels, 1645 Procarbazine Leukemia(s) Carcinoma, Walker 256 Clinical study, 1645 Metastatic brain tumor model, rat, 2691 Interferon, 1645 Microsomes, liver Lymphoma(s) Azo and azoxy derivatives, 4555 Immunosuppression, 4564 Metabolism, 4555 Polyribonucleotide synthetases Phorbol Actinomycin D Strain sensitivity, mouse, 3345 Uracil-DNA glycosylase, 2090 Procollagen Cycloheximide Cell transformation, viral Uracil-DNA glycosylase, 2090 Cortisol, 2077 Uracil-DNA glycosylase Dexamethasone, 2077 Lymphocyte transformation, 2090 Virus, SV4O Potassium cyanide Cell transformation, viral, 2077 Fibroblasts Proflavine @ DNA-protein cross-links, 704 Acridine, 3,6-diamino Precancerous conditions Progesterone Acetamide, N-fluoren-2-yl- Breast neoplasms Alpha fetoprotein, 3491 Plasma levels, 1835 Antigens, neoplasm Receptors, hormone, 1447, 1678, 1835 Leukocyte adherence inhibition, 604 Carcinoma(s) Bladder neoplasms Receptors, hormone, 2647 Concanavalin A, 3353 Estrogen Breast neoplasms Endometrium, post-menopausal, 1094 Steroid hydroxylases, 4584 Receptors, hormone, 2614 Cervix neoplasms Gynecologic neoplasms Retinol,3114 Estradiol,2591 Chlordane Neonatal mouse, 2591 Alpha fetoprotein, 3491 Ovariectomy, 2591 Epidermodysplasia verruciformis Lactalbumin Virus, papilloma, 1074 Nude mouse, 2046 Estradiol Mammary neoplasms, experimental Neonatal mouse, 2560 Neonatal mouse, 2560 Estrogen Prostaglandin F2a, 998 Endometrium, post-menopausal, 1094 Receptors, hormone, 4098 Hepatoma(s) Ovariectomy Adenosine triphosphatase, 1298 Vagina, cervix, mouse, 2560 Diethylamine, N-nitroso-, 1298 Receptors, hormone Leukocyte adherence inhibition Ovarian-dependent MXT-3590 mouse tumor, 4098 Identification of high-risk patients, 654 Prolactin Progesterone Benz(a)anthracene, 7, 12-dimethyl Neonatal mouse, 2560 Estrus, 4700 Thymoma Breast neoplasms Virus, Gross murine leukemia, 480 Plasma levels, 1835 Virus, Gross murine leukemia Receptors, hormone, 4381 Immune response, AKR mice, 480 Diethylstilbestrol Prednisolone Plasma levels, 773, 779 Lactalbumin Butyric acid, 4-[p-bis(2.chloroethyl)aminophenyl]- Nude mouse, 2046 Carcinoma, Walker 256@ 4256 Mammary neoplasms, experimental Sarcoma(s), 4256 Adrenalectomy, 2436 Cyclophosphamide Animal model, rat, 5028 Carcinoma, Walker 256, 4256 Antiestrogens, 5043 Sarcoma(s), 4256 Diethylstilbestrol, 773 L-Sarcolysin Estradiol benzoate, 2436 Carcinoma, Walker 256, 4256 Receptors, hormone, 5028 Sarcoma(s), 4256 Pituitary neoplasms Stomach neoplasms Diethylstilbestrol, 773, 779 Carcinoma(s), 4732 Prostaglandin F2a, 998 Preproteins Proline, 4-hydroxy Peptide sequence 12-O.Tetradecanoylphorbol-13-acetate Alpha fetoprotein, 3702 Metabolism, fibroblasts, chick embryo, 1667

DECEMBER1979 5287 Subject Index to Volume39

Pronase Prostatic neoplasms (cont'd) Retinoic acid Carcinoembryonic antigen Lung neoplasms, 2492 Isolation and characterization, 2447 Propane, 2,2-bIs(pglycidyloxyphenyl)- Pretense inhibitors Skin neoplasms Cell transformation, chemical Dose-response study, mouse, 1718 Cholanthrene, 3-methyl., 2755 Propane, 1,1,1-trichloro-2,3-epoxy Guanidine, N-methyl-N-nitro-N.nitroso Benz(a)anthracene-7-methanol, 12-methyl Mutagenic activity, hamster, 2755 DNA binding 1154 Ultraviolet rays Benzo(a)pyrene Mutagenic activity, hamster, 2755 DNA adducts, diploid fibroblasts, human, 1083 Proteases 1,2-Propanediol, 3-p(1,2,3,4-tetrahydro-6-methoxy acePeptidehydrolases 2-phenyl-l-naphthyl)phenoxy-, cia Protein arginine methyltransferase Mammary neoplasms, experimental Butyric acid, 2-amino-4-mercapto Castration, rat, 5043 S@Adenosylanalogs, 4497 2-Propanol, 1,l'-Iminodi-@nifroso Virus, Rous sarcoma Metabolism, hamster and rat, 4579 Cell transformation, viral, 4497 2-Propanol, 1,1,1-trichloro-2-methyl Protein kinase Lung neoplasms Diethylmine, N-nitroso Carcinogenicity, mouse, 391 Adenosine cyclic 3':S'-monophosphate, 3074 Propionic acid, 3-chloro Liver, rat, 3074 Lung neoplasms Proteins Carcinogenicity, mouse, 391 Cell transformation, neoplastic Proplonic acid, 2-(p-chlorophenoxy)-2-methyl-, ethyl ester Cell membrane, 2595 Hyperthermia Hepatoma(s) Carcinogenesis, mouse, 1628 Growth rate, Chinese hamster ovary cells, 2665 Lung neoplasms Propionitrile, 3-amino Cell membrane, 2935 DNA synthesis Lymphoma(s) Kidney/ bladder/ liven pancreas, rat, 2751 Cell membranes, mouse, 4782 Parotid/submandibular glands, mouse, 2751 Isolation and characterization, 4782 Mammary neoplasins, experimental Sodium dodecyl sulfate-polyacrylamide gradient gel Antitumor activity, 2923 electrophores, 4782 Collagen, 2923 Neoplasms PropyltbIouracil Radioimmunoassay, 699 s@ Uradil, 6-propyl-2-thio Urinary excretion, 699 Neuraminidase Prostaglandin Faa Cell membrane, 2595 Mammary neoplasms, experimental Retinoic acid Antitumor activity, rat, in vivo, 998 Lung neoplasms, 2492 Progesterone, 998 Nuclei, skin, chick embryo, 2492 Pituitary neoplasms Sarcoma(s) Estradiol, 998 Amino acids, 4657 Prolactin, 998 Thermotolerance Pm@ Growth rate, Chinese hamster ovary cefls, 2665 Macrophages Urological disease Leukemia, Moloney murine, 2894 Radioimmunoassay, 699 Mammary neoplasms, experimental Urinary excretion, 699 Dietary fats, 4430 Proteinuria Prostaglandins E Neoplasms Leukemia, myelocytic Urological disease, 699 Cell differentiation, 2190 Proteoglycans Muramidase, 2190 Glycosaminoglycans Prostatic neoplasms Chondrocytes, 2802 Adenocarcinoma(s) Proteus mirabilis Androgen, 2652 Androgen Glucocorticoid amplifying factor Enzyme assays, rat tissue, 2652 Antileukemic activity, 3258 Histological study, rat tissue, 2652 Pseudourea, 2-(2-aminoethyl)-2-thio-, dihydrobromide Antigens, neoplasm Hyperthermia Immune response, hamster, 459 Cytotoxicity, 4630 Immune response, human, 3328 Hyperthermia, localized Leukocyte adherence inhibition assay, 3328 Cytotoxicity in vitro/in vivo, 2269

5288 CANCERRESEARCHVOL.39 Subject Index to Volume39

Psoralen, 8-methoxy Pyridoxal phosphate Chromosome aberrations Carcinoma, Ehrlich tumor Mucosal cells, Chinese hamster, 2510 Ribonucleotide reductase, 4600 I'urlne, 2-amino-6-metboxy Pyridoxine Dimethylamine, N-nitroso Hepatoma(s) DNA alkylation, 1798 Tyrosine aminotransferase, 2988 Liver, hamster, 50 Tyrosine aminotransferase Disulfide, bis(diethylthiocarbamoyl) Inactivation, liver, rat, 2988 Colon,rat,465 Pyrimidine, 1-j3-D-arabinofuranosyl-2-amino-1,4(211)-4-imlno Hydrazine, 1,2-dimethyl Leukemia Ll2lO Colon,rat,465 Antitumor activity, 3129 Disulfide, bis(diethylthiocarbamoyl)-, 465 Urea, N-methyl-N-nitroso Pyrimidine, 2,4-diamino-5-(3,4-dichloropbenyl)-6-methyl DNArepair, 1041 Carboxypeptidase G, Virus, herpes simplex 2 Synergistic activity, rat, in vitro/in vivo, 3441 DNA repair,1041 Carcinoma, Walker 256 @JL. Carboxypeptidase G, 3441 Methotrexate @ HeLacells - Toxicity, lymphoblasts/leukemia cells, human Cell cycle kinetics, 1245 3612 Nucleosides,1245 Nucleosides Pyrimidine synthesis Membrane binding 1245 Aspartic acid, N-(phosphonoacetyl) Antitumor activity, 3089 Purlne-6.thiol Metabolism, mouse, 3089 Lymphoma(s) Pyrazofurin Metabolism, in vitro, 3744 Metabolism, mouse, 3089 Purlne(1fl)-thlone, 2-amino Pyrroidine, 1-nitroso Immunity, cellular Esophagus Leukemia, myeloblastic, 3357 DNA adducts, 4401 Purines Ethyl alcohol Caffeine Aryl hydrocarbon hydroxylases, 793 Synthesis, 4975 Cytochrome P-45cl, 793 Ultraviolet rays, 4975 Glucosephosphatase, 793 Metabolism, liver, hamster, 793 Putrescine Mutagenic activity, 793 Brain neoplasms NADPH cytochrome C reductase, 793 Biochemical marker, neoplasms, human, 5010 Laboratory animal food Burkitt's lymphoma Letter to the editor, 1857 Cell cycle kinetics, 2429 Metabolites Pyran copolymer Liver microsomes, rat, 2679 Adriamycin Postmicrosomal supernatant, rat liver, 2679 Immune response, mouse, 3014 Pyruvaldehyde bis(amidinohydrazone) Cyclophosphamide Cell division Immune response, mouse, 3014 Mitochondrial swelling 1919 P@n Fibroblasts Adenosine kinase Mitochondrial swelling 1919 Phosphorylation, 4485 L cells Leukemia L5178Y Cell division, 1919 Drug resistance, mutants, 4485 Leukemia(s) Orotidine-5'-phosphate decarboxylase, 4485 Mitochondrial swelling 1919 Orotic acid Lymphocytes Metabolism, mouse, 3089 Celldivision,1919 Orotidine-5'-phosphate decarboxylase Mitochondrial swelling 1919 Drug resistance, mutants, 4485 Pyrimidine synthesis Pyruvate kinase L-Alanine Metabolism, mouse, 3089 Patient prognosis, brain neoplasms, 4263 @â€˜@yrazolo(3,4-d)pyr1mIdin-4-ol Tumor detection, brain, 4263 Uracil, 5-fluoro Brain neoplasms Inhibition of cytotoxicity, 3095 Cell differentiation, neoplastic, 4263 Orotidine-5'phosphate decarboxylase, 3095 Quinoline, 4-hydroxyamino-, 1-oxide Pyrazolo(3,4-d)pyrimidine, 4-amino-1-(ft-D-rlbofuranosyl)- Maleimide, N-ethyl Leukemia L12l0 Fibroblasts, 2961 Antitumor activity, in vivo, in vitro, 3018 Metabolism, 2961

DECEMBER1979 5289 Subject Index to Volume39

Quinoline, 4-nitro-, 1-oxide Radiobiology (cont'd) Ascorbic acid, sodium salt Cell cycle kinetics, 1891 Oxygen consumption, 2961 Carcinoma, Ehrlich tumor Radiosensitization Nonprotein thiols, 2961 Methotrexate DNA repair Fibroblasts, mouse, in vitro, 244 Fibroblasts, in vitro, human, 2522 Uridine, 5-bromo-2'-deoxy-, Fibroblasts Fibroblasts, mouse, in vitro, 244 Nonprotein thiols, 2961 Radiotherapy Formamide, 1,1'-azobis(N,N-dimethyl)- Breast neoplasms Metabolism, 2961 Prognosis, 1552 Glutathione S-transferase Dose-response assay Nitro radicals, 2961 Spontaneous tumors, dog 2242 Maleimide, N-ethyl Head and neck neoplasms Cytochrome c, 2961 Hyperthermia, localized, 2332 Nitro radicals, 2961 Hyperthermia Oxygen consumption, 2961 Hyperthermic sensitivity, mammalian cells, 2290 Radiation, ionizing Review, 2290 Brain neoplasms Spontaneous tumors, dog 2242 Hyperthermia, localized Metastases, 1001 Metastases, 2258 Carbamic acid, ethyl ester Skin neoplasms, 2258 Mutagenic activity, Drosophila melanogaste, 4224 Hyperthermia, systemic Cell transformation, neoplastic Water blanket set, 2252 Dose fractionation, 123 Urogenital neoplasms Dose-response study, 1474 Post-therapy blood levels, 840 Dose-response study, embryo cells, mouse, 123 Hamster cells, 5069 Ranajaponica Mouse 3T3 cells, 1474 Carcinoma, Ehrlich tumor Neutrons, 123 Lectins, 1347 Statistical model, â€˜one-hit'curve, 5069 Lectins Flow cytometric analysis Isolation and characterization, 1347 Experimental tumor, mouse, 1891 Receptors, concanavalin A Hoechst 33432 Cystadenoma, mucinous Cell survival, 1891 Carcinoembryonic antigen, 1760 Lung neoplasms Virus, feline leukemia Metastases, 1001 Immunologic capping, 956 Transplantation immunology, I 126 Lymphocytes, 956 Mammary neoplasms, experimental Viral proteins, 443 Hyperthermia, 2966 lH-Imidazole-1-ethanol, a-(methoxymethyl)-2-nitro Receptors, hormone 2966 Bladder neoplasms Neuroblastoma(s) Estrogen,2614 Genotypes, Xiphophoru.s 519 Breast neoplasms Urea N-methyl-N-nitroso-, 519 Androgen, 1447 Phorbol Carcinoma(s), 1835 Strain sensitivity, mouse, 3345 Carcinoma, scirrhous, 1835 Sarcoma(s) Cortisol, 1973 Cell cycle kinetics, 1891 Diethylstilbestrol, 1973 Spirohydantoin mustard Estradiol, 1835 Radiosensitivity, 4336 Estrogen, I 124, 1447 Thyroid gland Estrogen sulfotransferase, 5124 Cell migration, 2698 Frozen tissue, I 124 Virus, C-type RNA tumor Glucocorticoids, 1447 Virus replication, 4322 Metastases, 1973 Virus, murine leukemia Progesterone,1447, 1678, 1835 Virus activation, 4322 Prolactin, 4381 Sucrose gradient assay, 1678 Radiation, non-ionizing Tamoxifen, 1973 HeLa cells Tissue culture, 4381 Growth recovery kinetics, 1218 Tumor size and location, 1447 Radiation-sensitizing agents Carcinoma(s) Nitro compounds 5a-Androstan-3-one, 17/3-hydroxy-, 4713 Electron affinity, 4512 Cell differentiation, 4713 Metabolic reduction, 4512 Kidney, hamster, 2647 Cell transformation, neoplastic Radiobiology Fibroblasts, Syrian hamster embryo, 4166 Anoxia Chondrosarcoma

5290 CANCER RESEARCH VOL.39 Subject Index to Volume39

Receptors, hormone (cont'd) 13-c/s-Retinoic acid Cortisone,4387 Bladder neoplasms Dexamethasone 1-Butanol, 4-(butylnitrosamino)-, 3141 Adrenalectomy, 5132 Dose-response study, rat, 3141 Normal/regenerating liver, rat, 5132 Papilloma(s) Estradiol Benz(a)anthracene, 7,12-dimethyl-, 419 Rotenone, 4438 trans-Retinoic acid Estrogen Cervix neoplasms Endometrium, post-menopausal, 1094 Carrier proteins, 3114 Progesterone, 2614 Hepatoma(s) Retinoids Glucagon, 1443 Cholanthrene, 3-methyl Insulin, 1443 Cell transformation, neoplastic, 1661 Kidney neopLasms Melanoma(s) Carcinoma(s), 2647 Cell colony formation, in vitro, 4055 Leukemia(s) Myeloma Glucocorticoids, 376 Cytotoxicity, spleen cells, mouse, 55 Lymphoma(s) Immune response, mouse, 55 Glucocorticoids, 4011 Ornithine decarboxylase Mammary neoplasms, experimental Chinese hamster ovary cells, 4930 Antiestrogens, 5043 Retinol Estrogen, 4098 Cervix neoplasms Immunologic deficiency syndromes, 1529 Carrier proteins, 3114 Progesterone, 4098 Precancerous conditions, 3114 Prolactin, 5028 Fanconi syndrome Melanoma Bence Jones protein, 4423 Melanocyte-stimulating hormones, 3058 Carrier proteins, 4423 Rotenone Leukemia, plasmacytic Uterus, rat, 4438 Carrier proteins, 4423 Thymoma(s) Ornithine decarboxylase Dexamethasone, 4749 Cell cycle studies, Chinese hamster ovary cells Genes, structural, 4749 2476 Hybrid cells, 4749 Chinese hamster ovary cells, 4930 Retinamlde, N@4-hydroxyphenyl)- Retinol acetate Mammary neoplasms, experimental Mammary neoplasms, experimental Pharmacokinetics, rat, 1339 Urea, N-methyl-N-nitroso-, 1339 Urea, N-methyl-N-nitroso-, 1339 Retinyl acetate Retinoblastoma Mammary neoplasms, experimental Antigens, neoplasm Carcinogenesis inhibition, rat, in vivo, 3977 Cultured cells, tumor/fetal, human, 183 Urea, N-methyl-N-nitroso Monkey antisera, 183 Carcinogenesis inhibition, rat, in vivo, 3977 Hematoporphyrin Reverse transcriptase Photosensitization, 96 Leukemia, myeloblastic Retlnoic acid Virus, C-type RNA tumor, 2063 Benz(a)anthracene, 7,12-dimethyl Leukemia, myelocytic Ornithine decarboxylase, 419 Virus, C-type RNA tumor, 2063 Breast neoplasms Virus, Friend spleen focus-forming Growth inhibition, human cell, in vitro, 1014 Erythropoietin, 1841 Deoxyribonuclease Review Lung neoplasms, 2492 Alcohol Melanoma(s) Neoplasms, 2887 Growth inhibition, human cell, in vitro, 1014 Antineoplastic agents Growth inhibition, in vitro, 4767 Dihydrofolate reductase, 293 Papilloma(s) Ascorbic acid Benz(a)anthracene, 7,12-dimethyl-, 419 Neoplasms, 663 Pronase Historical Review of the American Association Lung neoplasms, 2492 for Cancer Research, Inc., 1941-1978, 1863 Proteins Hyperthermia Lung neoplasms, 2492 Cell cycle kinetics, 2277 Nuclei, skin, chick embryo, 2492 Chemotherapy, 2285 Ribonuclease Radiotherapy, 2290 Lung neoplasms, 2492 Technology, 2313 12-O-Tetradecanoylphorbol-13-acetate Hyperthermia, localized S-Adenosyl-L-methionine decarboxylase, 419 Amphotericin B, 2264 Ornithine decarboxylase, 419 Bleomycin, 2264

DECEMBER 1979 5291 Subject Index to Volume39

Review (cont'd) Ristocetin Nitrosoureas, 2264 ThrombO5is Platinum(II), diamminedichloro-,cis-, 2264 Platelet aggregation, 2031 Hyperthermia, systemic RNA Actinomycin D, 2264 Benzenamine, N,N-dimethyl-4-((3-methylphenyl)azo)- Adriamycin, 2264 CytopLasm, liver, rat, 4460 Nitrosoureas, 2264 Carcinoma, EhrLich tumor Platinum(II), diamminedichloro-,cis-, 2264 Zinc, 2457 Immunity, cellular Cholanthrene, 3-methyl Leukocyte adherence inhibition, 556 Cell transformation, neoplastic, 4516 Leukemia, lymphoblastic Hyperthermia Chemotherapy, 4301 Growth rate, Chinese hamster ovary cells, 2665 Child, 4301 Immunotherapy Leukocyte adherence inhibition, 660 Cytotoxicity, mouse, in vivo vs in vitro, 1702 Antigens, neoplasm, 649 Leukemia, myelocytic Neoplasms Cell differentiation, 4170 Leukocyte adherence inhibition, 556 Interferon, 4170 Microfluorometry, 2341 Lung neoplasms Microinterferometry, 2341 Immunotherapy, 1702 Ultramicrospectrophotometry, 2341 Melanoma(s) Salmonella typhimurium Immunity, cellular, 1702 Mutagenicity vs carcinogenicity, 3289 Immunotherapy, 1702 Metastases, 1702 Nucleotide sequence Rhodamine B Hepatocarcinogenesis, 4460 DNA o-Toluidine, 4-chloro

Alkaline sucrose sedimentation, 4412 Uracil,Microsomes@5-fluoro liver, rat, 2528 RhodamineAmes test,6C 4412 Gastrointestinal tissue, mouse, 2406 LD@,,,mouse, 2406 Rhodamine 6C Uridine, 2'-deoxy-S-fluoro DNA Gastrointestinal tissue, mouse, 2406 Alkaline sucrose sedimentation, 4412 LD5@ mouse@ 2406 Rhodamine B Uridifle, 5-fluoro Ames test, 4412 Gastrointestinal tissue, mouse, 2406 LD,,@,mouse, 2406 5-(J3-D-Ribofuranosyl)isocytosine see Isocytosine, 5-(fl-D-ribofuranosyl)- @lantDNA polymerase see Reverse transcriptase 9-$-D-Ribofuranosylpurine Nitrobenzylthioinosine RNAI @i@@senger Antitoxicity activity, mouse, in vivo, 3607 ChondrosarcomaAnimal model, Swarm rat, 5093 Ribonuclease Fructose l,5-biphosphate aldolase Retinoic acid Isolation and characterization, 502 Lung neoplasms, 2492 Hepatoma(s) RibonucleotideCarcinoma,reductaseEhrlich tumor AlphaFructosefetoproteins,1,5-biphosphate2141 aldolase, 502 Virus, murine leukemia Guanosine, 5'-deoxy-, 4600 Embryo ceLls, mouse, 321 Inosine, 4600 Polyribosomes, 321 Pyridoxal phosphate, 4600 @ Thiosemicarbazones, 4600 polymerases Guanosine, 5'-deoxy- Cholanthrene, 3-methyl Dialdehyde derivatives, 4600 Cell transformation, neoplastic, 4516 Inosine RNA, ribOsOmal Dialdehyde derivatives, 4600 Sarcoma(s) Leukemia L1210 Amino acids, 4657 Acyl hydroxamic acids, 844 Aryl hydroxamic acids, 844 RNA synthesis Leukemia, lymphoblastic Benzo(a)pyrene-3,6-dione Isolation and characterization, 436 Uracil,Uridine5-fluoroincorporation, 3194 Nucleoside triphosphates Molt.4F cells, human, 5081 Regenerating liver, rat, 3694 Nucleoside diphosphates, 5081 RNA, fr@fl5fer, methyltransferases Nucleotide triphosphates 5-Azacytidine Molt-4F cells, human, 5087 Liver, mouse, in vivo/in vitro, 940 Nucleotide diphosphates, 5087 Hepatoma(s)

5292 CANCER RESEARCH VOL.39 Subject Index to Volume39

RNA, transfer, methyltransferases (cont'd) Salmonella typhimurium (cont'd) Acetamide, N-fluoren-2-yl-, 2113 Endotoxins RNA, viral Cell wall immunotherapy, 1597 Breast neoplasms Heptoseless mutant, phenol-water extract DNA-RNA hybridization, 5106 Neoplasm regression, line 10 tumor, guinea pig Virus, Mason-Pfizer monkey, 5106 1766 Virus, murine mammary tumor, 5106 Polycycic aromatic hydrocarbons DNA, neoplasm Mutation assay, complex mixtures, 4152 Hybridization studies, normal/leukemic cells, hu Review man, 2532 Mutagenicity vs carcinogenicity, 3289 Leukemia, myeloblastic Soot DNA, neoplasm, 2532 Mutation assay, complex mixtures, 4152 Leukemm(s) Urea, N-methyl-N-aryl-N-methyl-nitroso DNA, neoplasm, 2532 4-(p-Nitrobenzyl)pyridine, 5147 Virus, AKR murine leukemia Urea, N-methyl-N-aryl-N-nitroso DNA synthesis, 1539 4-(p-Nitrobenzyl)pyridine, 5147 Virus, Mason-Pfizer monkey DNA-RNA hybridization, 1696 Virus, Moloney murine leukemia Sarcoma, Crocker 180 Hybridization studies, normal/leukemic cells, hu Acid-base equilibrium man, 2532 Laboratory diet, 4364 Virus, murine leukemia Neoplasm regression, spontaneous, 4364 Cell transformation, neoplastic, 321 Diet Embryo cells, mouse, 321 Acid-base equilibrium, 4364 2-Formylpyridine N-oxide benzenesulfonylhydrazone Rotenone DNA, 2625 Cell transformation, chemical Growth, 2718 Estradiol Sarcoma, mast cell Receptors, hormone, 4438 Peptides Receptors, hormone Lactate dehydrogenase, 1847 Uterus, rat, 4438 Macrophage cytotoxicity, 1847 Rubldazone Colonic neoplasms Sarcoma, osteogenic Phase 1 clinical trial, 823 Aflatoxin B, Daunorubicin Carcinogenic activity, monkey, 4545 Analytic method, plasma, 823 Alkaline phosphatase Gastrointestinal neoplasms Tumor tissue vs normal skin, human, 277 Phase I clinical trial, 823 Fetal globulins Phase 1 clinical trial Chemical/physical properties, 2006 Analytic method, plasma, 823 IgG Contact sensitization, 658 ss@k Leukocyte adherence inhibition ser Benzene,4-allyl-1,2-(methylenedioxy)- Diagnosis, 658 Salivary gland neoplasms Virus, Moloney murine sarcoma Virus, Gross murine leukemia Fetal globulins, 2006 Somatotropin, 415 Salmonella typhimurium Sarcoma, reticulum cell seealso Ames test Liquid suspension culture Benzo(a)pyrene Agar clonal culture, 1749 Metabolites, liver microsomes, 2660 Transplantation, homologous Mutagenic activity, Chinese hamster V79 cells Spontaneous tumor incidence, nude mouse, 833 2660 Sarcoma(s) Benzo(a)pyrene, 2-hydroxy Alloantibodies Metabolites, liver microsomes, 2660 RBC-binding, in vitro, 3363 Mutagenic activity, Chinese hamster V79 cells Amino acids 2660 Liver, mouse, 4657 Benzo(a)pyrene, 6-hydroxy Proteins, 4657 Metabolites, liver microsomes, 2660 RNA, ribosomal, 4657 Mutagenic activity, Chinese hamster V79 cells Anoxia 2660 Cell cycle kinetics, 1891 Carcinogens, chemical Antigens, neoplasm Histidine auxotrophs, 682 Characterization, 1683 Colonic neoplasms Antigens, nucleolar Hydrazine, 1,2-dimethyl, 2768 Immunofluorescence, 3024 Immune response, mouse, 2768 Butyric acid, sodium salt

DECEMBER 1979 5293 Subject Index to Volume39

Sarcoma(s) (cont'd) Serum albumin Interferon, 4720 Methotrexate Cholanthrene, 3-methyl Binding/activity, 1264 IgO, 4588 Methotrexate, 3',S-dichloro Immune response, 4034 Binding/activity, 1264 Cholesterol Serum proteins Growth, 4350 s@ Blood proteins Dietary fats Immune response, mouse, 4350 Slalic acid Fatty acids Melanoma(s) Growth, 4350 Patient surveillance, 5036 Histocompatibility antigens Plasma levels, 5036 Transplantation immunology, 2952 Thrombosis Hycanthone methanesulfonate Platelet aggregation, 2031 Histological study, mouse, 4491 IgO Sialyltransferase Immunoglobulins, Fc, 4588 Breast neoplasms Immunoglobulins, Fc Isolation and characterization, human serum, 1231 Macrophages, 4588 Colonic neoplasms Lymphocytes Adenocarcinoma(s), 1259 Immune response, mouse, 2711 Detergents Lysophosphatidylcholines Inhibitory activity, 1231 Phospholipid metabolism, 4681 Melanoma(s) Metastases Patient surveillance, 5036 Growth characteristics, 4575 Plasma levels, 5036 Microcirculation Nucleotide analogs Early tumor growth, 17 Inhibitory activity, 1231 Erythrocytes, 17 Nucleotide: sugar analogs Neoplasm transplantation Inhibitory activity, 1231 Cytotoxicity, immunologic, 2711 Nucleotides Immune response, mouse, 2711 Inhibitory activity, 1231 Nickel subsulfide Ovarian neoplasms Carcinogenic activity, mouse, in vivo, 4175 Serum levels, human, 1943 X-ray powder diffraction studies, 4175 Prednisolone Butyric acid, 4-[p.bis(2-chloroethyl)aminophenyl]- SKF 525A 4256 seeValeric acid, 2,2,-diphenyl-,2-(diethylamino)ethyles Cyclophosphamide, 4256 ter, HC L-Sarcolysin, 4256 Radiation, ionizing Cell cycle kinetics, 1891 Skin neoplasms Cell survival, 1891 N-Acetylmuramyl-L-alanyl(L-seryl)-D-isoglutamine Urea, hydroxy Endotoxins, bacterial, 4756 Cell cycle kinetics, 4407 Toxicity, guinea pig, 4756 Virus, bovine adeno 3 Adenosine 3':S'-monophosphate Angiogenesis factor, 1305 Mezerein, 4791 Virus, SV4O l2-O-Tetradecanoyl-phorbate-13-acetate, 4791 Histocompatibility antigens, 2952 Benz(a)anthracene, 7,12-dimethyl Sarcoma, Yoshida 12-O.Tetradecanoylphorbol-13-acetate, 419 Colony-stimulating factor Benz(a)anthracene, 7,12-dimethyl-2-fluoro Serum-free cell culture, 5127 Bcnz(a)anthracene, 7,12-dimethyl-5-fluoro-, 411 Leukemia, myelocytic Carcinogenicity, mouse, 411 Cell transformation, 5127 Benzo(a)pyrene Serum-free cell culture, 5127 Carcinogenic metabolite, 67 Dose-response study, mouse, 1718 Schwannoma Benzo(a)pyrene, 7,8-dihydro-9,10-epoxy-7,8,9,10- see Neurilemmoma tetrahydro Secretin Carcinogenic activity, mouse, 67 Pancreatic neoplasms Dekeratinization, 67 Adenosine cyclic 3':S'-monophosphate, 452 Carcinoma, epidermoid Ultraviolet rays, 408 Saline hydroxymethyltransferase Chalones Leukemia(s) Antitumor activity, mouse, in vivo, 239 Leukocytes, 3435 Purification, epidermal G chalone, 239 Lymphoma(s) Cynops pyrrhogaster Leukocytes, 3435 Neoplasm regression, spontaneous, 1904

5294 CANCERRESEARCHVOL.39 Subject Index to Volume39

Skin neoplasms (cont'd) Sodium saccharin Dibenz(a,h)anthracene Bladder neoplasms 12-O-Tetradecanoylphorbol-13-acetate, 1310 Formamide, N-[4-(5-nitro-2-furyl)-2.thiazolyl]- Dibenz(a,h)anthracene, l,2-dihydro-l,2-dihydroxy 1207 12-O-Tetradecanoylphorbol-13-acetate, 1310 Dibenz(a,h)anthracene, 3,4-dihydro-3,4-dihydroxy Somatotropin 12-O-Tetradecanoylphorbol-l3-acetate, 1310 Lactalbumin Dibenz(a,h)anthracene, 5,6-dihydro-5,6-dihydroxy Nude mouse, 2046 12-O.Tetradecanoylphorbol-13-acetate, 1310 Leukemia(s) Epidermodysplasia verruciformis Virus, Gross murine leukemia, 415 Virus, papilloma, 1074 Salivary gland neoplasms Bis(2,3-Epoxycyclopentyl)ether Virus, Gross murine leukemia, 415 Dose-response study, mouse, 1718 Virus, Gross murine leukemia Growth factors Immune response, 415 T-Lymphocytes, 415 Antitumor activity, mouse, in vivo, 239 Hyperthermia, localized Soot Radiotherapy, 2258 Salmonella typhimurium Mutagenic activity,hamster V79 cells Mutation assay, complex mixtures, 4152 Carcinogenicity, mouse, 411 Spermidine Ornithine decarboxylase Brain neoplasms Mezerein, 4791 l2-O-Tetradecanoyl-phorbate-13-acetate, 4791 Biochemical marker, neoplasms, human, 5010 Burkitt's lymphoma Pipiloma(s) Cell cycle kinetics, 2429 Benz(a)anthracene, 7,12-dimethyl-, 411, 419 Spermine Benz(a)anthracene, 7,12-dimethyl-Il-fluoro-, 411 Phorbol esters, 2036 Biochemical marker, neoplasms, human, 5010 12-O-Tetradecanoylphorbol-13-acetate, 2036 Spermine Ultrastructural study, Japanese newt, 1904 Burkitt's lymphoma m-Phenylenediamine Cell cycle kinetics, 2429 Dose-response study, mouse, 1718 Nicotinamide adenine dinucleotide Propane, 2,2-bis(p-glycidyloxyphenyl)- Nucleoproteins, 1382 Dose-response study, mouse, 1718 Polyadenosine diphosphate ribose Trehalose mycolate Normal/neoplastic/regenerating liver, rat, 1382 Endotoxins, bacterial, 4756 Spermidine Toxicity, guinea pig, 4756 Biochemical marker, neoplasms, human, 5010 Ultraviolet rays Spirohydantoin mustard Urea, 1,3-bis(2-chlorcethyl)-1-nitroso-, 408 Brain neoplasms Smoking Cell cycle kinetics, 4336 Benzo(a)pyrene DNA synthesis, 4336 Aryl hydrocarbon hydroxylases, 1199 Cell cycle kinetics Carcinogenic metabolites, 3177 Dose-response study, 4336 Placental metabolism, 3177 Radiation, ionizing Dimethylamine, N-nitroso Radiosensitivity, 4336 Urinary excretion, human, 829 Splenectomy Morpholine, N-nitroso Leukemia, hairy cell Urinary excretion, human, 829 5-Year survival rate, 2366 Sodium snide Plasmacytoma Cell transformation, chemical Immune response, mouse, 3783 Growth, 2718 Squalane Methotrexate Bacillus Calmette- Guerin Membrane transport, lymphoblasts, 2440 Vaccines, emulsified, 1518 Ozone Trehalose-6,6@-dimycolate Amestest, 2155 Vaccines, emulsified, 1518 Sodium butyrate Squalene .. see Butyric acid, sodium salt Bacillus Calmette- Guerin Sodium chloride Vaccines, emulsified, 1518 Carcinoma(s) Trehalose-6,6'-dimycolate Intratumoral injection with fine needle, rabbit Vaccines, emulsified, 1518 3429 Steroid hyÃ¢roxylases Hepatoma(s) Breast neoplasms Protein synthesis, rat, 1995 Carcinoma(s), 4584 Sodium Uthocholate Precancerous conditions, 4584 s@ 5@3-Cholan-24-oicacid, 3a-hydroxy-, monosodium Stomach neoplasms salt Adenocarcinoma(s)

DECEMBER1979 5295 Subject Index to Volume39

Stomach neoplasms (cont'd) Surgery Guanidine, N-methyl-N-nitro-N-nitroso-, 811 Adenocarcinoma(s) Arylamidase Cytokinetic parameters, in vivo, mouse, 3861 Immunological typing 4212 Mammary neoplasms, experimental Benz(a)anthracene, 7,12-dimethyl Cytokinetic parameters, in vivo, mouse, 3861 12-O.Tetradecanoylphorbol-l3-acetate, 1293 Synovioma Carcinoma(s) Case reports Alkaline phosphatase, 4732 Histogenesis, 4270 Prednisolone, 4732 Guanidine, N-methyl-N-nitro-N-nitroso T-2toxin New cell line, rat, 5141 Brain neoplasms Ultrastructural study, 5141 Histological study, rat, 2179 Vagotomy, 811 Digestive system neoplasms Metastases Histological study, rat, 2179 Vagotomy, 811 Heart neoplasms Neuraminidase Histological study, rat, 2179 Immunological typing 4212 Nicotinamide Carcinogenic activity, 2179 Streptodornase and streptokinase Tamoxifen Viral proteins Breast neoplasms Lymphocyte transformation, 443 Receptors, hormone, 1973 Streptovitacin A Teratocarcinoma Cell transformation, chemical Bone marrow Growth, 2718 Cytotoxicity of tumor cells, 30 Streptozotocin Teratoid tumor DNA repair Bacteriocins DNA alkylation damage, 82 Cell adhesion, 5114 Leukemia L12l0 Ovarian neoplasms Cytotoxicity, mouse, in vivo, 82 Chemotherapy, mouse, 3202, 3209 Mechanism of action, 82 TestiCUlarneoplasms Mammary neoplasms, experimental Bleomycin Adenosine cyclic 3':S'-monophosphate, 2501 Pulmonary function tests, 5076 Benz(a)anthracene, 7,12-dimethyl-, 2501 Nephrectomy Histone kinase, 2501 Parabiosed rats, 3971 Stress Macrophages sce Dirhodium(II), tetra-m-carboxylato Leukemia, Moloney murine, 2894 Tetracaine Sulfato-trana-(-)-1,2-diaminocyclohexane platin Cell transformation, chemical sce Platinum(II), sulfato-trans-(-)-1,2- Growth, 2718 diaminocyclohexane @@,,@,@Tefrachlorod1benzo-pdioxin Sulfhydryl compounds sor Dibenzo-p-dioxin, 2,3,7,8-tetrachloro Hyperthermia Cytotoxicity, 4630 12-O-Tetradecanoylphorbol-13-acetate Superoxide dismutase Manganese Actinomycin D Temperature sensitive mutants, 1579 Tumor mitochondria, review, 1141 Adenosine cyclic 3':S'-monophosphate Suppressor cells Plasminogen activators, 1579 Adenocarcinoma(s) Benz(a)anthracene, 3,4-dihydro-3,4-dihydroxy-7,12- Immune response, mouse, 4983 dimethyl Concanavalin A Skin neoplasms, 1934 T-Lymphocytes, 4372 Benz(a)anthracene, 7,12-dimethyl Fibrosarcoma(s) Co-carcinogenic effect, mouse, 1293 Immunogenetics, 2945 Ornithine decarboxylase, 419 Spleen, mouse, 2945 Stomach neoplasms, 1293 Histocompatibility antigens Benzo(a)pyrene Spleen, mouse, 2945 Metabolism, trachea, rat, 1980 Lymphocyte transformation Carcinoma, epidermoid Spleen, mouse, 2945 Tumor-promoting activity, skin, mouse, 2644 Macrophage inhibitory factor Cell transformation, viral Immune response, mouse, 4983 Embryocells,rat,3051 Urologic neoplasms Plasminogen activators, 1579 Lymph nodes, 4372 Cholera toxin Mitomycin C, 4372 Plasminogen activators, 1579

5296 CANCERRESEARCHVOL.39 Subject Index to Volume39

12-O-Tetradecanoylphorbol-13.acetate (cont'd) Choline Tosylphenylalaninechloromethyl ketone Phospholipids, 2743 Phospholipids, 2743 Colchicine Trachea Cell adhesion, 1989 Metabolism, organ/cell cultures, 1980 Phospholipids, 2743 Virus, Rous sarcoma Collagen Collagen, 1667 Cell transformation, viral, 1667 Plasminogen activators, 1579 3',S'-Cyclic AMP phosphodiesterase Epidermis, mouse, 2036 Cytochalasin B l-(Tetrahydro-2-furanyl).5-fluorouracjl Cell adhesion, 1989 Metabolism, human DNA synthesis Letter to the editor, 4289 Cells, cultured, 4477 Uracil-, 5-fluoro Fibroblasts, 4477 Plasma levels, 4289 Mixed lymphocyte culture blastogenesis, 4078 Erythroleukemia Cis(3-[p(1,2,3,4-tetrahydro-6-methoxy-2. Cell adhesion, 1989 see 1,2-Propanediol, 3-j*1,2,3,4-tetrahydro-6-methoxy. Cell differentiation, 1989 phenyl-l-naphthyl)phenoxy]-1,2@propanediol, 5043 GLucose, 2-deoxy Metabolism, in vitro vs in vivo, 714 Tetrahydrofolate dehydrogenase LETS protein Adriamycin Fibroblasts, chick embryo, 714 Drug sensitivity, 1937 Leukemia, myelocytic Hepatoma(s) Cell differentation, 4668 Methotrexate, 735 Phagocytosis, 4668 Leukemia L12l0 Lymphocytes Methotrexate, 2106 Mixed lymphocyte culture blastogenesis, 4078 Methotrexate Melanoma(s) Adriamycin resistance, 1937 Cell differentiation, 2618 Tetrabydrouridine Cell differentiation, neoplastic, 3915 Cytosine, 1-/3-D-arabinofuranosyl Mezerein Kidney cells, rat, 3981 Carcinogenesis, skin, mouse, 4791 DNA synthesis Ornithine decarboxylase Kidney cells, rat, 3981 Cells, cultured, 4477 Fibroblasts, 4477 Theophylline Papilloma(s) Cell transformation, neoplastic 3',5'-Cyclic AMP phosphodiesterase, 2036 Growth inhibition, mixed normal and malignant fi Tumor-promoting activity, skin, mouse, 2644 broblasts, 3502 Phorbol esters Thermotolerance Melanogenesis, mouse skin, 3915 Phospholipids see also Hyperthermia DNA synthesis Cell transformation, viral, 2743 HeLa cells, 2743 Cultures, exponentially growing vs plateau phase L cells,2743 981 Plasminogen activators Heat-conditioning Fibroblasts, chick embryo, 1579 Survival, Chinese hamster ovary cells, 2486 Platelet aggregation Hydrogen-ion concentration Correlation with tumor promotion, 3602 Lung cells, mouse, 2772 Prostaglandin synthetase, 3602 Mammary neoplasms, experimental Proline, 4-hydroxy Cultures, exponentially growing vs plateau phase Metabolism, fibroblasts, chick embryo, 1667 981 Retinoic acid X-rays S.Adenosyl-L-methionine decarboxylase, 419 Body temperature, 396 Ornithine decarboxylase, 419 Sensitivity, mammalian cells, 396 Polyamines, 419 6-Thioguanine Skin neoplasms see Purine-6(l H)-thione, 2-amino Adenosine 3':S'-monophosphate, 4791 Benz(a)anthracene, 7,12-dimethyl-, 419 6-Thioguanosine Dibenz(a,h)anthracene, 1310 2'-Deoxy-6-thioguanosine 5'-triphosphate Dibenz(a,h)anthracene, 1,2-dihydro-1,2-dihydroxy DNA synthesis, 3955 1310 Thiosemicarbazones Dibenz(a,h)anthracene, 3,4-dihydro-3,4-dihydroxy Carcinoma, Ehrlich tumor 1310 Ribonucleotide reductase, 4600 Dibenz(a,h)anthracene, 5,6-dihydro-5,6-dihydroxy 1310 Thiourea Ornithine decarboxylase, 4791 see Urea, thio

DECEMBER1979 5297 Subject Index to Volume39

Threonine Thymidylate synthetase (cont'd) Hepatoma(s) Uridine, 2'-deoxy-S-fluoro Protein synthesis, rat, 1995 Intracellular levels, hepatoma, rat, 3397 Uridine, 2'-deoxy-S-fluoro-, monophosphate Thrombocytopenia Radioassay, 2471 Chromosome aberrations Chromosome 20, human, 2984 Thymoma(s) Benz(a)anthracene, 7,12-dimethyl Thrombosis Virus, murine leukemia, 3080 Adenocarcinoma(s) Dexamethasone Platelet aggregation, 2031 Receptors, hormone, 4749 Adenosine diphosphate Receptors, hormone Platelet aggregation, 2031 Ristocetin Genes, structural, 4749 Hybrid cells, 4749 Platelet aggregation, 2031 Thymidine Sialic acid Cytotoxicity, mouse, in vivo/in vitro, 4856 Platelet aggregation, 2031 Virus, Gross murine leukemia Thymidine Precancerous conditions, 480 Carcinoma(s) Virus, murine leukemia Xenografts, nude mice, 3875 Isolation and characterization, 3080 Deoxyribonucleosides Virus replication, 3080 Leukemia(s), 3531 Fibroblasts Thyroid gland Cell transformation, viral, 1855 Metastases Leukemia, lymphoblastic Cell migration, 2698 Methotrexate, 3373 Poecilia formosa Melanoma(s) Metastases, 2698 Xenografts, nude mice, 3875 Radiation, ionizing Methotrexate Cell migration, 2698 Gonadotropins, chorionic, 1952 Ultraviolet rays Marrow recovery kinetics, human, 1315 Cell migration, 2698 Neoplasms Antitumor activity, 2928 Heterologous tumors, nude mouse, 2928 Thyroid neoplasms Pharmacokinetics, 4777 Phosphofructokinase Phase I clinical trial, 4777 Citrate, 2796 Ribonucbeosides Thyroidectomy Leukemia(s), 3531 Anemia, aplastic Thymoma Benz(a)anthracene, 7,l2-dimethyl-, 4252 Cytotoxicity, mouse, in vivo/in vitro, 4856 Benz(a)anthracene, 7,12-dimethyl Uridine, 2'-deoxy-S-fluoro Carcinogenesis, rat, 4252 Gonadotropins, chorionic, 1952 Leukemia(s) Virus, Rous sarcoma Benz(a)anthracene, 7,12-dimethyl-, 4252 Cell transformation, viral, 1855 Thyroxine Thymidine kinase Hepatoma(s) Breast neoplasms Short-term survival, rat, 2371 Dexamethasone, 2422 Leukemia(s) Uracil, 5-fluoro Antitumor activity, 4252 Cytotoxicity vs enzyme activity, human/mouse, in Sarcoma(s) vitro, 383 Tumor growth/metastases, mouse, 3515 Virus, herpes simplex 2 Phenotype, mouse, 1041 Tobacco Alcohol Thymidine labeling index Mechanisms of carcinogenesis, review, 2844 Breast neoplasms DNA synthesis Carcinoma(s), 4042 L/neoplastic cells, rat, mouse, 4802 Patient prognosis, 4042 Lymphocytes, human, 4802 Thymidine phosphorylase Head and neck neoplasms Uracil, 5-fluoro Alcohol, 2844 Cytotoxicity vs enzyme activity, human/mouse, in Nitrosamines vitro, 383 Analysis, side-stream/ mainstream smoke, 2505 Thymidylate synthetase @-Toluithne,4-chloro Hepatoma(s) DNA Methotrexate, 735 Microsomes, liver, rat, 2528 Uracil, 5-fluoro Proteins Inosine, 4905 Microsomes, liver, rat, 2528 Intracellular levels, hepatoma, rat, 3397 RNA

5298 CANCERRESEARCHVOL.39 Subject Index to Volume39

@-Toluidine,4-chloro- (cont'd) Transplantation, heterobogous (cont'd) Microsomes, liver, rat, 2528 Spontaneous tumor incidence, nude mouse, 833 m-Toluldlne, N,2%@dlmethyl-4-(phenylazo)- Transplantation, homologous Hepatoma(s) Adenocarcinoma(s) Barbituric acid, 5-ethyl-5-phenyl-, 112 I.v. injection, neoplastic cells, 4724 Histological study, rat, 112 Metastases,4724 Carcinoma, epidermoid o.Toluidine, 4-(o.tolyazo)- Iv. injection, neoplastic cells, 4724 Hepatoma(s) Metastases, 4724 a-Glutamyltranspeptidase, 3495 Fibrosarcoma(s) Tomography, ultrasound Human serum-adapted cells, mouse, 2376 Dosimetry, thermal Leukemia(s) Hyperthermia, 2325 Spontaneous tumor incidence, nude mouse, 833 Lung Tongue neoplasms Iv. injection, neoplastic cells, 4724 Bleomycin Lymphosarcoma(s) Necrosis,. 4645 Spontaneous tumor incidence, nude mouse, 833 Carcinoma(s) Papilboma(s) Bleomycin, 4645 Virus, Shope papilloma, 273 Tosylarginine methyl ester Sarcoma, reticulum cell Bone marrow Spontaneous tumor incidence, nude mouse, 833 Tumor-induced cytotoxicity, 1193 Virus, Shope papilboma Nude mouse, 273 Tosylline chloromethyl ketone Bone marrow Transplantation immunology Tumor-induced cytotoxicity, 1193 Antigens, neoplasm Virus, Kirsten murine sarcoma Immune response, hamster, 459 Virus activation, 2995 Cobonic neoplasms Carbamic acid, methylnitroso-, ethyl ester, 1174 Tosylphenylalanine chboromethyl ketone Histocompatibility antigens, I 174 Bone marrow Hydrazine, 1,2-dimethyl-, 1174 Tumor-induced cytotoxicity, 1193 Dexamethasone l2-O-Tetradecanoylphorbol-13-acetate Nude mouse, 3167 Phospholipids, 2743 Glomerulonephritis Toyoeyamycin Ultrastructural study, kidney, hamster, 459 see4-Amino-5-cyano-7($-D-ribofuranosyl)pyrrolo(2,3-d)- Leukemia, myelocytic pyrimidine Lipopolysaccharides, 3167 Leukocyte adherence inhibition Trachea Antigens, neoplasm, 582 Benzo(a)pyrene Lipopolysaccharides Metabolism, organ/cell cultures, 1980 Nude mouse, 3167 Tracheal neoplasms Lung neoplasms Epithelial focus-forming unit Hyperthermia, 1126 In vitro assay, 4003 T-Lymphocytes, 1126 Carcinogenesis, rat, in vivo, 4003 Nude mouse, 1126 Glycerolipids Radiation, ionizing 1126 Phospholipids, 207 T-Lymphocytes Newborn/weanling hamster, 4949 Transformation, viral Neuroblastoma(s) Virus, Rous sarcoma Administration route, 3277 Antigen, neoplasm, 4744 Papilboma(s) Transplantation, heterobogous Nude mouse, 273 Sarcoma(s) Cobonic neoplasms Adenocarcinoma(s), 833 Histocompatibility antigens, 2952 Antibody-dependent cell cytotoxicity, 2160 Thymectomy Carcinoembryonic antigen, 2160 Newborn/weanling hamster, 4949 Nudemouse, 2160 Virus, adeno 2 Spontaneous tumor incidence, nude mouse, 833 Age factors, hamster, 1455 Hepatoma(s) Virus, adeno 12 Age factors, hamster, 1455 Alpha fetoproteins, 1819 Blood proteins, 1819 Virus, SV4O Age factors, hamster, 1455 Nudemouse, 1819 Lactalbumin Histocompatibility antigens, 2952 Nude mouse, 2046 Trehalose-6,6'-dimycolate Mammae Mineral oil Nude mouse, 2046 Vaccines, emulsified, 1518 Urogenital neoplasms Peanut oil

DECEMBER1979 5299 Subject Index to Volume39

Trehalose-6,6'-dimycolate (cont'd) Tyrosinase (cont'd) Vaccines, emulsified, 1518 Diagnostic marker, 3485 Skin neoplasms Metastases, 3485 Endotoxins, bacterial, 4756 Toxicity, guinea pig, 4756 TyrOSine, acetyldehydro-3-(2-furyl)alanyl Squalane Lactate dehydrogenase Antitumor activity, mouse, 1518 Macrophage cytotoxicity, I847 Vaccines, emulsified, 1518 Tyrosine, acetyldehydro-3-(2-thienyl)alanyl Squalene Lactate dehydrogenase Antitumor activity, mouse, 15 18 Macrophage cytotoxicity, 1847 Vaccines, emulsified, 1518 Tyrosine aminotransferase Triamcinolone acetonide Hepatoma(s) Leukemia L1210 Adrenalectomy, 2988 Growth inhibition, 3258 Pyridoxine, 2988 1,3,5-Triazin-2(1Th-one, 4-amino-1j3-D-ribofuranosyl- Proteus mirabilis Ultraviolet rays GluCO@Orticoidamplifying factor, 3258 Ornithine decarboxylase, 1035 Pyridoxine Inactivation, liver, rat, 2988 Triazinate Carboxypeptidase G Ultramicrospectrophotometr@@ Synergistic activity, rat, in vitro/in vivo, 3441 Neoplasms Carcinoma, Walker 256 Review, 2341 Carboxypeptidase G, 3441 Ultrasonics NTrifluoroacetyladriamycin-14-valerate Mammary neoplasms, experimental see Adriamycin, N-trifluoroacetyl-, valeric acid Hyperthermia, 2166 Triglycerides Ultraviolet rays Carcinoma, Ehrlich tumor Acetamide, N-(acetyboxy)-N-fluoren-2-yl Metabolism, 51 18 DNA repair, 471 S.Adenosylmethionine decarboxylase Triiodothyronine Nude mouse, 1035 Glucosamine 6-phosphate synthetase Adriamycin Regenerating liver, rat, 2783 DNA repair, 1321 Tryptophan Caffeine Bladder neoplasms DNA repair, 4975 Formamide, N-[4-(5-nitro-2-furyl)-2-thiazolyl]- Lethality, CHO-KI cells, 4975 1207 Purines, 4975 Hepatoma(s) Cell transformation, neoplastic Protein synthesis, rat, 1995 Acetamide,N-fluoren-2-yl, 3903 Dose-response study, 1474 Tubercidin Mouse 3T3 cells, 1474 sec 4-Amino-7(J3-D-ribofuranosyl)pyrrolo(2,3-c@pyrimi. Chromosome aberrations dine Mucosal cells, Chinese hamster, 2510 Tubulin Synchronized hamster embryo cells, 2356 Vincristine Cockayne's syndrome Aggregation, 1604 DNA repair, 4237 DNA synthesis, 4237 Tumor-associated antigen Cycloheximide see also Antigens, neoplasm Ornithine decarboxylase, 1035 Mammary neoplasms, experimental DNA Immunity, cellular, 35 Synchronized hamster embryo cells, 2356 Tumor-associated transplantation antigens DNA repair see Histocompatibility antigens Aging, 2792 Cardiac cells, rat, 1321 Tumor-specific transplantation antigen Fibroblasts, in vitro, human, 2522 seeHistocompatibility antigens Fibroblasts Tyrosinase Xeroderma pigmentosum, 471 Benzene, 4-hydroxy-, â€˜y-L-glutaminyl- Ornithine decarboxylase Cytotoxicity, 1494 DNA synthesis, 1035 Quinone metabolite, 1490 Nude mouse, 1035 Breast neoplasms Protease inhibitors Metastases, 3485 Mutagenic activity, hamster, 2755 Melanoma Skin neoplasms Metastases, 3485 Carcinoma, epidermoid, 408 Metastases Urea, 1,3-bis(2-chborcethyl)-l-nitroso-, 408 Serum levels, human, 3485 Thyroid gland Neoplasms Cell migration, 2698

5300 CANCERRESEARCHVOL. 39 Subject Index to Volume39

Ultraviolet rays (cont'd) Uracib, 5-fluoro- (cont'd) 1,3,5-Triazin-2(lH)-one, 4-amino-l/3-D-ribofuranosyl Thymidylate synthetase Ornithine decarboxylase, 1035 Intracellular levels, hepatoma, rat, 3397 Urea, 1,3-bis(2-chboroethyl)-l-nitroso Uridine, 2'-deoxy-S-fluoro-, monophosphate Co-carcinogenic activity, mouse, 408 Gastrointestinal tissue, mouse, 2406 Uridine, 5-bromo-2'-deoxy LD50, mouse, 2406 Synchronized hamster embryo cells, 2356 Uridine phosphorylase Virus, adeno 2 Cytotoxicity vs enzyme activity, human/mouse, in Cell transformation, viral, 1455 vitro, 383 Xeroderma pigmentosum X-rays DNA repair,471 Cell cycle synchronization, 3763 Uracil, 1-/3-D-arabinofuranosyl Cytotoxicity, L-cells, 3763 DNA synthesis Mechanism of action, in vitro, I 102 Uracil, 5-fluoro-1-(tetrahydro-2-furyl)- Methotrexate Urine Serum levels, mouse, 4048 Hydroxylated metabolites, 3199 Ursdil.DNA glycosylase Uracil nucleotides Actinomycin D Leukemia Ll210 Polyribonucleotide synthetases, 2090 Cycboheximide Aspartic acid, N-(phosphonoacetyl)-, 3089 Lung neoplasms Polyribonucleotide synthetases, 2090 Aspartic acid, N-(phosphonoacetyl)-, 3089 Polyribonucleotide synthetases Lymphocyte transformation, 2090 Uracil, 6-propyl-2-thio Uracil, 5-fluoro Hepatoma(s) Breast neoplasms Short-term survival, rat, 2371 Dose-response study, 1552 Cycbophosphamide Urea, 1,3-bis(2-chloroethyl)-1-nitroso DNA synthesis, 1396 Therapeutic synergism, 1396 Ames test DNA synthesis Mutagenic activity, 1328 Bone marrow/intestine, mouse, 1396 Bone marrow Fluorouridine kinase Cytotoxicity, in vitro, mouse, 2547 Tumor-induced cytotoxicity, 1193 Cytotoxicity vs enzyme activity, human/mouse, in vitro, 383 Cobonic neoplasms FUra phosphoribosyltransferase Cytotoxicity, human, in vitro, 2630 Cytotoxicity vs enzyme activity, human/mouse, in Hyperthermia vitro, 383 Bone marrow, 2547 Hepatoma(s) Cytotoxicity, in vitro, mouse, 2547 Hyperthermia, localized Metabolism, drug-resistant cell line, 4905 Inosine Cytotoxicity in vitro/in vivo, 2269 Cytidine, deoxy-, 4905 Hyperthermia, systemic Metabolism, drug-resistant cell line, 4905 Cytotoxicity in vitro/in vivo, 2269 Thymidylate synthetase, 4905 In vitro vs in vivo activity, mouse/human, 402 Leukemia L12l0 Leukemia Ll210 Cyclophosphamide, 1396 Antitumor activity, 1328 Metabolites, 3397 Leukemia, Moboney murine Mammary neoplasms, experimental Immunosuppression, 2894 Carcinoma(s), 4466 Skin neoplasms Poly(A)RNA Ultraviolet rays, 408 Regenerating liver, rat, 3694 Structure-activity relationship H-Pyrazolo(3,4-d)pyrimidin-4@ol Toxicity, mouse, 1328 Inhibition of cytotoxicity, 3095 Ultraviolet rays Orotidine-S'phosphate decarboxylase, 3095 Co-carcinogenic activity, mouse, 408 RNA Urea, 1-(2-chboroethyl)-3-cycbohexyl-1-nitroso Gastrointestinal tissue, mouse, 2406 Binding, nonhistone chromosome proteins Intracellular levels, hepatoma, rat, 3397 HeLacells, 1411 LD,0, mouse, 2406 Histones RNA synthesis DNA alkylation, 1411 Regenerating liver, rat, 3694 HeLacells, 1411 l-(Tetrahydro-2.furanyl).5-fiuorouracil Poly ADP ribose polymerase Plasma levels, 4289 HeLacells, 1411 Thymidine kinase Cytotoxicity vs enzyme activity, human/mouse, in Urea, 1-(2-chloroethyl)-3-(4-methylcycbohexyl)..nitroso.. vitro, 383 Melanoma(s) Thymidine phosphorylase Antigen-antibody reactions, 4472 Cytotoxicity vs enzyme activity, human/mouse, in Antitumor activity, mouse, 934 vitro, 383 Hypersensitivity, delayed, 4472

DECEMBER1979 5301 Subject Index to Volume39

Urea, 1-(2-chboroethyl)-3-(trans-4-methylcycbohexyl)-1-nitro Urea, Nmethyl-P@nitroso- (cont'd) Cytochrome P450 Neuroblastoma(s) Metabolism, liver microsomes, rat, 762 Radiation, ionizing 519 Metabolism, liver microsomes, rat Nucleoproteins Cytostatic metabolites, 762 Binding, tumor cells, 923 Organic synthesis, 762 HeLa cells, 1405 Urea, 1-(chboroethyl)-1-nitroso Plasma membrane Ames test Ultrastructural study, urinary bladder, rat, 3757 Mutagenic activity, 1328 Poly ADP ribose polymerase Structure-activity relationship HeLa cells,1405,1411 Toxicity, mouse, 1328 Purine, 2-amino-6-methoxy DNA repair,1041 Urea, 3-/3-D-glucopyranosyl-1-methyl-1-nitroso Virus, herpes simplex 2 DNA repair Cell transformation, biochemical, 1041 DNA alkylation damage, 82 DNA repair,1041 Leukemia L1210 Cytotoxicity, mouse, in vivo, 82 Mechanism of action, 82 Urea, nitroso Urea, hydroxy Leukopenia Cell cycle Thrombocytopenia, 4540 Synchronized hamster embryo cells, 2356 Choriocarcinoma Gonadotropins, chorionic, 1952 Urea, N@nitroso-N@propyl Leukemia L1210 Ames test Cytokinetics, 1616 Mutagenic activity, 1328 Dose-response study, 1616 Related compounds, 844 Sarcoma(s) Urea, thio Cell cycle kinetics, 4407 L-Phenylalanine mustard Urea, ]%@methyl-N-aryl-N-methyl-nitroso DNA interstrand crosslinks, 4989 4-(p.Nitrobenzyl)pyridine Leukemia Ll210, 4989 Salmonella typhimurium, 5147 Platinum(II), diamminedichboro-, cia DNA interstrand crosslinks, 4989 Urea, N@methyl-N-aryl-JV@nitroso Leukemia Ll210, 4989 4-(p-Nitrobenzyl)pyridine Platinum(II), diamminedichboro-, trans. Salmonella typhimurium, 5147 DNA interstrand crosslinks, 4989 Urea, J%@methyl-JV@nltroso Leukemia Ll210, 4989 Ames test Mutagenic activity. 1328 Binding, nonhistone chromosome proteins Urethan HeLa cells,1405. 1411 see Carbamic acid, ethyl ester Deoxyribonuclease Brain cell nuclei, rat, 2675 DNA Uridine Lymphocytes, 3524 Dichloroallyl lawsone DNA repair Dihydroorotate dehydrogenase, 4868 Brain cell nuclei, rat, 2675 Lymphoma(s) Epithelium Phosphorylation inhibitors, 3102 Ultrastructural study, urinary bladder, rat, 3757 Guanine, 7-methyl DNA repair,1041 Uridine, 5-bromo-2'-deoxy HeLa cells Chromosome aberrations Immunoreactivity, in vitro, 3524 Synchronized hamster embryo cells, 2356 Histones Cytosine, l-/3-D-arabinofuranosyl Binding, tumor cells, 923 DNA repair,1814 DNA alkylation, 1411 DNA HeLacells, 1405, 1411 Synchronized hamster embryo cells, 2356 Leukemia L12l0 Radiosensitization Fibroblasts, mouse, in vitro, 244 Antitumor activity, 1328 Ultraviolet rays Histones, 923 Synchronized hamster embryo cells, 2356 Nucleoproteins, 923 X-rays Lymphocytes Immunoreactivity, in vitro, 3524 Fibroblasts, mouse, in vitro, 244 Mammary neoplasms, experimental Uridine-cytosine kinase Retinamide, N-(4-hydroxyphenyl)-, 1339 Lymphoma(s) Retinol acetate, I339 Isolation and characterization, human, 3102

5302 CANCERRESEARCHVOL.39 Subject Index to Volume39

Uridine, 2'-deoxy-S-fluoro Urobogic Diseases (cont'd) Choriocarcinoma Neoplasms Gonadotropins, chorionic, 1952 Glycoprotein EDCI, 699 Leukemia L1210 Proteins Metabolites, 3397 Radioimmunoassay, 699 RNA Urinary excretion, 699 Gastrointestinal tissue, mouse, 2406 Intracellular levels, hepatoma, rat, 3397 LD,,, mouse, 2406 Urologic neoplasms Thymidine Concanavalin A Gonadotropins, chorionic, 1952 Lymph nodes, 4372 Thymidylate synthetase T-Lymphocytes, 4372 Intracellular levels, hepatoma, rat, 3397 Lymph nodes Uridine, 2'-deoxy-S-fluoro-, monophosphate Suppressor cells, 4372 Gastrointestinal tissue, mouse, 2406 T-Lymphocytes LD,,,, mouse, 2406 Mitomycin C, 4372 Uridine, 2'-deoxy-S-fluoro-, monophosphate Suppressor cells Thymidylate synthetase Mitomycin C, 4372 Radioassay, 2471 Vaccines Uracil, 5-fluoro Bacillus Calmette- Guerin Gastrointestinal tissue, mouse, 2406 Antitumor activity, rat, in vivo, 959 LD,@, mouse, 2406 Immune response, rat, 959 Uridine, 2'-deoxy-S-fluoro Gastrointestinal tissue, mouse, 2406 Leukemia L1210 LD,, mouse, 2406 Concanavalin A, 2807 Uridine, 5-fluoro Immunotherapy, 2807 Gastrointestinal tissue, mouse, 2406 Lung neoplasms LD,@,,mouse, 2406 Autobogous tumor cell preparations, human, 3276 Uridine, 2'-deoxy-5-iodo Letter to the editor, 3276 Virus, AKR murine leukemia DNA-RNA hybridization, 1539 Valeric acid, 2,2,-diphenyl-, 2-(diethylamino)ethyl ester, HCI Virus, Kirsten murine sarcoma Aryl hydrocarbon hydroxylases Protease inhibitors, 2995 Lymphocytes, mitogen-stimulated, 4620 Uridine, 5-fluoro Venereal tumor Cell transformation, neoplastic Blocking factor, serum, dog DNA synthesis, 4516 Isolation and characterization, 3920 RNA Gastrointestinal tissue, mouse, 2406 Vinblastine LD@,,,mouse, 2406 Bleomycin Uridine, 2'-deoxy-S-fluoro-, monophosphate Toxicity, 5076 Gastrointestinal tissue, mouse, 2406 Glycoproteins LD,@,,mouse, 2406 Drug resistance, 2070 Leukemia(s) Uridine phosphorylase Drug resistance, 2070 Uracil, 5-fluoro Glycoproteins, 2070 Cytotoxicity vs enzyme activity, human/mouse, in Melanoma(s) vitro, 383 Immunologic capping, 2125 Urine In vitro vs in vivo activity, mouse/human, 402 Uracil, 5-fluoro-l-(tetrahydro-2-furyl)- Vincristine Hydroxylated metabolites, 3199 Adriamycin Urogastrone Synergistic activity, rat, 1071 Receptors, hormone Amphotericin B Fibroblasts, Syrian hamster embryo, 4166 Drug resistance, mouse, 2041 Leukemia L12l0 UrOgenital neoplasms Synergistic activity, 2106 Leukocytes Leukemia L5222 Lymphocytes, 840 Adriamycin, 1071 Radiotherapy Methotrexate Lymphocytes, 840 Synergistic activity, 2106 Post-therapy blood levels, 840 Microtubules Transplantation, heterobogous Spiral formation, brain tissue, bovine, 1604 Spontaneous tumor incidence, nude mouse, 833 Proteins Urologic diseases Microtubules, 1604 Leukocytes Tubulin Cell migration inhibition, 1985 Aggregation, 1604

DECEMBER1979 5303 Subject Index to Volume39

Vincristine sulfate Virus, adeno group B Leukemia Ll210 DNA, neoplasm Cytotoxic thresholds, 4346 Hybridization studies, human/hamster, 3479 Leukemia, lymphoblastic DNA, viral Cytotoxic thresholds, 4346 Hybridization studies, human/hamster, 3479 Viral proteins Neoplasms Lymphocyte transformation DNA viral sequences, 3479 Candida a/bicans 443 Virus, AKR murine leukemia Streptodornase and streptokinase, 443 Leukemia, lymphocytic Virus, feline leukemia Amphotericin B, 2041 Immune response, cat, 950 RNA, viral Immunosuppression, 950 DNA synthesis, 1539 Immunosuppressive activity, interspecies, 443 Uridine, 2'-deoxy-S-iodo Lymphocyte transformation, 443 DNA-RNA hybridization, 1539 Receptors, concanavalin A, 443 DNA synthesis, 1539 Virus, feline sarcoma Virus activation, 1539 Viral vaccines, 950 Virus, B77 Viral vaccines Fibronectin Virus, feline leukemia Cell transformation, viral, 1803 Immune response, cat, 950 Temperature sensitive mutants, I803 Immunosuppression, 950 Virus, feline sarcoma Virus, bovine adeno 3 Viral proteins, 950 Adrenal cortex hormones Angiogenesis factor, 1305 Virus activation Angiogenesis factor Virus, Kirsten murine sarcoma Cell transformation, viral, 1305 Antipain, 2995 Chorioallantoic membrane, 1305 Leupeptin, 2995 DNA, viral Protease inhibitors, 2995 Angiogenesis factor, 1305 N-a-Tosyl-L-lysine chboromethyl ketone, 2995 Hepatoma(s) Virus, adeno 2 Angiogenesis factor, 1305 Transplantation immunology Lung neoplasms Age factors, hamster, 1455 Angiogenesis factor, 1305 Ultraviolet rays Sarcoma(s) Cell transformation, viral, 1455 Angiogenesis factor, 1305 Virus, adeno 5 Virus, bovine leukemia Agglutination Antibodies, viral Embryo cells, rat, 3051 Milk/serum levels, cow/sheep, 1118 Benz(a)anthracene, 7,12-dimethyl Antigens, viral Cell transformation, viral, 3051 Immunoperoxidase assay, 3952 Benzo(a)pyrene Lymphosarcoma(s) Cell transformation, viral, 3051 Antibodies, viral, I 118 Cell transformation, viral Virus, C-type RNA tumor Temperature sensitive mutants, 3051 Leukemia, myeloblastic Membrane proteins Reverse transcriptase, 2063 Embryo cells, rat, 3051 Leukemia, myelocytic Plasminogen activators Reverse transcriptase, 2063 Embryo cells, rat, 3051 Lymphoma(s) Virus, adeno 7 Murine fibrotropic isolate, 4322 Antimony Placental basal plate, monkey/baboon Co-carcinogenic effect, metal salts, 193 Ultrastructural study, 1772 Arsenic Radiation, ionizing Co-carcinogenic effect, metal salts, 193 Virus replication, 4322 Cadmium Virus replication Co-carcinogenic effect, metal salts, 193 Bone marrow, 4322 Cell transformation, viral Virus, cytomegabo Co-carcinogenic effect, metal salts, 193 Ornithine decarboxylase Chromium Embryo cells, human, 864 Co-carcinogenic effect, metal salts, 193 Polyamines Platinum Co-carcinogenic effect, metal salts, 193 Embryo cells, human, 864 Putrescine Virus,adeno12 Embryo cells, human, 864 Transplantation immunology Spermidine Age factors, hamster, 1455 Embryo cells, human, 864

5304 CANCER RESEARCH VOL.39 Subject Index to Volume39

Virus, feline leukemia Virus, Gross murine leukemia (cont'd) Antibodies, neoplasm Thymoma Immune response, cat, 75 Precancerous conditions, 480 Antigen-antibody reactions Infectivity, human cell, 3388 Virus, herpes simplex 1 Complement DNA repair Immune response, cat, 75 Bloom's syndrome, 3392 Histocompatibility antigens Ultraviolet rays Infectivity, human cell, 3388 Bloom's syndrome, 3392 Leukemia, feline Virus, herpes simplex 2 Clinical and pathological characteristics, 3866 Cervix neoplasms Epidemiology, 3866 Serum antibody levels, patients, 4022 Lymphocytes Chromosomes Receptors, concanavalin A, 956 Cell transformation, viral, 3225 Lymphoma, feline DNA, viral Clinical and pathological characteristics, 3866 Nucleic acid hybridization, 3225 Epidemiology, 3866 Guanine, 7-methyl Methylprednisobone acetate DNA repair, 1041 Leukemogenesis, cat, 3789 Lymphocyte transformation Resistance to infection, cat, 3789 Immune response, hamster, 3996 Receptors, concanavalin A Polypeptides Immunologic capping, 956 Cell transformation, viral, 3225 Viral proteins Purine, 2-amino-6-methoxy Immune response, cat, 950 DNA repair, 1041 Immunosuppression, 950 Thymidine kinase Immunosuppressive activity, interspecies, 443 Phenotype, mouse, 1041 Lymphocyte transformation, 443 Urea, N-methyl-N-nitroso Receptors, concanavalin A, 443 Cell transformation, biochemical, 1041 Viral vaccines DNA repair, 1041 Immune response, cat, 950 Immunosuppression, 950 Virus, Kirsten murine sarcoma Antipain Virus, feline sarcoma Virus activation, 2995 Viral proteins Cycboheximide Viral vaccines, 950 Protease inhibitors, 2995 Virus, Friend marine leukemia Histidinol Erythroleukemia Protease inhibitors, 2995 Thymectomy, 1611 Leupeptin Leukemia, lymphocytic Virus activation, 2995 Cell-free spleen extract, 1611 N-a-Tosyl-L-lysine chboromethyl ketone Leukemia, myelocytic Virus activation, 2995 Cell-free spleen extract, 1611 Uridine, 2'-deoxy-5-iodo T-Lymphocytes Protease inhibitors, 2995 Lymphocyte depletion, 1611 Virus activation Protease inhibitors, 2995 Virus, Friend spleen focus-forming Erythropoietin Virus, Mason-Pfizer monkey Heme, 1841 Breast neoplasms Reverse transcriptase, 1841 RNA, viral, S106 Heme DNA, viral Erythropoiesis, 1841 Placenta, 1696 Virus, Gross murine leukemia Placenta Leukemia(s) Transmission, vertical, 1696 RNA, viral T-Lymphocytes, 415 Somatotropin, 415 DNA-RNA hybridization, 1696 T-Lymphocytes Placenta, 1696 Concanavalin A, 480 Virus, Moboney murine leukemia Cortisone, 480 Antigens, neoplasm Graft vs host reaction, 480 Immune spleen cells, infected mouse, 4887 Immune response, AKR mice, 480 Antigens, viral Precancerous conditions Immune spleen cells, infected mouse, 4887 Immune response, AKR mice, 480 Migration inhibitory factor Salivary gland neoplasms Immune response, mouse, 4887 Somatotropin, 415 Immune spleen cells, infected mouse, 4887 Somatotropin RNA, viral Immune response, 415 Hybridization studies, normal/leukemic cells, hu T-Lymphocytes, 415 man, 2532

DECEMBER1979 5305 Subject Index to Volume39

Virus, Moboney munne sarcoma Virus, Rous sarcoma (cont'd) Sarcoma, osteogenic Cell transformation, viral, 1855 Fetal globulins, 2006 Plasminogen activators Virus, murine leukemia Temperature sensitive mutants, 1579 Protein arginine methyltransferase Lymphoma(s) Cell transformation, viral, 4497 Thymus gland, rat, 3749 l2-O@Tetradecanoylphorbol-l3-acetate Radiation, ionizing Virus activation, 4322 Collagen, 1667 Plasminogen activators, 1579 RNA, messenger Thymidine Embryo cells, mouse, 321 Cell transformation, viral, 1855 Polyribosomes, 321 RNA, viral Virus, Shope papilloma Cell transformation, neoplastic, 321 Papilboma(s) Embryo cells, mouse, 321 Transplantation, homologous, 273 Thymus neoplasms Transplantation, homologous Isolation and characterization, 3080 Nude mouse, 273 Virus replication, 3080 Virus, 5V40 Virus, murine mammary tumor Bacteriocins Breast neoplasms Cell transformation, viral, 5114 RNA, viral, 5106 Cell transformation, neoplastic Concanavali n A Proteins,2595 Oligosaccharides, 199 Fibronectin Immunologic deficiency syndromes Cell transformation, viral, 2077 Antigens, viral, 1529 Fibrosarcoma(s) Mammary neoplasms, experimental IgG, 2919 Immunologic deficiency syndromes, 1529 Immune complex, 2919 Oligosaccharides Radioimmune assay; sera, hamster, 2919 Cell membrane, 199 Histocompatibility antigens Ferritin, 199 Transplantation immunology, 2952 Plant agglutinins Procollagen Ferritin, 199 Cell transformation, viral, 2077 Virus, papilboma Sarcoma(s) Histocompatibility antigens, 2952 Epidermodyspbasia verruciformis Transplantation immunology DNA-RNA hybridization, 1074 Age factors, hamster, 1455 Virus, Rauscher murine leukemia Viruses, type C Guanine, 9-/3-D-arabinofuranosyl-, 5'-triphosphate Hormones DNA polymerases, 4673 Normal physiology, review, 2902 Leukemia, myebocytic Immunity Cell differentiation, 1056 Normal physiology, review, 2902 Virus replication Thymus neoplasms Virus, murine leukemia, 3080 Vitamin A Virus, C-type RNA tumor sec Retinol Bone marrow, 4322 Radiation, ionizing 4322 Vitamin A analogs see Retinoids Virus, RNA tumor Hormones Vitamin B Normal physiology, review, 2902 seePyridoxine Immunity Normal physiology, review, 2902 VP16 seeEpipodophyllotoxin,4'-demethyl-,9- Virus, Rous sarcoma (4,6-O.ethylidene-/3-D-glucopyranoside) Antigen, neoplasm Transformation, viral, 4744 Water pollutants, chemical Butyric acid, 2-amino-4-mercapto Ozone Cell transformation, viral, 4497 Carcinogenic/mutagenic activity, 2149 Carbohydrates Mutagenic activity, 2155 Fibroblasts, chick embryo, 2550 Wy-14,653 Collagen see 4-[Chboro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic Cell transformation, viral, 1667 acid Hypoxanthine Cell transformation, viral, 1855 X-rays Leukocyte adherence inhibition Thermotolerance Immunity, cellular, 593 Body temperature, 396 Methotrexate Sensitivity, mammalian cells, 396

5306 CANCERRESEARCHVOL.39 Subject Index to Volume39

X-rays (cont'd) Xeroderma pigmentosum (cont'd) Uracil, 5-fluoro Cell cycle synchronization, 3763 Virus, SV4O Cytotoxicity, L-cells, 3763 Cell transformation, 4064 Xanthlne, 3-isobutyl-1-methyl Cell transformation, neoplastic Growth inhibition, mixed normal and malignant fi broblasts, 3502 Carcinoma, Ehrlich tumor Xenograft DNA, 2457 see Transplantation, heterologous Glycolysis, 2457 Xeroderma pigmentosum Oxidative phosphorylation, 2457 Acetamide, N-(acetyloxy)-N-fluoren-2-yl- RNA, 2457 DNA repair, 471 Tumor growth, in vivo, mouse, 2451 Ultraviolet rays DNA repair, 471 Ultrastructural study, 2457 Virus, SV4O, 4064 Uptake, cultured cells, 2451

DECEMBER1979 5307 Contents of Volume 39, 1979

January, Number 1

1 Ef$scts of Dose and SchduI of Immun. Stimulant 90 Inhibition of Sugar Uptake by Methotrexats in Cul 199 Strain-related Variation in the Interaction of Ferritin on Efficacy of Combination Corynebactarium par tured Ehrllch Ascftss Carcinoma Cells. Edvardas conjugated Plant Lectina with Mouse Mammary vum-Cyclophosphamids Trsatmsnt for a Murina Kaminskas. Tumor vIruses. Douglas C. Hisson, James M. Mammary Adnocarclnoma. Dallas M. Purnell. 96 Photodynamlc Killing of Rstinoblastoma Cells wIth Bowen, Yuli Ohtsuki, Michael Scanlon, and Leon Gerald L. Bartlett, and John W. Kreider. Dmochowski. Hematoporphyrin and Light. Theodore W. Sery. 6 Effsct of Hapten plus Antlhaptsn-Tumor Serum 207 MetabolIsm of Ether-linked Glycerolipids In Cuftures 101 in Vitro Synthesis and Secretion of Albumin by Mor Trestmnt on Established Rat Fibrosarcoma. Kazu of Normal and Neoplastic Rat Respiratory Tract na Hepatomas 5123C and 7800. C. M. Redman, S. Epithellum. Christina C. Scott, C Ariste Heckman, hiko Aral. John S. Spencer. Mm Sohn. and Herbert Yu, 0. Banerjee, and H. P. Morris. w_Wallace. Paul Netteaheim, and Fred Snyder. 112 Promotion by Dietary Phenobarbital of Hepatocarci 215 Splenic Granulopoiesia in Mice following Adminis 17 lismodynamlc Charactsrlatics in Microcirculatory nog.nesis by 2-Methyl.N,N-dlmethyl-4-aminoazo tration of Cyclophosphamide. Robert A. Joyce. Blood Channels during Early Tumor Growth. benzene in the Rat. Tomo Kitagawa, Henry C. Pitot, Oliver Hartmann, and Paul A. Chervenick. Bernhard Endrtch. Marcos Inlaglietta. Huibert S. Elizabeth C. Miller, and James A. Miller. Reinhold. and Joseph F. Gross. * 219 Recall Antigen Delayed-type HypersensItivIty Skin 116 Two-DimensIonal Gel Electrophoresis of Cytosol TestIng In Melanoma and Acute Leukemia PatIents 24 Autoradlographlc cytoi@lneticsof Colonic Mucosal Phosphoproteina of Novikoff Hepatoma and R.gen and Their Associates. Dexter L. Morris, Evan M. Hypsrplasl. In MIce. Stephen W. Barthold. crating LIver. Benlamin C. Wu, William H. Spohn, and Hersh, Bartholomew P. Hsi, Jordan U. Gutlerman. 30 Bone Marrow Cytolysis Induced by Hepatoma, Tsr@ Harris Busch. Martha M. Marshall, and Giora M. Mavligit. atocarcinoma, and Transformed Flbroblasta. Rita 123 TransformatIon of MOuseC3H/1OT% Cells by Single * 227 BandIng Studies of Chromosomal Abnormalities in Marie Lysik. Kenneth Cornelta. John F. DiSlefano, and FractIonated Doses of X-Rays and Fission-Spec PatIents wIth Acute Lymphocytlc Leukemia. Michael and Stanley Zucker. trum Neutrons. Antun Han and M. M. Elklnd. C. Cimino, Janet 0. Rowley. Ann Kinnealey. Daina 35 Cellular Immunity to Tumor-associated Antigens of 131 Oncogenesis, Mutagenesis, DNA Damage, and Cy Variakojis, and Harvey M. 0010mb. Transplantable Mammary Tumors of c3wIf.N Mice. totoxIcfty In Cultured Mammalian Cells Treated wIth 239 Effects of Epldermal Chalone and Epldermal Growth Aido Tagliabue. Ronald B. Herberman, Larry 0. Alkylating Agents. A. R. Peterson, Hazel Peterson. Factor on a Transplantable Epidermal Carcinoma Arthur. and James L. McCoy. and Charles Heidelberger. (HewItt) of the Mouse in Vise. Stefan Bertsch and Fr,edrich Marks. 42 CorrelatIon btween Lsuksmic Cell Retsntion of 1- 139 Cytotoxlc Activity of 1-(o-Chiorophenyl)-1-(p-chioro @i.D-Arablnofuranosylcytoslne5'-Trlphosphate and phenyl)-2,2-dichloroethane (Mltotane) and Its Ana 244 In VItro Correlation of Drug Concentrations and Ra Rsponsstolhsrapy. Youcef M. Rustum and Harvey logs on FeminizIng Adrenal Neoplastlc Cells In Cul diosensftization In CombinatIon Therapy wIth 5- D. Preisier. ture. Victor S. Fang. Bromo-2'-deoxyurldlne, Methotresate, and Radla so FormationandLossofAlkylatsdPurinâ€¢sfromDNA 146 Determination of (â€˜H)-and (â€˜@CJHematoporphyrin Hon. Shinichiro Wakisaka. of Hamstsr Liver after Administration of Dlmethylni Derivative DistrIbution In Malignant and Normal Tis 250 CorrelatIon of the Electrophoretic MobIlIty and Oxy trosemles. Rebecca Stumpf. Geoffrey P. Margison, sue. Charles J. Gomer and Thomas J. Dougherty. gen Uptake of Ehrlich Ascftes Tumor Cells. Takeo Ruggero Montesano, and Anthony E. Pegg. 152 Mltogenlc and Carcinogenic Effects of a Hypollpl Terasaki and Kaneatsu Miyamoto. demlc Peroxisome Proliferator, (4-Chloro-6-(2,3-xyll 55 Stlmulatory Effects of Vftamin A Analogs on Induc 257 InhibItion of SodIum-PotassIum-actIvated Adenosine dlno)-2-pyrlmldlnylthiojacetic Acid (Wy-14,543), In 5'-Trlphosphatase and ion Transport by Adrlamycln. elm of Cell-mediated Cytotoxicfty in Viwo. Reuben Rat and Mouse Liver. Janardan K. Reddy, M. Lotan and Gunther Dennert. Mario Gosalvez, George D. V. van Rossum. and Mary Sambasiva Rao, Daniel L. Azarnoff, and Stewart Sell. F. Blanco. 59 PurIfIcation and Partial Characterization of Nuclo 162 Correlation of Isoxyms Patterns of S-Adsnoxylme 252 CommIttee on Growth, 1945-1956: Another Noble ar Antlgsn-1 of the Novlkoff Hepitoma. Farhad thionine Synthetase with Fetal Stages and Patholog ExperIment. Michael B. Shimkin. Marashi, Frances M. Davis, Rose K. Busch, cal States of the Liver. Ming C. Liau, Chen Fee Howard E. Savage, and Harris Busch. Chang. Luc Belanger, and A. Grenier. 269 y-Glut.smyl Transpeptldase and MalIgnant Transfor matlon of Cuftured Liver Cells. E. Huberman, R. 57 Marked Dlffsrenc.s In the Skin Tumo@-inltlating Ac. tIvitisa of the Optical Enantlomers of the Dlastsreo 170 Opposite Effects of Dextrans Substituted with Montesano, C. Drevon, T. Kuroki, L. St. Vincent, T. D. Sulfhydryls or Mercury on Tumor Growth. Josef Pugh. and S. Goldfarb. mario Benzo(.)pyrene 7,8-Dlol-9,1O-Epoxldes. 1. J. Pitha. Karol Kociolek, and Charles A. Apffet. Slaga. W. J. Bracken, G. Gleason, W. Levin. H. Yagu. Communications D. M. Jerina. and A. H. Conney. 174 SpecifIc in Vise Inhibition of Macrophage Receptors 273 PrImary Neoplastic Transformation in Vise of Xeno 72 ki Vim Autoradiography and NItrOsOIwPtamSthyI for Cytophilic AntIbody by Soluble Immune Com genelc SkIn Grafts on Nude Mice. John W. Kreider. ensimlns Carcinogsnssis In Hamsters. Hildegard plexes. V. Srinivasa Rao, Robert L. Grodzicki, and Gerald L. Bartlett, and Francis E. Sharkey. Malcolm S. Mitchell. Reznik-SchUlier and WillIam Lljlnsky. 217 Alkaline Phosphatase Measurements of Paired Nor 75 Complsimet and Tumor AntIbody Levels in Cats, 183 Spectrum of Melanoma Antigens on Cultured Human mal and Osteosarcoma Tissue Culture Lines Ob and Changss Associatd wfth Natural Feline Lsuke Malignant Melanoma Cells as Detected by Monkey tamed from the Same Patient. William Thorpe, Walter mis Virus InfeCtIon and Malignant DIsease. Chris K. Antibodies. Shuen-Kuei Liao, Pak C. Kwong, James Loeb, Cornelia Hyatt, and Steven A. Rosenberg. Grant, D. K. Pickard, C. Ramaika, B. R. Madewell, C. Thompson, and Peter B. Dent. 280 Announcements and N. Essex. 193 Enhancement of viral Transformation for Evaluation 281 Errata 82 Effect of Carbamoylation on the Repair of Nitrosou of the CarcinogenIc or Mutagenic Potential of Inor 283 Instructions for Authors rss4nducsd DNA Alkylatlon Damag in L1210 Cells. ganlc Metal SaNs. Bruce C. Casto, Judy Meyers. and JoannaM. Heal. PatriciaA. Fox, and PhilipS. Schein. Joseph A. DiPaolo. 291 Author Index

February, Number 2, Part I

293 Toward improved SelectIvIty In Cancer Chemother- 321 ComplexIty and Abundance of Murine Leukemia Tissues. Helene S. Smith, E. Louise Springer. and apy: The Richard and HInds Rosenthal Foundation virus-related Nuclear and Messenger RNA Se Adeline J. Hackett. Award Lecture. Joseph R. Bertino quences In Mouse Embryo Cell Lines Which Are 305 PurifIcation, PropertIes, and lmmunotftration of DifferentIally SensItIve to Carcinogen-Induced vIrus 345 Imidoester InhIbItIon of Lymphocyte DNA Synthe 515.Gary A. Present and Susan Parker. Hepstoma Glutamlne Phosphorlbosylpyrophos Activation. Michael J. Getz, Paula K. Elder, and ph.te Amidotransterase (Amldophosphorlbosyl Harold L. Moses. * 349 Pharmacokinetics and DisposItion of 3-Deazauri trsnsfersss, EC 2.4.2.14). Michio Tsuda, Nobuhiko * 328 Fecal Bile Acids in Two Japanese Populations wIth dine In Humans. John A. Benvenuto, Stephen W. Katunuma, Harold P. Morris, and George Weber. Different Colon Cancer RIsks. Howard F. Mower. Hall, David Farquhar. David J. Stewart. Robert S. Benlamin, and Ti Li Loo. 312 DIfferences In the AbIlity of Human Lymphoblastold Ralph M. Ray. Robert Shoff. Grant N. Stemmermann, Lines to Exclude Bromodeoxyurldlne and In TheIr Abraham Nomura, Gary A. Glober, Sigetosi Kamiyama. Akio Shimada. and Hiroshi Yamakawa. 353 EvIdence for Active Transport of Melphalan by Two SensItIvity to Methyl Mthanesulfonate and to In Amino Acid CarrIers in Ui 78Y Lymphoblasts in corporatsd (â€˜HlThymldine. N. Patrick Higgins and 332 Nuclear Ultrastructure of Epithelial Cell Lines Dc VItro. Asher Begleiter. Hing-Yat Peter Lam, Judy Bernard S. Strauss. rived from Human Carcinomas and NonmalIgnant Grover, Evelyn Froese, and Gerald J. Goldenberg.

DECEMBER1979 III Contents of Volume 39, 1979

360 Comparison of the SensItivIties of Human, Canine, Ajit K. Verma. Barbara 0. Shapas. Hope M. Rice, and David S. Duch. Darell D. Bigner. Sexton W. Bowers. and Murine Hematopoietic Precursor Cells to Adria R.K Boutwell. and Charles A. Nichol. mycin and N.Trifluoroacetyladriamycin-14-valerate. 492 Creatine Klnase Activity and Isozyme Composition John C. Marsh. 426 Effects of Free Fatty Acids on the Growth of Normai in Normal Tissues and Neoplasms of Rats and and Neoplastic Rat Mammary Epithelial Cells. Mas 365 DNA-Protein and DNA lnterstrand Cross-linking by Mice. Jennie B Shatton. Harold P Morris. and S Wicha. Lance A. Liotta, and William A Kidwell cia. and trans-Platinum (II) Diamminedichioride in Sidney Weinhouse L1210 Mouse Leukemia Cells and Relation to Cyto 436 Demonstration ofTwo Components and Association 502 Characterization of Messenger RNA for Fructose toxicity. Leonard A. Zwelling. Tom Anderson. and of Adenoslne Diphosphate-Cytidine Diphosphate 1,8-Bisphosphate Aldolase A Isozyme of Rat As. KurtW Kohn. Reductasi from Cultured Human Lymphoblsst Cells cites Hepatoma AH 7974 Cells. Shigeru Sakiyama. 370 Effect of Hyperbaric Oxygen on the Cytotoxicity of (Molt-4F). Chi-Hsiung Chang and Yung-chi Cheng. Namiko Akiba, and Shinji Fulimura Adriamycin and NItrogen Mustard in Cuftured Burk 507 Two-Dimensional Gel Electrophoretic Comparison 443 InhIbItion of Human Lymphocyte Mftog.n and Anti ift's Lymphoma Cells. Richard H. Wheeler. John W of Proteins of Nuclear Fractions of Normal Liver and gen Response by a 15,000-Dalton ProteIn from Fe Dirks. Ivaldo Lunardi. and Martin J Nemirolf. Novlkoff Hepatoma. Hiroshi Takami and Harris line Leukemia virus. Lynn C. Hebebrand. Richard G. Busch. * 376 GlucocorticoId Receptors and Glutamine Synthe Olsen, Lawrence E. Mathes. and W. S. Nichols. tase in Leukemic Sezary Cells. Thomas J Schmidt 519 Genetic Basis of Susceptibility for Neuroblastoma and E Brad Thompson. as Effects of N-Trtfluoroacetyladriamycin-14-valerate following Treatment wIth N-Methyl.@-nItrosourea and Related Agents on DNA Strand Damage and and X-Rays in Xiphophorus. Manfred Schwab. 383 Basis for Natural variation In SensItivIty to 5-Fluo Thymidine Incorporation in CCRF-CEM Cells. Peter Gerhard Kollinger. Joachim Haas. Mulkh R Ahula. rouraciI in Mouse and Human Cells in Cufture. M. Kanter and Herbert S. Schwartz. Safia Abdo. Annerose Anders, and Fritz Anders. Jeffrey D. Laskin. R. Mark Evans. Harry K. Slocum. Daniel Burke. and Maire T. Hakala. 452 Transplantable Ductal Adenocarcinoms of the Syr * 527 SensItivIty of Human Granulopolesis in Vifroto Ad Ian Hamster Pancreas. Dante G. Scarpelli and M. riamycin before and after Exposure in Vise. 391 Induction of Pulmonary Adenomas in Strain A Mice Sambasiva Rao. Hans-Peter Lohrmann and Wolfgang Schreml by Substituted Organohalldes. Jeffrey C. Theiss, Michael B. Shimkin, and Lionel A. Poirier. 531 Presence and Cell Growth-related Variations of Gly 459 ImmunIty to Cell Surface Antigens and Immune cogen In Human Colorectal Adenocarcinoma Cell 396 intrinsic Differences in Heat and/or X-Ray Sen Complex Glomerubnephrltis in Hamsters Bearing Lines In Cufture. Monique Roussel, Guillemette sitivfty of Seven MammalIan Cell Lines Cuftured Human EpIthelial Tumors. Alan V. Richman and Chevalier. Jean-Pierre Rousset. Elisabeth Dussaulx. and Treatod under Identical CondItIons. G. P. Ronald W. Alexander. and Alain Zweibaum. Raaphorst. S. L. Romano, J. B. Mitchell. J. S. Bedford. and W. C. Dewey. 465 1,2-Dimethylhydrazlne-Induced Methylation of DNA 535 Influence of DII Concentration on the Efficacy of Bases In various Rat Organs and the Effect of Tumor Regression by Emulsified Components of * 402 A Methodological Approach to the Prediction of Pretreatment wIth Dlsulflram. J. A. Swenberg, H. K. Mycobacterla. Eliyahu Yarkoni and Herbert J. Rapp. Anticancer Drug Effect in Humans. Walter J. Durkin. Cooper, J. Blicheler. and P. Kleihues. VithalK. Ghanla. CharlesM. Balch. DoloresW. Davis. Communications and Raymond N. Hiramoto. 465 In Vise Tumor Diecrimination in a Rat by Proton 538 Effect of Thymidine on the SensItivIty of Cuftured Nuclear Magnetic Resonance ImagIng. Paul A. Mouse Tumor Cells to 1.fl-o-Arablnofuranosylcyto 408 Stimulation of Ultraviolet-induced Carcinogenesis Bottomley. sine. Alan W. Harris, Eric C. Reynolds. and Lloyd R. by 1,3-Bis(2-chioroethyl)-1-nftrosourea. John H. Finch. Epstein. 471 DNA Repair in Xeroderma Pigmentosum Cells Treated with Combinations of Uftravioiet Radiation * 542 Srum Acute-Phase Proteins and Immunoglobulins 411 Mutagenicfty and Tumor-inItIating ActIvIty of Fluori and N-Acetoxy-2-acetylamlnofluorene. Farid E. in Patients wIth Gliomas. Joseph F. Weiss. Robert A. nated DerivatIves of 7,12-Dlmethylbenz(a)anthra Ahmed and R. B. Setlow. Morantz, William P. Bradley. and Paul B. Chretien. cene. Eliezer Huberman and ThomasJ. Slaga. 545 Meeting Report: Workshopon Papillomaviruses and 415 InhibItory Effect of Growth Hormone on Gross Pas 480 Gross Murine Leukemia vIrus-Induced Aftsratlons Cancer. Joseph H. Coggin. Jr. and Harald zur sage A virus-induced Thymus Leukemia in C3Hf in the Thymus of Preleukemic AKR Mice. Terry R. Hausen. Mice. RenGJ. Duquesnoy and Grete M. Pedersen. Beardsley and Esther F. Hays. 547 Announcements 487 Dlhydrofolate Reductase in PrImary Brain Tumors, 419 Correlation of the InhIbition by Retinoids of Tumor 548 Erratum Promoter-Induced Mouse Epidermal Ornlthlne Dc Cell Cultures of Central Nervous System Origin, and carbosylase ActIvIty and of SkIn Tumor Promotion. Normal BraIn during Fetal and Neonatal Growth. 549 Author Index

February, Number 2, Part II

PROGRAM

List of Participants 554 Introduction to the Leukocyte Adherence Inhibition Workshop. Gera/d P Murphy 555 Current Status of Leukocyle Adherence Inhibition John H. Howell 556

SESSION I

MechanIsm of the Leukocyte Adherence Inhibition Assay

Chairman: Suzanne Eccles

Co'Chairman Dorothy Glaves

Historical Background and Aspects of the Mechanism of Leukocyte Adherence Inhibition. w j. Halliday 558 Evaluation of the Microplate Leukocyte Adherence Inhibition Test and Its Reproducibility. Sensitivity. and Relation@ ship to Other Tests of Cellular Immunity. Patrick G. Holt, Peter J. Fimmel, Lynette M. Finlay-Jones. and Robert L. Flower . . . 564 Antigenic Speciticily and Cellular Mechanisms in Leukocyte Adherence Inhibition Analysis of Immunity to Simple Proteins and Hapten-Protein Conjugates. Arnold Powell, Alice M. Sloss, A. Neal Smith, and Helen Murrell 570 Immunological Mechanisms of Tube Leukocyte Adherence Inhibition. 0. M. P. Thomson and Norman Grosser 576 Correlations between the Leukocyte Adherence Inhibition Microassay and in Vise Tests of Transplantation Resislance Stephen H Leveson, John H. Howell, Norman S. Paolini, Mong H. Tan, Edward 0. Holyoke, and Martin H Goldrosen 582 Cellular and Humoral Factors lnvolved in the Mechanism of the Micro'Leukocyte Adherence Inhibition Reaction. Martin H. Goldrosen, Anthony J. Russo, John H. Howell, Stephen H. Leveson. and Edward D. Holyoke 587 Cross'Reactivily between Bacillus Calmette-GuOrin and Rous Virus'induced Sarcoma Detected in Rats by Tube Leukocyte Adherence Inhibilion Assay Vladimir Hol5n, Jitka ChutnS, and Milan Hasek 593 Assessment of the Mechanism of the Leukocyte Adherence Inhibition Test. Ales W Tong. Denis R Burger. Patricia Finke. Carolyn Barney, Arlhur A. Vandenbark, and R Mark Verb . 597

iv CANCER RESEARCH VOL. 39 Contents of Volume 39, 1979

SESSION II PreparatIonand Characterizationof AntigensUsed in LeukocyteAdherenceInhibftlonAssays Chairman: William J. Halliday

Co-Chairman: Martin H. Goldrosen

Evidence for the Expression of Human Tumor@speciIic Antigens Associated with $@MicroglobuIin in Human Cancer and in Some Colon Adenomas and Benign Breast Lesions. 0. M. P. Thomson, Donna N. Tataryn,Richard O'Connor, Joyce Rauch, Paula Friedlander, Phil Gold, and Joe Shuster Characterization of Murine Tumor@associated Antigens by the Micro-Leukocyte Adherence Inhibition Assay John H. Howell, AnthonyJ. Russo, and Martin H. Goldrosen 612 Association of Melanoma Tumor Antigen Activity wilh $.-Microglobulin. Arlhur Malley, Denis R Burger. Arthur A. Vandenbark, Maureen Frikke, Patricia Finke, Don Begley. Karen Acott, John Black, and R Mark Vetto 619

SESSION III Demonstrationand Evaluationof LeukocyteAdherenceInhibitionAssay Chairman: Milsuo Takasugi

Co'Chairman James L McCoy

Demonstralion and Evaluation 01 the Leukocyle Adherence Inhibition Assay Martin H. Goldrosen 624 Hemocytometer Leukocyte Adherence Inhibition Technique. Annette E. Maluish and W. J Halliday 625 Demonstration 01Tube Leukocyte Adherence Inhibition Assay with Coded Samples of Blood 0. M. P Thomson . . 627 Demonstration of the Microtesl Version of the Leukocyte Adherence Inhibition Assay Martin H Goldrosen. John H. Howell, and Edward D. Holyoke 630

SESSION IV Detectionand Monitoringof HumanCancerwith LeukocyteAdherenceInhlbiton Chairman Mitsuo Takasugi

Co'Chairman: James L. McCoy

Evaluation of Micro-Leukocyte Adherence Inhibition as an Immunodiagnostic Test for Pancreatic Cancer. Martin H. Goldrosen. Anthony J. Russo, John H. Howell, Stephen H. Leveson, Michael C. Moore, Edward 0. Holyoke. and Harold 0. Douglass. Jr 633 Human Tumor'specific Immunity Assayed by a Computerized Tube Leukocyte Adherence Inhibition 0. M. P. Thomson, Donna N. Tataryn,MarvinLopez, Rosemarie Schwartz, and John K. MacFarlane 638 Esperiences with Leukocyte Adherence Inhibition in Human Cancer. Annette E. Maluish 644 The Need to Establish Whether the Leukocyte Adherence Inhibition Test Is a Reliable Assay of Tumor Immunity in Humans. Karl Erik Hellstrom and Ingegerd HelIstrom 649 Monitoring of Antitumor Immunity in Patients with Larynx Cancer by Tube Leukocyte Adherence Inhibition Assay Vladimir Holan, Otakar SibI, and Milan Hasek 651 Cellular Antitumor Immune Response in Women with Risk Factors for Breast Cancer Tore Sanner. Ivar Brennhovd, Ingrid Christensen, Ole Jorgensen. and Stein Kvaloy 654 Immunological Basis of Close@ContactSensitization to Osteosarcoma Arnold Powell, Alice M. Sloss, and John T. Makley . . 658 Summary and Future Prospects of Leukocyte Adherence Inhibition. Martin H. Goldrosen 660

March, Number 3

513 Ascorbic AcId and Cancer: A Review. Ewan isocytoslne in P815 Cells. Ting-Chao Chou, Joseph 773 Neoplastic Responses and Correlated Plasma Pro Csmeron, Linus Pauling, and Brian Leibovltz. H. Burchenal, Jack J. Fox, Kyoichi A. Watanabe, lactln Levels in Dlethylstilbestrol-treated ACI and Chung K. Chu, and Frederick S. Philips. Sprague-Dawley Rats. John Patrick Stone. Seymour â€¢52Assay of 155 Test Chemicals in Ten Tester Strains UsInga NewModificationof the AmesTestfor 729 Effects of Iodine Deficiency and High-Fat Diet on N- Holtzman, and Claire J. Sheltabarger. Bacterial Mutagens. Robert E. McMahon, John C. Nltrosomethylurea-Induced Mammary Cancers In 779 Influence of Dlethylstllbestrol Treatment on Prolec Rats. William T. Cave, Jr., John T. Dunn, and Robert Cline, and Christina Z. Thompson. tin Cells of Female ACI and Sprague-Dawley Rats. M. MacLeod. Seymour Holtzman, John Patrick Stone, and Claire 594 MetabolIsm of Aftatoxin B, and IdentifIcatIon of the 735 Transport and MetabolIsm of Methotrexate in Nor J. Shellabarger. Major Aflatoxin B-DNA AdduCts Formed in Cuftured mal and ResIstant Cuftured Rat Hepatoma Cells. Human Bronchus and Colon. Herman Autrup, John John Galivan. 785 AugmentatIon of Antftumor Cytotoxicfty in MOPC M. Esslgmann. Robert G. Croy, Benjamin F. Trump, 315 Tumor Bearer Spleen Cells by Depletion of Gerald N. Wogan. and Curtis C. Harris. la Effectsof PerlnatalTestosterone on MouseMam Glass-adherent Cells Prior to in Vitro ActIvation. mary Duct Morphology and Lobule Induction in Margalit B. Mokyr. Donald P. Braun, and Sheldon * 599 Protelnurla wIth DissemInated Neoplastic Disease. Vitro. M. R. Warner. Dray. Daniel Rudman, Rajender K. Chawla, Daniel W. NIxon. W. Ralph Vogler, James W. Keller, and 751 Changes in Macromolecular Synthesis by Thy-Pea ftlve Lymphomas in Response to Mftogen. Ronald 793 Enhanced Metabolism and Mutagenesla of Nftroso Robert C. MacDonell. pyrrolldine In Liver Fractions Isolated from Chronic W. Gillette, Joseph Szekerczes, David A. Wunder Ethanol-consuming Hamsters. G. David McCoy. 104 DNA-Protein Cross-Linking by Chemical Carcino lich, and Sheila Gillette. Chi-hong B. Chen. Stephen S. Hecht. and Elena C. gene In MammalIan Cells. Albert J. Fornace, Jr. and John B. Little. * 757 Pharmacoklnetics of the Protein Antftumor Anti McCoy. biotic Neocsrzlnostatin after Bolus Injection in Hu 797 Production of Sister Chromatid Exchanges by var 711 Development of a Neonatal and Metastatic Murine mans. Robert L. Comis, Thomas W. Griffin, Vic Raso, and Sandra J. Ginsberg. ious Cancer Chemotherapeutic Agents. Ashutosh Neuroblastoma Model. Beth Allyson Sheffler, Mary Banerjee and William F. Benedict. Ann Repman, and Cara-Lynne Schengrund. 762 SynthesIs and IdentIfication of Products Derived 500 Carcinogen-induced Abnormalities in Rat Liver 714 QuantItative Correlation between in Vitro and in Vise from the Metabolism of the Carcinostatic 1-(2. Cells and Their Modification by Chemical Agents. Activities of Phorbol Esters. Paul E. Driedger and Chioroethyl)-3-(trana-4-methylcyclohexyl)-1 -nitro. E. Borenfreund, P. J. Higgins. M. Steinglass, and A. Peter M. Blumberg. sourea by Rat Liver Microsomes. Hubert E. May. Bendich. Sue J. Kohlhepp, Richard B. Boose. and Donald J. 720 MetabolIsm and Effects of 5-(/I-o-Rlbofuranosyl)- Reed. 805 Mutation Induction by 5-Fluorodeoxyuridine in Syn

DECEMBER 1979 V Contents of Volume 39, 1979

chronous Chinese Hamster Cells. Paul M carboxamide, I -(2-Chloroethyl)-3-(4-methyicyclo 1051 ComparatIve StudIes of Glucose Metabolism In Aebersold. hexyl)-1-nftrosourea, and i-Phenylalanlne Mustard HTC, RLC, MH,C , and Reuber H35 Rat Hepatoma on 816, Cloudman 891 , and Harding-Passey Mouse Cells. Denia H. J. Schamhart. Klaas W. van de Poll, 811 Enhancement of Gastric Carcinogenesis in Dogs Melanomas. Helene Z. Hill, George J. Hill, II, Cathie and Roeland van Wi1k. Given N-Methyi-N-nltro-N-nftrosoguanldine follow L. Miller, Michael Pfaller, Kevin Weiss, and Mugs ing vagotomy. Masahide Fulita. Motohisa Takami. Galin. 1056 InductIon of DifferentIatIon of Rauscher Virus-In Masao Usugane. Shigeru Nampei, and Tetsuo duced Mouse Myeloid LeukemIa Cells wIth a Fec Taguchi 940 Effects of 5-Azacytldine on Transfer RNA Methyl tot(s) in Ascltic Fluid and Inhibitors of Nucleic Acid transferases. Lee-Jane W. Lu and Kurt Randerath. sly Inhibition of the Lectin-induced Mftogenic Re and ProteIn Syntheses. Kenhi Sugiyama. Motoo sponse of Thymocytes by Glycolipids. Ernest E 950 Immunosuppressive Properties of a virion Poly Hozumi, and Junko Okabe. Lengle. Rajabather Krishnaraj. and Robert G. Kemp. peptide, a 15,000-Dafton Protein, from Feline Leu 1063 ComparIson of Cytotoxic Effect and Cellular Uptake kemla virus. Lawrence E. Mathes. Richard G. Olsen. * 5@3 Phase I Trial and Assay of Rubldazone (NSC of 1-$-o.Arableofuranosyicytoslee and its N-Acyl Lynn C. Hebebrand. Edward A. Hoover. Joseph P. DerIvatives, UsIng Cultured KB Cells. Takashi 164011) in Patients wIth Advanced Solid Tumors. Schaller. Patrick W. Adams. and W. S. Nichols. John S. Kovach, Matthew M. Ames, Margo L. Tsuruo, Harumi lids, Shigeru Tsukagoshi. and Sternad. and Michael J. OConnell. 955 MobilIty of Lymphocyte Surface Membrane Concan Yoshlo Sakurai avalln A Receptors of Normal and Feline Leukemia 1071 Synergistic Action of Vincristine and Adrlamycin In 4' @gVolatile N-Nftrosamines In the Urine of Normal Do vIrus-infected vlremic Felines. Jo Ellen Dunlap, nors and of Bladder Cancer Patients. Tadao the Treatment of Experimental Rat LeukemIa L5222. W. S. Nichols, Lynn C. Hebebrand. Lawrence E. W. J. Zeller, N. Berger. and D. Schmahl. Kakizoe, Tusn-T,en Wang. Vincent W. S. Eng. Mathes. and Richard G. Olsen. Rudolf Furrer, Peter Dion. and W. Robert Bruce. C 1074 CharacterIstics ofthe Lesions and Risk of MalIgnant 959 Dose-dependent Adjuvant ERects of Bacillus Cal 833 IncIdence and Pathological Features of Sponta Conversion Associated wIth the Type of Human mefte-Gu.@rin on Tumor ImmunIty In LewIs Rats. nsous Tumors In Athymic Nude Mice. Francis E. Papillomavirus Involved In Epidermodysplasla Ver Martin Davies and Edna Sabbadini. Sharkey and Jorgen Fogh. ruclformls. Gerard Orth, Stefsnia Jablonska. Maria 966 Response of Cells to Hyperthermia under Acute and Jarzabek@Chorzelska, Slavomir Obalek. Genowefa * 540 Clinical Status and Rate of Recovery of Blood Lym Chronic Hypoxlc CondItions. Leo E. Gerweck. Rzesa, Michel Favre, and Odite Croissant. phocyte Levels after RadIotherapy for Bladder Can Torbtoern G. Nygaard. and Margaret Burlett. cer. Carol OToole and B. Unsgaard. 1083 MetabOlIsm and Formation of DNA Adducts of 973 Fatty Acid Oxidation to ftO by Ehrlich Ascltes Car Benzo(a)pyrene in Human Dipiold FibrOblasts. 844 New Rlbonucleotide Reductase InhibItors wIth An clnoma In Mice. Murad Ookhtens and Nome Baker. Hugo W. Rudiger, Julia Marxen, F.-Valentin Kohl. tineoplastic ActivIty. Howard L. Elford, Galen L. Hans Melderis, and Peter v. Wichert. Wampler, and Bart vant Riet. 951 Influence of Growth State on Several Thermal Re sponses of EMTS/AZ Tumor Cells in Vitro. Eugene 1019 ActIvatIon of 2-Acetylamlnofluorens In the NucleI of 552 BIochemical and Pharmacological Effects of the W. Gerner. Paul W. Holmes, and James A. Rat LIver. Kaname Kawajiri, Hiromichi Yonekawa, Fermentation-derived Antltumor Agent, (eS,SS)-a McCullough. Eiichi Hara, and Yusaku Tagashira. Amino-3-chioro-4,5-dlhydro-5-isoxaseleecetic Acid (AT-125). Gary L. Neil. Ann E. Berger, Richard P. 987 CondItions for Effective Bacillus Caimefte-Gucrln * 1094 Effect of Estrogen and Progestle Treatments on McPartland, Gerald B. Grindey. and Alexander Immunotherapy of Postsurgical Metastasea of Endometrla from Postm.nop.usai Women. R. J. B. Bloch. 13762A Rat Mammary Adenocsrclnoma. John W. King, N. I. Whitehead, S. Campbell. and J. Minardi. 557 SIlver Staining of Nucleolar Granules in Tumor Kre,der, Gerald L. Bartlett, Cinda M. Boyer. and 1102 MetabolIsm of 1-$-o-Arablnofuranosyluracil in Cells. Harris Busch. Yerach Daskal. Ferenc Gyorkey. Dallas M. Purnell. Mouse L5178Y Cells. Werner E. G. Muller and @ and Karel Smetana. C Predictive Value of Cerebrosplnal Fluid Polyamlnes Rudolf K. Zahn. 804 Aberrant Regulation of Omithine Decarboxylase by in Medulloblastoma. Laurence J. Marton, Michael S. 1105 In Vise and In Vitro StudIes of ExperImental OvarIan Serum, Putreeclne, and Spermldlne In Cytomegalo Edwards, Victor A. Levin. Warren P. Lubich, and Adenocarcleoma In Rats. S. Sekiya. N. Endoh. V. virus-transformed Human Cells. Harriet C. Isom and Charles B. Wilson. Kikuchi, T. Katoh, A. Matsuura. H. Iwasawa. B. Takeda, and H. Takamizawa. Jay T. Backstrom. 995 InhIbitory Effect of Prostaglandln F.., on the Growth 870 Glycosaminoglycans of Normal and Malignant Cul of a Hormone-dependent Rat Mammary Tumor. 1113 Early Decrease In Hyaluronidsse-sensitlve Cell tured Human Mammary Cells. E. V. Chan@ William Jubiz, Jacqueline Frailey, and Jean B. Surface Charge during the DIfferentiation of Friend drasekaran and Eugene A. Davidson. Smith. Erythroleukemlc CeNs by Dlmethyl Sulfoxlde. Chikako Sato. Kiyohide Kojima. Kimiko Niahizawa, 581 Activation of Tumoricidal Properties in Mouse Mec 1001 Development of a Metastatic BraIn Tumor Model In and Yoji Ikawa. rophages by LymphokInes Encapsulated in Lipo Mice. Frances K. Conley. somes. G. Poste. R. Kirsh, W. E. Fogler. and I. J. ills Humoral AntIbOdy Response to BovIne Lukemia 1005 QuantItatIve StudIes of in Vitro Morphological Fidler. VIrus Infection In Cattle and Sheep. Francoise Dcx. Transformation of Syrian Hamster Cells by Inor Claudine Bruck. Marc Mammerickx, Daniel 593 Microtubules and Actln-cont.alning FIlaments of ganic Metal Safts. J. A. DiPaolo and B. C. Casto. Portetelle, Jacques Ghysdael, Yvette Cieuter, Normal, Preneoplastic, and Nsoplastic Mouse Madeleine Leclercq. Daniel Dekeget. and Ars5ne Mammary Epithellal Cells. Bonnie B. Asch. Daniel 1014 DIfferent SusceptIbIlIties of Human Melanoma and Burny. Medina, and B. R. Brinkley Breast CarcInoma Cell Lines to Retlnoic Acid-In duced Growth lnh@Ition. Reuben Lotan. Communications 41 so@ A ClInical and Pharmacological Study of High-Dose Methotresate wIth MinImal Leucovorin Reecue. 1020 N,N-Dimethylfonnamlde-induced Alteration of Cell 1124 StabIlIty of Estrogen Receptors In Frozen Human Ronald G. Stoller. Henry G Kaplan. Frank Culture CharacterIstics and Loss of Tumorlgeniclty Breast Tumor Tissue. Pearl C. Namkung. Roger E. Cummings, and Paul Calabresi. in Cuftured Human Colon CarcInoma Cells. Daniel Moe. and Philip H. Petra. 913 Carcinogenicfty of Antftumor cia-Platinum (II) Coor L. Dexter, James A. Barbosa. and Paul Calabresi. 1125 StImulatIon of Resistance to Tumor Growth of dination Complexes in the Mouse and Rat. Wilbur 1025 A Survey of Growth In Soft Agar and Cell Surface Athymlc Nude Mice Prâ€¢treatedby CombIned Local R Leopold, Elizabeth C. Miller. and James A. Miller PropertIes as Markers for TransformatIon In Aduft Hyperthermia and X-Irrsdlatlon. A. Yerushalmi and Rat LIver Epithellal-INceCell Cultures. Richard H. C. V. Weinstein. 919 Mutually Exclusive Genetic Signatures of Human Breast Tumor Cell Lines wIth a Common Chromo. San, Michael F. Laspia. Andrew I. Soiefer, Carol J. 1129 InhIbItion of Spontaneous Breast Cancer Formation somal Marker. Michael J. Siciliano, P. E. Barker, Maslansky, Jerry M. Rice, and Gary M. Williams. in Female C3H (A' /a) Mice by Long-Term Treatment wIth Dshydroeplandrosterone. Arthur G. Schwartz. and Relda Cailleau. 1035 Induction of Mouse Epldermal Ornfthlne Decarbox 923 ModifIcation of L1210 Cell Nuclear Proteins by 1- ylase ActIvIty and DNA Synthesis by UltravIolet 1133 PreparatIon of Permanent Slides of Intact Boft-Agar Methyl-1-nitrosourea and 1-Methyl-3-nltro-1-nftro LIght. Ajit K. Verma, Nicholas J. Lowe. and R. K. Colony Cultures of Hemalopoletlc and Tumor Stem soguanidine. Seth D. Pinsky. Kenneth 0. Tew, Mark Boutwell. Cells. Sydney E. Salmon and Ronald N. Buick. E. Smulson. and Paul V. Woolley, Ill. 1041 Enhancement of Biochemical TransformatIon of 1137 Letter to the Editor: Request for SpecImens from 929 Increased SusceptibilIty of Mouse Cells to Fluores MammalIan Cells by Herpes Simplex Virus followIng Organ Transplant and Immunodeflclency Patients cent Light-Induced Chromosome Damage after Nftrosomethylurea Treatment. Mary K. Howett, Who Developed Lymphomas. George Klein. Israel Long-Term Culture and Malignant Transformation. Anthony E. Pegg. and Fred Rapp. Penn. and Werner Henle. Ram Parshad. Katherine K. Sanford. Robert E. 1138 Announcements 1045 Unusual SensitivIty of Ataxla Telanglectasla Cells Tarone, Gary M. Jones. and Anne E. Baeck. to Bleomycin. Alexander M. R. Taylor. Christine N. 1139 Errata 934 Effects of 5-(3.3-Dimethyl-1 -triazeno)imidazole-4- Rosney, and Jean B. Campbell. 1140 Author Index

April, Number 4

1141 Role of Superoxide Dlsmutase in Cancer: A Review. I 159 EffIcacy of Tumor Cell Extracts In Immunotherapy 1150 PurIfication and Mechanism of Action of Macrome Larry W Oberley and Garry R Buettner of Murlne EL-4 Leukemia. John L. Cantrelt. Charles mycln. Thomas H. Sawyer. Archie W. Prestayko. and A McLaughlin. and Edgar Ribi. StanleyT Crooke. 1150 Patterns of Urinary Excretion of MOdIfIed Nucleo sides. Charles W Gehrke. K. C Kuo. T. P Waalkes. 1165 MetabolIsm of 2-Aminofluorene and 2-Acetylamlno *1 155 ExpressIon of Cell-mediated ImmunIty and Blocking and Ernest Borek fluorene to Mutagens by Rat Hepatocyte NucleI. Factor Using a New Line of Ovarian Cancer Cells in VItro . Roland A. Pattitlo. Michael T. Story. and Anna 1154 ComparIson of Metabolism-mediated BIndIng to Daniel L. Stout and Frederick F. Becker. C F Ruckert DNA of 7 - Hydroxymethyl - I 2- methylbenz(a). 1174 lmmunogenicfty of ChemIcally Induced Murlne Co. anthracene and 7,12-Dimethylbenz(a)anthracene. Ion Cancers. LeGrand P. Belnap. Patrick H 1193 Pharmacological Studies of the Mechanism of Tu A Dipple. J E Tomaszewski. A C. Moschel. C. A H Cleveland. M. E. M. Colmerauer, Robert M. mar-Induced Bone Marrow Cytolysls. John F Bigger J A Nebzydoski and M Egan Barone and Yosef H. Pilch DiStefano. Rita Lysik. and Stanley Zucker.

vi CANCER RESEARCH VOL. 39 Contents of Volume 39, 1979

1199 @haracterlstIcs of Benzo(a)pyrene Metabolism by ylbenz(a)anthracene as Initiator and the Phorbol 1377 Formation and Removal of SpecIfIc Acetylaminoflu Kidney, Liver, and Lung Microsomal Fractions from Ester 12-O-Tetradecanoylphorbol-13-acetate as orene-DNA Adducts In Mouse and Human Cells Rodents and Humans. Russell A. Prough. Virginia Promoter. Klaus Goerttler. Heinz Loehrke, Jiirgen Measured by Radloimmunoassay. Miriam C. Poirier. W. Patrizi. Richard T. Okita. Bettie Sue S. Masters, Schweizer. and Brigitte Hesse. Marc A. Dubin. and Stuart H Yuspa. and Sten W. Jakobason. 1295 Cell Kinetics of Hepatocytes during thePreneoplas 1382 Spermine-Induced Variations in the Adenosine 5- 1207 PromotIng Effect of Saccharin and oi.-Tryptophan in tic Period of Diethylnitrosamine-induced Uver Car Diphosphate Ribosylation Patterns of Nuclear Pro Urinary Bladder Carcinogeneala. Samuel M. Cohen, clnogenesis. H. M. Rabes and R. Szymkowiak. teins from Rat Liver and Hepatoma. Frank W Perrella and Michael A. Lea. Masayuki Arai, Jerome B. Jacobs. and Gilbert H. 1305 Tumor Angiogenesis Activity in Clonal Cells Trans Friedell. formed by BovIne AdenovirusType 3. Kyozo 1390 Role of Liposome Type and Route of Administration 1215 Cell Growth Recovery after Treatments at VarIous Tsukamoto and Yukio Sugino. in the Antitumor Activity of Llposome-entrapped 1- Supraoptlmal Temperatures. Jacques Landry and /f-o-ArsblnofuranosylcytosineagainstMouseL1210 1310 Tumorlgenicity of the Dlhydrodlols of Dlbenzo Leukemia. Youcef M Rustum. Chandrakant Dave. Normand Marceau. (a,h)anthrscene on Mouse Skin and In Newborn Eric Mayhew. and Demetrios Papahadjopoulos 1224 Renzo(a)pyrene Uptake by Human Plasma Upopro MIce. Mildred K. Buening. Wayne Levin. Alexander telnsin Vitro. Helen P. Shu and Alex V. Nichols. W. Wood. Richard L. Chang. Haruhiko Yagi. Jean M. 1396 A Biochemical and Pharmacological Study of Ther Karle, Donald M. Jerina, and Allan H. Conney. apeutic Synergism with 5-Fluorouracil plus Cycle 1231 Effects of Nucleotldes and Nucl.otlde: Analogs on phosphamide in Murine L1210 Leukemia. Daniel Human Serum Slalyltransferaa.. Wayne D. Klohs, * 1315 Cytokinetlc Comparison of Thymidlne and Leuco Fernandes and Philip Klubes. Ralph J. Bernacki, and Walter Korytnyk. vorin Rescue of Marrow in Humans after Exposure to High-Dose Methotrexate. Slephen B. Howell, 1405 Effect of 1-Methyl-1-nitrosourea on Poly (Adenosine 1239 Acute Ultraatructural ERects of the Antitumor Anti Awtar Krishan. and Emil Frei, Ill. Diphosphate-Albose)PolymeraseActIvity at the blotIc Carmlnomycin on Nucloll of Rat TIssues. Nucleosomal Level. Swaroop Sudhakar. Kenneth Jerome A. Merski. Yerach Daskal, Stanley T. Crooke, 1321 Differential Effect of Adriamycin on DNA Replicatlve D. Tew. and Mark E. Smulson. and Harris Busch. and Repair SynthesisIn CulturedNeonatal Rat CardIac Cells. Henie Fialkoff, Myron F. Goodman, 1411 Nitrosourea Interaction with Chromatin and Effect 1245 fluctuatIons In Nucl.oslde Uptake and BindIng of and Maria W. Seraydarian. on Poly(Adenosine Diphosphate-Ribose) Polymer the InhIbItor of Nucleoside Transport, Nftrobenzyl ase Activity. Swaroop Sudhakar. Kenneth D. Tew. thloinoslne, during the ReplIcation Cycle of HeLa 1328 Comparison of Mutageniclty, Anthumor Activity, Philip S. Schein. Paul V. Woolley. and Mark E. Cells. Carol E. Case, Ewa Dahlig. Eda V. Lau. and Chemical PropertIes of Selected Nltrosoureas Smulson. Thomas P. Lynch. and Alan R. P. Paterson. and Nitrosoamldes. Robert B. Brundrett, Michael Colvin, Emil H. White. James McKee. Philip E. 141a Evidence for a New Mechanism of Cytotoxicity of 1- 1253 Tumor-saaoclated Phenylalanyl Transfer RNA Hartman, and Diane L. Brown. $-o-Arabinofuranosylcytoslne. David M Woodcock. Found In a Wide Spectrum of Rat and Mouse Tu Richard M. Fox, and Ian A. Cooper more bid Abeent in Normal Adult, Fetal, and Regen 1334 Effects of cia-Dlchlorodiammlneplatlnum(II) on crating Tissues. J. Frederic Mushinski and Marina Human Colon CarcInoma Cells in Vitro. Jean 1425 Communication: Recovery of 2'-Deoxycoforntycin MsrIni. Pierre Bergerat. Barthet Barlogie. and Benjamin inhibited Adenosine Deaminase of Mouse Erythro Drewinko. cytes and Leukemia Ll2lOin Viva . Ram P. Agarwal. 1259 Olycosyltrsnaferaae and Glycosidaae ActivItIes In Cultured Human Fetal and Colonlc Adenocarcinoma 1339 N-(4-Hydroxyphenyl)retinamide, a New Retinold for Cell LInes. James S. Whitehead. Frank J. Fearney. PreventIon of Breast Cancer In the Rat. Richard C. LetterstotheEditors and Young S. Kim. Moon. Henry J. Thompson. Peter J. Becci. Clinton J. Grubbs. Robert J. Gander, Dianne L. Newton, Joseph 1428 Cell Survival following Treatment with Antitumor 1264 A Comparison of the BIological Effects of Dlchloro M. Smith, Sandra L. Phillipa. William R. Henderson, Drugs. Correspondence re: Hohko Tsukeda, methotrsxate and Methotrexate on Human Lee Larry T. Mullen, Charles C. Brown, and Michael B. kemlc Cells In Culture. lsao Takahashi, Takao Sporn. SatoshiMizuno,andKazuoNltta.SusceptIbilitIesof Ohnuma, and James F. Holland. Normal and Malignant Human Lung Cells in Culture 1347 Egg Lectln of Rana japonica and Its Receptor Gly to the Cytocidal Action of Antitumor Agents. Cancer 1269 Effects of Mannitol or Furosemide Dluresls on the coprotein of Ehrilch Tumor Celia. Fusso Sakakibara. Res. 38: 2529-2532, 1978. Pamela R Roper and Nipllrotoxiolty and PhysIologIcal DIsposItIon of cia Hiroaki Kawauchi. Giichi Takayanagi, and Hitomi las. Benlamin Drewinko. Dlchlorodlammlneplatlnum(lI)In Rats. Martin F. Hohko Tsukeda. Satoshi Mizuno. and Kazuo Hilts. Pers, Jr., Bernard C. Zook. and Harold C. Harder. 1353 PreparatIon of Immunotherapeutic Autologous Tu mar Cell Vaccines from SolId Tumors. L. C. Peters. 1431 Correspondence re: Donald C. Buffkin, Nib M. 1279 Effects of Mannltol or Furosemlde Diuresis on cia J. S. Brandhorst, and M. G. Hanna, Jr. Webber, Warren D. Davidson, Linda F. Bassist, and Dlchlorodlammlneplatlnum(lI) Antltumor ActIvIty Ramesh C. Verma. Ornithine as a Possible Marker and ToxIcIty to Host-renewing Cell Populations In 1361 Effect of Corynebacterium parvum on Uver Prolifer of Cancer. Cancer Rca. 38: 3225-3229, 1975. Rats. Martin F. Pera. Jr. and Harold C. Harder. ation and Regeneration. Bernard Fisher. Mark C. Anthony E. Pegg. Gebhardt. Elizabeth A. Gaffer. and Edwin R. Fisher. 1251 A 3.5 Megadafton, Highly RepetItIve Eco R Frag Donald C. Buffkin and Milo M. Webber. meat In the Genome of Novlkoff Hepatoma. David L. 1369 Physical and Chemical Composition of Subcellular 1433 Announcements Parker. Lawrence I. Rothblum. and Harris Busch. FractIons from Tumor Cells Treated with Metabolic 1434 Erratum 1293 SystemIc Two-Stage Carclnogenesis in the Eplthe Inhibitors or Hormones. Seymour I. Schlager and lImeofthe ForestomachofMiceUsing7,12-Dimeth Sarkis H. Ohanian. 1435 Author Index

May, Number 5

1437 Dlfferencea In Serum a-Fetoproteln Concentrations *1481 Total-Body Hyperthermia with and without Chemo (Squalane), Peanut Oil, or Mineral OIl. Eliyahu durIng the CarcInogenic Sequences Resulting from therapy for Advanced Human N.opiasms. B. Yarkoni and Herbert J. Rapp. Exposure to Dlethylnltrosamlne or Acetylaminoflu Barlogie, P. M. Corry. E. Yip. L. Lippman, 0. A. 1521 Effect of Cholesterol Metabolltes and PromotIng orene. Frederick F. Becker and Stewart Sell. Johnston, K. Khalil. T. F. Tenczynski, E. Reilly, R. Lawson. G. Dosik, B. Rigor. R. Hankenson, and E. J Effect of Uthochollc Acid In Colon Carcinogenesis 1443 Inaulin and Glucagon Receptors In MorrIs Hepato In Germ-free and Conventional P344 Rats. Bandaru Freireich. was of Varying Growth Rates. Vincenzo Pezzino, S. Reddy and K. Watanabe. Riccardo Vigneri. Marvin 0. Siperatein. and Ira D. 1490 Intracellular Activation of â€˜y-L-Glutaminyt..4-hydrox Goldfine. ybensene by Tyrosinase, a Mechanism for Selective 1525 Mediated Mutagenesla of Dimethyinltrosamlne In Cytotoxicity against Melanocarclnoma. F. Stephen Neuroapora craw by Various MetabolIc Activation *1447 Distrlbilllon,Frequency,andQuantitativeAnalysIs Vogel, Liesetotte A. K. Kemper. Kim Boekelheide. Systems. Wen-Zong Whong and Tong-man Ong. of Estrogen, Progesterone, Androgen, and Gluco Doyle G. Graham, and Peter W. Jeffs. corllcold Receptors In Human Breast Cancer. 1529 High Incidence of Mammary Tumors In MIce wIth Joseph C. Allegra, Marc E. Lippman, E. Brad 1494 The Cytotoxicity of y-L-Glutamlnyl-4-hydroxyben InherIted Asplenia CarrIers for the Nude Gene. Thompson, Richard Simon, Audrey Barlock, Linda zene for Cells that Contain Tyrosinase, a Study of Bismarck B. Lozzio, Diana M. Lopez. Patricia Green, Karen K. Huff, Hoan My T. Do, and Susan C. Melanocytes in the Hair Follicle of the Mouse. Peter Coulson, and Stephen V. Lair. Aitken. C. Burger. Lieselotte A. K. Kemper. and F. Stephen * 1534 Correlation of Tumor Cell KInetic Studies with Sur Vogel. 1455 Host Response to Adenovlrus 2-tranaformed Ham face Marker Results In Childhood Non-Hodgkin's ster Embryo Cells. James L. Cook and Andrew N. Lymphoma. Sharon B. Murphy, Susan L. Melvin, 1504 Correlation ofin Vitro Growth Properties and Tumor Lewis, Jr. and Alvin M. Mauer. Igeniclty of SyrIan Hamster Cell Unes. J. Carl 1462 IntestInal Tumors Induced by a Single Intraperlto Barrett, Brian D. Crawford. Laura 0. Mixter. Leonard 1539 Correlation of the Induction of TranscrIption of the neal Injection of Methyl(acetoxymethyl)nltrosamlne N. Schechtman. Paul 0. P. Tao. and Robert AKR Mouse Genome by 5-lododeoxyurldlne with in Three StraIns of Rats. Jules J. Berman, Jerry M. Pollack. the ActIvation of an Endogenous Murlne LeukemIa Rice, Martin L. Wenk, and Peter P. Roller. VIrus. Sisir K. Chattopadhyay, Gilbert Jay. Marilyn R. 1511 Endogenous Tumor Growth Factor IndIcated by In Lander. and Arthur S. Levine. 1417 Growth of Nontumorlgenic Cells In Mlllipore DItto creased Ornlthlne Decarboxylase ActIvIty In Malig slotsOhambers Implanted In Mice and Implications nant Cells Treated with Host Serum or Ascites Fluid. 1547 Pharmacokinetlc Analysis of Neocarsinostatin in forln Yii'o Growth Regulation. Lola N. Reid, Charles Jan Vaage and Sudha Agarwal. Normal and Tumor-bearing Rodents. Ivan S. D. Stiles, Milton H. Saier. Jr. . and Michael J. Rindler. Lowenthal, Leroy N. Parker, David J. Greenblatt, 1515 Tumor RegressIon after Intralesional Injection of Barbara L. Brown. and T. S. Anantha Samy. 1474 QuantItatIve StudIes of RadIatiOn Tranatormatlon Mycobacterlal Components EmulsIfIed in 2,6,10,15. with the A31-11 Mouse BALB/3T3 Cell Line. John B. 19,23-Nexamethyl-2,6,10,14,15,22-tetracosahexaene * 1552 Prognostic Factors In Metastatlc Breast Cancer Little. (Squalene), 2,6,10,15,19,23.Hexamethyitetracosane Treated with Combination Chemotherapy. Kenneth

DECEMBER 1979 VII Contents of Volume 39, 1979

D. Swenerton. Sews S. Legha, Terry Smith, Gabriel 1651 InhIbItion of Chemical Carcinogen-Induced Neopla McLaughlin. Sendra L. Hargrave. William D. Bickel, N. Hortobagyl. Edmund A. Gehan, Hwee-Yong Yap. ala by Coumarlns and a-Angellcalactone. Lee W and Edgar Ribi. Jordan U. Gutterman, and George R. Blumenschein. Wattenberg. Luke K. T. Lam, and Alan V. Fladmoe. 1772 VIrus Particles in the Basal Plate of Rhesus Monkey 1563 Antiproliferative Effects of 9.p-o-Arabinofuranosyl 1655 Soluble Factors from Liver and Hepatomas Which and Baboon Placenta. Dorothy Feldman. adenine 5'-Monophosphate and Related Com Inhibit (â€˜HjThymidlneIncorporation Into DNA of No 1754 Transformation of Cultured Mouse Mammary pounds In Combination with Adenosine Deaminase vikoff Hepatoma Cells. Rosemary Barra. Janey Glands by Aromatic Amlnes and Amldes and TheIr Inhibitors against Mouse Leukemia L1210/C2 Cells Parsons. Michael R. Koch, and Michael A. Lea. Derivatives. Quentin J. Tonelli. R. Philip Custer. and In Culture. Carol E. Gaas, Terasita H. Tan. and 1661 ReversIble Inhibition by Retinolds of 3-Methylchot Sam Sorof. Milada Selner. snthrene-induced Neoplastlc Transformation in 1793 Excision Repair of cia-Diammlnedichloropiatl 1570 ActIvity of a Novel Anthracenedlone, 1,4-Dlhydroxy C3H/1OT.x Clone S Cells. Ronald L. Merriman and num(II)-lnducedDamageto DNAof ChIneseHam 5,8-bls (j(2.((2-hydroxyethyl)amlnojethyl} amlno}) John S. Bertram. ster Cells. H. N. A. Fraval and J. J. Roberts. 9,10-anthracenedlone Dlhydrochlorlde, against Es 1667 Decrease In Collagen Productlon In Normal and 1795 Increased Excision of O'.Methylguanlne from Rat perlmental Tumors In MIce. Roslyn E. Wallace, K. C. Rous Sarcoma VIrus-transformed Chick Embryo Fl Murdock, Robert B. Angier, and Frederick E. Durr. Uver DNA after Chronic Admlnlatration of Dlmeth broblasta Induced by Phorbol Myriatate Acetate. K. ylnitrosamine. Ruggero Montesano, Henriette 1575 Leukemlc Host Influence on Normal Erythrocytic Barry Delclos and Peter M. Blumberg. BrÃ©sit.and Geoffrey P. Margison. and Oranulocytic Colony Formation In in Vise 1673 Formation of DNA Adducts In lOTS Mouse Embryo 1803 Heterogeneity In Cell-associated Transformation Plasma Clot Diffusion Chamber Cultures. Howard Fibroblasts Incubated with Benzo(a)pyrene or DI N. Steinberg and Eugene S. Handler. sensitive Proteins Antlgenically Related to Fibre hydrodlol OxIde Derivatives. Hstina Szejnwald nectln. Manuel Richer and Mary S. Richer. 1579 ModulatIon of Plasminogen ActIvator Synthesis in Brown. Alan M. Jeffrey. and I. Bernard Weinstein 1507 Growth and Treatment of Ehrllch Tumorln Mice wIth Chick Embryo Fibroblasta by CyclIc Nucleotldes 1675 Measurement of Progesterone Receptor In Human Alloxan-Induced DIabetes. KreSimirPsychE, Milivoje and Phorbol Myristate Acetate. E. L. Wilson and E. Breast Cancer BiopsIes. Bernard Powell. Roberto SlijepCevl@. Jasminka PaveliE, Jasna viE, Silvana Reich. E. Garola, Gary C. Chamness. and William L. Audy-Jurkovi@, Ziatko P. Paveli@. and Milivoj 1557 Evidence for Several Demethylase Enzymes In the McGuire. Borani@. Oxidation of Dlmethylnitrosamine and Phenyl 1653 Isolation and Immunochemical Characterization of methylnltrosamlne by Rat Uver Fractions. Marilyn Antibodies from the Sera of Cancer Patients Which 1514 IdentIfication of Benzo()pyrene Metabolltea by Gas B. Kroeger-Koepke and ChristopherJ. Michelda. Are Reactive against Human Melanoma Cell Mem Chromatograph-Masa Spectrometer. Gonya branes by AffinIty Chromatography. Rishab K. Takahashi, Kazuyuki Kinoshita, Kenji Hashimoto, 1592 PersIstence of DNA Damage during Development of Gupta. Hulbert K. B. Silver, Ralph A. Reisfeld. and and Kimio Yasuhira. Liver Angiosarcoma in Rats Fed Dletethylnitrosa Donald L. Morton. mine. SamuelE. Abanobi,EmmanuelFarber.and 1519 ProductIon of a-Fetoprotein and Normal Serum Pro D. S. R. Sarma. 1696 Use of Molecular HybrIdization to Detect Type D telna by Xenotransplanted Human Hepatomas in RetrovlrusMarkersin RhesusPlacentasandOther Relation to Their Growth and MOrphOlOgy. Setsuo 1597 Eradication by Immunization with Mycobacterial Tissues. W. Drohan. D. Cotcher, and J. Schlom. Hirohashi, Yukio Shimosato. Toru Kameya. Tsutomu Vaccines and Tumor Cells of Microscopic Metas Koide, Tatsu Mukojima. Yumiko Taguchi. and Keizo tases RemaInIng after Surgery. B. Zbar, G. Canti. 1702 In Vivo Eftects and Parallel in Vitro Cytotoxicity of Kageyams. N. P. Ashley, H. J. Rapp, J. T. Hunter, and E. Ribi. Splenocytes Harvested from Treated or Control C57BL/6J Mice after Adluvant immunotherapy of 1529 Alteration of Hexosaminidase isozymes In Human 1604 Effect of Mlcrotubule-asaociated Proteins on the Pulmonary Metastases Using Xenogeneic RNA Renal CarcInoma. Toshikazu Okochi. Hiromas.a Interaction of Vlncristine wIth Mlcrotubules and Tu SpecIfIc to B16 Murine Melanoma. Boaco Shang Seike, Kazuya Higashino, Toshikazu Hada. bulin. J. Ale@androDonoso. Kathryn N. Haskina, and Wang, Glenn Steele. Jr. . John A. Mannick, Shinichiro Watanabe, Yuichi Yamamura. Fumio Ito, Richard H. Himea. Marguerite Falton. and Suzanne R. Onikul. Minoru Matsuda, Maaao Osafune, Toshihiko Kotske, and Takao Sonoda. 1611 Erythroid Leukemia Induced by Friend Lymphatic 1705 Glemsa-banding Karyotype of Rat Hepatomas of LeukemIa Virus in T-CeIl-depleted Mice. Peter J. DIfferent Growth Rates. Edith Olah and George 1535 Estrogen and Progesterone Receptors In Human Dawson, Steven L. Dresler, and A. Howard Weber. Breast Cencer wlth Concomitant Aaaay of Plasma Fieldsteel. 17fl-Estradlol, Progesterone, and Prolactin Levels. 1715 Epldermal Carcinogenicity of BI5(2,3-epoxycyclo 1616 Cytoldnetic Analysis of L1210 Leukemia after Con R. Nagai. N. Kataoka, S. Kobayashi, K. Ishihars, N. pentyl)ether, 2,2-Bla(p-glycidyloxyphenyl)propane, Tobioka, K. Nakashima, N. Naruae. K. Seito, and S. SInuous Infusion of Hydroxyurea in Viro . Ruth E. and m-Phenylenedlamlne In Male and Female C3H Sakuma. Moran and Marc J. Straus. and C57BLI6 Mice. J. N. Holland, D. G. Gosslee. 1623 Enhancement by Caffeine of Neocarsinostatin Cy and N. J. Williams. 1541 Alterations In the Response to Erythropoietln and totoxlclty in Murlne LeukemIa L1210 Cells. Kouichi RNA-dependent DNA Polymerase Activity In Mouse 1726 Effect of ModIfIcation of Plasma Membrane Fatty Tatsumi, Masaro Tashima, Shigeru Shirakawa, Toni Spleen Cells Infected wIth Friend LeukemIa Vlrue. Acid ComposItionon FluidItyand Methotrexate Nakamura, and Haruto Uchino. A. Horikoshi, R. Sasaki, H. Mizoguchi, Y. Miura, F. Transport In L1210 Murlne LeukemIa CelIa. C. Takaku, and I. Amaki. 1625 Changes In Peroxlsomes In Prensoplastic Uver and Patrick Bums, Diana G. Luttenegger, David T. Hepatoma of Mice Induced by a-Senzene Hexa Dudley, Garry R. Buettner, and Arthur A. Spector. 1847 KillIng of Tumor Cells in Vitro by Macrophages from chlorIde. Hideyuki Tsukada, Mikio Gotoh. Yohichi MIce Treated with Synthetic Dehydrodlpeptides. * 1733 SpecIfIc Cellular Immune Responses In Patients Mochizuki, and Kazunori Furukawa. Hana-Ulrich Schorlemmer, Wolfgang Opitz, Eugen with Malignant Gllomas. Khatid M. A. Sheikh, Etschenberg. Dieter Bitter-Suermann, and Utrich *3835 FacilItated Light Microacopic Cytochemical Diagno Michael L. J. Apuzzo. and Martin H. Weiss. Hadding. ala of Acute Myelogenous Leukemia. Jacob S. 1739 Immunological Analysis of A Strain Mice Bearing Hanker, Wallace W. Ambrose, Cheryle J. James, Joel 1554 Communication: Thymidlne and Hypoxanthine Re the A-b Mammary Adenocarcinoma. A. Tax and qulrements for the Proliferation of Normal and Roes Mandelkorn, Peggy E. Yates. Stanley A. Gall, L. A. Manson. Edward H. Bossen, Joseph W. Fay. John Laszto, and SarcomaVIrus-infectedChickenAbroblastsin the Presence of Methotrexate. Samuel D. Balk, Richard Joseph 0. Moore. 1745 Feeder Layer and Nutritional Requirements for the Establishment and ClonIng of Human Malignant S. Mitchell, Dana LeStourgeon. and Baldev Singh * 1640 Serum InhIbitor Activity of Granulocyte-Macro Lymphoma Cell Unea. Alan L. Epstein and Henry S. Noon. phage Colony Formation In Patients with Cancer. Kaplan. Yong K. Lw. Stephen Stallard. Victor Koo. and 1557 Letter to the Editor: Volatile Nitrosamlne Contaml Charles L. Dannaher. 1760 Characterization of the Carclnoembryonlc Antigen nation of Laboratory Animal DIets. Gordon S. ACtIvity Asaoclated with Cyst Fluids of Muclnous Edwards, James G. Fox, Peter Policastro, Ulku Goft. * 1645 Initial Clinical TrIals in Cancer Patients of Poiyriboi OvarIan Cystadenoc.arclnoma.Kohki Yamashita. Martin H. Wolf, and David H. Fine. nosinic-polyribocytidylic Acid Stabilized with PoIy-L Mirja-Liisa Aitio. and Jeffrey R. Dawson. tysine, in Carboxymethylcellulose [Poly(ICLC)j, a 1559 Announcements Highly EffectIve Interferon Inducer. Arthur S 1766 1860 Erratum Levine, Mary Sivulich. Peter H. Wiernik. and Hilton and Mutant Salmonella In Causing Regression of B. Levy. Line-lO Tumors In GuInea PIga. Charles A. 1861 Author Index

June, Number 6, Part I

carotovora L-Asparaginasesby Attachment of Poly 1863 Historical Review of the American Association for 1904 Spontaneous Regressive Epitheliomaa in the Japa x.-aianyl Peptides. Jack R. Uren and RichardC. Ragin. Cancer Research. Inc., 1941-1978. Hugh J. Creech. ness Newt, Cynops pyrrhogaster. Carl J. Pfeiffer, Toshihiro Nagai, Masaki Fujimura, and Takayoshi Tobe. 1934 Potent Tumor-initiating Activity of the 3,4-Dihydrodiol 1891 Cell Cycle Distribution of Chronically Hypoxic Cells of 7,12-Dimethylbenz(a)anthracene in Mouse Skin. and Determination of the Clonogenic Potential of 191 1 Effects of Hyperthermia (41.5@)on Chinese Hamster Ovary Cells Analyzed in Mitosis. Ronald A. Coss. T. J. Slaga, G. L. Gleason. J. DiGiovanni. K. B. Cells Accumulated In G, + U Phases after Irradiation Sukumaran. and R G. Harvey. of a Solid Tumor In Vivo. Maria G. Pallavicini,Marc. E. William C. Dewey, and James R. Bamburg. Lalande, Richard G. Miller, and Richard P. Hill. 1919 The Generality of Methylglyoxal Bis(guanylhydra 1937 Collateral Sensitivity to Methotrexate in Cells Resist zone)-Induced Mitochondrial Damage and the Dc ant to Adriamycin. Terence S. Herman. Anne E. Cress. 1898 Resting Host and Tumor Perfusionas Determinants of pendenceof this Effect on Cell Proliferation. F. Mikles and Eugene W. Gerner. Tumor Vascular Responsesto Norepinephrine. Stuart Robertson, B. Feuerstein, C. Dave. and Carl W. Porter. W. Young, Norman K. Hollenberg,Elias Kazam, Daniel * 1943 Glycoayltransferase and Glycosidase Activities in N. Berkowitz. Ron Hainen, Tamas Sandor, and Herbert 1927 Improvement in the Therapeutic, immunological, and Ovarian Cancer Patients. Sunil K. Challerjee. Malaya L. Abrams. Clearance Properties of Eachrlchla coil and Erwinia Bhattacharya, and Joseph J. Barlow.

VIII CANCER RESEARCH VOL. 39 Contents of Volume 39, 1979

1952 StImulation of Human Chorionic Gonadotropin by JAr 2057 Frequency of Association of Mammary Tumor Glyco 2166 Tumor Eradication and Cell Survival after Localized Line Chorlocarcinoma after InhibItion of DNA Synthe protein Antigenand Other Markers with HumanBreast Hyperthermia Induced by Ultrasound. Jane B. Marmor, 545.Jane C. Azizkhan, K. V. Speeg, Jr., Kurt Stromberg. Tumors. Julia P. Leung, Gerald N. Bordin, Robert M. Fred J. Hilerio, and George M. Hahn. and Dennis Goode. Nakamura, David H. DeHeer. and Thomas S. Edgington. 2172 Karyotypic, Antigsnic, and Kidney-invasiveProperties 1960 MorphologIcal Differentiation of Human Choriocarci 2062 DetectionofReverseTranscriptaseActivItyinHuman of Cell Lines from Fibrosarcomas Arising in C3H/ noise Cells Induced by Methotrexata, Susan J. Cells. Ann A. Kiesslingand Mehran Goulian. lOT/a Cells Implanted Subcutaneously Attached to Friedman and Philip Skehan. 2070 Altered Surface Membrane Glycoproteina in ymca Plastic Plates. Charles W. Boone, Devi Vembu, Beverly *1968 Gluconeogenesls from Alanine in Patients wIth Pro Alkaloid-resistant Human Leukemic Lymphoblasts. J. White, Noritoshi Takeichi, and Meera Paranjpe. greaslve MalIgnant Disease. Christine Waterhouse, William T. Beck, Thomas J. Mueller, and Lee R. Tanzer. Nicolas Jeanpretre, and Julian Keilson. 2179 Cardiovascular Lesions and Various Tumors Found in Rats Given T-2 Toxin, a Trichothecene Metabolite of *1973 RelatIonshIp between the Progesterone, Androgen, 2077 Reversal by Glucocorticoid Hormones of the Loss of Fusarmum. Regina Schoental, Abraham Z. Joffe. and and Giucocorticoid Receptor and Response Rate to a FibronectinandProcollagenMatrixaroundTrans. Boris Yagen. Endocrine Therapy in M.tastatIC Breast Cancer. formed Human Cells. Leo T. Furcht, Deane F. Masher, Joseph C. Allegra, Marc E. Lippman, E. Brad Gwen Wendelschafer-Crabb,and Jean-Michel Foidart. 2190 Inhibition of Differentiation of Cultured Mouse Mye Thompson. Richard Simon, Audrey Barlock. Linda 2084 Affinity Cytotoxicity with an AlCOhOlDehydrogenase bid Leukemia Cells by Nonsteroidal Antlinflammatory Green. Karen K. Huff, Hoan My T. Do, Susan C. Aitken, Antibody Conjugate and Allyf Alcohol. Gordon W. Agents and Counteraction of the InhibitIon by Pros and Robert Warren. Philpott, Eileen H. Grass, and Charles W. Parker. taglandin E. Yoshio Honma, Takashi Kasukabe, and 1950 Comparative Metabolism of Benzo(a)pyrene In Organ Motoo Hozumi. and Cell Cultures DerIved from Rat Tracheas. Gerald 2090 Induction of the DNA Repair Enzyme Uracil-ONA Gly N. Cohen, Ann C. Marchok. Paul Nettesheim, Vernon cosylase In Stimulated Human Lymphocytes. Michael 2195 QuantItative Evaluation of the Activity of the Malate E. Steele, Fred Nelson, Shilling Huang, and James K. A. Sirover. Aspartate Shuttle in Ehrlich Ascites Tumor Celia Selkirk. B. Chiaretti, A. Caaciaro, G. Minotti, M. L. Eboli, and 2096 Comparison of Sait-extractable Nuclear Proteins of T. Galeatti. *1985 Leukocyte Migration Inhibition in Vitro in Bladder Car. Regenerating Liver, Fetal Liver, and Morris Hepato clnoma. J. A. Lavergne, D. L. Lamm. H. M. Radwin. and mas 9618A and 3924A. Hiroshi Takami, Fredric N. 2200 ActIve Efflux of Daunorubicin and Adrismycin in Sen. J, T. Harrlngton. Busch, Harold P. Morris, and Harris Busch. sitive and Resistant Sublinea of P388 Leukemia. Makoto Inaba, Harumi Kobeyashi,YoahioSakursi, and 1989 TumorPromoter-induced Adhesion of the DS19 Clone 2106 Different Effects of Vincristine on Methotrexate Up of Murine Erythroleukemia Cells. Hiroshi Yamasaki, RandallK. Johnson. take by L121O Cells and Mouse Intestinal Epithelia in I. Bernard Weinstein, Eitan Fibach. Richard A. Rifkind, vmt,oand in Vivo.PaulL.Chello,FrancisM.Sirotnak, and Paul A. Marks. 2204 Adequacies and Inadequacies in Assessing Murlne and Diane M. Dorick. Toxicity Data with Antineoplastic Agents. AnthonyN. 1995 Effect of NutrItional Alterations on Protein Synthesis Guarino. Marcel Rozencweig, Ira Kline, John S. PenIs, In TranaplantabIe Hepatomas and Host Liversof Rats. 21 13 Alteration of S-AdenoaylmethionlneSynthetasea dur John N. Venditti, Harris H. Lloyd. Donald A. Holzworth, Herschel Sldransky and Ethel Verney. ing Chemical Hepatocarcinogenesis and in Resulting and Franca M. Muggia. Carcinomas. Ming C. Liau, Chen Fee Chang, and 2001 Traneter of Tumor Cells between Cell Aggregates as Frederick F. Becker. 221 1 Eponymic Cancer Institutes in the United States. a Model for Adhesive Changes in MetastasIs. Jay N. M. B. Shlmkin Umbreit and Richard W. Erbe. 2120 RegionalLymph Node Reactivity in Expianted Bladder Cancer of Mice as Measured by Flow CytOmetry. Lars 2o@ BiochemIcal and PhysIcal Characterizations of Tu 2216 Communication: Drug Sequence-dependent Toxicity G. Collate, Zbigniew Darzynkiewicz, Frank Traganos, mor-associstad Fetal Antigens. D. L. Evans. D. V. andSmallBowelMucosalInjuryinMiceTreatedwith Thomas K. Sharpless, Willet F. Whitmore, Jr., and Low Doses of 3-Deazauridine and 1-fl-o-Arabinofura Parker. and N. K. Frank. Myron R. Melamed. nosylcytosine. Alan R. P. Paterson, Ewa S. Jakobs, 2016 Immunoblologlcal Characterizations of Tumor-asso 2125 Antibody-Induced Movement of Common Melanoma Gilles J. Lauzon, and Wilfred N. Weinstein. dated Fetal Antigens. D. L. Evans, M. K. Frank, K. P Membrane Antigens on the Surface of Unfixed Human McKlnnon. and N. Cerrone. Melanoma Cells. Stanley P. L. Leone, Sidney R. Letters to the Editor 2026 Effect of 2-Nltrofluorene, I ,2-Dimethylhydrazlne, and Cooperband, Peter J. Deckers, Carl N. Sutherland, Azoxymethane on Salmonella typhimurlum Mutants James F. Cesare. and Edward T. Krementz. 2220 Critical Temperature of Mammalian Cells. Corre IntheGaetrolntestlnalTractofGnotobloticRats.John spondence re: S. A. Sapareto, L E. Hopwood, W. C. H. Carter. Martha A. McLafferty. and Peter Goldman. 2132 EffeCtof Hepatocarclnogenson the AdeninePurina Dewey, N. R. Raju, and J. W. Gray. Effects of Hyper Nucleotide Cycle durIng the Initiation Phase of Car thermiaonSurvivalandProgressionofChineseHam *2031 AltsrationsIn Platelet Surface Sialyftransferaae Activ cinogenesis. Larry D. Smith, Richard L. Emerson,and ster Ovary Cells. Cancer Rca.. 38: 393-400, lty and Platelet Aggregation in a Group of Cancer Linda K. Nixon. 1978.RobertSchrek. Patients wIth a High Incidence of Thrombosis. Stephen A. Sapareto. Salvatore J. Scialta, Steven F. Speckart, Michael J. 2139 ResIstanceto EhriichAsciteaTumorin a Strainof Haul, and Daniel B. Kimball. Dystrophic Mice. Paul J. Carry, David M. Prescott, and Gregory K. Ogilvie. 2221 Correspondencere: D. L. Klein, K. Perk, J. E. 2035 Increased Cyclic Adenosine 3':5'.Monophosphate Dahlberg,W.Brown,andJ. W.Pearson.Isolationand Pfiouphodlesterase Activity in the Epidermis of Poor 2141 IsolatIon of Rat a,-Fetoprotein Messenger RNA from Characterization of a Spontaneous Lymplsocytic Lee hal Ester-treated Mouse Skin and in Papillomas. R. A. MorrIs Hepatoma 7777. Luc Belanger, Patricia kemia (L-76) in the Strain 2 Guinea Pig. Cancer Res., Mutson. R. C. Simalman,and R. K. Boutwell. Commer, and Jen-Fu Chiu. 38: 3154â€”3160, 1978. Eli M Nadel, Stephen C. Thompson and Vernon W. Fischer. 2041 Potentiatlon of AntIcancer Agent Cytotoxicfty against 2149 Ozonation of Mutagenic and Carcinogenic Polyaro David L. Klein. SensitIve and Resistant AKR Leukemia by Amphoter matic Aminea and Polyaromatic Hydrocarbons in Wa 1cm B. Fred Vateriote, Gerald Medoff, and Julia ter. Gary R. Burleaon, Michael J. Caulfield. and Morris 2223 Books Received Dieckman. Pollard.

2046 Hormone-induced Growth and Lactogeneals of Grafts 2155 Ozonatlon of MutageniC and Carcinogenic Alkylating 2226 Special Announcement of BovIne Mammary Gland Maintained in the Athymic Agents, Pesticides, Aflatoxin B,, and Benzldine In @@Nude'@Mouse. Clifford W. Welsch. M. Jean McManus, Water. Michael J. Caulfield, Gary R. Burleson, and Jane V. DeHoog, Gordon T. Goodman. and H. Allen Morris Pollard. 2227 Announcements Tucker. 2160 Increased Tumorlgenicity and Resistance to Antibody 2228 Errata 2051 MetabolIsm and Excretion of Benzo(a)pyrene 4,5-Ox Lysis of Human Colon Tumor Cells Xenografted in Ide by the Isolated Perfused Rat Liver. Brian R. Smith Congenitally Athymic Mice. M. B. Tompkins, G. V. and John R. Bend. Rams Rao. and W. A. F. Tompkins. 2229 Author Index

June, Number 6, Part II

PROGRAM

List of Participants 2234 Foreword. Jack W. Milder 2235

SESSION I

Animal Models and Clinical StudIes

Chairman: Joan N. Bull

Hypertherrnic Treatment of Human Tumors Heterotranspianled in Nude Mice. Beppino C. Giovanelia. John S. Steblin, Randall C. Shepard, and Leo J. Williams 2236 Large Animal Studies of Hyperthermia and Irradiation. Edward L. Gillette 2242

DECEMBER 1979 ix Contents of Volume 39, 1979

Normal Tissue and Solid Tumor irtlecla of Hyperthermia in Animal Models and Clinical Trials. F. Kristian Storm, William H. Harrison, Robert S. Elliott, and Donald L. Morton 2245 A ClinicalInvestigationof Total-BodyHyperthermiaas Cancer Therapy. James M. Larkin 2252 Resuts of Eleven Years' Experience with Heated Perfusion for Melanoma of the Extremities. John S. Stehiin, Jr., Beppirio C. Giovanella, Peter 0. de Ipolyi, and Robert F. Anderson 2255 Clinical and Biological Studies of Localized Hyperthermia. J. H. Kim and E. W. Hahn 2258 Summaryof the InformalDiscussionon AnimalModels and ClinicalStudies. Joan Bull 2262

SESSION II

Adjuvant Techniques for Hyperthermia

Chairman: George N. Hahn

Potential for Therapy of Drugs and Hyperthermia. George M. Hahn 2264 Interactions of Hyperthermia and Chemotherapy in Animals. Jane B. Mermor 2269 Kinetics of Cell Kill by Hyperthermia. Buoy K. Bhuyan 2277 Possible Benefits of Hyperthermia to Chemotherapy. C. D. Kowal and J. R. Bertino 2285 Potential for Hyperthermia and Radiation Therapy. Herman D. Suit and Leo E. Gerveck 2290 Summaryof the InformalDiscussionof AdluvantTechniquesfor Hyperthermia. George M. Hahn 2299

SESSION III

Thermal Dosimetry

Chairman: Richard Johnson

Thermal Dosimetry and Clinical Requirements. Kenneth H. Luk and Theodore L. Phillips 2300 Regional Blood Flow in Human Tumors. Math J. MÃ¤ntylÃ¤ 2304 Aspects of Thermoregulatory Physiology Pertinent to Hyperthermic Treatment of Cancer John Bligh 2307 Assessmentof Current HyperthermiaTechnology. E. Ronald Atkinson 2313 Thermal Dosimetry and Temperature Measurements. 0. A. Christensen 2325 Summaryof the InformalDiscussionof Thermal Dosimetry. Richard Johnson 2328

SESSION IV

Future Clinical and Basic Research Needs

Chairman: Henry S. Kaplan

Recommendationsfor Future Researchin Hyperthermiaat the Molecular.Cellular,snd AnimalLevels. William C. Dewey 2330 Clinical Instrumentation Requirements with a Review of the Perth Hyperthermia Experience. William L. Caldwell 2332 Remarks on Physiology and Tissue Response in Animals. John Bligh 2336 Combined Modalities. Joan Bull 2337 Summary of the Informal Discussion of Future Clinical and Basic Research Needs. Henry S. Kaplan 2338

July, Number 7, Part I

2341 Quantitative Tumor Cytochemistryâ€”G. H. A. Clowes 2390 Morphological Markers of Oncogenic Transformation lion of Burkitts Lymphoma Cells hi VItrO. Kwsng B. Memorial Lecture. Torblorn0. Caspersson. in Respiratory Tract Eplthelial Cells. C. A. Heckmsn Woo, Fulvio Penni, Joan Sadow. Carole Sullivan, and and A. C. Olson. William Funkhouser. 2356 Morphological Transformation. DNA Damage, and Chromosomal Aberrations Induced by a Direct DNA 2400 Persistent Binding of 3-Methylcholanthren. to Mouse 2436 Role of Adrenais and Estrogen in RegressIon of Main Perturbation of Synchronized SyrIan Hamster Embryo Lung DNA and Its COrrelation wIth Susceptibility to mary Tumors during Postpartum Lactation In the Rat. Cells. Takeki Tsutsui, J. Carl Barrett, and Paul 0. P. Pulmonary Neoplasla. Alan Eastman and Edward Charles F. Aylsworth, Charles A. Hudson. G. Berg, Tso Bresnick. Gary Kledzik, and Joseph Meitea. 2406 Mechanism of Induction of Gastrointestinal Toxicity * 2366 Splenectomy as Initial Therapy in Twenty-aix 2440 Characteristics of Transport of 4-Amino Antifoiatea in the Mouse by 5-Fluorouracil, 5-Fluorouridine, and Patients with Leukensic Reticuioendotheliosia (Hairy and Folate Compounds by Two Lines of L5178Y Lym S-Fluoro-2'-deosyuridine. Janet A. Houghton, Peter J. Cell Leukemia). Un Mintz and Harvey M. Golomb. phoblasts, One with Impaired Transport of Methotrex Houghton, and Robert S. Woolen. ate. Bridget T. Hill, Brenda D. Bailey, J. COUrtland White, and I. DavidGoldman. 2371 Increased Survival of Rats Bearing Morris Hepatoma 2414 Correlation of Ultrastructural and Functional Damage 7800 after induction of Hypothyroidism. Seymour to Mitochondria of Ascites L12IO Cells Treated In 2447 Carclnoembryonic Antigen-like Substance Derived Mishkin, Harold P. Morris, Marty A. Yalovsky, and Vivo with Methylglyoxal-bis(guanylhydrazone) from Human Prostate. Richard D. Williams, David L. P. V Narasimha Murthy. or Ethidium Bromide. Carl W. Porter, F. Mikles Bronson, A. David Myl, Jacques P. Vandevoorde. and Robertson, D. Kramer, and C. Dave. Arthur V. Elliott. 2376 Hydrolytic Enzyme Activities, Migratory Activity, and In Vlvo Growth and Metastatlc Potential of Recent 2422 DirectInhibitionofGrowthandAntagonismof Insulin 2451 Zinc Deficiency and Growth of Ehriich Ascitea Tumor. Tumor Isolates. James Varani, William Orr, and Peter Action by Glucocorticoids in Human Breast Cancer Daniel 1. Minkel, Patricia J. Dolhun, Barbara L. A. Ward Cells in Culture. C. Kent Osborne, Marie E. Monaco, Calhoun, Leon A. Saryan, and David H. Petenng. C. Ronald Kahn, Karen Huff, Diane Bronzert, and Marc 2381 inhibition of in Vitro Lymphocyte Function by Cystic E. Lippman. 2457 Effectsof ZincDeficiencyonCellularProcessesand and Ascitic Fluids from Ovarian Cancer Patients. Morphology in Ehriich Ascites Tumor Celia Leon A. Allan D. Hess, Stanley A. Gall, and Jeffrey R. Dawson. 2429 Polyamine Content and Release during the Prolitera Saryan. Daniel T. Minkel, Patricia J. Dolhun, Barbara

x CANCER RESEARCH VOL. 39 Contents of Volume 39, 1979

L. Calhoun. Susan Wielgus, Marilyn Schaller, and ium(Il) in L121O Tumor Suspension Culture. R A in the Amazon Molly, Poeciiia formosa. A. D. David H. Petering. Howard, A. P. Kimball, and J. L. Bear. Woodhead, R. B. Setlow, and P. M. Scully. 2466 Increase In Immunogenicity with Concomitant Loss of 2574 Effects of 9,10-Anthracenedione, 1,4-Bisl (2.1(2-by. *2704 Circulating Colony-forming Cells in Different Stages Tumorlgenlcity of Respiratory Tract Carcinomas dur droxyethyl)amino)ethyl(amino)-diacetate on Cell Sur@ of Chronic Myeiocytic Leukemia. Susan S. Leang, leg In Vitro Culture. Roudabeh J. Jamasbi and Paul vival and Cell Cycle Progression in Cultured Mamma Joseph E. Sokal, German A. Gomez, and Julius S. Netteaheim. han Celia Donald P Evenson, Zbigniew Horaszewicz. Darzynkiewicz, Lisa Slaiano-Coico, Frank Traganos. 2471 Competitive BInding Radloasaay for 5-Fluorodeoxyu 271 1 Immunological Activity of Regional Lymph Nodes in and Myron R. Melamed. ridine 5'-Monophoephate in Tissues. Donald S. Tumor-bearing Mice. Barbara P Barna and Shared D. Murinson. Tom Anderson, Howard S. Schwartz, Charles 2582 Rapid Decay of Tumoricidal Activity and Loss of Re Deodhar. E. Myers, and Bruce A. Chabner. sponsiveness to Lymphokines in Inflammatory Mac 2718 Different Responses to Drugs and Serum of Cells rophages. George Paste and Richard Kirsh. 2476 Ccl Cycle-specific Locus of Vitamin A Inhibition of Transformed by Various Means. Robert Dubrow, Growth. Marl K. Haddox and Diane Haddock Russell. 2591 Transplantability and Sex Steroid Hormone Respon Veronica 0. H. Riddle, and Arthur B. Pardee. siveness of Cervicovaginal Tumors Derived from Fe 2481 Differences In the Peripheries of Walker Cancer Cells 2727 Relevance of Recruitment-Synchronization in the male BALB/cCrgl Mice Neonatally Treated with Ovar Growing In Different Sites in the Rat. Leonard Weiss Scheduling of 1-fJ-o-Arabinofuranosylcytosine in a ian Steroids. Lovell A. Jones and Roberta Pacillas and James P. Harloa. Slow-growing Acute Myelold Leukemia of the Rat. N. Verjan. 2486 Induction of Thermotolerance by Multiple Heat Frac Aglietta and L. Colly. lions In Chinese Hamster Ovary CelIa K. J. Henle, 2595 Two-Dimensional Electrophoresis of Membrane Pro 2733 Gastrointestinal Carcinogenesis in Germ-free Rats A. F. Bitner. and L. A. Delhlefsen. teina from Normal and Transformed Cells. Bradley S Given N-Methyl-N-nitro-N-nitrosoguanidine in Drink Litin and William J. Grimes. 2492 LocalizatIon of Retinoic Acid-bindingProtein in Nuclei ing Water. Yukiko Sumiand MasasumiMiyakawa. and the Nuclear Uptake of Retinoic Acid. Brahma P. 2604 Morphological and Biochemical Properties of a New 2737 Calcium Transport and Translocation of Adenine Ne Sani and M. Kathleen Donovan. Human Breast Cancer Cell Line. A. J. Langlois,W. D cleotidea in Mitochondria from Morris Hepatoma Holder, Jr., J. D. Iglehart, W. A. Nelson-Rees, S. A. 2497 Temporary Dieappearanc (â€˜Eclipseâ€•)of LPC-1 Plas 3924A. Maria L. Eboli, Kerstin Malmstrom, Tommaso Wells, Jr., and D. P. Bolognesi. macytoma M Component Synthesis following Tumor Galeotti, Luisa LÃ³pez-Alarcon,and Ernesto Carafoli. Ccl Transfer. Carmelita 3. Frondoza, Sudhir M. 2614 increased Progeaterone Receptor Concentrations in 2743 Stimulation of Choline Incorporation in Cell Cultures Trivedi. and Richard L. Humphrey. Bladder Lesions of Estrogen-treated Syrian Hamsters. by Phorboi Derivatives and its Correlation with Their Young C. Lin, Deanna J. Talley, and Claude A. Villee 2501 Cyclic Adsnoeine 3':5'-Monophoaphate and Protein Irritant and Tumor-promoting Activity. Volker Kinzel, klnmoActivity In Insulin-dependent and -independent 2618 Stimulation of Differentiated Functionsin Human Mel Gert Kreibuch, Erich Hecker, and Rudolph Suas. Mammery Tumors. Samir N. Shafie, Yoon Sang Cho anoma Cells by Tumor-promoting Agents and Di 2751 Potentlating Effect of fl-Aminopropionltrile on the Otung. and Pietro N. Gullino. methyl Sultoxide. Eliezer Huberman. Carol Heckman, DNA Synthesis Induced by Isoproterenol. Takehito and Robert Langenbach. 2505 Asseesment of Tobacco-specific N-Nitrosaminea in Sasaki and Masahiko Yamamoto. Tobacco Products. Dietrich Hoffmann. John D. 2625 Biochemical Action of the Antineopiastic Agent 2- 2755 Inhibition of Chemical Transformation in C3H/IOT'A, Adams. Kiaua D. Brunnemann, and Stephen S. Hecht. Formylpyridine N-oxide B@nzenesuIfonylhydrazone. Cells by Protease Inhibitors. Toshio Kuroki and Cecile Sang He Lee and Alan C. Sartorelli. 2510 Sister chromatid Exchange Induction Resulting from Drevon. Systemic, Topical, and Systemic-Topical Presents 2630 Response of Exponentially Growing, Stationary *2762 Comparative Metabolism of 2(Bls(2-chloroethyl)- Sons of Carcinogens. Charles F. Shuler and Samuel Phase, and Synchronized Cultured Human Colon Car amlno)tetrahydro-2H-1 ,3,2-oxazaphoephorine-2-ox A. Left. cinonta Cells to Treatment with Nitrosourea Deriva ide (Cyclophoephamide) and its Enantiomers in He fives. Benjamin Drewinko, Barthel Barlogie, and Emil mans. Michael Jarman. Robert A. V. MilsIed, John F. 2515 Effects of a CholIne-devoid Diet on the Emergence of Freireich. y.Glutamyltranapeptidase-positIve Foci in the Uver of Smyth, Ryazard W. Kinas, Krzyszlof Pankiewicz, and Carcinogen-treated Rats. Hiaaahi Shinozuka, Mary 2637 Neutral Fucolipids and Fucogangiioaides of Rat Hep Wojciech J. 51cc. Aiwi Sells. Sikandsr L Kalyal. Stewart Sell, and Benito atoma HTC and H35 Cells, Rat Liver, and Hepato 2768 Protective Effect of Oral Salmonella .nte,ItIdia 11RX Lombarcii. cytea. Heinz Baumann, Edward Nudelman, Kiyohiro Infection against Colon Tumor Induction by I ,2-DI Watanabe, and Sen-itiroh Hakomori. 2522 OverlappIng Pathways for Repair of Damage from methylhydrazine in Mice. Leonie K. Ashman, Martin Ultraviolet Light and Chemical Carcinogens in Human 2644 Effects of Structural Changes on the Tumor-promot G. Cook. and leva Kotlarski. Fibroblaets. Alex J. Brown, Ted H. Fickel, James E. log Activity of Phorbol Myristate Acetate on Mouse 2772 Effect of Extracellular pH on Thermotolerance and Cleaver. P. H. N. Lohman, M. H. Wade, and Raymond Skin. Benjamin L. Van Duuren, Shin-Shyong Tseng. Recovery of Hyperthermic Damage In Vitro. Ole S. Waters. Alvin Segal, Ann Carol Smith, Susan Melchionne, and Nielsen and Jens Overgaard. Irving Seidman. 2528 Macromolecular Binding and Metabolism of the Car 2779 Characterization of Rat Hepatoma Glucosamine 6- cinogen 4-Chloro-2-methyianiline. Donald L. Hill, Tzu 2647 Nuclear Retention of All Steroid Hormone Receptor Phosphate Synthase and Its Relation to Liver and Wee Shut. and Robert F. Struck. Classes in the Hamster Renal Carcinoma. Jonathan Fetal Forms. Taeko Miyagi and ShigeruTsuiki. J. Li, Sara Antonia Li, and Terry L. Cuthbertson. 2532 DetectIon of Sequences in Human Leukemic Cell DNA 2783 Glucosamine 6-Phosphate Synthase of Regenerating Homologous with Moloney Mouse Leukemia Viral 2652 Models for Development of Nonreceptor Methods for Rat Uver. Taeko Miyagi and Shigeru Tsuiki. RNA. Charles Van Beveren and Mehran Goulian. Distinguishing Androgen-senaitive and -insensitive Prostatic Tumors. John T. Isaacs, William B. Isaacs. 2787 DNA Strand Scisslon In Vivo and In Vitro by Auromo 2538 ModulatIon of the Cell Cycle of Cultured Mouse Liver and Donald S. Coffey. mycin. Hidea Suzuki, Toshio Nishimura, and Nobuo Cells by Benzo(a)pyrene and Its Derivatives. James Tanaka. C. Bartholomew. Andrew L. Pearlman, Joseph R. 2660 Carcinogenicity of 2.Hydroxybenzo(a)pyrene and 6- Landolpit, and Kenneth Straub. Hydroxybenzo(a)pyrene in Newborn Mice. Richard L. 2792 Age-related Decrease of Ultraviolet Light-induced Chang. Peter G. Wialocki, Jaime Kapitulnik, Alexander DNA Repair Synthesis in Human Peripheral Leuko 2544 Bacua Calmefte-Guodn Enhancement of Colony W. Wood, Wayne Levin, Haruhiko Yagi, He Duck Nab, cytes. Ba Lambert, Ulrlk Ringborg, and Lambert stimulating ActivIty and Myeloid Colony Formation Donald N. Jerina, and Allan H. Conney. Skoog. following AdmInistration of Cyclophosphamide. Stephen Ladiach. Gregory H. Reaman, and David 0. 2665 Effects of Hyperthermia (45@)onMacromolecular Syn 2796 Phoaphofructokinase Regulation in Some Transplant Popiack. thesis in Chinese Hamster Ovary Cells. Kurt J. Henle able Thyroid Tumors. Mana-Fiore Meldoiesi and Paoio Laccetti. 2547 Increased k, Vitro Toxicity to Mouse Bone Marrow and Dennis B. Leaper. wIth 1,3-Bla(2-chloroethyl)-1-nitroeourea and Hyper 2675 Dlfferencesin the Removalof N-Methyl-N-nitrosourea 2002 Glycoeaminogiycans and Proteoglycans of Normal thermia. Joseph F. O'Donnell, Wilma S. McKoy. methylated Products in Dltaae I-sensitive and -resist and Tumoral Cartilages of Humans and Rats. Paula Robert W. Makuch, and Joan M. Bull. ant Regions of Rat Brain DNA. Ray Cox. A. S. MourÃ¡o,Yara N. Michelacci, and Olga N. S. Toledo. 2550 Enact of Growth Conditions on the Content of the 2679 Metabolism of the Liver Carcinogen N-Nitrosopyrroli Ma(or Groups of Carbohydrates in Chick Embryo Fl dine by Rat Liver Microsomes. Lanny I. Hecker, 2807 Immunotherapeutic Response of Conc.anavalin A- broblasts. David E. Roll. Michael J. Weber, and H. James 0. Farrelly, Jacqueline H. Smith, Jose E. bound L1210 Vaccine Enhanced by a Streptococcal Edward Conrad. Saavedra, and Philip A. Lyon. immunopotentiator, OK-432. Taleshi Kataoka, Fujiko Oh-.hashi,and Yoshio Sakurai. 2556 Dose Response for Benzo(a)pyrene Adducts in Mouse 2687 Effect of 1-(4-Amino-2-nsethyI-5-pyrimidinyl)methyl-3- Epidermal DNA. M. A. Pereira, F. J. Burns, and R. E. (2-chioroethyl)-3-nitrosourea Hydrochlorideon Exper 281 1 Obituary: Wilhelm Bernhard. Elizabeth H. Leduc and Albert. imental Brain Tumors. Hiroshi Hasegawa, William R. Etienne de Harven. Shapiro, Jerome B. Posner, and George Basler. 2560 Cervlcovaginal and Mammary Gland Abnormalities in 281 2 Special Announcement BAL5/cCrgl Mice Treated Neonatally with Progester 2691 Chemotherapy of Experimental Metastatic Brain Tu. 2813 Announcements one and Estrogen, Alone or in Combination. Lovell A. mors in Female Wistar Rats. Hiroshi Hasegawa, Jones and Howard A. Bern. William R. Shapiro, and Jerome B. Posner. 2813 Errata 2568 Mechanism of Action of Tetra-@i-carboxylatodirhod 2698 Migration of Intraperitoneally Injected Thyroid Cells 2814 Author Index

DECEMBER 1979 xi Contents of Volume 39, 1979

July, Number 7, Part II

PROGRAM

List of Participants 2818

SESSION I

introduction

Chairperson: John B. Maloney

Cancer Overview Diane J. Fink 2819 A HialoricalOverviewof Alcoholand Alcoholism Mark Keller 2822

SESSION II

Drinking Patterns, Alcohol Abuse, and AlCOhOlIsm

Chairperson: Donald W. Goodwin

Measurements of Drinking Patterns in the General Population and Possible Applications in Studies of the Role of Alcohol in Cancer Robin Room 2830 The Family Physician and Confrontation in Alcoholism William M. Lukash 2834 The Disease of Alcoholism Stanley E. Gitlow 2836

SESSION Ill

AlCOhOl as a Factor in the Incidence and Development of Cancer

Chairperson: Joseph F. Fraumeni, Jr.

Epidemiology of Alcohol and Cancer A. J. Tuyns 2840 Etiolagical and Preventive Implications in AlcOhOlCarcinogenesis G. David McCoy and Ernst L. Wynder 2844 Epidemiologicat Opportunities in Alcohol-related Cancer Joseph F. Fraumeni, Jr. 2851

SESSION IV

Alcohol Use and Abuse in the Treatment, Rehabilitation, and Continuing Care of Cancer Patients

Chairperson: Diane J. Fink

Rehabilitation and Continuing Care of Cancer Patients Guy F. Robbins 2853 Delivery of Essential Services to Alcoholics through the Continuum of Careâ€• Daniel John Anderson 2855 Continuing Care of the Cancer Patient as a Social Engineering Problem Norman T. Walter 2859

SESSION V

Experimental Approaches to Studies on Alcohol and Cancer

Chairperson. Kurt J. laselbacher

Alcohol-relaled Diseases and Carcinogenesis CharlesS. Lieber, HelmutK. Seitz, AnthonyJ. Garro. and TheresaM. Worner 2863 Current Status of Experimental Chemical Carcinogenesis and Its Applications to Human Cancer Risk William Lijinsky 2887 Modes of AlcoholAdministrationAppropriatefor the Studyof the Role of Alcoholin Carcinogenesis David Lester 2891 Animal Models In Cancer Research Which Could Be Useful in Studies of the Effect of Alcohol on Cellular Immunity Michael A. Chirigos and Richard M. Schultz 2894 Possible Relationships of Alcohol in Membranes to Cancer GerhardFreund 2899 Type C Retrovirus Aclivation and Possible Functions in the Normal and Tumor-bearing Host A. Hellman, 0. S. Weislow.D. R. Twardzik,and A. K. Fowler 2902

xii CANCER RESEARCH VOL. 39 Contents of Volume 39, 1979

August, Number 8

*2909 Forssman.like Antibody Levels in Sera of Patients Berezney, Joseph Basler, Benlamin B. Hughes, and the Clonogenicity of Murine Leukemic Stem Cells. wIth Lung Cancer. Haiime Kitamura, Philip Levine, Steven C. Kaplan. Yau-kwan Ho, Harvey D. Preisler, and Thomas J. Po-Jun Cheng, Ruedi A. Egeli, Yen-Ping Liu, Robert Bardos. A. Good, and Naarbibi K. Day. 3040 Inhibition of N-n-Butyl.N.(4hydroaybutyl)nitros. amine-induced Urinary Bladder Cancer in Rats by 3167 Prolongationof SurvivalTime of Mice Inoculated with 2914 Formation of Methotrexate Polyglutamates in Rat Administration of Disultiram in the Diet. Charles C Myeloid Leukemia Cells by Inducers of Normal Differ Hepatocytes. David A. Gewirtz, J. Caurtland While, Irving, Arvil J. Tice, and William M. Murphy. entiation. Yoshia Honma, Takashi Kasukabe, Junko Joyce K: Randolph, and I. David Goldman. 3044 Effects of 2'-Deoxycoformycin Infusion on Mouse Okabe, and Motao Hazumi. Adenoalne Deaminase. Antonio Tedde, M. Earl BaIts, 2919 CIrculating Immune Complexes in Sera of Hamsters 3172 Tissue Distribution of the Receptor for 2,3,7,8-Te Bearing Simian Virus 40-Induced Tumors. Ralph Rhonda Schonberg, and Paul P. Trotta. trachlorodibenzo-p.dioxin in the Rat. Jan M. B. Heimer and Chriatiane de Vaux Saint Cyr. Carlstedt-Duke. 3051 Phenotypic Properties and Tumor Promoter-induced 2923 Collagen Synthesis in Capsules Surrounding Di Alterations in Rat Embryo Cells Transformed by Ad *3177 Effects of Smoking on Benzo(a)pyrene Metabolism methylbenzanthracene-Induced Rat Breast Tumors enovirua. Paul B. Fisher, Neil I. Goldstein, and by Human Placental Microsomes. J. B. Vaught, and the Effect of Pretreatment with fS-Aminopropio. I. Bernard Weinstein. nitric. I. Keiman Cohen, Charles W. Moncure, H. L. Gurtoo, N. B. Parker, R. LeBoeul, and G. Doctor. Raphael J. Witorsch, and Robert F. Diegelmann. 3058 Immunological Block to Synthetic a-Melanocyte-atim elating Hormone-Melanocyte interaction by Antibod 3184 Comparison of Benzo( a)pyrene and (â€”)-trans-7,8-Di 2928 RegressIon of Human Tumors Established in Nude lea isolated from Cell-Column Immunoadsorbents. Mice after Continuous Infusion of Thymidine. hydroxy-7,8.dihydrobenzo(a)pyrene Metabolism in Jeffrey L. Winkelhake, Barbara M. Elcombe, and Human Blood Monocytes and Lymphocytes. Paul Shih-Shun Lee. Beppino C. Giovanella, John S. Albertina Hodach. Stelslin.Jr., and Jan C. Brunn. Okano, Haruko N. Miller, Richard C. Robinson, and 3065 Plasma and Brain Amino Acids in Walker 256 Carci Harry V. Gelbain. 2934 CharacterizatIon ofa Tumor Cell Surface Protein with nosarcoma-bearing Rats. Rudolf Krause, J. Howard 3194 ToxicIty of Metabolic Benzo( a)pyrenediones to Ccl Heterologous Antisera to a Spontaneous BALB/c James, Christopher Humphrey, and Josef E. Fischer. tured Cells and the Dependence upon Molecular Ox Lung CarcInoma. Stephen J. Kennel. ygen. Ronald J. Lorenlzen, Stephen A. Lesko, 3070 Synthesis of the Glucuronic Acid Conjugate of Math Kathleen McDonald, and Paul 0. P. Tso. 2940 ModifIcation by Adenoelne of the Effect of Adriamy ylazoxymethanol. Hiromu Malsumoto, Ronald H. ciii on Myocardial Cells in Culture. Maria W. Takata, and David Y. Kameiii. 3199 Human Urinary Metabolites of 1.{Tetrahydro-2-fur Seraydarian and Luz Artaza. anyl)-5-fluorouracil (Ftorafur). John A. Benvenulo, 3074 Prolonged Induction of Hepatic Ornithine Decarbox 2945 Presence of Suppressor Celia in Spleens of Mice Joachim G. Liehr. Tammo Winkler, David Farquhar, ylase and Its Relationto Cyclic Adenosine3:5-Mono Richard M. Caprioli, and Ti Li Lao. Bearing a Weakly Immunogenic Syngeneic Tumor. phosphate-dependent Protein Kinase Activationafter Subbash C. Gautam and Sharad D. Deadhar. a Single Administration of Diethylnitrosamine. 3202 Kinetic Characterization and Response to Chemo 2952 induction of Transplantation Resistance with Soluble Jack W. Olson and Diane Haddock Russell. therapy in a Transplantable Murine Ovarian Cancer. Simian Virus 40-Induced Hamster Tumor-specific Robert F. Ozols, Karen R. Grotzinger, Richard I. Transplantation Antigen. Joseph H. Coggin, Jr. 3080 Biological Characterization of a Leukemogenic Virus Fisher, Charles E. Myers, and Robert C. Young. Isolated from the CFW Mouse. J. K. Ball and 3209 Pharmacokinetics of Adriamycin and Tissue Penetra 2960 Interactions of the Carcinogen 4-Nitroquinoline 1- J. A. McCarter. tion in Murine Ovarian Cancer. Robert F. Ozols, Oxide with the Non-Protein Thiols of Mammalian Gershon Y. Locker, James H. Dorashow, Karen R. Cells. Marie E. Vames and John E. Biaglow. 3089 Selective Inhibition of Pyrimidine Synthesis and Dc pletion of Nucleotide Pools by N-(Phosphon. Grotzinger, Charles E. Myers, and Robert C. Young. 2966 Enhancement of Radloresponse of a Mouse Main acetyl)-i.-aapartate. James D. Moyer and R. E. 3215 PossIble Mechanisms of Action of Uthium on Aug. mary CarcInoma to Combined Treatments with Hy Handschumacher. mentation of In VItro Spontaneous Myeloid perthermia and Radloeensitizer MisonIdazole. Colony Formation. Gary Spitzer, Dharmvir S. Anna Goidteder, Dennis M. Brown, and Agnes Berger. 3095 Selective Antagonism of 5-Fluorouracil Cytotoxicity b14-Hydroxypyrazolopyrimidine(Allopurinol) In Vitro. Verma, Barthel Barlagie, Miloslav A. Beran, and 2971 Elevation of Extrahepatic Glutathione S-Transferase Pauline M. Schwartz and Robert E. Handschumacher. Karel A. Dicke. and Epoxlde Hydratase ActivitIes by 2(3)- tert-Butyl 3102 Some Properties of Uridine-Cytidine Kinaae from a 3220 Efficacy of 6-Diazo-5-oxo-t-norleucine and N-(N-y 4-Ilydroxyanlsole. Ann N. Benson, Young-Nam Cha, Glutamyt-6-diaso-5-oxo.horleucinylj.6.diazo-5.oxo ErnestSeeding. Henry S. Heine, and Paul Talalay. Human Malignant Lymphoma. Nahed K. Ahmed and Arnold D. Welch. norieucine against Experimental Tumors in Conven 2978 p@@osp@odp@Content of Mitochondrial and Micro tional and Nude Mice. Artemio A. Ovelera, David aomal Membranes from Morris Hepatomas of Varying 3107 Metabolism of Bensidineto N-Hydroxy-N,N'.diacetyl P. Houchens, Raphael Calane, Margaret A. Sheridan, Growth Rates. Karl Y. Hosleller, Bruce D. Zenner, and benzidine and Subsequent Nucleic Acid Binding and and Franca M. Muggia. Harold P. Morris. Mutagenicity. Kenneth C. Morton, Charles M. 3225 Analysis of Chromosomes, Nucleic Acids, and Poly King, and Karl P. Baetcke. peptides in Hamster Cells Transformed by Herpes *2964 Chrcinoeomai DNA Cytophotometry in 20q- Nonspe Simplex Virus Type 2. AllÃ©griaKessous, Viviane *3114 Cellular Binding Proteins for Vitamin A in the Normal clflc Myeloid Disorders. A. V. Carrano, B. H. Mayall, Bibar-Hardy, Martha Suh, and RenÃ©Simard. J, R. Tests, L. K. Aahworth,and J. D. Rowley. Human Uterine Cervix and in Dysplasias. Prabhudas R. Palan and Seymour L. Romney. 3235 Surface Antigens of Human Glioma Cells Shared with 2988 ERects of Dietary Vitamin B, on the In Vitro Inactive Normal Adult and Fetal Brain. Carol J. Wikstrand and tlon of Rat Tyrosine Aminotransferase in Host Liver * 31 19 Chromosome Abnormalities in Poorly Differentiated Darell D. Bigner. and Morris Hepatomas. Robert D. Reynolds and Lymphocytic Lymphoma. Shirou Fukuhara, Janet Harold P. MorrIs. D. Rowley, Dame Variakalis, and Harvey M. 3244 Cytotoxicity of an â€˜2'i-labeledDNA-binding Coin Golomb. pound That Induces Double-Stranded DNA Breaks. 2995 EffeCts of Protease Inhibitors on Chemical Induction Roger F. Martin, T. Ray Bradley, and George S. of Type C Virus. Cedric W. Long, Joan A. Bruszewski, 3129 Antileukemic Activity of 1-fl-o.Arabinofuranosyl.2. Hadgsan. Wayne L. Christensen, and William A. Suk. amino-i ,4(2H)-4-iminopyrimidine, a New Depot Form of l-$-o-Arabinofuranosylcytosine, Tasneem A. 3248 Time-Temperature Relationship in Hyperthermic Treatment of Malignant and Normal Tissue In VIvo. 3000 Occurrenceofa Low-Molecular-Weight Calcium-bind Khwala, Linda J. Kigwana, and A. Mohsin Mien. Jens Overgaard and Herman D. Suit. ing Protein in Neoplastic Liver. J. P. MacManus. 3134 In Vitro and In Vivo Stability of Anthramycin.DNA Conjugate and its Potential Application as an Anthra 3254 Dose-dependent DNA Ruptures Induced by the Pro 3006 Characterization of Adenosine Cyclic 3:5-Mono carcinogen Dimethylnitrosamine on Primary Rat phosphate-binding Proteins in Human Neuroblas mycin Prodrug. Laurence H. Hurley, Cathy S. Allen, Jose N. Feala, and William C. Lubawy. Uver Cultures. TomÃ¡s Mendaza-Figueroa, Ruben tome. Shinasku Imashuku, Milligan C. Fossett, III, and LÃ³pez-Revilla,and SaUl Villa-Trevino. Alexander A. Green. 3141 Effect of Delay in Administration of 13-cla-Retinolc 3258 Amplification of the Growth Inhibition by Glucocorti 3014 Effects of Adrlamycin and Cyclophosphamide Treat Acid on the Inhibition of Urinary Bladder Carcinogen cold on L5178Y and L1210 Lymphobiasts In VIvo. mentonlnduction of Macrophage Cytotoxic Function esis in the Rat. Peter J. Becci, Henry J. Thompson, Hirashi Kido, Yasuhiro Tomihara, Ichiro Watanabe, in Mice. Jordan N. Stoychkov, Richard M. Schultz, Clinton J. Grubbs, Charles C. Brown, and Richard C. Nakaaki Ohsawa, and Nobuhika Katunuma. MIchael A. Chirigoa, Nicholas A. Pavlidis, and Moon. AbrahamGoldin. *3262 Nonspecific Adjuvant Immunotherapy of Lung Can 3145 Human Pharmacology and Toxicology of Succl cer with Cell Wall Skeleton of Mycobacterium boris 3018 StudyOftite Cytotoxicity and Metabolism of 4-Amino nylatad Acinetobacter Glutaminase-Asparaginase, Baclllua Calmetteâ€”GusirIn, Kosei Yasumota. Hideo 3.Carboxamldo-1-tft.o-ribofuranoayl)pyrazolo(3,4.d'j. John S. Holcenberg, Luis D. Borella, Bruce M. Manabe, Etsuro Yanagawa, Nobuyoshi Nagano, pyrimidine Using Inhibitors of Adenosine Kinase Camitla, and Barbara J. Ring. Hidehiko Ueda. Nobuo Hirota, Milsuo Ohta, Kikuo and Adsnoeine Deaminase. Linda L. Wotring and Nomolo, Ichiro Azuma, and Yuichi Yamamura. Leroy B. Townsend. 3152 Cell Cycle Phase-specific Cytotoxicity of the Antitu mor Agent Maytansine. Potu N. Rao, Emil J Freireich, Marion L. Smith, and Ti Li Lou. 3268 Metabolism and Activation of 2'AcetylaminofIuo 3024 A Nucleolar Antigen Found in a Broad Range of rene in Isolated Rat Hepatocytes. Erik Dybing, Human MalIgnant Tumor Specimens. Harris Busch, 3156 Relationship between the Intracellular Cyclic Adeno Erik Soderlund, Lise Timm Haug. and Snorri S. Ferenc Gyorkey, Rose K. Busch, Frances M. Davis. sine 3':5'-Moriophospbate Level of Tumor Cells and Thorgeirssan. Phyllis Gyorkey, and Karel Smelana. Their Sensitivity to Killing by Antibody and Compie @1Isolation and Characterization of the Nuclear Matrix ment. Theresa N. Lo and Michael D. P. Boyle. Letters to the Editor from Zajdela Ascites Hepatoma Cells. Ronald 3163 Effects of Partially Thiolated Polycytidylic Acid on 3276 Preparation of Autologous Tumor Cell Vaccine from

DECEMBER1979 xIIi Contents of Volume 39, 1979

Human Lung Cancer. Carole Mayer and Martin Meeting Reports 3285 Special Announcements McKneally. 3279 A Report of the US-Japan Conference on Gene Dc 3277 Correspondence re: Beth Allyson Sheffler, Mary Ann repression and Host-Tumor Relationships in Card 3287 Announcements Repman, and Cara-Lynne Schengrund. Development nogenesis. SidneyWeinhouse. of a Neonatal and Metastatic Murine Neuroblastoma 3287 Errata Model. Cancer Res., 39: 711-713, 1979. David C. 3281 Sixth Meeting of the international Research Group Lueker, Ian B. Stewart. and Robert A Kainer. for Carcinoembryonic Proteins. Frank-Gunler C-L. Schengrund. M. A. Repman. and B. A. Sheffler. Lehmann. 3288 Author Index

September, Number 9

3289 Chemical Characterization of 485 Known or Sue Kadiubar, James A. Miller, Henry C. Pilot, and Norman ice. Robert Bases, Arye Rubinatein, Anna Kadish. pected Carcinogens and Their Correlation with Mu A. Drinkwater. Frances Mendez, David Wittner, Flora Elequin, and Doreen Liebeskind. tagenic Activity in the Salmonella typhimurium Sys 3419 Tumors in Male Rats Fed Ethyl Chlorophenoxylsobu tem. Stephen J. Rinkusand MarvinS. Legator. tyrate. a Hypoiipideinic Drug. Donald J. Svaboda and 3531 Evaluation of Ribonucleoside and Deosyribonucleo side Thphosphate Pools in Cultured Leukemia Cells 3319 Prolonged Retention of Estradiol by Human Breast Daniel L. Azamoff. during Exposure to Methotrexate or Methotrexate Cancer Cells in Tissue Culture. JeannineS. Strobland 3429 Treatment of VX2 CarcInomas In Rabbits by Percu plus Thymidine. James J. Kinahan, Maureen Often. Marc E. Lippman. taneous intratumoral In(ection of Heated 0.9% MaCI and Gerald B. Grindey. Solutions. Francis A. Burgener and Zoran L. Barbaric. *3328 Arming of Normsi Leukocytes with Sera from Patients 3540 Altered COmpOsition of Membrane Glycoconjugates with Adenocarcinoma of the Prostate. Rashid A. 3435 Serine Hydroxymethyltransferase ActivIty and Serine in Rat Hepatoma Tissue Culture Cells after Dcxc Bhatti, Richard J. Ablin. William Condoulis. and Patrick incorporation in Leukocytes. Janet Thorndike. methaeone Treatment or in VIvo Growth. Heinz Bau D. Guinan. Taria-TerttuPelliniemi,and WilliamS. Beck. mann and Fang-Fang Chu. 3332 Inhibition of Phorbol Myristate Acetate and Phytohe 3441 Enhancement of Antitumor Activity of 2,4-Diamino 3549 TUmOrIgSniCActivity of 3-Methylchoianthrene Metab magglutinin Stimulation of Human Lymphocytes by 5.(3',4'.dlchlorophenyo.6-methylpyrimidine and olites on Mouse Skin and in Newborn Mice. W. Levin. Retinol. Lea F. Skinniderand Karen Giesbrecht. Baker's Antifol (Triazinate) with Carboxypeptidase N. K. Buening.A. W. Wood, R. L. Chang.0. R. Thakker. G,. KrishnaK. Kalghatgi,Barbara A. Morosan, Caaba D. N. Jerina, and A. H. Conney. 3335 Age-related and Thymus-dependent Rejection of Ad HarvÃ¡th,and Joseph A. Bertino. enovirus 2-transformed Cell Tumors in the Syrian 3554 Antitumor Activity and Lymphoretlcular Stimulation Hamster. James L. Cook. Andrew N. Lewis. Jr., and 3446 An Improved Method for AnalyzIng Survival Data from Properties of Fractions Isolated from Corynebacte Charles H. Kirkpatrick. Combination Chemotherapy Experiments. Walter H. rium parvum. John L. Cantrell and Robert W. Wheat. Carter. Jr., DonaldN. Stablein.and Galen L. Wampler. 3341 An Estimate of the Maximum in Vivo Covalent Binding 3564 Metabolic Conversion of Indicine N-Oxide to Indicine 3454 Enhancement of the Thermal Response of Animal of 2,3,7,8-Tetrachlorodibenzo-p-diOxin to Rat Liver In Rabbits and Humans. Garth Powis. Matthew N. Tumors by Coryn.bact.rium parvum. M. Urana. H. D. Protein, Ribosomal RNA, and DNA. Alan Poland and Ames,and John S. Kovach. Suit, P. Dunn, T. Lanadale, and R. S. Sedlacek. Edward Glover. 3571 a-Fetoprotein as a Carrier Protein in Plasma and Its 3458 inhibition of Lymphocyte Function In Rats Fed High 3345 Apparent Rat Strain-related Sensitivity to Phorbol Bllirubin.blndteg Ability. Yutaka Aoyagi. Tokuli Fat Diets. G. Mark Kollmargen, William A. Sansing. Ikenaka. and Fumihiro Ichida. Promotion of Mammary Carcinogenesis. Claire J. Ann A. Lehman. Gerhard Fischer. Ross E. Langley. Shellabarger. Seymour Holtzman, and J. Patrick Stone. Steve S. Alexander,Jr., N. Margaret King,and Paul B. 3575 Cytotoxic Effects of Chemotherapeutic Drugs on Mouse Testis Cells. Cheryle C. Lu and Marvin L. 3349 Eariy Effects of Dimethylnitrosamine on Protein McCay. Meistrich. Chain Initiation and Postmicrosomal Polyadenylic 3463 MetabolIsm and Macromolecular Binding of the Car Acid-containing RNA Content in Mouse Liver. Odd cinogen Benzo(a)pyrene and Its Relatively Inert iso 3583 Immunogenicity of Friend Erythrolsukemia Cells Al NygÃ£rdand Tore Hultin. mar Benzo(e)pyrene by Hamster Embryo Celia tered In Culture by Chemical or Physical Agents. Michael C. MacLead, Gerald N. Cohen. and James K. Thomas P. Fondy, Aslerios S. Tsiftaoglou. Robert 0. 3353 Agglutination of Bladder Cells by Concanavalin A Selkirk. Jacoby, and Alan C. Sartorelli. during the Early Phase of Treatment of Rats with N- Butyl.N@(4-hydroxybutyI)nitrO5amIne. Tadaa Kakizoe. 3471 Ovarian Aryl Hydrocarbon Hydroxylase Activity and 3591 Induction of Sarcomas in Nude Mice by Implantation Takashi Kawachi, and Takashi Sugimura. Primordial Oocyte Toxicity of Polycycllc Aromatic of Syrian Hamster Fetal Cells Expoeed in Vitro to Hydrocarbons in Mice. Donaid A. Mattison and Snorri Nickel SUbSUIfIde.Max Coats. Julie S. Nye, F. William *3357 Deficiency of Antibody-dependent Cellular Cytotox S. Thorgeirason. Sunderman. Jr., Patricia R. Altpass. and Bernard icily and Mitogen-induced Cellular Cytotoxidity Effcc Gondos. br Cell Function in Patients with Acute Myelogenous 3476 immunoeuppreeslve Effects of Sulfato-trana-(-)-1 .2- Leukemia in Remission. Jacob Zighelbaim. diaminocydlohexanePIatlnum(Il). Amanullsh Khan, 3598 isolatIon and Characterization of e-Lactalbumin from Susan Hogan, and J. N. Hill. a Rat Mammary Tumor. Raiani V. Prasad and Kurt E. 3363 Distribution of RadiOlabeled Alloantibodies in Mice Ebner. Bearing 3-Methylcholanthrene-induced Sarcomas. 3479 AnalysIs of Human Cancer DNA's for DNA Sequences Donald J. Buchabaum. Paul C. Walker, and Eugene A. of Human AdenovlrusSerotypes 3. 7. 11, 14, 16. and 3602 Effects of Phorbol Ester Tumor Promoters in Platelet Aggregation and Platelet PrOdUCtIOnof Cyclooxygen Johnson. 21 in Group B. WilliamS. N. Wold, Jesse K. Mackey. Patricia Rigden. and Maurice Green. see Products. A. A. Mufson, P. Kulkarni, K. E. Eakina. 3369 Metabolic Activation of Arylhydroxamic Acids by N- and I. B. Weinstein. O-Acyltransferase of Rat Mammary Gland. Charles M. 3485 Serum Tyroeinaae In Malignant Disease, Its Activity, 3607 ProtectIon of Mice against Lethal Doeages of Nebu King, Nancy Raab Traub, Zenon N. LorIs. and N. Rita and the Electrophoretic Patterns of the Enzyme as larine by Nltrobenzylthioinoelne. an inhibitor of Mu Thissen. Carried by immunoglobullns. Y. N. Chen, B. T. Lim, and W. Chavin. cleoelde Transport. Alan A. P. Paterson, John H. 3373 isolation of Thymidine-resistant Cells from a Thymi Paran, Suh-er Yang. and ThomasP. Lynch. dine-sensitive Acute Lymphoblastic Leukemia Cell 3491 a-Fetoprotein Levels and Hepatlc Alterations during 3612 New Doae-Time Reiatlonshipe of Folate Antagonists Line. H. Ronald Zielke. Chemical Carcinogenesis In C57BL/6N Mice. Frederick F. Becker and Stewart Sell. to Sustain InhIbition of Human Lymphoblasts and 3377 Electrofocusing Patterns of Fucosyltransferases in Leukemic Cells in Vitro. W. David Sedwick, Marc Plasma of Patients with Neoplastic Disease. David 3495 Differential Expression of a-Fetoprotein and y-GIu Kutier, Thomas Fraser, Oliver E. Brown, and John Kessel, VoravitRatanatharathorn.and Ta-Hsu Chou. tamyltranapeptldaae in Chemical and Spontaneous Laszia. Hepatocarcinogenesla Hannu Jaianka and Erkki 3381 Effects of Estrogen to Alter Amino Acid Transport in Ruoslahti. *3619 Evolution of Karyotypes in Acute Nonlymphocytic R3230AC Mammary Carcinomas and Its Relationship LeukemIa. JosephA. Teats,Un MintZ,JanetD. Rowley, to Insulin Action. Paul J. Hissinand RussellHilf. 3502 Modulation of Cellular Interactions between C3H/ JamesW. Vardiman.and Harvey N. Golomb. 3388 Incorporation of HLA Antigens into the Envelope of 107Â½Cells and Their Transformed Counterparts by Phoephodlesterase Inhibitors. John S. Bertram. 3628 Breast Cancer Mortality and Diet in the United States. RNA Tumor Viruses Grown in Human Cells. J. Azocar Sharon Parten Gaskill. WilliamL. McGuire, Charles K. and M. Essex. 3509 Maintenanceof Adult Rat Hepatocyteson C3H/1OT'/, Osborne. and Michael P. Stern. 3392 Defective Reactivation of Ultraviolet Light-irradiated Cells. Robert Langenbach, Linda Malick, Anna Tompa, 3638 Effect of Local Immunotherapy of Syngeneic Rat Fl Herpesvirus by a Bloom's Syndrome Fibroblast Charles Kuszynaki.Heather Freed. and Eliezer Huber broearcoma with Hapten and Antihapten-Tumor Be Strain. Clifford A. Selsky. Patricia Henson. Ralph A. man. rum upon Nonlocally Treated Tumor. Kazuhika Arsi Weichselbaum.and John B. Little. 3515 Enhancing Effect of Thyroxine on Tumor Growth and and Herbert W. Wallace. Metastases In Syngeneic Mouse Tumor Systems. 3397 Assay of intracellular Free and Macromolecular 3644 Carcinogenesis in Rat Esophagus by Intraperitoneal bound Metabolites of 5-Fluorodeoxyuridine and 5- Manjula S. Kumar. Theresa Chiang, and Sharad D. Deadhar. Injection of Different Doeea of Methyl-n-amyinitroe.a Fluorouracil. Wendy L. Washlienand DanielV. Santi. mine. Orhan Bulayand Sidney S. Mirvish. 3405 fl-liexosaminidase Iaoenzymes in Tissues, Cultured 3519 Temperature-dependent Alteration In Immunogenic 3647 RestoratIon of Cyclophoaphamide-induced Suppres Cells, and Media from Human Fetal Intestine and by of Tumor-associated Transplantation Antigen MOnItored via Paratormaldehyde Fixation. Tauneyuki sin of Thymes-derived Cytotoxic Cell Generation by Colonic Adenocarcinoma. Dean Tsao. Hugh J. Normal Thymocytes. Vincent J. Merluzzi, Ronald B. Freeman. and Young S. Kim. Oikawa. Eiki Gotahda. Faye C. Austin, Norilashi Takeichi, and Charles W. Boone. Faanes, and Yang Sung Choi. 341 1 The N-Hydroxy Metabolites of N-Methyi-4-aminoazo 3655 Biochemical Basis of the Increased Activity of 9-/3.o- benzene and Related Dyes as Proximate Carcinogens 3524 Mutagen-induced Disturbances in the DNA of Human in the Rat and Mouse. Elizabeth C. Miller, Fred F. Lymphocytes Detected by Antinucleoside Antibod Arabinofuranoayladenine in the Presence of Inhibi

xiv CANCER RESEARCH VOL. 39 Contents of Volume 39, 1979

tars of Ad.noeine Deaminase. William Piunkett, Lube vanced Cancer. Michael J. OCanneli, Charles G. 3774 Concentration of Fibronectin in Plasma of Tumor Alexander, Shent Chubb, and Ti Li Lou. Maertel, Roy E. Rifts, Jr., Siephen Frytak, and Richard bearing Mice and Synthesis by Ehrlich Ascites Tumor J. Reitenteler. Cells. Luciano Zardi. ClauduoCecconi, OttavuaBsrbien, 3661 Ouantltative Models for Growth inhibition of Human Leukemia Cells by Antltumor Anthrecycline Deriva 3725 Enhanced Radioeenaltlvlty of Cultured Flbrobiasts Barbara Carnemalla, Marina Picca, and Leonardo Santi. fives. Peter N. Kanter and Herbert S. Schwartz. from Ataxia Telangiectasia Heteroxygotes Mani fasted by Defective Colony-forming Ability and Re 3673 Toxicity of Intrapleural BacIllus Calmff-GuIrin 3780 Mutagenicity of the Naturally Occurring Carcinogen duced DNA Repair Replication after Hypoxic y-lrrs Cycaain and Synthetic Methylazoxymethanol Con@u Treatment In Animals. Martin J. Filardi, Stephen D. diation. Malcolm C. Paterson. Anne K. Anderson, Blake Codiah. UndaCiVerChia. Richard K. Howard. and Martin gates in Salmonella typhimurium. TaijiroMatsushima, P. Smith, and Paul J. Smith. F. Mckneelly. Hiromu Malsumolo, Alsuko Shirai, Mutauka Sawamura, and Takashi Sugimura. 3735 Photodynamic Inactivation of Synchronized Human 3677 CorrelatIon of Glycosylation in a Membrane Protein Cells in Vitro in the Presence of Hematoporphyrin. withaMolecularWeightof 150,000with TumOrigenic 3783 Effect of Splenectomy on the Immune Response of Terje Christensenand Johan Moan. Property of Rat Flbrosarconia Variants. Kolaro Kay BALB/c Mice Bearing an Immunoglobulin M Plasma cytoma (TEPC-183). H. Francis Havas, Steve Barney, ama. Edward Nudelman. Minoru Fukuda, and Sen-ibroh 3738 EReCtS of DaunotubicIn and DoxorubicIn, Free and AudreyGoadis, and Gerald Schiffman. Hakomon. Associated with DNA, on Hemopoletic Stem Celia. N. 3183 SpecificIty of ONA-aeaoclated Nuclear Antigens In Huybrechta, N. Symann, and A. Trouet. 3788 American Association for Cancer Research Certifi lisLa Cells arud Distribution during the Cell Cycle. cafes of Award 3744 Quantltatlon of Intracellular Metabolites of [@â€˜S}6. RobertC. Brigga.AilsaCampbell,Jen-FuChiu.Lubomir Mercaptopurine in L5178Y Cells Grown in Time S. Hruiiica.Gloria Lincoln.Janet Stein. and Gary Stein. Course incubates. Hans-Joachim Breter and Rudolf K. Communications @ I.Iltraetructure of Doxorubicin (Adriamycln)nduced Zahn. SIIIIIUICSI5In Rats. Ross RUdOlph.Marilyn Woodward. 3789 Influence of Adrenal COrtiCOSt.rOids on the Suacep and Irwin Hum. 3749 A Thymus Cell Marker in Marine Leukemia Virus induced Lymphomas of Rats. Noritoahi Takeichi, tibility of Cats to Feline Leukemia Virus InfectIon. 3694 Effect of 5.Fluorouracll on the Synthesis and Trans. Kazufumi Suzuki, and Hiroshi Kobayashi. Jennifer L. Rajka, Edward A. Hoover, Lawrence E. laboit of Polyadenylic Acid-contaIning RNA front Re Mathes, Steven Krakowka, and Richard G. Olsen. generating Rat User. ChristineK. Carrico and Robert 3752 EffeCt of Dietary Fiber on the Induction of Colorectal I. Glazer. Tumors and Fecal /I-Glucuronidaae Activity In the 3792 Enhancement of Bleomycin Activity against Lewis Rat. Hans G. Bauer, Nils-Georg Asp, Richard Oste. Lung Tumors In Mice by Local Hyperthermia. Richard 3702 SnVitro Synthesis of Merle Pre-uu-fetoprotein. Erwin Arne Dahlqvist,and Per E. Fredlund. L Magin, BranimirI. Sikic, and Richard L. Cysyk. H. Peters. Shinzo Nishi, Kazunobu Miura, Fritz L. Loracheider. Gordon H. Dixon, and Taiki Tamaoki. 3757 Lumlnal Plasma Membrane Organization In Rat Uri 3796 Letter to the Editor: Bypassing the â€œSpeciesBarrierâ€• nary Bladder Urotheiium after Direct Exposure In Vivo *3707 A Phase I Study of High Doees of Aminopterin with with Carbohydrate-altered Interferon from Leuko to N-Methyl-N-nitrosourea. Ba Hainau. LeucovorIn Rescue In Patients with Advanced Mets cytes. WilliamA. Carter. static Tumors. L. Michael Diode, Susan W. Pitman, 3763 Enhancement of Mammalian Cell Killing by 5-FIuo 3799 Meeting Report. WOrkIng Conference on Meaothell William D. Ensminger, Andre Rosowsky, Nick rouracil In Combination with X-Rays. Yukio Nakajima, OflM Treatment Trials. Raymond B. Weiss and Franca Papathanaaopouios, and Emil Frei, iii. Tadsaki Miyamoto, Masahiro Tanabe, lkuo Watanabe, N. Muggia. and ToyozoTerasima. 3715 Rat a-Macrofetoproteln (Acute-Phase e,-Macroglob 3801 Books Received i*i) darIng Hepatocarclnog.nesis. Dorothy Hudug, 3768 AdditIve Effects of BleomycIn and Neocaralnostatin Stewart Sell. Laurie Newell, and Frederick F. Becker. on Degradation of DNA, Inhibitionof DNA Polymerase 3803 SpecIal Announcements *3720 A Comperative ClInical and Immunological Aseess p. and Cell Growth.WernerE. G. Muller,Armin 3804 Announcements mantel Methanol ExtractIon Residue of Bacillus Cal Maidhaf, Josef Arendes, Werner Geurtsen, Rudolf K. mette.Giiei*u versus Placebo In Patients with Ad. Zahn, and RaIf Schmidseder. 3804 Erratum

October, Number 10

36.05 Oncogenic Transformation in Epithelial Cell Unes Cases of Feline Leukemia and Lymphoma. D. P. 3920 isolation and Characterization of Canine Venereal Derived from Tracheal Explants Expoaed in Vitro to Francis, 5. N. Cotter. W. D. Hardy, Jr., and N. Essex. Tumor-asaoclated Inhibitory and BlockIng Factors. N-Methyt.N'-nltro-N.nltroaoguanidlne. Vernon E. William E. Beschorner, Allan D. Hess, Samuel T. 3871 Accelerating Effect of Ascorbic Acid on N-Nitroea Steele. Ann C. Marchok, and Paul Netteaheim. Nerenberg, and RObert B. Epstein. mine Formation and Nitrosation by Oxyhyponitrite. 3812 Effect of Methylprednlsolone on the Cell KInetiC Re Shaw-Kong Chang, George W. Harringlon, Marc 3928 Augmentation of Antitumor Cytotoxicity of MOPC aponseof C3H/HeJ Mammary Tumors to Cyclophoe RothsteEn, William A. Shergalis, Daniel Seem, and 315 Tumor Bearer Spleen Cells by Depletion of Dini phamldeand Adriamycin. PaulG. Braunachweigerand Saraj K. Vohra. trophenol-adherent Cells prior to in Vitro immuniza LewisM. Schiffer. 3875 Activity of Thymidine as a Chsmotherapeutlc Agent tin. Margalil B. Mokyr, James C. D. Hengsl, Donna against Human Tumor Xenografta in Nude Mice. Przepiorka,and SheidonDray. 3816 Influence of Immune Status on the Metastasis of Stephen B. Howell, Robert S. Jenkins, and Jerome Three Muriel Fibrosarcomas of Different Immuno. 3935 Identification of a Transaminative Pathway for Ethi Streifel. genicitles. Isaiah J. Fidler, Douglas M. Gersten, and onine Catabolism. Robert D. Steele and Norlin J. Margaret L Knpke. *3881 Phase I Cilnical and Pharmacological Study of 4'- Benevenga. (8-AcridInyIamIno@nethanesuiton-m-anisidide Using 3822 SynergistIc Action of S.Aza-2-deoxycytldine and 3- an Intermittent Biweekly Schedule. David A. Van 3942 Formation of Carbonyl Chloride in Carbon Tetrachlo Deasauridlee on L1210 Leukemic Cells and EMI, Echo. Delia F. Chiuten, Paul E. Gormiey, J. Leonard ride Metabolism by Rat Uver in Vitro . Harshida Shah, â€˜fumorCells.Richard 1. Momparler. Jifi Vesely. Louise Lichtenfeld, Mary Scoitock, and Peter H. Wiernik. Sally P. Hartman, and Sidney Weinhause. F. Momparler, and Georges E. Rivard. 3885 Content of Gonadotropins In Cultured Human Maiig *3945 Us. of PM.2 DNA Degradation as a Pharmacokinetic 3628 CarcInogenic Effect of N-Nitroso(2-hydroxypropyl)- nant Cells and Effects of Sodium Butyrate Treatment Assay for Bleomycin. Louis Galvan, James E. Strong, (2.oxcpropyl)amin., a Poetulated Proximate Pan on Gonadotropin Secretion by HeLa Cells. Raymond and Slanley T. Crooke. W. Ruddon, Carmen Anderson, Kimberly S. Meade, mactic Carcinogen In Syrian Hamsters. Parviz Pour, 3952 An Infectivity Assay for the Bovine Leukemia Virus Paul H. Aldenderler.and Paul D. Neuwald. Lawrence Wailcave, Ralph Gingell, Donald Nagel, Using the Immunoperoxidase Technique. Lois Terrence Lawson, Shahrokh Salmasu,and Susan Tines. *3@93 Effective Dose of u.-Asparaginaae for Induction of Jerabek, Phalguni Gupta, and Jorge F. Ferrer. 3834 Ultrastructure and Cytokinetics of Leukemic Myelo Remission In Previously Treated Children with Acute Lymphocytic Leukemia: A Report from Chiidrens 3955 Utilization of 2'-Deoxy-6-thioguanosine 5'-Triphos blastaContalnlng Giant Granules. Richard T. Parmley. phate in DNA Synthesis in Vitro by DNA Polymerase Gary V. Dahi, Ronald L. Austin, Patsy A. Gauthier, and Cancer Study Group. Inta J. Ertel, Mark E. Neabit, Denman Hammond, John Weiner, and Harland Sather. a from Calf Thymes. Shonen Yoshida, Machuko Francis R. Denys. Yamada, Sigeo Masaki, and Mineo Saneyoshi. 3897 N.Bromoacetyl-fl-o-glucosamineTetra-O-acetateand 3845 Suppression of Tumor-associated Hyperflbrinogene N-Sromoacetyl./l-o.galactoeamine Tetra-O-acetate 3959 influence of Factors Derived from EMT, Tumors and mis and Free Fatty Acidemia with p-Plsenoxybenzal as ChemOtherapeutlCAgents with Immunopotentiat from Bone Marrow of Tumor-bearing Mice on Tumor butyrate(Cloflbrate). 1. Pickart and N. Michael Thaler. ing Effects in Ehriich Ascites Tumor-bearing Mice. and Bone Marrow Stem Cell Kinetics. Marie-Pierre 3649 InhIbition by Dexamethasone of Commitment to Paul Simon, William J. Burlingham.Richard Conklin, Fache, FranÃ§oiseLepault. Randy Zelick, and Emilia Frindel. Erythroid Differentiation in Murine Erythroleukemla and ThomasP. Fondy. Celia. Asterios S. Tsiftaoglau. James F. Gusella. 3903 Establishment of Photoafflnity Label Derivatives of 3964 SensitIvity to Chemotherapeutic and Immunomodu Vladimir Voiloch, and David E. Housman. Fluorene as Probes in Studies of Chemical Carcino lating Agents of Two Mouse Lymphomas and of a geneais in Mammalian Cell Culture. Awni N. Sarrif, Macrophage Tumor. George S. Tamowaki, Peter 3666 Galactoeyl Transferas. Activity in Human Tranal William E. White, Jr., and Nick DiVita. Ralph, and C. Chester Stock Venal Cad CarcInoma Unes and in Benign and Neo plastic Human Bladder Epitheiluin. George N. Plalkin. 3g09 Glutamine-Phosphoribosylpyrophosphate AmMo 3968 MOdifIcation of the Effect of a Gonadolibermn Analog Ronald J. Wides. Susan L. Gilbert, George Wolf. transferase (Amidophosphoribosyltransferaae, EC on 7, 12-Dimethylbenz(a)anthracene-induced Rat I. KathleenHagen, and George R. Praut, Jr. 2.4.2.14) ActivIty in Normal, Differentiating, and Neo Mammary Tumors by Hormone Replacement. David plastic Kidney. Macmi Prajda, Harold P. Morris, and P. Rose and Brian Pruitt. 3661 Effect of Surgical Removal on the Growth and Kinet George Weber. IceoffiesiduaiTumor. Nurten Gunduz, Barnard Fisher. 3971 Hormonailyinduced Tumors of the ReproductiveSys and Elizabeth A. Setter. 391 5 Effect of Phorbol Ester Tumor Promoters on the tem of Parabiosed Male Rats. Clark E. Brown,Shields Expression of Melanogenesis in 5-16 Melanoma Warren, Rasanna N. Chute, Kenneth J. Ryan, and 3666 Comparison of Virus-positive and Virus-negative Cells. A. A. Mufson, Paul B. Fisher. and I. B. Weinstein. Roberta B. Todd.

DECEMBER 1979 xv Contents of Volume 39, 1979

3977 Effect of the Duration of Retinyl Acetate Feeding on 4091 Effects of Macromomycin on the Ultrastructure and 4206 in Vitro Metabolism and Activation of Carcinogenic Inhibition of 1-Methyi-1.nitrosourea.induced Mam. Biological Properties of Cultured Mammalian Cells. Aromatic Amines by Subcelluiar Fractions of Human mary Carcinogenesis in the Rat. Henry J. Thompson. Dale D Vandre. Virginia L. Shepherd, and Res Liver. Erik Dybing.Christenvan Bahr. Tore Aune, Hans Peter J. Becci, Charles C. Brown, and Richard C. Moon Montgomery Glaumann. David S. Levitt, and Snorri S. Thorgeursaon. 3981 Effect of Tetrahydrouridine on the Action of 1-fl.o. 4098 Characterization and Estrogen Stimulation of Cyto 4212 Immunological Properties of and NeuramInidase Ac Arabinofuranosylcytosine in Synchronized Cultures piasmic Progesterone Receptor in the Ovarian.de lion on Aminopeptidases and Arylamidases in Human of Normal Rat Kidney Cells. Charn-WingWan and Tak pendant MXT-3590 Mammary Tumor Line. Cheryl S Normaland Cancer Tissues. MichioNiinobe,Yoahiyuki W. Mak Watson, Daniel Medina, and James H. Clark. Tamura, Teruo Anima,and Selsuro Fujii. 3986 Effects of Dietary Fat on Hepatic Mixed-Function *4105 A Clinical-Pharmacological Evaluation of Hepatic Ar. 42i8 Ultrastructural and Autoradiographic Study of the Oxidases and Hepatoceiluiar Carcinoma Induced by terial Infusion of Adriamydin. Marc B. Garnick. William Effects of Bleontycin on the Interphase Nucleus of Atiatoxin B in Rats. Paul M Newberne,Jean Weigerl. D. Ensminger. and Mervyn Israel. Cultured Normal CelIa Gerardo H. VÃ¡zquez-Nin.Olga and Nora Kula 41 11 Establishment and Characterization of the Epitheilal M. Echeverria,and JacquelinePedron. * 3992 Phase I Trial of N'(Phosphonacetyl)-t.-aspartate. Mouse Embryo Cell Line MMC-E. Ull A Rapp, Jorma 4224 Potent MutageniCity of Urethan (Ethyl Carbamate) Charles Erlichman, John M Strong, Peter H. Wiernik, Keski-Ota, and Ursula I. Heine Gas in Droaopliiia meianogaafer . Taisei Nomura. Linda N. McAvoy, Martin H. Cohen, Arthur S. Levine. *41 19 Penetration of 3-Deazauridine into Human Brain, In 4228 Alkylation of DNA and RNA by (â€œC]Dimethyinitro Susan M. Hubbard, and Bruce A. Chabner. tracerebral Tumor, and Cerebroapinal Fluid. David samine in Hydroxyurea-synchronIzed Regenerating 3996 Lymphocyte Transformation for the Detection of Her Stewart. John A. Benvenulo. Milam Leavens, Stephen Rat Liver. H. M. Rabes, R. Kerler, R. Wilhelm, G. Rode, pesvirus-inducedTumor.associated Antigens. Lester W. Hall, Robert S. Benjamin,WilliamPlunkett.Kenneth and H. Riess. F Harris. Vincent V Hamparian. Elizabeth A Young. B McCredie, Michael A. Burgess. and Ti Li Lou. 4237 Abnormal Kinetics of DNA Synthesis in Ultraviolet and John H. Hughes 41 23 inhibitionofBenzo(a)pyreneandBenzo(a)pyrenel,8- Light-irradiated Cells from Patients wIth Cockayne's 4003 Dynamics of Neoplastic Development in Carcinogen Dihydrodiol Metabolism by Benzo(a)pyrene Oui Syndrome. Alan R Lehmann. Susan Kirk-Bell, and exposed Tracheal Mucosa. Margaret Terzaghi and nones. Anna L. Shen, William E. FahI, Steven A. Lynne Mayne. Paul Nettesheum Wrighton. and Cohn R. Jelcoate. 4242 Inhibition of Energy Matabolism in Ehriich Aacites Cells Treated with Dactytarin In Vitro. Milan Miko. 4130 A Selective Effect of Methylglyoxal-bis(guanylhy 401 1 Physicochemical Differences between Glucocorti Ludovil Drobnica. and Britton Chance. cold-binding Components from the Corticood-sensi drazone) on the Synthesis of Mitochondrial DNA of tive and -resistant Strains of Mouse Lymphoma Cultured Li 210 Leukemia Cells. B. Feuerstein, Carl 4252 Thyroid Hormone in 7,12-Dimethylbenz(a)anthra P1798. John Stevens and Yee-Wan Stevens W. Porter, and C Dave cene-induced Leukemia in Rata Alan K. Burnett. *4,c@22 Serological Response Patterns to Herpesvirus Type 4138 Production of Fibronectin by Human Epithelial Cells 4256 Enhancement of the Nuclear Reactivity of Alkylating 2 Early and Late Antigens in Cervical Carcinoma in Culture. Helene S. Smith, John L. Riggs, and Michael Agents by Prednisolone. Ray Wilkinson,Michael S. C. Patients. Eugene A Heise. Louis S Kucera. Milton W. Mosesson Birbeck, and Kenneth A. Harrap. Raben, and Howard Homesley *4253 L-a-Alanlne Inhibition of Pyruvate Kinsae from Tu 4i45 Enhancement of the Chromoaome.damaging Action more of the Human Central Nervous System. Cees W. 4027 Anticarcinogenic Effects of 2.3,7,8-Tetrachlorodu of Aacorbate by Transition Metals. H F. Stich.L. Wei. M. van Veelen, Henk Verbueat,KlausJ. Zulch, Berry A. benzo-p@dioxinon Benzo( a)pyrene and 7,12-Dimeth and A. F Whiling. van Ketel. Margreel J. M. van den Vlist, Annie M. C. ylbenz(a)anthracene Tumor Initiation and Its Rela VIug. Cart Ritksen. and Gerard E. J. SIsal. tionship to DNA Binding. Gerald M. Cohen. WilliamM 41 52 Mutagenidity of Soot and Associated Polycyclic Aro Bracken. Radhakrishnan P lyer. David L Berry. James matic Hydrocarbons to SalmOnelLa typhimurium. 4270 The Potential Histogenic Relationship of the Periph K Selkirk. and Thomas J Slaga Debra A. Kaden, Ronald A. Hitea, and William G. Thilly. eral Nerve to Synovioma. Herbert Ichinose. Leon Powell, Harry E. Hoerner. Vincent J. Derbes, and John 4160 Identification of the Proximate and Ultimate Forms of 4034 Immune-mediated Arrest and Reversal of Established F. Byers. Visceral Metastases in Athymic Mice. Robert H the Carcinogen 15, 16-Dihydro-i 1-methylcydlo Wiltroul, Philip Frost, Murdach K Morrison. and penta(a@phenanthren-17-one. Maurice M. Caombs, 4274 Funding Impact of the National Cancer Act and Be Robert S. Kerbel Anna-Maila Kissonerghis, Jeffrey A. Allen, and Cohn W. yond. John T Kalberer, Jr. and Guy R. Newell, Jr. Vose. *4f@42 Advanced Stage and Early Relapse of Breast Carci Letters to the Editor nomas Associated with High Thymidine Labeling In 4166 Selective Reduction in Receptors for EPId.rmal dices. John S Meyer and Barbara Hixon. Growth Factor-Urogastrone in Chemically Trans. 4285 Appropriateness of Animal Models for the Immunol fanned Tumorigenic Syrian Hamster Embryo Fibro. ogy of Human Cancer. Correspondence re: H. B. 4048 Methotrexate-Induced Changes in the Levels of 1./i- blasta Morley D. Hollenberg, J. C. Barrett, P. 0. P. Hewitt. The Choice of Animal Tumors for Experimen D-Arabinofuranosylcytosine Triphosphate in Li 210 Ts a, and Paulos Berl'ianu tal Studies of Cancer Therapy. Mv. Cancer Rca.. Cells. DeWayneRoberts.CharlesPeck. SusanHilliard. 27: 149-200. 1978. Herbert J. Rape. Harold B. Hewitt. and William Wingo 4170 Stimulation of Differentiation of Mouse Myeloid Len kemic Cells and induction of interferon in the Cells 4288 Utility and Efficiency of Viable Cell Counts. Corre. *44@55 Inhibition of Human Melanoma Colony Formation by by Double-Stranded Polyribonucleotides. Yuri spondence re: Pamela R. Roper and Benjamin Retinoids. Frank L Meyskens. Jr and Sydney E Yamamato, Mikia Tomida, and Mob Hozumi. Drewinko. Cell Survival following Treatment with An. Salmon titumor Drugs (Letter to the Editor). Cancer flee., 41 75 Fate of Nickel Subsulfide during Carcinogenesis 39: 1428-1429. 1979. Robert Schrek. 4058 Dimethyl Sulfoxide-induced Differentiation of Friend Studied by Autoradiography and X-Ray Powder Dif *4289 5-Fluorouracll Concentrations in Human Plasma fol Erythroleukemia Cells in the Absence of Cytokinesis. fraction. Agneta Oskarsson. Yvonne Andersson, and lowing R,S-1-(Tetrahydro-2-furanyl)-5-fluorouracll Asterios S. Tsiftsoglou and Alan C Sarlorelli Hans TIalve. (Ftorafur) AdmInistration. Jessie L. Au and Wolfgang 4064 Enhanced Transformation of Xeroderma Pigmento 4183 Ornithine Decarboxylaae Activity. Cell Proliferation, Sadhe sum Variant Cells by Ultraviolet Light-irradiated Shut and Tumor Promotion in Mouse Epidermis in Vise. ian Virus 40. Jennifer Dean Hall and Shin.ichi Tokuno Fniednich Marks, Slelan Bertach, and Gerhard Meeting Reports Furstenberger. 406g Mutagenicity and Tumorigenicity of Phenanthrene 4291 Interdisciplinary Cancer Research Workshop. Peter and Chrysene Epoxidea and Diol Epoxides. Alexander 4189 Immune Elimination of Host Fibrobisats for the Cul Politzer, Patricia H. Reggio. and leva R. Politzer. W. Wood. Richard L Chang. Wayne Levin. Dene E tivatlon of Human Tumors Transplanted into Nude Ryan, Paul E Thomas. He Duck Mah. Jean M Kane. Mice. TetsuroOkabe. AtsukaSuzuki,NakaakiOhsawa. 4293 Culture Systems for Studying Malignancy. Mina Haruhiko Yagi. Donald M Jenina.and Allan H Conney Kinori Kasaka, and Toyazo Terasima. Bissell,JamesC Bartholomew,JudahFolkman,Helene 4078 Interaction of the Tumor Promoter 12-O@Tetradeca. *4195 Effect of High-DOse Methotrexate with Citrovorum Smith, and Martha Stampfer. noylphorbol-1 3-acetate with Cells In Mixed-Lympho Factor on Human Granulopoiesis. Wolfgang Schreml cyte Culture. Andrea M. Mastro. Theodore A. Krupa. and Hans-Peter Lohrmann. 4296 Special Announcement and Paula Smith 4200 Purification of y.Glutamyltransferases from Rat Hep 4297 Announcements 4083 Isoenzymes of /J-Heaosaminidase from Normal Rat atomas and Hyperplastic Hepatic Nodules, and Com Colon and Colonic Carcinoma. Michael G Bnatlain. pariaon with the Enzyme from Rat Kidney. Shigeki 4298 Erratum Catherine Green. Pamela M. Kimball. Michael Mantis, Tsuchuda,Keiii Hoshino,TsuyoshiSato, NobuyukiIto. and Mahnaz Khaled and Kiyomi Sata. 4299 Author Index

November, Number II

4301 Childhood Leukemia as a Model for Cancer Research: MiriamLieberman,Jacques Boniver,and Henry S. ease Robert 6. Parsons, Heather D. Todd, and Robert The Richard and Hinds Rosenthal Foundation Award Kaplan. Kowal. Lecture. JosephV. Simone. 4330 Isolation of a DNA Polymerase a-associated Regula 4348 Cytotoxic Thresholds of Vincrletine In a Mere and 4308 Use of Logrank Scores In the Analysis of Litter tory Protein from Calf Thymue. Jay A. Steinberg. aHumanLeukemiaCellUneinVitro.DonV.Jackson, matched Data on Time to Tumor Appearance. Nathan Maureen Often, and Gerald B. Grindey. Jr. and RichardA. Bender. Mantel and Joseph L. Cimunera. 4336 Response of 91. Tumor Cells in Vitro to Spirohydan 4350 Effect of Dietary Fats on TumOrIgenICIty of Two 4316 Metabolism and DNA Binding of 3-Methyicholan toln Mustard. DennisF. Deen, Takao Hoahino,Mary E. Sarcoma Cell Unes. Laurence N. Corwin, Faina threne. Alan Eastman and Edward Bresnick. Williams, Kazuhiro Nomura, and Patricia N. Bartle. Varshavsky-Rose, and Selwyn A. Broitman. 4322 In Vise Infectivity of the Fibrotropic C-Type Viral 4341 isolation and IdentIficatIOn of a Human Serum Fibro 4356 In Vitro Cytokmnetic Response of Human Colon isolates from Strain C57BL/Ka Mice. Alain Declhve, nactin-like Protein Elevated during Malignant Die Cancer Cells to cia-Dichlorodlammineplatinum(ll).

xvi CANCER RESEARCH VOL. 39 Contents of Volume 39, 1979

Jean-Pierre Bergerat. Barthel Barlogie, Wolfgang 4497 Relationship between Inhibition of Protein Methylase trol on Carcinogenic Susceptibility during Postnatal GÃ¶hde,Dennis A Johnston, and Benjamin Drewinko I and Inhibition of Rous Sarcoma Virus-induced Cell Life in Hamster Progeny. Mano Rustia and Philippe Transformation. Jocelyne Enouf. FranÃ§oiseLawrence. Shubik. 4364 Effects of Systemic Acidification of Mice with Sar Christiane TempÃªte,Malka Robert-Gero, and Edgar coma 1BO. Salvador Harguindey. Edward S. Lederer. *4645 Effects of Bleomycin on Human Tongue Carcinoma Henderson, and Carl Naeher Cells Revealed by Electron Microscopy. Gonpachiro *4372 Concanavalin A-inducible Suppressor Cells in Re *4503 Survival of Patients with Metastatic Breast Cancer Yasuzumi. Yukikazu Hyo. Tsutomu Hoshiya. and Treated with Either Combination or Sequential Chem gional Lymph Nodes of Cancer Patients. William J. Fumioki Yasuzumi Catalona. Timothy L. Ratlitt, and Robert E McCool. otherapy. A Western Cancer Study Group Project Rowan T. Chlebowski. Lowell E Irwin. Reginald P. 4653 Ontogeny of the Rat Hepatic Receptor for 2,3,7.8- 4378 Transplacental and Lactational Carcinogenesis by Pugh, Leonard Sadoff. Robert Hestorff. John M Tetrachlorodibenzo-p-dioxin and Its Endocrine Inde Safrole. S D. Vesselinovitch. K. V. N Rao. and N. Wiener, and Joseph R. Bateman pendence. Jan M B Carlsledt-Duke. Gunilla Elfstrom. Mihailovich. Berlil Hogberg. and Jan-Ake Gustafsson 4507 Risk Factors for Nodular Sclerosis and Other Types 4381 Prolactin Receptors in Human Breast Cancer Cells in of Hodgkin's Disease. B E Henderson. R. Dworsky, 4657 Protein Synthesis in Liver Tissue under the Influence Long-Term Tissue Culture. Robert P. C. Shiu. M C. Pike. J Baptista. H. Menck. S Preston-Martm, of a Methylcholanthrene-induced Sarcoma in Mice. K Lundholm. L Ekman. S Edstrom, t Karlberg. R and T. Mack 4387 Hormone-dependent Growth of a Rat Chondrosar- Jagenburg, and T. Schersten coma /n Vfvo. David S. Salomon. Larry M. Paglia, and 4512 Correlation between Metabolic Reduction Rates and Leon Verbruggen. Electron Affinity of Nitroheterocycles. Peggy L. Olive. 4662 Cytogenetic Analysis of Human Renal Carcinoma Cell Lines of Common Origin (NC 65). Anne Hagemeijer. 4396 Cellular Accumulation and Disposition of Aclaclno- 4516 Comparison of RNA Metabolism in Gi-arrested and Willibald Hoehn. and Elizabeth M E Smit mycln A. Merrill J. Egorin. Ronald E. Clawson. Louis A. Stimulated Nontransformed and Chemically Trans 4668 Enhancing Effect of Phorbol Esters on Induction of Ross, Norman M. Schlossberger. and Nicholas R. formed Mouse Embryo Cells in Culture. Harold L Differentiation of Mouse Myeloid Leukemia Cells by Bachur, Moses, David J Wells, Douglas E Swartzendruber. and Human Urinary Protein and Lipopolysaccharide. 4401 Metabolism of Benzo(a)pyrene. N-Nitrosodimethyla Michael J. Getz. Michie Nakayasu. Mihoko Shoji. Naoko Aoki. Shigeaki Sato, Masanao Miwa, and Takashi Sugimura mine, and N-Nitrosopyrrolidine and Identification of 4525 Transformation of Hamster Fetal Cells by Nitrosated the Major Carcinogen-DNA Adducts Formed In Cul Pesticides in a Transplacental Assay. John M 4673 Inhibitory Effects of 9-/(-D-Arabinofuranosylguanine tured Human Esophagus. Curtis C. Harris. Herman Quarles. Marsha W Sega, Cynthia K. Schenley, and 5'-Thphosphate and 9-/i-D-Arabinoturanosylademne Autrup. Gary D. Stoner, Benjamin F. Trump. Elizabeth William Lijmsky. 5'-Triphosphate on DNA Polymerases from Murine Hillman. Paul W. Schafer, and Alan M. Jeffrey. Cells and Oncornavirus. Katsuhiko Ono. Atsuko 4534 Effects of Local Tumor Hyperthermla on the Growth Ohashi. Akiyo Yamamoto. Akio Matsukage. Taijo 4407 In Vivo Cell Cycle Synchronization of the Murine of Solid Mouse Tumors. Richard L. MagÃnand Randall Takahashi. Mineo Saneyoshi, and Tohru Ueda Sarcoma 180 Tumor following Alternating Periods of K.Johnson Hydroxyurea Blockade and Release. Katsuro Tornita 4681 Disturbance of Phospholipid Metabolism during the *4540 Toxicity and Pharmacokinetics of a Pyrrolizidine Al and John E. Plager. Selective Destruction of Tumor Cells Induced by Al- kaloid, Indicine N-Oxide. in Humans. John S Kovach, kyl-lysophospholipids. Manuel Modolell, Reinhard 4412 Mutagenic Activity of Rhodamine Dyes and Their Matthew M Ames, Garth Powis. Charles G Moertel, Andreesen. Wulf Pahlke. Uwe Brugger. and Paul G Impurities as Detected by Mutation Induction In Sal Richard G. Hahn, and Edward T Creagan Munder monella and DNA Damage in Chinese Hamster Ovary 4545 Induction of Osteogenic Sarcomas and Tumors of the Cells. Earle R. Nestmann. George R. Douglas, Tibor I. 4687 Inhibition of Ligand-independent Cap Formation of Hepatobiliary System in Nonhuman Primates with Matula, Caroline E. Grant, and David J. Kowbel. Mouse Lymphocytes and Raji Cells by Neocarzino- Aflatoxin B,. Susan M. Sieber. Pelayo Correa. Dan W statin. Ichiro Yahara, Shmtaro Iwashita. Takusaburo 4418 The T Lymphocyte as a Diploid Reference Standard Dalgard, and Richard H. Adamson. Ebina. Masanobu Satake. and Nakao Ishida for Flow Cytometry. Stanley E. Shackney. Burdette W. 4555 Oxidative Metabolism of N-lsopropyl-o-{2-methylhy- 4694 Characterization of an Established Cell Line from Erickson, and Karen S. Skramstad. drazino)-p-toluamide Hydrochloride (Procarbazine) Human Renal Carcinoma. Mmoru Matsuda. Masao by Rat Liver Microsomes. Danny L. Dunn, Ronald A *4423 Retlnol-blnding Protein In the Urine of Cancer Pa Osafune. Etsuji Nakano. Toshihiko Kotake. Takao Lubet, and Russell A. Prough. tients. Ben K. Seon and David Pressman. Sonoda, Shinichiro Watanabe. Toshikazu Hada. 4564 Matching of Chemotherapy to Mouse Strain and Toshikazu Okochi. Kazuya Higashmo. Yuichi 4430 Effect of Dietary Polyunsaturated Fatty Acids on Lymphoid Tumor Type to Prevent Tumor-induced Yamamura. and Tatsuo Abe Growth of Mammary Adenocarcinomas in Mice and Suppression of Specific T- and B-Cell Functions. 4700 Inhibition of Preovulatory Gonadotropi Secretion Rats. LewisA. Hillyardand S. Abraham. Ronald B. Faanes, Vincent J Merluzzi. Neil Williams. and Stimulation of Prolactin Secretion by 7,12-Dt- George S Tarnowski. and Peter Ralph methylbenz(a)anthracene in Sprague-Dawley Rats. 4436 Failure of Rotenone to Interfere with 17/i-Estradiol *4575 Growth Characteristics of Pulmonary MÃ©tastases Bernard Kerdelhue and Amor El Abed Action in the Rat Uterus. Mary Ellen Olson and Daniel from Human Sarcomas. Stojan Plesnicar. Gojko M. Sheehan. 4706 Association of Macrophage Activation with Antitumor Klanjscek. Sonia Modic. and Mano Rustia Effect on Rat Syngeneic Fibrosarcoma by Nocardia 4441 Growth Characteristics and Enzyme Activities in a 4579 Metabolism of Three Radiolabeled Pancreatic Carci rubra Cell Wall Skeleton. Takeshi Ogura. Namabu Survey of Transformation Markers In Adult Rat Liver nogenic Nitrosamines in Hamsters and Rats. Ralph Namba, Fumio Hirao. Yuichi Yamamura, and Ichiro Epithelial like Cell Cultures. Richard H. C. San, Gingell. Galen Brunk, Donald Nagel, and Parvis Pour Azuma. Tomiko Shimada. Carol J. Maslansky, Dawn M. Kreiser, Michael F. Laspia. Jerry M. Rice, and Gary M. Williams 4584 Catecholestrogen Synthesis and Metabolism by Hu 4713 Development of Androgen-independent Spindle Cell man Breast Tumors in Vitro. Andrew R. Hoffman, Tumors from Androgen-dependent Medullary Shion- 4449 Comparison of Four New Cell Lines from Patients Steven M. Paul, and Julius Axelrod ogi Carcinoma 115 in Androgen-depleted Nude Mice. with Adenocarclnoma of the Ovary- Linda K. Woods. Yukihiko Kitamura, Shigeru Okamoto. Isamu Hayata. Robert T. Morgan. Laurie A Quinn, George E Moore, 4588 Association between Immunoglobulin and Macro Naomi Uchida. Kenji Yamaguchi. and Keishi phages in Primary Methylcholanthrene-induced Sar Toni U. Semple. and Kim E. Stedman. Matsumoto comas. Gary W Wood. Seth A. Tilzer, Katherine A 4460 Release of Repetitive Nuclear RNA into the Cyto Gollahon, and John M Lindsay 4720 Enhancement of Interferon Antitumor Action by So plasm in Liver of Rats Fed 3'-Methyl-4-dimethylami- dium Butyrate. M F Bourgeade. I Cerutti. and C. noazobenzene. Ã‘utan T. Pate!. Dean S Folse. and 4594 Enhanced Collagenase Production by Fibroblasts De Chany Viktor Holoubek. rived from Human Basal Cell Carcinomas. Eugene A Bauer, Jouni Uitto. Richard C. Walters, and Arthur Z 4724 Fate of Cultured Cells after Injection Into the Circu 4466 Effects of Combination Drug Therapy on the Subcu Eisen lation of Syngeneic Animals. G H Reid and J R taneous and Pulmonary Growth of a Slow- and a Fast- Gibbms. 46OO Specific Inhibitors Directed at the Individual Compo growing C3H/He Mammary Carcinoma. Jan Vaage 4732 Characterization of Liver-type Alkaline Phosphatase and Mary E Costanza. nents of Ribonucleotide Reductase as an Approach to Combination Chemotherapy. Joseph G. Cory and from Human Gastric Carcinoma Cells (KMK-2) in *4472 Effect of 1-{2-Chk>roethyl}-3-(4-methylcyclohexyl)-1- Alfred E Fleischer Vitro. Shm-ichi Tokumitsu. Kumi Tokumitsu. nitrosourea Adjuvant Therapy on the Immune Re Kazuhiro Kohnoe. and Tadao Takeuchi. sponse of Patients with Malignant Melanoma. David 4605 Aryl Hydrocarbon Hydroxylase in a Stable Human 8 Lymphocyte Cell Line, RPMI-1788, Cultured in the 4739 Junctional Intercellular Communication Pattern of Berd. Eileen J Wilson. Robert E Bellet, and Michael J Cultured Human Breast Cancer Cells. I S Fentiman. Mastrangelo. Absence of Mitogens. H. J Freedman. H. L. Gurtoo, J Mmowada, B Paigen. and J B Vaught J Hurst. R L Cenani, and J Taylor-Papadimitnou 4477 Ornithine Decarboxylase Activity and DNA Synthesis 4744 Relationship between Rous Sarcoma Virus-Induced after Treatment of Cells in Culture with 12-O-Tetra- 4612 Induction, Inhibition, and Biological Properties of Aryl decanoylphorbol-13-acetate. Thomas G. O'Brien. Hydrocarbon Hydroxylase in a Stable Human B-Lym- Expression of Membrane Antigen and Phenotypic phocyte Cell Line. RPMI-1788. Harvey J. Freedman. Transformation. Paolo M Comoglio, Bianca Pani. Monica A. Lewis, and Leila Diamond. Natalie B. Parker, Anthony J. Mannello. Hira L Gurtoo, Mana Prat, Guido Tarone, and Carlo Monti-Bragadin 4481 Tumorigenicity and Intracisternal A-Particle Expres and Jun Minowada. sion of Hybrids between Murine Myeloma and Lym phocytes. DarÃoGiacomoâ„¢ 4620 Induction, Inhibition, and Some Enzymological Prop Communications erties of Aryl Hydrocarbon Hydroxylase in Fresh Mi- 4485 Pyrazofurin Metabolism, Enzyme Inhibition, and Re togen-activated Human Lymphocytes. Hira L Gurloo. 4749 Correlation between Glucocorticoid Receptor and Cy- sistance in L5178Y Cells. D E. Dix. C. P. Lehman. A. Natalie B. Parker, Beverly Paigen. Mary B Havens. Jun tolytic Response of Murine Lymphoid Cell Lines. Jakubowski. J D Moyer. and R E Handschumacher Minowada. and Harvey J Freedman Suzanne Bourgeois and Ronald F Newby

44gi Induction of Hepatic Neoplastic Lesions in Mice with 4630 Thermosensitization by Sulfhydryl Compounds of Ex 4752 Increased Production of Mutagenic Metabolites of a Single Dose of Hycanthone Methanesulfonate after ponentially Growing Chinese Hamster Cells. D S Carcinogens by Tissues from Senescent Rodents. Partial Hepatectomy. Hiroyuki Tsuda, D S. R Sarma, Kapp and G. M Hahn Malcolm B Baird and Linda S Birnbaum S Rajalakshmi. J Zubroff. Emmanuel Farber. Robert P. Batzmger. Young-Nam Cha. and Ernest Bueding 4636 Effects of Transplacental Exposure to Diethylstilbes- 4756 Enhancement of Endotoxic Shock by N-Acetylmura-

DECEMBER 1979 xvii Contents of Volume 39, 1979

myl-i.-alanyl-(L'aeryl)-o-lsoglutamine (Muramyl Dipep' Correspondence re: Men A. Smith. Gregory D. Bar 4762 Announcements tide). Edgar E. Ribi, John L. Cantrell, Kenneth B. Von gee, Paul G. Seybold. and M. P. Serve. RelatiOnships Eschen. and Steven N Schwartzman. between Carcinogenicity and Theoretical Reactivity 4763 Erratum Indices in PolycyclicAromatic HydrocarbOns.Cancer 4760 Letter to the Editor Res., 38: 2568-2977, 1978. Martin R. Osborne. 4764 Author Index

December, Number 12

4767 Heterogeneity in Growth inhibition by $-trana-Reti 4875 Mutageniclty and Cytotoxicity of Nineteen Hetero of Diethylnitrosamine. Anthony E. Pegg and Balint nolc Acid of Metastatic B16 Melanoma Clones and In cyclic Mustards (ICR Compounds) In Cultured Main Being. Vise-selected Cell Variant Lines. Reuben Lotan and malian Cells. James C. Fuacoe. J. Patrick O'Neill, 5010 PutreacIne as a Biochemical Marker of Malignant Garth L. Nicolson RichardN. Peck, and AbrahamW. Hsie. Brain Tumors. Sami I. Hank and Carl H. Sutton. 4772 Cellular Cytotoxidlty and Serum Inhibition in Normal 4882 Effect of Catechol Estrogens on Rat Mammary Tu * 5016 DisposItion and Metabolism of Pentamethylmslamlne Mice following Transfer of XenogeneIc Tumor-actual more. Yuauf J. Abul-Hajj. and HexamethylmelamIne in Rabbits and Humane. tized Cells. Bernard Fisher, Norman Woimark, and Matthew N. Ames, Garth Powis, John S. Kovach. and 4887 In Vltro5tudlesofCeli-mediatedimmunltytoMoloney Elizabeth A. Setter. Robert T. Eagan Murine Leukemia VIrus and Moloney Leukemia-as. 4777 Pharmacokinetic Studies during Phase I Trials of sodlated Surface Antigens. Ah-Kau Hg, RObert S. 5022 Effect of Dietary CholesterOl on Ultraviolet Light Car High-Doae Thymidine infusions. Daniel S. Zaharko, Ames, Jr., RObert K. Mclntire, and Ronald B. cInogenesis. Homer S. Black. Susan V. Henderson. Bruce J. Bollen, Delia Chiulen. and Peter H. Wiemik. Herberman. Charles N. Klelnhans. A. Warner Phelps, and John I. Thornby. 4782 Variable Expression of Membrane Proteins among 4894 Hiatamlnase and Other Tumor Markers In Malignant Merle Lymphoblastoid Tumors as Seen with Sodium Effusion FluMe. @hi-WeILin, Norma R. Inglis.AltynH. 5028 Effects of Hormones on Growth and a.Lactaibumin Dodecyl Sulfate-PolyacryiamIde Gradient Gel Electro Rule, R. Nursn Turksoy, CliffordN. Chapman, Sandra Activity In the Transplantable Rat Mammary Tumor phoresis of(@SJMethiOnine-labeled Cell Membranes. D. Kirley. and Leo 1. Stolbach. MCCLX. Toby N. Horn and Tamiko Kano-Sueoks. DavidJ. Malenka, KevinN. Rogan. RawleighC. Howe. Richard S. Nelson, Charles J. Wrobel, Aftab Ahmed, *4@fl@ Lactate Metabolism In Patients with Metastatic Go *5036 Serum Sialic Acid and Slalyltrsnsferaae as Monitors of Tumor Burden in Malignant Melanoma Patients. and Robert E. Humphreys. lorectal Cancer. Christopher P. Hoiroyde. Rita S. Axelrod, Charles L. Skutches, Agnes C. Haff, Pavie Huibert K. B. Silver, Karim A. Karim, Elizabeth L 4791 Effects of 12-O.Tetradecanoylphorbol-13-acetate Paul, and George A. Reichard. Archibald,and FernandoA. Salinas. and Mezerein on Epidermal Ornithine Decarboxylaae 5043 Antisatrogen Modulation of the Growth and Proper 4905 Effect of 5.Fluorouracil on RNA Metabolism In Novi Activity. laoproterenol-stimuiated Levels of Cyclic ties of Ovarian-Autonomous and Ovarian-Dependent koff Hepatoma Cells. Joseph 0. Gory. Jeanne Crumley Adenosine 3':5'-Monophosphate. and Induction of Mammary Tumors in Rats. Ten-Lin Sic Tsai, Susan Mouse Skin Tumors In Vise. R. Allan Mufson. Susan Breland, and Gay L. Carter. Rutledge. and Benita S. Kalzenellenbogen. N. Fischer, A K Verma, Greta L. Gleason, ThomasJ. Slaga, and R. K. Boutwell. 4914 Cell Unes from Human Colon Carcinoma with Unit 5051 Development of an Agar-Methyl CelluloseClonogenic sual Cell Products, Double MInutes, and Homogene. Assay for Cells in Transitional Cod Carcinoma of the 4796 Detection of Breast Tumor Antigeru-aenaitiveCircu' ouaiy StainIng Regions. Laurie A. Quinn, George E. Human Bladder. R. N. Buick, T. H. Stanisic. 5. E. Fry, lating T-Lymphocytes by Antigen-etimuiated Active Moore, RObert T. Morgan. and Linda K. Woods. S. E. Salmon,J. N. Trent, and P Krasovich. Rosette Formation. William G. Ramey. George A. Hashim, Warren B. Burrows. Alexander J. Swistel, 4925 Biochemical Basis for Cytotoxicity of 712-Dimethyl 5057 Assay for Microsomal a-Hydroxylation of N'-Nitroeo. Antoine Munther, and Hugh F. Fitzpatrick benz(a)enthracene In Rat Liver Eplthelial Cells. P. 1. nornicotine and Determination of the Deutsrium Iso lype. J. E. Tomsszewski.and A. Dipple. tops Effect for a-Hydroxylation. Chi-hong B. Chen. 4802 Inhibition of DNA Synthesis in Cultured Lymphocytes Ping T. Fung. and Stephen S. Hecht. 4930 Retinol Inhibition of Omithlne Decarboxylaee Induc and Tumor Cells by Extracts of Betel Nut, Tobacco, 5063 Tumorlgenicity of Bay-Region Epoxides and Other and Miang Leaf, Plant Substances Associated with ton and G, Progreaslon In ChInese Hamster Ovary Celia. Man K. Haddox. Karen F. Frasier Scott, and Derivatives of Chrysene and Phenanthrene in New Cancer of the Ororespiratory Epitheilum. Jean A. born Mice. Mildred K. Buening, Wayne Levin. Jean N. Diane Haddock Russell. Yang, Sally A. Huber, and Zoltan J. Lucas Karle, Haruhiko Yagi, Donald M. Jerina. and Allan H. 4810 Detection of Both T-CeII and ia-like Antigens on Cells 4939 CharacterIzatiOn of CytOsOIICand Nuclear Giucocor Conney. from Patients with Acute MySIOmOnOCytICLeukemia ticoid.bindIng Components In Human Leukemia Lym 5069 MathematiCal Models and the Statistical Analyses of and Chronic Myelogenous Leukemia in Blast Crisis. pliocytes. John Stevens, Yea-Wan Stevens, and RObert Call Transformation Experiments. John J. Gaff. Joy K. Anderson, Joseph 0. Moore. and Richard S. L. Rosenthal. JosephA. DiPaolo.and Paul J. Donovan. Metzgar. 4949 Rejection of Adenovirus 2-transformed Cell Tumors *5078 Role of Single-Breath Carbon Monoxide-dIffusIng Ca 4818 Comparative Biological and Biochemical Effects of and Immune Responsiveness In Syrian Hamsters. pacity In MOnItOrIng the Pulmonary Effects of Mao. Nogalamycin and its Analogs on L1210 Leukemia. Li James L. Cook, Charles H. Kirkpatrick, Alan S. Rabson, mycIn In Germ Call Tumor Patients. Robert L. ComEs, H. Li, Sandra L. Kuentzel, Lana L. Murch, Loraine N. and AndrewN. Lewis. Jr. Mitchell S. Kuppinger. Sandra J. Ginsberg. Stanley T. Pschigoda, and William C. Krueger Crooke. Robert Gilbert, J. Howland Auchincloss. and 4956 PromotIon of Azoxymethanenduced Intestinal Can ArchieW. Prestayka. 4823 Quantitative Assessment of Generalized Epitheiial car by High-Fat Diet In Rats. ArthurW. Bull, Barbara Changes in Tracheal Mucosa following Exposure K. Souil,er,Paulette S. Wilson,Molly Tan Hayden. and 5061 Substrate Specificity of Human Ribonucleotide Re to 7,i2-Dimethylbenz(a)anthracene. Douglas C. Norman0. Nigro. ductase from Molt-U Cells. Chi-Hsiung Chang and Topping,RichardA. Griesemer,and Paul Neftesheim. Yung-chi Cheng. 4960 AdaptatIOn of Sinclair Swine Melanoma Celisto Long 4829 Development and Fate of Focal Epithelial Lesions in 5087 Effects of Nucleoside Triphosphates on Human Ri. Term Growth in Vitro. Jane Berkeihammer. Sharon N. Tracheal Mucoes following Exposure to 7.12@Dimeth bonucleotide Reductase from Moft-4F Cells. Caines, DanielL. Dexter, Edward H. Adetstein,Ronald ylbenz(a)anthracene. Douglas C. Topping, Richard A. Chi-HsEungChang and Yung-chi Cheng. Griesemer.and Paul Nefteaheim. W. Osenhandier,and Reuel R. Hook. Jr. 5093 HIstological and Biochemical Studlesof a Transplant 4g.5 Effect of Age at Treatment on Incidence and Type of 4838 Comparative Antitumor Effects of Corynbacte able Rat Otondrosarcoma. Dint Breitkreutz. Lino Dies Renal NeopIaam Induced In the Rat by a Single Dose rium parvum, Bordt.iIa parfuaaia. Bacillus tie Leon, Larry Paglia. Sleffen Gay. Richard L. Swarm. of DInuathylnltrOSamIn..GordonC. Hard. Calmctfe-Gu@rIn, and Levamlsole Alone or in Combi and Robert Stern. nation with Cyciophosphamide in the CaD, Murine Mammary Adenocarcinoma System. Dallas N. Purnell, 4971 Effect of Hypoxia on â€˜GaIncorporation Into Human *5101 Diet and Urinary Steroids in Black and White North Gerald 1. Bartlett, John W. Kreider, TimothyG. Biro, Granulocytes. F. Ostroy, R B. Johnston. and R A American Men and Black South African Men. P. Hill, and Joseph Kontra. Gams. E. L. Wynder. L. Garbaczewski, H. Games. and A. R. P. Walker. 4843 Renal Tubular Transport of Methotrexate in the Rite 4975 Effects of Caffeine on Purina Metabolism and Ultra sue Monkey and Dog. Kee C Huang, Barbara A. violet Ught'lnduced Lethality in Cultured Mammalian 5106 Sequence Homology of Nucleic Acids from Human Wenczak, and Yang K. Liu. Cells. Charles A. Waldren and David Patterson. Breast Cancer Cells and Complementary DNA's from buries Mammary Tumor Virus and Maeon.Pfizer Mon. 4849 Chronic Cardiotoxicity Studies In Rabbits with 7-con 4983 SuppressIon of Proliferative Response and Lympho O-Methylnogarol, a New Anthracydllne Antitumor key Virus. Mukkaftu Ramachandra Des and Michael N. kine Production during the Progression of a Sponta Mink. Agent. J. Patrick McGovren. Gary L. Neil. Robert H. neous Tumor. L. Varesio, N. Giovarelli. S. Landolfo, Denlinger. Thomas L. Hall, Shari L. Crampion. and and 3. Forni. 51 14 Effect of a Bacteriocin Produced by Mycobact.rium James A. Swenberg. amâ€¢gmatiaon Growth of Cultured Tumor and Normal 4989 Effect of Thiourea on Survival and DNA Cross-Link Cells. Hajime Saiio and Takashi Walanabe. 4856 Effect of Thynuidine on the Survival of Mice with EL4 Formation in Cells Treated with Platinum(lI) Coin Tumors. Harvard Reiler. plexea, L.Pltenylaianine Mustard, and Bla(2-chloro 51 18 Evaluation of Impaired TriglycerIde Fatty Acid Trans. ethyl)methyl.mine. Leonard A Zwelling. Jan Filipski, port and Oxidation for the Detection of Cancer In 4861 Relationship between Inhibition of Polyamine Biosyn and Kurt W. Kahn. Mice. Murad Ookhtens and Home Baker. thesis and DNA Replication in Activated Lympho cytes. Christine E. Seytried and David R. Morris. 4996 Kidney Tumors Induced in Rats by the Antiechisto 5124 A Correlation between Estrogen Sulfotransferase somsi Drug Niridazole. Orhan Bulay, Kashinath PaId, Levels and Estrogen Receptor Status in Human PrI 4868 InhibitIon of Synthesis of Pyrimidine Nucleotides by RichardWilson.and PhilippeShubik. 2-Hydroxy'3'(3.3-dichloroallyl)-i ,4-naphthoquinone. mary Breast Carcinoma. John B. Adams, Thanil 1. Lee Bennett. Jr , Donald Smdtuers,Lucy M. Rose. 5003 Formation and Subsequent Excision of 0 -Ethylgua Pewnim, David P. Chandra, Lesley Archibald. and Ming Doris J. Adamson, and H. Jeanetle Thomas. nine from DNA of Rat Liver following Administration San Foo

xviii CANCER RESEARCH VOL. 39 Contents of Volume 39, 1979

5127 Oiaradsrlzation of Factors Stimulating Differentia N'-nltro-N-nitrosoguanidine. OichiroKobari. FranÃ§ois Lesions in Epitheliold Human Lung Cells. Tzu-chien lieu of MouseMyeloid Leukemia Cells from a YOshida Martin. MoniqueMartin. and Claude Turc V Wang and Peter A Cerulti Sarcoma Cell Une Cultured in Serum-free Medium. 5171 Reactivity of Anti-Daudi Serum with Acute and Moloo Hozumi, Takehiko Umezawa. Keizo Takenaga. 5147 Mutagenicity of N-Methyl-N'-aryl-N-nitroaoureas and Chronic Leukemias. Slephane Carrel, Nicole Gross. Tadao Ohno, Mikio Shikita. and lsao Yamane. N-Methyl-N'.aryl-N'-methyl-N-nitrosoureas in Pals lion to Their Alkytating Activity. Kazuyuki Yano and and Jean-Pierre Mach. 5132 Alteration In BindIngof Dexamethasone to Glucocor Masayoshi Isobe 5177 Letter to the Editor: Lack of Proportionality between ticoM Receptors In Regenerating Rat User after Par. Rate of Cell Division and Induction of Tumors in tial Hepatectomy. Fumihide isohashi. Kazue 5150 Control of Permeation of Bleomycin A, by Polyene Carcinogen-exposed Regenerating Livers. Frederick Taukanaka. Masako Terada. Yako Nakanishi, Hisao Antibiotics in Cultured Chinese Hamster Cells. F Becker Fukushlina, and Yukiya Sakamola Shin-ichi Akiyama. Kalsuhiko Hidaka. Sahiaro Komiyama, and Nichihiko Kuwano 5179 Announcements 513S Correlation of DNA Methylation by Methyl(acetoxy 5180 Acknowledgment to Reviewers methyl)nitrosamine with Organ-specific Carcino 5155 BindIng Characteristics of a Major Protein in Rat genicity In Rats. Paul Kleihuea. Gerhard Doerier, Larry Ventral Prostate CytOaOIThat interacts with Estrs. 5187 Author Index to Volume 39 K. Keefer, Jerry N. Rice, Peter P. RaIler, and Ruth M. mustine, a Nitrogen Mustard Derivative of 17/l-Estrs. 5217 Suplect Index to Volume 39 Ho@. diol. Biorn Forsgren, Jan-Ake Gustafasan, Ake Pousette, and Bertil Hogberg iii Contents of Volume 39 5141 EstablIshment of a Cell Culture Une from a Trans. @abI.Rat Stomach Cancer induced by N-Methyl 5185 Formation and Removal of Aflatoxin B-induced DNA vi Cover illustrations for Volume 39

Cover Illustrations for 1979

January: Members of Chinese Academy of Medical Sciences. ternational Symposium on â€˜â€˜Topicsin Chemical Carci New screening techniques, new methods of teaching nogenesis' â€˜and the first six symposia issues. prevention, and key features from the group's publica August: Henry S. Kaplan, Sir RichardDoll, and George Klein, tion, Acta Zoologica Sinica. who received the newly established General Motors February: Mathematicalstatisticians,JeromeCornfield,Sam award for individual excellence in cancer research. uel W. Greenhouse, Jacob Lieberman, Nathan Mantel, September: H. J. Tagnon, of European Organization for Re and Marvin Schneiderman. search on Treatment of Cancer and editor of European March: Georges Barski, Yoshio Okada, and Henry Harris and Journal of Cancer, and a map identifying participating a hybrid cell nucleus. members of the EORTC. April: Stanley N. Cohen and Herbert W. Boyer and chart October: Michael A. Epstein and Yvonne Barr; lymphoblasts showingmolecularcloningprocedure. from an Epstein-Barr virus cell line; section of cell nu cleus producing EB virus; mature EB virus particle. May: AmericanType Culture Collection'sfacility in Rockville, November: Elizabeth C. and James A. Miller; Gertrude and Md., and a photo of a cloned epithelial cell line from rat Werner Henle; as well as Mary Lasker and Benno C. pancreas. Schmidt who received the Bristol-Myers award for dis June: Jesse E. Edwards and Allen B. Eschenbrenner. The tinguished achievement in cancer research. histopathology of CCL hepatoma and a schematic rep December: Frontcover,GordonResearchConference,group resentationof dose-scheduleare shown. photograph of participants in 1954. Back cover, Flow July: PrIncessTakamatsu and participantsin the Second In diagram entitled â€˜â€˜Topicsof Cancer.â€•

DECEMBER 1979 xix AUTHOR INDEX

December 1979

Abul-Hajj, Y. J., 4882 Fry, S. E., 5051 Krueger, W. C., 4816 Rose, L. M., 4868 Adams, J. B., 5124 Fukushima, H., 5132 Kuentzel, S. L., 4816 Rosenthal, R. L., 4939 Adamson, D. J., 4868 Fung, P. T., 5057 Kuppinger, M. S., 5076 Rule, A. H., 4894 Adelstein, E. H., 4960 Fuscoe, J. C., 4875 Kuwano, M., 5150 Russell, D. H., 4930 Ahmed, A., 4782 Rutledge, S., 5043 Akiyama, S-i., 5150 Gams, R. A., 4971 Landolfo, S., 4983 Levin, W., 5063 Saffer, E. A., 4772 Ames, M. M., 5016 Garbaczewski, L., 5101 Lewis, A. M., Jr., 4949 Saito, H., 5114 Ames, R. S., Jr., 4887 Games, H., 5101 Li, L. H., 4816 Sakamoto, Y., 5132 Anderson, J. K., 4810 Gart, J. J., 5069 Lin, C-W., 4894 Salinas, F. A., 5036 Archibald, E. L., 5036 Gay, S., 5093 Liu, Y. K., 4843 Salmon, S. E., 5051 Archibald, L., 5124 Gilbert, R., 5076 Lotan, R., 4767 Scott, K. F. F., 4930 Auchincloss, J. H., 5076 Ginsberg, S. J., 5076 Giovarelli, M., 4983 Lucas, Z. J., 4802 Seyfried, C. E., 4861 Axelrod, R. S., 4900 Shikita, M., 5127 Gleason, G. L., 4791 Mach, J-P., 5171 Baker, N., 5118 Griesemer, R. A., 4823, 4829 Shubik, P., 4996 Malenka, D. J., 4782 Balog, B., 5003 Gross, N., 5171 Silver, H. K. B., 5036 Martin, F., 5141 BarileÂ«, G. L., 4838 Gustafsson, J-Ã‚., 5155 Skutches, C. L., 4900 Martin, M., 5141 Becker, F. F., 5177 Slaga, T. J., 4791 McGovren, J. P., 4849 Bennett, L. L., Jr., 4868 Haddox, M. K., 4930 Smithers, D., 4868 Mclntire, R. K., 4887 Berkelhammer, J., 4960 Haff, A. C., 4900 Soullier, B. K., 4956 Metzgar, R. S., 4810 Biro, T. G., 4838 Hall, T. L., 4849 Stanisic, T. H., 5051 Mink, M. M., 5106 Black, H. S., 5022 Hard, G. C., 4965 Stern, R., 5093 Moore, G. E., 4914 Bollen, B. J., 4777 Harik, S. I., 5010 Stevens, J., 4939 Moore, J. O., 4810 Boutwell, R. K., 4791 Hashim, G. A., 4796 Stevens, Y-W.. 4939 Morgan, R. T., 4914 Breitkreutz, D., 5093 Hayden, M. T., 4956 Stolbach, L. L., 4894 Morris, D. R., 4861 Breland, J. C., 4905 Hecht, S. S., 5057 Sutton, C. H., 5010 Mufson, R. A., 4791 Buening, M. K., 5063 Henderson, S. V., 5022 Swarm, R. L., 5093 Munther, A., 4796 Buick, R. N., 5051 Herberman, R. B., 4887 Swenberg, J. A., 4849 Murch, L. L., 4816 Bulay, O., 4996 Hidaka, K., 5150 Swistel, A. J., 4796 Bull, A. W., 4956 Hill, P., 5101 Nakanishi, Y., 5132 Takenaga, K., 5127 Burrows, W. B., 4796 Hodgson, R. M., 5136 Neil, G. L., 4849 Terada, M., 5132 HÃ¶gberg, B., 5155 Nelson, R. S., 4782 Gaines, S. M., 4960 Holroyde, C. P., 4900 Thomas, H. J., 4868 Carrel, S., 5171 Nettesheim, P., 4823, 4829 Hook, R. R., Jr., 4960 Ng, A-K., 4887 Thornby, J. l., 5022 Carter, G. L., 4905 Tomaszewski, J. E., 4925 Horn, T. M., 5028 Nicolson, G. L., 4767 Cerutti, P. A., 5165 Topping, D. C., 4823, 4829 Howe, R. C., 4782 Nigro, N. D., 4956 Chandra, D. P., 5124 Hozumi, M., 5127 Trent, J. M., 5051 Chang, C-H., 5081, 5087 Hsie, A. W., 4875 Ohno, T., 5127 Tsai, T-L. S., 5043 O'Neill, J. P., 4875 Chapman, C. M., 4894 Huang, K. C., 4843 Tsukanaka, K., 5132 Chen, C-h. B., 5057 Huber, S. A., 4802 Ookhtens, M., 5118 Turc, C., 5141 Cheng, Y-c., 5081, 5087 Humphreys, R. E., 4782 Ostroy, F., 4971 Turksoy, R. N., 4894 Chiuten, D., 4777 Oxenhandler, R. W., 4960 Comis, R. L., 5076 Inglis, N. R., 4894 Umezawa, T., 5127 Conney, A. H., 5063 Isobe, M., 5147 Paglia, L., 5093 Varesio, L., 4983 Cook, J. L., 4949 Isohashi, F., 5132 Patii, K., 4996 Verma, A. K., 4791 Cory, J. G., 4905 lype, P. T., 4925 Patterson, D., 4975 Crampton, S. L., 4849 Paul, P., 4900 Waldren, C. A., 4975 Jerina, D. M., 5063 Crooke, S. T., 5076 Peck, R. M., 4875 Walker, A. R. P., 5101 Johnston, R. B., 4971 Pegg, A. E., 5003 Wang, T-c. V., 5165 Das, M. R., 5106 Pewnim, T., 5124 Watanabe, T., 5114 de Leon, L. D., 5093 Kano-Sueoka, T., 5028 Wenczak, B. A., 4843 Denlinger, R. H., 4849 Karim, K. A., 5036 Phelps, A. W., 5022 Wiernik, P. H., 4777 Dexter, D. L., 4960 Karle, J. M., 5063 Pousette, A., 5155 Powis, G., 5016 Wilson, P. S., 4956 DiPaolo, J. A., 5069 Katzenellenbogen, B. S., 5043 Prestayko, A. W., 5076 Wilson, R., 4996 Dipple, A., 4925 Keefer, L. K., 5136 Pschigoda, L. M., 4816 Wolmark, N., 4772 Doerjer, G., 5136 Kirkpatrick, C. H., 4949 Purnell, D. M., 4838 Woods, L. K., 4914 Donovan, P. J., 5069 Kirley, S. D., 4894 Wrobel, C. J., 4782 Kleihues, P., 5136 Eagan, R. T., 5016 Quinn, L. A., 4914 Wynder, E. L., 5101 Kleinhans, C. M., 5022 Filipski, J., 4989 Kobori, O., 5141 Rabson, A. S., 4949 Yagi, H., 5063 Fischer, S. M., 4791 Kohn, K. W., 4989 Ramey, W. G., 4796 Yamane, l., 5127 Fisher, B., 4772 Komiyama, S., 5150 Reichard, G. A., 4900 Yang, J. A.. 4802 Fitzpatrick, H. F., 4796 Kontra, J., 4838 Reiter, H., 4856 Yano, K., 5147 Foo, M. S., 5124 Kovach, J. S., 5016 Rice, J. M., 5136 Forni, G., 4983 Krasovich, P., 5051 Rogan, K. M., 4782 Zaharko, D. S., 4777 Forsgren, B., 5155 Kreider, J. W., 4838 Roller, P. P., 5136 Zwelling, L. A., 4989 ...,@...